Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,vascular transport (GO:0010232),-0.519458552680706,-2.0923022560184346,0.0,0.06495881407428253,0.058,27/81,10.11%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;INSR;ABCC4;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC2A13;SLC1A1;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,positive regulation of nuclear division (GO:0051785),-0.6685662479013181,-2.0797580457463485,0.0,0.04059925879642658,0.072,11/25,17.58%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;EDN1;SIRT2;EDN3;EGF
prerank,amino acid import across plasma membrane (GO:0089718),-0.682054417903697,-2.078149059612123,0.0,0.027742826844224827,0.073,9/24,5.61%,SLC1A3;SLC6A13;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLC6A6;SLC1A1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.6105353262667119,-2.070973983047704,0.0,0.023852064542900616,0.083,15/36,9.23%,PTPRM;DCN;SP100;NR2F2;ADAMTS9;ACVRL1;NOTCH1;FGF2;DAB2IP;THBS1;RGCC;SLIT2;TGFB1;MECP2;PPARG
prerank,transport across blood-brain barrier (GO:0150104),-0.5151216945764525,-2.0706304488325022,0.0,0.019081651634320494,0.083,27/83,10.11%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;INSR;ABCC4;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC2A13;SLC1A1;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.8511194716837168,-2.0622294739808273,0.0,0.018607993615028847,0.097,6/10,4.50%,RAPGEF2;LYN;CXCL12;GAS6;AXL;LGALS9
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.6113703236692926,-1.9999229573547659,0.0,0.044224192617536094,0.242,11/33,7.20%,PTPRM;PTPRG;DCN;MCC;SP100;NR2F2;ADAMTS9;ACVRL1;DAB2IP;THBS1;SLIT2
prerank,aorta development (GO:0035904),-0.7415862229658687,-1.9931250266114708,0.0,0.04288296710372558,0.262,9/14,13.45%,PDGFRB;JAG1;ADAMTS9;ROBO1;PKD2;ROBO2;TBX2;PDE2A;TBX1
prerank,vitamin D metabolic process (GO:0042359),0.9205645933550535,1.9875880860561386,0.0,0.5826073974132832,0.354,1/13,0.03%,CUBN
prerank,cell-substrate junction assembly (GO:0007044),0.7786356569156112,1.9845459739219549,0.0013869625520110957,0.3062168573435003,0.366,5/33,1.11%,FN1;ITGB4;SORBS1;ACTN2;LAMC2
prerank,tetrapyrrole metabolic process (GO:0033013),0.8253576602148353,1.9188598554091045,0.001466275659824047,0.7907288112787789,0.766,2/18,2.69%,CUBN;AMN
prerank,cobalamin metabolic process (GO:0009235),0.8400744639137547,1.9177047441805675,0.0014970059880239522,0.6067170038762048,0.771,2/17,2.69%,CUBN;AMN
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7767353660546493,-1.9162135096259816,0.0,0.10691138149725667,0.578,5/11,4.58%,MECOM;ETV6;WNT5A;CD34;RUNX1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7608170057141871,1.9007386923126026,0.0,0.6448449794577736,0.843,4/27,1.72%,AGTR1;GPR4;LPAR1;LPAR4
prerank,regulation of acrosome reaction (GO:0060046),-0.7897560432690112,-1.8983458812130756,0.002457002457002457,0.12149328194830654,0.666,2/10,7.24%,PLCB1;GLRA1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6555490567969744,1.893836492134718,0.0,0.6043143283180442,0.872,7/76,1.72%,ADRA1B;AGTR1;GPR4;LPAR1;CHRM1;ACTN2;LPAR4
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.8914298395339821,1.8905508646163316,0.0,0.5480940874251242,0.884,3/10,1.66%,DPP4;CCL5;PODXL
prerank,steroid metabolic process (GO:0008202),0.6573340177279874,1.890041956205547,0.0,0.4838077214440936,0.885,12/72,8.75%,CUBN;SULT1A1;FDFT1;STARD3;SULT2B1;HSD17B14;DHRS4;NPC1;CYP39A1;CYP51A1;MSMO1;FDX1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.7509306518779684,-1.876697416242167,0.0,0.1445887239409101,0.749,6/12,7.45%,ADAMTS12;DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,aorta morphogenesis (GO:0035909),-0.67766321272185,-1.8628727211319571,0.0,0.1546155105830579,0.789,6/17,3.01%,PDGFRB;JAG1;ENG;ADAMTS9;MYLK;ACVRL1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7704964000023606,-1.8503178001150473,0.0,0.16567620608849462,0.835,7/10,13.69%,GHR;LYN;STAT5B;JAK2;STAT5A;STAT3;STAT6
prerank,heterotypic cell-cell adhesion (GO:0034113),0.7487065208636409,1.8387830628468416,0.00430416068866571,0.9161098116701472,0.977,6/25,2.84%,CXADR;DSG2;PARVA;CD200;NINJ1;ITGB7
prerank,ganglioside biosynthetic process (GO:0001574),-0.6930840023941971,-1.8344942242216389,0.0028653295128939827,0.18117419237905363,0.885,8/15,17.07%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7746849803802347,-1.8243080654112487,0.0,0.19230515583240726,0.907,5/10,7.45%,DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.7312508717918248,1.8233614032280803,0.0056179775280898875,1.0,0.988,6/30,2.55%,GPR4;LPAR1;RTN4R;PRAG1;LPAR4;AKAP13
prerank,endothelial cell differentiation (GO:0045446),-0.719250533783619,-1.8216239983172342,0.002652519893899204,0.18479006386561037,0.911,8/12,17.15%,JAG1;ACVRL1;TIE1;KDR;KDM6B;SCUBE1;BMPR2;SOX18
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.7730973704694356,-1.811277710324078,0.0026595744680851063,0.19618994765449668,0.938,5/10,9.87%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5755322828376996,-1.8111912112892121,0.0,0.1854596696964542,0.938,20/27,29.11%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT;EPHA8;P2RY12;FLT3;CCL19;NOD2;FGFR3;AGAP2;FGR;AMBRA1;IRS1;ATG14
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8644210398695052,1.8094645128837572,0.006482982171799027,1.0,0.993,1/11,0.18%,AGTR1
prerank,cell-matrix adhesion (GO:0007160),0.6152527893781834,1.8083045831732247,0.0011273957158962795,0.9996787339574337,0.995,12/95,2.84%,FN1;ITGB4;SORBS1;ITGA10;MSLN;CD44;ITGB8;LYPD5;ACTN2;ITGBL1;EMP2;ITGB7
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7918149041160802,1.8046297105143634,0.0030911901081916537,0.9606368494235032,0.996,3/17,2.55%,ADRA1B;ADCY9;AKAP13
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7575177004149294,1.8025727133486986,0.0070921985815602835,0.9140345943571875,0.996,2/22,4.82%,CUBN;UBIAD1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5014796347677511,-1.8007742071118025,0.0,0.19567774338330338,0.952,18/43,16.84%,BMP6;IGF1;PRKD1;WNT4;ZHX3;BMPR1B;RUNX2;FBN2;IL6R;ACVR2A;LRP5;CCN4;IL6ST;CCN1;BMPR2;CTNNBIP1;SOX11;SUCO
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.631436749819901,1.7935078476036024,0.0023228803716608595,0.9400592397625249,0.997,21/67,16.82%,FN1;CDH13;UTRN;DOCK5;EMP2;CDK6;LIMS2;S100A10;PTK2B;DMTN;ILK;CDC42;NPNT;DOCK1;RREB1;SFRP1;GSK3B;FLNA;TESK1;CRK;ABL1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8025340234040717,1.7934057398243606,0.0015360983102918587,0.8823618860141447,0.997,3/14,1.37%,ANK2;ACTN2;GAL
prerank,cell-cell junction organization (GO:0045216),0.615778563135983,1.7901522149821798,0.0011574074074074073,0.8598166991337168,0.999,17/79,8.30%,CDH1;CXADR;SDK1;DSG2;CDH13;NECTIN3;TJP2;TJP1;OCLN;PKP4;LIMS2;CTNNA1;CSK;PVR;TGFB2;ANG;PARD6B
prerank,positive regulation of nervous system development (GO:0051962),-0.5152541082266059,-1.7871286115545626,0.005154639175257732,0.21405959200415917,0.963,20/42,20.54%,IL1RAPL1;NRXN1;GRID2;TGM2;EPHB2;CLSTN2;SERPINF1;NLGN1;LRRC4B;DLG5;NLGN3;SYNDIG1;BDNF;MME;SRPX2;SOX11;EPHB3;NUMB;OPRM1;CX3CR1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.5359232482811237,-1.785540731648709,0.0,0.2073462145674643,0.963,12/34,17.58%,IGF1;PDGFRB;TGFA;INSR;ANAPC11;RGCC;IGF2;LRP5;ANAPC7;EDN1;EDN3;EGF
prerank,positive regulation of vasoconstriction (GO:0045907),0.8191001715786302,1.7845459892633453,0.00819672131147541,0.8644108617290368,1.0,2/13,2.65%,ADRA1B;CAV1
prerank,regulation of complement activation (GO:0030449),0.679098358916601,1.7787938673969133,0.007926023778071334,0.8680504864100012,1.0,7/40,6.32%,CD55;CLU;CFHR1;C8A;CFH;CD81;CFP
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6570214486877064,-1.77761208627208,0.0,0.2147608519288247,0.975,8/16,9.62%,IGF1;ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,regulation of vasoconstriction (GO:0019229),0.7150094948558751,1.7773901481929621,0.011544011544011544,0.8369761732293043,1.0,3/27,2.65%,ADRA1B;AGTR1;CAV1
prerank,acidic amino acid transport (GO:0015800),-0.6372412594231908,-1.7770511056117106,0.009202453987730062,0.2064825346831304,0.977,6/17,8.62%,SLC1A3;SLC6A13;SLC1A2;SLC6A6;SLC1A1;SLC6A1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7071535672692085,-1.7764467049198773,0.013054830287206266,0.1991901134699679,0.977,4/11,2.88%,MERTK;CXCL12;GAS6;AXL
prerank,sulfation (GO:0051923),0.8553893703545761,1.7754034680971478,0.004665629860031105,0.8129801908321873,1.0,3/11,3.24%,UST;SULT1A1;SULT2B1
prerank,heart morphogenesis (GO:0003007),-0.47952857715322694,-1.7742898169042653,0.0,0.19629741628072253,0.978,17/50,14.11%,FLRT2;ENG;INSR;NOS3;PTK2;ACVRL1;TBX3;NOTCH1;EPHB4;CHD7;SOX17;HEYL;TBX2;MEGF8;TBX1;NIPBL;RYR2
prerank,positive regulation of synapse assembly (GO:0051965),-0.5573660682168865,-1.7716709571649585,0.011673151750972763,0.19386146075293695,0.98,12/27,13.96%,IL1RAPL1;NRXN1;GRID2;EPHB2;CLSTN2;NLGN1;LRRC4B;DLG5;NLGN3;SYNDIG1;BDNF;SRPX2
prerank,regulation of humoral immune response (GO:0002920),0.6610258108866437,1.7695877894516656,0.010282776349614395,0.8224832945176662,1.0,6/44,3.22%,CD55;CLU;CFHR1;C8A;CFH;CD81
prerank,myofibril assembly (GO:0030239),0.6737711825859924,1.7692499752566986,0.0076726342710997444,0.7904406343002889,1.0,8/42,5.10%,PGM5;MYOM2;KRT19;ACTN2;TMOD3;TMOD2;CSRP3;LMOD3
prerank,regulation of immune effector process (GO:0002697),0.67235178612842,1.7688704066233651,0.006561679790026247,0.7603639632765081,1.0,7/41,6.32%,CD55;CLU;CFHR1;C8A;CFH;CD81;CFP
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7162714826862157,1.7688102395986223,0.008836524300441826,0.7304663942448589,1.0,5/25,2.65%,CXADR;FGF13;DSG2;ANK2;CAV1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.48332046709823673,-1.7646165394188442,0.0,0.20160539344929235,0.983,21/56,13.96%,PTPRJ;IL1RAPL1;CNTNAP2;TEK;NRXN1;CLDN5;GRID2;KDR;TSC1;EPHB2;CLSTN2;NLGN1;ROCK1;LRRC4B;MAP4K4;DLG5;MYOC;NLGN3;SYNDIG1;BDNF;SRPX2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7314083547177205,-1.7633026211600897,0.0103359173126615,0.1969064051626689,0.983,4/11,1.02%,PLCB1;IGF1;GHR;PIK3R1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6922073781001925,-1.7617129771795614,0.010282776349614395,0.1936164652257171,0.984,3/12,3.32%,PLEKHH2;SEMA5A;LIMA1
prerank,integrin-mediated signaling pathway (GO:0007229),0.6113509909327194,1.7607070642695706,0.0,0.7601887017968014,1.0,20/73,12.98%,FN1;ITGB4;ITGA10;ITGB8;ITGBL1;ADAM10;ITGB7;LAMA5;PTK2B;FYB2;FBLN1;PTPRA;ILK;CDC42;ADAMTS1;TXK;ADAM15;BCAR1;PTN;DOCK1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.8360708634041811,1.756848399017812,0.01631321370309951,0.7584722014864622,1.0,1/10,0.04%,FN1
prerank,regulation of cell-cell adhesion (GO:0022407),0.6679489294554882,1.7541733443929786,0.006402048655569782,0.750664492242456,1.0,8/39,6.11%,DPP4;CDH1;WNT1;B4GALNT2;PODXL;SPINT2;FLOT2;EFNA5
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7145468348978703,-1.75356394214162,0.0027397260273972603,0.20191364708089488,0.99,5/11,9.69%,RAPGEF2;LYN;LGALS9;PIK3CB;PIK3CD
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8155678006429785,1.7505865140455172,0.018092105263157895,0.7497033403927076,1.0,4/12,5.33%,CLU;LDLR;PFDN1;CRYAB
prerank,vitamin transport (GO:0051180),0.7005238669011095,1.7500683468927845,0.011004126547455296,0.7275632993635504,1.0,2/29,2.69%,CUBN;AMN
prerank,epithelial structure maintenance (GO:0010669),0.8427514735358833,1.7493939768287834,0.011272141706924315,0.7087438553031015,1.0,2/11,1.01%,CXADR;VSIG1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5949099859841892,-1.7479780928204973,0.01,0.20584479036543057,0.993,10/19,13.02%,HS6ST2;NDST3;HS6ST3;XYLT1;CSGALNACT1;EXTL3;XYLT2;EXT2;HS3ST3B1;B3GAT3
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6513149988259739,-1.7449964844416475,0.005813953488372093,0.20458220252886833,0.994,9/14,13.69%,GHR;PIK3R1;LYN;STAT5B;PTK2;JAK2;STAT5A;STAT3;STAT6
prerank,phosphate ion homeostasis (GO:0055062),-0.7321429878870821,-1.7443232791549013,0.0023923444976076554,0.1997975645012023,0.994,4/10,12.69%,ENPP1;XPR1;SFRP4;FGFR4
prerank,sarcomere organization (GO:0045214),0.7200813685894061,1.7420673168792624,0.012311901504787962,0.7355294116020725,1.0,4/27,3.66%,MYOM2;KRT19;ACTN2;CSRP3
prerank,actomyosin structure organization (GO:0031032),0.606925946531292,1.7408009245289742,0.005780346820809248,0.7213449641258783,1.0,12/75,5.10%,SORBS1;PGM5;MYOM2;PHACTR1;KRT19;ACTN2;TJP1;TMOD3;TMOD2;CSRP3;EPB41L1;LMOD3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6953246642691341,1.7407050570273095,0.01637107776261937,0.7007722484947465,1.0,7/27,5.41%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,regulation of intracellular pH (GO:0051453),0.6804370876095809,1.7403052621061874,0.012080536912751677,0.6832783197161926,1.0,14/34,16.87%,SLC9A2;CFTR;SLC9A4;SLC4A2;TMEM165;CHP1;SLC9A6;SLC9A7;GPR89A;GPR89B;SLC9A8;ATP5F1B;SLC4A4;SLC9A1
prerank,regulation of amyloid fibril formation (GO:1905906),0.7710741121194736,1.7367257535189018,0.01910828025477707,0.6881318032492783,1.0,4/15,5.33%,CLU;LDLR;PFDN1;CRYAB
prerank,cGMP-mediated signaling (GO:0019934),-0.674311981613035,-1.7333696757483237,0.01020408163265306,0.21407153296262868,0.997,5/13,9.95%,IRAG1;PDE3A;GUCY1B1;PDE9A;PDE2A
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6316416146007539,-1.7240376050550799,0.013736263736263736,0.22781984078909087,0.997,8/16,15.00%,IGF1;TRPC3;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,autonomic nervous system development (GO:0048483),0.7549387508404819,1.7213588679705811,0.012121212121212121,0.7651122144611116,1.0,2/17,3.81%,FN1;GDNF
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5629642316966605,-1.71936252758659,0.0031746031746031746,0.230710926896638,0.997,9/24,13.19%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;RORA;TGFB1;IL6ST;FLT4
prerank,entry into host (GO:0044409),0.7924317045159159,1.7183310646562289,0.014218009478672985,0.7647572402726003,1.0,3/13,7.10%,CDH1;CXCR4;CBLL1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.803657242014666,1.7166034875094136,0.00980392156862745,0.7563393223879713,1.0,1/12,0.05%,FZR1
prerank,striated muscle cell development (GO:0055002),0.7792497089886128,1.7146061677171172,0.01238390092879257,0.7507532610438657,1.0,4/14,5.10%,PGM5;TMOD3;TMOD2;LMOD3
prerank,bone morphogenesis (GO:0060349),-0.6466727631764464,-1.7136412685344353,0.005571030640668524,0.23734107236938023,0.999,7/14,14.37%,CYP26B1;BMPR1B;LRP6;LRP5;FGFR2;SFRP4;BMPR2
prerank,lipid modification (GO:0030258),0.6457850391778945,1.7040098410340576,0.012311901504787962,0.8016974596637206,1.0,2/37,1.64%,PLPPR2;MBOAT2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.7273993351578345,1.7020030589643158,0.01524390243902439,0.7958655659203637,1.0,3/20,2.55%,ADRA1B;ADCY9;AKAP13
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6854158339901643,-1.701345260311296,0.007751937984496124,0.2595414458716297,1.0,3/12,2.51%,IL34;LYN;PTK2
prerank,positive regulation of ion transport (GO:0043270),0.6296684345467022,1.7011374953175782,0.016455696202531647,0.7828830254946331,1.0,10/48,8.02%,ANK2;CHRM1;ACTN2;STIM2;CCL5;FHL1;GDNF;AHCYL1;ANK3;RAB3B
prerank,phospholipid metabolic process (GO:0006644),0.5882938142852732,1.699512235738793,0.007202881152460984,0.7751679093879961,1.0,3/71,1.69%,PLPPR2;PLB1;FDFT1
prerank,phospholipid catabolic process (GO:0009395),-0.5516846749845515,-1.6968132763648074,0.0,0.26363493051782133,1.0,9/24,20.90%,PLA2G4A;GPCPD1;ENPP2;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3
prerank,camera-type eye morphogenesis (GO:0048593),-0.6910531423425852,-1.6912660939817088,0.007731958762886598,0.27181203764207595,1.0,6/10,20.94%,IFT122;LRP6;TBX2;NF1;KDM2B;TENM3
prerank,phospholipid dephosphorylation (GO:0046839),0.6460511960881313,1.6902743174891466,0.015193370165745856,0.8197376665235131,1.0,1/37,0.01%,PLPPR2
prerank,dendrite self-avoidance (GO:0070593),-0.621093272169686,-1.689015287491567,0.01529051987767584,0.2710990750485777,1.0,7/16,10.61%,PALLD;EMB;NEXN;DSCAML1;CNTN6;BSG;ROBO4
prerank,negative regulation of response to wounding (GO:1903035),0.7353180098758293,1.6873975227959583,0.020558002936857563,0.8211963223296368,1.0,6/19,11.51%,CD109;RTN4R;EPHA4;ALOX5;CASK;CERS2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.7561874438718202,1.6840337489182506,0.0140625,0.8257236133188406,1.0,5/15,6.87%,DAXX;CPEB2;ZC3H12A;MKNK2;GSTO1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7463502180915862,1.6815127470211595,0.01740506329113924,0.8246355344573036,1.0,3/15,7.51%,CD55;GLI3;NKAP
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5710253825026403,-1.6811742831819865,0.00967741935483871,0.2836389883890826,1.0,10/22,15.00%,IGF1;CAMK2D;NOTCH1;LMCD1;ROCK1;PDE9A;GLRX3;IL6ST;MTPN;EDN1
prerank,peptide cross-linking (GO:0018149),0.699528539279437,1.6810686719085453,0.018387553041018388,0.8105048093985862,1.0,1/25,0.04%,FN1
prerank,regulation of lamellipodium organization (GO:1902743),0.7646898562645685,1.6800559261442167,0.025,0.8009956924914431,1.0,6/14,12.80%,CD44;CAPZB;TWF1;DMTN;CDC42;PDPN
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5407631729386789,-1.6790232204705242,0.0035211267605633804,0.2823064739565476,1.0,13/24,24.27%,PDE3A;RAPGEF2;PDE4D;PDE3B;GNAI1;PRKAR2B;PDE2A;PDE11A;PEX5L;PRKAR1B;CGAS;APLNR;RNF157
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5928612461651835,-1.67449509324651,0.011834319526627219,0.2868014685318021,1.0,9/19,13.01%,ZFPM2;NOTCH1;RUNX1;FGF2;GLI1;ERBB4;FGFR2;TBX2;RBP4
prerank,regulation of feeding behavior (GO:0060259),-0.6565689701974671,-1.673611617106279,0.023376623376623377,0.28239040007292265,1.0,5/11,10.70%,LEPR;AGRP;SGIP1;CFAP20;STAT3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5467320719158022,1.6703120972211447,0.0010822510822510823,0.8478666778992144,1.0,16/140,4.60%,ADRA1B;CD55;AGTR1;GPR4;LPAR1;CCR4;LPAR4;CACNA1A;CAV1;CXCR4;CACNB3;PTGFR;ACKR4;ACKR2;CCR10;ACKR3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.692759704032445,1.6697586418446906,0.033236994219653176,0.8355957500836872,1.0,4/23,5.38%,DPP4;MCU;RIPOR2;MOSPD2
prerank,glycerolipid catabolic process (GO:0046503),-0.5799240311290692,-1.6684764724866894,0.011869436201780416,0.2892476541099761,1.0,10/19,20.90%,PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1;ABHD12;PNPLA6;ABHD2;PLA2G4C;GDPD3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.8067481797060803,1.6625564770560084,0.017241379310344827,0.8673267958915757,1.0,2/10,1.00%,DPP4;ADTRP
prerank,response to iron ion (GO:0010039),-0.6525102536136247,-1.661939831956184,0.021447721179624665,0.29913879406813887,1.0,5/12,13.00%,BMP6;HIF1A;BCL2;B2M;FXN
prerank,protein localization to cell-cell junction (GO:0150105),0.7448675948949596,1.6618860067261152,0.018461538461538463,0.8552604421703716,1.0,7/15,11.61%,TJP2;TJP1;ARHGEF18;LSR;ACTB;ACTG1;JAK1
prerank,sodium ion import across plasma membrane (GO:0098719),0.718896199143986,1.6604378712071726,0.015552099533437015,0.8487304537185375,1.0,2/17,0.16%,SLC9A2;SLC9A4
prerank,nuclear membrane disassembly (GO:0051081),0.7251188578446827,1.647999168120957,0.03328050713153724,0.9192009385992422,1.0,1/14,0.09%,PRKCB
prerank,dopamine metabolic process (GO:0042417),-0.5789692228029417,-1.6455036147264746,0.01466275659824047,0.33428837620453533,1.0,6/18,12.83%,MOXD1;SNCAIP;MAOB;MAOA;GCH1;DRD2
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5084215660953706,-1.6451566765015377,0.015432098765432098,0.32852257373026816,1.0,16/27,34.88%,PLA2G4A;GPCPD1;ENPP2;PNPLA8;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3;PLA2G15;PLA2G4F;PLA2G4E;LIPC;PLA2G4B;PLA2G5
prerank,mucosal immune response (GO:0002385),0.7324112070870874,1.6433304414818524,0.02225519287833828,0.9365812469763382,1.0,3/15,9.98%,RAB17;OTUD7B;RNASE3
prerank,stress fiber assembly (GO:0043149),0.7207047894168314,1.638257902780665,0.04251968503937008,0.940051375950061,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),0.7207047894168314,1.638257902780665,0.04251968503937008,0.940051375950061,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,cellular response to amino acid starvation (GO:0034198),0.5765424478350838,1.637969375719289,0.015330188679245283,0.9262894232878253,1.0,6/71,3.79%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6453095882673356,-1.6313703598637277,0.02349869451697128,0.3615769988409751,1.0,2/12,0.92%,PTPRJ;CBLB
prerank,negative regulation of developmental growth (GO:0048640),0.6571880394906774,1.6311866934784647,0.03287671232876712,0.9575877698266273,1.0,6/30,4.06%,FGF13;RTN4R;OSTN;CDKN1A;GDF15;DUSP10
prerank,response to amino acid starvation (GO:1990928),0.5747136203663925,1.631119614300587,0.01542111506524318,0.9425597328128197,1.0,6/72,3.79%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,neuron cell-cell adhesion (GO:0007158),-0.6376082144789884,-1.6308206936429055,0.021917808219178082,0.35613908635394786,1.0,8/14,18.29%,NRXN3;NRXN1;NCAM2;NLGN1;ASTN2;NLGN3;RET;ASTN1
prerank,neural crest cell migration (GO:0001755),0.6252897666433316,1.6294356434775015,0.026385224274406333,0.9391660283563384,1.0,4/36,3.81%,FN1;SEMA3D;SEMA3B;GDNF
prerank,smooth muscle contraction (GO:0006939),-0.6275233247750592,-1.6289646962206334,0.027624309392265192,0.35450179724072095,1.0,6/14,12.24%,SLC8A1;MYLK;SMTN;ROCK1;MYH11;ACTA2
prerank,negative regulation of cell adhesion (GO:0007162),0.5637479149379829,1.6189747115753055,0.013969732246798603,0.9984825743584357,1.0,17/72,7.30%,CDH1;CDH13;ANGPT1;WNT1;B4GALNT2;PLXNB1;PODXL;ADAM10;PLXNA2;SPINT2;GCNT2;RIPOR2;DUSP1;FBLN1;DMTN;CBLL1;ERBB3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.71950973217587,1.6168792461330534,0.028875379939209727,0.9983862602089059,1.0,1/16,0.19%,CLDN11
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5704430341964906,-1.6157736454522549,0.02710843373493976,0.3865738858795599,1.0,5/17,4.54%,CACNA1C;SLC8A1;GJC1;GJD3;ATP1B1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6843633035806942,1.6129314957344218,0.019287833827893175,1.0,1.0,5/22,6.86%,CD44;KLF4;GCNT2;FLOT2;MAPK7
prerank,regulation of establishment of cell polarity (GO:2000114),0.7081858242653716,1.6127971039212228,0.03815580286168521,0.9990629169589963,1.0,12/16,18.80%,KANK1;GSN;RAP1B;PTK2B;RIPOR2;KRIT1;BCAS3;ARFGEF1;CDH5;SHTN1;KIF20B;ROCK2
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6859211290898852,-1.611372663220781,0.014563106796116505,0.3934556872155544,1.0,7/10,19.24%,GABRG3;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE
prerank,positive regulation of bone mineralization (GO:0030501),-0.472161895397398,-1.611339988755987,0.01293103448275862,0.38643112690780573,1.0,10/35,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6678774455034964,-1.6112164955256223,0.024390243902439025,0.38009243581243835,1.0,9/11,27.43%,ADIPOR2;CD34;NDNF;KDR;GATA2;PRCP;SRF;MCAM;HPSE
prerank,water transport (GO:0006833),0.7379480467625376,1.610925114215495,0.03827751196172249,0.9978950032185152,1.0,1/12,0.12%,CFTR
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.5156074487987309,-1.6107528433964753,0.006600660066006601,0.37449254901212603,1.0,9/26,13.19%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;RORA;TGFB1;IL6ST;FLT4
prerank,positive regulation of cyclase activity (GO:0031281),-0.6053306266718523,-1.6094049668129293,0.01358695652173913,0.3719732090417428,1.0,3/14,2.50%,CACNA1C;STIM1;NOS3
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6321272752902075,-1.6076273041489657,0.027848101265822784,0.3707090795780493,1.0,7/13,9.62%,ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,nucleoside catabolic process (GO:0009164),0.7778287701922187,1.6063575099606722,0.02337228714524207,1.0,1.0,5/11,9.45%,NT5E;NT5C1A;NT5C3A;UPP2;DERA
prerank,epithelial cell migration (GO:0010631),0.6197378607248248,1.6059680787672137,0.036684782608695655,1.0,1.0,5/37,3.59%,DPP4;CDH13;KANK1;FAT2;KANK2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6040708200207827,-1.6051388196023455,0.02666666666666667,0.37138171984031215,1.0,7/15,15.00%,IGF1;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.727057507276052,1.6040151364922652,0.04674457429048414,1.0,1.0,1/12,0.09%,PRKCB
prerank,embryonic heart tube development (GO:0035050),-0.6018753205682024,-1.6013198292895658,0.0223463687150838,0.37595911987920433,1.0,6/14,17.15%,IFT122;SOX17;TBX2;MEGF8;RYR2;SOX18
prerank,cellular component maintenance (GO:0043954),-0.6232778192863533,-1.6012172417113397,0.046511627906976744,0.3702390471532192,1.0,4/12,13.17%,INSR;IGF1R;MTMR2;CLDN1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6716592686250381,-1.6008494999395886,0.029197080291970802,0.36547388325275276,1.0,4/10,7.16%,PRKG1;RDX;SERPINE2;SH2B3
prerank,regulation of cell communication (GO:0010646),0.6147906902516141,1.600270053165017,0.027379400260756193,1.0,1.0,4/35,1.92%,CXADR;ANK2;GRK5;VEPH1
prerank,diterpenoid metabolic process (GO:0016101),0.5715428660931613,1.6002541346844943,0.021170610211706103,1.0,1.0,12/55,10.37%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;SDC4;GPC3;PECR;AKR1B10
prerank,stabilization of membrane potential (GO:0030322),-0.5750300290109898,-1.5998487048977363,0.02,0.36252283469824814,1.0,9/16,32.17%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNN4;KCNK6;KCNK4
prerank,regulation of transferase activity (GO:0051338),0.6977910611235828,1.5997395145736417,0.03669724770642202,0.9931626241025898,1.0,8/17,15.62%,SPTSSB;EMP2;NABP2;FEM1A;JMJD8;FEM1B;PINX1;HMBOX1
prerank,selective autophagy (GO:0061912),0.5777202039061446,1.5993297307568897,0.03190184049079755,0.9828102945215201,1.0,19/56,18.47%,CFTR;DYNC1I1;VIM;DDRGK1;TEX264;WDFY3;LGALS8;RAB7A;ULK1;MAP1LC3B;RB1CC1;UBE2N;DYNC1LI2;UFM1;RPS27A;UBC;DYNC1H1;HDAC6;PARK7
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6776182012532642,1.5972385056491796,0.01772525849335303,0.9847001667300623,1.0,1/21,0.05%,FZR1
prerank,sterol transport (GO:0015918),0.6823292991848643,1.5963603393490444,0.045317220543806644,0.9783677657062341,1.0,4/19,6.45%,LDLR;CAV1;STARD3;NPC1
prerank,hemidesmosome assembly (GO:0031581),0.7591689687299087,1.5944305683189428,0.03424657534246575,0.9786983415503656,1.0,4/11,10.70%,ITGB4;LAMC2;LAMC1;PLEC
prerank,regulation of extracellular matrix organization (GO:1903053),-0.6109233057824945,-1.593945474490064,0.049079754601226995,0.3732789544340683,1.0,6/15,5.11%,AEBP1;FAP;TIE1;NOTCH1;RUNX1;RIC1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5220741427985668,-1.5931905064918335,0.023890784982935155,0.37000688130379683,1.0,12/23,28.19%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;EGF;SPHK1;BMP7;STOX1;TRIM6;RIPK2;CALM3
prerank,T cell activation (GO:0042110),0.5616689087256016,1.5927848984255772,0.023529411764705882,0.9779256582580156,1.0,3/69,0.58%,DPP4;CXADR;CD44
prerank,lamellipodium assembly (GO:0030032),0.6323636381818212,1.5910777578927273,0.03602305475504323,0.9772717131055533,1.0,6/26,7.18%,CDH13;SRGAP2;ABLIM2;ABLIM1;DMTN;GOLPH3
prerank,regulation of cellular pH (GO:0030641),0.641320625690764,1.5892885658887375,0.03899721448467967,0.9772598991835879,1.0,6/29,10.07%,SLC9A2;SLC9A4;SLC4A2;CHP1;SLC9A6;SLC9A7
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7283592337851315,1.588932509372774,0.034375,0.9676457541862297,1.0,5/15,8.18%,SMO;GDNF;SOX9;BMP4;SIX1
prerank,regulation of fibroblast proliferation (GO:0048145),0.6007119718108389,1.588849349968973,0.026923076923076925,0.956562336757937,1.0,7/45,5.41%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,aggrephagy (GO:0035973),0.6432263532355906,1.5881408480433332,0.03719599427753934,0.9503469520539198,1.0,11/27,18.47%,CFTR;DYNC1I1;VIM;WDFY3;UBE2N;DYNC1LI2;RPS27A;UBC;DYNC1H1;HDAC6;PARK7
prerank,keratinocyte differentiation (GO:0030216),0.6356910295384497,1.5862227662906405,0.035961272475795295,0.9513542516765067,1.0,2/29,0.45%,WNT16;SCEL
prerank,endothelial cell migration (GO:0043542),0.6036557616654913,1.5831813272300856,0.03183023872679045,0.9613322632609526,1.0,3/37,2.06%,DPP4;CDH13;EMP2
prerank,icosanoid secretion (GO:0032309),-0.6255044490546455,-1.5829324479545905,0.05555555555555555,0.3946005571378058,1.0,4/12,12.83%,ABCC4;PNPLA8;ACE;DRD2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.7461732657012208,1.5822203013606975,0.03801652892561983,0.9563277245406338,1.0,1/11,0.37%,CDH13
prerank,embryonic axis specification (GO:0000578),0.694208557509552,1.581949729287639,0.03412462908011869,0.9472115303895761,1.0,5/15,8.71%,WNT1;COBL;SMAD6;FZD5;CXXC4
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7089407446740703,1.58159082972912,0.030816640986132512,0.9386688344104641,1.0,4/16,9.08%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6371269297154074,1.5813580421515128,0.037815126050420166,0.9296310755008992,1.0,7/26,7.90%,FGFR1;EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5000536800234893,-1.5786449484724092,0.02214022140221402,0.4023207432348831,1.0,9/29,10.12%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5998463417303547,1.577904914530689,0.03506493506493506,0.9419762816932801,1.0,9/39,6.86%,CDH1;ADTRP;WNT1;KLF4;B4GALNT2;PODXL;SPINT2;AKNA;MAPK7
prerank,muscle tissue development (GO:0060537),0.7311003057602472,1.5778476291809773,0.0361247947454844,0.9320616081669805,1.0,5/13,6.81%,PGM5;SMO;STRA6;CSRP3;BMP4
prerank,striated muscle tissue development (GO:0014706),0.6140140209950563,1.574920686787614,0.038781163434903045,0.9407263229875715,1.0,6/29,4.13%,PGM5;SGCG;SGCD;CAV1;CSRP3;BMP5
prerank,positive regulation of lyase activity (GO:0051349),-0.5858751232210724,-1.5739265949756305,0.036211699164345405,0.4098759953274022,1.0,6/14,18.10%,CACNA1C;STIM1;NOS3;NF1;FXN;ISCU
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6647978867373164,1.572413075088844,0.048316251830161056,0.9460019395729952,1.0,4/20,5.86%,B3GALT1;ST3GAL4;B4GALNT2;FUT8
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5585359520065958,-1.5706744648075002,0.041666666666666664,0.41424293734111106,1.0,4/18,7.03%,IGF1;IGFBP2;IL18;IGF2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.719899139586274,1.5705791442013892,0.04276315789473684,0.9482361856911322,1.0,5/14,11.40%,NT5E;NT5C1A;NT5C3A;UPP2;UMPS
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7740378729044717,1.569620740378342,0.04074702886247878,0.9446139669628655,1.0,4/10,9.08%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5544811604065105,1.5692569649220562,0.02603550295857988,0.937263833944271,1.0,18/70,9.95%,FN1;POF1B;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;TMEFF2;UNK;ANTXR1;PXN;ILK;SRCIN1;LAMC1;GRHL2;OPHN1;DACT2;LAMB2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6093451594918817,1.5682783318863072,0.03753351206434316,0.9339999659200026,1.0,3/32,1.93%,FZR1;FOXN3;CDKN1A
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5777978281360684,1.567674838501727,0.03400503778337532,0.9283516570427605,1.0,18/47,16.82%,DOCK5;KANK1;LIMS2;S100A10;FBLN1;EFNA5;DMTN;ILK;CDC42;PDPN;DOCK1;RREB1;ITGB1BP1;ACTN4;FLNA;TESK1;CRK;ABL1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6464217663216252,-1.566104586612439,0.0364963503649635,0.4223609511057828,1.0,4/10,4.52%,ACER2;NEXMIF;PDE3B;CYP1B1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6903847981658642,1.5644166518905303,0.048414023372287146,0.93944945727604,1.0,5/15,8.47%,SCEL;FGFR1;CELF1;TGFB2;RAI2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5422550555446448,-1.5634507776798694,0.04093567251461988,0.42413538173891896,1.0,9/19,9.77%,DCN;SEMA6A;CCBE1;ROBO1;XDH;DAB2IP;PIK3CB;TSPAN12;ADAMTS3
prerank,apoptotic cell clearance (GO:0043277),-0.4763247842229345,-1.56208655996757,0.019455252918287938,0.42287186884743766,1.0,13/30,21.75%,RHOBTB1;TGM2;GAS6;MEGF10;THBS1;NR1H3;XKR6;ITGAV;HMGB1;TXNDC5;RHOBTB2;LRP1;TYROBP
prerank,negative regulation of potassium ion transport (GO:0043267),0.7248132436527039,1.5596956330775893,0.04874213836477988,0.9596002353501922,1.0,4/13,6.35%,ACTN2;CAV1;PTK2B;STK39
prerank,negative regulation of platelet activation (GO:0010544),-0.5806353309748198,-1.5591501159333694,0.03389830508474576,0.42618248963600225,1.0,5/16,7.16%,PRKG1;NOS3;PDGFRA;SERPINE2;SH2B3
prerank,xenobiotic transport (GO:0042908),-0.5650414999773307,-1.558996193050256,0.043227665706051875,0.42097371446014714,1.0,9/16,31.40%,SLC47A1;SLC7A5;ABCA3;SLC15A2;ABCC3;SLC22A2;ABCG2;SLC22A3;ABCC1
prerank,base conversion or substitution editing (GO:0016553),-0.6212339699445844,-1.5587808642239813,0.061224489795918366,0.4161156926246906,1.0,5/11,23.18%,ADAR;ADARB1;ADARB2;APOBEC1;NUDT16
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5671823455224011,-1.5587681638425626,0.031496062992125984,0.4107906821856616,1.0,8/16,20.58%,INSR;IRAK3;GSPT1;OGFOD1;IGF1R;CLN3;SHFL;UPF1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4763668094254879,-1.5573794407447783,0.01532567049808429,0.4097662370190619,1.0,18/34,25.51%,GRID2;GABRG3;GRIN2A;GRIN2B;LRRK2;GLRA1;GABRG2;GABRG1;GABRA3;NLGN3;DRD2;MPP2;GABRA1;GABRE;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,regulation of gastrulation (GO:0010470),0.7103996020056133,1.5564903637148377,0.041666666666666664,0.9709635932095997,1.0,3/14,3.12%,PHLDB2;DAG1;CRB2
prerank,protein localization to plasma membrane (GO:0072659),0.514357238299599,1.5554066869770709,0.007608695652173913,0.9683514482901682,1.0,27/129,10.09%,CDH1;FGF13;NECTIN3;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;RAP1A;CD81;S100A10;CACNB3;EHD1;FYB2;RAMP1;FLOT2;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5876454940971098,1.555306761540253,0.03280839895013123,0.9596999971501622,1.0,9/41,11.61%,CD44;TJP1;CCL5;PODXL;GCNT2;PTPRU;ANK3;DENND6A;JAK1
prerank,cellular response to alcohol (GO:0097306),0.5820449096325798,1.5553012406823976,0.046632124352331605,0.9506262778823562,1.0,9/42,11.14%,CDH1;CFTR;SMO;PTGFR;CTNNA1;GOLPH3;ADCY6;ADAM15;OSBPL7
prerank,cholesterol biosynthetic process (GO:0006695),0.6186184201079947,1.5533950051987073,0.04016620498614958,0.9536636671194278,1.0,13/31,18.19%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5387009221373876,1.5518759393175907,0.03419811320754717,0.954488611197083,1.0,16/72,10.78%,GPR4;LPAR1;RTN4R;KANK1;PRAG1;LPAR4;AKAP13;EPS8L2;KANK2;RIPOR2;ARHGEF18;CCDC125;BCR;OPHN1;RAF1;DLC1
prerank,protein localization to cell surface (GO:0034394),0.6355055262397948,1.5496769768532053,0.04450625869262865,0.9591002134196104,1.0,9/26,12.41%,ANGPT1;ANK2;EMP2;PIGU;WNT11;PTPRU;UNC50;GGA1;MESD
prerank,central nervous system neuron development (GO:0021954),-0.5974293524601157,-1.5489246775242884,0.03508771929824561,0.4302879039085831,1.0,8/15,19.68%,RAPGEF2;MAP2;NTRK2;LHX6;GBA2;B4GALT5;ARHGAP35;HSP90AB1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6242468344539138,-1.5485061398166717,0.04415584415584416,0.4259242865796365,1.0,3/11,9.30%,SEMA5A;STMN2;NES
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6783144627707183,1.5483780857404645,0.04918032786885246,0.9587199945942444,1.0,3/18,2.15%,FN1;ITGB8;CD200
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7069433886264227,1.5474923037945056,0.05654281098546042,0.9556442437278723,1.0,3/14,5.82%,CD55;CD81;RASAL3
prerank,mesoderm formation (GO:0001707),0.6841987171881275,1.5455097341250572,0.0350076103500761,0.9593863350818125,1.0,2/17,3.12%,ITGB4;CRB2
prerank,negative regulation of neuron projection development (GO:0010977),0.5575560048566492,1.5431738291667716,0.034047919293820936,0.9657956824592848,1.0,8/56,2.88%,LPAR1;RTN4R;KANK1;PRAG1;NGEF;EPHA4;EFNB2;ITM2C
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5749745013662633,1.5417484104379011,0.03580562659846547,0.966715814291952,1.0,13/46,9.95%,FN1;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;TMEFF2;ANTXR1;PXN;ILK;SRCIN1;LAMC1;LAMB2
prerank,dicarboxylic acid transport (GO:0006835),-0.47722501084831304,-1.541423161801584,0.023622047244094488,0.44144175559855303,1.0,5/28,5.61%,SLC1A3;SLC13A3;SLC26A7;SLC1A2;SLC1A1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.6210152063981947,1.5398930437658873,0.039160839160839164,0.9699832338647411,1.0,13/30,18.19%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6269239445107846,1.5386993670226323,0.04992867332382311,0.9690959521151797,1.0,5/26,6.35%,ANK2;ACTN2;FHL1;WWP2;STK39
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.62019619395135,-1.5373964873609418,0.054187192118226604,0.44872083228294396,1.0,6/11,18.79%,IL34;TGFB1;ID2;HSF1;RIPK1;CSF1
prerank,camera-type eye development (GO:0043010),-0.4987823526375286,-1.5372622218551306,0.03272727272727273,0.4436569605826374,1.0,8/25,10.36%,CACNA1C;LAMA1;FBN1;CYP1B1;IFT122;FBN2;NES;NF1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7307098337558555,1.5371914414338084,0.06103286384976526,0.9706409285196879,1.0,5/10,11.20%,HDAC5;SMARCB1;PIH1D1;KMT2A;RAPGEF3
prerank,vasoconstriction (GO:0042310),-0.6215594624824063,-1.5348297868573857,0.0525,0.4457822782073113,1.0,7/11,29.62%,SLC8A1;ACTA2;EDNRB;EDN1;EDN3;HTR2B;PIK3C2A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6085376018528277,-1.5342675069117957,0.027932960893854747,0.4423766884209457,1.0,5/13,9.87%,ENG;KDR;COL4A1;SEMA3E;NOTCH4
prerank,positive regulation of heart rate (GO:0010460),0.6693490837222259,1.5337976263404263,0.062402496099843996,0.9834527075089539,1.0,1/17,0.06%,ADRA1B
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5725273564931899,-1.53260834527529,0.045845272206303724,0.44207163858655535,1.0,3/14,7.20%,PRKG1;IGFBP5;SLIT2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5488034097378143,1.5306430260696358,0.030525030525030524,0.9955081048471256,1.0,10/61,4.46%,GPR4;MAPRE2;LPAR1;NOTCH2;RTN4R;PRAG1;LPAR4;AKAP13;NGF;EPO
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5849309753360875,1.5292731215421311,0.04946524064171123,0.995338461737911,1.0,14/35,16.82%,BAIAP2L1;NOTCH2;NTRK3;TJP1;PTK2B;DAPK3;HAX1;CDC42;BCAS3;RAPGEF3;TRPM2;HRAS;ARHGDIB;ABL1
prerank,sphingoid metabolic process (GO:0046519),-0.6057939615897209,-1.5291228992654513,0.05945945945945946,0.4470235055467463,1.0,7/12,33.29%,DEGS2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.7382424674089383,1.5274726442256368,0.06030150753768844,0.9994136111372228,1.0,2/10,1.44%,MAPRE2;MMP9
prerank,positive regulation of lipid storage (GO:0010884),0.6430206771393252,1.525468536757351,0.05308464849354376,1.0,1.0,4/21,3.69%,SREBF2;ZC3H12A;IKBKE;EHD1
prerank,protein localization to cell periphery (GO:1990778),0.501077457465631,1.5252802671713368,0.012944983818770227,0.9971035655807957,1.0,28/133,10.09%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;CAV1;RAP1A;CD81;S100A10;CACNB3;EHD1;ARL3;FYB2;RAMP1;FLOT2;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,regulation of cell killing (GO:0031341),0.6706230439651649,1.5236420575188725,0.05731523378582202,0.9994483680923113,1.0,3/16,7.39%,CD55;CFH;TGFB2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5835623162612524,1.5234972302116345,0.04376657824933687,0.9923584577018142,1.0,6/37,7.31%,CXADR;ALCAM;NECTIN3;CRB2;PTPRD;PVR
prerank,regulation of axon regeneration (GO:0048679),0.7250849106680405,1.5232314678228913,0.07085346215780998,0.9859785122230394,1.0,7/12,22.99%,RTN4R;EPHA4;CERS2;PTN;STK24;RTN4RL1;SCARF1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6780815150305448,1.522047582654355,0.04231974921630094,0.9856019746938589,1.0,6/15,11.61%,KLF4;TJP1;PKM;JMJD8;S100A1;JAK1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6853240977531995,1.5212827321368525,0.06116207951070336,0.9824992449135561,1.0,1/15,0.04%,DPP4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7158944822886107,1.5207414159681696,0.06765676567656766,0.9707194607905102,1.0,9/12,21.74%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;RCC2;MELTF;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7158944822886107,1.5207414159681696,0.06765676567656766,0.9707194607905102,1.0,9/12,21.74%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;RCC2;MELTF;AP1AR
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.49698303530283405,1.5205730740855306,0.007478632478632479,0.9641242342124302,1.0,16/142,5.95%,ADRA1B;CD55;AGTR1;LPAR1;CCR4;CACNA1A;CAV1;ATP1A2;CXCR4;PTGFR;ACKR4;ACKR2;CCR10;ACKR3;CAV2;CCRL2
prerank,limb development (GO:0060173),-0.47460777653706954,-1.519350777761946,0.025735294117647058,0.47275068737157183,1.0,8/28,9.95%,PCSK5;SMOC1;ZNRF3;IFT122;BMPR1B;SALL1;CHD7;MEGF8
prerank,lymphocyte mediated immunity (GO:0002449),0.712404391759753,1.5192983622113478,0.05490848585690516,0.9645056888162011,1.0,1/12,0.15%,CD55
prerank,homotypic cell-cell adhesion (GO:0034109),0.5793788732216762,1.519169065298044,0.041884816753926704,0.9579746130623391,1.0,9/39,10.73%,FN1;TJP2;HSPB1;DSC2;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,cellular response to UV-A (GO:0071492),0.7157044975673741,1.5191337309978892,0.0734094616639478,0.9509437275749771,1.0,3/11,4.45%,OPN1SW;MMP9;TIMP1
prerank,purine nucleotide catabolic process (GO:0006195),0.6986418489939987,1.518459706510233,0.06885245901639345,0.9480984957268654,1.0,3/13,6.85%,NT5E;NT5C1A;NT5C2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5500195664875969,-1.5166059917955677,0.0431266846361186,0.4764254594043586,1.0,4/16,6.61%,GUCY1B1;NOS3;NDNF;GUCY1A1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.59230494404731,-1.516129558313289,0.03896103896103896,0.472834756543827,1.0,2/12,5.93%,IL1R1;IL18
prerank,cardiac muscle cell differentiation (GO:0055007),0.6282102254559474,1.515682172395544,0.051698670605613,0.9580065817862408,1.0,2/21,2.55%,CXADR;AKAP13
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4483344362232685,-1.5144106270265498,0.017467248908296942,0.47304828683352856,1.0,12/37,6.85%,PLCB1;GRIK2;GRID2;GRM3;GRM7;GRIN2A;GRIA3;GRIA2;GRM8;GRIN2B;GRM5;GRIK3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6427869061942971,1.5138604603748325,0.07357357357357357,0.9622788714151936,1.0,5/18,6.35%,MMP9;CAV1;ATP1A2;EPO;STK39
prerank,carbohydrate biosynthetic process (GO:0016051),0.6358901477699248,1.513856683638349,0.06695778748180495,0.9552694520702039,1.0,4/21,5.86%,B3GALT1;ST3GAL4;B4GALNT2;FUT8
prerank,negative regulation of wound healing (GO:0061045),0.6048818854390571,1.5119750039678816,0.051490514905149054,0.9598959020768857,1.0,5/28,6.08%,CD109;PHLDB2;ADTRP;ALOX5;THBD
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6625875810636042,1.5109954405714023,0.059748427672955975,0.9589768973996183,1.0,2/16,1.57%,AGTR1;JCAD
prerank,regulation of keratinocyte migration (GO:0051547),0.7073474867194692,1.5107829479528252,0.06393442622950819,0.9535189572242994,1.0,2/12,1.44%,MAPRE2;MMP9
prerank,proteoglycan biosynthetic process (GO:0030166),-0.45740228326328847,-1.5107222049615916,0.033582089552238806,0.47982145749298505,1.0,16/31,16.87%,IGF1;NDST3;XYLT1;BMPR1B;CSGALNACT1;CHST8;EXTL3;XYLT2;EXT2;PXYLP1;HS3ST3B1;CANT1;B3GAT3;BMPR2;CHST10;B4GALT7
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5866131643470078,1.5102733057317685,0.054959785522788206,0.9497249408780832,1.0,12/34,16.82%,DOCK5;LIMS2;S100A10;DMTN;ILK;CDC42;DOCK1;RREB1;FLNA;TESK1;CRK;ABL1
prerank,regulation of neuron death (GO:1901214),0.5194858599404171,1.509782007197454,0.026376146788990827,0.9459703584159577,1.0,23/82,15.66%,EGLN3;CLU;DAXX;PPARGC1A;CCL5;MAP3K5;EFNB2;CD200;FOS;CTSZ;GPR75;EGLN2;CHMP4A;CHMP4B;CHP1;CD200R1;MEF2C;GSK3B;EIF4G1;NENF;SNCB;IKBKG;ITGB2
prerank,actin cytoskeleton reorganization (GO:0031532),0.5391493478687045,1.5095282812846578,0.04819277108433735,0.9409542610314533,1.0,10/63,6.39%,CXADR;PHACTR1;PARVA;GSN;PTK7;SIPA1L1;GAB1;MCU;ANTXR1;DMTN
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6047619855574582,1.5066550958613634,0.049707602339181284,0.9514526167914805,1.0,4/27,2.65%,FGF13;DSG2;ANK2;CAV1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6061183224206701,1.506288632329556,0.055408970976253295,0.9471809872433604,1.0,10/32,16.67%,FHIT;DDX5;EP300;PMAIP1;PHLDA3;PPP1R13B;PML;PDK2;USP28;POU4F1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5711772164287195,-1.5061873825838155,0.0679886685552408,0.4894284303026209,1.0,5/13,8.18%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5227867784631655,1.5038096407276857,0.03707995365005794,0.9554363633347526,1.0,22/78,15.24%,FZR1;CLU;TRIB2;CAV1;NFE2L2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;PLK3;RBX1;SUMO2;BCAP31;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2
prerank,epithelial cell development (GO:0002064),0.6450730417146481,1.5031257383294836,0.06395348837209303,0.9532112253794117,1.0,6/20,9.77%,POF1B;ROS1;WNT5B;GRHL2;PDZD7;DACT2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5946409492262138,1.5017376860726783,0.06845637583892618,0.9550198697151646,1.0,8/30,10.34%,CLU;CD44;YJU2;ACKR3;BCL2L1;FBXO5;DDX39B;TWIST1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6322055994590943,-1.5016452062944894,0.05365853658536585,0.4995004552985887,1.0,3/10,6.77%,PLA2G4A;ENPP2;PNPLA8
prerank,transition metal ion transport (GO:0000041),-0.43938155840246457,-1.5002513616005264,0.024291497975708502,0.49910378280922835,1.0,10/35,12.48%,SLC30A10;TRPC3;TRPC4;SLC39A8;TFRC;ATOX1;TRPC6;TRPC5;TTYH1;SLC30A1
prerank,positive regulation of protein import (GO:1904591),0.5935421373301052,1.5000802481959141,0.07607192254495158,0.9584323401705243,1.0,10/30,15.67%,CDH1;ZC3H12A;MAVS;ARHGEF5;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.49183864122760235,-1.499326490185752,0.041666666666666664,0.4967488477321111,1.0,7/25,11.72%,PDE4D;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,neutrophil activation (GO:0042119),0.7174797393798837,1.498960530949968,0.06129032258064516,0.9584189950621245,1.0,3/12,11.65%,CCL5;IL15;FCER1G
prerank,non-motile cilium assembly (GO:1905515),-0.4757229501459217,-1.498842407977794,0.027237354085603113,0.49306125612021057,1.0,18/30,31.80%,CEP250;IFT122;TTC8;GORAB;C2CD3;BBS1;CSNK1D;BBS4;ARL13B;FUZ;RPGRIP1L;TMEM17;TMEM107;IFT88;PIBF1;CCDC13;IFT57;DISC1
prerank,retinoid metabolic process (GO:0001523),0.5237787122838462,1.4986299428931282,0.039192399049881234,0.9537969035110978,1.0,13/71,10.37%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;DHRS13;SDC4;GPC3;ALDH8A1;AKR1B10
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6855548976749068,1.498415905901371,0.06477093206951026,0.9486273290623973,1.0,5/13,5.41%,CDH13;LDLR;SREBF2;CD81;CD9
prerank,cellular response to cadmium ion (GO:0071276),0.6024738110397128,1.4977935018514872,0.060117302052785926,0.9460920835439889,1.0,5/24,8.54%,DAXX;MMP9;FOS;JUN;MAPK9
prerank,second-messenger-mediated signaling (GO:0019932),0.5107353995264462,1.4974189342552573,0.03211009174311927,0.9419886969102604,1.0,13/82,6.76%,AGTR1;NUDT4;CCR4;CXCR4;MCU;PPP2CA;RCAN1;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;DDAH2
prerank,maturation of 5.8S rRNA (GO:0000460),0.6599820877576373,1.4971543769654931,0.05692307692307692,0.9373673879024811,1.0,7/17,14.56%,NSA2;PES1;EIF6;MAK16;MPHOSPH6;MTREX;RPF1
prerank,platelet aggregation (GO:0070527),0.5923667540073959,1.496576625244742,0.06199460916442048,0.9346662847033327,1.0,7/33,10.73%,FN1;HSPB1;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,negative regulation of protein transport (GO:0051224),0.5966907217293833,1.4964787039982952,0.06162464985994398,0.929327253755233,1.0,8/25,13.94%,ADTRP;WWP2;HMGCR;CSK;CYP51A1;SNX12;SERGEF;RHBDF2
prerank,regulation of cholesterol esterification (GO:0010872),0.7473632175993151,1.4957070146238987,0.06968641114982578,0.9276236371006108,1.0,3/10,11.53%,AGTR1;ABCA2;STARD4
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6769230480917736,1.4946949292009448,0.08143322475570032,0.9274483976917421,1.0,3/12,4.40%,UST;CHST12;DSE
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6331688391005462,1.4938433196393817,0.061654135338345864,0.9264489112343584,1.0,3/21,1.83%,NT5E;NUDT4;NT5C1A
prerank,heterochromatin organization (GO:0070828),-0.5577077010156626,-1.492793071439037,0.05572755417956656,0.5074907349553323,1.0,6/14,17.32%,MECOM;PRDM16;SMCHD1;HMGA2;HP1BP3;SETDB2
prerank,hemopoiesis (GO:0030097),-0.3719749302072509,-1.4925429761832345,0.0,0.5031539959475321,1.0,26/87,15.34%,FLT1;MECOM;JAG1;TEK;KIRREL3;KITLG;SNRK;MFAP5;ETV6;WNT5A;CD34;KDR;RUNX1;RUNX2;SH2B3;TGFB1;FGFR2;NOTCH4;KIT;TP53;MEIS1;TIRAP;FLT4;KAT6A;TOX;FLT3LG
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.6269267871280687,1.4925387731926232,0.05890804597701149,0.9277281468529367,1.0,11/21,20.75%,DAG1;ADAM10;SPPL2B;HM13;BACE1;PRTN3;SPPL3;PRKCQ;SPPL2A;ADAM17;APH1A
prerank,dermatan sulfate metabolic process (GO:0030205),0.6710274840321815,1.4925119394565147,0.07928802588996764,0.9221548574550469,1.0,3/13,4.40%,UST;CHST12;DSE
prerank,extracellular structure organization (GO:0043062),0.4777394133966532,1.4923272639762428,0.007276507276507277,0.9176624609060955,1.0,22/204,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;COL5A2;ITGB7;LAMA5
prerank,external encapsulating structure organization (GO:0045229),0.476975263061259,1.491554857707061,0.0062176165803108805,0.9163166020812364,1.0,22/205,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;COL5A2;ITGB7;LAMA5
prerank,purine-containing compound catabolic process (GO:0072523),0.6942268824954686,1.4906604926944484,0.0628099173553719,0.9159029355301342,1.0,3/13,6.85%,NT5E;NT5C1A;NT5C2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5841458078132695,1.4892183521876416,0.06618705035971223,0.9184289708780656,1.0,5/29,8.66%,SORBS1;LDLR;CREBL2;CREB1;CHP1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.443149813250062,-1.4885405899677893,0.029045643153526972,0.510992421026524,1.0,10/34,7.31%,FLT1;PDGFRB;PRKD1;PIK3R1;TEK;PTK2;PDGFRA;FGF2;DAB2IP;TGFB1
prerank,regulation of gluconeogenesis (GO:0006111),0.584586016235782,1.487915130150287,0.0638002773925104,0.9202103514967113,1.0,9/27,16.37%,PPARGC1A;OGT;EP300;ZNF692;NNMT;PDK2;PTPN2;PGP;DDB1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6208797550737383,1.4875589302456713,0.06296851574212893,0.9167686734406116,1.0,3/22,6.07%,SORBS1;CREBL2;CREB1
prerank,myelin maintenance (GO:0043217),0.7293832332276334,1.4872098156189186,0.06821963394342762,0.9132088869263217,1.0,3/10,2.99%,CLU;ABCD1;CXCR4
prerank,energy reserve metabolic process (GO:0006112),-0.514539698469233,-1.486553171840072,0.0473186119873817,0.512887220592382,1.0,4/19,6.03%,PID1;PRKAG2;LEPR;PHKA1
prerank,skin development (GO:0043588),0.5329659515949136,1.4847516409781938,0.030978934324659233,0.9220250396906844,1.0,5/65,2.33%,WNT16;ITGB4;SCEL;WNT10A;COL5A2
prerank,amino acid transport (GO:0006865),0.5379404153322346,1.484171037398498,0.054707379134860054,0.9199587438407516,1.0,11/49,12.80%,SLC7A14;SLC36A3;SH3BP4;SLC36A4;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;SLC25A44;PDPN
prerank,focal adhesion assembly (GO:0048041),0.618344324445467,1.4827427365238706,0.05588235294117647,0.9224829069825309,1.0,2/21,1.06%,SORBS1;ACTN2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.42944309401834563,-1.4822719337702568,0.02575107296137339,0.52212835987924,1.0,13/39,9.87%,ENG;GLI2;TIE1;KDR;COL4A1;PKD2;FGF2;SEMA3E;SALL1;SLIT2;LRP6;LRP5;NOTCH4
prerank,negative regulation of transmembrane transport (GO:0034763),0.7212191813645863,1.482248634469718,0.08143322475570032,0.9199493673491638,1.0,1/10,0.09%,PRKCB
prerank,positive regulation of inflammatory response (GO:0050729),0.5091227983818503,1.4822068871720875,0.03968253968253968,0.9149079977365767,1.0,14/86,9.74%,AGTR1;GPR4;NAPEPLD;IL17RA;NUPR1;NINJ1;IL15;IL16;CD81;NFKBIA;FEM1A;LBP;TNFRSF1A;NMI
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6978450691760385,1.4798597147846075,0.07424960505529225,0.9227012699764364,1.0,2/11,1.09%,CD44;KANK1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5708349716714709,-1.479564392983007,0.07520891364902507,0.5258589433040067,1.0,4/13,7.64%,LEF1;LGALS9;IL18;TNFRSF21
prerank,modulation by host of symbiont process (GO:0051851),0.5889079528041045,1.479286636591505,0.07267833109017496,0.9208875458260298,1.0,10/31,12.28%,NAPEPLD;CCL5;HPN;EP300;SMARCB1;POU2F3;JUN;SMARCA4;AQP1;SP1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5504602402292068,1.4790583882939543,0.06048906048906049,0.916999171413086,1.0,15/43,21.19%,FZR1;FOXN3;CDKN1A;NABP2;MRE11;HUS1B;TOPBP1;ABRAXAS1;DONSON;NBN;INTS3;CDK5RAP3;TAOK3;NABP1;CHFR
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5571500121886871,1.4781807657813377,0.055771725032425425,0.9165839545414979,1.0,8/44,5.14%,BAIAP2L1;GSN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;LMOD3;FCHSD1
prerank,inhibitory synapse assembly (GO:1904862),0.6920758595006833,1.477531023986498,0.0935374149659864,0.9149292251825697,1.0,2/11,1.61%,FGF13;PLXNB1
prerank,defense response to tumor cell (GO:0002357),0.7165107045761333,1.4768131792971382,0.07729468599033816,0.9137457998566008,1.0,3/10,6.96%,KLF4;DAPK1;RBMS3
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5413920179005539,-1.4763443205210893,0.05539358600583091,0.5312842428749688,1.0,6/17,18.35%,PCSK5;NR1H3;SORT1;NR1H2;LPL;PCSK6
prerank,endothelial cell proliferation (GO:0001935),-0.5221108363127381,-1.475998724751517,0.07356948228882834,0.5272490409029265,1.0,5/17,4.68%,TEK;SEMA5A;ACVRL1;CD34;BMPER
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6800100596569864,1.475449792964862,0.07928802588996764,0.9158711767191748,1.0,1/12,0.12%,CFTR
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.48014200986989664,1.4734962089700443,0.011652542372881356,0.921245352379405,1.0,17/159,7.39%,CDH1;CXADR;CLDN11;ALCAM;SDK1;DSG2;CDH13;NECTIN3;GPC6;FAT2;CRB2;GPC4;PTPRD;MYOT;PTPRF;PVR;TGFB2
prerank,regulation of peptide hormone secretion (GO:0090276),0.5151130416804194,1.4730384095917188,0.04352941176470588,0.9187646617687063,1.0,7/67,6.35%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;ALOX5;ABCC8
prerank,negative regulation of cell development (GO:0010721),-0.47039190780237583,-1.472453780339652,0.04693140794223827,0.5332291329847649,1.0,7/25,15.38%,IGF1;FBN1;NOTCH1;APPL2;B2M;PTHLH;SORL1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5123654282123461,1.4718011298676168,0.0425531914893617,0.9202769708528539,1.0,16/72,8.32%,FN1;WNT16;FGFR1;NTRK3;CCL5;PLXNB1;PDGFC;GAB1;EPO;SOX9;HAX1;MYDGF;ERBB3;TGFB2;UNC5B;MAZ
prerank,response to interferon-alpha (GO:0035455),-0.5372357977906884,-1.4715626216875475,0.08064516129032258,0.5311198830071777,1.0,6/16,12.52%,GAS6;AXL;ADAR;IFNAR2;IFITM3;KLHL20
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5288676591560756,1.4715214895227142,0.05412054120541206,0.9168180001043138,1.0,6/59,2.48%,CDH1;SDK1;DSG2;CDH13;NECTIN3;FAT2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5879207983822894,1.470758968811577,0.08066759388038942,0.9158977846835539,1.0,9/28,15.67%,CDH1;ZC3H12A;MAVS;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,regulation of activated T cell proliferation (GO:0046006),-0.45258920821629295,-1.4701543703490147,0.03007518796992481,0.5309856763884495,1.0,5/30,7.03%,IGF1;IGFBP2;LGALS9;IL18;IGF2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5403156157090094,-1.4700136178502679,0.06217616580310881,0.5264960301854943,1.0,5/15,5.34%,PRKD1;SEMA5A;NOTCH1;FGF2;THBS1
prerank,positive regulation of defense response (GO:0031349),0.502344672933142,1.4698721272282274,0.045657015590200446,0.9158327559600785,1.0,20/89,15.84%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;FEM1A;POLR3B;TNFRSF1A;NMI;TLR4;POLR3C;MEF2C;TNIP1;TLR3;DHX9;POLR3G
prerank,negative regulation of autophagy (GO:0010507),0.5303867007161148,1.4697234180544698,0.06583850931677018,0.9117175397705997,1.0,12/54,14.88%,DAPL1;NRBP2;NUPR1;SNRNP70;TAB3;RUBCN;SMCR8;EIF4G2;WDR6;FOXK1;EIF4G1;WASHC1
prerank,negative regulation of cell projection organization (GO:0031345),0.5493062199622962,1.4691661997153347,0.05590851334180432,0.910081423734401,1.0,9/48,7.66%,LPAR1;RTN4R;KANK1;PRAG1;EPHA4;EFNB2;ITM2C;PTPN9;ADCY6
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7198321433748442,1.4687388030860162,0.09385665529010238,0.9076305327009484,1.0,3/10,6.57%,CD55;CD81;ZBTB7B
prerank,regulation of MAP kinase activity (GO:0043405),-0.35575726272566643,-1.468437489630839,0.0,0.5270706502203362,1.0,32/92,19.60%,FLT1;PDGFRB;KSR1;PDGFD;PTPRJ;IL34;LYN;ROBO1;FGF2;DAB2IP;CDK12;IRAK3;LRRK2;SH2B3;TGFB1;PIK3CB;EZH2;TPD52L1;PIK3R6;KIT;NF1;CD300A;EDN1;SORL1;PIK3R5;EDN3;EGF;CD40;SPRY4;SPRY1;PAQR3;MST1R
prerank,regulation of hemopoiesis (GO:1903706),0.7118023663828363,1.4684018760426887,0.08983050847457627,0.9046899816416508,1.0,4/10,12.73%,PRKCB;LGALS3;PTN;MYSM1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7117415944893191,1.4659012551676995,0.07792207792207792,0.9137779045731106,1.0,4/12,8.18%,SMO;GDNF;SOX9;SIX1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5281469713198141,-1.4658991910008212,0.057926829268292686,0.5307713009228328,1.0,9/18,13.25%,IL34;DAAM2;NOTCH1;TNFRSF21;PTPRZ1;TENM4;NF1;SLC45A3;TNFRSF1B
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5393557319672941,1.4657217065146828,0.047979797979797977,0.909934487604399,1.0,16/48,16.82%,DOCK5;FBXW8;LIMS2;S100A10;PTPRD;DMTN;ILK;CDC42;DOCK1;RREB1;CAPRIN2;SS18L2;FLNA;TESK1;CRK;ABL1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6679181836073008,1.4654973870557342,0.081377151799687,0.906407432517286,1.0,5/14,8.46%,CCL5;ADAM10;PTK2B;STK39;OXSR1
prerank,adherens junction organization (GO:0034332),0.5378194195838526,1.465483320150947,0.0547945205479452,0.9018611595890732,1.0,9/48,9.27%,CDH1;CDH13;NECTIN3;TJP1;CTNNA1;CSK;PVR;ANG;ACTB
prerank,activin receptor signaling pathway (GO:0032924),-0.5417160780803136,-1.4653651768782199,0.06793478260869565,0.5277269280116761,1.0,9/15,39.01%,ACVR1B;ACVR2A;SMAD3;ACVR1C;ACVR1;SMAD2;ACVR2B;AMHR2;INHBB
prerank,atrial septum development (GO:0003283),0.6685667927346269,1.4640347771074533,0.0867430441898527,0.9046352464136161,1.0,4/13,12.27%,ANK2;NOTCH2;TGFB2;DAND5
prerank,regulation of protein modification process (GO:0031399),0.5401629091529655,1.4632847853566873,0.06896551724137931,0.9041159199580294,1.0,13/50,14.84%,FN1;SESN2;PPP2CA;KDM4D;HSPB1;SPRED3;PML;PPP1R16A;ABCA2;RABL3;PLXNB2;CCDC88A;FLCN
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5644866010679952,-1.4632717450690036,0.07532467532467532,0.5256535612589968,1.0,4/12,10.89%,IGF1;STIMATE;LMCD1;CHERP
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5644866010679952,-1.4632717450690036,0.07532467532467532,0.5256535612589968,1.0,4/12,10.89%,IGF1;STIMATE;LMCD1;CHERP
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5603711919995984,-1.463222092477438,0.06162464985994398,0.5212680051686414,1.0,5/14,28.34%,MOXD1;ALDH9A1;SLC5A7;SLC22A2;CHAT
prerank,regulation of multicellular organism growth (GO:0040014),-0.5315659664178001,-1.4628020887294515,0.07303370786516854,0.5182267889517149,1.0,3/15,2.23%,IGF1;GHR;STAT5B
prerank,Golgi localization (GO:0051645),0.6934158780295928,1.462407844834932,0.07666098807495741,0.9043600503198947,1.0,8/11,19.80%,ARHGAP21;CDC42;YWHAZ;RIPOR1;TBCCD1;COPG1;HOOK3;UVRAG
prerank,endoderm formation (GO:0001706),0.5676809534186864,1.4611914747367645,0.06946264744429882,0.9061455013209339,1.0,4/35,5.45%,FN1;MMP9;COL6A1;DUSP1
prerank,regulation of cell junction assembly (GO:1901888),0.5987211518067357,1.461107018890617,0.06868131868131869,0.9020224001504035,1.0,6/27,3.22%,RAB17;PDLIM5;TJP1;OCLN;RAP1B;RAP1A
prerank,mitochondrion localization (GO:0051646),-0.5207465391777225,-1.4600785048240343,0.07624633431085044,0.5225072556768311,1.0,9/19,16.83%,MARK1;LRRK2;MTM1;BRAT1;MFN1;ZBED3;TRAK2;ATCAY;MSTO1
prerank,purine nucleotide metabolic process (GO:0006163),0.5964372199523293,1.459490535556522,0.07994186046511628,0.9058841168259463,1.0,4/24,6.85%,NT5E;NT5C1A;FHIT;NT5C2
prerank,dendritic cell differentiation (GO:0097028),-0.48289387971956377,-1.4592560779894583,0.05245901639344262,0.5206768925262903,1.0,5/22,4.50%,LYN;GAS6;AXL;CAMK4;LGALS9
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5223519167264679,1.4583392412137577,0.05162064825930372,0.9075813661643969,1.0,18/57,19.02%,FZR1;FOXN3;CDKN1A;MRE11;FBXO31;SDE2;CCND1;HUS1B;MDC1;TOPBP1;ABRAXAS1;CDK2;DONSON;NBN;CHEK2;ATF2;CDK5RAP3;TAOK3
prerank,regulation of developmental growth (GO:0048638),-0.4638227868561958,-1.456488956770664,0.0456140350877193,0.5249245343208566,1.0,5/29,2.23%,PLCB1;IGF1;GHR;INSR;STAT5B
prerank,regulation of T cell cytokine production (GO:0002724),0.6512595415761694,1.4562591891640126,0.08936825885978428,0.9140615310969257,1.0,4/15,11.35%,CD55;FZD5;FOXP3;TRPM4
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6993069697689249,1.4554599799250596,0.08319738988580751,0.9139134510517339,1.0,3/11,6.35%,ACTN2;CAV1;STK39
prerank,endodermal cell differentiation (GO:0035987),0.5802073441151044,1.4554270228959754,0.08176943699731903,0.9096347795407708,1.0,3/31,3.90%,FN1;MMP9;COL6A1
prerank,positive regulation of neuron death (GO:1901216),0.5387541772319467,1.4553727173566662,0.07052896725440806,0.9054748687688102,1.0,11/46,11.16%,CLU;DAXX;MAP3K5;EFNB2;NUPR1;FOXO3;FOS;TGFB2;TLR6;SRPK2;TLR4
prerank,response to cadmium ion (GO:0046686),0.5802962569680097,1.4548016498179364,0.08151382823871907,0.9041408611635283,1.0,5/26,8.54%,DAXX;MMP9;FOS;JUN;MAPK9
prerank,dendritic spine organization (GO:0097061),-0.4610265286190739,-1.4547716286151364,0.06802721088435375,0.5261241031071089,1.0,7/26,12.24%,INSR;SHANK3;DOCK10;PAK3;EPHB2;IGF1R;MTMR2
prerank,calcium import into the mitochondrion (GO:0036444),0.7095959748084342,1.4541664017196658,0.09149277688603531,0.9032498678228218,1.0,5/10,10.91%,MCU;MCUB;MICU1;AFG3L2;MCUR1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6979622702765083,1.4539917323028555,0.08731466227347612,0.8997795990440834,1.0,4/12,11.16%,VSIG1;SOX9;MUC6;TLR4
prerank,regulation of protein import into nucleus (GO:0042306),0.5568863654514,1.4539072932369093,0.09271523178807947,0.8959494305499492,1.0,12/36,16.24%,CDH1;ZC3H12A;MAVS;BMP4;CHP1;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA;UFM1
prerank,T cell mediated immunity (GO:0002456),0.6723948888057397,1.453764685469412,0.07692307692307693,0.892447704675186,1.0,2/13,2.06%,CD55;EMP2
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.472105051874892,-1.4532263801376568,0.0726643598615917,0.5268592656497432,1.0,7/25,9.23%,ERRFI1;CBLB;SLC6A9;EPHB2;ZFYVE28;SOCS5;PPARG
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.41369879663737535,-1.453199317140933,0.05172413793103448,0.5226489008420309,1.0,11/39,14.19%,ERRFI1;PTPRJ;TGFA;ITGA1;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;EPS15
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.604528341473227,1.4531890288682907,0.07334273624823695,0.891220677418241,1.0,4/23,3.61%,ANK2;ATP1A2;DIAPH1;PTK2B
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5455622961729001,1.4527891976057103,0.06037735849056604,0.8890156286234849,1.0,22/42,21.36%,EPRS1;QARS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;EEF1E1;HARS2;TARS1;SARS2;SARS1;YARS1;TARS3;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,artery morphogenesis (GO:0048844),-0.4372577077844535,-1.4522912116674978,0.023529411764705882,0.5214281634323982,1.0,11/30,14.37%,PDGFRB;JAG1;ENG;ADAMTS9;NOTCH1;PKD2;TBX2;NF1;HPGD;TBX1;BMPR2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5684904839241993,1.4522634097990348,0.07053941908713693,0.8875048351141452,1.0,4/31,11.39%,FZR1;ARRDC3;DCUN1D5;DCUN1D1
prerank,detection of visible light (GO:0009584),0.6395586601618023,1.4522386441671953,0.08928571428571429,0.8835433781170026,1.0,8/16,20.93%,RP1;CACNA2D4;GNAQ;CNGB1;PDE6B;GNA11;ABCA4;TULP1
prerank,epidermis development (GO:0008544),0.5207755761155227,1.4520725837516169,0.06273525721455459,0.8802768055010283,1.0,10/56,8.90%,SCEL;LAMC2;EDA2R;WNT10A;CCN2;FLOT2;POU2F3;OVOL2;TGM5;GRHL2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6035690549963153,-1.4511283230605572,0.07859078590785908,0.5207755327429533,1.0,7/10,24.27%,PDE3A;PDE4D;PDE3B;PDE2A;PDE11A;APLNR;RNF157
prerank,vasculature development (GO:0001944),-0.5259513240782321,-1.450853983041174,0.08206686930091185,0.517502512174531,1.0,8/16,17.15%,ERRFI1;PDGFRB;ACVRL1;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18
prerank,GPI anchor biosynthetic process (GO:0006506),0.5760642345758652,1.4496757352350333,0.08378378378378379,0.8882057366566372,1.0,12/30,19.30%,PIGU;GPAA1;PIGZ;PGAP2;PIGT;PIGA;PIGX;DPM2;PIGS;PIGN;PIGP;PIGQ
prerank,response to organonitrogen compound (GO:0010243),-0.41756411129856913,-1.449120881431234,0.03614457831325301,0.5188810825621075,1.0,16/38,21.67%,IRAK3;KAT7;RCN3;GLRA1;DNAJB12;SEL1L;DRD2;SYVN1;GLRA3;DHFR;ERLEC1;GLRA2;GLRB;BRSK2;NR1H4;UBXN6
prerank,positive regulation of exocytosis (GO:0045921),0.5544488321207881,1.4488564390131364,0.07672301690507152,0.8880899983223692,1.0,15/35,20.30%,CFTR;SYTL4;UNC13D;SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;RAB2B;RAB27A;RAB9A;ATP6AP1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5942425228795559,-1.448676906376641,0.06443298969072164,0.5163058889814067,1.0,6/11,27.64%,LYN;TNFRSF21;CD300A;RC3H1;TYROBP;FCGR2B
prerank,antibacterial humoral response (GO:0019731),0.6379666575022663,1.4482457667912574,0.09417040358744394,0.8873669872004877,1.0,6/16,19.33%,SLPI;ANG;RNASE3;PLA2G6;RNASE7;JCHAIN
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6308244954387285,-1.4472886149580708,0.06,0.5162211615051107,1.0,1/10,0.28%,ABCA1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5439658590252996,1.447171607816807,0.06901041666666667,0.8887926207839173,1.0,7/42,3.61%,CDH13;UTRN;EMP2;GFUS;CDK6;S100A10;PTK2B
prerank,positive regulation of ossification (GO:0045778),-0.4165857711677593,-1.446851328634951,0.03669724770642202,0.5136278322152572,1.0,11/39,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;WNT5A;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6811207178792278,1.4449529670756458,0.10726072607260725,0.8960581489009971,1.0,2/13,2.17%,B3GALT1;B4GAT1
prerank,epidermal cell differentiation (GO:0009913),0.5414132805118272,1.4438617265363531,0.08545918367346939,0.8972929583550717,1.0,2/41,0.45%,WNT16;SCEL
prerank,aminoglycan catabolic process (GO:0006026),0.5823392841345298,1.4434120135595518,0.08977900552486189,0.8953245194182303,1.0,8/28,10.09%,GPC6;GPC1;GPC4;NAGLU;SDC4;GLB1;GPC3;GUSB
prerank,aminoglycan metabolic process (GO:0006022),-0.6126792059910933,-1.4425722146885824,0.07506702412868632,0.522410962563019,1.0,8/10,34.97%,XYLT1;XYLT2;B3GAT3;B4GALT7;CLN6;B3GAT1;CHST9;B3GALT6
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3428792687166021,-1.4418394523859195,0.0,0.5208869407681226,1.0,47/107,21.36%,GRIK2;CDH2;NRG3;SLC8A3;GRID2;GRM3;SNCAIP;GRM7;LRRC4C;LGI1;GRM8;SLC12A2;MCTP2;DLGAP1;SYT1;LRRK2;GRM5;GRIK3;CLSTN2;NLGN1;LRP8;DGKI;CNTNAP4;GRIK1;GRIK4;TMEM108;NLGN3;DRD2;BDNF;CAMK2A;MCTP1;CLN3;KCNMB4;BAIAP3;CPLX2;GRM1;NPTX1;FMR1;PXK;KCTD13;STX1B;GRIK5;CX3CR1;CACNA1B;TPRG1L;RIMS1;DGKZ
prerank,cellular response to fluid shear stress (GO:0071498),0.679933246609919,1.4417211198792574,0.08723747980613894,0.9001023309759079,1.0,8/12,19.45%,KLF4;SREBF2;NFE2L2;MAPK7;HDAC3;MEF2C;ASS1;KLF2
prerank,lipoprotein transport (GO:0042953),0.6919476857687973,1.4412630442774732,0.08881578947368421,0.8983863511390537,1.0,2/10,5.90%,PRKCB;UNC119
prerank,B cell receptor signaling pathway (GO:0050853),0.5589364854416805,1.4404383338205582,0.08133333333333333,0.8986035915266172,1.0,2/32,0.33%,PRKCB;NFATC2
prerank,regulation of cell morphogenesis (GO:0022604),0.5681245205934696,1.4404321690105708,0.08930987821380243,0.8946625045256328,1.0,12/30,18.39%,CD44;FMNL2;ZMYM6;CAPZB;EFNA5;MOV10;STRIP1;ZMYM4;PDPN;CAMSAP1;NTNG2;WTIP
prerank,amino acid import (GO:0043090),-0.4898078971505757,-1.440381645334596,0.08024691358024691,0.5216620292662819,1.0,7/21,8.62%,SLC1A3;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC1A1;SLC6A1
prerank,actin filament depolymerization (GO:0030042),0.6857645444577101,1.4401739490939294,0.1038961038961039,0.8921164871459145,1.0,4/11,7.80%,GSN;MICAL2;TWF1;MICAL1
prerank,UV protection (GO:0009650),0.6987875804040333,1.4399695054923893,0.1054421768707483,0.889236700192155,1.0,2/10,2.72%,SCARA3;FEN1
prerank,negative regulation of complement activation (GO:0045916),0.697768381926706,1.4394736440650837,0.09523809523809523,0.8879510785119585,1.0,1/10,0.15%,CD55
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5831543180531529,1.4388013531306845,0.09305555555555556,0.8873178750964947,1.0,5/25,6.82%,CFTR;ANK2;ACTN2;STK39;ANK3
prerank,transport along microtubule (GO:0010970),0.6323918599971673,1.4377152122872525,0.10108864696734059,0.8889699580308216,1.0,4/13,9.28%,DYNC1I1;ARHGAP21;CDC42;BAG3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6515551057263985,1.4376901952968437,0.08530805687203792,0.8853551852369647,1.0,2/13,6.57%,SORBS1;ZBTB7B
prerank,protein K11-linked ubiquitination (GO:0070979),0.5675815310452812,1.4375767588026371,0.08969210174029452,0.882208930540946,1.0,1/27,0.05%,FZR1
prerank,response to UV-A (GO:0070141),0.6489057058200355,1.4372204636484638,0.09779179810725552,0.8803840415708165,1.0,4/14,9.75%,OPN1SW;MMP9;TIMP1;CCND1
prerank,negative regulation by host of viral transcription (GO:0043922),0.6832706392187061,1.4371426486495884,0.09908536585365854,0.8770285360609629,1.0,3/12,8.33%,CCL5;POU2F3;JUN
prerank,regulation of stress fiber assembly (GO:0051492),0.49259632158821687,1.4371309575620537,0.07052023121387284,0.8733825284720359,1.0,27/74,16.87%,PHLDB2;LPAR1;TJP1;ARAP1;CCN2;WNT11;S100A10;TMEFF2;ARHGEF18;PXN;CDC42;ARHGEF5;RHPN2;ACTG1;DLC1;RAPGEF3;RHOA;ASAP3;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PPFIA1;PFN2;ABL1;SLC9A1
prerank,nucleotide catabolic process (GO:0009166),0.6382661298437405,1.437057520176457,0.0878594249201278,0.8700888159650995,1.0,4/16,9.45%,NT5E;NT5C1A;NT5C2;DERA
prerank,cellular response to organonitrogen compound (GO:0071417),0.48251793034144064,1.4367349232122206,0.043429844097995544,0.8682203845396672,1.0,22/99,14.10%,CDH1;CFTR;RAP1B;RAP1A;DIAPH1;CTNNA1;SESN2;SH3BP4;SOX9;DMTN;AANAT;GOLPH3;CAPN2;ACTB;EZR;HTR1B;AQP1;RAPGEF3;CPEB3;TRPM2;MEF2C;SFRP1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5650621685288328,-1.4366434698123869,0.06914893617021277,0.5292098121234958,1.0,2/13,2.37%,KCNT2;KCNK5
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.688473871199375,1.436628626036124,0.09046849757673667,0.8651868983173622,1.0,2/12,4.26%,CD44;GCNT2
prerank,cardiac cell development (GO:0055006),0.6801058507619165,1.4363171042349656,0.0985691573926868,0.8631274179244202,1.0,1/11,0.07%,CXADR
prerank,embryonic appendage morphogenesis (GO:0035113),0.6640299547692837,1.4361723528483044,0.0929853181076672,0.8602139966997353,1.0,2/12,7.39%,MBNL1;TGFB2
prerank,neutrophil chemotaxis (GO:0030593),0.5240853418075413,1.4358888224524287,0.07347447073474471,0.8581714743706803,1.0,4/53,8.28%,CXADR;CCL5;TGFB2;LGALS3
prerank,cell-cell junction maintenance (GO:0045217),0.6801079015846553,1.4343356514006838,0.09888357256778309,0.862106882849165,1.0,4/11,17.29%,TJP1;NLGN2;PRTN3;F2R
prerank,negative regulation of angiogenesis (GO:0016525),-0.36174685015632146,-1.434228594791371,0.034722222222222224,0.5327516543743775,1.0,33/84,17.33%,PTPRM;DCN;SULF1;SEMA6A;TEK;ADAMTS9;CLDN5;EPN2;PDE3B;SLC12A2;DAB2IP;THBS1;COL4A2;SEMA3E;RGCC;THBS2;GTF2I;SERPINF1;PIK3CB;ROCK1;MECP2;PPARG;ISM1;NPR1;SPARC;AMOT;AGO1;HSPG2;NAXE;STAB1;HHEX;MINAR1;SPRED1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6598648755474287,1.4338585557934973,0.09134615384615384,0.8609863586346469,1.0,6/13,12.86%,CLU;NUPR1;ALOX5;USP19;EIF2AK3;LPCAT3
prerank,establishment of melanosome localization (GO:0032401),0.6199786037321549,1.4334659840708555,0.08968609865470852,0.8593737975787915,1.0,5/19,13.36%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6245274013759211,1.432098778330657,0.08431952662721894,0.862519938510664,1.0,2/18,2.01%,PRKCB;OCLN
prerank,muscle contraction (GO:0006936),0.4733662931329679,1.4320371547434951,0.04432432432432432,0.859346712967315,1.0,15/126,7.04%,SORBS1;MYOM2;UTRN;ACTN2;CALD1;VIM;TMOD3;SGCA;TMOD2;LMOD3;MYOT;CRYAB;GAMT;PXN;SNTB1
prerank,melanosome transport (GO:0032402),0.6225590558068972,1.4308184518232787,0.10391566265060241,0.8584650406144422,1.0,5/18,13.36%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,pigment granule transport (GO:0051904),0.6225590558068972,1.4308184518232787,0.10391566265060241,0.8584650406144422,1.0,5/18,13.36%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,cellular response to cAMP (GO:0071320),0.5641663976991179,1.430661283288652,0.07534246575342465,0.8557895288520284,1.0,8/30,11.20%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6190955223265863,1.430497460700668,0.0913312693498452,0.8530405645884475,1.0,7/17,16.82%,BAIAP2L1;NTRK3;HAX1;CDC42;BCAS3;HRAS;ABL1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.6239380508469652,1.4300694544483379,0.09345794392523364,0.8517122995086952,1.0,10/19,21.53%,SREBF2;HAX1;FZD5;VDAC1;GSK3A;DNM1L;HDAC6;PARK7;SREBF1;FBXW7
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6842930625496789,1.4300562490759992,0.10217755443886097,0.848453042635901,1.0,2/11,7.17%,EGLN3;EGLN2
prerank,basement membrane organization (GO:0071711),-0.5420702086377531,-1.4299776940984497,0.06561679790026247,0.5417745534945368,1.0,8/14,9.67%,FLRT2;NID1;NID2;COL4A1;LAMB1;NTN4;NTNG1;RAMP2
prerank,lipoprotein localization (GO:0044872),0.6723657956304663,1.4292473934108731,0.09562398703403566,0.8491221124302127,1.0,2/11,5.90%,PRKCB;UNC119
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6562475294535786,1.4269115685845084,0.08429752066115702,0.8567376618771669,1.0,4/13,13.96%,B4GALNT2;NAGK;UAP1L1;GFPT1
prerank,response to laminar fluid shear stress (GO:0034616),0.6987981058928245,1.4259551804600021,0.09515859766277128,0.8580540177146109,1.0,5/10,6.86%,KLF4;SREBF2;SMAD6;NFE2L2;MAPK7
prerank,negative regulation of blood pressure (GO:0045776),-0.5470672716930881,-1.425233952167035,0.08222811671087533,0.5527395044558349,1.0,8/13,38.51%,NOS3;DRD2;BMPR2;PRCP;GPR37L1;APLN;NOS2;DRD3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5224271690558736,1.4229420760524554,0.09923664122137404,0.868847558536247,1.0,14/46,15.67%,CDH1;ZC3H12A;MAVS;TCF7L2;BAG3;ZIC1;HDAC3;RAPGEF3;UBR5;GSK3B;NEDD4;ZPR1;DHX9;FLNA
prerank,Rho protein signal transduction (GO:0007266),0.5199756725332533,1.4228890537168513,0.06997455470737914,0.8657616403191393,1.0,15/53,16.31%,AGTR1;CDH13;CELSR1;EPS8L2;CDC42EP4;CDC42EP5;ARHGAP29;CDC42;GNA13;RHOA;PDPN;RHOU;ARHGDIB;RIPOR1;ARHGEF1
prerank,regulation of protein processing (GO:0070613),-0.48399669953916524,-1.4222798547137459,0.065625,0.5576619357891645,1.0,9/21,25.77%,CCBE1;RUNX1;SERPINE2;LRRK2;NKD2;CLN3;GAS1;BAG2;ADAM8
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.40590113447656095,-1.4216465498824449,0.0392156862745098,0.5556435152705866,1.0,10/40,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,positive regulation of phospholipase activity (GO:0010518),0.5774526186909258,1.420997038180586,0.10289855072463767,0.8713185008492091,1.0,4/22,1.51%,AGTR1;FGFR1;NTRK3;CCL5
prerank,granulocyte chemotaxis (GO:0071621),0.5168308884231958,1.4209289721220253,0.07462686567164178,0.8682543807749091,1.0,4/55,8.28%,CXADR;CCL5;TGFB2;LGALS3
prerank,artery development (GO:0060840),-0.4713294805044255,-1.4203225264016517,0.07,0.5554577369398153,1.0,9/23,14.37%,ENG;ROBO1;ACVRL1;PKD2;ROBO2;PDE2A;NF1;TBX1;BMPR2
prerank,positive regulation of cation channel activity (GO:2001259),0.539767305625349,1.4191390477708161,0.08300907911802853,0.8734860900722583,1.0,7/40,7.99%,ANK2;ACTN2;GAL;STAC3;ANK3;GSTO1;JPH2
prerank,cation transmembrane transport (GO:0098655),0.5218727895024137,1.4186797253385484,0.0842911877394636,0.8722628991197546,1.0,13/44,15.34%,TRPM3;ATP1A2;TRPM8;ABCC8;SFXN3;SLC36A4;SFXN1;TRPM6;SLC25A38;TRPM4;PKD2L1;TRPM2;SLC7A3
prerank,nuclear migration (GO:0007097),0.6494567411351391,1.4186086943974958,0.09967320261437909,0.8692789786645366,1.0,9/13,24.61%,DOCK7;SYNE3;PAFAH1B1;DYNC1H1;SUN2;TMEM201;HOOK3;CEP120;PCM1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6840414181954073,1.4178216377844237,0.11467116357504216,0.8697991912479756,1.0,2/12,2.17%,B3GALT1;B4GAT1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5613752170008361,-1.417545719325605,0.08743169398907104,0.5607337629197888,1.0,5/11,7.45%,SEMA6A;ADAMTS9;EPN2;THBS1;PIK3CB
prerank,aortic valve morphogenesis (GO:0003180),-0.45338412801018696,-1.4175333507244252,0.07924528301886792,0.5568145153229058,1.0,12/30,8.93%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5473076048969391,1.4171364162491424,0.07458563535911603,0.8699940559566595,1.0,6/32,7.25%,SORBS1;PRKAA2;CREBL2;AVIL;CREB1;EIF6
prerank,positive regulation of neuron migration (GO:2001224),-0.577956111400525,-1.4169941108184956,0.08557457212713937,0.5547374076039906,1.0,5/11,13.56%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL
prerank,myoblast fusion (GO:0007520),0.6730928083172925,1.4169494023953526,0.10766721044045677,0.8676702836666473,1.0,3/12,5.41%,ADAM12;CD81;CD9
prerank,replicative senescence (GO:0090399),0.6669501796382055,1.4168726926936286,0.12399355877616747,0.8647814236310416,1.0,1/12,0.08%,WNT16
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.35690101296300847,-1.4168557470529053,0.029411764705882353,0.551177524796592,1.0,26/75,19.38%,PTPRJ;NR2F2;SLC8A1;SLC8A3;LYN;PKIG;DAB2IP;IRAK3;SH2B3;APC;PIK3CB;LRP6;IPO5;LRP5;PRKAR2B;NF1;RASIP1;CD300A;SORL1;MYOCD;HHEX;INCA1;PRKAR1B;SPRY4;SPRY1;PAQR3
prerank,regulation of endocytic recycling (GO:2001135),0.6598205087991849,1.4167985320577023,0.09286898839137644,0.8619399137593831,1.0,3/11,10.94%,ACTN2;EHD1;ATP9A
prerank,epiboly involved in wound healing (GO:0090505),0.6271986474465245,1.416294134674008,0.09865470852017937,0.8610968264764015,1.0,7/16,15.67%,CD44;TMEFF2;TOR1A;RHOA;PDPN;DDR1;FLNA
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.46954830324190533,1.4152129009420726,0.05423728813559322,0.862846376206329,1.0,18/100,8.32%,FN1;WNT16;FGFR1;NTRK3;PIK3IP1;CCL5;PLXNB1;PDGFC;GAB1;EPO;TSC2;SOX9;HAX1;MYDGF;ERBB3;TGFB2;UNC5B;MAZ
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6055591242348364,1.415142632478809,0.1046875,0.8599994584307372,1.0,12/18,18.80%,KANK1;RAP1B;PTK2B;RIPOR2;KRIT1;LLGL2;BCAS3;ARFGEF1;CDH5;SHTN1;KIF20B;ROCK2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6537334051983364,1.4150219577244534,0.09369951534733441,0.8574720245480612,1.0,2/12,6.57%,SORBS1;ZBTB7B
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4563987154080964,1.413978008717443,0.043478260869565216,0.8591430777131083,1.0,42/144,16.89%,CDH1;SREBF2;BBC3;ZC3H12A;MAVS;PMAIP1;CD81;PPP1R13B;ANK3;BAD;PLK3;FZD5;TCF7L2;CHP1;YWHAB;BAG3;MIEF2;ZIC1;YWHAQ;MYO1C;KCNB1;AKAP5;BCAS3;HDAC3;RAPGEF3;SAE1;VPS11;YWHAZ;NPEPPS;RHOU;GSK3A;UBR5;GSK3B;HRAS;ZPR1;ITGB1BP1;RNF31;ITGB2;FLNA;RIPOR1;E2F1;UBE2D3
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6455755220001781,1.4137926517062371,0.0970873786407767,0.856958901974899,1.0,7/14,19.44%,PPARGC1A;PMAIP1;NNMT;IRS2;PTPN2;DDB1;GPLD1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5975888257640365,1.4137623312795258,0.11353711790393013,0.8509401658489508,1.0,6/21,7.90%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5975888257640365,1.4137623312795258,0.11353711790393013,0.8509401658489508,1.0,6/21,7.90%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.568557675673617,1.413584074119804,0.09523809523809523,0.8488162198238003,1.0,10/27,16.83%,CD44;DDX5;PMAIP1;YJU2;SPRED3;TWIST1;EEF1E1;MDM2;ATR;KDM1A
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5577284308995347,-1.4126728146683765,0.08831908831908832,0.5606292439946136,1.0,7/13,20.98%,ENPP1;ENTPD1;ITPA;ENPP3;ENTPD3;ENTPD5;ENTPD6
prerank,regulation of wound healing (GO:0061041),0.5351225795531697,1.4112605145420303,0.09445843828715365,0.856948937192458,1.0,12/42,17.29%,CD109;KANK1;OCLN;CAV1;ALOX5;DMTN;CASK;ACTG1;ARFGEF1;HRAS;CRK;F2R
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.500792286922429,-1.4106612684228115,0.0790273556231003,0.5630767201454052,1.0,7/19,11.38%,PTPRJ;TEK;KDR;TSC1;ROCK1;MAP4K4;MYOC
prerank,response to acidic pH (GO:0010447),0.65924354995719,1.409814577925331,0.12597200622083982,0.8605780221481616,1.0,4/13,11.40%,GPR4;CHP1;RAB11FIP5;PKD2L1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6509624781191952,1.4094653142382068,0.10526315789473684,0.8591217715405486,1.0,5/12,12.86%,SOAT1;DGAT1;ACSL3;SOAT2;LPCAT3
prerank,presynapse organization (GO:0099172),-0.5892813332398089,-1.407460376219323,0.08716707021791767,0.569286421845989,1.0,5/10,16.06%,WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,membrane raft organization (GO:0031579),0.6304843645574819,1.4073052433308362,0.12844036697247707,0.8663840054131412,1.0,5/15,6.90%,EMP2;S100A10;FLOT2;NPC1;ANXA2
prerank,regulation of neuron apoptotic process (GO:0043523),0.4799163206433694,1.4062912227167528,0.05102040816326531,0.8681952635870225,1.0,18/96,10.71%,EGLN3;CRLF1;PPARGC1A;NRBP2;NUPR1;NGF;PTK2B;FOXO3;GDNF;CLCF1;EGLN2;ERBB3;TGFB2;UNC5B;SIX1;KCNB1;SRPK2;SOD2
prerank,cholesterol transport (GO:0030301),0.5175485649467956,1.4060608244471389,0.09831824062095731,0.8662759789868286,1.0,12/45,18.14%,CLU;LDLR;SOAT1;CAV1;STARD3;NPC1;SOAT2;STARD4;VPS4A;OSBPL5;RELCH;OSBPL2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5937743598010782,1.4052118361585915,0.11988304093567251,0.8670527873760498,1.0,1/22,0.15%,CD55
prerank,actin polymerization or depolymerization (GO:0008154),0.5159320877223617,1.4048426647513286,0.08793969849246232,0.8658531236909646,1.0,14/50,12.09%,COBL;VILL;GSN;MICAL2;DIAPH1;CORO7;ENAH;TWF1;AVIL;ANG;MICAL1;MSRB2;ABI1;WASF1
prerank,cell junction organization (GO:0034330),0.4827640586361446,1.4039863686788008,0.07879490150637311,0.8668407693422641,1.0,13/71,9.27%,CXADR;SDK1;TJP2;TJP1;OCLN;LIMS2;MYOT;TGFB2;ILK;CDC42;GRHL2;OPHN1;ACTB
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5141820611248896,-1.4038163301507423,0.09144542772861357,0.5772068431300803,1.0,7/15,22.43%,GNAS;UBR3;DRD2;GNAL;BBS4;SYT10;ADCY3
prerank,AMP metabolic process (GO:0046033),0.6625338567381396,1.4035681349422027,0.12479474548440066,0.865753736430365,1.0,4/13,10.00%,NT5E;NT5C1A;NUDT2;AK3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6499834391211419,1.4035560951510362,0.11352253756260434,0.8628406129611214,1.0,6/12,19.48%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.6462137531626237,1.4035229035083436,0.11726384364820847,0.8600367161191504,1.0,10/12,26.19%,IDH3G;GLUD1;ACO2;IDH3A;ASS1;SIRT4;ACO1;ACLY;IDH1;IDH2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6308652459534414,1.4034824557639571,0.11700468018720749,0.8572486735146645,1.0,3/15,2.86%,CDH13;NTRK3;IL16
prerank,sensory perception of pain (GO:0019233),-0.4817223513489907,-1.4031038247990093,0.078125,0.5757756707384436,1.0,16/21,38.44%,RETREG1;PTGES;MME;OPRM1;OPRK1;NIPSNAP1;TRPA1;CHRNA4;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,negative regulation of protein metabolic process (GO:0051248),0.5213238595676222,1.4020882463207351,0.07633587786259542,0.8608365460821306,1.0,11/48,12.17%,CLU;LDLR;PFDN1;HMGCR;FLOT2;CRYAB;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6862709672355094,1.4018692019063284,0.12141652613827993,0.8588045245041578,1.0,1/10,0.09%,PRKCB
prerank,cellular response to organic cyclic compound (GO:0071407),0.4557926549998919,1.401678545163846,0.04216216216216216,0.8568573412433534,1.0,25/141,11.20%,CDH1;CFTR;ADTRP;NCOA3;CCL5;RORC;RAP1B;ZC3H12A;ATP1A2;RAP1A;DIAPH1;CTNNA1;FAM210B;INSIG1;LCOR;DMTN;AANAT;MSN;GOLPH3;ADCY6;ACTB;EZR;ARL6IP5;AQP1;RAPGEF3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.46578878590004025,-1.4015704583690411,0.10344827586206896,0.5769931237976041,1.0,10/21,13.02%,SULF1;HS6ST2;NDST3;HS6ST3;XYLT1;EXTL3;XYLT2;EXT2;HS3ST3B1;B3GAT3
prerank,proteoglycan metabolic process (GO:0006029),-0.4468193738419569,-1.4008220404265808,0.06620209059233449,0.5754741938099485,1.0,11/26,16.87%,IGF1;ADAMTS12;SULF1;XYLT1;BMPR1B;CSGALNACT1;CHST8;CANT1;BMPR2;CHST10;B4GALT7
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4445878551389566,-1.400169776078418,0.08064516129032258,0.5738207822737325,1.0,6/27,5.61%,SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC7A5;SLC1A1
prerank,lamellipodium organization (GO:0097581),0.5515166367591567,1.4001469901499255,0.10072992700729927,0.8612492346512967,1.0,10/29,18.38%,CDH13;ABLIM2;ABLIM1;DMTN;GOLPH3;ARFIP2;WASF1;CCDC88A;VCL;ARHGEF6
prerank,negative regulation of cholesterol transport (GO:0032375),0.6995596996564766,1.399847402169789,0.11904761904761904,0.8598611540978569,1.0,2/10,11.07%,SREBF2;ABCA2
prerank,intraciliary retrograde transport (GO:0035721),-0.5619667615698919,-1.3972956703420885,0.10294117647058823,0.5794809667126143,1.0,7/12,28.11%,IFT122;TTC21B;WDR19;IFT43;DYNC2LI1;DYNC2I2;IFT140
prerank,positive regulation of protein sumoylation (GO:0033235),0.6767657229454267,1.3970258712232646,0.11993243243243243,0.8702388772591763,1.0,5/10,12.89%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,positive regulation of vascular permeability (GO:0043117),0.6488302640542138,1.396962644878309,0.11987381703470032,0.867645567726184,1.0,4/12,2.01%,ANGPT1;TJP2;TJP1;OCLN
prerank,N-terminal protein amino acid modification (GO:0031365),0.635306160301187,1.3959960510512668,0.13186813186813187,0.8693523579948113,1.0,8/14,21.55%,PDF;NAA40;NTMT1;AANAT;NAA15;NAA10;NAA35;METAP1D
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6799882765638317,1.3957633339209654,0.09866220735785954,0.8674255291305173,1.0,9/10,30.15%,ACADL;ACADM;IVD;GCDH;ACAD11;ETFDH;ETFB;ETFA;ACADVL
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4902295811432714,1.3935017946643744,0.07792207792207792,0.8751365184575268,1.0,15/68,19.00%,CUBN;AMN;CYB5R3;GSTO1;NNMT;SHMT1;ALDH1L2;PCCA;SLC19A2;ALDH1L1;VNN1;MMAB;PDXK;SLC19A1;MCCC2
prerank,protein localization to membrane (GO:0072657),0.4491396143300157,1.3929441695067675,0.02821316614420063,0.8749184750477124,1.0,36/187,10.19%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;MAGI2;CAV1;ITGB7;RAP1A;CD81;S100A10;CACNB3;EHD1;ARL3;FYB2;RAMP1;FLOT2;FRMPD1;NPC1;SYNE3;ANK3;CPE;ZFYVE27;PACS1;RAB3B;STXBP1;NDC1;TNFRSF1A;MYO5A;EZR;KCNB1;SYNJ2BP
prerank,negative regulation of protein secretion (GO:0050709),0.5244936520340355,1.3929356136095545,0.09411764705882353,0.8720736112273744,1.0,12/38,17.29%,ADTRP;CD200;HMGCR;RAB11FIP3;CYP51A1;KCNB1;RAB11FIP5;SERGEF;RHBDF2;SFRP1;RAB11FIP1;F2R
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.496341174914233,1.3929103907456601,0.08561236623067776,0.8693128722068931,1.0,17/66,15.77%,CDH1;LIMK2;ZC3H12A;MAVS;SESN2;ORMDL3;LARP7;BAG3;ZIC1;HDAC3;EIF2AK3;PINX1;UBR5;ZPR1;FLNA;TESK1;MEPCE
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3215725763381328,-1.3928562963111937,0.0,0.589750671078811,1.0,40/138,13.71%,FLT1;PTPRG;ROR1;PDGFRB;EPHA7;TEK;IL31RA;INSR;MERTK;MPZL1;LIFR;LYN;PTK2;AXL;TIE1;PDGFRA;KDR;ACVR1B;EPHB2;EPHB4;ROR2;PIK3CB;NTRK2;JAK2;ACVR2A;ERBB4;FGFR2;RYK;AHI1;KIT;NPR1;BLNK;PTPRT;IGF1R;IL6ST;FGFR4;BDNF;FLT4;RET;EPHA5
prerank,platelet degranulation (GO:0002576),0.46535198076108114,1.3926505247293834,0.06304347826086956,0.8677078740683526,1.0,16/118,8.79%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;VEGFB
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6591483539680809,1.391801675088803,0.1445578231292517,0.8686281340407237,1.0,3/10,5.14%,ADTRP;CD200;RIPOR2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5766391839207199,1.3915685954892683,0.10113960113960115,0.8668803757289104,1.0,7/24,10.78%,PHLDB2;TJP1;ARAP1;TMEFF2;ARHGEF18;RHPN2;DLC1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6009348236666971,1.3913359188357175,0.12050078247261346,0.8652052976689272,1.0,4/17,9.19%,KLF4;ANXA4;OTUD7B;TLR6
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6809225792062461,1.3907031880419196,0.13266998341625208,0.8653428671123831,1.0,2/10,6.82%,CAV1;ANK3
prerank,response to cAMP (GO:0051591),0.5288983970018536,1.3905937959712287,0.08994708994708994,0.8630709937129176,1.0,8/37,11.20%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5318370740970761,1.3905555658722881,0.09635416666666667,0.8604301122031758,1.0,7/37,11.35%,PHLDB2;MAPRE2;PRKAA2;MAP6;EFNA5;GAS2L1;EPHA3
prerank,macrophage differentiation (GO:0030225),0.6355413966327914,1.390328258758522,0.13385826771653545,0.858704772826102,1.0,4/13,8.49%,MMP9;IL15;BMP4;CDC42
prerank,extracellular matrix organization (GO:0030198),0.43873289687000283,1.388441755996885,0.019328585961342827,0.8644486254960262,1.0,26/276,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;COL25A1;CD44;ITGB8;LAMA4;TMPRSS6;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;ADAM10;GSN;COL5A2;ITGB7;LAMA5
prerank,signal transduction by p53 class mediator (GO:0072331),0.5509575565737632,1.387534914820138,0.11288180610889774,0.865925748756409,1.0,12/30,17.99%,FHIT;NDRG1;DDX5;PMAIP1;SESN2;PPP1R13B;USP10;ATRX;PDK2;POU4F1;NBN;TRIAP1
prerank,"phototransduction, visible light (GO:0007603)",0.6326289752572994,1.3867720114796958,0.12261146496815287,0.8666580932527285,1.0,5/14,15.15%,RP1;GNAQ;CNGB1;PDE6B;GNA11
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5281589531628404,-1.3865031475258767,0.10761154855643044,0.6066491519345916,1.0,4/12,17.23%,LYN;RUNX1;CD300A;RC3H1
prerank,positive regulation of locomotion (GO:0040017),-0.43389691295178306,-1.3862760074557339,0.07473309608540925,0.6034490476009507,1.0,14/27,32.90%,PDGFRB;SPOCK2;THBS1;TGFB1;CFAP20;RARRES2;P2RY12;CCL19;AKT2;PPM1F;AIF1;TRIM32;TREM2;CAVIN1
prerank,transepithelial transport (GO:0070633),0.6231285437541144,1.386259984911453,0.125,0.866275181349533,1.0,1/15,0.07%,CXADR
prerank,cell chemotaxis (GO:0060326),0.4969666852650158,1.38538692275677,0.07756563245823389,0.8674597044656621,1.0,10/60,5.95%,AGTR1;LPAR1;CCR4;PARVA;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6520534021980424,1.3853230361657178,0.12355848434925865,0.864972580282864,1.0,5/12,11.69%,PPARGC1A;ABCD1;MTLN;TWIST1;IRS2
prerank,response to glucocorticoid (GO:0051384),-0.43612869275488697,-1.3850845732339943,0.08,0.6034650404851541,1.0,8/26,21.46%,SLIT2;BCL2L11;SLIT3;ADAM9;PDCD7;ZFP36;NR3C1;GOT1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5242603938242328,1.3848212756498082,0.10040160642570281,0.8644988204494306,1.0,6/43,6.57%,PRKCB;SORBS1;KANK1;OGT;TSC2;ZBTB7B
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.632759761195903,1.3830639756100684,0.11904761904761904,0.8695117143220511,1.0,5/13,16.83%,CD44;YJU2;TWIST1;MDM2;KDM1A
prerank,histone H3-K4 trimethylation (GO:0080182),0.6389102594082148,1.3825219609313035,0.13838550247116968,0.8692311827865303,1.0,3/11,9.04%,OGT;BEND3;KMT2A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.5235729882603785,1.3823245472393255,0.09595959595959595,0.8673375733998682,1.0,6/39,6.35%,UTRN;ANK2;FHL1;WWP2;AHCYL1;STK39
prerank,ketone body metabolic process (GO:1902224),-0.5825507892830767,-1.3818775608861422,0.10972568578553615,0.6095060699565442,1.0,4/10,9.40%,ACSS3;HMGCLL1;HMGCS2;BDH1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5889689438791621,1.3816345010795792,0.10932944606413994,0.8678842716388163,1.0,4/20,6.35%,ACTN2;MMP9;EPO;STK39
prerank,respiratory system development (GO:0060541),-0.41853682332535974,-1.3815442520750525,0.07894736842105263,0.6067212334724844,1.0,14/32,18.01%,GLI2;FGF2;CHD7;FGFR2;LOXL3;SPEF2;BASP1;SMCHD1;NPHP3;ZIC3;RBP4;ABCA3;FGF9;DISP1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6099542527831233,1.3809162060113842,0.11864406779661017,0.8683570185206007,1.0,3/15,4.40%,UST;CHST12;DSE
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5802546581457868,1.3806722112097751,0.11473087818696884,0.8666977160038808,1.0,5/24,9.59%,NT5E;CCL5;GFUS;MSN;EZR
prerank,positive regulation of insulin secretion (GO:0032024),0.5248127953740394,1.3806274466356414,0.11409395973154363,0.8642800623826649,1.0,14/36,20.24%,CFTR;MCU;GLUD1;BAD;TCF7L2;TRPM4;IRS2;AACS;PLA2G6;NLGN2;STX4;GPER1;GPLD1;SOX4
prerank,manganese ion transport (GO:0006828),-0.521544845241554,-1.3805715046048894,0.1048158640226629,0.606186511724444,1.0,6/14,10.96%,SLC30A10;TRPC3;TRPC4;SLC39A8;TRPC6;TRPC5
prerank,regulation of lymphocyte migration (GO:2000401),0.6694149965147177,1.3802762237161372,0.16155088852988692,0.8632940217142343,1.0,5/10,21.68%,ADTRP;MSN;SLC8B1;JAM2;MIA3
prerank,nucleotide biosynthetic process (GO:0009165),-0.49481246781599786,-1.3800531650183152,0.10149253731343283,0.6043263108189966,1.0,5/18,11.72%,ME1;HPRT1;PRPSAP2;RRM1;PNP
prerank,negative regulation of defense response to virus (GO:0050687),0.6746840277539934,1.379958777832099,0.12933753943217666,0.8619381333931782,1.0,6/10,24.23%,PPM1B;TARBP2;MUL1;ILRUN;PCBP2;C1QBP
prerank,steroid hormone biosynthetic process (GO:0120178),0.5542679179795149,1.3799030580722669,0.10482758620689656,0.8595449043955828,1.0,6/29,11.13%,STARD3;HSD17B14;DHCR7;SRD5A3;FDX1;HSD17B11
prerank,tRNA aminoacylation (GO:0043039),0.5305038926667394,1.3798881034268209,0.10677083333333333,0.8569974652942023,1.0,19/37,21.36%,EPRS1;QARS1;VARS1;FARS2;HARS1;LARS2;AARS1;EEF1E1;HARS2;TARS1;SARS2;SARS1;YARS1;GATB;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,cardiac muscle cell development (GO:0055013),0.5898988433817876,1.379627609425172,0.10183875530410184,0.8555227059537918,1.0,3/20,3.66%,CXADR;PDLIM5;CSRP3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.671629664663457,1.3796200242958407,0.1273344651952462,0.8504202588516954,1.0,3/10,14.45%,KLF4;MAPK7;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.671629664663457,1.3796200242958407,0.1273344651952462,0.8504202588516954,1.0,3/10,14.45%,KLF4;MAPK7;WNK1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3932681643154233,-1.3793779166041917,0.03902439024390244,0.6028611677305405,1.0,21/48,22.81%,ROBO1;GAS6;IRAK3;NR1H3;PARP14;SH2B3;SLIT2;RFFL;SAMHD1;PPARG;NLRC5;PADI2;SLIT3;NR1H2;PELI3;CCDC3;CNOT7;TRAIP;SIGIRR;GPS2;YTHDF2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5440633219474348,1.3787414728254241,0.1166429587482219,0.8516901920831679,1.0,8/29,14.70%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;TMEM86B;LPCAT3;PLA2G6
prerank,actin filament bundle assembly (GO:0051017),0.5405703207843746,1.3782937502381318,0.11066666666666666,0.8511837391366281,1.0,8/33,9.59%,BAIAP2L1;PAWR;CALD1;ESPN;ADD1;DMTN;MICAL1;EZR
prerank,negative regulation of macrophage activation (GO:0043031),0.6059171174992974,1.377764212978178,0.13884785819793205,0.8509673199155193,1.0,3/16,2.55%,LDLR;CD200;ZC3H12A
prerank,blood circulation (GO:0008015),0.5107560196032493,1.3771010073225756,0.10165184243964422,0.8516047870292641,1.0,7/49,4.46%,AGTR1;SGCG;F5;COL4A3;SGCD;CYB5R3;EPO
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5889315272726088,-1.3770520828542774,0.10101010101010101,0.6064388976361911,1.0,6/10,12.35%,DCN;KDR;BCL2;LRRK2;MYOC;RACK1
prerank,regulation of mast cell activation (GO:0033003),-0.5692806086270532,-1.3765846385293334,0.1111111111111111,0.6043000411682223,1.0,6/10,30.58%,LYN;PLSCR1;CD84;CRLF2;MILR1;CD300LF
prerank,neural tube closure (GO:0001843),0.5291871862573105,1.3759419857807262,0.09556786703601108,0.8542474934596878,1.0,9/34,13.01%,CELSR1;COBL;LMO4;TSC2;TGFB2;DVL3;GRHL2;DLC1;PLXNB2
prerank,tRNA metabolic process (GO:0006399),0.5916408847422955,1.3758485118547084,0.12463343108504399,0.852114715591088,1.0,10/17,21.36%,FARS2;TRPT1;POP1;THG1L;AARS1;RPP21;DTD1;SARS1;DARS2;YARS2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.35081891827896416,-1.3748692878433442,0.04790419161676647,0.6061419827015274,1.0,30/75,17.33%,PTPRM;DCN;SULF1;SEMA6A;TEK;WNT4;CLDN5;PDE3B;DAB2IP;THBS1;COL4A2;SEMA3E;RGCC;THBS2;GTF2I;SERPINF1;ROCK1;MECP2;PPARG;ISM1;NPR1;SPARC;AMOT;AGO1;HSPG2;NAXE;STAB1;HHEX;MINAR1;SPRED1
prerank,estrogen metabolic process (GO:0008210),0.6251972376340154,1.374701539195982,0.12749615975422426,0.854611714354578,1.0,3/15,11.13%,SULT1A1;HSD17B14;HSD17B11
prerank,proton transmembrane transport (GO:1902600),0.5260068810946518,1.3745162584218555,0.10620689655172413,0.8528548240426237,1.0,14/36,22.83%,SLC36A3;ATP6V1B1;ATP1A2;SLC25A14;SLC25A27;HVCN1;ATP6V0D1;ATP5F1B;SLC9A1;ATP1A3;ATP1A4;ATP1A1;SLC4A11;ATP6V0E1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2942827560547524,-1.3741404639842796,0.0,0.604812079412645,1.0,70/224,20.92%,PDE7B;SLC1A3;GRIK2;UNC13B;KCND2;NRXN1;NOVA1;CACNA1E;GRM3;GABRG3;GRM7;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;PTCHD1;DLGAP1;SLC1A1;SYT1;RIT2;GRIN2B;GABRB1;GRM5;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;LRP6;SLC6A1;CHRM3;PRKAR2B;APBA1;PLP1;SNAP25;DTNA;HCRTR2;MBP;GRIK1;GABRA3;GRIK4;NLGN3;GLRA3;HTR2A;AMPH;KCNMB4;GLRA2;GABRB2;CHRM2;MPZ;KCNQ3;GRM1;PRKAR1B;GABRA1;NPTX1;GLRB;RPS6KA1;RPS6KA3;GABRE;OPRK1;HRH1;KCNK3;SYT10;GRIA4;CACNA1B;KCNIP2;PCDHB16
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5729415033165652,-1.3736152626379443,0.14358974358974358,0.6027889348952576,1.0,6/10,34.35%,LGALS9;CX3CR1;ARRB2;FCGR2B;CEACAM1;LILRB1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5880288815364443,1.3736090622905763,0.1265625,0.8543960797594502,1.0,4/17,7.39%,CCL5;PODXL;FOXC2;TGFB2
prerank,membrane protein proteolysis (GO:0033619),0.5230687604079236,1.3734316133158708,0.11719745222929936,0.8526413666588419,1.0,16/37,20.75%,TMPRSS6;DAG1;ADAM10;AFG3L2;NAPSA;SPPL2B;CTSH;HM13;BACE1;PRTN3;SPPL3;PRKCQ;SPPL2A;ADAM17;RHBDD1;APH1A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5686013134901702,1.3729952653692228,0.09957924263674614,0.8519835506591014,1.0,4/24,5.85%,CLU;CD44;ACKR3;BCL2L1
prerank,circulatory system development (GO:0072359),0.4641135155249366,1.372801686880683,0.06892778993435449,0.8503612734377197,1.0,17/118,8.25%,FN1;CXADR;NTRK3;PDLIM5;NXN;CDKN1A;MICAL2;AKAP13;CRB2;STRA6;FOXC2;TSC2;SOX9;RBM20;ERBB3;TGFB2;PKD1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5790519887069218,1.3727424296108013,0.1345875542691751,0.8481133430868382,1.0,3/21,7.54%,PRKCB;CD81;NFAM1
prerank,cellular response to starvation (GO:0009267),0.45220303984282134,1.3723610637650867,0.052801724137931036,0.8474226904335155,1.0,11/147,3.79%,DAPL1;RNF152;PRKAA2;ATP6V1B1;MAP3K5;SREBF2;CDKN1A;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.42559195988199444,-1.3721707251429307,0.06484641638225255,0.6036769429960878,1.0,11/29,15.56%,GRIK2;SLC4A10;SHISA6;EPHB2;NETO1;SHISA9;DRD2;CAMK2A;MCTP1;CLN3;NCDN
prerank,positive regulation of calcium ion import (GO:0090280),-0.548248761536166,-1.3715391301341775,0.11082474226804123,0.6018115129806019,1.0,2/12,2.67%,PDGFRB;CXCL12
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.6131903238839351,1.3712505158057975,0.11937984496124031,0.8498214881455964,1.0,7/16,19.30%,PIGZ;PIGA;PIGX;DPM2;PIGN;PIGP;PIGQ
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6734724970974935,1.371213771091624,0.14359861591695502,0.8475459990455926,1.0,3/10,11.16%,ADTRP;TLR6;TLR4
prerank,actin filament bundle organization (GO:0061572),0.5384911947544698,1.3709503553337303,0.1118508655126498,0.8462976075277524,1.0,8/33,9.59%,BAIAP2L1;PAWR;CALD1;ESPN;ADD1;DMTN;MICAL1;EZR
prerank,positive regulation of telomere maintenance (GO:0032206),0.5318677512831089,1.370564322588348,0.10641200545702592,0.845461378104994,1.0,13/31,19.56%,NEK7;NABP2;MRE11;MAPK15;MAP3K4;ATRX;PML;TNKS2;NBN;PRKCQ;RAD50;PPP1R10;PNKP
prerank,negative regulation of nervous system development (GO:0051961),-0.509796497025192,-1.3704775740605597,0.09451219512195122,0.6016617967789962,1.0,6/17,15.38%,NOTCH1;APPL2;ROBO2;B2M;SLIT1;SORL1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4560736881879026,1.369619220335646,0.07015590200445435,0.8471577933531962,1.0,28/101,17.31%,AGTR1;CYFIP2;KLF4;OGT;VIM;SAMD4A;YTHDF1;NFKBIA;RPS4X;PERP;EIF4A3;MSN;UPF3A;EIF6;BAD;EZR;VPS11;POLDIP3;CPEB3;PLXNB2;FXR1;UPF3B;EIF4G1;PYM1;HSP90AA1;EEF2;TBC1D10A;STUB1
prerank,regulation of insulin secretion (GO:0050796),0.4579298761055382,1.3694235464942612,0.06201550387596899,0.8456338321512631,1.0,20/101,14.10%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;MCU;ALOX5;EFNA5;ABCC8;GLUD1;BAD;CDK16;TCF7L2;KCNB1;ITPR3;RAPGEF3;IRS2;KCNA5;AACS;SFRP1
prerank,positive regulation of cell death (GO:0010942),0.4835549568038043,1.369132470432889,0.09352517985611511,0.8445257140450746,1.0,16/59,15.66%,CLU;DAXX;MAP3K5;EFNB2;ZC3H12A;CELF1;PRR7;FOS;RARG;BMP4;HP;HPR;MARK4;GSK3B;EIF4G1;ITGB2
prerank,nitrogen compound transport (GO:0071705),0.4482833719046015,1.3682105730531735,0.05825242718446602,0.8461964260973227,1.0,21/141,13.27%,CUBN;SLC7A14;SCAMP5;AMN;RAMP1;SLC48A1;SLC3A1;RAB7A;ARRDC3;NDC1;SLC25A47;ARL6IP5;TOM1;SLC7A6;SLC1A4;AQP1;SCAMP2;SLC25A45;SLC18A1;PDPN;CHMP1A
prerank,positive regulation of biosynthetic process (GO:0009891),0.5162976628420585,1.3680633406389704,0.09296148738379814,0.8445092732493534,1.0,8/40,11.16%,SORBS1;CCL5;VIM;CREBL2;CREB1;BMP4;TLR6;TLR4
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3788354306588802,-1.3678201499055527,0.08333333333333333,0.6065171035432044,1.0,9/43,7.46%,ERRFI1;PTPRJ;TGFA;ITGA1;CBLB;DAB2IP;SH3KBP1;ZFYVE28;SOCS5
prerank,triglyceride catabolic process (GO:0019433),-0.47186085571718756,-1.3674458651135346,0.1094224924012158,0.6042997862666943,1.0,9/19,43.52%,LPL;PNPLA3;FABP7;PNPLA2;LIPH;LIPC;FABP4;FABP12;FABP5
prerank,receptor-mediated endocytosis (GO:0006898),0.44656954467885296,1.3673328953910617,0.05921052631578947,0.8454438117901448,1.0,34/132,16.82%,CUBN;LDLR;CAV1;AMN;CD81;CLTB;FCHSD2;AP2A2;ASGR1;GPR107;ACKR3;RAMP1;CD9;CAV2;STAB2;GRK2;HP;HPR;HYOU1;FCER1G;AP2A1;WASF1;LMBR1L;PDLIM7;NEDD4;ARHGAP27;HSP90AA1;HSPH1;ITGB2;AP4E1;LRP3;CANX;COLEC12;LRP2
prerank,regulation of cellular protein localization (GO:1903827),0.5153972966612753,1.3673167981328,0.11211340206185567,0.8431544421342242,1.0,12/45,11.22%,GPC6;PRKAA2;GPC1;NDEL1;GPC4;GPC3;DVL3;SUMO3;TOR1A;RAB11FIP5;ABCA2;CSNK1E
prerank,aerobic respiration (GO:0009060),0.5801183130037412,1.3660446868543812,0.11937984496124031,0.8462725959907045,1.0,9/20,17.74%,SDHB;ME3;UQCRC2;MTFR1L;UQCRC1;MDH2;SLC25A14;UQCRH;MTFR2
prerank,canonical Wnt signaling pathway (GO:0060070),0.479914329928432,1.365458314118445,0.09090909090909091,0.8464349821795342,1.0,17/68,14.36%,WNT16;WNT1;WNT10A;WNT11;CAV1;DIXDC1;WNT6;RARG;DVL3;WNT5B;FZD5;TCF7L2;CSNK1E;WNT3;GATA3;SFRP1;GSK3B
prerank,primary neural tube formation (GO:0014020),0.5379779112951294,1.3654575642928743,0.09090909090909091,0.8440902869380397,1.0,8/30,13.01%,CELSR1;COBL;LMO4;TSC2;TGFB2;GRHL2;DLC1;PLXNB2
prerank,aortic valve development (GO:0003176),-0.4192331392583343,-1.3653766947110546,0.08203125,0.6071359506583061,1.0,15/34,14.37%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL;TNFRSF1B;SLIT3;BMPR2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4100468502475531,-1.3652379328279964,0.05737704918032787,0.6040078457154499,1.0,7/34,5.29%,FLT1;PRKD1;SEMA6A;VEGFC;KDR;NOTCH1;DAB2IP
prerank,protein localization to cell junction (GO:1902414),0.5757845829786953,1.3643171727355818,0.13444108761329304,0.8464851657059888,1.0,6/22,11.61%,TJP2;TJP1;BSN;ARHGEF18;PCLO;JAK1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4975033430118985,1.3641251350839194,0.10211706102117062,0.8449365680722977,1.0,15/49,18.47%,CLU;SMAD6;EP300;CRYAB;PPM1A;NLRP2B;CDC42;PYDC1;RAF1;LDLRAD4;ULK1;GSK3B;PRKCZ;HDAC6;PARK7
prerank,regulation of response to oxidative stress (GO:1902882),0.6566503939530866,1.3639403341525917,0.14261168384879724,0.8434210613464348,1.0,3/11,5.07%,ABCD1;SELENON;ALOX5
prerank,filopodium assembly (GO:0046847),0.6148524067775722,1.3637057017333403,0.1368584758942457,0.8421208724759467,1.0,2/16,0.86%,RAB17;SRGAP2
prerank,postsynaptic membrane organization (GO:0001941),-0.4928728694923767,-1.3635059209540985,0.11641791044776119,0.6058389394535725,1.0,5/17,12.76%,GPHN;NRXN1;SHANK3;NLGN1;NLGN3
prerank,regulation of macrophage differentiation (GO:0045649),-0.5005705667725483,-1.3630593018315165,0.11331444759206799,0.6037689772440009,1.0,6/15,18.79%,IL34;ID2;HSF1;RIPK1;C1QC;CSF1
prerank,fatty acid beta-oxidation (GO:0006635),0.49019039805800513,1.363013248513629,0.09759188846641319,0.8427618811674911,1.0,24/51,23.45%,ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;MTLN;ACAT2;HADHA;SLC25A17;CPT2;ECI2;ACADM;AUH;HADHB;IVD;ECHS1;PEX2;DECR2;HSD17B10;CRAT;MECR;GCDH;ACAD11;DECR1
prerank,regulation of cellular component movement (GO:0051270),0.5022102280640007,1.3628627799442299,0.10375,0.84111840124269,1.0,22/49,20.17%,PRAG1;ARAP1;YTHDF1;ARHGAP18;CDK6;DIAPH1;DAPK3;CD9;ERBB3;RAF1;RHOA;ZSWIM8;PDPN;TGFBR3;MEMO1;IGBP1;ACTN4;ABL1;HDAC6;ROCK2;ADAM17;HBEGF
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46107525676465977,1.3626654232591433,0.08323959505061868,0.8397188976220832,1.0,16/95,7.23%,UST;ANGPT1;GPC6;ST3GAL4;GPC1;CHST12;HEXA;B4GAT1;GPC4;GCNT2;DSE;CHST11;SDC4;PRELP;CHPF;GPC3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4818794278125954,1.3625771523215982,0.0966952264381885,0.8378554703062941,1.0,14/63,14.88%,DAPL1;NUPR1;TIMP4;TIMP1;TIMP2;TAB3;RUBCN;HP;EIF4G2;WDR6;FOXK1;GSK3A;EIF4G1;WASHC1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6472051218537046,1.3624606428752697,0.13629160063391443,0.8360666049052365,1.0,2/13,3.79%,RNF152;SESN2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6347165840325648,1.361388777569256,0.1488,0.8382481464093555,1.0,4/12,9.52%,ANK2;DIAPH1;PTK2B;MTLN
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.3204331611047418,-1.3611040689444565,0.023255813953488372,0.6065090976733215,1.0,34/101,19.60%,FLT1;PDGFRB;PDGFD;CEMIP;IL34;RAPGEF2;ROBO1;WNT5A;PKD2;FGF2;DAB2IP;LRRK2;RGCC;DIPK2A;TGFB1;EZH2;TPD52L1;CCNY;PIK3R6;ETAA1;KIT;IRGM;HMGA2;SPDYA;EDN1;PIK3R5;EDN3;INCENP;EGF;MAP2K1;TCIM;CD40;CIB1;MST1R
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5623730156976862,1.361100875356564,0.12624113475177304,0.8372829887510805,1.0,8/23,16.87%,ATP6V1B1;SLC12A8;SLC9A7;PDK2;SLC12A4;SLC26A4;SLC12A6;SLC9A1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.41956390904612967,-1.3609686302043653,0.10245901639344263,0.6034265541169448,1.0,13/33,18.09%,IGF1;PIK3R1;NYAP2;PIK3CB;PIK3CD;NF1;IGF1R;HTR2A;EDN1;PIK3R5;SIRT2;MYO16;PIK3R2
prerank,regulation of inclusion body assembly (GO:0090083),-0.5628320298976289,-1.360297136776628,0.14676616915422885,0.602089288808242,1.0,7/11,31.24%,SNCAIP;SACS;DNAJB2;BAG5;DNAJB1;HSPA1B;HSPA2
prerank,tight junction assembly (GO:0120192),0.49908139580634864,1.3601418568900236,0.12639405204460966,0.8391190568550599,1.0,8/49,10.73%,CLDN11;POF1B;OCLN;LSR;PATJ;PARD6B;GRHL2;ACTG1
prerank,Wnt signaling pathway (GO:0016055),0.4660465207627836,1.359144248545671,0.09184845005740529,0.8411526551427392,1.0,16/92,8.42%,WNT16;WNT1;NXN;WNT10A;WNT11;DIXDC1;GPC4;WNT6;RARG;CPE;WLS;DVL3;WNT5B;FZD5;RBX1;TCF7L2
prerank,positive regulation of chromosome organization (GO:2001252),0.6043515912154962,1.3590257564482566,0.1443609022556391,0.8393443828208376,1.0,7/15,18.16%,FEN1;MRE11;ATRX;PML;NBN;RAD50;PPP1R10
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.45898843324086896,-1.3588987801381616,0.1,0.6029840474400556,1.0,7/20,10.04%,IGF1;PDGFRB;IGFBP5;VTN;ACE;SLIT2;CCN4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5763740280334543,1.3587687541656845,0.11925287356321838,0.8382913869005764,1.0,6/23,8.18%,SMO;GDNF;SOX9;BMP4;WNT5B;SIX1
prerank,tube closure (GO:0060606),0.5339258600714333,1.3585783285484634,0.09845288326300984,0.8368694999725651,1.0,8/31,13.01%,CELSR1;COBL;LMO4;TSC2;TGFB2;GRHL2;DLC1;PLXNB2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.37371789223259677,-1.3583106943294974,0.05128205128205128,0.6012975779188535,1.0,16/46,12.83%,CDH2;NRXN1;SHANK3;GRM3;GRM7;GRM8;SYT1;LRRK2;GRM5;GRIK3;NLGN1;CACNG8;DGKI;GRIK1;NLGN3;DRD2
prerank,regulation of neuron differentiation (GO:0045664),-0.3412100819855714,-1.3579945954454575,0.027210884353741496,0.5988839283067355,1.0,22/76,13.08%,TCF4;ZEB1;VWC2;NREP;MOSMO;BRINP3;NRCAM;BIN1;LRRK2;DTX1;ZFHX2;NLGN1;ROCK1;ID2;TIAM1;HEYL;IMPACT;BEND6;NEPRO;ARHGEF2;MMD;BDNF
prerank,blood vessel morphogenesis (GO:0048514),-0.3698131717383359,-1.357289961294,0.06521739130434782,0.5976288970331678,1.0,21/54,14.10%,FLT1;ENG;LAMA1;CCBE1;CDH2;GLMN;KDR;COL4A1;CYP1B1;SLC1A1;ID1;TGFB1;SOX17;LRP5;RAMP2;NF1;LOX;RASIP1;FLT4;TBX1;EGFL7
prerank,nucleic acid metabolic process (GO:0090304),0.4753984537822031,1.356304599978726,0.09133489461358314,0.8445398011467672,1.0,21/69,19.75%,NT5E;GTF2F1;FEN1;RBFOX2;POLR2H;POLR2A;XRN2;HNRNPH2;POLG;DNASE1L2;TOPBP1;DNASE1L1;DUSP11;WTAP;POLR2C;RAD50;HNRNPA3;POLR2E;PTBP1;PCBP2;DXO
prerank,negative regulation of cytokine production (GO:0001818),0.43807729866802025,1.3560576302047878,0.05832449628844114,0.8433896184172242,1.0,22/163,10.21%,FN1;KLF4;TRIB2;CD200;ZC3H12A;TWSG1;ABCD1;IKBKE;MAVS;HOMER2;HOMER3;ANXA4;TRIM25;IRF3;OTUD7B;SRGN;LGR4;FOXP3;TLR6;PTPN6;EZR;PPP1R11
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6619229583530383,1.3559859997387298,0.14735099337748345,0.8414161083532954,1.0,1/10,0.40%,CLU
prerank,regulation of calcium ion transport (GO:0051924),0.489386095303147,1.3554905866660363,0.1185006045949214,0.8413239526278699,1.0,6/54,3.42%,ANK2;STIM2;CCL5;IL16;HOMER2;HOMER3
prerank,extracellular matrix disassembly (GO:0022617),0.49356541641227636,1.3553717166277093,0.0984009840098401,0.839665486810363,1.0,15/53,13.10%,CD44;TMPRSS6;MMP9;ADAM10;HPN;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12;EXOC8
prerank,regulation of cell adhesion (GO:0030155),0.4497480170936664,1.3550467577019742,0.06524064171122995,0.8388878870113956,1.0,20/129,7.85%,GPR4;CDH13;ANGPT1;CCL5;PLXNB1;PODXL;EPHA4;ADAM10;PKP4;PLXNA2;CXCR4;PTK2B;PPP2CA;RIPOR2;DUSP1;FBLN1;EFNA5;CBLL1;ERBB3;ZFHX3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6607321499007124,1.3549500322168413,0.15867768595041323,0.8371097702754262,1.0,5/10,14.45%,CCL5;ADAM10;STK39;OXSR1;WNK1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.604539852828145,1.3546233525960796,0.14307004470938897,0.836348012910964,1.0,1/15,0.18%,AGTR1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.49347137017606435,-1.3545120816360015,0.11396011396011396,0.6031874031621005,1.0,4/16,3.60%,PDGFRB;PDGFD;PTPRJ;PDGFRA
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6462552492045077,1.3527570074360449,0.13355048859934854,0.8421942333471649,1.0,2/11,10.51%,ACTN2;SNX33
prerank,response to muscle stretch (GO:0035994),-0.5021713278510093,-1.352030072425318,0.11370262390670553,0.6079463194582839,1.0,4/15,2.51%,DMD;CDH2;SLC8A1;PTK2
prerank,regulation of transmembrane transport (GO:0034762),0.5366383366134098,1.3516576794943984,0.12239221140472879,0.8447013435443718,1.0,4/31,4.49%,PRKCB;OCLN;WWP2;KCNJ13
prerank,protein homotrimerization (GO:0070207),-0.49987733906673426,-1.3514983647927563,0.12299465240641712,0.6029808464712823,1.0,11/14,37.94%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,protein trimerization (GO:0070206),-0.49987733906673426,-1.3514983647927563,0.12299465240641712,0.6029808464712823,1.0,11/14,37.94%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5651602713784032,-1.3514668969164205,0.14357682619647355,0.5998486210088074,1.0,3/10,5.61%,SLC1A3;SLC1A2;SLC1A1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6044849434296089,1.3509223382530429,0.14242424242424243,0.8457119018246272,1.0,3/16,5.85%,CLU;ACKR3;BCL2L1
prerank,SNARE complex assembly (GO:0035493),0.6500789991568922,1.3507598997648254,0.17704918032786884,0.8442253484648921,1.0,5/10,21.69%,STXBP6;STXBP1;VAMP1;UVRAG;VAMP2
prerank,regulation of pH (GO:0006885),0.6465678782128751,1.350487508099856,0.1507293354943274,0.8432588192909348,1.0,7/11,21.09%,ATP6V1B1;SLC9A7;PDK2;SLC26A4;SLC9A1;ATP6AP1;ATP1A4
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5608794100808093,-1.3504453109075543,0.13144329896907217,0.5997784649907201,1.0,2/10,1.18%,ZEB2;RAPGEF2
prerank,muscle cell development (GO:0055001),0.5227856419426461,1.3500156346170606,0.12133333333333333,0.8429964869627329,1.0,3/30,1.59%,CXADR;ANK2;NEBL
prerank,regulation of fibroblast migration (GO:0010762),-0.46456488669230506,-1.3497346481588663,0.13190184049079753,0.5985759239032411,1.0,9/20,17.76%,PTK2;FGF2;THBS1;APPL2;TGFB1;RFFL;GNA12;CLN3;PRR5L
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.33711037971109503,-1.349714587006132,0.04678362573099415,0.595505654419796,1.0,21/67,13.19%,FLT1;GHR;PDGFRB;TEK;INSR;LYN;PTK2;PDGFRA;KDR;EPHB2;ABI2;BMX;PKDCC;JAK2;ERBB4;FGFR2;KIT;ABL2;IGF1R;FGFR4;FLT4
prerank,response to ATP (GO:0033198),-0.48234492204044654,-1.3495657871605624,0.09444444444444444,0.5928182609362512,1.0,8/18,27.99%,TRPC3;ABCC9;SSH1;P2RY1;P2RY12;DGKQ;CIB2;TAF1
prerank,regulation of autophagy (GO:0010506),0.432700170820762,1.3481528085317471,0.037037037037037035,0.8484851751446678,1.0,54/216,15.54%,DAPL1;RNF152;PRKAA2;ATP6V1B1;SREBF2;TPCN1;NUPR1;ZC3H12A;EEF1A1;EP300;FOXO3;DAPK3;DAPK1;HSPB1;MTDH;ORMDL3;SH3BP4;USP10;RHEB;HAX1;MAPK15;TRIM21;BAD;TAB3;EXOC7;EXOC4;RUBCN;FZD5;CAPNS1;SMCR8;MTMR3;OSBPL7;EIF4G2;WDR6;FOXK1;TFEB;EXOC8;VDAC1;PIP4K2C;GSK3A;VPS26B;ULK1;GSK3B;EIF4G1;ATP6V1E1;GAPDH;NEDD4;DNM1L;FLCN;ATP6V1D;WASHC1;PLK2;RB1CC1;ATP6V0D1
prerank,maturation of LSU-rRNA (GO:0000470),0.5555399390789295,1.3478321164173281,0.11918604651162791,0.8476416746975086,1.0,8/26,15.15%,NSA2;NOP2;PES1;EIF6;MAK16;RPL10A;RPF1;DDX18
prerank,metal ion transport (GO:0030001),-0.3275650898110065,-1.3477524686526348,0.038461538461538464,0.5948531504331638,1.0,20/86,14.11%,ITPR1;CACNA1C;CALCRL;SLC8A1;SLC8A3;CACNA1E;TRPC3;TUSC3;PKD2;TRPC4;SLC39A8;PANX1;SELENOK;RAMP2;TPT1;CACNG8;TRPC5;SLC30A1;CAMK2A;RYR2
prerank,protein polymerization (GO:0051258),0.4916836587607416,1.346841143840584,0.10037174721189591,0.8495630305214389,1.0,10/55,9.62%,FGF13;COBL;GSN;DIAPH1;CORO7;ANG;MSRB2;CHMP4A;CHMP4B;HDGFL3
prerank,arachidonic acid secretion (GO:0050482),-0.5615759947596372,-1.3459000933628105,0.13819095477386933,0.5947163590086858,1.0,7/10,41.09%,PNPLA8;ACE;DRD2;NMUR2;PLA2G5;DRD3;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5615759947596372,-1.3459000933628105,0.13819095477386933,0.5947163590086858,1.0,7/10,41.09%,PNPLA8;ACE;DRD2;NMUR2;PLA2G5;DRD3;BDKRB2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5332815108688537,-1.3446753171404082,0.15064935064935064,0.5954193604486699,1.0,3/11,11.55%,PID1;TFRC;ZDHHC6
prerank,positive regulation of protein metabolic process (GO:0051247),0.4489521424450116,1.3443880853864056,0.06881243063263041,0.8573392418642151,1.0,26/110,19.53%,FZR1;AGTR1;CLU;KLF4;WWP2;NFKBIA;MAPK7;EGLN2;GPC3;RAB7A;ABCA2;GSK3A;RAB1B;GSK3B;EIF4G1;NEDD4;PLK2;DDB1;NSF;PRMT1;ROCK2;RNF41;IDE;APP;KLF2;ASB5
prerank,regulation of protein secretion (GO:0050708),0.4433882908293958,1.3428459914384077,0.06399132321041215,0.8617546122613943,1.0,20/119,10.24%,DPP4;ITPR2;ADTRP;CCL5;SYTL4;CACNA1A;RAP1A;HMGCR;ALOX5;ABCC8;GOLPH3;TGFB2;ANG;CYP51A1;EZR;LLGL2;APBB1;KCNB1;IER3IP1;ITPR3
prerank,microtubule nucleation (GO:0007020),-0.46456272336060905,-1.3426484102299585,0.1021021021021021,0.5984247890963081,1.0,9/19,15.97%,CLASP2;CCDC57;RANBP9;TUBGCP2;NDE1;TPPP;GOLGA2;CSNK1D;SLAIN2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.504352188536558,-1.342287892260575,0.14887640449438203,0.5965308860365307,1.0,3/14,12.36%,OSMR;PTGS2;IL6ST
prerank,regulation of blood circulation (GO:1903522),0.528427734350996,1.341870213613291,0.12653061224489795,0.8637511155003216,1.0,2/34,0.75%,AGTR1;CELF2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3612288649040659,-1.3417806634792562,0.032432432432432434,0.5951174685242863,1.0,17/56,10.13%,FLT1;PDGFRB;TEK;INSR;LYN;PTK2;TPST1;PDGFRA;KDR;EPHB2;ABI2;PKDCC;JAK2;ERBB4;FGFR2;KIT;ABL2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.48609065807713947,-1.3412079325013677,0.11550151975683891,0.5938202644011006,1.0,5/16,8.12%,HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5042830593225345,1.3408098041637497,0.13137755102040816,0.8659199412657687,1.0,12/43,12.95%,KLF5;KLF4;DDX5;FOXO3;FOS;SOX9;BMP4;TGFB2;JUN;NFIB;SMARCA4;GATA3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5539841799582672,-1.3407865825492695,0.14736842105263157,0.592079290657687,1.0,3/11,6.51%,CAMK2D;NOS1AP;BIN1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.47175128690672435,1.3407409666496446,0.11764705882352941,0.8640437430368902,1.0,19/62,18.87%,CLU;MMP9;YBX3;NFE2L2;EPO;HSPB1;ACKR3;BCL2L1;MAPK7;NDUFS3;SOD2;HYOU1;CREB3;OPA1;VNN1;MDM2;ARMC10;PARK7;CDKN2D
prerank,aminoglycan biosynthetic process (GO:0006023),0.4990525118913367,1.3399789409130352,0.12672521957340024,0.8649259180412172,1.0,9/49,7.23%,B3GALT1;GPC6;GPC1;HEXA;B4GAT1;GPC4;GCNT2;SDC4;GPC3
prerank,regulation of telomere capping (GO:1904353),0.54357109970257,1.3396168436004556,0.15486725663716813,0.8642863443612735,1.0,10/23,20.98%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;NBN;PRKCQ;RAD50;PNKP;TERF2
prerank,regulation of leukocyte migration (GO:0002685),0.5870518530486428,1.339585253669272,0.1558641975308642,0.8622476705591574,1.0,2/16,3.22%,ADTRP;CD81
prerank,regulation of T cell chemotaxis (GO:0010819),0.6415706267976661,1.339406720892907,0.184640522875817,0.8609123479218089,1.0,4/11,8.46%,CCL5;ADAM10;STK39;OXSR1
prerank,regulation of cell differentiation (GO:0045595),0.4419553463137535,1.3390923102015269,0.0646186440677966,0.8600241399833249,1.0,25/148,10.29%,PRKCB;PHLDB2;FGFR1;KLF4;MBOAT2;DAG1;RORC;EMP2;CCN2;DDX5;CDK6;NGF;GDNF;PPP2CA;PPP1R13L;FLOT2;LTBP4;ALOX5;PLEKHB2;ZFHX3;SIX1;LGALS3;CDK5RAP1;RAF1;FADS1
prerank,endothelial cell development (GO:0001885),-0.4366171906987212,-1.3388676549119134,0.1037037037037037,0.5950215250022549,1.0,8/25,4.00%,COL22A1;RAPGEF2;PECAM1;PDE4D;RDX;PPP1R16B;COL18A1;COL15A1
prerank,digestive tract morphogenesis (GO:0048546),-0.5021432132674796,-1.3387924696765017,0.1309192200557103,0.5922567616750991,1.0,9/14,17.30%,PDGFRA;GLI1;SOX17;ID2;FGFR2;NIPBL;BBS7;SOX11;EPHB3
prerank,positive regulation of glucose import (GO:0046326),0.5616187216900643,1.3387381443146964,0.12968299711815562,0.8594029862361656,1.0,4/21,5.15%,SORBS1;OCLN;CREBL2;RHOQ
prerank,negative regulation of leukocyte migration (GO:0002686),0.6641515412822235,1.3386587151869744,0.1563573883161512,0.857611919783811,1.0,3/10,4.13%,ADTRP;CD200;BMP5
prerank,cardiac muscle tissue development (GO:0048738),0.48573649110243516,1.337291147006117,0.12960609911054638,0.8612770491961188,1.0,8/50,6.81%,SGCG;NOTCH2;SGCD;AKAP13;GJB6;CSRP3;BMP5;BMP4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5759683448343965,1.3366163402453277,0.150074294205052,0.8620219946510954,1.0,5/19,11.69%,ABCD1;ABHD5;MTLN;TWIST1;IRS2
prerank,melanosome localization (GO:0032400),0.5694684139559489,1.336297335966925,0.14985163204747776,0.8611638094220131,1.0,5/21,13.36%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,fatty acid oxidation (GO:0019395),0.4758209354787475,1.334549146522297,0.12311557788944724,0.8662653743017107,1.0,17/57,14.63%,PPARGC1A;ABCD1;ADH7;ECHDC1;ACADL;EHHADH;PECR;MTLN;ACAT2;HADHA;SLC25A17;CPT2;ECI2;ACADM;AUH;ILVBL;HADHB
prerank,organic cation transport (GO:0015695),-0.4627145949134336,-1.3340540781760588,0.13353115727002968,0.6034939822644685,1.0,10/19,36.91%,SLC47A1;SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;PDZK1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3939189279725472,-1.3337854244499912,0.06827309236947791,0.6012819883341849,1.0,16/36,25.34%,SGMS1;FAS;DAB2IP;DEPTOR;BCL2;TPD52L1;DAPK2;TMBIM6;BDNF;NR4A2;CX3CL1;CX3CR1;TRAF1;CYLD;ASAH2;PYCARD
prerank,regulation of cell death (GO:0010941),0.44855666335116307,1.3330406990819623,0.09954751131221719,0.8705486807906085,1.0,23/94,15.43%,WNT16;CLU;SRGAP2;CCL5;CCN2;ZC3H12A;WNT11;CELF1;PRR7;CRYAB;CTSZ;GPR75;BMP4;CHMP4B;CHP1;HP;HPR;VPS4B;BNIP3L;DUS2;EIF4G1;SNCB;CHMP2A
prerank,nucleosome assembly (GO:0006334),0.5177110172434932,1.332821390592881,0.14027777777777778,0.8694323222639361,1.0,10/31,18.29%,DAXX;GRWD1;ASF1A;SOX9;KAT6B;ATRX;UBN1;IPO4;SPTY2D1;H3-3A
prerank,negative regulation of cell death (GO:0060548),0.45050988546517545,1.332512879654946,0.10896708286038592,0.8686993142879958,1.0,21/88,15.47%,WNT16;CLU;SRGAP2;PPARGC1A;CD200;CCN2;WNT11;KANK2;BMP4;CHMP4A;CHMP4B;TIGAR;VPS4B;CD200R1;BNIP3L;DUS2;GSK3B;EIF4G1;NENF;CHMP2A;IKBKG
prerank,alanine transport (GO:0032328),0.6325336021913575,1.332139193179581,0.18858131487889274,0.8682556229170579,1.0,3/10,10.88%,SLC36A3;SLC36A4;SLC1A4
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4936767560813643,1.3308771923440081,0.12368421052631579,0.8715417605549682,1.0,18/44,18.80%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PFN2;ABL1;FHOD1;ROCK2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5854171363706047,1.3299057797214384,0.15758468335787923,0.8735932355271837,1.0,5/17,10.71%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,atrial septum morphogenesis (GO:0060413),0.619903123648363,1.3297393295208053,0.16639477977161501,0.8721897051469729,1.0,2/10,7.39%,NOTCH2;TGFB2
prerank,regulation of RNA splicing (GO:0043484),0.4722792164420502,1.329440690339088,0.11387900355871886,0.8714683825760563,1.0,18/69,15.47%,MBNL1;AHNAK;AHNAK2;CELF1;SNRNP70;SON;POLR2A;RBM20;LARP7;HNRNPH2;SRPK2;SRRM4;HABP4;RPS26;SRPK1;ZPR1;GRSF1;MBNL2
prerank,melanocyte differentiation (GO:0030318),-0.5543110994119379,-1.3288742091837378,0.12834224598930483,0.6132171462161728,1.0,6/11,21.21%,ENPP1;MITF;KIT;LRMDA;MREG;SLC24A5
prerank,negative regulation of immune system process (GO:0002683),0.5906937401156617,1.328449633421806,0.14683153013910355,0.8734792433161206,1.0,4/16,8.99%,ADTRP;CD200;SOX9;FOXP3
prerank,bicellular tight junction assembly (GO:0070830),0.49370465995978813,1.3269592557636316,0.1432192648922687,0.877641752947177,1.0,6/46,8.90%,CLDN11;POF1B;OCLN;PATJ;PARD6B;GRHL2
prerank,negative regulation of cellular protein localization (GO:1903828),0.5055914202765315,1.3268012354252257,0.15415549597855227,0.8762206874337564,1.0,12/34,20.10%,ACTN2;CTNNA1;RIPOR2;OTUD7B;NSFL1C;LATS1;SNX33;GSK3B;FLCN;ROCK2;ILRUN;MAPT
prerank,regulation of macrophage migration (GO:1905521),0.6409220320814812,1.326502259469688,0.16271186440677965,0.8754801583082576,1.0,4/10,12.20%,CD200;CD81;PTK2B;CD200R1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6231829585518945,1.325991197046855,0.1717171717171717,0.8755211061540062,1.0,4/12,10.29%,ACOT8;ABCD1;ELOVL1;FADS1
prerank,regulation of filopodium assembly (GO:0051489),0.4988324496844927,1.3259053429191228,0.1320754716981132,0.8738079233243237,1.0,11/38,13.39%,RAB17;ARAP1;PALM;RIPOR2;RHOQ;CAPZB;DMTN;CDC42;BCAS3;FXR1;TRPM2
prerank,positive regulation of reproductive process (GO:2000243),-0.4071652040605301,-1.3255307758558956,0.09486166007905138,0.6205133560149474,1.0,5/31,7.24%,PLCB1;PDE3A;LHFPL2;ACVR1B;GLRA1
prerank,heart development (GO:0007507),0.43339103551599906,1.3253631967008837,0.06852248394004283,0.8741777784861368,1.0,21/150,7.39%,FN1;CXADR;SGCG;NTRK3;PDLIM5;CDKN1A;SGCD;MICAL2;AKAP13;STRA6;CSRP3;FOXC2;BMP5;TSC2;SOX9;BMP4;MEF2D;RBM20;GPC3;ERBB3;TGFB2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5107118605557598,-1.3248827318383067,0.14673913043478262,0.6195407665997694,1.0,7/13,15.20%,LTBP1;FBN1;GREM2;FBN2;CD46;NRROS;CHRDL1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6145220119097051,1.324515634358982,0.16150081566068517,0.8757828258893707,1.0,4/13,10.63%,GLUL;ACOT8;GLUD1;ACSF3
prerank,positive regulation of telomere capping (GO:1904355),0.5673703330966232,1.324427777541948,0.16850393700787403,0.8741299621483187,1.0,7/17,19.56%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;PRKCQ;PNKP
prerank,glycosaminoglycan catabolic process (GO:0006027),0.48305022172318407,1.3237355887874296,0.12623762376237624,0.8748054210537548,1.0,15/55,11.11%,CD44;GPC6;GPC1;HEXA;GPC4;NAGLU;SDC4;PRELP;GLB1;GPC3;ARSB;STAB2;CHP1;GUSB;HEXB
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5536758395944663,1.3234642594463215,0.15340086830680175,0.8738879210482278,1.0,8/22,17.69%,PPP2CA;DUSP10;PPM1B;DUSP1;PPM1A;PPM1D;PPP2CB;PDP1
prerank,respiratory tube development (GO:0030323),-0.41312492073789847,-1.3231165534897087,0.0989399293286219,0.6219445348435757,1.0,10/28,15.71%,PCSK5;GLI2;FGF2;FGFR2;LOXL3;NPHP3;ZIC3;RBP4;ABCA3;FGF9
prerank,dendritic spine morphogenesis (GO:0060997),-0.48680488295028546,-1.3227416975773636,0.12228260869565218,0.6199448541766306,1.0,4/15,6.15%,SHANK3;DOCK10;PAK3;EPHB2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5626138621151626,1.321451171933942,0.16591251885369532,0.8804983192139417,1.0,3/17,7.31%,RAET1E;LAMP1;PVR
prerank,protein K63-linked ubiquitination (GO:0070534),0.49689213776642893,1.3209355797958957,0.13871374527112232,0.8805591584851878,1.0,19/41,22.39%,RNF152;WWP2;RNF5;TRIM21;MAGEL2;UBE2B;RNF126;PELI1;NEDD4;BFAR;UBE2N;PRPF19;STUB1;ZFP91;TRIM5;ARIH2;TRAF3IP2;UBE2V1;RNF168
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5744030250933806,1.3200602620515909,0.16541353383458646,0.8820972234766078,1.0,5/17,12.95%,CAV1;SOX9;KLF7;MAFG;GATA3
prerank,macrophage chemotaxis (GO:0048246),0.6365400197461779,1.319758283580536,0.17851239669421487,0.8813734156841726,1.0,3/10,16.76%,CCL5;LGALS3;TAFA4
prerank,catecholamine metabolic process (GO:0006584),-0.5002559753852023,-1.3193286872818646,0.1464088397790055,0.6272053827087477,1.0,4/14,24.05%,SNCAIP;DRD2;RNF180;DDC
prerank,neutrophil migration (GO:1990266),0.47476018496182926,1.3192657616477683,0.1368038740920097,0.8813493489761274,1.0,2/58,1.51%,CXADR;CCL5
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3935809026957777,-1.3184454719750036,0.06910569105691057,0.627109427904472,1.0,11/33,19.93%,LEF1;IL34;RUNX1;ID2;HSF1;TRAF6;RIPK1;CTNNBIP1;CD74;CSF1;FES
prerank,sodium ion transmembrane transport (GO:0035725),0.4544933903518979,1.3184346033141896,0.10113636363636364,0.8828452780527186,1.0,6/84,2.78%,SLC9A2;SLC9A4;ASIC5;SCN3A;NALCN;ATP1A2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4261934473773884,-1.3182025361906118,0.11409395973154363,0.6249365389099478,1.0,7/26,7.58%,SHANK3;RDX;SYNPO;TSC1;ALMS1;SYNPO2;ROCK1
prerank,eye photoreceptor cell development (GO:0042462),0.587690717832764,1.3173745144926328,0.15447154471544716,0.8850754424021968,1.0,2/15,3.12%,RP1;CRB2
prerank,regulation of cytoplasmic translation (GO:2000765),0.59950110521294,1.3166205040290475,0.17965023847376788,0.8862283868689641,1.0,6/14,15.32%,CPEB2;YBX3;UNK;PKM;CPEB3;DHX9
prerank,negative regulation of immune effector process (GO:0002698),0.6127099318695253,1.315957124182034,0.18888888888888888,0.8870401234495429,1.0,1/13,0.15%,CD55
prerank,protein hydroxylation (GO:0018126),0.5803787410627853,1.3158795131782626,0.16825396825396827,0.8853524442495238,1.0,1/15,0.09%,EGLN3
prerank,calcium-mediated signaling (GO:0019722),0.4447854848846203,1.315023246545206,0.10738255033557047,0.8869940034695325,1.0,14/93,6.39%,AGTR1;NUDT4;ANK2;CCR4;CXCR4;MCU;PTGFR;RCAN1;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;DMTN
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.57101690410083,1.3142542625306435,0.17151607963246554,0.8881907555010073,1.0,3/16,7.31%,RAET1E;LAMP1;PVR
prerank,negative regulation of axonogenesis (GO:0050771),0.5290148133338907,1.3139097957147094,0.1536231884057971,0.887670340672212,1.0,2/27,0.73%,FGF13;RTN4R
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.508037091767674,1.3136667579362677,0.15281501340482573,0.8866450708536396,1.0,2/33,3.88%,DPP4;FOXC2
prerank,cellular response to chemokine (GO:1990869),0.4918456470290163,1.3135653579196889,0.1267427122940431,0.8850489416243894,1.0,9/46,8.46%,CCL5;ZC3H12A;PTK2B;ACKR3;RIPOR2;DUSP1;GPR75;STK39;OXSR1
prerank,apical junction assembly (GO:0043297),0.481772348301866,1.3135243787212916,0.14303482587064675,0.8832432704459409,1.0,7/53,8.90%,CLDN11;POF1B;OCLN;CTNNA1;PATJ;PARD6B;GRHL2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.443740454481945,-1.3131683880465712,0.16117216117216118,0.6377180992332127,1.0,8/22,14.77%,CACNA1C;STIM1;ADGRV1;GRM3;CAP2;NF1;DRD2;EDNRB
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5592646129295227,1.3127330787444387,0.1774193548387097,0.8845843701936584,1.0,3/22,8.99%,NFATC2;DUSP10;FOXP3
prerank,mRNA splice site selection (GO:0006376),0.5232414018211955,1.3125981677421295,0.16548797736916548,0.8831926190120367,1.0,13/30,20.96%,CELF2;CELF1;LUC7L3;KHDC4;SF3A2;SRSF9;ISY1;LUC7L2;SRSF1;SRSF5;SF3A3;SFSWAP;PUF60
prerank,response to sterol (GO:0036314),0.6196769178239279,1.3113702643414846,0.17684887459807075,0.8862921246965668,1.0,5/11,12.15%,RORC;INSIG1;PMVK;ABCA2;TGFBR2
prerank,synapse assembly (GO:0007416),0.46033418840041873,1.3110006189430499,0.11602870813397129,0.8858571229715732,1.0,4/67,1.61%,CDH1;FGF13;SDK1;PLXNB1
prerank,vesicle transport along microtubule (GO:0047496),0.5474642021192994,1.3108084580598978,0.1484593837535014,0.8846397329111225,1.0,5/23,10.56%,DYNC1I1;NDEL1;KIF13A;KIF1C;PAFAH1B1
prerank,regulation of cation channel activity (GO:2001257),0.44653752509961225,1.310446045501969,0.11609195402298851,0.8841001011782486,1.0,11/89,4.46%,FGF13;ANK2;ACTN2;SLMAP;AHNAK;MMP9;CACNB3;PTK2B;SELENON;DAPK1;EPO
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5288392803158718,1.3096900229513935,0.1467236467236467,0.8850541730600906,1.0,4/26,5.15%,SORBS1;OCLN;CREBL2;RHOQ
prerank,T cell differentiation in thymus (GO:0033077),0.5949975607478609,1.3093412505584157,0.16692426584234932,0.884627939920334,1.0,4/14,19.54%,GLI3;RABL3;MR1;ADAM17
prerank,cAMP-mediated signaling (GO:0019933),-0.4265466059575147,-1.3085206975976051,0.11469534050179211,0.6485826450810446,1.0,8/24,9.95%,PDE7B;KSR1;PDE3A;RAPGEF2;PDE4D;CAP2;ADCY1;PDE2A
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6097821226492088,1.3081591788626643,0.178743961352657,0.8875541178978438,1.0,4/12,10.73%,CELSR1;LAMA5;ACTB;ACTG1
prerank,regulation of phosphorylation (GO:0042325),0.43678455756264956,1.3077347317392354,0.1043956043956044,0.8875044675308987,1.0,18/120,9.58%,FN1;CCL5;OGT;CDKN1A;EMP2;EP300;SESN2;PPP2CA;KDM4D;HSPB1;NUP93;BMP4;EIF6;ILK;ANG;PML;NDC1;JMJD8
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.470212692235917,-1.306090248557101,0.15406976744186046,0.6531523779976278,1.0,8/17,8.72%,IL34;NOTCH1;SERPINE2;BIN1;TGFB1;PTPRZ1;ID2;TENM4
prerank,cellular response to dsRNA (GO:0071359),0.5833781393046772,1.3058984085214511,0.19148936170212766,0.8931979091757217,1.0,6/15,19.48%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.41976989140195403,1.3058543714524253,0.0851063829787234,0.8914326978210567,1.0,44/173,19.31%,CD55;ANK2;DYNC1I1;F5;NRBP2;ANK1;PEF1;ERGIC1;COPA;SPTBN2;TMED1;TFG;CAPZB;CTSZ;ANK3;ERGIC2;IER3IP1;BCAP31;ZW10;HYOU1;TRAPPC1;SPTAN1;MCFD2;VTI1B;ERGIC3;NAPA;GOLGB1;ARF4;COG8;PREB;VAMP7;RAB1B;CNIH1;ATL2;SEC23A;DYNC1LI2;NSF;DYNC1H1;COPG1;YKT6;TMED5;BET1L;SEC24B;VTI1A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5757001786904901,1.3055130035994873,0.16380655226209048,0.8908604327482498,1.0,1/17,0.15%,CD55
prerank,cellular response to interleukin-6 (GO:0071354),-0.42853083018046856,-1.3051486808851718,0.11870503597122302,0.6533144384541176,1.0,15/26,28.01%,PID1;PTGIS;ST18;IL6R;JAK2;STAT3;PTPRT;IL6ST;YAP1;SMAD4;SOCS3;CBL;SPI1;FER;CEBPA
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6091217310650101,1.3049513565694248,0.15979381443298968,0.8912957019615264,1.0,7/11,30.35%,UQCRC2;UQCRC1;UQCR11;UQCRH;UQCRFS1;UQCRB;UQCC3
prerank,positive regulation of response to stimulus (GO:0048584),0.4994916389138897,1.3049223219136261,0.12993630573248408,0.8894532010123379,1.0,13/40,15.32%,IL15;MAVS;SELENON;YPEL3;NSMCE4A;TGFB2;ILK;CDKN2AIP;GATA3;FXR1;MYC;EEF1E1;DHX9
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.37102444732681683,-1.3045351152989249,0.0975609756097561,0.6522261570978004,1.0,15/44,20.87%,PTPRJ;LYN;DAB2IP;IRAK3;SH2B3;PIK3CB;DNAJA1;NF1;CD300A;SORL1;PDCD4;SPRY4;SPRY1;PAQR3;BMP7
prerank,regulation of potassium ion transport (GO:0043266),0.515539142887133,1.304348647445182,0.16010854816824965,0.8899737433400727,1.0,5/31,6.82%,ANK2;ACTN2;FHL1;PTK2B;ANK3
prerank,cellular response to oxidative stress (GO:0034599),0.4353569695489955,1.303363851483004,0.09748083242059145,0.8920715789101774,1.0,20/118,11.21%,WNT16;PRKAA2;PPARGC1A;MMP9;CPEB2;ZC3H12A;FOXO3;FOS;SESN2;MGAT3;NFE2L2;DAPK1;NUDT2;PXN;ROMO1;JUN;MAPK9;SOD2;AGAP3;PDK2
prerank,response to estrogen (GO:0043627),0.5065712731974266,1.3033194715773075,0.1480978260869565,0.8903552960970398,1.0,9/31,18.35%,KRT19;CAV1;EP300;TRIM25;BCAS3;GATA3;SFRP1;SFR1;RARA
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4290090027668976,-1.303091971138471,0.12867647058823528,0.6538017106064451,1.0,6/26,7.46%,ERRFI1;TGFA;CBLB;NCK2;ZFYVE28;SOCS5
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2905816003647437,-1.3029176372099636,0.02702702702702703,0.6512751419074256,1.0,34/150,12.69%,PDGFRB;HIP1;PTPRJ;TGFA;ENG;PIK3R1;TEK;INSR;KITLG;SEMA5A;PTK2;ESR1;GAS6;AXL;PDGFRA;MFHAS1;KL;FGF2;THBS1;IL18;IGF2;TGFB1;PIK3CB;GAB2;ERBB4;FGFR2;PIK3AP1;PIK3CD;KIT;MYOC;IGF1R;GRB2;TXN;FGFR4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5277812114221077,-1.302879850263686,0.17195767195767195,0.648420912052428,1.0,7/12,19.94%,ABCA1;NR1H3;PPARG;ITGAV;NR1H2;PPARA;ABCG1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5900221568551188,1.3028630870747462,0.18798151001540833,0.8902984290588176,1.0,8/15,20.42%,REEP3;RTN3;ZFYVE27;TMEM33;ATL2;REEP4;ARL6IP1;RAB10
prerank,inner mitochondrial membrane organization (GO:0007007),0.47372105806320036,1.3028395822083316,0.15601023017902813,0.8885056797550784,1.0,25/47,26.38%,TIMM10;CHCHD3;MICOS13;AGK;ROMO1;MICOS10;AFG3L2;LETM1;ATP5PF;OPA1;APOO;IMMT;ATP5F1B;MTX1;SPG7;TIMM9;ATP5PD;MTX3;ATP5ME;MAIP1;ATP5F1D;MTX2;ATP5F1C;ATP5MC3;NDUFA13
prerank,negative regulation of hormone secretion (GO:0046888),0.6444296931777925,1.3025336697265932,0.18810289389067525,0.8879196511427592,1.0,3/10,15.61%,RAB11FIP3;RAB11FIP5;RAB11FIP1
prerank,negative regulation of T cell differentiation (GO:0045581),0.6296618482321423,1.3019903884668307,0.18288590604026847,0.8881813177249016,1.0,2/10,6.81%,GLI3;BMP4
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5776616682943798,1.3019543074690785,0.18209876543209877,0.8864364498696281,1.0,3/16,7.75%,CLU;HMGCR;CYP51A1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5153210909129762,-1.301901666385199,0.15762273901808785,0.6484813057462259,1.0,6/13,16.64%,WNT5A;SEMA7A;IRAK3;TGFB1;GPRC5B;CD74
prerank,barbed-end actin filament capping (GO:0051016),0.5703399188080626,1.3013333587181517,0.1791044776119403,0.8850377932021766,1.0,6/18,6.22%,VILL;GSN;CAPZB;TWF1;AVIL;ADD1
prerank,actin filament capping (GO:0051693),0.5703399188080626,1.3013333587181517,0.1791044776119403,0.8850377932021766,1.0,6/18,6.22%,VILL;GSN;CAPZB;TWF1;AVIL;ADD1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6216644472097729,1.3009909563609543,0.1880064829821718,0.884551893386507,1.0,4/11,5.27%,MMP9;GSN;PRR7;PIH1D1
prerank,lipid phosphorylation (GO:0046834),-0.548555470733354,-1.3005480870388402,0.1636828644501279,0.6496612925604764,1.0,7/10,23.01%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,regulation of microtubule-based process (GO:0032886),0.505046861001403,1.3000940532407403,0.16042780748663102,0.8863850686407548,1.0,11/36,17.35%,PHLDB2;PRKAA2;DIAPH1;MAP6;EFNA5;EPHA3;MARK4;GSK3B;MEMO1;IGBP1;HDAC6
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.44235601812875475,1.2999943991947742,0.11683848797250859,0.8849398971583456,1.0,21/80,14.70%,CLU;VIM;EPHA4;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TNFRSF1A;ABCA2;POLDIP3;SP1;CPEB3;PLXNB2;FXR1;GSK3A;UPF3B;SMPD2;PYM1;PLA2G6
prerank,neuron apoptotic process (GO:0051402),-0.4491820417916707,-1.2998681651081445,0.13522012578616352,0.649051065346191,1.0,7/19,12.14%,FAS;FAM162A;BCL2;CIT;TNFRSF21;TRPC5;BID
prerank,regulation of intracellular protein transport (GO:0033157),0.5140132429275363,1.2998623486201384,0.14763231197771587,0.883605697979216,1.0,13/32,24.61%,PTPN14;NDEL1;BMP4;PLK3;GCC2;BCAS3;RIPOR1;KIF20B;VAMP2;SIRT7;TPR;ICE1;PCM1
prerank,aerobic electron transport chain (GO:0019646),0.44926145443292304,1.2997614928482255,0.12667478684531058,0.8821494389121598,1.0,25/68,21.45%,NDUFV1;NDUFB11;UQCRC2;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;AFG1L;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,positive regulation of blood coagulation (GO:0030194),0.5671167498441039,1.298650453735968,0.17846607669616518,0.8848223483214583,1.0,6/17,19.95%,ST3GAL4;THBD;DMTN;ANO6;F2R;USF1
prerank,negative regulation of macroautophagy (GO:0016242),0.5355507072729453,1.2984010384620737,0.15229885057471265,0.8840741375613395,1.0,8/26,9.89%,NRBP2;NUPR1;TSC2;TMEM39A;RUBCN;CHMP4A;CHMP4B;SMCR8
prerank,regulation of cell population proliferation (GO:0042127),0.40324497242209806,1.2981066246795883,0.008008008008008008,0.8834184947432273,1.0,95/691,9.09%,FN1;DPP4;EGLN3;AGTR1;CDH13;CLU;FGFR1;ZBTB7C;PTPN14;CRLF1;CHRM1;IGFBP6;NTRK3;CNOT6;WNT1;KLF4;TFAP2C;LAMC2;TJP1;TFAP2D;COL4A3;PDGFC;EFNB2;GRK5;CDKN1A;ADAM10;SMAD6;EMP2;NIBAN2;CD200;MAGI2;NUPR1;IL15;CDK10;PDF;CELF1;CDK6;CD81;SULT2B1;NGF;RBFOX2;PTGFR;TNFSF13;KANK2;PTK2B;SGK3;TNFRSF8;GDNF;NOP2;HDAC4;BMP5;CLCF1;GCNT2;TIMP1;EPO;PTPRU;CIAO1;DOT1L;NACC1;S100A11;CDK4;RPS4X;RARG;SH3BP4;TSC2;JUND;FOXM1;ZBTB17;KRAS;SOX9;TES;SHC1;CGREF1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TGFB2;STAT4;TGFB1I1;SLURP1;ROMO1;FGF22;SIX1;MAZ;JUN;TCF7L2;FBXO5;SSR1;ADAMTS1;PML;IL7R;FOXP3;BRD7
prerank,GPI anchor metabolic process (GO:0006505),0.5291827964720899,1.2978964910776916,0.1571627260083449,0.8824085869284561,1.0,9/26,19.44%,PIGU;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ;GPLD1
prerank,regulation of platelet aggregation (GO:0090330),-0.4673950335636448,-1.2976763639070232,0.15294117647058825,0.6527418331671906,1.0,4/17,7.16%,PRKG1;LYN;SERPINE2;SH2B3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.42159360025080406,-1.2974522742317858,0.1382636655948553,0.6505535008964293,1.0,12/25,25.51%,GRID2;GRIN2A;GRIN2B;LRRK2;GLRA1;NLGN3;DRD2;MPP2;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5490867878771754,1.2968501935645556,0.17985611510791366,0.8849613324154304,1.0,3/20,8.36%,CD55;CD81;FZD5
prerank,protein oxidation (GO:0018158),-0.5213845062799485,-1.2964441123500516,0.1760204081632653,0.6507737828138713,1.0,4/11,12.29%,LOXL1;TMX3;LOXL3;LOX
prerank,regulation of phospholipase activity (GO:0010517),0.6280368617686631,1.2960486719242041,0.1933884297520661,0.8864596458197679,1.0,1/10,0.51%,FGFR1
prerank,positive regulation of gene expression (GO:0010628),0.40527911851455967,1.2958951682248492,0.022110552763819097,0.885247571896989,1.0,87/442,14.63%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;SMO;VIM;SCAMP5;HPN;OCLN;GSN;SAMD4A;DDX5;YTHDF1;IL15;ZC3H12A;WNT11;EP300;CELF1;NGF;WNT6;NFE2L2;POLR2H;OLFM1;RPS4X;TAF1C;OVOL2;POLR2A;HOXA5;KRAS;MOV10;SOX9;FOXD1;HCFC1;ZBTB7B;DDRGK1;EIF4A3;BMP4;ANK3;RBMS3;MSN;UPF3A;RBM20;EIF6;NFAM1;FGF22;MAZ;POU3F1;MAPK9;TENT4A;TLR6;TXK;ACTB;MAP2K2;EZR;POLR1C;MYO1C;MUSK;TWIST1;SRPK2;HABP4;ACTG1;POLR1E;TLR4;CALCOCO1;POLR1F;POLDIP3;SP1;EIF2AK3;WNT3;CPEB3;PLXNB2;FXR1;MYC;GSK3A;MEF2C;UBR5;UPF3B;GSK3B;PYM1;GAPDH;ZPR1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5275149564549901,1.2958567856667498,0.16338028169014085,0.8835670833063296,1.0,7/27,10.78%,PHLDB2;TJP1;ARAP1;TMEFF2;ARHGEF18;RHPN2;DLC1
prerank,sterol biosynthetic process (GO:0016126),0.5129037741678979,1.2956329616800561,0.13953488372093023,0.8826926048213807,1.0,13/33,18.19%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,negative regulation of cell activation (GO:0050866),0.5920599659911898,1.2955496500364208,0.20098846787479407,0.8811924073883951,1.0,3/14,6.08%,LDLR;CD200;THBD
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.4374378271008452,-1.2951947088316353,0.13353115727002968,0.6518416678830674,1.0,9/22,15.83%,APPL2;LRRK2;PTPRZ1;ID2;NES;GATA2;TAFA1;TOX;KDM2B
prerank,DNA catabolic process (GO:0006308),0.6224245500188073,1.2947908492608473,0.1771523178807947,0.8824150742342486,1.0,4/11,13.78%,XRN2;DNASE1L2;DNASE1L1;REXO4
prerank,cholesterol metabolic process (GO:0008203),0.45823308573596594,1.2944393475078528,0.15227817745803357,0.8820056442369876,1.0,19/68,18.19%,FDFT1;SOAT1;STARD3;SULT2B1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;FDX1;SOAT2;ACAT2;SQLE;OSBPL5;PLPP6;TM7SF2;HMGCS1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5355382474840868,1.2939139923011165,0.1747159090909091,0.8823129904120566,1.0,5/23,9.74%,UACA;ZC3H12A;PPM1B;PPM1A;NMI
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5568648647057538,1.2934358292205352,0.17455621301775148,0.8823629025893753,1.0,4/19,5.97%,CLU;RTN1;FLOT2;RTN3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5187212371143093,1.2929745955445684,0.16216216216216217,0.8823598570129695,1.0,4/26,7.53%,CFTR;EFNA5;KLF7;CDK16
prerank,mesenchyme morphogenesis (GO:0072132),-0.46476280219108057,-1.2928520963598558,0.15211267605633802,0.6563279738368812,1.0,6/17,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6177846812361256,1.2927541804796543,0.18892508143322476,0.8814618318370795,1.0,3/10,11.21%,OGT;ZNF692;PDK2
prerank,renal filtration (GO:0097205),-0.5518202422340284,-1.2927144019041443,0.17411764705882352,0.6539140006320515,1.0,2/10,3.25%,SULF1;CD34
prerank,positive regulation of angiogenesis (GO:0045766),0.43541119373209364,1.2924998204632567,0.11086474501108648,0.8806806193493929,1.0,24/108,12.28%,PRKCB;ADAM12;ITGB8;KLF4;ANXA3;TJP1;NINJ1;ZC3H12A;GAB1;FOXC2;HSPB1;MTDH;PKM;AGGF1;MYDGF;VEGFB;JMJD8;EMC10;TWIST1;AQP1;RAPGEF3;S100A1;JAK1;SP1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4465591715276182,1.292305521470253,0.12336892052194544,0.8796686441805375,1.0,12/75,14.07%,SLC9A2;SLC9A4;SLC12A8;ATP1A2;KCNJ13;SLC39A6;SLC9A6;SLC9A7;TRPM4;SLC12A4;TRPM2;ATP2B4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5879847120930334,1.2921243942548164,0.1947449768160742,0.87861447692078,1.0,1/14,0.18%,AGTR1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5427428229574683,1.2918749365617572,0.17316017316017315,0.8778116151869656,1.0,6/24,9.85%,EPHA4;PTK2B;NUB1;LATS1;PKD1;ATP5IF1
prerank,plasma membrane invagination (GO:0099024),0.5081943508032314,1.2917858126228663,0.15181058495821728,0.8763344843984142,1.0,9/29,15.66%,GSN;GULP1;CDC42;SNX33;SNX18;RHOA;DOCK1;VAMP7;ITGB2
prerank,lipid oxidation (GO:0034440),0.5860660615073837,1.2915475087183275,0.19741100323624594,0.8754794282958196,1.0,2/12,5.07%,PPARGC1A;ALOX5
prerank,regulation of stem cell population maintenance (GO:2000036),0.557282900055386,1.2914724619652433,0.19340974212034384,0.8740388661537611,1.0,5/18,13.48%,NCOA3;ESRRB;WDR43;PTN;MYC
prerank,response to interleukin-6 (GO:0070741),-0.5481217537685458,-1.2912140876553901,0.17857142857142858,0.6558810258562714,1.0,3/10,11.17%,PID1;PTGIS;PTPRT
prerank,apoptotic process (GO:0006915),0.41347178999264994,1.290672545255547,0.07804370447450572,0.8754153626223734,1.0,49/203,17.54%,EGLN3;RNF152;NOTCH2;CYFIP2;PAWR;OGT;BBC3;EP300;CXCR4;PMAIP1;PTK2B;DAPK3;PPP2CA;DAPK1;ZBTB16;AHCYL1;PPP1R15A;NUDT2;NFKBIA;IRF3;TSC2;BCL2L1;EFNA5;ERBB3;BAD;PLK3;TNFRSF10B;DPF2;RAF1;ADAM15;DLC1;FEM1B;PLSCR3;TGFBR2;FXR1;VDAC1;MYC;ING4;PAX3;YARS1;GAPDH;MDM2;IKBKG;ITGB2;PAK6;PDE1B;ERCC2;SIAH1;PIDD1
prerank,axonal transport of mitochondrion (GO:0019896),-0.5302345645492391,-1.290536564136989,0.18230563002680966,0.655370459419892,1.0,5/11,15.90%,HIF1A;SYBU;ACTR10;NEFL;TRAK2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5817727842785272,1.2897812697742435,0.18740399385560677,0.8772695394449451,1.0,3/13,8.62%,BMP5;ERLIN2;ERLIN1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.4661742535698817,1.2895949745214235,0.14619164619164618,0.8762587031282285,1.0,14/54,15.89%,NSA2;NLE1;NOP2;PES1;PPAN;EIF6;MAK16;SDAD1;NIP7;RPL10A;RPF1;HEATR3;PAK1IP1;RPL14
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.503523231837059,-1.2892806447533443,0.15977961432506887,0.6562905183803388,1.0,10/12,34.23%,PIK3R1;DAB2IP;BCL2L11;BAX;BOK;ERN1;BAK1;XBP1;PTPN1;ATF6
prerank,Golgi ribbon formation (GO:0090161),0.594696150252654,1.289190628458645,0.18506493506493507,0.8760955866878468,1.0,7/13,19.44%,GOLPH3;GCC2;STX16;FHDC1;TMED5;VTI1A;MYO18A
prerank,cell junction assembly (GO:0034329),0.4376633111068478,1.2880326225436414,0.12597547380156077,0.8789967895821694,1.0,13/100,9.27%,FN1;CDH1;SDK1;TJP1;PKP4;LIMS2;ILK;PARD6B;FZD5;CDC42;GRHL2;OPHN1;ACTB
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.4078390467254048,-1.2879103252792734,0.12546125461254612,0.6577079925021105,1.0,12/28,31.06%,CD47;SH3KBP1;NCKAP1L;CYRIB;HSPD1;TYROBP;NOD2;PYCARD;TNIP2;CCR2;PRKDC;CCL2
prerank,neuron remodeling (GO:0016322),-0.5266684483211623,-1.2872007602331967,0.18469656992084432,0.657105076158873,1.0,8/10,32.35%,ADGRB3;ANKS1A;C1QA;EPHA8;CX3CL1;C3;RND1;FARP2
prerank,defense response to bacterium (GO:0042742),0.43433079259236224,1.2870714539153087,0.11022727272727273,0.8810244360729024,1.0,23/105,15.50%,ANXA3;GALP;MAVS;SLPI;PGLYRP3;EPX;CFP;SHC1;ANG;ROMO1;STAB2;LBP;TLR6;RNASE3;PPP1R11;AQP1;TLR4;ANKRD17;FCER1G;PLA2G6;TLR3;MR1;OAS2
prerank,regulation of calcium ion import (GO:0090279),-0.441187104905492,-1.286735876835969,0.17105263157894737,0.6555225430392391,1.0,3/21,4.78%,PDGFRB;CXCL12;PKD2
prerank,dendritic cell chemotaxis (GO:0002407),0.577612365778616,1.2861597648512904,0.20662460567823343,0.8828806473739876,1.0,4/14,13.39%,CCL5;CXCR4;TRPM4;TRPM2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5539661627699047,1.285679469833586,0.18181818181818182,0.8831772958737356,1.0,6/20,12.12%,CNOT6;CELF1;MOV10;EIF6;MOV10L1;AJUBA
prerank,regulation of platelet activation (GO:0010543),-0.4363279114043909,-1.2851655179808845,0.15286624203821655,0.6575445632823792,1.0,4/21,3.60%,PLA2G4A;LYN;NOS3;PDGFRA
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3786414522203315,-1.2845760458052902,0.124,0.6564446189425172,1.0,11/35,11.59%,FLT1;PTPRM;SULF1;NR2F2;XDH;THBS1;RGCC;ATOH8;PPARG;NF1;ATP5F1A
prerank,cellular component disassembly (GO:0022411),0.4687988658540714,1.2844149061542118,0.13950617283950617,0.8866868000672138,1.0,14/53,13.10%,CD44;TMPRSS6;MMP9;ADAM10;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12;EXOC8
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.42584554940319164,-1.2839572990634798,0.14193548387096774,0.655631118654016,1.0,12/23,22.20%,IFNGR1;IFNGR2;NR1H3;PARP14;JAK2;PPARG;NLRC5;IRGM;NR1H2;CDC37;HSP90AB1;SOCS3
prerank,bile acid and bile salt transport (GO:0015721),-0.4228462386960418,-1.2834797239745657,0.15034965034965034,0.6543487860473016,1.0,4/24,3.43%,ABCC4;SLCO2B1;SLCO1C1;NCOA1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.4429684485521859,1.2831433702120407,0.1425091352009744,0.8901961870670771,1.0,25/69,21.45%,NDUFV1;NDUFB11;UQCRC2;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;AFG1L;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5572599442599014,1.2827475651865086,0.18882175226586104,0.889980586114088,1.0,1/17,0.66%,ANK2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5699210934280408,1.2823439025230123,0.21428571428571427,0.8897970215750569,1.0,6/16,13.92%,EP300;NAA40;AANAT;NAA15;NAA20;NAA10
prerank,in utero embryonic development (GO:0001701),0.5202484081393103,1.282101965207971,0.17647058823529413,0.889055783247036,1.0,4/25,8.25%,MBNL1;ADAM10;FUT8;PKD1
prerank,actin filament polymerization (GO:0030041),0.5164762214738996,1.2814401029260531,0.17787114845938376,0.8899602180123254,1.0,6/29,7.84%,COBL;GSN;DIAPH1;CORO7;ANG;MSRB2
prerank,DNA methylation (GO:0006306),0.5390545180229673,1.281432231640323,0.19208211143695014,0.888256411289519,1.0,11/23,26.59%,FOS;BEND3;ATRX;ZFP57;DNMT3A;PPM1D;KMT2E;N6AMT1;TEX15;BAZ2A;EHMT1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5229967127718791,1.281239914581218,0.19484240687679083,0.8872594369439144,1.0,2/24,2.09%,PRKCB;NIBAN2
prerank,peripheral nervous system development (GO:0007422),0.5407834366756182,1.2812159462605388,0.19094766619519093,0.8856215453485569,1.0,6/23,10.48%,GPC1;NGF;GDNF;GFRA3;ERBB3;ADGRG6
prerank,neuromuscular synaptic transmission (GO:0007274),0.5535390587288352,1.2809883262178712,0.18666666666666668,0.8848782406885292,1.0,4/18,6.67%,FCHSD2;STAC3;FCHSD1;KIF1B
prerank,regulation of protein localization to nucleus (GO:1900180),0.48229704585680433,1.2803901823720922,0.1690885072655218,0.8855416291225966,1.0,20/43,23.74%,LIMK2;GLUL;CTNNA1;SESN2;ORMDL3;OTUD7B;BMP4;LATS1;SUMO3;EIF2AK3;GSK3B;FLCN;TESK1;PARK7;CDK5RAP3;ILRUN;BYSL;TPR;LATS2;WWTR1
prerank,positive regulation of chromatin organization (GO:1905269),0.5965982387374651,1.280081025834942,0.1830065359477124,0.8850662155533123,1.0,6/12,23.36%,DAXX;ATRX;UBE2N;H3-3A;TERF2;TINF2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4058202883231292,-1.2791471204748577,0.1444043321299639,0.6649016736701024,1.0,6/26,8.12%,POR;HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.5402970154264385,-1.2788057386232257,0.2004950495049505,0.6632419578608766,1.0,4/10,7.34%,SOX5;ACVRL1;BMPR1B;PKDCC
prerank,anion transmembrane transport (GO:0098656),-0.3295245167410256,-1.2780393317052237,0.07386363636363637,0.6626151343194472,1.0,10/67,6.08%,SLC1A3;SLC6A13;SLC13A3;SLC16A12;LRRC8C;SLC6A9;SLC1A2;SLC7A5;SLC1A1;SLC39A8
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5279896540640631,1.2776928098482163,0.20029455081001474,0.8929792504001163,1.0,3/21,7.54%,PRKCB;CD81;NFAM1
prerank,fatty acid catabolic process (GO:0009062),0.44276145151553037,1.2775187719854557,0.13814180929095354,0.8919694016744285,1.0,18/67,14.63%,ADTRP;ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;PECR;MTLN;ACAT2;HADHA;PCCA;SLC25A17;CPT2;ECI2;ACADM;AUH;ILVBL;HADHB
prerank,positive regulation of calcium ion transport (GO:0051928),0.49588473525744514,1.2772749452750276,0.16689280868385345,0.8911523486194792,1.0,4/36,2.65%,ANK2;STIM2;CCL5;CAV1
prerank,heart process (GO:0003015),0.5866736626335276,1.276817040081059,0.17684887459807075,0.891330731993834,1.0,2/14,2.23%,SGCG;SGCD
prerank,inositol lipid-mediated signaling (GO:0048017),0.46562069726897604,1.2759208314162171,0.15049751243781095,0.8931584805938819,1.0,13/50,11.76%,PITPNM2;FGFR1;PLCL2;PLCB3;PLCD3;OGT;NGF;PIK3C2B;PLCL1;PI4KA;EZR;IRS2;RHOA
prerank,intestinal absorption (GO:0050892),0.5837162600543435,1.2758204169140182,0.21085271317829457,0.8918619095885405,1.0,1/13,1.20%,TJP2
prerank,regulation of RNA metabolic process (GO:0051252),0.4589274861387898,1.2756989346241883,0.15643802647412755,0.8906479210129479,1.0,19/59,20.55%,MBNL1;AHNAK;AHNAK2;CELF1;SNRNP70;SON;RBM20;HNRNPH2;SRRM4;RASA1;GRSF1;MBNL2;OAS2;BRDT;IGF2BP3;PTBP1;IGF2BP2;PCBP2;IGF2BP1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5507474325586097,1.2755496254689445,0.17592592592592593,0.8895084833279547,1.0,6/17,17.55%,CD44;YJU2;TWIST1;MDM2;KDM1A;ARMC10
prerank,cellular response to ketone (GO:1901655),0.4866439591034056,1.275141771591065,0.16853932584269662,0.8894392692685628,1.0,7/35,11.06%,CFTR;PTGFR;MSN;GOLPH3;ADCY6;ADAM15;AQP1
prerank,B cell homeostasis (GO:0001782),-0.5429062388476013,-1.2750895401952598,0.19121447028423771,0.6690189794178227,1.0,5/10,21.74%,LYN;DOCK10;NCKAP1L;TNFAIP3;DOCK11
prerank,regulation of endocytosis (GO:0030100),0.4494698359969414,1.2750242918326347,0.1529126213592233,0.8881953412486128,1.0,17/61,17.29%,RAB17;CDH13;SCAMP5;TSC2;STON1;CBLL1;GPC3;RUBCN;LGALS3;OPHN1;SNX33;EPHA3;SNX12;RAB5C;SYT11;ABL1;PACSIN1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4665380250969841,1.2748189648789539,0.17413572343149808,0.8873282403554046,1.0,17/52,16.89%,SREBF2;BBC3;PMAIP1;PPP1R13B;BAD;FZD5;YWHAB;YWHAQ;SAE1;VPS11;YWHAZ;NPEPPS;RHOU;GSK3A;RNF31;E2F1;UBE2D3
prerank,negative regulation of cell motility (GO:2000146),0.4295408847643126,1.2734575383493423,0.1291759465478842,0.8910340284516537,1.0,18/108,8.40%,CDH1;SRGAP3;SRGAP2;KANK1;EPHA4;DAG1;MAGI2;WNT11;SPINT2;FOXO3;DUSP10;PTPRU;TMEFF2;FBLN1;MAPK15;CCDC125;SLURP1;PIP5KL1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5583667756593567,1.2732264377554117,0.18053375196232338,0.8902453580091846,1.0,3/16,9.90%,NUPR1;ABCD1;COX7A2L
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.45035518957275555,-1.2730271028468179,0.17058823529411765,0.672637371582067,1.0,12/18,28.01%,ST18;IL6R;JAK2;STAT3;IL6ST;YAP1;SMAD4;SOCS3;CBL;SPI1;FER;CEBPA
prerank,cellular response to interleukin-15 (GO:0071350),-0.4820727594969517,-1.2726518717186919,0.19117647058823528,0.6683034088221536,1.0,6/13,12.27%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4820727594969517,-1.2726518717186919,0.19117647058823528,0.6683034088221536,1.0,6/13,12.27%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,central nervous system neuron differentiation (GO:0021953),-0.3849046649911822,-1.2722855215465432,0.109375,0.6667647502336211,1.0,13/33,20.22%,MAP2;GRID2;NTRK2;LRP6;RYK;KNDC1;GBA2;TOX;MDGA2;FAIM2;NR4A2;SPOCK1;CHD5
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.31022793321327413,-1.2721826177383826,0.0990990990990991,0.664338113394269,1.0,29/88,14.37%,PTPRM;SULF1;PRKD1;NR2F2;TEK;SEMA5A;HIF1A;VEGFC;PPP1R16B;AKT3;WNT5A;XDH;ACVRL1;TIE1;KDR;FGF2;THBS1;RGCC;ECM1;ATOH8;STAT5A;PIK3CD;NF1;ATP5F1A;PDCD6;FLT4;SPARC;EGFL7;BMPR2
prerank,acylglycerol homeostasis (GO:0055090),-0.4356709666671277,-1.2721085194067963,0.1456953642384106,0.6619554249986844,1.0,4/20,6.77%,IL18;NR1H3;RORA;PNPLA8
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.441869562305426,1.2719134653845663,0.1608643457382953,0.8936289829341473,1.0,20/65,21.19%,FBXL7;FHL1;NABP2;PSMD11;AVEN;PSMD4;PSMF1;ZFYVE19;RBX1;PSMD7;PSMB5;PINX1;VPS4A;INTS3;PSMD1;PSMC4;CDK5RAP3;PSMD8;NABP1;CHFR
prerank,spliceosomal complex assembly (GO:0000245),0.4683364060021181,1.2717404247340829,0.17838541666666666,0.8926033741311769,1.0,18/46,21.95%,CELF2;CELF1;DDX39B;LUC7L3;USP39;SRPK2;KHDC4;SF3A2;SRPK1;SRSF9;LUC7L2;PRPF19;PRPF6;SRSF1;SRSF5;SF3A3;PUF60;DDX23
prerank,retina homeostasis (GO:0001895),0.5115549828743,1.27165696576553,0.19665271966527198,0.8912632357573183,1.0,9/23,20.93%,CRB2;HSPB1;POTEF;ACTB;ACTG1;CNGB1;CDH3;JCHAIN;TULP1
prerank,connective tissue development (GO:0061448),0.4981232021647694,1.2713528015991324,0.17908496732026144,0.8908628510215354,1.0,8/35,8.25%,CD44;ITGB8;RORC;ZBTB16;SOX9;DDRGK1;DYRK1B;PKD1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5283573096181922,1.270946150264063,0.20058997050147492,0.8907551749235707,1.0,9/22,15.29%,NTRK3;MAGI2;RAP1A;NGF;EHD1;RAB35;WASF1;SH3GL2;RAPGEF1
prerank,positive regulation of phagocytosis (GO:0050766),-0.34918944662554385,-1.2709255843356537,0.09803921568627451,0.662872218221016,1.0,10/47,13.18%,PTPRJ;CD47;MERTK;GAS6;IL15RA;APPL2;GATA2;NCKAP1L;LMAN2;CAMK1D
prerank,smooth muscle cell differentiation (GO:0051145),-0.49977110466372693,-1.270816769504777,0.19148936170212766,0.660562880620664,1.0,9/12,22.25%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR;HEY1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.364972964244744,-1.2707234572093484,0.11009174311926606,0.6581913170115918,1.0,12/41,14.11%,ITPR1;SLC8A1;SLC8A3;GRIN2A;PKD2;FGF2;GRIN2B;SLC24A2;CHERP;DRD2;HTR2A;RYR2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.48459738978308864,1.2702815478675697,0.16689280868385345,0.8916513675114058,1.0,9/35,14.56%,NR3C2;DAXX;DDX5;RBFOX2;EGLN2;KDM3A;CALCOCO1;UBR5;NEDD4
prerank,plasma membrane organization (GO:0007009),0.4481368399406193,1.2698118997662762,0.15681544028950542,0.891840150035018,1.0,20/61,18.14%,ANK2;AHNAK2;SYTL4;ABCD1;CXCR4;OTOF;A4GALT;CAVIN2;ANK3;CHMP4A;TLCD2;SNX33;PLSCR3;ANO6;FER1L6;SYT11;NSF;PACSIN1;STX4;OSBPL2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.39895638240652936,1.2691082673138423,0.05852674066599395,0.8930039971774539,1.0,48/348,10.73%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;ANKRD31;SMO;HPN;OCLN;GSN;MAGI2;ZC3H12A;WNT11;CELF1;NGF;WNT6;NFE2L2;OLFM1;OVOL2;HOXA5;KRAS;MOV10;SOX9;FOXD1;HCFC1;ZBTB7B;DDRGK1;BMP4;ANK3;MAPK7;ANXA2;RBMS3;MSN;FGF22;MAZ;POU3F1;MAPK9;TLR6;EZR;MUSK;TWIST1;SRPK2;ACTG1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5884487002862197,1.2688980272998645,0.22327044025157233,0.8922469167204772,1.0,4/13,10.40%,CAV1;NFE2L2;TMEM259;BCAP31
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.5447899548615359,-1.2688179669532391,0.1715686274509804,0.6614870934691298,1.0,4/10,16.46%,ESR1;PSMC6;TP53;HMGB1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5196744731187235,-1.2687222769066508,0.18779342723004694,0.6592184767368595,1.0,4/10,4.75%,RAPGEF2;CD34;KDR;TMEM100
prerank,iron ion transmembrane transport (GO:0034755),-0.5088880802474873,-1.2686229273253966,0.17902813299232737,0.6569557121185297,1.0,3/10,6.08%,SCARA5;SLC40A1;SLC39A8
prerank,response to organophosphorus (GO:0046683),-0.46508930596869646,-1.2683535450558672,0.1989100817438692,0.6553132705965401,1.0,6/16,21.61%,TRPC3;ABCC9;TYMS;RFC3;DGKQ;VGF
prerank,positive regulation of wound healing (GO:0090303),0.49401461846055333,1.2682081714860316,0.17082785808147175,0.8932660421166462,1.0,9/36,14.37%,KANK1;ST3GAL4;OCLN;FOXC2;DMTN;ACTG1;RREB1;ARFGEF1;HRAS
prerank,positive regulation of GTPase activity (GO:0043547),0.40957443392496545,1.2665745091811589,0.10337552742616034,0.8984031618172601,1.0,44/188,17.29%,ARHGAP42;MAPRE2;RTN4R;NTRK3;SRGAP2;ARAP1;NGEF;CCL5;PLXNB1;PKP4;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;GRTP1;TBC1D16;TIAM2;CAV2;DOCK7;ARHGAP29;CCDC125;DVL3;BCR;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;TBC1D1;RGS6;ASAP3;SFRP1;GSK3B;HRAS;ARHGAP27;FLCN;USP6NL;RAPGEF1;TBC1D22A;TBC1D10A;PRTN3;RAP1GAP;F2R
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5274913758219064,1.2660515012487839,0.21106259097525473,0.8988542465324387,1.0,6/22,12.29%,SMARCB1;PIH1D1;UBTF;WDR43;SMARCA4;EIF2AK3
prerank,nuclear membrane organization (GO:0071763),0.5519717369555823,1.265673452900715,0.19601837672281777,0.8985013595340097,1.0,9/19,24.73%,NSFL1C;CHMP4B;TOR1A;VPS4A;TOR1AIP1;CHMP2A;GPER1;TMEM43;UBXN2A
prerank,sensory perception (GO:0007600),-0.36279023349259787,-1.2654716063686375,0.12264150943396226,0.661586248546672,1.0,26/45,36.57%,GNAS;ADGRV1;PCDH15;TTC8;RETREG1;ADORA2A;PTGES;MME;GNAL;OPRM1;BBS4;OPRK1;NIPSNAP1;NTSR2;WHRN;TRPA1;CHRNA4;CDH23;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;CLRN1
prerank,phospholipid homeostasis (GO:0055091),-0.5156433179963789,-1.2649297677323397,0.18863049095607234,0.6606821242511511,1.0,2/11,6.55%,ABCA1;RCN3
prerank,regulation of dendritic spine development (GO:0060998),-0.4387107522409704,-1.2649072320988484,0.1724137931034483,0.6582252803555013,1.0,6/19,10.79%,SHANK3;TANC2;PPFIA2;NLGN1;KIF1A;DLG5
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5796023748748179,1.2648032764922612,0.1987075928917609,0.90021845522722,1.0,7/14,15.74%,MSN;PATJ;CDC42;OPHN1;EZR;RHOA;FSCN1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.6083917606554661,1.2645340503866564,0.2146422628951747,0.8996786306584091,1.0,2/11,1.30%,TJP2;TJP1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.49681256437581367,1.2643485038684714,0.1784741144414169,0.8987300091225213,1.0,8/33,9.09%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PLK3;BRD7
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5532104823476764,1.2639515825851728,0.21739130434782608,0.8986375485605266,1.0,5/18,13.54%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,protein tetramerization (GO:0051262),-0.3187494101104331,-1.2635028988869657,0.08666666666666667,0.6600502574326738,1.0,21/67,15.50%,ALDH1A2;PKD2;OXA1L;APPL2;GBP5;GRIN2B;HPRT1;KCNJ2;B2M;UPB1;MCOLN1;NUDT21;SAMHD1;AQP4;ALDH9A1;CPSF6;KCNJ12;GOLGA2;CBY1;KCNC1;ACACB
prerank,synaptic membrane adhesion (GO:0099560),0.5811593399628815,1.2633201211982243,0.2106060606060606,0.8994183018758634,1.0,4/14,6.86%,GPC6;GPC4;PTPRD;PTPRF
prerank,intestinal lipid absorption (GO:0098856),0.5936407495290006,1.2627725116222233,0.22203947368421054,0.8998726457372053,1.0,2/11,8.95%,LDLR;SOAT2
prerank,positive regulation of hydrolase activity (GO:0051345),0.41373245976934525,1.2627630191663113,0.13232104121475055,0.8982647442895172,1.0,32/137,17.29%,MAPRE2;RTN4R;SRGAP2;ARAP1;CCL5;PLXNB1;PKP4;CD200;WNT11;NDEL1;RAP1A;S100A10;CAV2;DVL3;BCAS3;SNX18;SGSM2;RAPGEF3;RHOA;RGS6;ASAP3;SFRP1;GSK3B;HRAS;ARHGAP27;FLCN;USP6NL;RAPGEF1;CTSH;PRTN3;RAP1GAP;F2R
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.41107520243835677,-1.2623786802766774,0.1643835616438356,0.6607996027265511,1.0,5/24,4.78%,DMD;PDE4D;CAMK2D;JPH1;PKD2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5823367169056072,1.2614963179330485,0.224,0.9014211909290286,1.0,5/13,18.48%,DCTPP1;UPP2;MBD4;NEIL1;NT5M
prerank,steroid catabolic process (GO:0006706),0.6122814857152552,1.2612763140300556,0.23214285714285715,0.9006900590971412,1.0,3/10,19.57%,HSD17B14;HSD17B11;YWHAH
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5158753723697242,1.2609309457590772,0.1831610044313146,0.900462261226101,1.0,14/23,25.45%,NABP2;ZFYVE19;PLK3;ZW10;VPS4A;PLK2;INTS3;ZWINT;WEE1;CDK5RAP3;NABP1;CHFR;PLK5;PABIR1
prerank,regulation of cellular component organization (GO:0051128),0.41429494538330724,1.2602820751461357,0.12187159956474429,0.901433711050459,1.0,36/135,18.80%,AGTR1;RAB17;CDH13;TJP1;RAP1B;MLLT3;RAP1A;SGK3;LTBP4;TSC2;ROS1;STON1;HCFC1;SSRP1;EGLN2;LATS1;DCUN1D5;OPHN1;SOCS2;MARK4;CHPT1;SNX12;OGFR;BCAR1;RAB5C;NEDD4;RAPGEF1;HSP90AA1;RAB33B;ABL1;PACSIN1;PRKCQ;PTPN11;STK38L;PARK7;ROCK2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.42190324635822296,1.2591734162211294,0.13555555555555557,0.9039591438098256,1.0,17/108,10.78%,EGLN3;NLRP2;COL4A3;MAP3K5;UACA;GSN;BBC3;PMAIP1;PRR7;NGF;DAPK1;MUL1;BAD;TNFRSF10B;ARL6IP5;BCAP31;DLC1
prerank,negative regulation of cell migration (GO:0030336),0.4141157604920301,1.258522100333754,0.13469827586206898,0.9048904834689755,1.0,15/137,4.95%,CDH1;PHLDB2;SRGAP3;SRGAP2;ADTRP;KANK1;EPHA4;DAG1;MAGI2;WNT11;FOXO3;DUSP10;TIMP1;PTPRU;TMEFF2
prerank,microtubule-based transport (GO:0099111),0.5840993331106927,1.2579766384262556,0.19902120717781402,0.905397994498726,1.0,3/12,15.24%,DYNC1I1;SPAG17;ADCY10
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3722413632586195,-1.2574633269175892,0.13253012048192772,0.6730760516285823,1.0,11/35,9.95%,PDE7B;IRAG1;KSR1;PDE3A;RAPGEF2;PDE4D;GUCY1B1;CAP2;ADCY1;PDE9A;PDE2A
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5104962530284056,1.2573419754924,0.18938307030129126,0.906156244132596,1.0,5/25,7.99%,ATP6V1B1;CAV1;SELENON;ANK3;JPH2
prerank,motor neuron axon guidance (GO:0008045),0.5688939571509188,1.2571018018914142,0.2088607594936709,0.9054861587814167,1.0,2/15,1.67%,LAMC2;EPHA4
prerank,establishment of spindle orientation (GO:0051294),0.512965721615715,1.2566090825191703,0.19694868238557559,0.9058002674225554,1.0,11/28,22.96%,NDEL1;NSFL1C;MAP4;LLGL2;PAFAH1B1;ZW10;INSC;NUMA1;MISP;LLGL1;ITGB1
prerank,cardiac muscle cell contraction (GO:0086003),-0.4392620480076611,-1.2560467940752156,0.17721518987341772,0.6749588182454591,1.0,7/19,15.43%,CACNA1C;CAMK2D;KCNJ2;CACNA1G;FGF12;SCN1A;SCN1B
prerank,respiratory electron transport chain (GO:0022904),0.5568613072177561,1.2559711897611512,0.2294022617124394,0.906629823164848,1.0,2/14,4.01%,PPARGC1A;SDHB
prerank,modulation by symbiont of entry into host (GO:0052372),0.5459602644280572,1.2559638702381366,0.22575757575757577,0.9050547865544588,1.0,5/16,10.47%,CAV1;TRIM25;TRIM21;EXOC7;EXOC2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.42731583115005467,-1.2558027191100676,0.18243243243243243,0.6731403243968886,1.0,8/20,22.75%,ADGRV1;LRRK2;PRKAR2B;TCIM;PRKAR1B;AKAP7;MIF;IAPP
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.47002322807458097,-1.2556302394947574,0.19398907103825136,0.6711134081424401,1.0,13/14,53.04%,IL18;IL17D;PAEP;CD84;CD80;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,axon development (GO:0061564),-0.3205982317445867,-1.255609979181983,0.10810810810810811,0.6686323983229912,1.0,28/78,17.78%,MAP1B;SEMA5A;DCC;PAK3;GRM7;NREP;ZDHHC17;BRSK1;NRCAM;EPHB2;CTNNA2;SLITRK1;S100B;DSCAML1;FGFR2;RYK;NTNG1;PLP1;MAPK8IP3;DRD2;CAMSAP2;DHFR;MTR;MAP1A;SLITRK3;EPHB3;ARHGAP35;ATL1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.37078570199653793,-1.2555154092751155,0.11428571428571428,0.6663942571416082,1.0,11/40,8.90%,LEF1;JAG1;COL1A1;DAB2;NOTCH1;RGCC;TGFB1;EZH2;GLIPR2;AXIN2;TIAM1
prerank,regulation of neurogenesis (GO:0050767),-0.33610124172651107,-1.254884800166821,0.09340659340659341,0.6658581422157216,1.0,19/55,22.81%,TGM2;NOTCH1;APPL2;B2M;SERPINF1;HEYL;PRUNE1;MME;BHLHE40;SORL1;SOX11;NUMB;OPRM1;YAP1;CX3CL1;CX3CR1;HEY2;HEY1;YTHDF2
prerank,regulation of glucose metabolic process (GO:0010906),0.4844382147422123,1.2547703614197552,0.18926174496644296,0.9082113609846998,1.0,8/34,12.62%,OGT;RORC;PMAIP1;ZNF692;RUBCNL;PDK2;IRS2;FOXK1
prerank,rRNA transcription (GO:0009303),0.5511996823449465,1.2539794550937224,0.20579268292682926,0.9096217322705336,1.0,10/17,24.51%,ANG;POLR1E;GTF3C3;SPIN1;GTF3C2;GTF3C5;GTF3C4;SIRT7;POLR1G;TCOF1
prerank,reticulophagy (GO:0061709),0.5846883450104737,1.2538398827147421,0.2218700475435816,0.9085503762517095,1.0,5/12,16.24%,DDRGK1;TEX264;ULK1;RB1CC1;UFM1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5514103776531611,1.2538222754898538,0.22610015174506828,0.9070339140682211,1.0,2/18,3.81%,AGTR1;GDNF
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4684082988274447,-1.2535843969824791,0.20797720797720798,0.6673069250651319,1.0,6/13,15.99%,IRAK2;PIK3AP1;TRAF6;UNC93B1;PIK3C3;TLR7
prerank,positive regulation by host of viral transcription (GO:0043923),0.5647751740835713,1.2532593336046098,0.21758569299552907,0.9077422616285169,1.0,6/15,12.28%,HPN;EP300;SMARCB1;JUN;SMARCA4;SP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.593996999084424,1.2531429849541615,0.22607260726072606,0.9050368640584913,1.0,6/12,14.36%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.593996999084424,1.2531429849541615,0.22607260726072606,0.9050368640584913,1.0,6/12,14.36%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.4521354351442508,-1.2529991071215645,0.18209876543209877,0.6665947191497728,1.0,4/17,15.38%,PDE3B;PRKAA1;MFSD2A;SORL1
prerank,cGMP metabolic process (GO:0046068),-0.5004547769610106,-1.2527471844282283,0.20911528150134048,0.6648840238539513,1.0,5/12,10.43%,GUCY1B1;GUCY1A1;PDE9A;PDE2A;NPR1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.46858602821307493,-1.252157240315227,0.19210526315789472,0.6642270095165735,1.0,3/14,8.59%,SLC8A1;SLC8A3;SLC24A2
prerank,detection of calcium ion (GO:0005513),-0.4716041601851287,-1.2521548089502825,0.1984126984126984,0.6618013793093326,1.0,6/13,22.16%,STIM1;SYT1;RYR2;KCNMB4;KCNIP2;CASQ2
prerank,positive regulation of B cell proliferation (GO:0030890),0.4959255896073269,1.2518360830249922,0.17896174863387979,0.9084438077655544,1.0,4/29,4.18%,NFATC2;SASH3;CD81;CLCF1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4814198367423071,-1.2516944635441363,0.19143576826196473,0.6607492325999086,1.0,3/12,3.42%,PDE4D;GJD3;CAMK2D
prerank,cellular component assembly (GO:0022607),0.3985397444416183,1.2513164875243927,0.07755946225439504,0.9089761383506925,1.0,45/253,12.09%,REPS2;BAIAP2L1;RP1;PAWR;PPARGC1A;CALD1;PARVA;OCLN;GSN;YTHDF1;LIMS2;EPRS1;PTK2B;BSN;RHOQ;ESPN;ELOB;RTN3;SYCP2;ADD1;SOX9;DMTN;ANK3;ZFYVE27;ILK;MICAL1;GPAA1;AFG3L2;CFAP206;PARD6B;CDC42;LAMC1;PML;PCLO;GRHL2;KMT2A;OPHN1;ACTB;EZR;TLCD2;ACTG1;ZW10;RHOA;YWHAZ;WASF1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41205522234428626,-1.2510829246084636,0.1710914454277286,0.6602214557057803,1.0,5/21,6.00%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PLAAT3
prerank,glycolipid biosynthetic process (GO:0009247),0.4837401003909163,1.2505263333897243,0.17941952506596306,0.9104279473905855,1.0,12/38,19.30%,ST3GAL4;PIGU;SCCPDH;A4GALT;LARGE1;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ
prerank,chordate embryonic development (GO:0043009),0.4482432813277364,1.2503689218972263,0.17100371747211895,0.9094549902415249,1.0,9/55,8.90%,MBNL1;KIAA1217;FGFR1;ADAM10;WNT11;BMP5;FUT8;PKD1;GRHL2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4348987049600285,-1.2500599417042022,0.18461538461538463,0.6607271946281854,1.0,9/21,10.37%,ENPP1;NOS3;GAS6;NOTCH1;ECM1;ASPN;TGFB1;ROCK1;BCOR
prerank,positive regulation of cell population proliferation (GO:0008284),0.3899532308456044,1.2496239471954538,0.0592964824120603,0.9107539464659173,1.0,57/423,8.81%,FN1;DPP4;CDH13;FGFR1;CRLF1;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;PDGFC;EFNB2;GRK5;CDKN1A;ADAM10;EMP2;S100A6;IL15;PDF;CDK6;CD81;PTGFR;TNFSF13;PTK2B;GDNF;NOP2;HDAC4;BMP5;CLCF1;GCNT2;TIMP1;EPO;CIAO1;DOT1L;NACC1;CDK4;RPS4X;FOXM1;KRAS;SOX9;SHC1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TGFB2;BAD;ROMO1;FGF22;MAZ;TCF7L2;FBXO5;SSR1;LAMC1;IL7R
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5382295699817572,1.2495503680982416,0.20239880059970014,0.9094731108647395,1.0,3/16,4.13%,IGFBP6;WNT1;BMP5
prerank,mitochondrial transport (GO:0006839),0.4505076697306427,1.2492894808444561,0.1826309067688378,0.9089135114346731,1.0,25/53,26.61%,STARD3;PMAIP1;TIMM10;TIMM44;BCL2L1;TOMM5;BAD;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;SLC25A4;TMEM14C;SPG7;TIMM9;TOMM40;TSPO;FLVCR1;TIMM23;AIP;MAIP1;ABCB10;MTX2;FBXO7
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.5231251026099163,-1.2490342219553738,0.225,0.6613062300597,1.0,6/10,31.24%,SACS;DNAJB2;SORL1;DNAJB1;HSPA1B;HSPA2
prerank,regulation of synapse organization (GO:0050807),0.5145126217584877,1.2489636025838868,0.19701086956521738,0.9085880601474993,1.0,3/26,1.67%,RAB17;PDLIM5;EPHA4
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.603783330401772,1.2482437505993451,0.22077922077922077,0.9097850984505237,1.0,1/10,1.06%,ACTN2
prerank,cellular respiration (GO:0045333),0.46529402231352435,1.2478987455357557,0.20268456375838925,0.9095895425414854,1.0,21/41,28.58%,PPARGC1A;SDHB;ME3;UQCRC2;MTFR1L;UQCRC1;MTLN;MDH2;SLC25A14;UQCRH;MTFR2;COX10;UQCRFS1;SURF1;ATP5F1D;MTFR1;ETFDH;ETFB;ETFA;NDUFS4;LYRM7
prerank,signal transduction in response to DNA damage (GO:0042770),0.45888007463839825,1.2477369901556032,0.18385093167701863,0.9086810869796301,1.0,17/49,17.99%,WNT1;NDRG1;SESN2;DOT1L;USP10;ATRX;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;ABL1;NBN;CHEK2;TRIAP1
prerank,carboxylic acid catabolic process (GO:0046395),0.5852458786272298,1.2475487448922022,0.24077328646748683,0.9078270012260179,1.0,3/12,11.30%,ACOT8;NAGK;PON3
prerank,embryonic digestive tract development (GO:0048566),-0.4346333607349338,-1.2473138998163682,0.1716867469879518,0.6639950359955858,1.0,8/18,9.11%,PCSK5;GLI2;RARB;PDGFRA;SALL1;PKDCC;ID2;FGFR2
prerank,linoleic acid metabolic process (GO:0043651),0.546819374268525,1.247238896796928,0.20341614906832298,0.9074720980608487,1.0,6/17,19.39%,ABCD1;ELOVL1;ALOX5;FADS1;GSTM2;FADS2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.34648489712789815,-1.24668022902286,0.14354066985645933,0.6634668300177685,1.0,7/45,8.35%,BMP6;RBPMS;ENG;DAB2;ACVRL1;TGFB1;ACVR2A
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5847248443725336,1.2466585756023874,0.22148760330578512,0.9081483716160281,1.0,2/12,3.61%,NOTCH2;PTK2B
prerank,gland development (GO:0048732),0.45031215167967525,1.2461050474163027,0.17422434367541767,0.9088172346090919,1.0,12/59,9.59%,COBL;IGSF3;WNT10A;WNT11;CAV1;STRA6;NKX2-8;SOX9;MSN;LSR;SIX1;EZR
prerank,collagen fibril organization (GO:0030199),0.423520800477922,1.2460081056771388,0.16380297823596793,0.90763621186321,1.0,12/88,7.39%,ITGB4;ADAMTS14;COL23A1;COL25A1;LAMC2;COL4A3;COL4A4;COL5A2;COL6A1;COL6A3;PXDN;TGFB2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.43292359901337174,1.2458469129929672,0.17523364485981308,0.906733594839253,1.0,10/74,8.41%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;RBX1
prerank,regulation of MAPK cascade (GO:0043408),0.40419399580215754,1.2458158357285145,0.15026455026455027,0.9052980534641434,1.0,20/157,9.95%,FN1;ADRA1B;FGFR1;LPAR1;NTRK3;JCAD;DAG1;LBH;GDF15;CAV1;DUSP1;CAV2;ROS1;SHC1;MYDGF;IQGAP1;ARHGEF5;PTPN6;MAP2K2;PRDM15
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5712848695084444,1.2455306415058514,0.2336,0.9049392434954466,1.0,9/13,20.66%,NFKBIA;LATS1;PKD1;YWHAB;GET4;FLNA;KEAP1;SUFU;DBN1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.45567414595393846,-1.2455054934210419,0.20520231213872833,0.6645083683505121,1.0,6/15,19.85%,RUVBL1;DKC1;CCT7;CCT2;CCT4;NOP10
prerank,phosphate-containing compound metabolic process (GO:0006796),0.39745700056544964,1.2451226131537296,0.10948905109489052,0.90492878098192,1.0,19/198,8.04%,PLPPR2;PLB1;NUDT4;PLCB3;LIMK2;PLCD3;DUSP10;PTPRD;PFKP;HKDC1;DUSP12;IP6K1;INPP4A;AGK;SLC20A1;PFKFB2;NADK;PPIP5K2;PPM1A
prerank,regulation of ossification (GO:0030278),0.4827412719947526,1.2444139050907723,0.22526041666666666,0.9060673315788705,1.0,11/36,14.10%,ANKH;SMAD6;SGMS2;ZBTB16;SOX9;BMP4;TGFB2;TWIST1;PTN;MEF2C;SFRP1
prerank,carbohydrate derivative transport (GO:1901264),-0.4337703827245444,-1.2440925514237102,0.14825581395348839,0.6662901845750918,1.0,7/18,19.94%,PLTP;SLC29A1;MFSD2A;CLN3;SLC10A7;SLC15A2;ABCG1
prerank,regulated exocytosis (GO:0045055),0.40220825043500885,1.2435398684045258,0.12695109261186263,0.9080266259114955,1.0,33/173,15.67%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;OTOF;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;DNAJC5;SYNGR3;VEGFB;PCLO;STEAP2;HABP4;RAB11FIP5;VTI1B;OLA1;SYT6;VAMP7;ALDOA;SYT11;SYT12;RAB11FIP1;ACTN4;FLNA
prerank,neurotransmitter transport (GO:0006836),-0.32036522237508397,-1.2429768985958354,0.06293706293706294,0.6672891296400616,1.0,14/73,10.46%,SLC1A3;UNC13B;NRXN1;LIN7A;SLC1A2;BRSK1;SLC1A1;SYT1;PPFIA2;SLC29A1;SNAPIN;APBA1;SLC17A6;SNAP25
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5070960035677827,1.2425670191520164,0.22517482517482518,0.9103582187288816,1.0,1/25,0.15%,CD55
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4233863549467778,1.2421429377922402,0.1702857142857143,0.9104826467613796,1.0,25/87,20.25%,FBXL7;KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PSMD11;AVEN;PSMD4;PSMF1;RBX1;FBXO5;BRD7;PSMD7;PSMB5;PINX1;PSMD1;PSMC4;WEE1;GPNMB;CDKN2D;PSMD8;RB1;PRMT2
prerank,positive regulation of cell differentiation (GO:0045597),-0.2745315891883198,-1.2419929205025122,0.027777777777777776,0.6676318572626859,1.0,50/237,10.04%,TCF4;PLCB1;BMP6;SOX5;IGF1;ZEB1;LEF1;PRKD1;PRKCH;COL1A1;RAPGEF2;CDH2;DAB2;KITLG;WNT4;BOC;ZHX3;MEDAG;VWC2;AR;ACVRL1;CD34;KDR;TMEM100;SLC6A6;BMPR1B;RUNX2;BRINP3;IL18;NRCAM;CTNNA2;RGCC;FBN2;PPARD;TGFB1;PKDCC;IL6R;EZH2;GLIPR2;ID2;ACVR2A;AXIN2;NUDT21;TIAM1;HEYL;LRP5;PPARG;BTG1;IMPACT;CCN4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4961455344873249,-1.241462790290223,0.20604395604395603,0.666832104096061,1.0,4/13,7.46%,ERRFI1;CBLB;ZFYVE28;SOCS5
prerank,regulation of protein localization to membrane (GO:1905475),0.500511699203049,1.241354990613358,0.18219749652294853,0.9118732306936831,1.0,8/28,13.87%,GPC6;GPC1;GSN;GPC4;GPC3;ACTB;VTI1B;VPS4A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4705462846008552,1.241307140807964,0.20838627700127066,0.910508387768028,1.0,5/39,6.82%,FGF13;UTRN;SLMAP;STK39;ANK3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.435472570106158,1.2405519837162704,0.16887816646562123,0.911867624500861,1.0,6/63,4.18%,NFATC2;CCL5;SASH3;IL15;CD81;CLCF1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.49287683469006777,-1.2400490463838976,0.2159090909090909,0.6686234949767639,1.0,11/12,38.05%,EPHB2;B4GALT5;ARHGAP35;HSP90AB1;MYCBP2;PTEN;EPHB6;EPHB1;CHRNB2;SPTBN4;B4GALT6
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5341288724534737,1.2396117865250729,0.2247191011235955,0.9140253315257361,1.0,10/20,19.88%,MCU;MCUB;PMPCA;MICU1;AFG3L2;MCUR1;LETM1;SLC8B1;SPG7;STOML2
prerank,reverse cholesterol transport (GO:0043691),0.5809688503776945,1.23950062010242,0.23039215686274508,0.9129624924925471,1.0,1/13,0.40%,CLU
prerank,positive regulation of hemostasis (GO:1900048),0.6107009156157919,1.2390140317902125,0.21322314049586777,0.9117771195472897,1.0,2/10,6.39%,ST3GAL4;DMTN
prerank,positive regulation of coagulation (GO:0050820),0.6107009156157919,1.2390140317902125,0.21322314049586777,0.9117771195472897,1.0,2/10,6.39%,ST3GAL4;DMTN
prerank,negative regulation of neuron death (GO:1901215),0.4232833745938065,1.2385182346633574,0.1660939289805269,0.9121865517752776,1.0,27/93,18.77%,CRLF1;PPARGC1A;NRBP2;CD200;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;CHMP4A;CHMP4B;SOD2;CD200R1;RASA1;MEF2C;SET;GSK3B;EIF4G1;NENF;IKBKG;POU4F1;F2R;PARK7;GPNMB;TOX3
prerank,positive regulation of lipid localization (GO:1905954),0.5954854068911368,1.2385111408402558,0.249185667752443,0.9107018337454488,1.0,2/11,2.72%,ZC3H12A;IKBKE
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5091725694547873,1.2380458805266468,0.2217391304347826,0.9109816530361162,1.0,8/23,17.30%,NUPR1;EP300;HDAC4;TIGAR;NCOR1;GSK3A;PGP;GIT1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4830303792436295,1.2379016776218805,0.21825396825396826,0.9100609213203233,1.0,8/33,12.95%,KLF5;KLF4;FOXO3;FOS;TGFB2;JUN;SMARCA4;GATA3
prerank,chromatin assembly (GO:0031497),0.4654268944391647,1.2375455053018216,0.1803921568627451,0.9098765816685734,1.0,6/38,8.08%,DAXX;GRWD1;ASF1A;SOX9;KAT6B;ATRX
prerank,regulation of cytoskeleton organization (GO:0051493),0.41494634861656143,1.2374452201817814,0.1559432933478735,0.9088034649767068,1.0,19/108,11.76%,PHLDB2;PRKAA2;CELSR1;TJP1;PLXNB1;ARHGAP18;CDK10;DIAPH1;MAP6;RHOQ;EFNA5;DMTN;CAPN2;IQGAP1;ARHGEF5;EZR;DLC1;EPHA3;RHOA
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4345025336698702,1.2372278516231237,0.16880093131548313,0.9081148833136938,1.0,19/74,14.10%,PHLDB2;DAG1;HPN;CRB2;PPP2CA;BMP5;GCNT2;OLFM1;OVOL2;SPRED3;TGFB2;TGFB1I1;TWIST1;EPHA3;LDLRAD4;TGFBR2;PDPN;GATA3;SFRP1
prerank,morphogenesis of an epithelium (GO:0002009),0.5070953359587437,1.2368873447631985,0.2162534435261708,0.9078350628932059,1.0,6/25,10.73%,DAG1;WNT10A;LAMA5;SOX9;ACTB;ACTG1
prerank,negative regulation of cellular process (GO:0048523),0.38489958810555863,1.2361257316174645,0.04909819639278557,0.909391374848425,1.0,113/521,15.43%,WNT16;CDH13;CLU;ZBTB7C;ANGPT1;PTPN14;IGFBP6;SRGAP2;WNT1;KLF4;COL4A3;PLXNB1;PODXL;CDKN1A;ADAM10;SMAD6;NIBAN2;CD200;PLXNA2;CCN2;MAGI2;NUPR1;WNT11;CDK10;CELF1;CDK6;FHL1;SULT2B1;NGF;KANK2;PTK2B;TNFRSF8;SESN2;PPP2CA;BMP5;EPO;PPP1R13B;PTPRU;ALOX5;RIPOR2;CRYAB;S100A11;CD9;DUSP1;RARG;SH3BP4;TSC2;FBLN1;FOXM1;ZBTB17;TES;CGREF1;MUL1;BMP4;OSGIN2;CBLL1;ERBB3;TGFB2;TGFB1I1;SLURP1;NLRP2B;PSRC1;CHMP4B;FBXO5;NDUFS3;ADAMTS1;PML;FOXP3;BRD7;PTPN6;APBB1;NMI;DACT2;RAF1;ABI1;CASK;ADAM15;SOD2;DLC1;GSDME;SMARCA4;VPS4B;EIF2AK3;WDR6;PTPN2;CDKN2AIP;RASA1;PDPN;LPCAT3;PPM1D;GATA3;PLXNB2;CHMP1A;CAPRIN2;MYC;EEF1E1;BTG2;PRDM11;ING4;PINX1;MYBL1;SFRP1;BNIP3L;TGFBR3;DUS2;HRAS;P3H3;FLCN;ITGB1BP1;LMNA;SYT11;ARHGDIB;CHMP2A
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4425639861433381,1.2356918810590864,0.18742442563482467,0.9095725019775784,1.0,10/57,10.40%,CYFIP2;NLRP2;MAP3K5;UACA;PMAIP1;DAPK1;PERP;BAD;ARL6IP5;BCAP31
prerank,positive regulation of protein polymerization (GO:0032273),0.4342331728195037,1.2355927884460516,0.20359281437125748,0.9084826570078322,1.0,7/65,5.14%,BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5571374095035347,1.2354540589028937,0.22884012539184953,0.9074612428912199,1.0,8/15,18.00%,SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5162373130603675,1.2353744220013438,0.225,0.9062990438999949,1.0,4/21,8.36%,WNT1;CAV1;DVL3;FZD5
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.429146983905049,-1.2343193617103037,0.1712538226299694,0.6837248776626528,1.0,8/18,25.39%,RUVBL1;DKC1;PARN;CCT7;CCT2;CCT4;NOP10;DCP2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5254244933112805,1.233722395535893,0.2314674735249622,0.9095202973109435,1.0,4/19,8.08%,DAXX;POLR2H;POLR2A;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5254244933112805,1.233722395535893,0.2314674735249622,0.9095202973109435,1.0,4/19,8.08%,DAXX;POLR2H;POLR2A;ATRX
prerank,regulation of TORC1 signaling (GO:1903432),0.49164348707773553,1.2336428511776931,0.212,0.9083201279439637,1.0,8/33,16.17%,RNF152;SESN2;PIH1D1;SIK3;SMCR8;KPTN;FLCN;SESN1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.569147975923628,1.2332183546068205,0.26224328593996843,0.9083851065222165,1.0,3/13,4.29%,NAGK;MGAT3;LARGE1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.36557893672930886,-1.2331914769980905,0.13438735177865613,0.6849993235240638,1.0,5/36,1.90%,ERRFI1;EPHA7;PDGFD;ENG;ENPP1
prerank,zymogen activation (GO:0031638),0.46722634835069854,1.2329994842657332,0.20233463035019456,0.9077544095972807,1.0,8/39,10.79%,CYFIP2;PRSS12;PERP;KLKB1;BAD;KLK1;HP;HPR
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4412127475414463,1.2319335411950887,0.19828641370869032,0.9103569315498736,1.0,10/62,9.04%,PRKCB;EP300;CDK6;PTK2B;ZBTB16;HOXA5;MOV10;EIF6;LGALS3;KMT2A
prerank,dendrite morphogenesis (GO:0048813),-0.367651887620871,-1.2317215510897175,0.12878787878787878,0.6872058914713893,1.0,9/35,8.24%,FARP1;MAP2;SHANK3;DOCK10;PAK3;DCDC2;EPHB2;CTNNA2;SDC2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3985885809626466,1.2315910434545128,0.13099041533546327,0.9101445482154037,1.0,40/170,19.58%,CDH1;PRDM6;TRIM60;LDLR;ZC3H12A;CDK6;AFF3;TBC1D16;GDNF;CGGBP1;YBX3;TRIM44;CDK4;TOB2;TRIM21;NKAP;TXK;TRIM26;TRIM11;MTMR3;KDM6A;TFEB;RASA1;CDK2;CIAO3;TCF19;MYC;PRDM11;FOXP1;ADNP;HINFP;HMG20B;CAVIN4;ZNF462;IGF2BP3;ROCK2;IGF2BP2;APP;FLOT1;PCBP2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.546549427803789,1.2311098387646195,0.24845679012345678,0.91050347990059,1.0,3/15,4.29%,NAGK;MGAT3;LARGE1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4208617461128269,1.2309689840148423,0.18642117376294592,0.9095750093587176,1.0,8/86,5.14%,CLU;BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1
prerank,ureteric bud morphogenesis (GO:0060675),0.5511637332364179,1.2307723791459022,0.2251552795031056,0.9088582351734353,1.0,7/16,13.48%,WNT11;GDNF;BMP4;SIX1;NPNT;GATA3;MYC
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5789178700541013,1.2302911397866376,0.2384737678855326,0.9092588612473527,1.0,6/12,22.77%,PTPN14;BMP4;NEDD4;AAAS;SIRT7;TPR
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2761427140116449,-1.2302860177339912,0.02564102564102564,0.6891864662557758,1.0,45/151,15.14%,FLT1;BMP6;SOX5;ADAMTS12;PDE3A;PRKD1;SEMA6A;RAPGEF2;PDE8A;WNT4;WWOX;STAT5B;WNT5A;ACVRL1;STMN2;NDNF;KDR;NOTCH1;TMEM100;CLEC3B;BMPR1B;RUNX2;DAB2IP;APPL2;ACVR1B;MTSS2;TGFB1;CRKL;PTPN12;NTRK2;ACVR2A;RPS6KB1;RAMP2;PDE2A;GAREM1;ACAP2;RACK1;VSTM2A;FLT4;HYAL1;TBX1;SMAD3;BMPR2;DUSP22;SOX6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5501555988058697,1.2300488373173302,0.22290076335877862,0.9087005252935552,1.0,6/16,20.04%,ST3GAL4;ALOX5;RHOA;IRAK1;ITGB2;NFAT5
prerank,regulation of tube diameter (GO:0035296),0.5652554814373009,1.2300174439697227,0.25588697017268447,0.9059316424669633,1.0,1/13,0.18%,AGTR1
prerank,vascular process in circulatory system (GO:0003018),0.5652554814373009,1.2300174439697227,0.25588697017268447,0.9059316424669633,1.0,1/13,0.18%,AGTR1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5386235312929745,1.229778054630515,0.2313546423135464,0.9053164537198978,1.0,1/17,0.66%,ANK2
prerank,chondrocyte differentiation (GO:0002062),-0.38010005616143244,-1.229569190054451,0.15808823529411764,0.689067419986247,1.0,10/32,15.14%,SOX5;SULF1;RUNX1;BMPR1B;RUNX2;TGFB1;HMGA2;CCN3;BMPR2;SOX6
prerank,positive regulation of T cell proliferation (GO:0042102),-0.33226441252043415,-1.2294577136249998,0.12716763005780346,0.6871145518588694,1.0,11/55,12.36%,IGF1;IGFBP2;NCK2;VCAM1;IL18;TFRC;IGF2;CD46;NCKAP1L;PNP;IL6ST
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.549914708384679,1.2292093292987913,0.22462562396006655,0.9059420358926572,1.0,6/14,20.08%,ACOT8;ABCD1;EHHADH;ECI2;DECR2;CRAT
prerank,protein import into mitochondrial matrix (GO:0030150),0.5376989763966992,1.2291251626725122,0.21699544764795145,0.9048088289111343,1.0,9/18,22.77%,TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.4649522454151108,-1.2288664495928538,0.22994652406417113,0.6866314884306264,1.0,3/13,5.93%,GAS6;AXL;IL18
prerank,positive regulation of autophagy (GO:0010508),0.43086152833353475,1.2283706139404937,0.19839449541284404,0.9063094613231004,1.0,24/81,17.04%,RNF152;PRKAA2;TPCN1;ZC3H12A;FOXO3;SESN2;DAPK1;MTDH;ORMDL3;SH3BP4;TSC2;TRIM21;BAD;PLK3;TFEB;GSK3A;BNIP3L;ULK1;GSK3B;FLCN;PLK2;IKBKG;SESN1;EIF2AK4
prerank,regulation of phagocytosis (GO:0050764),-0.3341257900093144,-1.2283470144838466,0.13440860215053763,0.6857429584952404,1.0,21/53,27.64%,CD47;MERTK;TGM2;GAS6;IL15RA;DYSF;GATA2;PLSCR1;RACK1;LMAN2;CAMK1D;ITGAV;SPHK1;DOCK2;PIP4P2;LYAR;HCK;PYCARD;SLC11A1;FGR;FCGR2B
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4293329261554715,1.2283148806293784,0.18698224852071005,0.9050787338229078,1.0,9/72,6.27%,FGF13;CLU;KANK1;LDLR;SSH3;PFDN1;CRYAB;TWF1;EML2
prerank,protein homooligomerization (GO:0051260),-0.28400767338802074,-1.2280531670741035,0.06593406593406594,0.6842666742981063,1.0,40/114,21.03%,ALDH1A2;SLC1A5;SCARA5;SLC1A2;PKD2;EHD4;IKZF4;APPL2;GBP5;HPRT1;KCNJ2;EHD3;B2M;UPB1;MCOLN1;GSDMD;SAMHD1;AQP11;JMJD6;AQP4;ALDH9A1;TRMT61B;ALS2;KCNJ12;G3BP2;GLRA3;GOLGA2;CBY1;MPP2;ACACB;TIFA;BLM;ATL1;DISP1;HCN1;CBR4;RNF135;MIF;CRYZ;MLKL
prerank,bicarbonate transport (GO:0015701),0.4966516075856114,1.2274833539593277,0.24421965317919075,0.9069003830014807,1.0,3/25,6.79%,CFTR;SLC4A2;CYB5RL
prerank,regulation of interleukin-12 production (GO:0032655),-0.3362200710814221,-1.2274123785660864,0.14285714285714285,0.6837018399772803,1.0,5/47,5.53%,PLCB1;CD47;LGALS9;THBS1;IRAK3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5231631720397976,-1.227359003463891,0.23622047244094488,0.6815566280535588,1.0,4/10,16.46%,SH3RF1;RUNX1;NCKAP1L;HMGB1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.47129897609398297,1.226338139118478,0.21003963011889035,0.9097449503689311,1.0,9/36,10.44%,NECTIN3;AMN;KIF13A;ANK3;GOLPH3;GCC2;RAB7A;GOLGA7;GGA1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.44190109651255244,1.2253215298806726,0.2022613065326633,0.912230410340608,1.0,18/51,18.80%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PFN2;ABL1;FHOD1;ROCK2
prerank,negative regulation of chemokine production (GO:0032682),0.5584599322490544,1.225198942466199,0.2192846034214619,0.9113040270065665,1.0,2/14,6.66%,KLF4;MUL1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5918178078655669,1.2251938296790188,0.25205930807248766,0.9099068172644179,1.0,4/10,14.29%,EMC9;EMC10;EMC6;EMC2
prerank,response to organic cyclic compound (GO:0014070),-0.3287618439494324,-1.2251751445764747,0.12849162011173185,0.6860181153867568,1.0,15/52,14.58%,STAT5B;ESR1;IGFBP5;GGT5;CYP1B1;ALPL;SLC1A1;IL18;LRRK2;TGFB1;PAQR8;STAT3;FGFR4;DRD2;DHFR
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4135570311521483,1.2245053348791521,0.19089900110987792,0.9110360703749154,1.0,20/98,14.93%,AGTR1;ANGPT1;KLF4;CCL5;CDKN1A;HPN;MAGI2;ZC3H12A;DHRS4;NFKBIA;ANXA2;ROMO1;ACACA;STARD4;FASN;TGFBR2;GATA3;RAB1B;EIF4G1;DCXR
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5183780708747115,-1.2244789327435284,0.23703703703703705,0.6857902818290013,1.0,4/10,27.17%,LYN;KIT;CD40;FGR
prerank,regulation of primary metabolic process (GO:0080090),0.402861571946421,1.223995436550389,0.15538290788013318,0.9115077904250554,1.0,39/126,20.67%,LDLR;FDFT1;SREBF2;DHCR7;FDPS;HMGCR;PSMD11;PMVK;RUBCNL;PSMD4;PSMF1;AZIN1;CYP51A1;ELOVL6;NFYC;PSMD7;HDAC3;NCOR1;CERS2;ACACA;GPAM;IRS2;FASN;SP1;PSMB5;NCOR2;SQLE;PSMD1;TM7SF2;PSMC4;HMGCS1;ROCK2;PSAP;PSMD8;PRKAB1;SREBF1;OPA3;PRKAB2;ABCA7
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.3548044949214106,-1.2239521010439922,0.1646586345381526,0.685068362560572,1.0,11/36,14.58%,HIF1A;NPR3;NOS3;NOSTRIN;NOS1AP;NOSIP;PIK3CB;GCH1;CYGB;SPR;DHFR
prerank,positive regulation of DNA replication (GO:0045740),-0.4462179690094324,-1.2237912988972366,0.21739130434782608,0.6832821422722929,1.0,9/16,27.16%,GLI2;KAT7;GLI1;BCAR3;EGF;CTC1;STN1;FAF1;EGFR
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5917979510159458,1.2231556719055638,0.2529118136439268,0.9118118899390816,1.0,5/10,17.30%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.5917979510159458,1.2231556719055638,0.2529118136439268,0.9118118899390816,1.0,5/10,17.30%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4831653101489021,1.223038709641192,0.22916666666666666,0.9107958446199004,1.0,7/31,11.50%,FDFT1;MOCS3;ALOX5;CYP51A1;NFS1;PYCR3;NOXRED1
prerank,DNA alkylation (GO:0006305),0.5336430050286175,1.2225140404444967,0.2353846153846154,0.909890729081326,1.0,5/19,12.90%,FOS;BEND3;ATRX;DNMT3A;PPM1D
prerank,DNA methylation or demethylation (GO:0044728),0.5336430050286175,1.2225140404444967,0.2353846153846154,0.909890729081326,1.0,5/19,12.90%,FOS;BEND3;ATRX;DNMT3A;PPM1D
prerank,negative regulation of translation (GO:0017148),0.417166969375807,1.2224685968376192,0.18640093786635403,0.9086438271949121,1.0,25/87,19.01%,SAMD4A;CPEB2;YTHDF1;SAMD4B;CELF1;EPRS1;DAPK3;DAPK1;UNK;EIF4A3;EIF4EBP1;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH;MEX3D;EIF2AK4;IGF2BP3;YTHDF3;ROCK2;EIF4EBP2;IGF2BP2
prerank,regulation of sensory perception of pain (GO:0051930),-0.5017603536483389,-1.2222489895598436,0.23636363636363636,0.6855137639336167,1.0,4/11,13.64%,TMEM100;MGLL;ZFHX2;CCN3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.4298921281927536,-1.2219197093301162,0.20059880239520958,0.6842689148753025,1.0,10/19,30.53%,ZMIZ1;GAS6;AXL;NCKAP1L;CD27;RHOH;BTK;IL7;XBP1;PRKDC
prerank,calcium ion import into cytosol (GO:1902656),-0.451450292727431,-1.2212493167108869,0.23306233062330622,0.6840070668264295,1.0,3/15,8.59%,SLC8A1;SLC8A3;SLC24A2
prerank,sodium ion export across plasma membrane (GO:0036376),0.5542718731317497,1.2206415821364334,0.2549618320610687,0.913988385188231,1.0,7/13,21.09%,ATP1A2;SLC4A4;SLC9A1;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,photoreceptor cell development (GO:0042461),0.539678753827039,1.2201091667137576,0.2455573505654281,0.9144926852089077,1.0,2/14,4.78%,RP1;ARL3
prerank,ameboidal-type cell migration (GO:0001667),0.43791640286553185,1.2200110595416975,0.20689655172413793,0.9134864983001618,1.0,6/51,3.81%,SEMA3D;SRGAP2;FAT2;SEMA3B;ITGB7;GDNF
prerank,chemical synaptic transmission (GO:0007268),-0.25978883680513587,-1.2199141378110758,0.05555555555555555,0.6857101293052051,1.0,83/284,21.33%,PDE7B;SLC1A3;GRIK2;UNC13B;KCND2;NRXN1;NOVA1;GRID2;LIN7A;CACNA1E;GRM3;GABRG3;GRM7;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;SHISA6;BRSK1;PTCHD1;DLGAP1;SLC1A1;SYT1;CDH8;RIT2;GRIN2B;GABRB1;GRM5;GRIK3;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;LRP6;SLC6A1;TBC1D24;CHRM3;SNAPIN;PRKAR2B;APBA1;PLP1;SLC17A6;SNAP25;DTNA;HCRTR2;MBP;GRIK1;GABRA3;GRIK4;NLGN3;DRD2;GLRA3;HTR2A;AMPH;KCNMB4;GLRA2;GABRB2;CHRM2;MPZ;KCNQ3;GRM1;PRKAR1B;GABRA1;NPTX1;GLRB;RPS6KA1;RPS6KA3;GABRE;OPRK1;HRH1;KCNK3;SYT10;GRIA4;GRIK5;CACNA1B;KCNIP2;PCDHB16;RIMS1;GABARAP
prerank,chondroitin sulfate metabolic process (GO:0030204),0.47236841436506305,1.2198800758796249,0.2219215155615697,0.9125598850877346,1.0,9/30,11.89%,CHST12;HEXA;DSE;CHST11;CHPF;ARSB;HEXB;CHST13;CHPF2
prerank,cellular response to drug (GO:0035690),-0.39928760297362387,-1.219581720645071,0.19047619047619047,0.6843970134486139,1.0,6/25,10.36%,ACER2;GAS6;AIM2;TFRC;PDE4B;TP53
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4148531957571645,1.2193227520584569,0.18547486033519553,0.9132137215699563,1.0,22/92,14.85%,ANGPT1;MAPRE2;DOCK5;ANXA3;MMP9;ZC3H12A;GFUS;PTK2B;FOXC2;SOX9;BMP4;TGFB2;EMC10;NRP2;BCAS3;BCAR1;GATA3;DOCK1;RREB1;FOXP1;AAMP;ITGB1BP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5305190391513003,1.2190738112042236,0.2530487804878049,0.9127737506208431,1.0,9/16,27.69%,DDX5;SRSF9;DHX9;SRSF1;PUF60;SFPQ;CELF4;CDK13;HNRNPM
prerank,regulation of blood coagulation (GO:0030193),0.4898694579225925,1.2190517769102458,0.22375690607734808,0.9114505386263452,1.0,5/27,6.39%,ADTRP;ST3GAL4;CAV1;THBD;DMTN
prerank,prostanoid biosynthetic process (GO:0046457),-0.45961281739644255,-1.2187464032862685,0.22063037249283668,0.6845320289307627,1.0,8/15,19.88%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4529172599504234,1.2184858923189381,0.21139240506329113,0.9120939509091174,1.0,4/47,5.36%,AGTR1;KLF4;FOXO3;NFKBIA
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.48435689480442967,1.2184489629112099,0.24,0.9108486752983427,1.0,7/31,9.09%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;BRD7
prerank,eosinophil migration (GO:0072677),0.5538133220838927,1.2184276169921051,0.2676056338028169,0.9081531005476101,1.0,2/14,8.28%,CCL5;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),0.5538133220838927,1.2184276169921051,0.2676056338028169,0.9081531005476101,1.0,2/14,8.28%,CCL5;LGALS3
prerank,negative regulation of type I interferon production (GO:0032480),0.46361050085088173,1.2182449625275977,0.2065359477124183,0.907463436615374,1.0,6/40,5.69%,IKBKE;MAVS;RELB;TRIM25;PPM1B;IRF3
prerank,regulation of viral release from host cell (GO:1902186),0.5170678549772784,1.218222942026327,0.22781065088757396,0.9061829601969146,1.0,10/21,18.00%,TRIM25;VPS37B;TRIM21;PML;TRIM26;TRIM11;VPS4A;CHMP2A;DDB1;TSG101
prerank,peptidyl-lysine methylation (GO:0018022),0.47976765188264475,1.2181638465539755,0.23638968481375358,0.9049907212710024,1.0,13/26,27.19%,EEF2KMT;SMYD3;EEF1AKMT3;TRMT112;SETD7;SMYD1;ATPSCKMT;ANTKMT;KMT5A;N6AMT1;SMYD2;EHMT1;EEF1AKMT2
prerank,modified amino acid transport (GO:0072337),-0.434229588348524,-1.2181630266580306,0.2054794520547945,0.6840280820198917,1.0,2/15,1.07%,SLC6A13;SLC16A12
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5064014125726736,1.2175267856395595,0.23054755043227665,0.9046174849909431,1.0,7/23,11.78%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5064014125726736,1.2175267856395595,0.23054755043227665,0.9046174849909431,1.0,7/23,11.78%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,dendritic cell migration (GO:0036336),0.5369628790156469,1.217504603616352,0.24499229583975346,0.903331031695242,1.0,5/16,13.39%,CCL5;CXCR4;ALOX5;TRPM4;TRPM2
prerank,spinal cord development (GO:0021510),-0.4794453924854878,-1.2173435510593018,0.21614583333333334,0.6842589850445464,1.0,7/12,18.78%,GLI2;PKD2;LOXL3;VIT;NF1;SOX11;SOX12
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.47644714030129137,-1.2170907866116607,0.2342857142857143,0.6827442020932404,1.0,6/12,25.08%,DKC1;CCT7;GNL3L;CCT2;CCT4;WRAP53
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.45580543778955185,-1.2167627742800022,0.22020725388601037,0.6815240415734982,1.0,11/15,50.29%,PLTP;ABCG1;LCAT;ABCA5;APOC1;LIPC;PLA2G3;APOM;SCARB1;APOA1;APOE
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2973061846369262,-1.2165345895659223,0.0873015873015873,0.6800245304160948,1.0,19/82,10.04%,BMP6;IGF1;PRKD1;SMOC1;WNT4;ZHX3;PTK2;NOTCH1;RORB;BMPR1B;RUNX2;FBN2;IL6R;ACVR2A;LRP5;FGFR2;PPARG;TWIST2;CCN4
prerank,establishment of vesicle localization (GO:0051650),0.5262778217707375,1.2164959654187422,0.2374631268436578,0.9055880824774932,1.0,7/18,19.22%,LIMK2;TOR1A;TMEM230;SYT11;IKBKG;TESK1;RAB27A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5834719203804716,1.216251049060708,0.2521150592216582,0.9051442587347233,1.0,6/11,27.45%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3033793319722802,-1.2156815967303676,0.11450381679389313,0.6802392798758325,1.0,15/86,8.56%,BMP6;RBPMS;ZEB2;SULF1;ENG;DAB2;ACVRL1;NOTCH1;BMPR1B;THBS1;ACVR1B;TGFB1;JAK2;ACVR2A;ING2
prerank,negative regulation of anoikis (GO:2000811),-0.4579062039889555,-1.2155942364304841,0.20844327176781002,0.6783416253872273,1.0,4/14,6.45%,PTK2;TLE1;NOTCH1;BCL2
prerank,negative regulation of heart contraction (GO:0045822),0.5791004062270377,1.2151689769535683,0.2551505546751189,0.9078411444339549,1.0,3/11,10.68%,ZC3H12A;ATP1A2;GRK2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.41405545807650246,1.2150981879436533,0.19863013698630136,0.9067573093854737,1.0,13/86,10.47%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;MAPK7;PSMD4;PSMF1;EGLN2;RBX1;BAG3;PSMD7
prerank,protein-containing complex assembly (GO:0065003),0.3859738368269087,1.2148726949041015,0.10772357723577236,0.9062095447804508,1.0,54/259,15.47%,FN1;REPS2;FBXL7;F5;PPARGC1A;ADAM10;OCLN;ZC3H12A;CAND2;EP300;PEF1;EPRS1;MCU;PTK2B;PPP6R3;PYGO2;TFG;ELOB;CTSZ;SOX9;DMTN;BAD;TRAPPC9;GPAA1;AFG3L2;PARD6B;RBX1;TCF7L2;LAMC1;PML;TNFRSF1A;KMT2A;TLE2;ZW10;SMARCA4;TLE4;TRAPPC1;MCFD2;WASF1;ANO6;NAPA;OPA1;MYC;PREB;RAB1B;GSK3B;CNIH1;DNM1L;ITGB1BP1;SEC23A;ANKRD28;MDM2;DHX9;IKBKG
prerank,regulation of protein catabolic process (GO:0042176),0.40770650872949393,1.2148527619369096,0.18212290502793296,0.9049367077653357,1.0,26/99,19.53%,FZR1;EEF1A1;WWP2;HMGCR;EGLN2;GPC3;AZIN1;CYP51A1;RAB7A;BANP;SF3B3;SNX12;WDR91;GSK3A;GSK3B;NEDD4;MDM2;PLK2;FLNA;CENATAC;DDB1;NSF;CHEK2;RNF41;IDE;ASB5
prerank,regulation of mitochondrion organization (GO:0010821),0.44450648543985394,1.2146060841219053,0.2069408740359897,0.904510523408548,1.0,22/47,22.38%,PPARGC1A;SREBF2;EP300;HAX1;MUL1;GOLPH3;FZD5;MIEF2;PLSCR3;VDAC1;GSK3A;GSK3B;DNM1L;FLCN;HDAC6;PISD;RHOT2;SREBF1;MAPT;FBXW7;SIRT7;INF2
prerank,neuromuscular process controlling balance (GO:0050885),-0.4833810342514456,-1.2138263726057132,0.23482849604221637,0.6813014630399384,1.0,4/12,15.15%,NRXN1;PCDH15;TPP1;CLN3
prerank,diol metabolic process (GO:0034311),-0.4262809308591573,-1.2131968533220927,0.2,0.6809430127545735,1.0,9/19,27.72%,NOS3;DEGS2;GCH1;SPR;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2
prerank,engulfment of apoptotic cell (GO:0043652),-0.44646412583032513,-1.213129649019078,0.22822822822822822,0.6789840597701113,1.0,4/15,9.85%,RHOBTB1;MEGF10;THBS1;XKR6
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5931726083930712,1.2131061116732662,0.2721417069243156,0.9086299369722718,1.0,2/10,4.89%,SMOX;DMGDH
prerank,fatty acid elongation (GO:0030497),0.5547699258064723,1.2126287561097244,0.2633279483037157,0.909085733678587,1.0,4/13,9.25%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4512967986284951,-1.2126242058398655,0.20303030303030303,0.6781933282891404,1.0,7/15,20.54%,SMARCD3;LRRK2;NF1;TAFA1;DRD2;CX3CL1;CX3CR1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.517986846444911,1.2125631670426196,0.25975975975975973,0.9080200530061487,1.0,1/20,0.14%,NT5E
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.49231562235988957,1.2124294978888104,0.23895027624309392,0.907211250049409,1.0,6/23,8.24%,PMAIP1;TIMM10;AGK;BAD;ROMO1;HSPA4
prerank,response to nutrient levels (GO:0031667),0.5250980860945811,1.2124057802106296,0.24085365853658536,0.9059482431332891,1.0,4/17,14.39%,PRKAA2;KCNB1;ULK1;EIF4G1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4791168883963206,-1.2122281993040411,0.20466321243523317,0.6771713793056175,1.0,10/12,49.68%,IL18;IL17D;PAEP;CD80;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,negative regulation of response to external stimulus (GO:0032102),0.4074117738917708,1.2121998061602455,0.1984478935698448,0.9053566823935615,1.0,28/105,20.25%,CD109;RTN4R;KLF4;EPHA4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;CASK;CARD16;CERS2;PTPN2;LPCAT3;GATA3;CRK;CDH5;DUSP3;FNDC4;OTULIN;ILRUN;GPER1;PCBP2;RB1;RTN4RL1
prerank,mitochondrial membrane organization (GO:0007006),0.48274397923801093,1.2113177922219347,0.2513157894736842,0.9073059978828167,1.0,12/32,18.45%,PMAIP1;CHCHD3;MICOS13;BCL2L1;BAD;MICOS10;OPA1;APOO;IMMT;SLC25A4;MTX1;SPG7
prerank,establishment of epithelial cell polarity (GO:0090162),0.5201197532004245,1.2107894684438123,0.248868778280543,0.907844764164718,1.0,8/19,19.70%,MSN;GOLPH3;CDC42;OPHN1;EZR;RHOA;MYO18A;PARD3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.41542368428947324,1.2106552815083729,0.19492502883506344,0.9070231402450032,1.0,14/80,11.06%,CD44;NLRP2;KLF4;MAP3K5;UACA;PMAIP1;NGF;DAPK1;BAD;RAF1;ARL6IP5;BCAP31;CARD16;AQP1
prerank,sulfur compound biosynthetic process (GO:0044272),0.4093511615081867,1.2099221871892976,0.18292682926829268,0.9082683818853702,1.0,18/104,12.33%,UST;ANGPT1;ST3GAL4;CHST12;B4GAT1;HAGH;DSE;CHST11;PRELP;CHPF;MGST3;GSTO1;MAT2B;HPGDS;CHST13;CDO1;CHPF2;ST3GAL6
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4801947141621794,1.2098348779616739,0.22901849217638692,0.9072748175421598,1.0,4/26,9.04%,OGT;EEF2KMT;BEND3;KMT2A
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.47433319177928324,1.2097498211213815,0.2448700410396717,0.9062185664728145,1.0,7/31,11.35%,RANBP3L;SMAD6;CRIM1;CDK6;SOX9;TWIST1;TRPM4
prerank,postreplication repair (GO:0006301),0.4557331436790068,1.2096252230510698,0.24310776942355888,0.9053444536215671,1.0,18/45,22.44%,TRIM25;USP10;REV1;POLK;WDR33;UBE2B;PCLAF;RPA3;POLH;POLD2;PCNA;UBE2N;RPS27A;UBC;RFC1;POLN;UBE2V1;NSMCE1
prerank,protein targeting to lysosome (GO:0006622),0.5115650424399932,1.209499420171554,0.25251076040172166,0.9044423726469439,1.0,10/20,23.31%,CLU;GCC2;RAB7A;VPS4A;NEDD4;SNX16;AP3M1;M6PR;AP4M1;NCOA4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.46170986545949944,-1.208835217452811,0.2303370786516854,0.6848674966624787,1.0,6/13,24.79%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,glycoprotein catabolic process (GO:0006516),-0.41853808344249427,-1.2081007439248155,0.22388059701492538,0.6847889668461645,1.0,2/17,1.30%,ADAMTS12;ADAMTS9
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.46181445595495235,1.2073578463674215,0.24335664335664337,0.9110597379992822,1.0,7/38,13.02%,DSG2;ANK2;CAV1;DSC2;TRPM4;KCNA5;CACNB2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5217859213541118,1.2072292624462442,0.2406576980568012,0.91019543427662,1.0,11/18,23.62%,CTNNA1;OTUD7B;LATS1;CHP1;GSK3B;FLCN;UFM1;SUFU;ILRUN;RAB23;LATS2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4695672201642129,-1.2071101234086907,0.23013698630136986,0.6855994303403721,1.0,7/13,27.99%,DDIT3;TMSB4X;SOX11;HEY2;HEY1;SIN3A;TAF1
prerank,muscle organ development (GO:0007517),0.4478537037374413,1.2067597708177207,0.21975308641975308,0.9105984793904736,1.0,14/54,13.83%,UTRN;SGCG;MRAS;SGCA;SGCD;FHL1;LARGE1;COL6A3;MEF2D;EVC;MEF2B;ZBTB42;FXR1;MEF2C
prerank,neuron projection development (GO:0031175),-0.264214640339779,-1.2065802299254493,0.07272727272727272,0.6850242329314454,1.0,44/168,13.82%,PTPRM;CNTNAP2;RAPGEF2;MAP2;ADGRV1;DCLK1;SHANK3;TNIK;LYN;NRK;DOCK10;PAK3;GRM7;FRY;STMN2;NYAP2;SGK1;LGI1;LAMB1;DAB2IP;EPB41L3;LRP12;EPHB2;LRRK2;NLGN1;ROCK1;DTNBP1;TBC1D24;RYK;SNAPIN;PLP1;MAP4K4;NCKAP1L;ALS2;MYOC;MAPK8IP3;TBC1D23;MANF;TMEM108;BDNF;CNTNAP1;ATXN10;PPP1R9A;STMN3
prerank,metal ion homeostasis (GO:0055065),0.4537245086899183,1.2064169491704801,0.21739130434782608,0.9104873517650343,1.0,8/40,11.72%,ATP6V1B1;SLC12A8;CAV1;SELENON;ANK3;JPH2;LETM1;SLC12A4
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4595031315833735,-1.205892620759686,0.211864406779661,0.6849050965952277,1.0,6/14,23.18%,ENTPD1;NUDT1;ENTPD3;ENTPD5;ENTPD6;NUDT16
prerank,monocarboxylic acid transport (GO:0015718),-0.327006419635817,-1.2054388971499521,0.15384615384615385,0.6841288373083653,1.0,12/51,7.93%,SLC6A13;SLC16A12;ABCC4;SLCO2B1;SLCO1C1;SLC6A12;NCOA1;SLCO3A1;SLC16A9;SLC16A6;SLC16A1;SLC16A4
prerank,negative regulation of phagocytosis (GO:0050765),-0.4264686343440377,-1.205160513222665,0.23582089552238805,0.6828576718165432,1.0,6/17,16.46%,CD47;DYSF;PLSCR1;RACK1;CD300A;HMGB1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5300823328490128,1.2049501286532336,0.25190839694656486,0.9142783542588819,1.0,3/17,5.97%,CLU;RTN1;RTN3
prerank,regulation of actin filament polymerization (GO:0030833),0.4221954400121763,1.2047287522205634,0.2162485065710872,0.9137587678206327,1.0,12/69,7.60%,BAIAP2L1;KANK1;ARHGAP18;SSH3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;TWF1;HAX1;LATS1
prerank,regulation of exocytosis (GO:0017157),0.4438337676242114,1.2043139778508256,0.22919334186939821,0.914003249078542,1.0,14/46,20.42%,CFTR;STXBP6;SYTL4;UNC13D;RAB3B;CPLANE2;NSF;RAB8B;STX4;RAB2B;RAB27A;RAB9A;ATP6AP1;RAB10
prerank,negative regulation of ion transport (GO:0043271),0.49174217737557413,1.204064252230171,0.21961325966850828,0.9136306706550495,1.0,6/24,15.27%,ACTN2;PTK2B;HTR1B;WNK1;NEDD4;SYT11
prerank,bone development (GO:0060348),-0.35174390438939085,-1.2034770787048708,0.19421487603305784,0.6855888485237362,1.0,13/39,11.38%,SULF1;GNAS;TGM2;SH3PXD2B;CYP26B1;LRP6;LRP5;FGFR2;NOTUM;SFRP4;TP53;DYM;MYOC
prerank,dephosphorylation (GO:0016311),0.39428465319899303,1.2033051327113315,0.18054054054054053,0.9151815948699502,1.0,16/147,8.04%,PLPPR2;PTPN14;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;DUSP12;DUSP1;UBLCP1;PTPRF;PTPN9;PTPRA;PP2D1;PPM1A
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.40205467725456867,-1.20325569763346,0.21,0.6841099263952608,1.0,11/22,34.35%,WNT5A;SLC7A5;TNFRSF1B;TRIL;NOD2;TRIM6;BTK;CCR2;LACC1;TNFRSF14;LILRB1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3909285282788048,-1.20258819177956,0.2161290322580645,0.6840975107197879,1.0,9/25,13.69%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3;STAT6
prerank,cristae formation (GO:0042407),0.47398220957109327,1.202046132304122,0.26436781609195403,0.9183841121355484,1.0,14/27,26.16%,CHCHD3;MICOS13;AFG3L2;LETM1;ATP5PF;APOO;IMMT;ATP5F1B;SPG7;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,import into cell (GO:0098657),-0.3573525397935565,-1.2017851199997698,0.1581196581196581,0.6842918688736005,1.0,9/41,10.59%,SLC1A3;SLC6A13;LRRC8C;SLC47A1;SLC7A5;SLC6A6;SLC29A1;SNAP25;LRRC8A
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5076535165379098,-1.2013328332058366,0.2620320855614973,0.6835039003449613,1.0,5/10,13.02%,XYLT1;CSGALNACT1;XYLT2;PXYLP1;B3GAT3
prerank,sprouting angiogenesis (GO:0002040),0.43562249927440166,1.2008363347928914,0.2169576059850374,0.9213842934842215,1.0,7/51,3.61%,CDH13;ANGPT1;ADTRP;EFNB2;PARVA;RSPO3;PTK2B
prerank,neutrophil degranulation (GO:0043312),0.37543965842975513,1.2008189344022497,0.08375378405650857,0.9201176040151804,1.0,92/425,17.08%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,negative regulation of cartilage development (GO:0061037),0.5582491090804065,1.199992713907484,0.25862068965517243,0.9217858300586038,1.0,4/13,6.72%,ADAMTS7;WNT11;SOX9;EFEMP1
prerank,glutamate metabolic process (GO:0006536),0.5140496814884333,1.1995735359434958,0.2668621700879765,0.9219494139983104,1.0,6/19,20.91%,GLUL;GLUD1;PRODH;DGLUCY;ALDH18A1;GAD1
prerank,regulation of embryonic development (GO:0045995),0.4622344797734049,1.199208286040053,0.25688073394495414,0.9219987432685711,1.0,5/34,4.23%,PHLDB2;DAG1;NIBAN2;CRB2;RBM19
prerank,nerve growth factor signaling pathway (GO:0038180),0.5958914435623102,1.199111756758486,0.2823529411764706,0.921040938314866,1.0,3/10,3.27%,MAGI2;RAP1A;NGF
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4559106504402173,1.1990959484357868,0.23076923076923078,0.9197908649020211,1.0,10/40,14.74%,CLU;MMP9;BBC3;PMAIP1;BCL2L1;BAD;PLSCR3;HRK;OPA1;DNM1L
prerank,myelination (GO:0042552),-0.32650085328108697,-1.1988581697185454,0.14507772020725387,0.688623530809178,1.0,20/46,16.99%,SLC8A3;MAL;EPB41L3;TNFRSF21;NFASC;CMTM8;GAL3ST1;PLP1;NF1;PLLP;MBP;MYOC;TPPP;CNTNAP1;ABCD2;B4GALT5;MYRF;SIRT2;ACSBG1;MPZ
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.40943543114023595,1.1988075353940797,0.2226148409893993,0.9194804970980412,1.0,17/84,14.53%,CLU;RTN1;SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;ORMDL3;RTN3;EIF4A3;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3898771275602691,1.1987543862362995,0.1896551724137931,0.9183960088674252,1.0,56/132,28.20%,CELF2;NLE1;CELF1;NOP2;PPAN;SNRPB;TARBP2;MRPS7;EIF6;LSM4;DDX39B;RPSA;EIF4B;LUC7L3;USP39;SRPK2;KHDC4;PWP2;SF3A2;SRPK1;SRSF9;GEMIN6;ISY1;DHX9;HSP90AA1;LUC7L2;PRPF19;CLP1;PRPF6;SRSF1;SNUPN;SRSF5;RPL6;RPS28;DDX20;PUF60;PTGES3;DDX23;GEMIN5;SHQ1;EIF2S2;CELF4;CLNS1A;CPSF7;GEMIN8;GEMIN2;RPS27;NOP53;RRS1;MDN1;XRCC5;SNRPD2;SNRPD1;SF1;RSL24D1;RPL24
prerank,neutrophil activation involved in immune response (GO:0002283),0.3748697586607778,1.1984774908447968,0.08686868686868687,0.918072969579509,1.0,92/428,17.08%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,steroid biosynthetic process (GO:0006694),0.4375753390457534,1.1982318075890863,0.23232323232323232,0.9176267466716017,1.0,11/56,11.14%,FDFT1;OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;OSBPL7
prerank,sterol homeostasis (GO:0055092),0.4163014112789307,1.1981523245309667,0.20435308343409916,0.9165903311347761,1.0,13/65,11.07%,LDLR;SOAT1;CAV1;ABCD1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,glycine transport (GO:0015816),0.5704593502241124,1.1980721907395229,0.26101694915254237,0.9155863784737148,1.0,2/10,10.52%,SLC36A3;SLC25A38
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.43066250367125913,-1.1977211275279145,0.23314606741573032,0.6899397685179784,1.0,7/16,33.19%,PDS5B;NIPBL;BOD1;NAA50;RAD21;SGO1;DSCC1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.48826038187998155,1.197243580547048,0.24224519940915806,0.9172196390125198,1.0,2/24,3.02%,FGF13;KIF2A
prerank,nucleosome organization (GO:0034728),0.425937034291666,1.19685513791305,0.24010217113665389,0.9173071958223099,1.0,17/55,18.29%,DAXX;GRWD1;SMARCB1;ASF1A;SOX9;KAT6B;ATRX;SMARCA4;SRCAP;SMARCD2;SET;SMARCC1;SPTY2D1;LIN54;BRDT;ZNHIT1;H3-3A
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.46826491210675375,-1.1967719580592038,0.21703296703296704,0.6904556228706397,1.0,3/12,5.69%,JAG1;NOTCH1;N4BP2L2
prerank,regulation of lymphocyte activation (GO:0051249),0.5590779935006874,1.1967483928827343,0.27821939586645467,0.9163778906720387,1.0,1/12,1.51%,CCL5
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.468855320737526,1.1964830249895841,0.2328767123287671,0.9160608702212685,1.0,11/31,16.65%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;ZNF205;YWHAZ;GSK3A;GSK3B;E2F1
prerank,RNA splicing (GO:0008380),0.4030800136313986,1.196461342833518,0.20202020202020202,0.9148343114916867,1.0,32/95,23.25%,MBNL1;PPARGC1A;SRSF2;YJU2;PPP2CA;SNRPB;LSM4;DDX39B;RBM8A;DBR1;LUC7L3;SF3B3;USP39;SRPK2;SRSF7;DDX47;SRPK1;SYNCRIP;RNPS1;MAGOHB;MAGOH;PRPF6;PTBP1;ZMAT5;WBP4;SF3A3;PRPF8;SFPQ;DDX23;U2AF1;NRDE2;SRRM1
prerank,prostaglandin metabolic process (GO:0006693),-0.38237950452109304,-1.196379805726778,0.19601328903654486,0.6894854213370082,1.0,9/26,16.64%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;ACOX1;HPGD;EDN1;CD74
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4157452002847577,1.1957240298109126,0.21394799054373523,0.9162368574348578,1.0,12/75,10.16%,AGTR1;CDH13;FGFR1;JCAD;NRAS;AGGF1;MYDGF;BMP4;ANG;VEGFB;EMC10;NRP2
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.4397715053224671,-1.195617827715962,0.20923076923076922,0.6896268873842265,1.0,4/17,16.49%,N4BP2L2;KAT7;HMGA2;SOX11
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5030044499793065,1.195374088218436,0.26598837209302323,0.9162346681803655,1.0,8/21,24.64%,ANK2;KCNA5;FLNA;SCN4B;SNTA1;GJA5;KCNH2;CACNA2D1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.304830700797192,-1.1951855178143698,0.1270718232044199,0.688888464920021,1.0,16/72,10.17%,GRIK2;NRXN1;SHANK3;SLC8A3;GRIN2A;LGI1;SYT1;EPHB2;GRIN2B;CLSTN2;NLGN1;ADCY1;DTNBP1;SLC24A2;NFATC4;CACNG8
prerank,protein homotetramerization (GO:0051289),-0.3326594584951402,-1.194731241017475,0.15934065934065933,0.6881996020017414,1.0,18/49,18.47%,ALDH1A2;PKD2;APPL2;GBP5;HPRT1;KCNJ2;B2M;UPB1;MCOLN1;SAMHD1;AQP4;ALDH9A1;KCNJ12;GOLGA2;CBY1;ACACB;HCN1;CBR4
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5545444908229004,1.194562667148866,0.28125,0.9178510320569631,1.0,4/12,11.35%,DSG2;CAV1;DSC2;TRPM4
prerank,cellular response to reactive oxygen species (GO:0034614),0.42937735329364285,1.1940979476487035,0.2342233009708738,0.9182131749196434,1.0,17/59,18.47%,MMP9;MAP3K5;FOS;NFE2L2;PXN;MAPK7;ROMO1;JUN;MAPK9;AGAP3;AQP1;PDK2;TRPM2;CHUK;ABL1;HDAC6;PARK7
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5516202931757783,1.1940438843128065,0.27154471544715447,0.9171516297258571,1.0,5/13,9.89%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.42474486672367845,1.1939382150566624,0.22874251497005987,0.9162564354211111,1.0,19/69,18.77%,CRLF1;PPARGC1A;NRBP2;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;SOD2;RASA1;MEF2C;SET;ZPR1;POU4F1;F2R;PARK7;TOX3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.31477641862736977,-1.1938030071704495,0.1534090909090909,0.6887430028320712,1.0,9/56,8.35%,BMP6;RBPMS;ENG;DAB2;ACVRL1;SNX25;BMPER;TGFB1;ACVR2A
prerank,regulation of membrane repolarization (GO:0060306),0.5444265257670764,1.1933229508951986,0.2823712948517941,0.9171793063105549,1.0,2/13,3.47%,CAV1;CACNB3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.42342944691609885,1.193320158642341,0.21233689205219455,0.9159137312510329,1.0,14/69,11.76%,PITPNM2;FGFR1;PLCL2;PLCB3;PLCD3;OGT;NGF;PIK3C2B;PLCL1;ERBB3;PI4KA;EZR;IRS2;RHOA
prerank,cell projection assembly (GO:0030031),0.5004160254341765,1.1931992682136001,0.2595307917888563,0.9150874095785692,1.0,5/22,13.42%,PARVA;GSN;RHOQ;CDC42;RHOU
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5511062455954001,1.1929068569930337,0.2898550724637681,0.9148651359185227,1.0,1/12,0.14%,SORBS1
prerank,regulation of kinase activity (GO:0043549),-0.2974709319395624,-1.1927420833615783,0.168,0.6896694296445778,1.0,27/89,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;PLCE1;AXL;TIE1;PDGFRA;KDR;RBL1;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;NLRC5;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,regulation of neuron projection development (GO:0010975),0.38762273264951114,1.1922361205742071,0.18921775898520085,0.9159787170529614,1.0,24/163,7.81%,RAB17;LPAR1;RTN4R;NTRK3;TBR1;KANK1;PDLIM5;PRAG1;EPHA4;EFNB2;PTK7;MAGI2;SIPA1L1;NDEL1;ITM2C;EP300;RAP1A;PTK2B;TWF1;AVIL;PTPN9;SRCIN1;ADCY6;ARSB
prerank,protein stabilization (GO:0050821),0.3877172148418542,1.191572151770594,0.17684210526315788,0.9171812276712524,1.0,30/168,12.26%,CLU;ANK2;PPARGC1A;EPHA4;PARVA;CDKN1A;EP300;CREBL2;BAG1;LAMP1;FLOT2;TRIM44;CRYAB;FKBPL;CREB1;HCFC1;MUL1;DNLZ;IFT46;DVL3;CHP1;USP19;GOLGA7;BAG3;UBE2B;GNAQ;HYPK;RABL3;COA8;NAA15
prerank,negative regulation of cilium assembly (GO:1902018),0.5440484643815201,1.1913648220555755,0.28664495114006516,0.9166964340022229,1.0,3/12,6.97%,LIMK2;CDK10;MAP4
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.47535670758644827,-1.1903406743407632,0.2572944297082228,0.6945757017768067,1.0,3/12,4.92%,DMD;ATP1B1;WNK2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5866731064081717,1.1901859288167769,0.28399311531841653,0.9197652929791147,1.0,5/10,11.76%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5046518189749306,1.1899484427379354,0.27514792899408286,0.919308364722324,1.0,8/20,19.48%,OGT;NUPR1;FLOT2;PELI1;HSP90AA1;STUB1;PDCD6IP;FLOT1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4479494986968063,1.1896295314321053,0.251604621309371,0.919220058033392,1.0,6/42,8.46%,CCL5;PTK2B;ACKR3;GPR75;STK39;OXSR1
prerank,Golgi to plasma membrane transport (GO:0006893),0.4398687111385836,1.1894536597973018,0.23028785982478098,0.9186287512222532,1.0,17/47,17.51%,STXBP6;AMN;KIF13A;ARL3;ANK3;GOLPH3;GCC2;EXOC4;GOLGA7;STEAP2;GGA1;EXOC2;EXOC8;OSBPL5;CCDC22;NSF;ARFRP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4349244500325298,1.1894190943783491,0.24466750313676286,0.9175038250376026,1.0,5/52,3.48%,MBNL1;CELF2;DDX5;CELF1;RBFOX2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.38607656564499043,1.189159447338206,0.17970401691331925,0.9171313747484788,1.0,19/152,11.37%,ADRA1B;GPR4;LPAR1;GRK5;ADCY9;PTGFR;ADGRL2;ADGRD1;CRHR2;RAMP1;ADCY6;LGR4;ADGRG2;HTR1B;AKAP5;ADGRG6;GNAO1;GNAQ;GNA13
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.47473785630132553,1.1890088348968078,0.2681564245810056,0.9164339714025087,1.0,7/27,13.02%,ANK2;AHNAK;CACNB3;SELENON;JPH2;JPH3;CACNB2
prerank,lipid biosynthetic process (GO:0008610),0.41279411859736476,1.18870118772855,0.21967963386727687,0.9162511743380404,1.0,14/77,11.79%,PRKAA2;FDFT1;OLAH;HMGCR;ALOX5;CYP51A1;PDSS2;ACSM3;FADS1;NDUFAB1;ACSF3;ACACA;GPAM;SCD5
prerank,negative regulation of reproductive process (GO:2000242),-0.4318667652909529,-1.1878097002377497,0.21574344023323616,0.6996407166900913,1.0,2/17,0.61%,IGF1;SULF1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.43689066916246666,1.1876378651312591,0.22042341220423411,0.918707461463993,1.0,11/54,10.09%,GPC6;GPC1;HEXA;GPC4;GCNT2;NAGLU;SDC4;GLB1;GPC3;EXT1;GUSB
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.47496827050966084,1.1875179679167407,0.23676880222841226,0.9178606142396686,1.0,13/29,23.36%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,regulation of bone mineralization (GO:0030500),-0.32077836809773197,-1.1869882308345499,0.15819209039548024,0.6999899837354943,1.0,14/55,10.37%,BMP6;ADGRV1;WNT4;SLC8A1;ENPP1;KL;BMPR1B;FBN2;ECM1;TGFB1;PKDCC;ACVR2A;NOTUM;BCOR
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4655754811866599,-1.186877366961362,0.25133689839572193,0.6982924556502877,1.0,8/13,23.46%,AZIN2;ACSL1;ACSL5;CA2;SLC26A6;C2CD5;NR4A3;C3
prerank,telomere maintenance via telomerase (GO:0007004),0.47720683017606397,1.1868675093225323,0.24549237170596394,0.9189207379478352,1.0,13/28,23.36%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,early endosome to late endosome transport (GO:0045022),0.5028626744756725,1.1867207877328187,0.2708333333333333,0.9182121480995213,1.0,6/20,14.68%,EMP2;RAB7A;LMTK2;HOOK1;WDR91;SNX16
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.520718963668166,1.1865633284447683,0.264750378214826,0.9175526294569651,1.0,7/16,16.86%,IMPDH2;NUDT2;PAICS;GMPS;GART;AMPD2;ADSS2
prerank,regulation of chemokine production (GO:0032642),-0.3504569400159402,-1.1865545654670073,0.18518518518518517,0.6971890013651182,1.0,17/36,31.91%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;TLR7;CD74;LPL;SIGIRR;PYCARD;ACKR1;IL7;AIF1;SNAI2;HMOX1;TREM2
prerank,sulfur compound transport (GO:0072348),-0.36995130877327254,-1.1860797457659251,0.17843866171003717,0.6965567760098506,1.0,4/27,4.99%,SLC6A13;SLC26A7;SLC35F3;SLC6A6
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5106616439703572,1.1860179111616758,0.26169590643274854,0.9182469682784884,1.0,3/19,6.86%,KLF4;HPN;MAPK7
prerank,endoplasmic reticulum organization (GO:0007029),0.4132729005454376,1.1857564974761874,0.22823529411764706,0.9179653728498884,1.0,29/72,23.99%,SPTSSB;OTOF;REEP3;CAV2;RTN3;MAPK15;GET4;TMEM33;EIF2AK3;LPCAT3;DNM1L;ATL2;CCDC47;REEP4;SHTN1;RNF112;TLE6;SEC31B;APP;SMPD4;RAB10;TMCC1;MIA3;VAMP2;SEC16A;SGTA;SEC31A;VAPA;TOR1AIP2
prerank,autophagosome maturation (GO:0097352),-0.3623889149825881,-1.185707369960636,0.211864406779661,0.6956377913632229,1.0,13/32,17.59%,ATP2A2;VMP1;LAMP2;UBQLN1;SNX14;CHMP3;VPS16;VPS33B;LIX1;MAP1LC3A;CLN3;VPS33A;TECPR1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4796196592770527,1.1855290220918278,0.26584022038567495,0.9175007225521574,1.0,2/27,1.19%,UTRN;SLMAP
prerank,negative regulation of programmed cell death (GO:0043069),0.3702844652945751,1.1853436928883727,0.12763819095477386,0.9169086936632128,1.0,80/355,17.27%,ANGPT1;CD44;NOTCH2;PRKAA2;WNT1;TJP1;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;TNFAIP8;WNT11;NGF;KANK2;PTK2B;GDNF;SH3RF2;ANXA4;HSPB1;MTDH;BAG1;SON;CRYAB;NFKBIA;ANXA5;AVEN;BCL2L1;MRE11;SOX9;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;GOLPH3;CCND2;ARHGAP10;PLK3;RAB7A;BAG3;RAF1;TIGAR;HDAC3;PTMA;AQP1;SOCS2;HYPK;YWHAZ;NAA15;COPS5;OPA1;ERCC5;RASA1;PDPN;ARF4;CBX4;VDAC1;MYC;IRAK1;ZFAND6;SFRP1;BNIP3L;GSK3B;DNAJC3;PLK2;BFAR;DSTYK;FLNA;CTSH;UFM1;RPS27A;UBC;POU4F1;LRP2;CIAPIN1;XIAP
prerank,mitochondrion organization (GO:0007005),0.3833842047061553,1.1849929820316298,0.20297555791710944,0.9169270952853888,1.0,69/165,26.89%,CXADR;PPARGC1A;GABPB1;TIMM10;TIMM44;CHCHD3;AGTPBP1;CAV2;BCL2L1;HCFC1;HAX1;NRF1;MUL1;SLIRP;TOMM5;MTFR1L;AFG3L2;PITRM1;MIEF2;THG1L;COX7A2L;AFG1L;BCAP31;NIPSNAP2;WASF1;TOMM20;OPA1;BNIP3L;TIMM17B;DNM1L;VPS13D;ATP5F1B;SLC25A4;MTX1;CLUH;MTFR2;SPG7;PARK7;PISD;RHOT2;TIMM9;STOML2;HSD17B10;TOMM40;TSPO;TWNK;TIMM50;SIRT4;MIEF1;GABPA;LONP1;TFAM;TIMM23;MTX3;IFIT2;AIP;AIFM2;ADCK1;DNAJA3;ATP5F1D;MTX2;RAB32;MTFR1;RHOT1;FANCG;FBXO7;COX7A2;PARP1;ESRRA
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5478559896825286,1.184926237129189,0.27488151658767773,0.9159418827332865,1.0,6/13,19.25%,PMAIP1;VDAC2;BAD;BLOC1S2;BNIP3L;RHOT2
prerank,regulation of T cell migration (GO:2000404),0.5174208444532992,1.1848998732878737,0.275808936825886,0.9148045117896574,1.0,5/18,12.20%,CCL5;CD200;RIPOR2;RHOA;CD200R1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3621741524001236,-1.1847449598440467,0.19844357976653695,0.6964147642350439,1.0,16/32,22.99%,SNCAIP;MCTP2;LRRK2;DTNBP1;PREPL;SNAPIN;SLC30A1;CAMK2A;MCTP1;KCNMB4;BAIAP3;CPLX2;FMR1;STX1B;RIMS1;RIMS3
prerank,triglyceride homeostasis (GO:0070328),-0.37880062834380257,-1.1846726220591859,0.21691176470588236,0.6945798193486928,1.0,10/26,29.69%,IL18;NR1H3;RORA;PNPLA8;LPL;NR1H4;DGAT2;FITM2;ANGPTL4;XBP1
prerank,inner ear morphogenesis (GO:0042472),0.4892108640306048,1.184258805243776,0.2679083094555874,0.91575989811778,1.0,5/22,9.46%,ATP6V1B1;HPN;SOX9;SIX1;ZIC1
prerank,N-glycan processing (GO:0006491),-0.41844271939074335,-1.1839717146567008,0.2513812154696133,0.6946719308475677,1.0,7/18,17.07%,MAN1C1;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;ST8SIA5;ST8SIA2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.4045775619345842,-1.1836956268174357,0.23880597014925373,0.6934121406665108,1.0,12/19,46.74%,LRP6;RYK;MANF;NR4A2;LMX1A;WNT2;SHH;VEGFA;FOXA1;EN1;FOXA2;CDNF
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4688251406899363,1.1828398326718006,0.27184466019417475,0.9196075163464225,1.0,8/29,14.10%,HPN;PPP2CA;BMP5;OVOL2;SPRED3;LDLRAD4;GATA3;SFRP1
prerank,cellular response to estradiol stimulus (GO:0071392),0.5050925328003469,1.182605953301304,0.2767857142857143,0.9191968561837763,1.0,6/18,19.15%,NCOA3;FAM210B;LCOR;SFRP1;POU4F1;GPER1
prerank,negative regulation of apoptotic process (GO:0043066),0.36936889833458464,1.1823110060355608,0.10642570281124498,0.9190129478478453,1.0,96/444,17.29%,ANGPT1;CD44;CRLF1;NOTCH2;PRKAA2;WNT1;KLF4;PPARGC1A;TJP1;NRBP2;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;ZC3H12A;TNFAIP8;WNT11;CAV1;QARS1;NGF;PTK2B;GDNF;CLCF1;SH3RF2;ANXA4;HSPB1;MTDH;BAG1;SON;CRYAB;NFKBIA;ANXA5;AVEN;BCL2L1;MRE11;SOX9;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;GOLPH3;CCND2;ERBB3;ARHGAP10;PLK3;UNC5B;SIX1;MAZ;BAG3;RAF1;CARD16;HDAC3;SOD2;PTMA;AQP1;SOCS2;HYPK;YWHAZ;NAA15;COPS5;OPA1;ERCC5;RASA1;PDPN;ARF4;CBX4;VDAC1;MYC;IRAK1;MEF2C;ZFAND6;SFRP1;BNIP3L;SET;GSK3B;DNAJC3;PLK2;BFAR;DSTYK;IGBP1;FLNA;MAEA;CTSH;UFM1;RPS27A;UBC;POU4F1;LRP2;CIAPIN1;XIAP;F2R
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.41274820597704276,1.1819605267900306,0.23104693140794225,0.9190031853813813,1.0,18/67,17.02%,RAB17;PODXL;RABEP2;CAV1;TBC1D16;CAPZB;TWF1;DMTN;MAPK15;CDC42;TBC1D1;ODAD3;FXR1;TRPM2;USP6NL;FSCN1;TBC1D22A;TBC1D10A
prerank,positive regulation of kinase activity (GO:0033674),-0.2831078163003771,-1.1819024208888358,0.12121212121212122,0.6966532074216457,1.0,32/107,13.71%,FLT1;PRKAG2;ROR1;PDGFRB;EPHA7;TEK;RAPGEF2;INSR;MERTK;PTK2;GAS6;AXL;TIE1;PDGFRA;KDR;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;KIT;ALS2;IGF1R;CCN1;FGFR4;SPDYA;MMD;FLT4;RET;EPHA5
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3934207547394709,1.1818907140706971,0.2081949058693245,0.9180588115413154,1.0,14/110,11.37%,ADRA1B;GPR4;LPAR1;ADCY9;PTGFR;ADGRL2;ADGRD1;RAMP1;ADCY6;LGR4;ADGRG2;ADGRG6;GNAQ;GNA13
prerank,protein targeting to mitochondrion (GO:0006626),0.4238243470108347,1.1816977040780257,0.25094102885821834,0.9175532385492426,1.0,18/52,20.96%,TIMM10;TIMM44;PMPCA;AGK;TOMM5;DNLZ;ROMO1;HSPA4;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;TOMM40L;TIMM9;TOMM40;TSPO;TIMM50
prerank,neutrophil mediated immunity (GO:0002446),0.36927490103394534,1.1815116184908647,0.10181451612903226,0.9169803510764836,1.0,92/432,17.08%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,cellular response to alkaloid (GO:0071312),-0.43286228618239375,-1.1814673382485328,0.27070063694267515,0.6959456892989438,1.0,8/17,23.83%,SLC8A1;TGM2;CASP7;RYR2;BLM;SPIDR;CASQ2;RAD51
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5791321034797392,1.1813347444197126,0.2845394736842105,0.9163971159641533,1.0,1/10,0.09%,PRKCB
prerank,ventricular septum morphogenesis (GO:0060412),-0.37334117926578997,-1.1813288145672889,0.23076923076923078,0.6943594621818591,1.0,13/27,22.25%,ZFPM2;ROBO1;NOTCH1;ROBO2;SLIT2;HEYL;SLIT3;BMPR2;SOX11;SMAD4;HEY2;APLNR;HEY1
prerank,hyaluronan catabolic process (GO:0030214),0.5190239211449287,1.1812597178515627,0.2748447204968944,0.9154704150231707,1.0,6/18,11.11%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,regulation of actin filament-based movement (GO:1903115),0.5675982524065782,1.181174963718684,0.30247933884297523,0.9145185487115405,1.0,1/10,0.66%,ANK2
prerank,response to thyroid hormone (GO:0097066),0.5442549273078743,1.1808430193682458,0.29850746268656714,0.9145226937746094,1.0,2/13,2.00%,THRB;HPN
prerank,limb morphogenesis (GO:0035108),0.5014892992942164,1.1802138119853822,0.2717557251908397,0.9155853080257217,1.0,3/20,7.39%,MBNL1;GLI3;TGFB2
prerank,regulation of lamellipodium assembly (GO:0010591),0.45764262109212855,1.180045158807072,0.26541554959785524,0.914895102042633,1.0,7/34,8.49%,WNT1;OCLN;CAPZB;TWF1;AVIL;DMTN;CDC42
prerank,calcineurin-mediated signaling (GO:0097720),0.5768568620172493,1.1798848154760018,0.29431438127090304,0.9130680992442286,1.0,1/10,0.33%,NFATC2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5768568620172493,1.1798848154760018,0.29431438127090304,0.9130680992442286,1.0,1/10,0.33%,NFATC2
prerank,DNA damage checkpoint signaling (GO:0000077),0.4704505762051029,1.1790696224743908,0.2585034013605442,0.9147467950714913,1.0,14/28,27.30%,DOT1L;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;NBN;CHEK2;TIPRL;RAD9A;STK33;CEP63
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5408937320664293,1.178750155960271,0.2884927066450567,0.9146646085293956,1.0,1/13,0.14%,SORBS1
prerank,positive regulation of actin nucleation (GO:0051127),0.5602785577639359,1.1785394331341306,0.3060556464811784,0.9141623098892683,1.0,3/11,12.09%,GSN;FCHSD2;WASF1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4084624101787718,1.17760153767407,0.24065420560747663,0.916384031842032,1.0,21/72,17.99%,CNOT6;CDKN1A;NDRG1;EP300;SESN2;USP10;FOXM1;PLK3;ATRX;PML;BTG2;ING4;MDM2;PLK2;PCNA;E2F1;NBN;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,pore complex assembly (GO:0046931),0.501661111048133,1.1774739234386395,0.2672672672672673,0.9156147253767487,1.0,5/19,12.24%,ADAM10;NUP93;BAD;NDC1;ANO6
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.517963949115384,1.1773804329361433,0.28821656050955413,0.9147203941089923,1.0,4/16,10.40%,ANK2;PPP1R15A;DDRGK1;BCAP31
prerank,regulation of GTPase activity (GO:0043087),0.3810185437686029,1.1770341423863335,0.18967334035827185,0.9147617587887368,1.0,47/177,17.29%,MAPRE2;RTN4R;SRGAP2;ARAP1;NGEF;CCL5;PLXNB1;EPHA4;PKP4;PLXNA2;CPEB2;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;ADAP1;SH3BP4;CAV2;EFNA5;DVL3;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;EPHA3;RGS6;PLXNB2;ASAP3;OCRL;ARFGEF1;SFRP1;GSK3B;HRAS;WNK1;ARHGAP27;FLCN;ITGB1BP1;USP6NL;RAPGEF1;PLXNA3;CRK;FICD;PRTN3;RAP1GAP;F2R
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.48248054206148444,-1.1769189170179186,0.24494949494949494,0.7050737944312749,1.0,5/11,26.64%,HIF1A;NONO;RACK1;NR4A3;ATF4
prerank,positive regulation of protein localization to membrane (GO:1905477),0.39672122463570203,1.1768882392144144,0.21575342465753425,0.914069963356865,1.0,29/98,19.57%,SORBS1;BBC3;PMAIP1;CD81;PPP1R13B;STAC3;ANK3;PTPN9;BAD;LGALS3;CHP1;YWHAB;MIEF2;YWHAQ;MYO1C;KCNB1;AKAP5;CNPY4;EPHA3;YWHAZ;ATP2B4;HRAS;ITGB1BP1;ITGB2;E2F1;STX4;NECAB2;GPER1;YWHAH
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4451645754161172,1.176814761095348,0.2870748299319728,0.9131268930133164,1.0,16/38,22.72%,SREBF2;HAX1;FZD5;ATP5IF1;SIAH3;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;SREBF1;FBXW7;ARIH2;MICALL2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.39029332928928906,-1.1762824777149334,0.2347266881028939,0.7050718883627869,1.0,4/21,3.83%,DMD;PDE4D;GPD1L;NCK2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.42206526144262335,1.1760945657165203,0.26108374384236455,0.9143874589778891,1.0,10/55,13.85%,FBXL7;FHL1;PSMD11;AVEN;PSMD4;PSMF1;RBX1;PSMD7;PSMB5;PINX1
prerank,neurogenesis (GO:0022008),0.4405548941921023,1.1759293635421457,0.25868725868725867,0.9137735312914868,1.0,5/43,8.18%,LPAR1;CXCR4;CDK6;TGFB2;SIX1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.473733068533515,-1.1759001679627565,0.2958904109589041,0.7041576501082469,1.0,8/11,36.99%,TP53;DDIT3;ATF3;ATF4;HSPA5;ATF6;CREB3L1;ATF6B
prerank,negative regulation of interferon-beta production (GO:0032688),0.5722737164928591,1.1754440995072168,0.28317152103559873,0.9143084570190274,1.0,2/10,4.64%,RELB;PPM1B
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3983788895986825,-1.1751767000829716,0.24422442244224424,0.7041611640339603,1.0,5/21,3.42%,CACNA1C;DMD;SLC8A1;PDE4D;CAMK2D
prerank,muscle cell differentiation (GO:0042692),-0.351513495250591,-1.1751226520153504,0.2260536398467433,0.7023133094465365,1.0,12/32,13.45%,DMD;SYNE1;MRTFB;GLMN;MEGF10;TBX18;RORA;SPEG;TMEM204;GATA6;SGCZ;TBX1
prerank,mammary gland development (GO:0030879),-0.39674221441192276,-1.1751173245977136,0.2356902356902357,0.70037114119557,1.0,6/21,9.87%,GLI2;WNT4;TBX3;JAK2;ERBB4;NOTCH4
prerank,secretion (GO:0046903),-0.446137912042481,-1.1746788875867102,0.24396782841823056,0.6996182690305052,1.0,7/14,30.33%,FBLN5;NPR1;RIMS1;SLC22A6;SLC22A2;GUCA1B;PRKCI
prerank,hyaluronan metabolic process (GO:0030212),0.4874060004737497,1.1746737748724467,0.2830188679245283,0.9158696083398206,1.0,6/23,11.11%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5156873866611023,1.1745621381148206,0.2844574780058651,0.9150803939241459,1.0,4/19,15.53%,EP300;PHLDA3;PML;USP28
prerank,protein polyglutamylation (GO:0018095),-0.49455749597023485,-1.1744412263449344,0.24369747899159663,0.6983184976306137,1.0,7/11,29.38%,TTLL4;TTLL11;CFAP20;TTLL5;CEP41;TTLL7;TTLL6
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4374072496857576,-1.1742294998916143,0.2638522427440633,0.6969502042503692,1.0,6/14,16.64%,WNT5A;SEMA7A;CAMK4;KIT;GPRC5B;CD74
prerank,post-translational protein modification (GO:0043687),0.3672805691401793,1.1739258864390487,0.14602215508559918,0.9161817011805674,1.0,69/332,17.61%,FN1;MSLN;FBXL7;F5;FAM20C;FBXW8;PRSS23;ADAM10;PENK;ASB14;FBXL20;SPSB4;SERPINC1;ZBTB16;TIMP1;PSMD11;NUB1;ANO8;ELOB;KLHL21;BMP4;PSMD4;PSMF1;GPC3;FEM1C;FEM1A;SUMF1;WSB2;FBXL18;RBX1;FBXO31;LAMC1;LAMB2;COP1;PSMD7;FBXW9;FEM1B;SUMF2;DCUN1D1;SOCS2;CALU;KLHL13;COPS5;DCAF6;CP;PSMB5;UBXN7;LGALS1;DDA1;ASB7;CHML;SOCS6;DCAF17;TULP4;RAB1B;DNAJC3;PRKCSH;ASB6;CCDC22;FBXL15;ASB8;DDB1;CAND1;ASB3;CUL9;KEAP1;PTP4A2;UBE2F;PSMD1
prerank,regulation of gene expression (GO:0010468),0.363852302974762,1.1738807393998782,0.051,0.9151612383880545,1.0,149/903,14.37%,FN1;CDH1;WNT16;MBNL1;BNC2;NFATC2;CLU;ANGPT1;ANK2;NOTCH2;ITGB8;PRDM6;PRKAA2;NTRK3;FOXN3;DAXX;TRIM60;ADTRP;KLF4;TFAP2C;PPARGC1A;AHNAK;SMO;AHNAK2;ADAM10;HPN;OCLN;GSN;ZC3H12A;WNT11;EP300;CELF1;HDAC5;CDK6;NGF;AFF3;DAPK3;GDNF;ZNF219;PPP2CA;CREBL2;CGGBP1;WNT6;HDAC4;YBX3;NFE2L2;GCNT2;WWP2;OLFM1;FLOT2;SNRNP70;TRIM44;SON;IGSF1;MLF2;CDK4;ESRRB;PRRX2;OVOL2;PATZ1;PHF1;POLR2A;HOXA5;KRAS;MOV10;SOX9;FOXD1;HCFC1;ZBTB7B;KAT6B;DDRGK1;EFEMP1;BMP4;ANK3;RBMS3;MSN;RBM20;TOB2;TRIM21;TGFB2;NKAP;ZFHX3;FGF22;ATRX;SIX1;MAZ;POU3F1;MAPK9;PML;FOXP3;HNRNPH2;TLR6;TXK;MYCBP;TRIM26;MAP2K2;TRIM11;EZR;APBB1;SMCR8;MUSK;FADS1;NFYC;TWIST1;SRPK2;ZNF205;SRRM4;ACTG1;GON4L;MYT1;TLR4;CALCOCO1;KDM6A;AJUBA;SNX12;SFMBT2;SP1;EIF2AK3;ZNF148;TAF5;WNT3;TFEB;SPIN1;SH3GL2;CHD3;GATA3;RREB1;SBNO2;GPBP1;CDK2;CIAO3;NFIA;TCF19;MYC;GSK3A;PRDM11;REXO4;MEF2C;TLE5;MYBL1;ATP2B4;SFRP1;SRRT;FOXP1;UBR5;PTP4A3;IRF2;GSK3B;HRAS
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5582806708487676,1.1737021714900087,0.26916802610114193,0.914643059992353,1.0,3/12,5.86%,B4GALNT2;GFUS;FUT8
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.30369213007621937,-1.1733355970732113,0.1744186046511628,0.6975383259425443,1.0,15/66,10.65%,FLT1;PDGFRB;SASH1;PDGFD;IL34;ROBO1;FGF2;DAB2IP;LRRK2;TGFB1;EZH2;TPD52L1;PIK3R6;KIT;TRAF6
prerank,carboxylic acid transport (GO:0046942),-0.3165554634574539,-1.173187479838259,0.17733990147783252,0.6960374850443962,1.0,13/55,7.93%,SLC6A13;SLC13A3;SLC16A12;SLC1A5;SLC6A12;SLC6A9;SLC7A5;SLC16A9;SLC6A6;SLC16A6;SLC1A1;SLC16A1;SLC16A4
prerank,positive regulation of response to wounding (GO:1903036),0.4922123485008756,1.1726807144782312,0.2631578947368421,0.9170628981456699,1.0,7/24,14.37%,KANK1;OCLN;DMTN;ACTG1;PTN;ARFGEF1;HRAS
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.47981308767469927,1.1721783136678035,0.29004329004329005,0.9176946003230099,1.0,5/25,11.16%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,plasma membrane repair (GO:0001778),0.5415867678677013,1.1719917981793018,0.29541864139020535,0.9171968095752474,1.0,2/13,2.30%,AHNAK2;SYTL4
prerank,response to cytokine (GO:0034097),-0.26714326789637083,-1.1716775886632156,0.05660377358490566,0.6985769861001299,1.0,35/141,14.03%,PID1;LEF1;ALDH1A2;OSMR;IL1R1;SP100;IL1RAPL1;TIMP3;LIFR;IRAK2;GGT5;LGALS9;XAF1;ADAR;PTPN4;IRAK3;IFNAR2;BCL2;IL6R;PTPN12;IFITM3;GCH1;JAK2;CXCL16;TBK1;PLSCR1;TRAF6;STAT3;RIPK1;IL6ST;KLHL20;MME;SMAD3;YTHDC2;ADAM9
prerank,acylglycerol catabolic process (GO:0046464),-0.3638630028467759,-1.1710065563532186,0.2361111111111111,0.6986150735476083,1.0,8/30,26.68%,MGLL;LIPE;ABHD12;ABHD2;LPL;PNPLA3;FABP7;PNPLA2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.39327104858073997,1.1709063103788815,0.2210065645514223,0.9197159792715653,1.0,16/114,10.47%,TNFRSF11B;EDA2R;EDA;TNFSF13;PTK2B;FOXO3;TNFRSF8;NFKBIA;PSMD11;PSMD4;COMMD7;PSMF1;ILK;TNFRSF1A;PYDC1;PSMD7
prerank,regulation of B cell activation (GO:0050864),-0.37566359802893934,-1.1707731277712765,0.2490842490842491,0.6974471443853432,1.0,12/25,38.36%,SH3KBP1;TNFAIP3;NOD2;AHR;TNIP2;FCGR2B;BANK1;FOXJ1;SAMSN1;IL4I1;IKZF3;THEMIS2
prerank,positive regulation of translation (GO:0045727),0.3895376781532374,1.1705223945214662,0.24414715719063546,0.9199215870833314,1.0,27/94,20.72%,CCL5;VIM;SAMD4A;YTHDF1;YBX3;RPS4X;PKM;EIF4A3;UPF3A;EIF6;MRPS27;HABP4;POLDIP3;CPEB3;PLXNB2;FXR1;BOLL;UPF3B;PYM1;DHX9;JMJD4;EEF2;USP16;YTHDF3;TRUB2;SOX4;ZCCHC4
prerank,response to exogenous dsRNA (GO:0043330),0.49575715440342377,1.1704693324236242,0.2922374429223744,0.9189435090751534,1.0,7/18,19.48%,CAV1;MAVS;MUL1;TLR3;DHX9;COLEC12;FLOT1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4891608530261306,-1.1699274165021827,0.2641025641025641,0.6979349075527819,1.0,3/10,9.55%,SLC2A1;ACSL1;RPS6KB1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5123903948118248,1.1698559959238632,0.3050847457627119,0.9199272144004333,1.0,5/16,11.27%,ERLIN2;SOX9;ACADL;ERLIN1;NCOR1
prerank,regulation of apoptotic process (GO:0042981),0.36288611019471684,1.1697152091867533,0.08108108108108109,0.9192653129208753,1.0,144/676,17.32%,EGLN3;CLU;ANGPT1;CD44;NOTCH2;PRKAA2;DAXX;WNT1;PAWR;ACTN2;TJP1;MMP9;NGEF;MAP3K5;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NDRG1;ARHGEF17;NUPR1;AKAP13;TNFAIP8;WNT11;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;PTK2B;FOXO3;TNFRSF8;DAPK3;GDNF;TIAM2;DAPK1;SH3RF2;ANXA4;HSPB1;PPP1R13B;OLFM1;MTDH;BAG1;UTP11;SON;CRYAB;NFKBIA;ANXA5;RARG;AVEN;IRF3;PERP;BCL2L1;HOXA5;ARHGEF18;MRE11;SOX9;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;PNMA2;EGLN2;GOLPH3;CCND2;ARHGAP10;BAD;PLK3;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;BAG3;PTPN6;TRIO;APBB1;RAF1;IER3IP1;ARL6IP5;HDAC3;PTMA;USP42;AQP1;GNA13;SOCS2;PLSCR3;HYPK;YWHAZ;GADD45B;ANKRD13C;BCAR1;ANO6;NAA15;COPS5;HRK;OPA1;ERCC5;RASA1;PDPN;SOS2;ARF4;LGALS1;CBX4;RNPS1;VDAC1;MYC;EEF1E1;ING4;IRAK1;MEF2C;ZFAND6;SFRP1;BNIP3L;GSK3B;DNM1L;FLCN;DNAJC3;PLK2;HSP90AA1;BFAR;DSTYK;ACTN4;FLNA;IP6K2;CTSH;UFM1;ARHGEF1;FRZB;RPS27A;UBC;E2F1;ABL1;LRP2;SIGMAR1;CIAPIN1;SIAH1;XIAP;PLEKHG2
prerank,positive regulation of cell migration (GO:0030335),0.36937088162460885,1.1695583349521659,0.17959183673469387,0.9186594150724711,1.0,30/253,8.61%,FN1;SEMA3D;CDH13;DOCK5;NTRK3;LAMC2;TJP1;SMO;MMP9;CCL5;PODXL;PDGFC;ADAM10;GAB1;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2;S100A11;SOX9;DMTN;DDRGK1;CBLL1;TGFB2;WNT5B;MAZ;ELP5;FBXO5
prerank,positive regulation of cartilage development (GO:0061036),-0.42534088332740516,-1.1691385699180321,0.2755681818181818,0.6983347575714345,1.0,6/17,15.14%,SOX5;ACVRL1;BMPR1B;PKDCC;BMPR2;SOX6
prerank,brain morphogenesis (GO:0048854),-0.47882824458711537,-1.168975216389032,0.2813953488372093,0.6968862772406622,1.0,7/12,25.04%,SHANK3;CTNNA2;SPEF2;BBS4;VPS51;PAX2;PTEN
prerank,clathrin coat assembly (GO:0048268),-0.4327820652474335,-1.1680712223829104,0.25287356321839083,0.6974235881859195,1.0,7/15,21.13%,HIP1;CLTA;SGIP1;EPS15;FCHO2;CALY;HIP1R
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5033885357492616,1.1676303088003657,0.2950075642965204,0.9240430288844718,1.0,4/20,9.09%,PRKAA2;PPARGC1A;FOXP3;BRD7
prerank,skeletal muscle tissue development (GO:0007519),0.45948216924150226,1.1672570638635225,0.2694938440492476,0.9241949656090543,1.0,6/32,8.18%,CAV1;CSRP3;SELENON;LMOD3;CAV2;SIX1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.48107920499562434,-1.1670126352347703,0.2845953002610966,0.698440945094305,1.0,7/11,42.43%,JAK2;TMEM106A;HDAC2;XBP1;TAF7;PF4;IL4
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5130435418927309,1.1669035055440318,0.2924242424242424,0.9242898854357131,1.0,5/17,12.86%,SREBF2;ERLIN2;ERLIN1;ABCA2;LPCAT3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5604072453303451,1.166840908025013,0.3106796116504854,0.923351390682153,1.0,3/11,11.02%,SMARCB1;PIH1D1;SMARCA4
prerank,response to purine-containing compound (GO:0014074),-0.4256748493115177,-1.1667966832273091,0.2654320987654321,0.6972160781901345,1.0,6/17,21.61%,TRPC3;ABCC9;RYR2;P2RY1;DGKQ;VGF
prerank,recombinational repair (GO:0000725),0.40058211475671074,1.1667659278914624,0.26346604215456676,0.9224315849778256,1.0,29/77,22.44%,FEN1;RECQL4;KDM4D;NABP2;RNF138;MRE11;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;FAN1;UBE2N;LIG3;SFR1;SMC6;NBN;RAD50;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;SWI5;NSMCE1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5398717353914131,1.166421395537834,0.30392156862745096,0.9224305781919242,1.0,3/13,7.49%,CYFIP2;PERP;BAD
prerank,neuron differentiation (GO:0030182),0.37624306257122947,1.1664013954395758,0.20337197049525815,0.9213401996335212,1.0,15/165,9.21%,WNT16;WNT1;PBX3;PBX1;NRBP2;WNT10A;WNT11;ITM2C;WNT6;PTPRD;TGFB2;WNT5B;FZD5;ACSL3;OPHN1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.46085989486413753,1.1663576765713717,0.265389876880985,0.9203275989262684,1.0,10/30,17.61%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;DPM2;ALG5;UBE2J1;RPN2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.33656038062294436,-1.1657373572242251,0.21524663677130046,0.6983398175489086,1.0,9/41,8.02%,TGFA;IL34;DOCK3;GAS6;NOX4;GRM5;ACE;LRP8;NTRK2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40074638597494255,1.1652986216185535,0.2377142857142857,0.9230021168119763,1.0,22/85,17.31%,CLU;TRIB2;NUPR1;ZYG11B;SH3RF2;TMEM259;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;OSBPL7;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2;KEAP1;STUB1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5112247729685293,1.1651512002121829,0.2891566265060241,0.9223642042565091,1.0,4/17,12.24%,CCL5;MOSPD2;CREB3;ANO6
prerank,mesonephros development (GO:0001823),0.561094172030486,1.1649325690608439,0.31125827814569534,0.9219745743064525,1.0,3/11,12.95%,ZBTB16;BMP4;GATA3
prerank,DNA modification (GO:0006304),0.48823671200712276,1.164797795366626,0.2878120411160059,0.9212723513586497,1.0,13/22,30.00%,PARP3;EXOSC3;MUTYH;MBD4;NEIL1;PARP2;TERF2;TINF2;EXOSC4;PARP1;TERF1;TERF2IP;TDG
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4001761923264764,1.1645401570056177,0.259604190919674,0.9210018800422456,1.0,19/80,15.74%,WNT1;ARAP1;OCLN;EPS8L2;NDEL1;CDC42EP4;PALM;CDC42EP5;RIPOR2;RHOQ;AVIL;CDC42;BCAS3;PLEKHM1;MARK4;HRAS;CCDC88A;WASHC1;FSCN1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3736624800795873,1.1645268001632774,0.19401444788441694,0.9199041958526589,1.0,60/234,19.56%,PRKCB;CLU;WNT1;ANXA3;PPARGC1A;SMO;EDA2R;EDA;TSSK4;CD200;CAV1;IKBKE;MAVS;EP300;HDAC5;HDAC4;TRIM25;MTDH;FLOT2;SMARCB1;NFKBIA;ZIC2;DDRGK1;TRIM41;TRIM21;LPAR5;NFAM1;TAB3;RAB7B;ARHGEF5;TLR6;TRIM26;CARD16;SMARCA4;TLR4;COPS5;MAP3K13;IRAK1;CHUK;DHX9;IKBKG;RNF31;UBE2N;RPS27A;UBC;PRKCZ;RELN;KDM1A;PIDD1;TAB2;TRIM37;PRKCQ;PARK7;ATF2;FZD2;PRKD2;NFKB2;APP;FLOT1;ZBTB7A
prerank,Rap protein signal transduction (GO:0032486),0.5639001143871272,1.1640684609023166,0.29296235679214405,0.9203352754874828,1.0,6/10,15.45%,RAP1B;RAP1A;RAPGEF3;RAPGEF1;PLK2;RAP2C
prerank,positive regulation of intracellular transport (GO:0032388),0.43766536274048606,1.1638361869245013,0.26768377253814146,0.9200149805666419,1.0,13/38,24.61%,ACTN2;EHD1;PLK3;BCAS3;NEDD4;RIPOR1;DYNC1H1;NUMA1;KIF20B;VAMP2;TPR;ICE1;PCM1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4414731145689401,1.1631726770660213,0.2791946308724832,0.9211830885220671,1.0,4/35,2.81%,SEMA3D;PLXNB1;PLXNA2;SEMA3B
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4379778582724302,-1.1627881274117555,0.2832369942196532,0.7046001364119833,1.0,7/15,25.53%,KCNN2;ATP1B1;KCNJ2;KCNJ8;KCNIP2;YWHAE;KCNJ3
prerank,neuron projection extension (GO:1990138),0.4495187472835094,1.162772130743779,0.26038781163434904,0.9214565924381979,1.0,11/32,17.95%,ALCAM;FLRT1;IQGAP1;SLC9A6;NRP2;SH3GL2;FLRT3;ULK1;HSP90AA1;EIF2AK4;SEMA3A
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.47583871745055417,1.1619354206671018,0.276657060518732,0.9232478708096219,1.0,5/23,9.65%,DYNC1I1;MAP6;KIF1C;KIF1B;HOOK1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4093830388336805,1.1618801898514288,0.25616921269095183,0.9222886189082078,1.0,17/73,12.90%,TFAP2C;EP300;HDAC5;CGGBP1;HDAC4;POLR2H;TAF1C;PHF1;ZFP57;ACTB;DNMT3A;POLR1C;MYO1C;POLR1E;AEBP2;POLR1F;PPM1D
prerank,negative regulation of axon extension (GO:0030517),0.4597710546569024,1.161674936927215,0.27012278308321963,0.9218202334701501,1.0,3/30,2.81%,SEMA3D;RTN4R;SEMA3B
prerank,retrograde axonal transport (GO:0008090),-0.4080181615151808,-1.161204301931494,0.25903614457831325,0.7071424490406053,1.0,7/16,18.90%,DLG2;ACTR10;NEFL;KIF1A;TMEM108;MAP1A;SOD1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5612138567819666,1.1610252290618737,0.32094594594594594,0.9229125278733213,1.0,2/10,8.99%,ZC3H12A;FOXP3
prerank,proteasome assembly (GO:0043248),0.5596491920891709,1.160849195224503,0.30870279146141216,0.9223291511609261,1.0,3/11,7.01%,PSMD11;POMP;PSMD4
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.40149888030356073,-1.160600162275235,0.2694610778443114,0.707005938644111,1.0,8/22,15.91%,MAP2;MAP1B;AEBP1;PRUNE1;GBA2;CAMSAP2;GPX1;MAP1A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.30630332518632125,-1.1602029987775622,0.18354430379746836,0.7063519192452365,1.0,14/67,7.58%,FLT1;SULF1;PRKD1;PIK3R1;VAV3;VEGFC;PTK2;AXL;KDR;NCK2;CLEC14A;DAB2IP;PIK3CB;ROCK1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5120380475238689,1.1595098271459219,0.3125948406676783,0.9258000616458039,1.0,6/15,19.19%,CD44;MDM2;KDM1A;ARMC10;TRIAP1;TAF9B
prerank,regulation of synapse maturation (GO:0090128),-0.4857103147808832,-1.1586336643398938,0.29411764705882354,0.7089525055014261,1.0,3/10,7.33%,NRXN1;DAB2IP;ARHGEF15
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.44549974276483284,-1.1585868494249043,0.28651685393258425,0.7071990231757281,1.0,10/14,37.28%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1;ERN1;NCBP2;CPSF4L;CPSF2
prerank,calcium ion transport into cytosol (GO:0060402),-0.3894111096819096,-1.1580804867743573,0.28486646884273,0.7068160460882869,1.0,5/21,6.26%,CACNA1C;SLC8A1;GRIN2A;JPH1;GRIN2B
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.390441993013748,1.1578904942184345,0.24751381215469614,0.9301758234466546,1.0,13/104,8.04%,CD109;WNT1;VEPH1;SMAD6;MAGI2;NBL1;CRIM1;TRIM33;CAV1;IGSF1;SPRED3;TGFB1I1;PPM1A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2923180672146106,-1.1578088621296718,0.20710059171597633,0.7057522200909184,1.0,17/75,9.51%,FARP1;MAP2;MAP1B;DCC;PAK3;DCDC2;ZDHHC17;BRSK1;NRCAM;CTNNA2;SLITRK1;S100B;DSCAML1;SDC2;FGFR2;RYK;NTNG1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.3151350462687585,-1.157646909619395,0.23563218390804597,0.7044289411040036,1.0,14/55,17.58%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;RCC1;ANAPC15;TOM1L1;EDN1;BORA;EDN3;EGF
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.43760343028975707,1.1574901052581235,0.27860026917900405,0.9303976652544177,1.0,14/38,21.45%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4969336247343105,1.157301763985314,0.28549618320610687,0.9299300986489604,1.0,9/19,27.45%,NAGK;NANS;UAP1L1;GFPT1;GNPDA2;PMM1;UAP1;PMM2;PGM3
prerank,leukocyte tethering or rolling (GO:0050901),0.5047629565312228,1.157050575194994,0.3019145802650957,0.9296564221099888,1.0,3/17,7.18%,PODXL2;ITGB7;GOLPH3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4261476858710721,1.156916675791744,0.2696774193548387,0.9289581963824474,1.0,15/50,20.21%,CD44;KLF4;MMP9;NGF;PIH1D1;RAF1;CARD16;AQP1;IGBP1;XIAP;TRIAP1;PARK7;CDKN2D;BEX3;ARL6IP1
prerank,cellular response to sterol (GO:0036315),0.5253155753968778,1.156825587192842,0.31437598736176936,0.9281387725928499,1.0,4/13,11.14%,SMO;RORC;INSIG1;OSBPL7
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5137784416375093,1.1565928981167668,0.2986217457886677,0.9278379042339251,1.0,4/18,9.59%,HOMER2;HOMER3;FOXP3;EZR
prerank,macrophage migration (GO:1905517),0.5219029996305679,1.1564723619271238,0.3226837060702875,0.9270740484473641,1.0,2/13,8.28%,CCL5;LGALS3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4031345835783711,1.1563804933232151,0.28222996515679444,0.9262587078391423,1.0,17/76,15.64%,NR3C2;UACA;ZC3H12A;EP300;PPM1B;TRIM44;NFKBIA;ILK;PPM1A;EZR;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,peptide hormone secretion (GO:0030072),0.46994058044693415,1.1563019430161254,0.29353932584269665,0.9254053912652875,1.0,3/26,7.53%,GAL;LTBP4;CDK16
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.26968353417191854,-1.1560391319320842,0.11627906976744186,0.7070746823810727,1.0,35/124,17.39%,PTPRM;CNTNAP2;RAPGEF2;MAP2;LYN;FRY;STMN2;LIMA1;LGI1;PKD2;LAMB1;LRP12;CEP78;NLGN1;ROCK1;DTNBP1;ARMC2;TBC1D24;RYK;FAM161A;SNAPIN;PLP1;MYOC;TBC1D23;MANF;TMEM108;KIFAP3;ATXN10;PPP1R9A;STMN3;NCDN;ATCAY;HMGB1;RASGRF1;WDPCP
prerank,carnitine metabolic process (GO:0009437),0.5455032365765012,1.155686830039093,0.31309904153354634,0.9264131553339365,1.0,5/12,13.29%,ACADL;CPT1B;SHMT1;CPT2;ACADM
prerank,embryonic eye morphogenesis (GO:0048048),-0.46192081074049135,-1.1556697811368697,0.29545454545454547,0.7063427409616222,1.0,5/11,9.62%,FBN1;MFAP5;FBN2;LRP6;TBX2
prerank,response to X-ray (GO:0010165),-0.43900348990907445,-1.1553993096519843,0.2773109243697479,0.7052306870764511,1.0,4/14,16.81%,BRCC3;NIPBL;IKBIP;BLM
prerank,negative regulation of secretion by cell (GO:1903531),0.4355248628664238,1.1550723359547705,0.28063241106719367,0.9273496125605957,1.0,10/38,15.37%,ADTRP;STXBP6;HMGCR;CYP51A1;TNFRSF1A;HTR1B;SERGEF;RHBDF2;SYT11;PNKD
prerank,homologous chromosome segregation (GO:0045143),0.48943261051677933,1.1544672187411085,0.29839883551673946,0.9283658433366487,1.0,1/20,1.16%,ANKRD31
prerank,kidney development (GO:0001822),0.40299562837656594,1.1541789989483888,0.25149700598802394,0.9282263262550245,1.0,11/65,8.25%,AGTR1;STRA6;KANK2;GDNF;ZBTB16;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,response to axon injury (GO:0048678),-0.41025277383385267,-1.1541106222087674,0.2714285714285714,0.7069831135788072,1.0,8/18,21.75%,NREP;MAPK8IP3;DHFR;MTR;SARM1;SOD1;P2RY12;TYROBP
prerank,diol biosynthetic process (GO:0034312),-0.4329338472018512,-1.1537721591114483,0.27988338192419826,0.706066104493782,1.0,9/15,33.29%,ACER2;GCH1;SPR;DHFR;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5372665030195052,1.1534176301481913,0.326984126984127,0.9297710460132241,1.0,4/12,5.45%,ADTRP;NBL1;BMP5;DUSP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3352006044188008,-1.1533072343605393,0.23275862068965517,0.7055843292409044,1.0,16/37,28.19%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;SIRT2;SPRED1;EGF;SPHK1;BMP7;DGKQ;STOX1;TRIM6;CADM4;RIPK2;CALM3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5459397897663651,1.1531337008177507,0.3187702265372168,0.9295688555242496,1.0,1/11,0.58%,SCARA3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.46599169103326665,1.1525312249728257,0.32952924393723254,0.9304778355226957,1.0,5/26,11.16%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5292448683499473,1.152362139476046,0.3333333333333333,0.9300030416450168,1.0,4/12,21.68%,ADTRP;WNK1;ASS1;MIA3
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.37239012343682465,-1.1515730688894499,0.24528301886792453,0.7085715767275823,1.0,12/25,20.35%,SULF1;ENG;ACVRL1;NOTCH1;BMPR1B;ACVR2A;ZNF423;CCN1;BMPR2;SOX11;UBE2O;SMAD4
prerank,purine ribonucleotide transport (GO:0015868),-0.42241169224089214,-1.1512144007354412,0.28405797101449276,0.7078184843055773,1.0,2/16,1.29%,LRRC8C;ABCC4
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3921474780582438,-1.1509046551822057,0.25796178343949044,0.7068853982623485,1.0,6/20,9.13%,TGM2;CAMK2D;ATP2A2;BCL2;SELENOK;FIS1
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.34111550708105276,-1.1507415767412323,0.2222222222222222,0.7055903244414076,1.0,8/35,12.20%,PAM;ACSS3;GGT5;HMGCLL1;FAR2;HMGCS2;BDH1;HPGD
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.40220471568677046,1.1503354074067245,0.2672209026128266,0.9359019222865683,1.0,20/73,19.38%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;HAX1;LATS1;RAF1;RAPGEF3;CAPRIN2;ATP2B4;EIF4G1;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.44802956761346324,-1.150307485350329,0.2864450127877238,0.7050695009394394,1.0,3/12,2.85%,PRKG1;DOCK4;IGFBP5
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41451917737969884,1.1501940603398366,0.2727272727272727,0.9352506583591343,1.0,8/55,7.92%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ALOX5;FOXM1;EIF6;ROMO1
prerank,regulation of organelle organization (GO:0033043),0.39570801311343856,1.150111579361902,0.2556480380499406,0.934393036123608,1.0,23/80,15.46%,TJP1;PLXNB1;MAVS;EP300;DIAPH1;MUL1;MAPK15;MSN;GOLPH3;CAPN2;ARHGEF5;MIEF2;MYO5A;EZR;TMEM33;VPS11;ARMH3;CPLANE2;PREB;DNM1L;USP6NL;SYT11;RAB33B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.411676360652412,1.150030669675988,0.2777777777777778,0.9335350859448879,1.0,18/63,17.99%,CNOT6;CDKN1A;EP300;PLK3;FBXO31;PML;SDE2;CCND1;CDK2;BTG2;MDM2;PLK2;PCNA;E2F1;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,sensory perception of smell (GO:0007608),-0.4692592764843808,-1.1498361332577285,0.31891891891891894,0.704607845132008,1.0,6/11,28.82%,UBR3;DRD2;BBS4;SYT10;ADCY3;SLC24A4
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.48872170803550646,-1.1495887243460823,0.29310344827586204,0.7034923712824495,1.0,6/10,26.61%,ADGRV1;PLS1;SOD1;TSKU;WHRN;IFT88
prerank,nervous system development (GO:0007399),0.35887141450295784,1.1492484335861552,0.172,0.9351742564322195,1.0,48/429,9.50%,FN1;CDH1;MBNL1;FGF13;SDK1;LPAR1;NOTCH2;CHRM1;CELSR1;SMO;ZIC4;PDGFC;PCDHA8;SREBF2;GSN;NBL1;CRIM1;NINJ1;EP300;CXCR4;TMOD2;NGF;RBFOX2;GDNF;GLIS2;HDAC4;ZBTB16;UTP11;HMGCR;PCDHB12;NAGLU;GFRA3;UNC119;AVIL;EFNA5;EIF2B2;ZIC2;LRCH4;ERBB3;CYP51A1;PKD1;FZD5;POU3F1;GRHL2;OPHN1;DPF2;ZIC1;PCDHA4
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5077226456579345,1.1490076613758289,0.3153724247226624,0.934825842296507,1.0,2/16,3.17%,LDLR;ABHD5
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.49597312960195095,1.1489764591090568,0.31626506024096385,0.9337884983693028,1.0,3/17,6.81%,ADTRP;ATP1A2;BMP4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.48386784535163985,1.1489703480839317,0.3064971751412429,0.9326871148908562,1.0,3/21,2.93%,CNOT6;SAMD4A;SAMD4B
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4268201493005609,1.1488896894347091,0.2848020434227331,0.9318339466345403,1.0,8/47,8.78%,ANXA8;ANXA8L1;CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,regulation of establishment of protein localization (GO:0070201),-0.4302058118288349,-1.1481862326676604,0.27595628415300544,0.7057061338524955,1.0,9/13,34.81%,CORO2B;DNAJA1;SPIDR;CTSD;CEP135;SCFD1;GAPVD1;TREM2;CEP295
prerank,positive regulation of potassium ion transport (GO:0043268),0.4306903181437672,1.1480449804884163,0.2775616083009079,0.9335992805091639,1.0,3/38,3.11%,ANK2;ACTN2;FHL1
prerank,defense response to protozoan (GO:0042832),-0.4573316975032488,-1.1479437702141577,0.29508196721311475,0.7045578030139921,1.0,6/12,26.81%,LYST;GBP6;CD40;GBP2;GBP4;SLC11A1
prerank,cardiac conduction system development (GO:0003161),0.47291086161878176,1.147892830116534,0.30042918454935624,0.9330027118424493,1.0,3/24,6.81%,NOTCH2;GJB6;BMP4
prerank,positive regulation of response to external stimulus (GO:0032103),0.38034300938200327,1.1478611961751184,0.24487594390507011,0.9319997109387379,1.0,22/128,15.84%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;THBD;FEM1A;POLR3B;TNFRSF1A;NMI;TLR4;ANKRD17;PTN;POLR3C;TNIP1;TLR3;DHX9;POLR3G
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5088026528357124,1.1474324642787823,0.32164634146341464,0.9323298232425365,1.0,1/15,0.37%,CDH13
prerank,response to UV (GO:0009411),0.38781833979517066,1.1472142374216263,0.2694063926940639,0.9319361973404428,1.0,33/95,24.77%,SCARA3;FEN1;EP300;MAP3K4;REV1;POLK;SDE2;UBE2B;CCND1;PCLAF;AQP1;ERCC5;MYC;POLH;NEDD4;USP28;PCNA;ATR;ERCC2;KDM1A;EIF2AK4;TRIAP1;COPS9;CDKN2D;ERCC4;USF1;RHBDD1;YY1;MEN1;RPL26;CDC25A;EIF2S1;PTPRK
prerank,anterograde synaptic vesicle transport (GO:0048490),0.505786830996549,1.1469823243250825,0.3450479233226837,0.930491678817195,1.0,8/15,23.90%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.505786830996549,1.1469823243250825,0.3450479233226837,0.930491678817195,1.0,8/15,23.90%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,regulation of ruffle assembly (GO:1900027),0.47364087391407134,1.1466395665645817,0.293591654247392,0.9305752229909585,1.0,4/23,2.87%,KANK1;EPS8L2;CAV1;NDEL1
prerank,regulation of necroptotic process (GO:0060544),0.4742346426017812,1.1464491896996896,0.30161054172767204,0.930099839983584,1.0,10/23,20.56%,OGT;YBX3;FLOT2;PELI1;HSP90AA1;SLC25A4;STUB1;PDCD6IP;FLOT1;ZBP1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5535734591917094,1.1462287693510638,0.3217821782178218,0.9297041301773803,1.0,5/11,14.10%,RSPO3;MLLT3;WNT5B;CSNK1E;SFRP1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4565095254667574,1.1460121054001218,0.31145251396648044,0.9293198918844798,1.0,10/27,18.33%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;PIP4K2C;GSK3A;PRKCZ;PRKCQ;SLC27A4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.35711028609240825,1.1459849339854589,0.14529058116232466,0.928322486443692,1.0,94/509,15.76%,FN1;ADRA1B;WNT16;PRKCB;CDH13;FGFR1;NR3C2;ANGPT1;LPAR1;NTRK3;CCL5;JCAD;EDA2R;PLXNB1;PDGFC;NUPR1;BBC3;GDF15;AKAP13;GAB1;WNT11;CAV1;IKBKE;MAVS;EP300;PMAIP1;GCNT2;EPO;TRIM25;MTDH;TRIM44;TFG;CAV2;BCL2L1;SLC20A1;SOX9;RHEB;HAX1;SHC1;MYDGF;MUL1;CC2D1A;WLS;GOLPH3;ERBB3;TRIM21;TGFB2;BAD;TAB3;ILK;TNFRSF10B;UNC5B;FGF22;PPM1A;MAZ;TCF7L2;IQGAP1;TNFRSF1A;TLR6;PTPN6;JMJD8;NMI;SMCR8;BCAP31;CARD16;HDAC3;GSDME;TLR4;ANKRD17;IRS2;RHOA;MIB2;GATA3;EEF1D;PELI1;LGALS1;IRAK1;CHUK;PTP4A3;HRAS;GAPDH;NEDD4;DNM1L;FLCN;ITGB1BP1;GPR89A;TLR3;PLK2;HSP90AA1;IKBKG;RNF31;ACTN4;FLNA;UBE2N
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.45211484064090707,-1.1459107363728451,0.3021978021978022,0.7085359242070854,1.0,4/12,10.70%,SDK2;PROM1;RORB;STAT3
prerank,insulin receptor signaling pathway (GO:0008286),0.400005288159477,1.1455593479513377,0.2647754137115839,0.9286908137324332,1.0,17/69,15.54%,SORBS1;ATP6V1B1;GAB1;FOXC2;RHOQ;CAV2;SHC1;AP3S1;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1E1;ATP6V1D;ATP6V0D1
prerank,endomembrane system organization (GO:0010256),0.36828140927783715,1.1455195528554176,0.22292323869610936,0.9277396637849997,1.0,53/178,19.58%,SPTSSB;FBXW8;ANXA8;ANXA8L1;SYP;OTOF;TJAP1;A4GALT;REEP3;TMED1;CAV2;NUP93;MAPK15;ATP8B2;ANK3;NSFL1C;GOLPH3;ARHGAP21;SRGN;CDC42;HOOK1;TLCD2;TOR1A;BCAS3;SNX33;ZW10;VPS11;EIF2AK3;PHETA2;GOLGB1;EXOC8;ARFGEF1;NPLOC4;VPS18;PLEKHJ1;FER1L6;VPS4A;PHETA1;DNM1L;ATL2;USP6NL;REEP4;PI4K2A;WASHC4;SUN2;SEC23IP;OSBPL2;TMED5;RNF112;SEC31B;HOOK3;MYO18A;SMPD4
prerank,actin filament organization (GO:0007015),0.374596803513381,1.1454967910974896,0.25874867444326616,0.9267254734010487,1.0,22/151,10.17%,BAIAP2L1;POF1B;COBL;NEBL;TMOD3;MYO1H;VILL;EMP2;GSN;MPRIP;TMOD2;MCU;CORO7;LMOD3;ENAH;AVIL;DMTN;CDC42;MYO5A;GAS2L1;MYO1C;ABI1
prerank,positive regulation of JNK cascade (GO:0046330),0.4045153732720252,1.1454371449903022,0.28588098016336055,0.9258335688134375,1.0,6/70,4.38%,WNT16;MAP3K5;EDA2R;CCN2;PTK2B;SH3RF2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3730085197019784,1.1453208813549534,0.225635593220339,0.9251437554868921,1.0,37/158,15.95%,PRKCB;LPAR1;EDA2R;AKAP13;IKBKE;MAVS;TRIM25;MTDH;TFG;SLC20A1;MUL1;CC2D1A;WLS;TRIM21;TAB3;TNFRSF10B;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;CHUK;GAPDH;GPR89A;PLK2;IKBKG;RNF31;FLNA;UBE2N;CCDC22
prerank,secretory granule organization (GO:0033363),-0.5017804192196939,-1.145292317164224,0.32051282051282054,0.7084925903490907,1.0,4/10,10.86%,ABCA1;LYST;DTNBP1;VPS33B
prerank,negative regulation of ossification (GO:0030279),0.475790741884726,1.1446219702657352,0.3142857142857143,0.9263557039928779,1.0,7/23,14.10%,SMAD6;PTK2B;SOX9;SRGN;TRPM4;MEF2C;SFRP1
prerank,histone H3-K9 demethylation (GO:0033169),0.5586725593624826,1.1445034954070998,0.33772652388797364,0.9257156156787677,1.0,5/11,16.83%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,regulation of lipid metabolic process (GO:0019216),0.3879165941429185,1.1444505530617857,0.264472190692395,0.9248116648410819,1.0,21/88,12.28%,FDFT1;SREBF2;RORC;CAV1;DHCR7;FDPS;HMGCR;PMVK;RUBCNL;CYP51A1;ELOVL6;NFYC;HDAC3;NCOR1;CERS2;ACACA;GPAM;MBOAT7;IRS2;FASN;SP1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3632849668822329,1.1443627766657734,0.25241675617615467,0.9240058832460807,1.0,47/166,20.72%,SORBS1;CLU;KLF4;PPARGC1A;LDLR;CCL5;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;DDAH2;UPF3A;EIF6;NNMT;CHP1;TLR6;ZNF205;TLR4;STARD4;IRS2;POLDIP3;SP1;PTPN2;CPEB3;PLXNB2;FXR1;MYC;UPF3B;PYM1;DHX9;HSP90AA1;PCNA;EEF2;DDB1;PRMT1;ASS1;CDH3;PARK7;YTHDF3;PRKD2;GPLD1;KLF2;SREBF1;SOX4;PAOX;ZCCHC4
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3943353650985983,1.1440944297443085,0.2777142857142857,0.9238597730241199,1.0,16/84,19.73%,FZR1;PSMD11;PSMD4;PSMF1;FBXO5;FBXO31;PSMD7;PSMB5;ANAPC4;CDK2;RPS27A;UBC;PSMD1;PSMC4;PSMD8;RB1
prerank,supramolecular fiber organization (GO:0097435),0.358942504604038,1.1439861431867366,0.18724696356275303,0.9231551195986298,1.0,40/333,10.70%,ITGB4;FGF13;PGM5;ADAMTS14;COL23A1;TNXB;COL25A1;POF1B;TSPAN5;LAMC2;COL4A3;COL4A4;VIM;TMOD3;MYO1H;ADAM10;EMP2;GSN;COL5A2;MPRIP;TMOD2;KIF2A;CORO7;COL6A1;LMOD3;COL6A3;AVIL;PXDN;CLIP4;TGFB2;PLK3;CDC42;CHP1;MYO5A;HDGFL3;HOOK1;MYO1C;KLHL24;GGA1;PLEC
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5605026279844874,1.1439102154280105,0.3212520593080725,0.9223263830572348,1.0,3/10,14.02%,KLF4;MAPK7;TLE5
prerank,peptidyl-asparagine modification (GO:0018196),0.44996869317905624,1.1435016611485884,0.2829931972789116,0.9226112857727581,1.0,10/31,17.61%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;DPM2;ALG5;UBE2J1;RPN2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3144391785408328,-1.143415965688046,0.24242424242424243,0.7118614302795137,1.0,15/47,11.92%,LEF1;ENG;WNT4;HIF1A;WNT5A;TBX3;NOTCH1;TGFB1;ROCK1;TASOR;HEYL;LOXL3;NOTCH4;DLG5;HMGA2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.40355572894650577,1.1432128607043412,0.2775800711743772,0.9225065901317443,1.0,17/65,15.24%,EGLN3;NDRG1;CPEB2;PMAIP1;EGLN2;BAD;TWIST1;CARD16;TIGAR;AQP1;HYOU1;NPEPPS;MYC;SFRP1;BNIP3L;LMNA;MDM2
prerank,central nervous system myelination (GO:0022010),0.5548484922713068,1.1431672456317936,0.31900826446280994,0.9215711374329101,1.0,1/11,0.40%,CLU
prerank,positive regulation of cell adhesion (GO:0045785),-0.284239542515383,-1.143119089062785,0.22602739726027396,0.7109238244456605,1.0,18/74,15.07%,FRMD5;PTPRJ;CD47;TGM2;CXCL12;NDNF;MEGF10;JAK2;VIT;NCKAP1L;RSU1;PPP3CA;HYAL1;RET;FBLN2;ADAM9;ITGAV;TFE3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5126553225498856,1.14257930617812,0.3226788432267884,0.922394360353426,1.0,3/15,6.81%,NCOA3;SULT2B1;BMP4
prerank,regulation of anoikis (GO:2000209),-0.39627625993262583,-1.1424329388541505,0.26453488372093026,0.7109982975190825,1.0,5/19,6.45%,PTK2;TLE1;NOTCH1;SIK1;BCL2
prerank,cellular response to hypoxia (GO:0071456),0.37904878807482995,1.1421350212604042,0.2543859649122807,0.9228751069338603,1.0,32/126,18.10%,EGLN3;NDRG1;CPEB2;EP300;PMAIP1;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;BAD;PLK3;RBX1;TWIST1;CARD16;TIGAR;PSMD7;AQP1;HYOU1;PSMB5;NPEPPS;MYC;SFRP1;BNIP3L;LMNA;MDM2;RPS27A;UBC;STUB1;PSMD1;PSMC4
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5277989226940764,1.1421126935707424,0.34493192133131617,0.9218897742290445,1.0,6/14,15.67%,EMP2;LIMS2;TIMP1;DMTN;ITGB1BP1;FLNA
prerank,organelle fusion (GO:0048284),0.46847859351164944,1.1419705304001273,0.31759656652360513,0.9213334532735722,1.0,10/22,21.31%,CHCHD3;AFG3L2;MIEF2;THG1L;VPS11;OPA1;VPS18;STX4;SPG7;MIEF1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46399713295686973,1.1418318881420277,0.30099857346647646,0.9207521274889824,1.0,6/27,16.57%,MAP3K8;MAP3K5;CHUK;IKBKG;RPS27A;UBC
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.45381158168288194,1.141752161838751,0.296987087517934,0.9199552593877095,1.0,12/30,22.72%,SREBF2;FZD5;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;FBXW7;ARIH2;MICALL2
prerank,oligodendrocyte development (GO:0014003),-0.4177119435529968,-1.1417126728271265,0.2853107344632768,0.7112683636828666,1.0,6/15,15.62%,EIF2B3;PLP1;TPPP;CNTNAP1;B4GALT5;MYRF
prerank,excitatory postsynaptic potential (GO:0060079),-0.39659358866656397,-1.1409957401803883,0.27906976744186046,0.7115847126012204,1.0,6/19,14.93%,GRID2;GRIN2A;GRIN2B;LRRK2;DRD2;MPP2
prerank,negative regulation of DNA recombination (GO:0045910),0.4225730975106261,1.1409195937958396,0.30779054916985954,0.9215875977681576,1.0,8/43,9.56%,DAXX;POLR2H;SHLD2;POLR2A;PARP3;ATRX;KLHL15;RIF1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.44913820940056537,1.1407850646273914,0.30066225165562915,0.9209692578636162,1.0,14/30,20.25%,DDX5;EP300;KDM4C;SMARCA4;NCOR1;SFRP1;FOXP1;NCOR2;KDM1A;HDAC6;H3-3A;PARK7;ZBTB7A;PRMT2
prerank,regulation of exosomal secretion (GO:1903541),0.49847662588315944,1.1406072345094955,0.3143712574850299,0.9204888378090794,1.0,9/19,18.00%,SDC4;RAB7A;ATP9A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,regulation of AMPA receptor activity (GO:2000311),-0.36568084507863496,-1.1405824982470107,0.2608695652173913,0.7109745200375454,1.0,6/25,12.76%,SHANK3;SHISA6;NLGN1;CACNG8;SHISA9;NLGN3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.46488394055367,1.140076054475374,0.2971014492753623,0.9212241571209762,1.0,4/25,5.61%,LIMK2;KANK1;CDK10;CAPZB
prerank,regulation of monocyte chemotaxis (GO:0090025),0.47327199744676335,1.1396622146358446,0.31358381502890176,0.9215355986100211,1.0,6/24,12.24%,CCL5;NBL1;MOSPD2;DUSP1;CREB3;ANO6
prerank,positive regulation of cellular process (GO:0048522),0.35480573559675116,1.1395153884733304,0.16016016016016016,0.9209994937101339,1.0,84/565,12.15%,FN1;DPP4;FGFR1;CRLF1;PRKAA2;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;EPHA4;PDGFC;EFNB2;GRK5;ADAM10;HPN;EMP2;CCN2;NUPR1;IL15;ZC3H12A;CAV1;PDF;CELF1;CD81;PRR7;PTGFR;TNFSF13;PTK2B;GDNF;NOP2;PPP1R13L;HDAC4;BMP5;CLCF1;GCNT2;TIMP1;EPO;CIAO1;DOT1L;NACC1;CDK4;RPS4X;NSMCE4A;FOXM1;KRAS;SOX9;HCFC1;SHC1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TRIM21;TGFB2;ZFHX3;ROMO1;FGF22;MAZ;CDC42;FBXO5;SSR1;IL7R;LBP;PTPN6;MTLN;CAPNS1;CCND1;SRPK2;HP;HPR;KDM4C;TLR4;TBRG4;TRPM4;ANKRD17;ACACA;FCER1G;IRS2;FASN;EIF4G2;TGFBR2
prerank,regulation of neuroinflammatory response (GO:0150077),0.4756852471141107,1.139439592447008,0.3127629733520337,0.9202030352416729,1.0,3/19,2.39%,MMP9;CD200;NUPR1
prerank,amino sugar biosynthetic process (GO:0046349),0.5412359118297595,1.139259705143642,0.3293515358361775,0.919785035292751,1.0,6/12,27.45%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5150522273371584,1.1387917276417343,0.3163751987281399,0.9203825320449179,1.0,6/14,16.86%,IMPDH2;ADK;PAICS;GMPS;GART;ADSS2
prerank,cardiac muscle cell action potential (GO:0086001),-0.3475270899184263,-1.138525267136518,0.23684210526315788,0.7150008285948074,1.0,10/30,15.43%,CACNA1C;DMD;SLC8A1;ATP1B1;KCNJ2;CACNA1G;FGF12;HCN2;SCN1A;SCN1B
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3955277302448155,-1.138178126091894,0.28125,0.7124996205562856,1.0,5/20,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.3955277302448155,-1.138178126091894,0.28125,0.7124996205562856,1.0,5/20,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,toxin transport (GO:1901998),0.5463096233659359,1.1379059128259756,0.3247588424437299,0.9223644732846744,1.0,2/10,5.63%,ADAM10;ANTXR1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.369021682182404,1.1376687407470019,0.24066390041493776,0.9221032556967668,1.0,48/199,15.61%,PLCL2;LAMA4;HPN;SMAD6;IL15;GDF15;WNT11;TWSG1;FOXC2;PPP2CA;DUSP10;BMP5;TIMP1;HMGCR;PROCR;RAB11FIP3;IP6K1;OVOL2;DOCK7;SPRED3;SOX9;RHEB;BMP4;KLF7;PARP3;PLCL1;CYP51A1;SRGN;LGR4;ARRDC3;GRHL2;FOXP3;NFIB;PPP1R11;RAB11FIP5;TLR4;LDLRAD4;GATA3;GSK3A;MEF2C;ATP2B4;SFRP1;GSK3B;FLCN;SYT11;ARHGDIB;ABHD6;RAB11FIP1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4234647399555824,-1.1375909995058398,0.2877094972067039,0.7123461779225941,1.0,5/16,8.01%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3831076685998364,1.1375170778928905,0.2759815242494226,0.9215498837322684,1.0,9/87,8.00%,FGFR1;CD44;CCL5;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,keratan sulfate catabolic process (GO:0042340),0.5438033657908398,1.1374798928502992,0.3072,0.9206457412176643,1.0,4/11,11.11%,HEXA;PRELP;GLB1;HEXB
prerank,cellular response to retinoic acid (GO:0071300),0.4179062386955752,1.137444528235826,0.2874015748031496,0.9197301611416135,1.0,10/42,12.43%,PTK7;WNT11;PTK2B;WNT6;CREB1;SOX9;WNT5B;AQP1;EPHA3;WNT3
prerank,positive regulation of immune response (GO:0050778),0.4008958890033883,1.1365180406624107,0.28672985781990523,0.9217600048809701,1.0,13/64,17.90%,CCL5;SASH3;IL15;CD81;TGFB2;POLR3B;NMI;POLR3C;DHX9;ITGB2;POLR3G;EIF2AK4;STX4
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5004576427680056,1.1362201121930093,0.3143712574850299,0.9217116645699418,1.0,8/16,22.89%,SLC25A1;ACACA;SCD5;FASN;PPT2;ACLY;GCDH;MLYCD
prerank,positive regulation of vasculature development (GO:1904018),0.3861232475148879,1.1360442761991867,0.26644370122630995,0.92123910226837,1.0,16/94,11.20%,PRKCB;ADAM12;ITGB8;ANXA3;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;AGGF1;MYDGF;VEGFB;EMC10;TWIST1;AQP1;RAPGEF3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.42898848535660883,1.1359360114581907,0.3165374677002584,0.9205416969840013,1.0,14/42,20.28%,TRIM25;USP10;REV1;POLK;PCLAF;RPA3;POLH;POLD2;PCNA;RPS27A;UBC;RFC1;CDKN2D;POLN
prerank,regulation of response to biotic stimulus (GO:0002831),0.4589537205531347,1.1356242952155788,0.2971506105834464,0.9205440404866414,1.0,1/28,0.15%,CD55
prerank,regulation of proteolysis (GO:0030162),0.41278384885353053,1.1355689336505614,0.293398533007335,0.91971061697663,1.0,6/48,7.49%,CYFIP2;OGT;CAV1;LTBP4;PERP;BAD
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.38895749661691703,-1.1354055021524014,0.2802547770700637,0.7166658212433445,1.0,4/20,7.34%,PID1;DAB2;TGFB1;PKDCC
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.36986021938301894,-1.1352073517667163,0.23547400611620795,0.7154633943967358,1.0,5/24,13.29%,PLA2G4A;PNPLA8;SERAC1;CDS2;ABCA3
prerank,positive regulation of histone acetylation (GO:0035066),0.4755388646737019,1.134867722369189,0.34146341463414637,0.9210357857437205,1.0,5/23,9.09%,PPARGC1A;SMARCB1;PIH1D1;FOXP3;BRD7
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5308066774567668,1.1347037351177685,0.33114754098360655,0.9205443594766598,1.0,3/11,7.92%,TIMM10;AGK;ROMO1
prerank,cellular response to copper ion (GO:0071280),0.48406044535094583,1.1341681228611709,0.3215434083601286,0.9212917914013092,1.0,2/16,11.06%,DAXX;AQP1
prerank,polarized epithelial cell differentiation (GO:0030859),0.5231064204453185,1.1341315667730865,0.3246753246753247,0.920367945829576,1.0,5/13,11.76%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3912209219929982,1.1337538596085537,0.27450980392156865,0.9206301163019411,1.0,25/85,15.34%,NOTCH2;KANK1;OGT;AKAP13;EPS8L2;NGF;KANK2;EPO;DENND3;RASAL3;FOXM1;ARHGEF18;SHC1;TGFB2;BCR;OPHN1;RAF1;DLC1;IRS2;RABL3;MAPKAP1;SYNGAP1;FLCN;RAPGEF1;ARHGDIB
prerank,response to nitric oxide (GO:0071731),-0.45013336160898076,-1.1335623456181552,0.306282722513089,0.7182407009412621,1.0,5/13,15.59%,GUCY1B1;FOXO1;EGLN1;TXN;MTR
prerank,positive regulation of neuron differentiation (GO:0045666),-0.32609815107328405,-1.1335146052801395,0.248868778280543,0.7166382089084937,1.0,14/40,17.95%,TCF4;ZEB1;VWC2;BRINP3;NRCAM;HEYL;IMPACT;BEND6;ARHGEF2;MMD;GPRC5B;BRINP2;SOX11;HOXD3
prerank,positive regulation of isotype switching (GO:0045830),0.5111005358302171,1.1327446644862655,0.3153846153846154,0.9229854188107873,1.0,4/15,9.56%,TNFSF13;CLCF1;SHLD2;RIF1
prerank,regulation of microglial cell activation (GO:1903978),0.5092572101578737,1.1324688117326334,0.30618401206636503,0.9228421992464733,1.0,1/15,1.18%,LDLR
prerank,skeletal muscle organ development (GO:0060538),0.45296086034049193,1.1323535983815805,0.3237410071942446,0.922172886473096,1.0,7/26,13.83%,CAV1;STRA6;CSRP3;LARGE1;SIX1;FXR1;MEF2C
prerank,mammary gland epithelium development (GO:0061180),-0.42764896924396584,-1.1323528674466925,0.2900552486187845,0.7180810469231822,1.0,4/14,8.78%,WNT4;JAK2;ID2;ERBB4
prerank,embryonic organ morphogenesis (GO:0048562),-0.32595208217684696,-1.1322844061134607,0.2465753424657534,0.7165378800080864,1.0,16/42,17.95%,FBN1;MFAP5;PDGFRA;FBN2;DSCAML1;SOX17;ID2;FGFR2;MEGF8;RBP4;TBX1;NIPBL;RYR2;SOX11;HOXC4;HOXD3
prerank,cellular response to calcium ion (GO:0071277),-0.28879508818105937,-1.1322757699344557,0.192090395480226,0.7148585078822123,1.0,13/67,7.83%,CPNE8;ADGRV1;WNT5A;CAMK2D;RASGRP2;CPNE4;PKD2;SYT9;PRKAA1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,translesion synthesis (GO:0019985),0.42782868271317087,1.1321415437817364,0.3204633204633205,0.921836464586701,1.0,15/42,21.92%,TRIM25;USP10;REV1;POLK;PCLAF;NPLOC4;RPA3;POLH;POLD2;PCNA;RPS27A;UBC;RFC1;POLN;RCHY1
prerank,lung development (GO:0030324),-0.3374243167933648,-1.1312933290089313,0.2757352941176471,0.7157610474844651,1.0,12/33,16.49%,ERRFI1;GLI2;FGF2;RCN3;FGFR2;LOXL3;NPHP3;ZIC3;RBP4;ABCA3;FGF9;SOX11
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.38696293382596525,-1.1312460235812323,0.26688102893890675,0.7142175097576617,1.0,3/20,7.31%,PID1;DAB2;TGFB1
prerank,cellular response to lipid (GO:0071396),0.3625892247039977,1.1311297106190725,0.24583333333333332,0.9241678338273411,1.0,32/191,14.10%,CFTR;ADTRP;NCOA3;VIM;RORC;PTK7;ZC3H12A;WNT11;ATP1A2;FAM210B;PTK2B;WNT6;INSIG1;LCOR;CREB1;SOX9;MSN;TRIM41;ADCY6;WNT5B;LBP;CARD16;ADAM15;AQP1;TLR4;EPHA3;RHOA;WNT3;SBNO2;IRAK1;MEF2C;SFRP1
prerank,embryonic limb morphogenesis (GO:0030326),0.4372008036521293,1.1311238392168885,0.3092369477911647,0.9231586887211701,1.0,6/34,10.34%,MBNL1;GLI3;AFF3;RARG;TGFB2;TWIST1
prerank,positive regulation of T cell migration (GO:2000406),0.4799313570946205,1.13099470953739,0.34057971014492755,0.9225690608890156,1.0,8/20,19.54%,CCL5;ADAM10;STK39;OXSR1;RHOA;WNK1;APP;ADAM17
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45512718320864964,1.130762387963195,0.3220338983050847,0.9222908784529199,1.0,7/28,12.67%,DAXX;NGF;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4827665846589972,1.1306383616908318,0.32215743440233235,0.9216244151560976,1.0,5/20,12.86%,SREBF2;TTC39B;ACADL;ABCA2;LPCAT3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.49458277052512295,1.1305161719395824,0.3170731707317073,0.9199210131080546,1.0,4/16,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.49458277052512295,1.1305161719395824,0.3170731707317073,0.9199210131080546,1.0,4/16,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.44652749097062217,1.1304802752825218,0.30991735537190085,0.9190239484692063,1.0,10/29,16.89%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;RPS27A;UBC;UBE2D3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.443429119257791,-1.1304444871333506,0.3165266106442577,0.7147596176012796,1.0,4/13,11.82%,HIF1A;SYBU;NEFL;LRPPRC
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3904236240848945,1.1303821976841708,0.2857142857142857,0.9183443245484092,1.0,18/84,15.98%,MBNL1;CELF2;DDX5;CELF1;RBFOX2;SON;LARP7;RBM8A;SRPK2;SRRM4;SRSF7;SRPK1;FXR1;DAZAP1;RNPS1;SRSF9;MBNL2;MAGOH
prerank,regulation of interferon-beta production (GO:0032648),0.41566775843323633,1.1302132242635792,0.30973451327433627,0.9178726841953768,1.0,18/46,24.56%,MAVS;RELB;PPM1B;IRF3;POLR3B;TLR4;POLR3C;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;FLOT1;YY1;POLR3F;SIRPA;POLR3D
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4977233947779669,1.1299578484408728,0.319634703196347,0.9177513080190284,1.0,6/16,13.48%,GDNF;FOXD1;BMP4;SIX1;NPNT;MYC
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.4436985939201956,-1.129904262047597,0.3095890410958904,0.7146024051111884,1.0,6/13,22.02%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.516870097997073,1.12982248580069,0.33,0.917184329459845,1.0,4/13,12.15%,GLI3;ZBTB7B;NKAP;TGFBR2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4905183913552896,1.129602381959341,0.3257918552036199,0.9168864744042351,1.0,7/17,22.91%,EMC9;EMC10;GET4;EMC6;EMC2;SGTA;MMGT1
prerank,regulation of acute inflammatory response (GO:0002673),-0.39792030132239575,-1.1293797017027758,0.29793510324483774,0.7144627738895084,1.0,3/18,12.36%,OSMR;PTGES;IL6ST
prerank,positive regulation of catabolic process (GO:0009896),0.3989963102986019,1.129141648929098,0.28214285714285714,0.9174464242105882,1.0,14/65,19.53%,FZR1;WWP2;EGLN2;GPC3;RAB7A;GSK3A;GSK3B;NEDD4;PLK2;DDB1;NSF;RNF41;IDE;ASB5
prerank,response to interleukin-4 (GO:0070670),-0.4817636752908483,-1.128973186405768,0.32653061224489793,0.713882297920736,1.0,1/10,0.48%,LEF1
prerank,ribosomal large subunit assembly (GO:0000027),0.4656122929431738,1.1278243086046993,0.32152974504249293,0.9207074470250053,1.0,3/24,4.65%,NLE1;NOP2;PPAN
prerank,cell cycle checkpoint signaling (GO:0000075),0.5236828915371277,1.1274047602353614,0.3366013071895425,0.9210590362965264,1.0,7/12,21.19%,NABP2;ZW10;PLK2;ZWINT;WEE1;NABP1;CHFR
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4036906896571415,1.1273455434586868,0.29397590361445786,0.9202627760939694,1.0,20/64,17.85%,CDH13;UTRN;EMP2;CDK6;PTK2B;DAPK3;EFNA5;PTPRA;CASK;ADAM15;ACTG1;EPHA3;RHOA;RASA1;SFRP1;GSK3B;VCL;SLC9A1;DUSP3;PEAK1
prerank,cellular response to light stimulus (GO:0071482),0.3976695622523887,1.1272409396210425,0.27427184466019416,0.919573303414568,1.0,23/66,24.77%,OPN1SW;EP300;POLK;SDE2;AQP1;CNGB1;MYC;PDE6B;NEDD4;USP28;PCNA;ATR;KDM1A;EIF2AK4;TRIAP1;COPS9;ERCC4;RHBDD1;YY1;RPL26;CDC25A;EIF2S1;PTPRK
prerank,organic substance transport (GO:0071702),0.37410842142355366,1.127149576134391,0.2717391304347826,0.9188885767385248,1.0,14/120,11.50%,CUBN;SLCO2A1;SCAMP5;ABCD1;AMN;RAMP1;SLC48A1;RAB7A;ARRDC3;NDC1;ARL6IP5;TOM1;ABCA2;SCAMP2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5141350611951613,1.126464893404054,0.3146747352496218,0.920164581831243,1.0,2/13,3.24%,SULT1A1;SULT2B1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4841295471752049,1.1255163956512801,0.33081570996978854,0.9223035672405718,1.0,5/17,10.36%,COX5A;COX8A;COX7A2L;COX5B;AFG1L
prerank,positive regulation of type I interferon production (GO:0032481),0.3900821811522007,1.1253573477205754,0.29136690647482016,0.9218035782383227,1.0,23/73,20.56%,MAVS;EP300;POLR2H;IRF3;MRE11;POLR3B;POLR1C;TLR4;POLR3C;IRAK1;CHUK;GAPDH;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;POLR3H;POLR2E;NFKB2;FLOT1;ZBP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4546584948289952,1.1250796139973045,0.30800542740841247,0.9216935242261765,1.0,5/28,11.14%,CLU;NUPR1;DDRGK1;ATP5IF1;OSBPL7
prerank,embryonic hemopoiesis (GO:0035162),-0.44611923891062616,-1.1246343352352681,0.32954545454545453,0.724414298258079,1.0,8/12,26.64%,KITLG;KDR;SH2B3;KIT;FLT3LG;TAL1;THOC5;ATF4
prerank,positive regulation of receptor internalization (GO:0002092),0.4761180194285535,1.1246302869627833,0.329004329004329,0.9221679685372752,1.0,2/22,2.29%,ANGPT1;MAGI2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3749142316458599,-1.1245716225475118,0.277602523659306,0.7228936847873143,1.0,7/22,10.12%,GHR;NOTCH1;CYP1B1;ERBB4;OCIAD1;MGAT5;KIT
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5044709156664038,1.1245485486059659,0.3375,0.9214558580875966,1.0,4/15,11.16%,NLRP2B;PYDC1;TLR6;TLR4
prerank,negative regulation of organelle assembly (GO:1902116),0.4357058041330473,1.1242660581605706,0.31886024423337855,0.9213357995143587,1.0,12/35,20.16%,LIMK2;NUPR1;CDK10;TMEM39A;CHMP4A;CHMP4B;SMCR8;TESK1;FEZ1;TRIM37;NBDY;PHF23
prerank,apical protein localization (GO:0045176),0.534547418014361,1.1239595807067668,0.35062893081761004,0.9213414828553754,1.0,3/10,11.05%,CELSR1;ACTB;INSC
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4323052733888719,-1.123839347390243,0.3274336283185841,0.7232171838523306,1.0,2/13,0.18%,PLCB1;IGF1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.39752329347025805,-1.1238079818237492,0.3,0.7216446940891295,1.0,6/18,7.61%,RDX;RIC1;DAB2IP;DACT1;VPS35;AMER1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.4331439896863101,1.1237758283695982,0.29722589167767505,0.9209218289493328,1.0,13/33,23.93%,MAP3K5;NFE2L2;MAPK7;AQP1;TRPM2;ABL1;SIGMAR1;HDAC6;PARK7;RNF112;SIRPA;RHOB;IL6
prerank,cholesterol homeostasis (GO:0042632),0.3904652248875001,1.1232735947143688,0.3031400966183575,0.9215454478189976,1.0,12/64,11.07%,LDLR;SOAT1;CAV1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.431831751648153,1.1227088111135917,0.3169761273209549,0.9222970798520296,1.0,12/35,19.56%,FEN1;MUTYH;POLG;MBD4;RPA3;POLD2;PCNA;LIG3;NEIL1;PARG;RFC1;PNKP
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4628258622371874,-1.1226167047647968,0.3213367609254499,0.7233023557211035,1.0,6/10,32.05%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.36308733420742906,1.122117002444687,0.28152173913043477,0.9231624299066719,1.0,21/138,12.36%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;RARG;POLR2A;RXRB;MAZ;NR2C1;HDAC3;NCOR1;DR1;GTF2E1;TAF5
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4661560226259103,-1.1221029516622916,0.3160621761658031,0.7230524522164757,1.0,3/10,8.18%,KDR;IL33;JAK2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3777440208457263,-1.1214286204435795,0.30944625407166126,0.7232191453297863,1.0,5/23,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,regulation of cell motility (GO:2000145),0.37228647785143687,1.1213169093612203,0.3003264417845484,0.9247278441874525,1.0,30/121,17.09%,PRAG1;PLXNB1;PLXNA2;ARHGAP18;CDK6;KIF2A;SPINT2;DIAPH1;LMO4;SGK3;DAPK3;MGAT3;FBLN1;CCDC125;ERBB3;SRCIN1;FGF22;PARD6B;RAF1;TWIST1;RHOA;GATA3;PLXNB2;MEMO1;LMNA;FLNA;PLXNA3;CRK;ABL1;TBCCD1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.34963202978769015,-1.1211261068547957,0.2893772893772894,0.7223606636736358,1.0,4/29,9.11%,ENG;NOTCH1;TGFB1;FGFR2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4007266423931714,1.1208435405877923,0.3002450980392157,0.9252360182881492,1.0,14/57,15.12%,PPARGC1A;MMP9;BBC3;PMAIP1;MCU;MUL1;BAD;MIEF2;ZNF205;HRK;GSK3A;GSK3B;DNM1L;DDHD1
prerank,regulation of axonogenesis (GO:0050770),0.40451980749797956,1.120647088227078,0.295,0.9248723716188263,1.0,8/51,4.77%,RTN4R;PLXNB1;EPHA4;PLXNA2;SIPA1L1;NGF;TIAM2;MAP6
prerank,myoblast differentiation (GO:0045445),0.5053547629163773,1.120318599148,0.34169278996865204,0.9249018703995627,1.0,2/14,2.31%,MBNL1;DDX5
prerank,triglyceride biosynthetic process (GO:0019432),0.48012195221407183,1.1203082397777406,0.340393343419062,0.9239466552900009,1.0,7/18,24.24%,DGAT1;MOGAT3;MOGAT1;GPAM;PCK2;GPAT3;LPIN1
prerank,oligodendrocyte differentiation (GO:0048709),-0.4024772179300932,-1.1199340209165396,0.3032258064516129,0.7239026404957751,1.0,7/19,15.62%,SLC8A3;SOX13;EIF2B3;PTPRZ1;TPPP;SOX6;MYRF
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4495066105908926,1.119601301109521,0.32670454545454547,0.9251898674185451,1.0,4/25,9.21%,EPHA4;PSMF1;PML;OPHN1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.46306347291719924,1.1195420592289067,0.3235724743777452,0.9244070300658087,1.0,4/22,6.02%,KANK1;GSN;SSH3;TWF1
prerank,tryptophan metabolic process (GO:0006568),0.5305406567110739,1.1194604341272976,0.342809364548495,0.9236618592032558,1.0,4/11,24.55%,TDO2;HAAO;KYAT1;KMO
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4281794166967291,-1.1193973619059139,0.32360742705570295,0.7237122609310818,1.0,5/13,15.15%,GRIK2;SLC4A10;SHISA6;SHISA9;CLN3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4546423864645698,-1.1193871004444211,0.33753148614609574,0.7220657691621832,1.0,4/11,9.56%,NOVA1;NOVA2;ZNF445;PCBP3
prerank,cartilage development (GO:0051216),0.4146125580501471,1.1192742928443131,0.308953341740227,0.9232419210831678,1.0,9/49,10.02%,CD44;ITGB8;ZBTB16;SOX9;DDRGK1;BMP4;WNT5B;PKD1;NFIB
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.44872293779733297,1.1190339270121263,0.3154269972451791,0.9229676224159211,1.0,5/32,9.98%,GALP;PGLYRP3;ANG;ROMO1;RNASE3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.44366882843724664,1.1190159502989554,0.34383561643835614,0.9220405979003942,1.0,4/31,2.48%,PDLIM5;NGEF;EPHA4;SIPA1L1
prerank,regulation of defense response to virus by host (GO:0050691),0.4455288638130057,1.1187811860648693,0.3178082191780822,0.9218303589834007,1.0,8/30,17.04%,ZC3H12A;MAVS;TRIM44;TARBP2;MUL1;DHX9;HSP90AA1;EIF2AK4
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5213716844209346,1.1185434004431605,0.3333333333333333,0.9216142463528257,1.0,5/13,16.53%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR
prerank,negative regulation of TOR signaling (GO:0032007),0.4383791359979432,1.1178928316555845,0.32176234979973295,0.9227252572792174,1.0,5/36,5.70%,RNF152;PRKAA2;SESN2;SH3BP4;TSC2
prerank,regulation of interferon-gamma production (GO:0032649),-0.2883979813535669,-1.117879120432123,0.2111801242236025,0.7244424408260528,1.0,9/71,8.35%,IL1R1;CD47;PDE4D;GAS6;AXL;SLC7A5;LGALS9;IL18;PDE4B
prerank,chromatin remodeling (GO:0006338),0.37213363055791543,1.1178151393319933,0.2978723404255319,0.9219779194754829,1.0,33/100,19.73%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;SOX9;HCFC1;KDM5C;ATRX;FOXP3;ACTB;KDM4C;SMARCA4;DR1;SRCAP;KDM6A;ACTL6B;MPND;MYSM1;BAZ2B;CHD3;SMARCD2;MYC;GATAD2B;SMARCC1;GATAD1;BRDT;ARID1B;PBRM1;ZBTB7A;RB1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.401509906388617,-1.117660620411579,0.3274336283185841,0.7234047632873144,1.0,8/16,21.19%,SNCAIP;MCTP2;CAMK2A;MCTP1;KCNMB4;CPLX2;FMR1;RIMS1
prerank,actin crosslink formation (GO:0051764),0.5161689162419942,1.1176111367688237,0.33986928104575165,0.9216216553773726,1.0,1/12,0.43%,BAIAP2L1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4323791364607201,1.117575537580298,0.3257372654155496,0.9207575014047239,1.0,9/33,11.61%,KLF4;TJP1;GLUL;ALOX5;PKM;JMJD8;SYNJ2BP;S100A1;JAK1
prerank,cell differentiation in spinal cord (GO:0021515),-0.46467142782530935,-1.1168038452766966,0.3341772151898734,0.7241788270269923,1.0,3/10,16.01%,SOX13;SOX6;MDGA2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.47411170726462837,1.1162349341155926,0.3328335832083958,0.924019728195861,1.0,6/19,15.32%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4429108582566285,1.1159072588179444,0.32324621733149933,0.9240622171751464,1.0,12/31,22.77%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,response to chemokine (GO:1990868),0.5178569403894883,1.1157665705817748,0.3481717011128776,0.9235369445134086,1.0,7/13,14.45%,ZC3H12A;RIPOR2;DUSP1;STK39;OXSR1;RHOA;WNK1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4472420093217115,-1.1156871086518694,0.3435897435897436,0.725781270264886,1.0,4/12,16.81%,KAT7;TIPIN;WRNIP1;BLM
prerank,regulation of coagulation (GO:0050818),0.5327092106078479,1.1156554219401158,0.3576158940397351,0.9229678687955413,1.0,2/11,5.20%,CAV1;PROCR
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3845065170209068,1.115653730123808,0.31271878646441076,0.9220014685356838,1.0,20/76,18.97%,NLRP2;KLF4;CD200;ZC3H12A;ANXA4;NFKBIA;COMMD7;TRIM21;NLRP2B;CHP1;FOXP3;PYDC1;COMMD6;IRAK1;CHUK;CCDC22;MTURN;TRIM37;OTULIN;CDK5RAP3
prerank,indolalkylamine catabolic process (GO:0046218),0.5358045594912845,1.115338649023085,0.373109243697479,0.9220396420435731,1.0,4/10,24.55%,TDO2;HAAO;KYAT1;KMO
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4402226563196093,1.1151731857980431,0.3177441540577717,0.921597807779258,1.0,10/30,16.89%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;RPS27A;UBC;UBE2D3
prerank,Rac protein signal transduction (GO:0016601),0.4731264413835315,1.1151093778277774,0.33783783783783783,0.9208209877958512,1.0,1/18,0.37%,CDH13
prerank,negative regulation of locomotion (GO:0040013),0.5303257205160986,1.1149234737076181,0.3605015673981191,0.9204738108607124,1.0,7/12,17.81%,SPINT2;FBLN1;CCDC125;PTPN2;GATA3;CRK;DUSP3
prerank,regulation of myoblast fusion (GO:1901739),0.5333205086714989,1.1148533405200176,0.3572621035058431,0.9197454490215855,1.0,2/11,5.14%,EHD1;RIPOR2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.45784246089495545,-1.1146053473150852,0.3111111111111111,0.7271082175187584,1.0,5/10,12.51%,PDE8A;LRRK2;GPR37;RIPK1;TXN
prerank,response to zinc ion (GO:0010043),-0.3616592324897255,-1.1145809988503244,0.2903225806451613,0.725506447916075,1.0,14/25,36.66%,PAM;GLRA1;CRIP1;GLRA2;D2HGDH;SLC30A3;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,negative regulation of cell growth (GO:0030308),0.3687456859314098,1.114430206822616,0.3056768558951965,0.9200967907512808,1.0,28/121,16.36%,FGF13;RTN4R;OSTN;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;MUL1;OSGIN2;TGFB2;PSRC1;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;CAPRIN2;GSK3A;PRDM11;SFRP1;ULK1;FLCN;IP6K2;CCDC85B;FRZB
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4289731649400611,-1.1142320393713645,0.31382978723404253,0.7248970039558567,1.0,8/14,31.83%,THBS1;RGCC;ITGA4;PDCD4;CD40;PRKCI;CCL2;PLCG1
prerank,positive regulation of interferon-beta production (GO:0032728),0.4322492589385399,1.1138560108919169,0.32599724896836313,0.9209569334391318,1.0,12/33,19.48%,MAVS;IRF3;POLR3B;TLR4;POLR3C;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;FLOT1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3482183881993128,1.1135260631667545,0.23076923076923078,0.9209907430215917,1.0,68/351,14.97%,CDH13;ZBTB7C;PTPN14;IGFBP6;KLF4;COL4A3;PLXNB1;CDKN1A;HPN;SMAD6;NIBAN2;CD200;MAGI2;NUPR1;CDK10;CELF1;CDK6;SULT2B1;NGF;KANK2;PTK2B;TNFRSF8;DUSP10;BMP5;PTPRU;S100A11;RARG;SH3BP4;TSC2;FBLN1;SLC16A2;ZBTB17;SOX9;TES;CGREF1;BMP4;TGFB2;ANG;TGFB1I1;SLURP1;ADAMTS1;PML;FOXP3;BRD7;PTPN6;NMI;RAF1;ABI1;SOD2;DLC1;GSDME;WDR6;PTPN2;PDPN;PPM1D;GATA3;MYC;EEF1E1;BTG2;ING4;PINX1;SFRP1;TGFBR3;HRAS;P3H3;FLCN;ITGB1BP1;LMNA
prerank,regulation of cell division (GO:0051302),0.3906473163555922,1.1135135412460477,0.30327868852459017,0.9200695440892956,1.0,21/72,20.47%,NCOA3;MLLT3;KIF13A;ESRRB;RAB11FIP3;BCL2L1;KLHL21;PLK3;AURKC;PRDM15;INSC;KLHL13;MYC;FLCN;PLK2;GIT1;ZFYVE26;TLE6;UVRAG;CSPP1;PIK3R4
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4331765675290805,-1.1131423359664623,0.32904884318766064,0.7265154693446516,1.0,3/12,12.17%,CYP26B1;EZH2;DHRS3
prerank,protein ADP-ribosylation (GO:0006471),-0.3522682529028649,-1.1131355869731985,0.27364864864864863,0.7248938088083415,1.0,6/28,9.01%,ZC3HAV1;PARP12;ART3;PARP14;PARP8;TNKS
prerank,glycolipid metabolic process (GO:0006664),0.41541747306070037,1.1130945155892071,0.33081761006289306,0.9204769048535264,1.0,13/47,14.99%,ST3GAL4;HEXA;SCCPDH;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ST3GAL6;ESYT2;SMPD2;NAGA;ST6GALNAC4
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.518756555471759,1.1128287341426102,0.3446054750402576,0.9202955573711503,1.0,5/12,16.86%,IMPDH2;PAICS;GMPS;GART;ADSS2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4983935981853369,1.112703561274277,0.3751937984496124,0.9197385371787236,1.0,3/15,6.98%,SMOX;TPH2;AANAT
prerank,neural tube development (GO:0021915),-0.4277917498481974,-1.112461356203498,0.33060109289617484,0.725105962496201,1.0,4/15,7.31%,ALDH1A2;PKD2;DACT1;TGFB1
prerank,generation of neurons (GO:0048699),0.35358501789646296,1.1121752175889634,0.27666314677930304,0.9204300648726769,1.0,19/190,9.21%,WNT16;FGF13;FGFR1;CELSR1;WNT1;NRBP2;WNT10A;WNT11;ITM2C;CDK6;WNT6;PTPRD;DOCK7;TGFB2;WNT5B;SIX1;FZD5;ACSL3;OPHN1
prerank,regulation of cellular respiration (GO:0043457),-0.397850236332979,-1.1120975903106716,0.29745042492917845,0.724450436934753,1.0,12/17,42.43%,PRDM16;CBFA2T3;NOA1;SHMT2;PNPT1;TRAP1;IL10RB;IFNLR1;IFNAR1;NOS2;VCP;IL4
prerank,regulation of metal ion transport (GO:0010959),0.49568594014619216,1.1119290275736708,0.33979135618479883,0.9202483002981106,1.0,2/16,2.86%,ANK2;IL16
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.48186975963639495,1.1117248122601848,0.345565749235474,0.9199446891022944,1.0,5/18,14.84%,KANK1;RIPOR2;CCDC125;DLC1;FLCN
prerank,positive regulation of B cell activation (GO:0050871),0.4057129581505746,1.1110425375806365,0.3121098626716604,0.9212535774286235,1.0,5/50,4.72%,NFATC2;SASH3;CD81;CLCF1;SHLD2
prerank,regulation of telomerase activity (GO:0051972),0.41337759434251253,1.1107928218524716,0.3253652058432935,0.9211114994454218,1.0,15/45,22.09%,KLF4;NEK7;NABP2;MAPK15;MAP3K4;GRHL2;MYC;PINX1;HSP90AA1;HMBOX1;PRKCQ;PNKP;ERCC4;PTGES3;MEN1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4155558980242363,1.1107829040292823,0.33,0.9201997384580716,1.0,10/46,8.89%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,protein localization to lysosome (GO:0061462),0.44762640165386913,1.1103238721302677,0.33607681755829905,0.920735141118424,1.0,13/28,23.31%,CD81;SH3BP4;GCC2;RAB7A;KPTN;VPS4A;NEDD4;SNX16;AP3M1;M6PR;SZT2;AP4M1;NCOA4
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.39065764714280427,-1.110236122045351,0.33112582781456956,0.7280967298660945,1.0,6/20,4.54%,CACNA1C;DMD;SLC8A1;CAMK2D;ATP2A2;ATP1B1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4681225754814864,-1.1101627662674343,0.355,0.7267062965875141,1.0,3/10,1.90%,ERRFI1;ENG;ENPP1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.45847474397835963,-1.1093363341572813,0.32323232323232326,0.7274471880529814,1.0,5/11,25.53%,ATP1B1;KCNJ2;KCNIP2;YWHAE;KCNJ3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2550407036879099,-1.1093225655359562,0.20754716981132076,0.7258699886317682,1.0,42/161,16.15%,BICC1;MCC;FZD6;DAB2;IGFBP2;SOX13;WNT5A;DKK3;STK3;ANKRD6;TLE1;TMEM131L;ZNRF3;SHISA6;DAB2IP;HECW1;CHD8;PSMC6;TBX18;JADE1;DACT1;PSMA6;GLI1;APC;AMER1;SOX17;FZD4;LRP6;AXIN2;IGFBP4;NOTUM;SFRP4;INVS;NPHP3;DDIT3;CCDC88C;NKD2;TMEM64;PSME1;PSMB10;APC2;PSMD5
prerank,positive regulation of axonogenesis (GO:0050772),0.41572225360513543,1.109083225451572,0.3157199471598415,0.9237166522306755,1.0,10/43,13.18%,ISLR2;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;ZFYVE27;RHOA;PLXNB2;MAP3K13
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.33981838781986706,-1.1089810147564356,0.2744360902255639,0.7252087712799249,1.0,11/30,28.86%,CD34;LGALS9;CD46;STAT3;HMGB1;HSPD1;NOD2;PYCARD;PIBF1;ISG15;PLCG2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.4406456237918569,-1.1084145271650292,0.33678756476683935,0.7252233896136847,1.0,6/12,35.48%,MAOA;HNMT;DDC;SMS;SLC22A3;SLC29A4
prerank,proteolysis (GO:0006508),0.3509648234457187,1.1082792876628547,0.2797131147540984,0.9253497547911925,1.0,49/252,18.60%,DPP4;CPB1;TMPRSS6;CPA4;CPA3;MMP9;OGT;ADAMTS7;ADAM10;HPN;TINAGL1;ADAM33;DPP7;NAALAD2;CTSZ;KLKB1;CPE;DESI2;DESI1;CAPN2;SRGN;AFG3L2;PITRM1;SDE2;SPCS3;MMP12;RNF123;NAPSA;PSMB5;NPEPPS;PGPEP1;TRABD2B;TASP1;PGPEP1L;MDM2;SPPL2B;CTSH;HM13;BACE1;ATG4B;PRTN3;FBXL2;SPPL3;USP25;PSMC4;SPPL2A;SUFU;SPG7;CAPN15
prerank,establishment of mitotic spindle orientation (GO:0000132),0.46480467710758605,1.1082359524450653,0.36623748211731044,0.9245291607170987,1.0,7/23,18.68%,NDEL1;NSFL1C;PAFAH1B1;ZW10;INSC;NUMA1;MISP
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5070846422995015,1.1079778557862348,0.37201907790143085,0.924458962095212,1.0,6/13,17.95%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3;SEMA3A
prerank,keratan sulfate metabolic process (GO:0042339),0.44042639501563713,1.107838214905225,0.3319672131147541,0.9239564204871766,1.0,7/31,12.33%,ST3GAL4;HEXA;B4GAT1;PRELP;GLB1;HEXB;ST3GAL6
prerank,response to insulin (GO:0032868),0.37952704296072926,1.107570050961416,0.32616487455197135,0.9239052493988664,1.0,10/80,7.25%,SORBS1;OGT;CPEB2;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ZBTB7B;EIF6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3753563830477981,-1.1072858680337005,0.3151515151515151,0.7266885583742028,1.0,4/19,4.00%,PARD3B;DLG2;ERBIN;LRRC7
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.38842888333598236,1.1071057419600319,0.3213457076566125,0.9244218679469646,1.0,24/72,19.89%,ZC3H12A;FEN1;MRE11;RBX1;POLK;XRN2;DNASE1L2;ERCC5;RPA3;DNASE1L1;REXO4;DCP1A;POLD2;PCNA;FAN1;DDB1;RPS27A;UBC;ERCC2;RNASE4;RAD50;RFC1;DXO;ERCC4
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3441694181035302,-1.1063114209942857,0.26717557251908397,0.7278134123962271,1.0,7/31,9.11%,CDH2;BOC;MEGF10;CTNNA2;IGF2;ID2;FGFR2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3201153924574711,-1.105843939835705,0.3,0.7274555517494077,1.0,13/36,15.44%,PLCB1;LEF1;FZD6;WNT5A;NFATC1;FZD4;PPP3R1;PPP3CB;TNRC6A;PPP3CA;CAMK2A;AGO1;GNB1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4972717797608276,1.1057504545632033,0.3609375,0.9276491922419932,1.0,4/16,9.56%,KDM4D;SHLD2;PARP3;RIF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5248579357734487,1.1055208303289445,0.3689922480620155,0.9274454337804608,1.0,1/11,0.58%,CD44
prerank,negative regulation of endocytosis (GO:0045806),0.45181898649968333,1.105352604350482,0.346045197740113,0.9270375785578422,1.0,7/24,11.35%,SCAMP5;CAV1;UNC119;RUBCN;LGALS3;SNX33;EPHA3
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.36854913040783116,-1.1049838015160285,0.29780564263322884,0.7280963997582888,1.0,5/21,8.18%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,smooth muscle tissue development (GO:0048745),0.5378307094260018,1.104963414762083,0.36772046589018303,0.927341570481944,1.0,3/10,6.81%,SMO;STRA6;BMP4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.47096218303014237,1.1040575438796851,0.35131195335276966,0.9292261839174929,1.0,5/20,13.81%,CCL5;MTDH;LBP;TLR4;IRAK1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3900976435166604,-1.1039911167501575,0.338368580060423,0.7292107660534488,1.0,6/19,9.13%,PTPRJ;KDR;VCAM1;STIMATE;GRM5;FIS1
prerank,negative regulation of hippo signaling (GO:0035331),-0.43456935452400497,-1.1039103026642958,0.329608938547486,0.727810563872483,1.0,6/12,22.14%,WWC2;CIT;DLG5;LIMD1;MAPK14;WWC1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5006021198681152,1.103697826178818,0.3565640194489465,0.9294465885976645,1.0,3/12,8.62%,ERLIN2;ACADL;ERLIN1
prerank,cellular response to organic substance (GO:0071310),-0.25326240422971685,-1.1035728277647425,0.189873417721519,0.7271034723029458,1.0,26/116,10.70%,PID1;GHR;LEF1;IL1RAPL1;STAT5B;IGFBP5;ACVRL1;NCOA1;CYP1B1;CLEC3B;BMPR1B;PTPN4;SLC1A1;ACVR1B;ROBO2;IL18;LRRK2;SLIT2;TGFB1;PTPN12;ACVR2A;TBK1;RPS6KB1;RAMP2;TRAF6;STAT3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4438072288598874,-1.103371507011658,0.33157894736842103,0.726087670049055,1.0,5/11,37.34%,NOS1AP;KCNIP2;TREM2;RNF207;ALG10B
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4389563912334586,1.1030779147684358,0.34685314685314683,0.9304510247368674,1.0,10/28,18.33%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;PIP4K2C;GSK3A;PRKCZ;PRKCQ;SLC27A4
prerank,blood vessel endothelial cell migration (GO:0043534),0.4696800263355215,1.102993123346404,0.358600583090379,0.9297671960572738,1.0,3/22,2.06%,ADTRP;EFNB2;EMP2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.42661020142649564,1.1026195224116317,0.32985658409387225,0.9299883964813436,1.0,12/33,20.25%,DDX5;EP300;DDRGK1;LATS1;KDM4C;GPAM;UFM1;KDM1A;HDAC6;H3-3A;PARK7;PRMT2
prerank,peptide metabolic process (GO:0006518),-0.2826172484663777,-1.1023282210017196,0.2972972972972973,0.7274372194849732,1.0,17/75,13.30%,DMD;PCSK5;AEBP1;CPD;GSTZ1;ACE;GSTT1;CPXM2;TPP1;CPXM1;SPCS2;NLN;CPQ;BACE2;ETHE1;ENPEP;MME
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3333003775064776,-1.1023228203032585,0.2782258064516129,0.7258812815136373,1.0,15/33,20.63%,GRIK2;NRG3;GRID2;LRRC4C;GRIK3;NLGN1;LRP8;GRIK1;GRIK4;NLGN3;BDNF;PXK;GRIK5;CX3CR1;CACNA1B
prerank,androgen receptor signaling pathway (GO:0030521),0.5148972504586149,1.10173112663348,0.3646677471636953,0.9318618110467193,1.0,2/11,2.31%,DAXX;DDX5
prerank,metanephric mesenchyme development (GO:0072075),-0.45845593055932715,-1.1017224883655317,0.34953703703703703,0.7259314439449802,1.0,3/10,10.69%,WNT4;PKD2;BASP1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5177332076493515,1.1016329640636984,0.3753993610223642,0.9312579655340111,1.0,5/12,13.18%,PLK3;FBXO31;SDE2;CCND1;CDK2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.38238493164148973,1.1015339783129268,0.3118148599269184,0.9306011637346557,1.0,27/69,24.83%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;SP1;TAF5;ELL;SRRT;INTS3;POLR2C;INTS13;POLR2E;INTS6;TAF8;TBP;NABP1;SNAPC3;GTF2E2;TAF6;INTS1;CDK9;ICE1;ELL2;POLR2K
prerank,positive regulation of protein catabolic process (GO:0045732),0.37470258935028666,1.1014668484569883,0.3269230769230769,0.9298695167738475,1.0,21/84,19.53%,FZR1;WWP2;MSN;EGLN2;GPC3;PLK3;RAB7A;EZR;SNX33;VPS11;GSK3A;GSK3B;NEDD4;PLK2;HSP90AA1;DDB1;NSF;RNF41;IDE;GPLD1;ASB5
prerank,positive chemotaxis (GO:0050918),0.4812679772572109,1.1012290551615878,0.33893129770992364,0.9296439578534421,1.0,3/17,8.28%,ANGPT1;TSC2;LGALS3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4733613156497788,1.1011526543435437,0.3684210526315789,0.9289757589257588,1.0,3/18,7.18%,PODXL2;ITGB7;GOLPH3
prerank,double-strand break repair via homologous recombination (GO:0000724),0.36990912159321515,1.1009695484893547,0.328,0.9285726936562302,1.0,33/95,22.44%,FEN1;RECQL4;KDM4D;NABP2;RNF138;MRE11;RAD54L;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;FAN1;UBE2N;LIG3;SFR1;MCM6;SMC6;NBN;MCM7;RAD50;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;MCM4;SWI5;NSMCE1
prerank,protein depolymerization (GO:0051261),0.4455747854176152,1.1006108644308035,0.33618233618233617,0.928788325652719,1.0,6/27,11.70%,GSN;MICAL2;KIF2A;TWF1;MICAL1;VPS4B
prerank,myelination in peripheral nervous system (GO:0022011),-0.4250752481988457,-1.100533210569334,0.3116531165311653,0.7275531860503258,1.0,8/13,25.76%,NF1;MYOC;CNTNAP1;SIRT2;SOD1;DICER1;PRX;NCMAP
prerank,negative regulation of viral release from host cell (GO:1902187),0.5046977681590299,1.1004930883847734,0.365814696485623,0.9282097521503893,1.0,4/13,9.41%,TRIM21;PML;TRIM26;TRIM11
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25536934529579386,-1.1001106643172516,0.24299065420560748,0.7271182878075746,1.0,20/109,8.54%,PLCB1;PDGFRB;PLA2G4A;PIK3R1;INPP4B;PIP5K1B;INPP5D;PIP4K2A;SYNJ2;FGF2;ARF3;PLAAT3;MTMR14;MTM1;PLEKHA8;BMX;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6
prerank,telomere organization (GO:0032200),0.4098722881900542,1.098943090912541,0.33419354838709675,0.9321590844630865,1.0,24/43,28.18%,RECQL4;DOT1L;MRE11;PARP3;RIF1;HUS1B;RPA3;POLD2;PCNA;ATR;NBN;RAD50;H3-3A;ERCC4;TERF2;PTGES3;TINF2;APEX1;RPA2;PARP1;POLD1;XRCC5;TERT;TERF1
prerank,retinol metabolic process (GO:0042572),-0.41467769410388033,-1.0988029901266545,0.3136729222520107,0.7289575089339899,1.0,6/14,16.82%,CYP1B1;RDH10;DHRS3;RBP4;ADH1A;RDH11
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4237477245254947,-1.0985520514344715,0.35149863760217986,0.7281315887824142,1.0,6/14,18.30%,ADGRV1;WNT5A;GPD1L;FLT4;DGKG;CD40
prerank,adenine nucleotide transport (GO:0051503),-0.3984854529405361,-1.0982663430125172,0.35060975609756095,0.7273939686685894,1.0,2/17,1.29%,LRRC8C;ABCC4
prerank,Ras protein signal transduction (GO:0007265),0.35930701958742806,1.0979433484732397,0.31283710895361383,0.934372832967778,1.0,34/137,16.31%,AGTR1;CDH13;CELSR1;CDKN1A;MRAS;RAP1B;EPS8L2;RAP1A;CDC42EP4;CDC42EP5;NRAS;KRAS;SHC1;ARHGAP29;JUN;RALGDS;RAPGEF3;GNA13;RHOA;WASF1;PDPN;RREB1;CDK2;SHC2;BRAP;HRAS;SETDB1;RAPGEF1;ARHGDIB;PLK2;RAP2C;USP28;RIPOR1;ARHGEF1
prerank,sphingosine metabolic process (GO:0006670),-0.3985014183856936,-1.097894093960726,0.33433734939759036,0.7269327650193723,1.0,9/17,33.29%,ACER2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC2;ACER3;SPTLC3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4623424097654431,1.0974833026031132,0.3500717360114778,0.9347985402024916,1.0,6/24,12.86%,CLU;ALOX5;BCL2L1;CREB3;OPA1;LPCAT3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4007411800953269,1.0974780724459647,0.3421383647798742,0.9338805670046996,1.0,7/50,8.66%,NXN;OGT;CAV1;PRR7;SH3RF2;FBXO5;CHP1
prerank,intracellular pH reduction (GO:0051452),0.4292531369349065,1.097448947864475,0.34459459459459457,0.9330557108921055,1.0,10/33,19.75%,ATP6V1B1;RAB7A;DMXL2;ATP6V1E1;ATP6V1D;GPR89A;GPR89B;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,gliogenesis (GO:0042063),0.49006695508837606,1.0971421836607054,0.3488372093023256,0.933097849340718,1.0,4/15,10.02%,CDK6;CD9;TGFB2;NFIB
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.44226512777145266,1.0971339279738053,0.3558823529411765,0.9321872837546615,1.0,2/27,1.38%,NAPEPLD;ETNK2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4733344530561006,1.0971185547148843,0.3728813559322034,0.9313072189028041,1.0,5/16,23.04%,RAET1E;VAMP7;ULBP1;VAMP2;ARL8B
prerank,renal water homeostasis (GO:0003091),-0.3713600593045516,-1.0970394530734264,0.34812286689419797,0.7277979815554084,1.0,12/23,22.44%,ADCY5;ADCY7;RAB11FIP2;ADCY1;ADCY4;AQP4;PRKAR2B;MYO5B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,T cell proliferation (GO:0042098),-0.4255740430392839,-1.0969199130674032,0.3286118980169972,0.726579884073155,1.0,4/13,8.64%,CADM1;DOCK8;CTPS1;PPP3CB
prerank,regulation of pseudopodium assembly (GO:0031272),0.520414582621692,1.0968756520920326,0.34290271132376393,0.9302306076247886,1.0,4/10,14.88%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.520414582621692,1.0968756520920326,0.34290271132376393,0.9302306076247886,1.0,4/10,14.88%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,activation of GTPase activity (GO:0090630),0.3762075839567383,1.096768934526276,0.3116438356164384,0.9296362043649806,1.0,15/89,11.87%,ARHGAP42;NTRK3;NGEF;SIPA1L1;GRTP1;TBC1D16;TIAM2;DOCK7;ARHGAP29;CCDC125;BCR;ARHGEF5;BCAS3;SGSM2;TBC1D1
prerank,lytic vacuole organization (GO:0080171),-0.3392238703876822,-1.0966041420504995,0.3155893536121673,0.7258863019395492,1.0,10/32,17.79%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;CLN3;TMEM106B;CLVS1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3509678113905703,1.096254085768372,0.2944214876033058,0.930373191673891,1.0,45/208,15.95%,PRKCB;LPAR1;EDA2R;AKAP13;ZC3H12A;IKBKE;MAVS;TRIM59;HSPB1;TRIM25;PPM1B;MTDH;TFG;USP10;SLC20A1;OTUD7B;MUL1;CC2D1A;WLS;TRIM21;TAB3;TNFRSF10B;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;ZFAND6;CHUK;GAPDH;TNIP1;GPR89A;PLK2;IKBKG;RNF31;FLNA;UBE2N;CCDC22
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.40299130555757107,1.095564724867335,0.33292231812577067,0.9316186216596744,1.0,11/49,12.29%,MMP9;NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;NDUFS3;BCAP31;GSDME;EIF2AK3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37489197933706364,1.0954894404902915,0.3269230769230769,0.9309302035437522,1.0,16/94,11.21%,MAP3K5;CDKN1A;FHIT;DDX5;BBC3;IKBKE;PMAIP1;TMEM117;PPP1R13B;PPP1R15A;BCL2L1;BAD;TNFRSF10B;PML;ARL6IP5;PDK2
prerank,regulation of axon extension (GO:0030516),0.4174990711883136,1.0952041852410355,0.34146341463414637,0.9309170870990001,1.0,11/37,20.66%,ISLR2;RTN4R;OLFM1;ZFYVE27;MAP3K13;GSK3B;ABL1;SHTN1;SEMA3A;MAPT;DBN1
prerank,cellular response to UV (GO:0034644),0.3799882795686042,1.0949163916501456,0.3392018779342723,0.9308774973544881,1.0,19/76,18.18%,OPN1SW;MMP9;CDKN1A;EP300;TIMP1;POLK;SDE2;CARD16;AQP1;MYC;NEDD4;USP28;PCNA;DDB1;ATR;KDM1A;EIF2AK4;TRIAP1;COPS9
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4148701909557844,1.0948428061185087,0.3390728476821192,0.9301673347753099,1.0,12/38,19.45%,CLU;KLF4;ZC3H12A;CAV1;DDAH2;TLR6;TLR4;ATP2B4;HSP90AA1;ASS1;ROCK2;KLF2
prerank,regulation of translational initiation (GO:0006446),0.38926804611997445,1.0943585231403832,0.3373934226552984,0.9307231290222439,1.0,21/63,18.95%,CCL5;YTHDF1;HSPB1;EIF2B2;EIF4B;EIF4EBP1;HABP4;EIF4G2;EIF2AK3;BOLL;EIF4G1;PAIP1;DNAJC3;EIF5B;EIF3B;EIF1;EIF2AK4;CTIF;EIF4A2;YTHDF3;EIF4EBP2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4394456592522062,1.0942154869566318,0.3609129814550642,0.9302924255936709,1.0,2/29,6.13%,ANKRD31;SYCP2
prerank,negative regulation by host of viral process (GO:0044793),0.5312180624915799,1.094102326680681,0.3921232876712329,0.9297227735854706,1.0,6/10,32.65%,ZC3H12A;EIF2AK4;VAPA;PRKN;PSMC3;CCNK
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3350441903060361,-1.093946837896049,0.33840304182509506,0.7316597144305593,1.0,9/30,15.43%,CACNA1C;GJC1;GPD1L;KCNJ2;CACNA1G;FGF12;SCN1A;RYR2;SCN1B
prerank,membrane depolarization (GO:0051899),0.4364133495060351,1.0938764839984279,0.35800807537012114,0.9295136410231519,1.0,4/32,3.47%,SCN3A;CACNA1A;CAV1;CACNB3
prerank,positive regulation of filopodium assembly (GO:0051491),0.4502476286551198,1.0938498866311157,0.35174418604651164,0.9286804883397524,1.0,6/24,10.46%,ARAP1;PALM;RIPOR2;RHOQ;CDC42;BCAS3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.44707545126017784,1.0936544735121678,0.3514285714285714,0.928387987375744,1.0,6/25,14.74%,MMP9;BBC3;PMAIP1;BAD;HRK;DNM1L
prerank,positive regulation of dendrite development (GO:1900006),0.5359352372361762,1.0936254872009648,0.3879598662207358,0.9275595167493139,1.0,4/10,17.29%,COBL;BMP5;PTN;PACSIN1
prerank,glycolytic process (GO:0006096),0.436514951826906,1.0932963050674107,0.3527027027027027,0.927621814623398,1.0,8/28,16.09%,HKDC1;PKM;PFKFB2;ENO2;HK1;ALDOA;GAPDH;TPI1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.486881720348425,1.0932674151461763,0.3898550724637681,0.9268093186421941,1.0,1/17,0.15%,CD55
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4633631102222544,1.092877058093254,0.347949080622348,0.9270916528370667,1.0,4/22,7.99%,ANK2;STAC3;GSTO1;JPH2
prerank,regulation of cell migration (GO:0030334),0.34059363803144244,1.0927919972562425,0.2791164658634538,0.926433543406251,1.0,47/382,8.52%,CDH1;SEMA3D;CDH13;PHACTR1;NTRK3;SRGAP3;SRGAP2;KANK1;LAMC2;TJP1;SMO;MMP9;CCL5;PLXNB1;PODXL;EPHA4;PDGFC;DAG1;ADAM10;PLXNA2;MAGI2;WNT11;CAV1;SEMA3B;KIF2A;PTK2B;FOXO3;LMO4;SGK3;DUSP10;MGAT3;GCNT2;SH3RF2;PTPRU;TMEFF2;DDRGK1;MAPK15;CBLL1;SRCIN1;ARSB;SLURP1;WNT5B;FGF22;PARD6B;MAZ;PIP5KL1;ELP5
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3379382770056238,-1.0927753413038799,0.3125,0.7332608097834733,1.0,10/32,8.60%,SLC6A9;DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;EPHB2;GRIN2B;NLGN1;NEFL
prerank,pentose-phosphate shunt (GO:0006098),0.5120276718716497,1.0926241327503559,0.3719723183391003,0.9260683907027007,1.0,5/11,16.41%,PGM2;PGD;DERA;RPIA;RBKS
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4432726130985391,-1.0925955497430975,0.35714285714285715,0.7321892171179389,1.0,4/11,14.58%,NOS3;GCH1;SPR;DHFR
prerank,regulation of vacuole organization (GO:0044088),-0.37855208009890007,-1.0923631884253078,0.3302752293577982,0.7312503446071955,1.0,6/20,10.44%,TBC1D12;SCARB2;MTM1;LAPTM4B;TBC1D14;NPRL3
prerank,cellular glucan metabolic process (GO:0006073),-0.439797483275624,-1.0923423015982225,0.3609625668449198,0.7297823384358298,1.0,4/11,17.90%,PRKAG2;PHKA1;UGP2;GBE1
prerank,regulation of inflammatory response (GO:0050727),0.3520172496025643,1.091852541136,0.3023012552301255,0.9275258617664777,1.0,29/190,15.32%,AGTR1;GPR4;NAPEPLD;KLF4;MMP9;CCL5;CD200;IL17RA;NINJ1;IL15;IL16;CELF1;ALOX5;NFKBIA;AKNA;MAPK7;FEM1A;TNFRSF1A;NMI;TLR4;CD200R1;PTPN2;LPCAT3;GATA3;SBNO2;FOXP1;TNIP1;TLR3;DHX9
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3939295740245521,-1.0917460333323217,0.35542168674698793,0.729792955303292,1.0,6/18,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,response to ethanol (GO:0045471),-0.4056019647089838,-1.0909288681904994,0.3439153439153439,0.7304469155842438,1.0,8/14,25.90%,GRIN2A;ADCY7;GRIN2B;GLRA1;GLRA2;SOD1;GRIN3A;GOT2
prerank,cellular response to metal ion (GO:0071248),0.3552097217155424,1.0898846175413106,0.3167220376522702,0.9326797730153435,1.0,22/123,15.28%,CDH1;PRKAA2;DAXX;MMP9;FOS;ADD1;DMTN;ANK3;JUN;IQGAP1;MAPK9;TIGAR;AQP1;SLC41A1;CPNE2;TRPM2;MEF2C;SYT6;CHUK;HVCN1;SYT11;SYT12
prerank,cellular response to chemical stress (GO:0062197),0.36959069938943695,1.0897421475439224,0.32319819819819817,0.9322226575097335,1.0,10/96,5.24%,PRKAA2;PPARGC1A;CPEB2;ZC3H12A;CAV1;FOXO3;SESN2;MGAT3;NFE2L2;NUDT2
prerank,mitochondrion morphogenesis (GO:0070584),-0.4571254885599217,-1.089684550169167,0.34908136482939633,0.7322762866725202,1.0,3/11,9.13%,PID1;MTM1;FIS1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.39987016158000493,1.0894969707387725,0.33766233766233766,0.9320994418872874,1.0,17/46,23.65%,TIMM10;TIMM44;TOMM5;DNLZ;ROMO1;PITRM1;HK1;BCAP31;TOMM20;TIMM17B;TOMM40L;TIMM9;TOMM40;TSPO;TIMM50;TIMM23;AIP
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.45532321923598174,-1.0894673954593508,0.34474327628361856,0.7312878054364468,1.0,2/10,7.75%,PTPRJ;PTPN12
prerank,myotube cell development (GO:0014904),0.533053287187142,1.089190993833799,0.38823529411764707,0.9321664356874173,1.0,4/10,8.18%,SELENON;LMOD3;CAV2;SIX1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4194996177087319,1.0890782463221154,0.3437908496732026,0.9315772362804602,1.0,12/36,19.02%,QARS1;DUSP10;SH3RF2;DUSP1;FOXM1;EZR;HDAC3;NCOR1;MYC;IGBP1;DUSP3;TAOK3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.49286613464992823,1.0889659891656787,0.35858585858585856,0.9309959147755792,1.0,3/13,7.67%,CD81;INSIG1;GCC2
prerank,cellular response to radiation (GO:0071478),0.4118619185991991,1.0887845276920876,0.34889753566796367,0.9306234057730002,1.0,3/40,4.50%,OPN1SW;CDKN1A;KDM4D
prerank,endocardial cushion development (GO:0003197),-0.3687595122180497,-1.0886926931503773,0.375,0.7319366893150989,1.0,6/21,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5083870701529989,1.0886023285708142,0.3829457364341085,0.930318857889562,1.0,1/12,0.58%,CD44
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3572757666771771,-1.0884194675788426,0.30914826498422715,0.7311930720777796,1.0,7/21,18.72%,IGF1;KDR;LGALS9;ITGAV;EGF;MAP2K1;PTGER4
prerank,mononuclear cell differentiation (GO:1903131),-0.3475832199376798,-1.0882494439124937,0.288135593220339,0.7301583364733527,1.0,4/24,2.88%,IL31RA;LYN;GAS6;AXL
prerank,regulation of mRNA metabolic process (GO:1903311),0.5080529432055322,1.0881413216857878,0.3938879456706282,0.9308718767435251,1.0,5/11,19.78%,SLTM;SRPK2;SRPK1;DHX9;CDK11B
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.44289774619667904,1.0879033354344967,0.36507936507936506,0.9306894362544182,1.0,1/23,0.32%,DSG2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.40514626394697983,1.087142692988052,0.34155844155844156,0.9321576602191318,1.0,3/40,0.84%,FGFR1;LPAR1;NTRK3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.41292989114782697,-1.086915512714002,0.3527777777777778,0.7322336360510469,1.0,3/14,4.92%,DMD;ATP1B1;WNK2
prerank,O-glycan processing (GO:0016266),-0.2948954537479062,-1.0865656732919478,0.24725274725274726,0.7316823533235585,1.0,15/54,18.27%,ST3GAL1;GALNT7;ST3GAL3;GALNT13;GALNT15;C1GALT1;GXYLT2;POMGNT1;GALNT2;GALNT14;B4GALT5;GCNT1;C1GALT1C1;POFUT1;GALNT9
prerank,regulation of interferon-alpha production (GO:0032647),0.4491583181974298,1.0864872992314443,0.35474452554744523,0.9333015423153226,1.0,6/23,15.32%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,carbohydrate catabolic process (GO:0016052),0.4156270312938759,1.0863992739569412,0.3646907216494845,0.9326708530925631,1.0,11/38,16.09%,HKDC1;PKM;PFKFB2;MANBA;DERA;ENO2;HK1;ALDOA;GAPDH;NAGA;TPI1
prerank,organelle transport along microtubule (GO:0072384),0.42484894055492756,1.086276654160713,0.35497237569060774,0.9321521617614823,1.0,9/31,20.10%,DYNC1I1;NDEL1;ARHGAP21;CDC42;PAFAH1B1;COPG1;TMEM201;RHOT2;MAPT
prerank,positive regulation of telomerase activity (GO:0051973),0.42003475445073923,1.086086390223411,0.3583106267029973,0.9318605964276416,1.0,10/33,19.56%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PRKCQ;PNKP
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.34802386771582045,1.0859142309998056,0.31696905016008536,0.9314961920874079,1.0,25/166,12.36%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;TAF1C;RARG;POLR2A;RXRB;MAZ;UBTF;NR2C1;POLR1C;HDAC3;POLR1E;NCOR1;GTF2E1;POLR1F;TAF5
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4085889080032874,-1.085352279575353,0.36239782016348776,0.7335956091114599,1.0,3/14,9.87%,RAPGEF2;PKIG;PRKAR2B
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3375807240190579,-1.0852704471666181,0.3283018867924528,0.7323122567668379,1.0,13/30,19.51%,NOS3;FAS;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.2998614368925568,-1.0846729173071048,0.33476394849785407,0.7324256038239768,1.0,6/48,8.35%,IL1R1;PDE4D;SLC7A5;LGALS9;IL18;PDE4B
prerank,positive regulation of developmental process (GO:0051094),0.3529712021188795,1.0846536814618284,0.3343949044585987,0.9344093810421702,1.0,29/164,13.18%,PHLDB2;FGFR1;NCOA3;COBL;DAG1;NIBAN2;CCN2;MCU;GDNF;PPP1R13L;BMP5;RBM19;ZBTB16;SHLD2;ESRRB;SOX9;FOXD1;MUL1;BMP4;DVL3;FBXO5;MIEF2;RIF1;RAPGEF3;TRPM4;PTN;CPEB3;RREB1;MAP3K13
prerank,granulocyte differentiation (GO:0030851),0.4690944223647546,1.0842860746033305,0.37147102526002973,0.9346159765016414,1.0,7/18,18.35%,CDKN1A;EP300;CDK4;PML;CDK2;E2F1;RARA
prerank,regulation of mast cell degranulation (GO:0043304),-0.40586097169308066,-1.0842807634876392,0.35,0.7320320343723786,1.0,8/14,27.17%,LYN;LGALS9;GAB2;CD300A;CD84;FES;FER;FGR
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.26178737804184016,-1.0841020735203486,0.2807017543859649,0.7309937974111704,1.0,29/94,23.55%,CEP250;IQCB1;CCP110;CEP78;ALMS1;TMEM67;NDE1;AHI1;CEP162;PRKAR2B;TCTN1;C2CD3;NEDD1;SCLT1;CSNK1D;SDCCAG8;TCTN2;TCTN3;CKAP5;B9D1;NPHP4;CEP41;MAPRE1;HAUS4;RPGRIP1L;HAUS7;CEP72;YWHAE;SSNA1
prerank,regulation of fatty acid oxidation (GO:0046320),0.47583653481599464,1.0839113773722544,0.3689759036144578,0.9348164740123808,1.0,4/16,7.50%,PPARGC1A;ABCD1;SOX9;ACADL
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.38712806031833147,-1.0834244069250718,0.38977635782747605,0.7313716680220016,1.0,9/18,11.93%,GRIK2;UNC13B;GRID2;GRIA2;CDH8;GRIK3;SLC17A6;GRIK1;GRIK4
prerank,positive regulation of translational initiation (GO:0045948),0.4666145710383124,1.082676048365415,0.39850746268656717,0.9377285898702418,1.0,4/18,13.47%,CCL5;YTHDF1;HABP4;BOLL
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3809853632184513,1.082505830585505,0.3424170616113744,0.9373555814988817,1.0,20/76,17.31%,CLU;TRIB2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2;CCDC22;KEAP1;STUB1
prerank,ion transport (GO:0006811),0.3623717619395788,1.0814558755031842,0.3377926421404682,0.9396351443456387,1.0,21/111,16.87%,SLC9A2;SLC9A4;TRPM3;SLC4A2;CTNS;SLC20A1;VDAC2;CNGB3;SLC9A6;SLC9A7;PKD2L1;SLC12A4;ANO6;CNGB1;VDAC1;SLC26A4;WNK1;SLC9A8;SLC12A6;SLC8B1;SLC9A1
prerank,cytoskeleton organization (GO:0007010),-0.2560009550192326,-1.081237418246073,0.32142857142857145,0.7359729660904658,1.0,26/114,13.42%,MAST4;MARK1;RHOBTB1;SEMA6A;FGD5;TNIK;PLCE1;RND3;FMNL3;PALLD;MICAL3;LRCH3;EPB41L3;SH3KBP1;RANBP9;BIN1;ABI2;RHOBTB3;FGD3;ARAP3;ZMYM3;CNN2;KLHL20;DES;CNTNAP1;CECR2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.48177338876514825,1.0811737251079039,0.37668161434977576,0.9396000091632312,1.0,4/15,10.61%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5199160518012718,1.0810648663784337,0.38599348534201955,0.9390465513117768,1.0,4/11,16.55%,NUPR1;YBX3;PELI1;SLC25A4
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3197539777016975,-1.080617294222907,0.30039525691699603,0.736141560573483,1.0,9/39,11.91%,ABCA1;STEAP3;MTTP;RCN3;SEL1L;TVP23B;PPY;TMEM167A;TANGO2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4171121875207014,1.0802432423803343,0.35927367055771725,0.9407027674444719,1.0,8/37,10.84%,NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;BCAP31;GSDME
prerank,myotube differentiation (GO:0014902),0.48338024077125635,1.0801140020473194,0.3776119402985075,0.9401927453422179,1.0,1/17,0.10%,ADAM12
prerank,mitotic recombination (GO:0006312),-0.4037005150184417,-1.0799609710367095,0.3660477453580902,0.7364368588260718,1.0,10/15,27.74%,MSH3;RAD51D;RAD54B;SMC5;RAD51;ERCC1;TEP1;TPRKB;GEN1;RAD52
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4513852048915754,-1.07933685174314,0.35509138381201044,0.7367740237743433,1.0,6/11,13.26%,CD34;LGALS9;THBS1;PTGS2;CD46;GATA6
prerank,cell part morphogenesis (GO:0032990),-0.425496337129461,-1.0791049975742775,0.3611111111111111,0.7358799826877099,1.0,3/13,9.13%,PID1;MTM1;FIS1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.38064295819910204,1.0790001803813176,0.35286783042394015,0.9426333081685233,1.0,13/64,13.95%,ADTRP;ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;SLC27A3;ACADL;ELOVL6;ACSL3;FADS1;CPT2;LTA4H
prerank,endocytic recycling (GO:0032456),0.39598291955465525,1.0788943100649102,0.35561160151324084,0.9420790735705291,1.0,11/50,16.18%,RAB17;EHD1;RAB11FIP3;RAB7A;LMTK2;RAB35;SNX12;VPS52;WASHC1;CCDC22;VPS50
prerank,negative regulation of metabolic process (GO:0009892),0.39203070598440465,1.0784981339589312,0.3592233009708738,0.9424579610740772,1.0,10/54,8.89%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,cochlea morphogenesis (GO:0090103),0.5244867473797032,1.0784399828979578,0.39434276206322794,0.9417469208370647,1.0,2/10,6.28%,HPN;SOX9
prerank,protein kinase A signaling (GO:0010737),0.5112743241029857,1.0783640938538759,0.4031746031746032,0.941113341032106,1.0,2/12,9.59%,GAL;EZR
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3507679699471558,1.0781004854582628,0.33508403361344535,0.9410358005188396,1.0,28/175,14.21%,TNFRSF11B;CCL5;EDA2R;EDA;ADAMTS7;ZC3H12A;TNFSF13;PTK2B;FOXO3;TNFRSF8;YBX3;NFE2L2;NFKBIA;PSMD11;PSMD4;COMMD7;PSMF1;ILK;TNFRSF1A;PYDC1;PSMD7;GSDME;NPNT;PSMB5;GATA3;ZFAND6;SFRP1;CHUK
prerank,histone lysine demethylation (GO:0070076),0.44256603989556575,1.0780278314110863,0.3972027972027972,0.940365631700976,1.0,7/25,12.11%,KDM4D;KDM4B;KDM5C;KDM3A;RIOX2;KDM4C;KDM6A
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.37400196606435865,1.0779136353536196,0.3751438434982739,0.9398091722202759,1.0,24/87,16.82%,NOTCH2;CELSR1;ARHGAP18;CDK10;PTK2B;DAPK3;RHOQ;TWF1;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;DLC1;RAPGEF3;EPHA3;RHOA;TRPM2;CCDC88A;ARHGDIB;TESK1;FSCN1;CRK;ABL1
prerank,histone H4-K16 acetylation (GO:0043984),0.46791767881473273,1.0776820572622925,0.36891679748822603,0.939646015140911,1.0,7/19,16.03%,OGT;HCFC1;KMT2A;JADE2;ING4;MSL2;MEAF6
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4547288253241858,1.0776191735168519,0.3701492537313433,0.9389594040556343,1.0,6/21,11.25%,HKDC1;PGM2;PGD;DERA;HK1;RPIA
prerank,regulation of B cell proliferation (GO:0030888),0.399354751252187,1.0770813007573636,0.3713188220230474,0.9397336295695639,1.0,4/44,4.18%,NFATC2;SASH3;CD81;CLCF1
prerank,protein deacylation (GO:0035601),0.443637900787008,1.0767397234872849,0.39355742296918766,0.9399024065449354,1.0,8/23,22.27%,HDAC5;HDAC4;ABHD10;HDAC3;HDAC6;LYPLAL1;ABHD17C;SIRT7
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3916008302259053,1.0766840429933184,0.3620474406991261,0.939176450409487,1.0,14/54,17.99%,CNOT6;CDKN1A;EP300;PLK3;PML;BTG2;MDM2;PLK2;PCNA;E2F1;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.48922305368924657,1.076170345060412,0.3751937984496124,0.9397414402432657,1.0,2/14,2.15%,LDLR;CD200
prerank,cell proliferation in forebrain (GO:0021846),0.5214789977032793,1.076137215654516,0.38333333333333336,0.9389471761353344,1.0,6/10,26.75%,DOCK7;AKNA;HOOK3;CEP120;PCM1;NUMBL
prerank,protein import (GO:0017038),0.3641201229099983,1.076060399756662,0.36027713625866054,0.9383115744366871,1.0,23/84,18.72%,CLU;PEX26;ABCD1;IPO7;TSC2;NUP93;HSPA4;TNPO2;SNX33;MMP12;SLC25A17;TNPO1;NXT2;RANBP6;HEATR3;PXMP4;HSP90AA1;IPO4;RAB8B;CSE1L;PPP1R10;PEX3;PEX2
prerank,regulation of lipid kinase activity (GO:0043550),-0.43513179780720695,-1.075628926438677,0.3871794871794872,0.7439017710112644,1.0,4/11,18.09%,PIK3R1;RBL1;PIK3R3;PIK3R2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3525127351938935,-1.075454082969648,0.328125,0.7429052925125637,1.0,7/23,10.12%,GHR;NOTCH1;CYP1B1;JAK2;ERBB4;OCIAD1;KIT
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5094862084835053,1.0749753671007376,0.42504118616144976,0.9407322676694386,1.0,5/11,22.08%,MAP3K5;ARL6IP5;PRODH;STK24;DIABLO
prerank,negative regulation of phosphatase activity (GO:0010923),0.44328338589585004,1.0747129131738218,0.3924581005586592,0.9406522385634726,1.0,8/25,15.10%,SH3RF2;PPP1R15A;TGFB2;CRY2;CHP1;PPP1R11;GSK3B;PPP1R1B
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4389061333242877,-1.0739034557103373,0.3496143958868895,0.7457062757340646,1.0,4/12,13.56%,PRKD1;SAP30BP;ING2;NIPBL
prerank,maintenance of blood-brain barrier (GO:0035633),0.4217656720261809,1.073785631180376,0.38294993234100133,0.9426025145028588,1.0,8/30,10.73%,TJP2;TJP1;OCLN;GJB6;LSR;LAMC1;ACTB;ACTG1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.48752715308996764,1.0737225703182285,0.37181663837011886,0.9419167673316208,1.0,4/13,16.45%,CRLF1;JAK1;OAS2;CANX
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.293484145461453,-1.073691992106517,0.3145539906103286,0.7448197921386632,1.0,8/51,7.48%,IL34;VEGFC;PTK2;CXCL12;GAS6;LGALS9;THBS1;IL6R
prerank,snRNA transcription (GO:0009301),0.37245926289094805,1.0736316494930727,0.3616504854368932,0.9413267193904322,1.0,27/70,24.83%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;SP1;TAF5;ELL;SRRT;INTS3;POLR2C;INTS13;POLR2E;INTS6;TAF8;TBP;NABP1;SNAPC3;GTF2E2;TAF6;INTS1;CDK9;ICE1;ELL2;POLR2K
prerank,cAMP metabolic process (GO:0046058),-0.41702694278033003,-1.0733847948556023,0.34574468085106386,0.7441900862896285,1.0,9/13,22.44%,ADCY5;PDE4D;ADCY7;ADCY1;ADCY4;PTHLH;ADCY2;ADCY3;ADCY8
prerank,pulmonary valve development (GO:0003177),0.4608118642641669,1.0729744929583676,0.37574850299401197,0.9424949786026245,1.0,6/18,9.01%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2;TNFRSF1A
prerank,pulmonary valve morphogenesis (GO:0003184),0.47133850601897886,1.0728486833955593,0.3794162826420891,0.9420228364492955,1.0,5/17,7.39%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4171740120050108,-1.0723420392804572,0.3922077922077922,0.7456332896774195,1.0,5/13,12.51%,PDE8A;LRRK2;GPR37;RACK1;TXN
prerank,sensory perception of sound (GO:0007605),0.36513119677196393,1.0719915424562936,0.3687214611872146,0.9437347725652804,1.0,17/88,14.02%,ATP6V1B1;USP53;COL4A3;HPN;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1;TMC2;PDZD7;GSDME;MKKS;SLC26A4;PAX3
prerank,sensory perception of light stimulus (GO:0050953),-0.26456557558613636,-1.0717775719638662,0.3208955223880597,0.74563605920461,1.0,11/87,4.93%,COL1A1;ADGRV1;PCDH15;SLC4A10;COL18A1;RP2;ATXN7;EYA4;MYO9A;GRM8;COL11A1
prerank,ganglioside metabolic process (GO:0001573),-0.37200551444777985,-1.071541453546426,0.3242424242424242,0.7448514015615834,1.0,9/20,19.52%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;NEU1;ST8SIA2;GM2A;NEU3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4732275275085571,1.0713834527607455,0.4030534351145038,0.944697413478996,1.0,6/18,14.55%,DDX5;ZC3H12A;BMP4;MAP2K2;NCOR1;NCOR2
prerank,negative regulation of coagulation (GO:0050819),0.4860215130627297,1.0713731859940705,0.38544891640866874,0.943855054041785,1.0,3/14,6.08%,ADTRP;PROCR;THBD
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.36483401695634976,1.0710043932911821,0.3420158550396376,0.943256593995997,1.0,18/78,17.03%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.36483401695634976,1.0710043932911821,0.3420158550396376,0.943256593995997,1.0,18/78,17.03%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.510086307852073,1.070815471868449,0.39228295819935693,0.942936140901245,1.0,4/11,19.15%,EFNB2;TGFB2;MEF2C;GPER1
prerank,positive regulation of protein acetylation (GO:1901985),0.49369332140199207,1.0704251059635168,0.4052718286655684,0.9433038730580688,1.0,1/12,0.82%,PRKAA2
prerank,ribosome assembly (GO:0042255),0.39428108624582514,1.0704197835927733,0.36114570361145704,0.9424565957438039,1.0,19/47,28.55%,NLE1;NOP2;PPAN;MRPS7;EIF6;RPSA;PWP2;RPL6;RPS28;EFL1;C1QBP;EIF2A;RPS27;NOP53;RRS1;MDN1;RSL24D1;RPL24;DDX3X
prerank,oligosaccharide metabolic process (GO:0009311),0.40138624415568314,1.070323909966811,0.3650586701434159,0.9418958567186627,1.0,8/46,14.99%,B3GALT1;ST3GAL4;B4GALNT2;FUT8;MANBA;ST3GAL6;NAGA;ST6GALNAC4
prerank,positive regulation of developmental growth (GO:0048639),-0.29552521339166005,-1.070175510891232,0.32367149758454106,0.7471851411337004,1.0,9/49,13.08%,PLCB1;GHR;INSR;SEMA7A;SYT1;CDKL5;ITSN2;MACF1;BDNF
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3373509719023543,1.0701652869502851,0.34893184130213634,0.9415110069182235,1.0,52/291,14.21%,CFTR;NCOA3;MMP9;VIM;RORC;PTK7;RAP1B;ZC3H12A;WNT11;RAP1A;FAM210B;PTK2B;FOS;SESN2;WNT6;DAPK1;SH3BP4;INSIG1;LCOR;CREB1;SOX9;DMTN;PXN;AANAT;TRIM41;CAPN2;ADCY6;ROMO1;WNT5B;JUN;MAPK9;LBP;SHMT1;ACTB;EZR;CARD16;AGAP3;AQP1;TLR4;RAPGEF3;PDK2;EPHA3;RHOA;WNT3;CPEB3;SBNO2;CDK2;IRAK1;MEF2C;ATP2B4;SFRP1;CHUK
prerank,regulation of mRNA catabolic process (GO:0061013),0.35443062964735633,1.0698969556339943,0.361353711790393,0.941428695470693,1.0,31/121,19.46%,VIM;SAMD4A;YTHDF1;ZC3H12A;SAMD4B;TNFSF13;HSPB1;PSMD11;MOV10;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;YWHAZ;PSMB5;FXR1;CARHSP1;DCP1A;TNPO1;SET;EIF4G1;RPS27A;UBC;MAPKAPK2;PSMD1;PSMC4;IGF2BP3;YTHDF3;IGF2BP2;PSMD8
prerank,membrane lipid biosynthetic process (GO:0046467),0.3832943963856195,1.0698374082126418,0.3535980148883375,0.9407370330754077,1.0,6/58,4.19%,SPTSSB;ST3GAL4;SGMS2;PPM1L;SCCPDH;ELOVL1
prerank,activation of phospholipase C activity (GO:0007202),0.42367670389581696,1.0695501391442848,0.37193460490463215,0.940756921784581,1.0,4/29,11.31%,LPAR1;ANG;TXK;GNAQ
prerank,protein K48-linked ubiquitination (GO:0070936),0.38788824039440006,1.0694988409579276,0.36732186732186733,0.9400561993632105,1.0,12/54,16.89%,RNF152;RNF5;UBE2G2;RBX1;RNF146;UBE2B;RNF126;PELI1;UBR5;UBE2H;BFAR;UBE2D3
prerank,axon guidance (GO:0007411),0.34313334150389346,1.0693425505753973,0.36770833333333336,0.9396711543877524,1.0,35/201,11.69%,ALCAM;SEMA3D;NOTCH2;LAMC2;SMO;GPC1;PLXNB1;EPHA4;EFNB2;DAG1;NIBAN2;PLXNA2;GAB1;SEMA3B;CXCR4;LAMA5;DOK6;GDNF;SPTBN2;ENAH;GFRA3;EFNA5;SHC1;MAPK7;KLF7;PTPRA;UNC5B;OPHN1;EZR;NFIB;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,determination of bilateral symmetry (GO:0009855),-0.34322729211258907,-1.0691926755139722,0.3442622950819672,0.74830010342222,1.0,8/24,18.26%,NOTCH1;PKD2;NPHP3;ZIC3;TBX1;BBS7;DNAH11;KIF3B
prerank,negative regulation of B cell activation (GO:0050869),-0.36298013967889997,-1.0687875457560052,0.3465346534653465,0.7479452504039314,1.0,11/21,32.50%,LYN;TNFRSF21;ID2;CD300A;RC3H1;TNFAIP3;TYROBP;FCGR2B;BANK1;FOXJ1;SAMSN1
prerank,outer dynein arm assembly (GO:0036158),0.4834779315708138,1.0685455875874361,0.37042925278219396,0.9412624894850201,1.0,6/14,26.71%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DNAAF4
prerank,negative regulation of calcium ion transport (GO:0051926),0.47859301606803006,1.0677438940136958,0.40752351097178685,0.9428663761921633,1.0,2/15,4.46%,ATP1A2;EPO
prerank,microglial cell activation (GO:0001774),0.45069197426345425,1.0675340347595197,0.3670520231213873,0.9426479435701044,1.0,1/21,0.40%,CLU
prerank,regulation of nuclear division (GO:0051783),0.46649061812291376,1.067298902859118,0.37593984962406013,0.9424635042416969,1.0,6/20,18.49%,DAPK3;CAV2;FBXO5;PKMYT1;CUL9;KIF20B
prerank,glycerolipid metabolic process (GO:0046486),-0.44637815088746385,-1.0669269289857164,0.38974358974358975,0.7516117604240227,1.0,8/11,26.56%,DGKB;GAL3ST1;DGKG;PNPLA3;PIP5K1A;DGKZ;DGKQ;PLA2G15
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4865468653254654,1.0669221457257465,0.3888888888888889,0.9427864851601179,1.0,5/14,18.03%,KLF4;HDAC5;RHOA;ITGB1BP1;MEOX2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4212126607305739,-1.066647851399677,0.38524590163934425,0.7509247680893676,1.0,3/12,12.09%,INSR;IRGM;IGF1R
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4864845556102788,1.0665916577441823,0.3967479674796748,0.9429548063158029,1.0,3/13,11.84%,NR3C2;BMP4;CALCOCO1
prerank,phosphate ion transmembrane transport (GO:0035435),0.4993989529229441,1.066443668804833,0.3890675241157556,0.942543317443421,1.0,4/12,14.52%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,histone H4 acetylation (GO:0043967),0.3921288480914991,1.0662117298458353,0.35686777920410784,0.9423677864668083,1.0,16/47,18.47%,OGT;EP300;NAA40;BEND3;HCFC1;MORF4L2;KMT2A;APBB1;ACTL6B;JADE2;ING4;MSL2;MEAF6;TRRAP;TRIM16;ATF2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5039095073103944,1.0661684588276035,0.4075907590759076,0.9416340090593908,1.0,2/11,12.21%,HPN;BCAR1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4062306218518935,1.0661430941792636,0.40551181102362205,0.9408555112300382,1.0,3/40,2.29%,CLU;ANGPT1;MAGI2
prerank,mitochondrial gene expression (GO:0140053),0.4018131574717747,1.0660349827526276,0.375,0.940296755646602,1.0,11/42,17.41%,MRPS16;FOXO3;MRPL2;HARS1;MRPS7;MRPS34;LARS2;MRPL57;MRPS15;MRPS28;GATB
prerank,regulation of synapse assembly (GO:0051963),0.39274058835174985,1.0656923044063784,0.36982968369829683,0.9403771828363542,1.0,5/46,4.84%,RAB17;GPC6;PDLIM5;GPC4;PTPRD
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3409445847658299,1.0655777829853694,0.34093264248704663,0.9398504915637311,1.0,17/214,6.54%,FN1;ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;DUSP10;GCNT2;ACKR3;ROS1;FBLN1;SPRED3;SHC1
prerank,organic anion transport (GO:0015711),0.36120996886271933,1.0654615308319038,0.36885245901639346,0.9393607431015848,1.0,7/76,7.92%,CFTR;SLCO2A1;SLC4A2;SLC35A2;SLC16A2;CYB5RL;SLC2A8
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.39426759183253934,1.0652712999762508,0.37531486146095716,0.9390687447416287,1.0,8/47,12.15%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ROMO1;TLR6;TLR4;TGFBR2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3521067756476036,1.0650733402456403,0.3671444321940463,0.9387566173423563,1.0,31/107,22.34%,CFTR;MAP3K5;SCAMP5;BBC3;TMEM117;RNF5;TMEM259;PPP1R15A;DDRGK1;TNFRSF10B;JUN;USP19;BCAP31;TMEM33;HYOU1;EIF2AK3;GSK3B;DNAJC10;CCDC47;CREB3L2;UFM1;FICD;ERP27;CDK5RAP3;FLOT1;RHBDD1;GORASP2;TMX1;PPP1R15B;SEC16A;THBS4
prerank,positive regulation of behavior (GO:0048520),-0.4370972662996435,-1.065052775216956,0.3711340206185567,0.7539819701627544,1.0,5/10,9.37%,NLGN1;NPAS2;AGRP;SGIP1;CFAP20
prerank,negative regulation of catabolic process (GO:0009895),0.39619695507653474,1.0650133911850774,0.37435897435897436,0.9380906190742762,1.0,10/47,12.17%,NUPR1;HDAC4;HMGCR;AZIN1;CYP51A1;BANP;SF3B3;TIGAR;NCOR1;SNX12
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.49082886042040236,1.0649548863770062,0.405320813771518,0.937415063970873,1.0,3/12,8.46%,PODXL;MAGI2;IQGAP1
prerank,negative regulation of viral process (GO:0048525),0.3837879372333584,1.064854440546418,0.37668711656441717,0.9368392514562481,1.0,14/57,16.63%,CCL5;MAVS;SLPI;RNASEL;TRIM21;LARP7;PML;TRIM26;TRIM11;SRPK2;SRPK1;TNIP1;OAS2;HEXIM1
prerank,regulation of tissue remodeling (GO:0034103),-0.37759594681727093,-1.064740821588568,0.36923076923076925,0.7533685063423601,1.0,6/18,16.84%,LEPR;RUNX1;IL18;TGFB1;FLT4;SUCO
prerank,cellular protein modification process (GO:0006464),0.32949642562318726,1.064689813779867,0.251,0.9364962491703891,1.0,204/982,17.76%,FN1;EGLN3;PRKCB;MSLN;UST;FGFR1;PTPN14;FBXL7;B3GALT1;PRKAA2;F5;LIMK2;FAM20C;PRAG1;FBXW8;ST3GAL4;NRBP2;MAP3K5;TRIB2;PRSS23;GRK5;ADAM10;TSSK6;TSSK4;PENK;PIGU;WNT11;IKBKE;NEK7;CDK10;PDF;ASB14;CDK6;PPM1L;FBXL20;MKNK2;PTK2B;SGK3;DAPK3;PPP2CA;SPSB4;ATE1;DUSP10;SERPINC1;GCNT2;LARGE1;DAPK1;ZBTB16;TIMP1;WWP2;PPM1B;PTPRU;PTPRD;CDKL2;CDK4;DUSP12;DUSP1;PSMD11;NUB1;ANO8;UBLCP1;MGAT1;ROS1;ELOB;CREB1;RNASEL;PHKA2;KLHL21;STK39;NPC1;MACROD1;SIK3;DDOST;CSK;BMP4;PTPRF;PTPN9;PSMD4;PARP3;PTPRA;CPE;PSMF1;TGM5;GPC3;TGFB2;PP2D1;FEM1C;FEM1A;CDK16;ILK;LATS1;SUMF1;WSB2;DYRK1B;PPM1A;GPAA1;FBXL18;RBX1;OXSR1;MAPK9;AURKC;FBXO31;LAMC1;MANBA;BCR;LMTK2;TXK;PTPN6;LAMB2;MTMR3;SRPK2;PIGT;COP1;PSMD7;CDKL4;GRK2;FBXW9;FEM1B;PDK2;CSNK1E;SUMF2;DCUN1D1;PARP6;PTPRE;SOCS2;JAK1;ALG1;CALU;YWHAZ;KLHL13;MARK4;TGFBR2;EIF2AK3;COPS5;ST3GAL6;PPP1CB;DCAF6;CDK18;SRPK1;CP;PPM1D;PSMB5;UBXN7;ARF4;MAP3K13;CDK2;LGALS1;DDA1;GSK3A;ASB7;ALG5;IRAK1;CHML;SOCS6;DCAF17;CHUK;TULP4;ULK1;SERP2;RAB1B;GSK3B;WNK1;NUS1;NTAQ1;DNAJC3;PIGS;CDC42BPA;PPP2CB;PLK2;JMJD4;PRKCSH;ASB6;DUSP11;CCDC22;TNKS2;AAK1;FBXL15;ASB8;DDB1;PAK6;CAND1;ASB3;PRKCZ;ATG4B;CUL9;ABL1;UBE2D3;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;PTPN13;KEAP1;PTP4A2;MAPKAPK2;UBE2F;CHEK2;FBXL2;PSMD1;RPN2;PDP1;USP25;BMPR1A
prerank,acylglycerol metabolic process (GO:0006639),-0.3176415889108022,-1.0646279100517873,0.3076923076923077,0.7522103004163905,1.0,18/37,27.40%,DGKH;DGKB;PLAAT3;MGLL;SEL1L;DGKI;ABHD12;DGKG;ABHD2;LPL;PNPLA3;DGAT2;DGKZ;DGKQ;DGKK;GK5;PNPLA2;AWAT2
prerank,cytoplasmic microtubule organization (GO:0031122),0.383754876586647,1.0645928573189731,0.3800738007380074,0.9359366037502268,1.0,20/54,24.71%,LIMK2;CLIP4;PLK3;CHP1;EZR;HOOK1;VPS4B;RHOA;CCDC88A;CAMSAP1;DYNC1H1;NUMA1;KATNAL2;TUBGCP5;HOOK3;MAPT;TRPV4;PCM1;SLK;CEP126
prerank,phagosome acidification (GO:0090383),0.43222552814544385,1.0643318492117684,0.36775106082036774,0.9358764091765437,1.0,7/26,19.75%,ATP6V1B1;RAB7A;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,activation of protein kinase B activity (GO:0032148),-0.33223584929128613,-1.0641936903354647,0.3694915254237288,0.7519805793993881,1.0,5/29,5.93%,IGF1;INSR;WNT5A;GAS6;IL18
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.39952257618231446,-1.063941041109668,0.3663101604278075,0.7512087174053595,1.0,6/14,32.78%,MRNIP;FANCB;WDR48;ERCC6;WRAP53;RAD51AP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.4135756878168798,1.0637951665308414,0.37916666666666665,0.9366177599226159,1.0,9/28,15.66%,DMTN;ANK3;CHP1;MIEF2;MYO1C;KCNB1;HRAS;ITGB1BP1;ITGB2
prerank,regulation of cholesterol efflux (GO:0010874),0.4209630561150681,1.0633647787920817,0.423943661971831,0.9370153801192748,1.0,4/30,5.36%,SREBF2;CAV1;TTC39B;NFKBIA
prerank,stress granule assembly (GO:0034063),0.43357207347176036,1.0632993011354952,0.39046199701937406,0.9363949145471648,1.0,7/20,20.10%,YTHDF1;PRRC2C;ATXN2L;DYNC1H1;UBAP2L;YTHDF3;MAPT
prerank,regulation of Notch signaling pathway (GO:0008593),0.36882890435762644,1.0629485139795187,0.3814553990610329,0.936607777372108,1.0,8/76,4.47%,TSPAN5;WNT1;PRAG1;ELF3;SREBF2;NIBAN2;EP300;WWP2
prerank,cell projection organization (GO:0030030),0.41959054874349444,1.0627179618404328,0.3736111111111111,0.9364343136178535,1.0,6/30,16.16%,PARVA;GSN;RHOQ;CDC42;RHOU;KIF17
prerank,potassium ion transport (GO:0006813),0.34873080155272757,1.062481140815832,0.38232044198895027,0.9362887028174488,1.0,17/120,14.04%,SLC9A2;SLC9A4;HPN;NALCN;ATP1A2;KCNJ13;ABCC8;CHP1;KCNA4;SLC9A6;SLC9A7;KCNB1;AQP1;PKD2L1;KCNA5;KCNQ5;TMEM175
prerank,RNA interference (GO:0016246),0.45909720597674475,1.0624384642495432,0.39593114241001565,0.9355548148829832,1.0,5/17,16.64%,CELF1;TARBP2;TSNAX;DHX9;CLP1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4164609154762455,1.0623591717955587,0.39697802197802196,0.9349756693262881,1.0,10/30,19.02%,CAV1;PPP2CA;DMTN;SRCIN1;PTPN6;MVP;PTPN2;SFRP1;PRKCZ;SH3BP5L
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.36874409951952725,1.0617454208477237,0.38615023474178406,0.9359154551487752,1.0,10/76,10.46%,BAIAP2L1;NTRK3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;HAX1;CDC42;BCAS3
prerank,positive regulation of protein processing (GO:0010954),0.45879284482481886,1.0613871142244804,0.41002949852507375,0.9361311488951359,1.0,5/19,13.98%,HPN;GSN;KLKB1;LPCAT3;PLGRKT
prerank,establishment of endothelial barrier (GO:0061028),0.4285207573843649,1.0613543842794306,0.4076607387140903,0.9354026664209795,1.0,10/29,15.45%,TJP2;TJP1;RAP1B;RAP1A;MSN;EZR;RAPGEF3;RAB1B;RAPGEF1;RAP2C
prerank,regulation of vasculogenesis (GO:2001212),-0.405789709271687,-1.0613064095427367,0.37057220708446864,0.7570815763386844,1.0,5/14,4.75%,RAPGEF2;XDH;CD34;KDR;TMEM100
prerank,"wound healing, spreading of cells (GO:0044319)",0.43625328957842774,1.0612309282309933,0.383638928067701,0.9349370668760518,1.0,8/24,15.67%,CD44;TMEFF2;TOR1A;RHOA;MMP12;PDPN;DDR1;FLNA
prerank,protein-DNA complex disassembly (GO:0032986),0.45733176340481496,1.061152080130736,0.3932411674347158,0.9343195426148524,1.0,7/16,16.27%,GRWD1;SMARCB1;SMARCA4;SMARCD2;MYC;SET;SMARCC1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.44823881228736895,1.0609211137960792,0.3781021897810219,0.934182134938548,1.0,8/20,16.86%,IMPDH2;PAICS;NT5C2;GMPS;AK3;GART;AMPD2;ADSS2
prerank,cellular copper ion homeostasis (GO:0006878),0.47704837133023525,1.0608359686656599,0.4028892455858748,0.9335690190214863,1.0,6/14,23.40%,COX19;SLC31A2;CCDC22;ABCB6;APP;MT2A
prerank,regulation of lipid storage (GO:0010883),0.44268582005635265,1.0604443364584533,0.3979591836734694,0.9339098110537951,1.0,8/22,23.93%,ZC3H12A;IKBKE;NFKBIA;PTPN2;HILPDA;FBXW7;FTO;IL6
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.42731853886752325,1.060172955789861,0.40599455040871935,0.9338725518285124,1.0,4/27,7.79%,CPA4;EP300;KAT6B;MORF4L2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3941919737364837,1.0600378450581978,0.3955321944809461,0.9334397839908022,1.0,14/44,20.02%,OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;MSMO1;OSBPL7;SQLE;TM7SF2;OSBPL2;PARK7;HSD17B10
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.364048884997761,1.0598478298836176,0.35064935064935066,0.9332071498424737,1.0,15/85,12.90%,CELSR1;WNT1;MAGI2;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;FZD5;CDC42;PSMD7;AP2A1;RHOA;PSMB5
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.26835357505175716,-1.0597636358668694,0.34394904458598724,0.7597470695401255,1.0,29/72,25.34%,LIFR;GAS6;AXL;IRAK2;RUNX1;IRAK3;IFNGR1;IFNGR2;IFNAR2;JAK2;CFLAR;RBCK1;RIPK1;RACK1;CD74;CDC37;VRK2;TRADD;TNFAIP3;AGPAT2;HSP90AB1;TRAF1;SPHK1;SOCS3;CYLD;SIGIRR;BIRC2;AGPAT1;PYCARD
prerank,translational termination (GO:0006415),0.36174561705542013,1.059343746329634,0.37911464245175935,0.933869979114801,1.0,43/95,28.39%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;GSPT2;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;TRMT112;MTRF1L;ETF1;MRPL19;MRPL14;MRPL32;AURKAIP1;N6AMT1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.39386436337661934,1.0591992967902688,0.3859191655801825,0.933463783572439,1.0,12/44,20.21%,CD44;KLF4;NGF;RAF1;CARD16;AQP1;IGBP1;XIAP;TRIAP1;CDKN2D;BEX3;ARL6IP1
prerank,copper ion homeostasis (GO:0055070),0.46362482814239747,1.0591113124462463,0.3971518987341772,0.9328848644151679,1.0,7/17,23.40%,COX19;SLC31A2;CCDC22;XIAP;ABCB6;APP;MT2A
prerank,brain development (GO:0007420),-0.24415422763919237,-1.058902245387765,0.3287671232876712,0.7606942554587327,1.0,35/136,15.57%,EPHA7;ARNT2;CNTNAP2;RAPGEF2;CDH2;ADGRL3;SHANK3;EML1;GRIN2A;AFF2;COL4A1;SYNJ2;CHD8;ROBO2;GRIN2B;CTNNA2;ZFHX2;DSCAML1;TUBGCP2;UBE3A;NES;SPEF2;NNAT;NF1;PAFAH1B2;EEF1AKMT4-ECE2;MEIS1;TBC1D23;PCDH18;NIPBL;MFSD2A;TMX2;SOX6;MEIS2;HSPG2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.43557218183794844,1.0587665578673635,0.3963585434173669,0.9330491216721442,1.0,2/25,2.17%,B3GALT1;B4GAT1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.348848335531394,1.0587176434798058,0.3913978494623656,0.9323885160553433,1.0,31/132,15.38%,RNF152;PRKAA2;TPCN1;ZC3H12A;ABCD1;ABHD5;FOXO3;DAPK1;MTDH;ORMDL3;SH3BP4;MOV10;PFKFB2;MSN;TRIM21;BAD;MTLN;EZR;TWIST1;SNX33;VPS11;IRS2;ZSWIM8;TFEB;GSK3A;ULK1;GSK3B;FLCN;GRSF1;PLK2;HSP90AA1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.45324106145228166,1.0585910418356346,0.42263610315186245,0.9319064218252905,1.0,5/22,13.54%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,regulation of myoblast differentiation (GO:0045661),-0.32328286025903585,-1.0584319453002407,0.3551020408163265,0.7605796954978244,1.0,8/32,10.88%,PLCB1;BOC;TBX3;NOTCH1;TGFB1;BTG1;LRRC8A;SRA1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33383958169964423,1.0583356349578368,0.36382322713257964,0.931861614229439,1.0,56/259,18.73%,RAB17;CDH13;CYS1;SRGAP2;ABLIM2;ACTN2;ABLIM1;PARVA;EMP2;GSN;RAP1B;RAP1A;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;DMTN;GOLPH3;IFT46;EXOC7;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;OPHN1;EZR;EXOC2;ARFIP2;ANO6;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;CCDC88A;ATP6V1D;RAP2C;ATP6V0D1;FLNA;FSCN1;TMEM138;PTPDC1;VCL;RAB8B;HDAC6;RILPL1;SHTN1;FHDC1;ARHGEF6;WDR35;GALNT11
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4067701232229415,1.057579502430181,0.37566137566137564,0.9332253502257748,1.0,6/40,8.80%,CLU;PTK2B;NUB1;DESI1;LATS1;PML
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4698544523127669,1.0574050071940024,0.41297935103244837,0.9329189315209223,1.0,4/18,7.49%,PMAIP1;BCL2L1;MUL1;BAD
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37306974549110133,-1.0572705833870122,0.38328530259365995,0.7622237048266494,1.0,8/17,10.34%,TMEM100;FGF2;VEZF1;ATOH8;BTG1;AHI1;SFRP4;RFX3
prerank,phosphate ion transport (GO:0006817),0.4690785638990565,1.057250276058755,0.390625,0.9325634259812096,1.0,4/16,14.52%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,response to copper ion (GO:0046688),0.43574481778341295,1.0569592270840569,0.3786259541984733,0.9325912657297097,1.0,1/20,0.93%,DAXX
prerank,protein kinase B signaling (GO:0043491),0.4374595167274568,1.0569282573461123,0.3834048640915594,0.9318603628976486,1.0,4/23,7.57%,ADTRP;CCL5;TSC2;PLK3
prerank,positive regulation of cytokine production (GO:0001819),-0.2185516282384748,-1.056859665560273,0.17857142857142858,0.7619446375744937,1.0,51/292,14.06%,PLCB1;SULF1;IL1R1;CCBE1;AFAP1L2;PDE4D;NOD1;PLA2R1;CADM1;HIF1A;WNT5A;TMED10;SLC7A5;CD34;GLMN;LGALS9;CYP1B1;RUNX1;SPTBN1;RFTN1;GBP5;IL18;PTGS2;RGCC;RORA;TGFB1;LRRFIP1;IL6R;IL33;PDE4B;TBK1;CRCP;PIK3CD;CD46;TRAF6;STAT3;MBP;TIRAP;ARHGEF2;PNP;POLR3A;RIPK1;IL6ST;DDIT3;DRD2;IL17D;POLR2F;FLT4;POU2F2;STAT6;CYRIB
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3829481302182235,1.0567664742741836,0.38461538461538464,0.9315301575944327,1.0,7/54,8.66%,NXN;OGT;CAV1;PRR7;SH3RF2;TRIM21;CHP1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.31726564052992745,-1.056733432551705,0.3592592592592593,0.7608211483963554,1.0,10/33,14.77%,DNAJC6;DNM3;SYNJ2;SYT1;NLGN1;ITSN2;STON2;NLGN3;AMPH;FCHO2
prerank,protein destabilization (GO:0031648),0.41662363665418967,1.0561403115555577,0.38778220451527223,0.9325183347303374,1.0,8/32,18.72%,GSN;EP300;MUL1;TRIM21;SERF2;MDM2;CTSH;PEX2
prerank,tryptophan catabolic process (GO:0006569),0.5011618742883012,1.0560025095909509,0.40553745928338764,0.9321153210142245,1.0,4/11,24.55%,TDO2;HAAO;KYAT1;KMO
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4462190330306823,1.0551729883472147,0.3994082840236686,0.9336685211548778,1.0,5/20,15.68%,CLU;HSPA4;MKKS;HSP90AA1;PTGES3L
prerank,membrane assembly (GO:0071709),0.41480076859008785,1.0548792337191917,0.3914835164835165,0.9336857356205246,1.0,14/34,19.48%,EMP2;S100A10;PTPRD;FLOT2;ANK3;ANXA2;NSFL1C;CHMP4B;TLCD2;VPS4A;CHMP2A;NLGN2;STX4;FLOT1
prerank,activation of protein kinase activity (GO:0032147),-0.25135714929392955,-1.0548533922436538,0.3711340206185567,0.7643549343826855,1.0,24/106,12.51%,IGF1;GHR;INSR;ADCY5;TNIK;NRK;PAK3;WNT5A;GAS6;STK3;ADCY7;CARD10;IL18;ADCY1;ADCY4;JAK2;PRRC1;STRADA;PRKAR2B;MAP4K4;TRAF6;TIRAP;TOM1L1;TXN
prerank,mitochondrial translational termination (GO:0070126),0.36135876061753774,1.0546993533521454,0.38522727272727275,0.9333916890112012,1.0,39/88,28.39%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4700520973995735,1.0544957253695573,0.4078740157480315,0.9331802124261337,1.0,5/16,14.84%,NAPEPLD;ZBTB7B;SIX1;RREB1;FLCN
prerank,regulation of protein export from nucleus (GO:0046825),0.4368482489793337,1.0538644057740667,0.4034833091436865,0.9341661256169272,1.0,9/23,22.77%,PTPN14;TCF7L2;BAG3;RAPGEF3;GSK3B;PARK7;XPO4;SIRT7;TPR
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3220121574448211,-1.0537907176093537,0.35766423357664234,0.765812252157758,1.0,8/29,10.70%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.38849087227710183,1.0537169714154762,0.3984476067270375,0.9337749896361963,1.0,12/47,14.10%,NAPEPLD;ZC3H12A;CREBL2;ZBTB16;CREB1;WDFY2;ZBTB7B;AAMDC;SIX1;TRPM4;RREB1;SFRP1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4261204282942233,1.0536538901035415,0.41117478510028654,0.9331743171662701,1.0,1/24,0.14%,SORBS1
prerank,anion transport (GO:0006820),-0.3225697192413768,-1.0533477710553782,0.35826771653543305,0.7655555846427327,1.0,4/33,1.71%,SLC13A3;LRRC8C;SLC26A7;SLCO2B1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.39502673809764893,1.052821940926205,0.412987012987013,0.9346646790019364,1.0,8/43,9.64%,CDH13;MMP9;CCL5;BMP4;MEF2D;JUN;ADAMTS1;HTR1B
prerank,regulation of isotype switching (GO:0045191),0.4830768641257867,1.052647951195942,0.40717628705148207,0.9343635713554956,1.0,3/14,9.56%,SHLD2;PARP3;RIF1
prerank,translation (GO:0006412),0.34054369305033155,1.052268790134305,0.3962655601659751,0.9346043434653566,1.0,88/208,28.39%,MRPS16;EEF1A1;EPRS1;QARS1;MRPL24;MRPL37;MRPL2;VARS1;FARS2;HARS1;TMA7;RPS4X;MRPS7;ABCF1;RPL31;RPSA;MRPS34;LARS2;GSPT2;RPL22;AARS1;MRPS33;RPL28;SRBD1;RPS26;MRPL9;COPS5;MRPL57;EEF1D;EEF1E1;HARS2;TARS1;RPL10A;MRPS15;SARS2;SARS1;EIF4G1;YARS1;TNIP1;MRPS18C;MRPS28;RPL14;RRBP1;EEF2;RPS27A;GATB;FARSA;HBS1L;IGF2BP3;DARS2;EIF4EBP2;RPL6;FARSB;TRMT112;RPS28;ETF1;RPL41;NARS1;EEF2K;RPLP2;YARS2;RPLP1;RPL7;IGHMBP2;MRPL32;RPL21;N6AMT1;RPL26;KARS1;MRPS21;RPS27;MRPS12;RPS12;FTSJ1;RPL18;MRPL35;RPS17;GFM2;PTCD3;RPS3;LARS1;RPL22L1;MRPL18;MRPS6;RSL24D1;RPL24;EEF1A2;MRPS24
prerank,peptide catabolic process (GO:0043171),-0.34333836710582655,-1.05201195349503,0.3707482993197279,0.7677532501188438,1.0,6/23,12.62%,ECE1;GGT5;ACE;TPP1;CPQ;ENPEP
prerank,cytosolic calcium ion transport (GO:0060401),0.41828685412979544,1.0519268902232701,0.39645776566757496,0.9347897519991636,1.0,9/28,11.89%,MCU;CACNB3;MCUB;MICU1;JPH2;AFG3L2;ITPR3;MCUR1;JPH3
prerank,negative regulation of response to stimulus (GO:0048585),0.38303615265995195,1.05182008389108,0.3926829268292683,0.9342851552525537,1.0,14/60,14.21%,CLU;KLF4;CDK6;ALOX5;MAPK7;KLF7;ERBB3;FBXO5;FOXP3;CASK;TWIST1;LPCAT3;TLE5;BRAP
prerank,nucleic acid-templated transcription (GO:0097659),0.3877541820661819,1.051602796127026,0.39819587628865977,0.934105404015549,1.0,10/42,18.70%,THRB;CREBL2;POLR2H;NKX2-8;POLR2A;PTMA;RNPS1;E2F1;POLR2C;POLR2E
prerank,RNA processing (GO:0006396),0.34133705118576285,1.0509176125703847,0.3757894736842105,0.9351976271174961,1.0,47/176,20.33%,MBNL1;CELF2;PPARGC1A;SRSF2;CELF1;YJU2;PPP2CA;SON;SNRPB;RNASEL;LSM4;DDX39B;RBM8A;TENT4A;XRN2;LUC7L3;SF3B3;USP39;SRPK2;SRRM4;SRSF7;DDX47;SF3A2;ZCCHC8;SRPK1;HNRNPUL1;SYNCRIP;TUT7;RNPS1;SRSF9;PABPN1;DUSP11;MAGOHB;MAGOH;CLP1;PRPF6;TSEN2;RBMS2;SRSF1;PTBP1;SRSF5;ZMAT5;CSTF3;WBP4;SF3A3;DDX20;THOC1
prerank,regulation of cell cycle phase transition (GO:1901987),0.3542948734539069,1.0505345647814102,0.3931818181818182,0.9355076604678728,1.0,14/91,18.10%,FZR1;CDKN1A;PSMD11;PSMD4;PSMF1;FBXO5;PSMD7;PSMB5;ANAPC4;ATP2B4;DDB1;ERCC2;PSMD1;PSMC4
prerank,negative regulation of cell aging (GO:0090344),0.47659772296578023,1.0502151304479728,0.4109985528219971,0.9355675394288844,1.0,9/16,21.57%,WNT1;CDK6;FOXM1;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,mitochondrial fusion (GO:0008053),0.44717695348170666,1.0502031056447079,0.41310975609756095,0.9348022232231126,1.0,8/18,21.31%,CHCHD3;AFG3L2;MIEF2;THG1L;OPA1;SPG7;STOML2;MIEF1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3584611761686632,1.0500013741221974,0.38738738738738737,0.934592930628221,1.0,12/93,10.23%,WNT16;MAP3K5;EDA2R;CCN2;ZC3H12A;PTK2B;SH3RF2;MAP3K4;TGFB2;RELL1;EMC10;ARL6IP5
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.4420002597353484,-1.0497393985056869,0.3925925925925926,0.7725591276524579,1.0,2/10,4.05%,LYN;FAS
prerank,regulation of interleukin-4 production (GO:0032673),-0.35324473290299296,-1.049554586455935,0.36451612903225805,0.7715688834312351,1.0,3/21,4.50%,LEF1;SLC7A5;LGALS9
prerank,modification-dependent protein catabolic process (GO:0019941),0.3340339354470533,1.0495456355495905,0.38645833333333335,0.9350874479048706,1.0,34/193,17.31%,FZR1;FBXL7;PCYOX1;RNF43;SPSB4;RNF5;TRIM25;PSMD11;NUB1;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RBX1;RNF146;UBE2B;PPP1R11;RNF126;WDR91;ANAPC4;NPLOC4;UBE4A;NEDD4;UBE2H;MDM2;BFAR;UBA6;DDB1;RPS27A;UBC;SIAH1;KEAP1;STUB1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.46081450727965517,1.0492412708569077,0.4107946026986507,0.9351466297674615,1.0,6/16,23.69%,SHOC1;CENPS;RMI1;ERCC4;TOP2B;FANCM
prerank,canonical glycolysis (GO:0061621),0.4364081857941702,1.0490909839389946,0.386066763425254,0.9339575026918173,1.0,8/24,16.09%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4364081857941702,1.0490909839389946,0.386066763425254,0.9339575026918173,1.0,8/24,16.09%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,response to reactive oxygen species (GO:0000302),0.3856931829644909,1.0490600165249528,0.4077791718946048,0.9332637679893648,1.0,14/54,14.95%,MMP9;FOS;PXN;PLK3;ROMO1;JUN;MAPK9;SOD2;HP;AGAP3;PDK2;COA8;CHUK;APTX
prerank,regulation of protein phosphorylation (GO:0001932),0.33267075706917515,1.0489155369784486,0.3829787234042553,0.932888754230337,1.0,34/256,10.50%,FN1;ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;OCLN;ZC3H12A;MAVS;SESN2;PPP2CA;KDM4D;HSPB1;FBLN1;TWF1;EFNA5;KRAS;SOX9;WDFY2;MYDGF;BMP4;CCND2;ILK;DVL3;FGF22;PIP5KL1;CHP1;VEGFB;PML;FKBP8;CCND1;MUSK;HDAC3
prerank,positive regulation of integrin activation (GO:0033625),0.4793184892006541,1.0488852541306792,0.415,0.9321809975286749,1.0,1/11,2.26%,RAP1B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4747528133402271,1.048674081786384,0.4207221350078493,0.9319948612932861,1.0,3/15,11.20%,EHD1;RIPOR2;RAPGEF3
prerank,positive regulation of programmed cell death (GO:0043068),0.3330164796351022,1.0484403034122864,0.3861082737487232,0.9318971153239561,1.0,70/272,20.75%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;AKAP13;TNFAIP8;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;HOXA5;ARHGEF18;BMP4;PNMA2;BAD;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;TRIO;APBB1;ARL6IP5;GNA13;GADD45B;MARK4;ANO6;HRK;SOS2;RNPS1;EEF1E1;ING4;SFRP1;BNIP3L;DNM1L;FLCN;IP6K2;ARHGEF1;FRZB;RPS27A;UBC;E2F1;ABL1;SIAH1;PLEKHG2;HDAC6;PIDD1;SLC27A4;ARHGEF6;GPER1;MTCH1;GPLD1;UBE2Z;DDX20;SOX4;PRMT2;ZBP1;APH1A
prerank,natural killer cell mediated immunity (GO:0002228),0.46123286976582856,1.0484352822527518,0.44568690095846647,0.9311200879925656,1.0,1/15,1.91%,RAET1E
prerank,response to fatty acid (GO:0070542),-0.3707989399624255,-1.0484270586833364,0.39072847682119205,0.7732678619408977,1.0,2/17,3.91%,PID1;FOXO1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3383327378330983,-1.0484239190844649,0.3691275167785235,0.771815701346207,1.0,8/26,12.76%,NRXN1;SHANK3;SLC8A3;LRRK2;NLGN1;MTMR2;TMEM108;NLGN3
prerank,ceramide metabolic process (GO:0006672),0.38070934905830334,1.0480631310694386,0.38902743142144636,0.9313842452384582,1.0,5/49,5.86%,SPTSSB;SGMS2;PPP2CA;ORMDL3;AGK
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3534322559248557,-1.047829157275597,0.37797619047619047,0.7719776704796567,1.0,9/20,22.25%,ENG;ACVRL1;TBX3;NOTCH1;HEYL;PDCD4;SPRY1;HEY2;HEY1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.38340938046450873,-1.0476112367019106,0.3824451410658307,0.7711374282599988,1.0,4/18,7.31%,CLASP2;RUNX1;RGCC;TGFB1
prerank,regulation of response to external stimulus (GO:0032101),0.347667142342202,1.0475276683805332,0.37363834422657954,0.932134500170981,1.0,9/121,6.43%,CD55;AGTR1;EFNB2;GUCY2F;CAV1;CELF1;CXCR4;ALOX5;AKNA
prerank,cell-cell junction assembly (GO:0007043),0.3750240620181717,1.0473483499559229,0.39383155397390274,0.9318546674959031,1.0,11/63,11.76%,CLDN11;TJP1;PKP4;CTNNA1;GJB6;CD9;PATJ;PARD6B;ACTB;ACTG1;RHOA
prerank,regulation of protein transport (GO:0051223),0.4214579594568193,1.047072444992686,0.4035812672176309,0.9318729824023384,1.0,6/27,13.94%,NDEL1;WWP2;CHP1;LLGL2;SNX12;RHBDF2
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3372647632363206,-1.0469728093513055,0.3859060402684564,0.7716015053014658,1.0,9/24,18.58%,ERRFI1;PRKCH;RUNX1;ROCK1;HOXA7;CTSL;SGPP1;ZFP36;NME2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.37753876530675967,1.0469180480466747,0.4084848484848485,0.9315306542950015,1.0,15/53,16.53%,DDX5;EYA2;PMAIP1;NSMCE4A;SPRED3;EYA1;TIGAR;ABRAXAS1;FXR1;MYC;EEF1E1;DHX9;PCNA;UBE2N;ATR
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.41754409489653704,-1.0463775831479745,0.3979328165374677,0.7717953374248457,1.0,6/11,32.05%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,negative regulation of viral genome replication (GO:0045071),0.39741910071097075,1.0462607315039594,0.40379746835443037,0.932609928311415,1.0,9/40,15.50%,CCL5;MAVS;SLPI;RNASEL;SRPK2;SRPK1;SETDB1;TNIP1;OAS2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4459643158106532,1.0456758835513649,0.424597364568082,0.9334871882287836,1.0,6/20,11.92%,DGAT1;SLC25A1;ACSL3;ACACA;SCD5;FASN
prerank,translational elongation (GO:0006414),0.3542297540014466,1.04550702954626,0.3984287317620651,0.9331897461312424,1.0,23/101,16.10%,MRPS16;MRPL38;EEF1A1;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;LTN1;MRPS33;MRPS27;MRPL9;MRPL57;EEF1D;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;EEF2
prerank,carnitine shuttle (GO:0006853),0.5004807574552164,1.0450531865398496,0.42649434571890144,0.933672892301526,1.0,4/11,12.65%,PRKAA2;CPT1B;ACACA;CPT2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4889629791062439,1.044774740844871,0.41788617886178864,0.9337105550139955,1.0,4/13,13.12%,NAPEPLD;ZBTB7B;SIX1;RREB1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.27024681954207075,-1.0446007438170117,0.35374149659863946,0.7751303244274684,1.0,24/74,20.10%,IGF1;SH3RF1;AR;NOS3;EYA4;FAS;THBS1;BCL2;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;ITGA6;ITGAV;GPX1;PELI3;ICAM1;ZMYND11;RNF34;FAIM2;TRADD;TNFAIP3;SIAH2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4118440100763618,-1.0442906659024507,0.39746835443037976,0.774567457178909,1.0,5/11,25.33%,GRK3;ARRB1;ADM;SAG;ARRB2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.36680060468693054,1.0440032741008303,0.3981042654028436,0.935050855086797,1.0,13/66,9.75%,KLF4;LSM10;CDKN1A;CDK6;FHL1;KANK2;CDK4;CCND2;PKD1;ADAMTS1;BRD7;PTPN6;CCND1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4874711378271736,1.0438553699989717,0.43140495867768597,0.9346919544631389,1.0,2/11,9.99%,RNF5;TOR1A
prerank,cellular zinc ion homeostasis (GO:0006882),-0.33742789516987104,-1.0438306182274506,0.38,0.774345648545296,1.0,5/26,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,activation of protein kinase A activity (GO:0034199),-0.3826551788165924,-1.0436585473134254,0.3971830985915493,0.7733931989217607,1.0,10/16,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;PRRC1;PRKAR2B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3154604571948859,-1.0433921837284352,0.40074906367041196,0.7727027518272679,1.0,5/31,9.11%,ENG;ZFPM2;NOTCH1;TGFB1;FGFR2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.45244200615280283,1.0432823241114764,0.4225352112676056,0.9355873006776809,1.0,5/17,14.98%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1
prerank,error-free translesion synthesis (GO:0070987),0.4304580681271985,1.0430401247377985,0.40782122905027934,0.9354994728733775,1.0,11/22,27.17%,REV1;NPLOC4;RPA3;POLH;PCNA;RPS27A;UBC;RFC1;RCHY1;RPA2;POLD1
prerank,histone H3-K4 methylation (GO:0051568),0.42017616870661123,1.0429337973743897,0.4206128133704735,0.9350258050435224,1.0,10/26,23.68%,OGT;BEND3;KMT2A;KDM6A;DYDC2;MEN1;KMT2B;CTR9;KMT2C;CXXC1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3130593724211985,-1.0428139264438239,0.40441176470588236,0.772824592165522,1.0,11/31,28.86%,PLCB1;LGALS9;TIRAP;HMGB1;CD40;HSPD1;MAPK14;CCL19;RIPK2;MAPK11;PLCG2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4583633034127131,1.0426832300641609,0.43788819875776397,0.9349870128098643,1.0,3/16,13.54%,PLCB3;KLK1;GSK3A
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.47655783822503706,1.042428857428458,0.4270516717325228,0.9349182591699469,1.0,3/14,6.27%,MMP9;CAV1;SPRED3
prerank,response to cholesterol (GO:0070723),0.45188869519237446,1.0421384957522795,0.41021897810218977,0.9349687927216622,1.0,5/17,12.15%,SMO;PMVK;ABCA2;OSBPL7;TGFBR2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4383907472847675,1.0420603904653085,0.4310099573257468,0.9344255463674797,1.0,7/21,11.64%,MCU;MCUB;MICU1;AFG3L2;BCAP31;MCUR1;LETM1
prerank,protein autoprocessing (GO:0016540),-0.3724119793750511,-1.041937212496603,0.37433155080213903,0.7737842807535975,1.0,7/17,22.35%,FAM111A;CASP4;CTSL;FXN;MYRF;HTRA2;SPRTN
prerank,apoptotic mitochondrial changes (GO:0008637),0.40928352922769773,1.041854734001753,0.3850267379679144,0.9342151673877312,1.0,5/32,10.71%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,negative regulation of vascular permeability (GO:0043116),-0.4090026358584439,-1.0418137130677154,0.41644562334217505,0.7726429182131404,1.0,6/12,9.95%,PTPRJ;PDE3A;CLDN5;SLIT2;RAMP2;PDE2A
prerank,organic hydroxy compound transport (GO:0015850),-0.308997161144163,-1.041595848174732,0.38589211618257263,0.7718166288259785,1.0,5/36,7.18%,ABCC4;SLCO2B1;SLCO1C1;NCOA1;SLC16A1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3544298505588205,1.041497805083431,0.3902714932126697,0.9344432246382514,1.0,18/79,17.03%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,response to retinoic acid (GO:0032526),0.3663770977486718,1.040508864756812,0.40644361833952913,0.9364583203554384,1.0,12/59,12.43%,PTK7;WNT11;PTK2B;WNT6;RARG;CREB1;RXRB;SOX9;WNT5B;AQP1;EPHA3;WNT3
prerank,ethanol metabolic process (GO:0006067),0.48931644529242463,1.040442561217571,0.4223300970873786,0.9358708303340525,1.0,2/12,2.95%,SULT1A1;ADH7
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.35177967270534743,1.0403993130854288,0.40656851642129105,0.9352229594931787,1.0,20/100,15.24%,CLU;OGT;TRIB2;FHIT;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;DESI1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2
prerank,blood vessel diameter maintenance (GO:0097746),0.40248859076284565,1.0403711882437214,0.4133148404993065,0.9345339144875687,1.0,1/34,0.18%,AGTR1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3171488569163832,-1.0402687454115658,0.42084942084942084,0.773864490666362,1.0,8/32,11.59%,ADGRB3;IL1RAPL1;RAPGEF2;TNIK;HECW1;SDC2;KNDC1;CDKL5
prerank,positive regulation of MAPK cascade (GO:0043410),0.3304562669537578,1.0397825365154718,0.38556701030927837,0.9354958601293873,1.0,19/245,6.64%,ADRA1B;FGFR1;ANGPT1;CD44;LPAR1;NOTCH2;NTRK3;CCL5;JCAD;PDGFC;CCN2;GDF15;RAP1A;PTK2B;GCNT2;ACKR3;CAV2;SHC1;MYDGF
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.41346927322011584,1.0394764004450379,0.4016393442622951,0.9355347820834237,1.0,3/27,8.54%,AGTR1;NFKBIA;MAPK9
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.39843606893379035,-1.0389928771489416,0.4005524861878453,0.7758171321891598,1.0,3/13,3.42%,SLC8A1;PDE4D;CAMK2D
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40194921255246585,1.03892161667575,0.41374837872892345,0.9363380988327205,1.0,6/33,8.42%,ANGPT1;NUPR1;NFE2L2;MAPK7;KRIT1;TCF7L2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.43719690149410617,1.038792589693476,0.41522988505747127,0.9359262194193005,1.0,11/21,18.80%,DAPK3;EFNA5;PTPRA;ACTG1;EPHA3;RHOA;VCL;SLC9A1;DUSP3;PEAK1;ROCK2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4223305491355286,1.038763275805564,0.43,0.9352452254005225,1.0,3/23,7.31%,RAET1E;LAMP1;PVR
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3432177051897039,1.038626155809516,0.43626373626373627,0.9348283401393851,1.0,15/121,7.65%,ANGPT1;CD44;CRLF1;CCL5;EPHA4;IL15;CD81;PTK2B;CLCF1;EPO;UNC119;EFNA5;HAX1;ERBB3;SRCIN1
prerank,pharyngeal system development (GO:0060037),0.47046237447302264,1.038386544498091,0.4233687405159332,0.9347292716489203,1.0,5/15,17.76%,BMP5;BMP4;TGFB2;GATA3;BMPR1A
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.40794131365336134,1.0378520591773557,0.4186666666666667,0.9354723186849576,1.0,14/33,24.27%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2;ZBTB48
prerank,DNA integrity checkpoint signaling (GO:0031570),0.39422891949427274,1.0376672301310728,0.40992167101827676,0.9352289717062149,1.0,11/36,17.50%,DOT1L;HUS1B;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;NBN;CHEK2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3330456717104868,-1.0374296231713744,0.38697318007662834,0.7786621237430059,1.0,7/30,13.19%,FLT1;KDR;ACE;TGFB1;KIT;TP53;FLT4
prerank,negative regulation of binding (GO:0051100),0.35596549676196354,1.0372362282500855,0.41149943630214203,0.9356515728765199,1.0,23/81,19.06%,CFHR1;SMO;CDKN1A;GTF2F1;CAV1;SLPI;NFKBIA;CTSZ;JUN;SUMO3;ACTB;CARD16;HABP4;CSNK1E;TLE5;GSK3B;ITGB1BP1;E2F1;KDM1A;BTAF1;WAPL;PARK7;ILRUN
prerank,positive regulation of immune effector process (GO:0002699),-0.33533301644980584,-1.0370662019386414,0.4155405405405405,0.7782416894050546,1.0,5/27,9.92%,PTPRJ;LGALS9;APPL2;DDX60;CD46
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3861885813165795,1.036953564118516,0.4012738853503185,0.9356794042047769,1.0,5/48,4.59%,FGFR1;ANGPT1;JCAD;FOXC2;HSPB1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4684711521195692,1.036775925787485,0.4521604938271605,0.935413520146244,1.0,2/15,5.85%,CLU;BCL2L1
prerank,pyruvate metabolic process (GO:0006090),0.3785388700308286,1.0366153407532774,0.4081381011097411,0.9351005359679428,1.0,13/52,16.09%,HAGH;ME3;HKDC1;PKM;LDHB;PFKFB2;LDHAL6B;ENO2;HK1;VDAC1;ALDOA;GAPDH;TPI1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.33570737854043364,1.0365420273929902,0.40641711229946526,0.9345227262062813,1.0,32/152,14.45%,SCEL;KANK1;RSPO3;PTK7;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;WNT5B;LGR4;PPM1A;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;SMARCA4;CSNK1E;TRPM4;SPIN1;PSMB5;CAPRIN2;SFRP1;UBR5;WNK1
prerank,regulation of cell aging (GO:0090342),0.4954429276240172,1.0364179718241677,0.4129353233830846,0.9341087053533487,1.0,2/11,6.12%,WNT1;FOXM1
prerank,positive regulation of apoptotic process (GO:0043065),0.32716120772729945,1.0360005893538429,0.40040444893832156,0.934499073511689,1.0,65/293,17.54%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;NUPR1;AKAP13;ZC3H12A;TNFAIP8;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;HOXA5;ARHGEF18;BMP4;PNMA2;TGFB2;BAD;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;TRIO;APBB1;ARL6IP5;SRPK2;DLC1;GNA13;GADD45B;ANO6;HRK;SOS2;RNPS1;EEF1E1;PRDM11;ING4;TLE5;SFRP1;BNIP3L;DNM1L;FLCN;IP6K2;ARHGEF1;FRZB;BACE1;RPS27A;UBC;E2F1;ABL1;SIAH1;PLEKHG2;PIDD1
prerank,intracellular lipid transport (GO:0032365),0.43166959346577183,1.0359350901399917,0.4177396280400572,0.9339084774734269,1.0,6/21,15.83%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2;CERT1
prerank,membrane repolarization during action potential (GO:0086011),-0.4061610883904702,-1.0357729864891165,0.4312169312169312,0.7802795299022729,1.0,4/13,23.55%,ATP1B1;KCNJ2;KCNIP2;YWHAE
prerank,cellular response to osmotic stress (GO:0071470),0.43180917615793213,1.0353051909438775,0.41743119266055045,0.9349203628323548,1.0,5/21,11.06%,YBX3;EPO;STK39;OXSR1;AQP1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4193069803753847,-1.0352589084402581,0.40384615384615385,0.7802447791222195,1.0,3/11,11.43%,LYN;MFHAS1;TIRAP
prerank,ventricular septum development (GO:0003281),-0.3000877981167709,-1.034488590044496,0.41295546558704455,0.7809385751558362,1.0,15/37,22.25%,ZFPM2;ROBO1;NOTCH1;ROBO2;SALL1;SLIT2;HEYL;PDE2A;SLIT3;BMPR2;SOX11;SMAD4;HEY2;APLNR;HEY1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3898326907046085,1.03447616768131,0.40288713910761154,0.9364134203735224,1.0,10/40,12.17%,TIMP4;TIMP1;HMGCR;SNRNP70;TIMP2;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,cellular response to insulin stimulus (GO:0032869),0.33866232356692416,1.0341853876377751,0.420479302832244,0.9364868727455244,1.0,33/124,20.42%,SORBS1;ATP6V1B1;CPEB2;GAB1;HDAC5;EPRS1;FOXC2;RHOQ;CAV2;INSIG1;PKM;SHC1;AP3S1;MYO5A;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1E1;ATP6V1D;ATP6V0D1;RAB8B;ATP6V1B2;PCK2;SLC27A4;IDE;GPLD1;ATP6V0B;USF1;ATP6AP1;RAB10
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3392871109058113,1.0341196351235982,0.4026258205689278,0.9359039118261002,1.0,28/129,14.45%,SCEL;KANK1;PTK7;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;LGR4;PPM1A;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;CSNK1E;TRPM4;PSMB5;CAPRIN2;SFRP1;UBR5;WNK1
prerank,regulation of type I interferon production (GO:0032479),0.3526915913281414,1.0337620457914936,0.4140715109573241,0.9361477018528842,1.0,22/84,20.56%,IKBKE;MAVS;EP300;POLR2H;TRIM25;IRF3;MRE11;TRIM21;POLR3B;POLR1C;POLR3C;NPLOC4;IRAK1;GAPDH;DHX9;POLR3G;POLR3H;POLR2E;ILRUN;NFKB2;PCBP2;ZBP1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.48095451220970803,1.033667276270219,0.41898527004909986,0.9356415738658231,1.0,3/12,14.18%,KLF4;TLR4;FOXP1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.42690129746248084,-1.033533954149458,0.41732283464566927,0.7821299573463231,1.0,1/10,0.68%,TGFA
prerank,glucan catabolic process (GO:0009251),0.4604189549372101,1.0333300388054587,0.42700156985871274,0.9358185742608195,1.0,4/15,11.00%,MGAM;PHKA2;PGM2;PHKB
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.39577146560837817,1.0332589343353502,0.4147339699863574,0.9352478016426784,1.0,5/36,9.21%,OGT;FHIT;DDRGK1;PSMF1;OPHN1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.41119986233305916,1.0332410209661154,0.4214992927864215,0.9345287474578904,1.0,10/28,20.35%,EPHA4;YTHDF1;AKAP5;PTN;GSK3B;RELN;ABL1;EIF2AK4;APP;AGER
prerank,regulation of chromatin binding (GO:0035561),0.49770097827763904,1.0327405172418431,0.44350758853288363,0.935174562472308,1.0,4/10,18.46%,KDM4D;HMBOX1;BTAF1;WAPL
prerank,regulation of defense response (GO:0031347),-0.2647334942156352,-1.0326439805757868,0.36496350364963503,0.7830738616449601,1.0,18/76,11.65%,ADAMTS12;IL1R1;WNT5A;SEMA7A;NR1D2;APPL2;MGLL;PTGS2;PSMA6;ELMOD2;LRP8;BRD4;JAK2;SAMHD1;PIK3AP1;PTGES;TIRAP;CASP4
prerank,regulation of monooxygenase activity (GO:0032768),-0.3337134039532391,-1.0324951484038873,0.40390879478827363,0.7820947071334812,1.0,7/23,12.79%,POR;NOS3;NOSTRIN;NOS1AP;NOSIP;CYGB;SPR
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.43430042543228975,1.031057083436775,0.4260355029585799,0.9390594158371206,1.0,2/20,2.81%,SEMA3D;SEMA3B
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3070474371125531,-1.0308489114852248,0.4072727272727273,0.7851735135190289,1.0,6/32,6.00%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PTDSS1;PLAAT3
prerank,error-prone translesion synthesis (GO:0042276),0.436816732074959,1.030688610807415,0.4342105263157895,0.9392879243486405,1.0,8/21,18.65%,REV1;POLK;RPA3;POLH;PCNA;RPS27A;UBC;RFC1
prerank,macromolecule catabolic process (GO:0009057),-0.3355243527296382,-1.0306527039835554,0.3723404255319149,0.7843260148252079,1.0,16/26,36.17%,SNX25;TGFB1;SH3GLB1;TPP1;MVB12A;CLPX;USE1;SMURF1;CLN6;CLN8;TRIM24;PPT1;UCHL3;CAPN3;BECN1;LGMN
prerank,cellular response to interleukin-4 (GO:0071353),-0.43373709096616475,-1.0305403937406912,0.4192634560906516,0.7831725037511578,1.0,1/10,0.48%,LEF1
prerank,cardiac atrium morphogenesis (GO:0003209),0.4523998747355089,1.0302917690990878,0.41512345679012347,0.9396057827438106,1.0,2/16,7.39%,NOTCH2;TGFB2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.33896348669619514,-1.0302712523728188,0.43312101910828027,0.7824849950764518,1.0,8/24,11.38%,PTPRJ;PIK3R1;TEK;KDR;TSC1;ROCK1;MAP4K4;MYOC
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4257455822725548,1.0298740894643243,0.4145616641901932,0.9399869286440149,1.0,4/24,8.49%,WNT1;OCLN;AVIL;CDC42
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46535500527834467,1.029694401782656,0.42504118616144976,0.9397541440820427,1.0,8/13,30.38%,DESI2;DESI1;SAE1;UBA6;UBA7;UBA3;UBA2;SENP6
prerank,negative regulation of developmental process (GO:0051093),0.3668506605921495,1.0296859649719372,0.4231227651966627,0.9390145526400638,1.0,10/69,7.03%,WNT1;KANK1;WNT11;CDK6;FOXM1;SOX9;MUL1;BMP4;KLF7;PARP3
prerank,fatty acid transmembrane transport (GO:1902001),0.4455912749317571,1.0295047552571344,0.45803698435277385,0.9387587629142784,1.0,5/19,12.65%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2
prerank,glycoprotein biosynthetic process (GO:0009101),0.35983781262088665,1.0294805201434423,0.42758620689655175,0.9380565964353655,1.0,17/79,14.90%,B3GALT1;ST3GAL4;CHST12;GCNT2;LARGE1;CHST11;MGAT1;NPC1;DDOST;GOLPH3;CHST13;ALG1;ST3GAL6;ALG5;SERP2;NUS1;TNIP1
prerank,protein modification by small protein conjugation (GO:0032446),0.3191062653015465,1.029233164244077,0.41967871485943775,0.9380119381787853,1.0,116/361,25.48%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;RNF220;SPSB4;NFE2L2;WWP2;MOCS3;TRIM44;NUB1;ELOB;RNF138;NUP93;KLHL21;DDRGK1;MUL1;EYA1;CBLL1;TRIM41;TRIM21;UBE2G2;RBX1;DCUN1D5;NDC1;SDE2;SUMO2;SUMO3;TRIM47;TRIM26;TRIM11;UBE2B;RNF182;PCNP;KLHL24;SAE1;TRPM4;DCUN1D1;VPS11;KLHL13;NSMCE2;MIB2;ZSWIM8;PIAS1;PIAS3;DTX3;VPS18;BRAP;NEDD4;UBE2H;MDM2;PCNA;UBE2N;CCDC22;MSL2;FBXL15;UFM1;UBA6;DDB1;CAND1;RPS27A;UBC;CUL9;DTX2;UBE2D3;KEAP1;STUB1;UBE2F;FBXL2;AAAS;PDZRN3;OTULIN;RAE1;PEX2;CDK5RAP3;RNF41;UBE2Z;ASB5;FBXO9;CHFR;VHL;FBXW7;CUL2;TRIM5;UBE2E1;RCHY1;ARIH2;POM121;SMURF2;RNF168;DET1;TPR;RNF213;CTR9;RNF14;RNF7;CDC23;URM1;RANBP2;LEO1;FBXO4;NUP42;GAN;ATG3;UBA7;TMEM129;RANGAP1;UBE2M;NUP62;FBH1;TRIM39;TSPAN17;SEH1L
prerank,positive regulation of viral process (GO:0048524),0.3658484027843389,1.0289461848685255,0.43144654088050316,0.9380533509392807,1.0,16/60,18.97%,CCL5;GTF2F1;POLR2H;TARBP2;POLR2A;TMEM39A;RAB7A;SRPK2;SRPK1;VPS4A;DHX9;DDB1;NELFB;POLR2C;POLR2E;NELFA
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3363868663868969,1.0285015052414426,0.42950819672131146,0.9384737496175888,1.0,37/140,17.32%,SRGAP3;SRGAP2;ARAP1;NGEF;ARHGEF17;ARHGAP18;AKAP13;ARHGEF12;ARAP2;TIAM2;RHOQ;FOXM1;ARHGEF18;ARHGAP29;ARHGAP21;ARHGAP10;CDC42;BCR;ARHGEF5;OPHN1;TRIO;DLC1;GNA13;RHOA;RABL3;SOS2;INPP5B;OCRL;ARHGAP31;RHOU;FLCN;ARHGDIB;ARHGEF1;TAGAP;RELN;ARHGAP33;PLEKHG2
prerank,lung epithelium development (GO:0060428),0.4899016184318796,1.0284574801315247,0.4451939291736931,0.9378438914512717,1.0,4/10,8.90%,STRA6;BMP4;PKD1;GRHL2
prerank,regulation of cell cycle (GO:0051726),0.32784053682403985,1.0283973780401756,0.4247967479674797,0.9372631561485676,1.0,69/271,20.02%,NOTCH2;GRK5;CDKN1A;ADAM10;MAGI2;NUPR1;NEK7;CDK10;EP300;CDK6;DAPK3;PES1;PPP1R13B;PPP1R15A;SON;CDK4;DUSP1;TSC2;JUND;FOXM1;ZBTB17;SOX9;HCFC1;BMP4;TRIM21;TGFB2;NLRP2B;PKD1;JUN;TCF7L2;IQGAP1;FBXO5;PML;GAS2L1;APBB1;CCND1;PCLAF;SRPK2;TBRG4;ANKRD17;GADD45B;EIF4G2;WDR6;GATA3;CHMP1A;MYC;PRDM11;ING4;SFRP1;HRAS;MDM2;MAEA;POU4F1;ABL1;LIN54;NBN;XIAP;INTS13;CAMK2N1;GADD45GIP1;RARA;KIF20B;RNF112;CDKN2D;CDK5RAP3;GPER1;RB1;CDK11B;CENPF
prerank,positive regulation of myelination (GO:0031643),-0.4225135353647108,-1.0281462771518286,0.42010309278350516,0.7869021957968972,1.0,6/11,25.76%,TENM4;TPPP;TNFRSF1B;MYRF;DICER1;NCMAP
prerank,snRNA metabolic process (GO:0016073),0.446224355858018,1.0280813220030707,0.44745222929936307,0.9373483001758486,1.0,8/17,22.46%,INTS2;MTREX;ZCCHC8;MEPCE;INTS3;INTS6;TUT1;INTS1
prerank,renal system development (GO:0072001),0.3693957746919963,1.0279416826214387,0.42641509433962266,0.9370082460519225,1.0,8/52,8.25%,AGTR1;STRA6;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,cellular protein metabolic process (GO:0044267),0.3225865564647953,1.0274712587675534,0.42943548387096775,0.9375773659604548,1.0,89/396,19.54%,FN1;MSLN;IGFBP6;F5;FAM20C;PRSS23;ADAM10;PENK;MRPS16;EEF1A1;MRPL24;MRPL37;SFTPC;SERPINC1;TIMP1;WWP2;RNF5;DENND3;HARS1;RPS4X;DUSP12;ANO8;MRPS7;PHKA2;BMP4;CPE;TGM5;GPC3;MSRB2;AFG3L2;UBE2G2;ABCF1;LAMC1;FDX1;MANBA;RPL31;RPSA;GSPT2;RPL22;LAMB2;MRPS33;SPCS3;RPL28;CALU;SRBD1;RPS26;MRPL9;COPS5;ST3GAL6;NAPSA;CP;LGALS1;HARS2;RPL10A;LTA4H;MRPS15;SARS1;EIF4G1;NTAQ1;DNAJC3;TNIP1;MRPS18C;PRKCSH;RPL14;RRBP1;CTSH;HM13;RPS27A;ABL1;UBE2D3;SEC11A;CHEK2;FBXL2;RPN2;SPPL3;USP25;HBS1L;IGF2BP3;YES1;SPG7;GALNT11;EIF4EBP2;RPL6;FARSB;IDE;APP;SFTPA1;SFTPA2;ADAM17
prerank,mitotic cytokinetic process (GO:1902410),0.44277174275298264,1.0272790943387677,0.41185185185185186,0.9373487638562216,1.0,12/20,26.60%,CHMP4A;CHMP4B;VPS4B;RHOA;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;KLHDC8B;CHMP5;CHMP1B
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.48617343122742596,1.0270762676431646,0.42546063651591287,0.9371740326859535,1.0,6/11,21.65%,ASF1A;ATRX;UBN1;IPO4;H3-3A;HAT1
prerank,regulation of amyloid-beta formation (GO:1902003),0.4050747951530158,1.0270555551226384,0.43716577540106955,0.9364841244935183,1.0,7/34,13.54%,CLU;RTN1;EPHA4;RTN3;ABCA2;SP1;GSK3A
prerank,protein autophosphorylation (GO:0046777),-0.23293601617960008,-1.0268728354280048,0.35384615384615387,0.7889425500130687,1.0,33/157,13.62%,FLT1;PDGFRB;PRKD1;TEK;INSR;TNIK;LYN;PTK2;CAMK2D;PDGFRA;CAMK4;KDR;SIK1;WNK2;CDK12;ACVR1B;LRRK2;EPHB4;BMX;NTRK2;JAK2;ERBB4;DAPK2;FGFR2;KIT;STK17B;CDKL5;IGF1R;RIPK1;NEK6;FGFR4;FLT4;CAMK2A
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3946936111766347,-1.026824151947679,0.4376731301939058,0.7876691976726397,1.0,8/15,27.82%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.39331027149879766,-1.0266540100504917,0.45652173913043476,0.7867048874601138,1.0,3/13,12.79%,NOS3;GCH1;SPR
prerank,positive regulation of cellular component organization (GO:0051130),-0.24250714638784607,-1.0259941274948272,0.39622641509433965,0.78716426543708,1.0,29/107,16.12%,FRMPD4;INSR;NRXN1;DAB2;SHANK3;ASAP1;AR;SLF1;RUNX1;DAB2IP;FNIP1;TFRC;TGFB1;SH3GLB1;TIRAP;TPPP;BCL2L11;IGF1R;BID;RACK1;HYAL1;BMF;SLF2;SURF4;FNIP2;CDC42EP2;BAX;GPX1;GNL3L
prerank,neuropeptide signaling pathway (GO:0007218),0.36945952138486393,1.025913938479229,0.4282238442822384,0.9388951549819641,1.0,5/58,8.84%,SORCS2;GAL;PENK;CPE;HCRTR1
prerank,sterol metabolic process (GO:0016125),0.3659973656518251,1.0254740118957442,0.4394124847001224,0.9393457662115008,1.0,12/60,8.95%,SOAT1;STARD3;SULT2B1;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;FDX1;SOAT2
prerank,regulation of cartilage development (GO:0061035),0.45230871550277035,1.0254372360988382,0.45385779122541603,0.9386900045729573,1.0,5/18,6.81%,MBOAT2;WNT11;ZBTB16;SOX9;BMP4
prerank,zinc ion homeostasis (GO:0055069),-0.32142893153537955,-1.0251629932125157,0.4232081911262799,0.7879759879196483,1.0,5/28,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.42846947126502655,1.0246694267823577,0.43243243243243246,0.9400929103606915,1.0,1/21,0.23%,FGF13
prerank,regulation of mRNA stability (GO:0043488),0.3331556925179175,1.024438414116377,0.4401294498381877,0.9399796075485406,1.0,36/145,19.46%,VIM;SAMD4A;YTHDF1;SAMD4B;CELF1;TNFSF13;GDNF;HSPB1;PSMD11;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;TBRG4;YWHAZ;PSMB5;FXR1;CARHSP1;DCP1A;TNPO1;SET;EIF4G1;PAIP1;MEX3D;RPS27A;UBC;E2F1;MAPKAPK2;PSMD1;PSMC4;IGF2BP3;YTHDF3;ROCK2;IGF2BP2;PSMD8
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.37328054933409754,1.0242677986708326,0.42910915934755334,0.9396751081364366,1.0,8/52,11.35%,SORBS1;STAC3;PTPN9;LGALS3;ACSL3;AKAP5;CNPY4;EPHA3
prerank,neuron projection regeneration (GO:0031102),-0.42305944444773386,-1.024152631327114,0.4430693069306931,0.7893959790937525,1.0,4/10,15.59%,NREP;MAPK8IP3;DHFR;MTR
prerank,cellular glucose homeostasis (GO:0001678),-0.289324934624668,-1.023734845299649,0.4146341463414634,0.7891714878185005,1.0,12/41,12.35%,PIK3R1;UNC13B;ZBTB20;HIF1A;GAS6;FOXO1;FOXK2;PRKAA1;HK2;LRRC8A;IGF1R;RACK1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.34840539350523164,-1.0236832808030223,0.39570552147239263,0.7878843061934494,1.0,5/20,12.07%,PLOD2;GATM;PTDSS1;PLSCR1;CNDP2
prerank,carboxylic acid metabolic process (GO:0019752),-0.310804109254157,-1.0235320029090182,0.3667953667953668,0.7869083192585127,1.0,5/33,5.08%,PLA2G4A;ST3GAL1;SLC2A1;PTGIS;CSGALNACT1
prerank,regulation of presynapse assembly (GO:1905606),0.43747158885978277,1.0234588306637507,0.43377001455604075,0.9403170685338542,1.0,7/18,19.38%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1;APP
prerank,regulation of presynapse organization (GO:0099174),0.43747158885978277,1.0234588306637507,0.43377001455604075,0.9403170685338542,1.0,7/18,19.38%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1;APP
prerank,COPII-coated vesicle budding (GO:0090114),0.3599965406093169,1.0234177461663263,0.437046004842615,0.9396676290629505,1.0,24/68,23.86%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B;SEC31B;MIA3;SEC16A;SEC31A;VAPA;GRIA1;SEC24D
prerank,histone H4-K5 acetylation (GO:0043981),0.46560883415333876,1.023228491433909,0.42592592592592593,0.9386660794536963,1.0,5/15,16.03%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.46560883415333876,1.023228491433909,0.42592592592592593,0.9386660794536963,1.0,5/15,16.03%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,membrane organization (GO:0061024),0.32589553640933716,1.022097563959731,0.44763860369609854,0.9409776332202147,1.0,54/227,18.14%,CFTR;REPS2;ANK2;LDLR;SYP;OTOF;CLTB;A4GALT;AP2A2;REEP3;NUP93;NPC1;ANK3;NSFL1C;SLC2A8;CHMP4A;CHMP4B;CHP1;IL7R;ACTB;AGFG1;TLCD2;TOR1A;TMEM33;ACTG1;VPS4B;AP2A1;LPCAT2;VTI1B;NAPA;OPA1;SH3GL2;LPCAT3;STX11;CHMP1A;OCRL;FER1L6;VPS4A;VAMP7;TOR1AIP1;CCDC88A;DNM1L;CHMP2A;REEP4;CERT1;AAK1;RPS27A;UBC;LRP2;ARPC2;PDCD6IP;STAM;SUN2;OSBPL2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4949391462117524,1.0217534105476018,0.4510135135135135,0.9411533715282996,1.0,2/10,6.90%,EPHA4;ANXA2
prerank,response to interferon-beta (GO:0035456),-0.3414061214638767,-1.0217252834111317,0.40192926045016075,0.790452173985753,1.0,11/22,26.70%,XAF1;AIM2;IFNAR2;IFITM3;PLSCR1;IRGM;SHFL;HTRA2;BST2;TRIM6;IFITM1
prerank,regulation of vasculature development (GO:1901342),-0.3244905096475148,-1.0217098776036186,0.4083044982698962,0.7891159279498049,1.0,7/26,13.50%,SP100;BMPER;FGF2;TSPAN12;NF1;EGLN1;RNH1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48408658970208873,1.0217012883500807,0.4403225806451613,0.940563446554533,1.0,3/11,9.40%,DDX5;BMP4;MAP2K2
prerank,mitochondrial translational elongation (GO:0070125),0.3510807141722718,1.0214867377531687,0.43507972665148065,0.9404112475989547,1.0,38/88,28.39%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4366398716962701,1.0211215328112095,0.45374449339207046,0.9407020365526517,1.0,4/20,6.12%,CDK6;PTK2B;ZBTB16;HOXA5
prerank,regulation of nervous system development (GO:0051960),-0.30521267655010675,-1.0209299931045235,0.42731277533039647,0.789800071286565,1.0,14/37,22.81%,PTPRZ1;TENM4;HEYL;PRUNE1;NPHP3;TNFRSF1B;BHLHE40;SIRT2;YAP1;CX3CL1;CX3CR1;HEY2;HEY1;YTHDF2
prerank,cation transport (GO:0006812),0.3271628036603679,1.0207899913755067,0.4293304994686504,0.9408908185845876,1.0,23/166,13.39%,FGF13;TRPM3;SLC36A3;SCN3A;ATP1A2;TRPM8;SLC66A1;KCNJ13;ABCC8;SLC36A4;CNGB3;CHP1;KCNA4;TRPM6;SLC7A6;AQP1;TRPM4;PKD2L1;SLC41A1;ANO6;KCNA5;CNGB1;TRPM2
prerank,immunoglobulin mediated immune response (GO:0016064),0.4980849796644583,1.0201376705659755,0.4659090909090909,0.941922493158599,1.0,2/10,11.65%,CD81;FCER1G
prerank,amyloid precursor protein catabolic process (GO:0042987),0.46175758126698524,1.0194675466996392,0.4645669291338583,0.9429266006985006,1.0,6/14,24.00%,ADAM10;BACE1;ADAM17;ABCA7;APH1A;PSEN1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4604958609761689,1.019401796535476,0.4504065040650406,0.9423710542119818,1.0,4/14,11.69%,ABCD1;MTLN;TWIST1;IRS2
prerank,RNA 3'-end processing (GO:0031123),0.3572520810450001,1.0193448355198718,0.4371327849588719,0.9417873508996292,1.0,24/69,21.01%,SRSF2;EIF4A3;DDX39B;RBM8A;TENT4A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;TUT7;RNPS1;CSTF1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;CSTF3;THOC1;TUT1
prerank,regulation of actomyosin structure organization (GO:0110020),0.4690221279617488,1.019274979988058,0.46589018302828616,0.9412390676755727,1.0,7/13,18.80%,AKAP13;CDC42;ACTG1;ASAP3;SLC9A1;FHOD1;ROCK2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.31220913466559497,-1.0192545878975048,0.44129554655870445,0.7929551637023293,1.0,17/32,34.19%,ABHD3;SLC44A2;PCYT1A;LPIN2;MFSD2A;SLC44A1;STARD10;PCTP;SLC44A5;LCAT;CHAT;SLC44A3;CSNK2B;PEMT;LPIN3;CSNK2A1;CSNK2A2
prerank,hippo signaling (GO:0035329),0.4181293554751605,1.0192316188442523,0.43380281690140843,0.9406054679843068,1.0,4/26,8.94%,TJP2;TJP1;LATS1;YWHAB
prerank,production of siRNA involved in RNA interference (GO:0030422),0.48981353094553604,1.0187050008065477,0.4312393887945671,0.941314658943661,1.0,2/10,7.98%,TARBP2;TSNAX
prerank,fat cell differentiation (GO:0045444),0.3606384169161344,1.0185703561387958,0.45614035087719296,0.940933873897178,1.0,6/57,8.42%,KLF4;PPARGC1A;SMAD6;EP300;WNT5B;TCF7L2
prerank,heart contraction (GO:0060047),0.3825951635059375,1.0180655784317372,0.4304291287386216,0.9415322659033543,1.0,4/41,3.66%,SGCG;SGCD;ATP1A2;CSRP3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4078493492505118,1.0180055303751732,0.43937232524964337,0.9409644686219486,1.0,6/27,15.27%,CD200;ZC3H12A;PTPN6;TLR4;CD200R1;SYT11
prerank,calcium ion transmembrane transport (GO:0070588),0.3484909781242586,1.0172147622906171,0.43383199079401613,0.9423430626749296,1.0,20/86,14.07%,TRPM3;CACNA1A;NALCN;TRPM8;MCU;CACNB3;MCUB;PMPCA;CACNA2D4;TMEM165;MICU1;AFG3L2;PKD1;TRPM6;MCUR1;TRPM4;LETM1;ANO6;TRPM2;ATP2B4
prerank,regulation of muscle contraction (GO:0006937),0.42410065192438345,1.0170632801998098,0.43937232524964337,0.9420039936260712,1.0,3/26,3.76%,CAV1;ATP1A2;DAPK3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.39465285581527115,-1.0169925525415915,0.43989071038251365,0.7977043333203665,1.0,6/13,20.52%,RCL1;UTP20;NOP9;RPS21;TBL3;KRI1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4401858111757222,1.016931393943981,0.4642857142857143,0.9415898773297569,1.0,8/19,20.66%,FBXW8;PTPRD;CAPRIN2;SS18L2;RELN;SS18L1;CAMK2B;DBN1
prerank,substrate-dependent cell migration (GO:0006929),-0.38474141818361196,-1.01690135108532,0.4358974358974359,0.7965315507162029,1.0,5/14,19.69%,VEGFC;ITGA11;ANKS1A;EPHA8;P2RY12
prerank,exit from mitosis (GO:0010458),-0.4064668563797298,-1.0167777757999588,0.4490358126721763,0.7954762277617472,1.0,5/12,16.68%,CLASP2;EPS8;UBE2S;CTDP1;CHMP7
prerank,regulation of ATP metabolic process (GO:1903578),0.36722103908985054,1.0160110864583354,0.4236024844720497,0.9433158697999774,1.0,10/54,9.90%,OGT;ABCD1;EP300;BEND3;NUP93;EIF6;NDC1;JMJD8;ATP5IF1;COX7A2L
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.41272585699108527,1.0158594443494304,0.44365192582025675,0.9429667222398016,1.0,2/24,2.81%,SEMA3D;SEMA3B
prerank,fatty acid biosynthetic process (GO:0006633),0.35957101232285665,1.0151522844458263,0.44565217391304346,0.944088837153837,1.0,13/63,13.95%,ABCD1;OLAH;ELOVL1;ALOX5;ELOVL6;ACSM3;HACD4;FADS1;NDUFAB1;ACSF3;ACACA;SCD5;LTA4H
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4438108271899792,1.015088978380118,0.4526627218934911,0.9435136036953888,1.0,6/18,21.68%,ADTRP;WNK1;ASS1;DUSP3;GPNMB;MIA3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4306248531855863,-1.0145896020281235,0.45260663507109006,0.8000900882140908,1.0,7/10,31.46%,NUDT21;CPEB1;HSF1;PAF1;NCBP1;DHX36;NCBP2
prerank,cellular response to nitrogen compound (GO:1901699),0.4236350756160167,1.0141924737424413,0.43703703703703706,0.9452039884469906,1.0,7/20,23.81%,DAXX;ATRX;ATP2B4;ROCK2;DDI2;EPG5;RTF2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3658337596779868,-1.013805449215104,0.4265129682997118,0.8008556834628155,1.0,10/17,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.39610645898613694,1.0130934382305408,0.4596774193548387,0.9474035761709156,1.0,4/32,3.88%,KLF4;JCAD;HDAC5;FOXC2
prerank,cytosolic transport (GO:0016482),0.34668484971777497,1.0129933677717116,0.45514950166112955,0.946923193119916,1.0,35/108,19.81%,EMP2;RAB9B;CORO7;VPS13A;LAMP1;GCC2;MAGEL2;MON2;RAB7A;LMTK2;HOOK1;GGA1;VPS54;AP2A1;VTI1B;RNF126;PHETA2;WDR91;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;SNX16;WASHC1;VPS50;TBC1D10A;ARFRP1;YKT6;TMEM87B;BET1L;HOOK3;RAB9A;VTI1A;TBC1D17
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.31899669356343513,1.0125316932178217,0.458502024291498,0.9474308001391927,1.0,72/306,19.17%,THRB;ST3GAL4;MRPS16;FEN1;GRWD1;EEF1A1;MRPL24;MRPL37;CREBL2;LARGE1;RECQL4;POLR2H;HARS1;RPS4X;NKX2-8;MRPS7;POLR2A;MRE11;GOLPH3;PTMS;REV1;ABCF1;RPL31;RPSA;GSPT2;RPL22;EXT1;PCLAF;MRPS33;PTMA;RMI1;RPL28;SRBD1;TOPBP1;RPS26;EIF4G2;MRPL9;COPS5;EEF1D;CDK2;RNPS1;ING4;RPA3;HARS2;RPL10A;MRPS15;SET;SARS1;EIF4G1;DONSON;TNIP1;POLD2;MCM8;MRPS18C;RPL14;RRBP1;EEF2;MCM6;ATR;RPS27A;E2F1;NBN;MCM7;POLR2C;RAD50;HBS1L;IGF2BP3;NT5M;POLR2E;EIF4EBP2;RPL6;FARSB
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3601718451887912,1.0125241131885374,0.4539877300613497,0.9452509193240309,1.0,17/61,19.08%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,vesicle coating (GO:0006901),0.3601718451887912,1.0125241131885374,0.4539877300613497,0.9452509193240309,1.0,17/61,19.08%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,COPII vesicle coating (GO:0048208),0.3601718451887912,1.0125241131885374,0.4539877300613497,0.9452509193240309,1.0,17/61,19.08%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,regulation of JUN kinase activity (GO:0043506),0.3919614755706994,1.0123610659614501,0.44881889763779526,0.9449732233077018,1.0,6/33,9.19%,MAP3K5;DUSP10;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4130906219698201,1.0121922277216986,0.4488950276243094,0.9446797607824053,1.0,9/26,14.55%,KANK2;CRY2;SMARCA4;NCOR1;VPS11;VPS18;SFRP1;FOXP1;NCOR2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3821013691283558,-1.0121304008761551,0.4677871148459384,0.8039921968529852,1.0,2/14,5.53%,THBS1;IRAK3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.45612504502005213,1.012037814708176,0.4616564417177914,0.9443566957087328,1.0,3/16,12.58%,ZC3H12A;MOV10;CPEB3
prerank,amino acid transmembrane transport (GO:0003333),-0.28384151306891686,-1.011769600346318,0.4309623430962343,0.8035152699014608,1.0,8/45,10.92%,SLC7A11;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC7A7;SLC38A11;SLC38A9
prerank,organophosphate catabolic process (GO:0046434),-0.4103579949403525,-1.0114948679178573,0.4710526315789474,0.802862634862466,1.0,2/11,12.70%,ENPP2;ABHD12
prerank,regulation of immune response (GO:0050776),0.3291558804933221,1.0114946865956307,0.4524838012958963,0.9451407775967632,1.0,9/135,7.39%,CXADR;RAET1E;CD200;IL15;ITGB7;CD81;CSK;PVR;TGFB2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3532837917375588,1.011372778577913,0.44946492271105826,0.9447432130551969,1.0,7/73,7.63%,EGLN3;COL4A3;BBC3;NGF;MUL1;BAD;TNFRSF10B
prerank,peptidyl-lysine acetylation (GO:0018394),0.4798492488339807,1.0112154135978684,0.459546925566343,0.9444177728080093,1.0,1/10,2.90%,EP300
prerank,ESCRT III complex disassembly (GO:1904903),0.4942224106036234,1.0107290078017108,0.47466216216216217,0.9442582119961341,1.0,7/10,26.60%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.4942224106036234,1.0107290078017108,0.47466216216216217,0.9442582119961341,1.0,7/10,26.60%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,negative regulation of centrosome duplication (GO:0010826),-0.40112953976487054,-1.0105585637457133,0.45,0.8040739300326648,1.0,6/11,27.50%,TMEM67;RBM14;CCNF;KAT2B;BRCA1;NPM1
prerank,axoneme assembly (GO:0035082),0.3932908766893974,1.010476096446976,0.43977591036414565,0.9442116031920306,1.0,2/30,8.14%,RP1;CFAP206
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41472648728020006,1.0103461647910126,0.4614285714285714,0.943827785879261,1.0,3/24,5.03%,ZC3H12A;MAVS;TRIM44
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42355039015819573,1.010222116383132,0.46199701937406856,0.9434644748142543,1.0,6/19,15.32%,KLF4;MAVS;MAPK7;IRAK1;TLE5;DHX9
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.35414724717680485,-1.0100196129024213,0.4260355029585799,0.8041575688338585,1.0,5/19,9.87%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3514980960179865,1.0096438791146776,0.44046242774566474,0.9442857444904932,1.0,17/76,17.31%,ANGPT1;ZC3H12A;CAV1;HDAC4;MUL1;CENPS;DCUN1D5;HDAC3;HSPBP1;SAE1;DCUN1D1;PIAS1;PIAS3;GSK3A;TNIP1;XIAP;STUB1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45416920866844834,1.0095496880088242,0.45705024311183146,0.9438018052659046,1.0,6/15,16.62%,USP46;ZDHHC12;NPS;STXBP1;NLGN2;SYN3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.29379995623205446,-1.0094799146422755,0.46226415094339623,0.8042845936232542,1.0,5/41,5.53%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,organic acid transport (GO:0015849),0.34162734148849894,1.0094488042112615,0.4486607142857143,0.9433178458014035,1.0,11/94,13.17%,SLC7A14;SLC10A5;SLC27A3;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;SLC25A17;PDPN;SLC25A14
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32673931117279625,1.0094400923885762,0.44739638682252925,0.9426101305839426,1.0,11/151,4.60%,ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;GCNT2;ACKR3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3502703510208787,1.009090676653617,0.447520184544406,0.9427527390819768,1.0,28/71,21.80%,ADAMTS7;PMAIP1;ATE1;ZYG11B;CTSZ;OTUD7B;CAPN2;CHMP4B;VPS4B;RNF123;VPS4A;SOCS6;MDM2;PRPF19;CTSH;HM13;DDB1;RPS27A;UBC;STUB1;HDAC6;PDCD6IP;RNF41;IDE;RHBDD1;CHFR;CTSK;LONP1
prerank,nuclear envelope organization (GO:0006998),0.43089077363532724,1.008996476392802,0.461086637298091,0.9422905207367607,1.0,7/20,17.82%,REEP3;NUP93;TOR1A;VPS4A;TOR1AIP1;REEP4;SUN2
prerank,protein-containing complex subunit organization (GO:0043933),0.33750011805143826,1.0088224244716828,0.4536532170119956,0.942046137219737,1.0,15/109,9.04%,REPS2;PPARGC1A;OCLN;EPRS1;PTK2B;ELOB;SOX9;DMTN;GPAA1;AFG3L2;PARD6B;LAMC1;PML;NDC1;KMT2A
prerank,positive regulation of viral genome replication (GO:0045070),0.3963910102534771,1.0087966133805761,0.4394366197183099,0.941401703169917,1.0,13/29,28.55%,CCL5;TARBP2;TMEM39A;SRPK2;SRPK1;DDB1;TOP2B;PABPC1;PPID;PDE12;PPIE;LARP1;DDX3X
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.44810955284662335,1.0087435177052138,0.4561128526645768,0.940835084067499,1.0,2/17,1.77%,ADTRP;EFNB2
prerank,L-serine metabolic process (GO:0006563),0.4845137792201279,1.008625452035612,0.4593698175787728,0.9404122301229202,1.0,3/10,9.13%,SERINC5;PHGDH;SHMT1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2888748046321842,-1.008228818209497,0.4801980198019802,0.806205710995054,1.0,5/43,5.53%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4928046290803514,1.0082126581701403,0.46,0.9407958720750587,1.0,2/11,8.99%,ZC3H12A;FOXP3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4461917900266398,1.0079355561743883,0.4539781591263651,0.9408366466580477,1.0,4/16,11.00%,MGAM;PHKA2;PGM2;PHKB
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4120816006614147,1.007515416570608,0.46620689655172415,0.9412216546904972,1.0,4/26,7.18%,ST3GAL4;SCCPDH;LARGE1;GOLPH3
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.31351278628529167,-1.0073932245210266,0.429042904290429,0.8071679311133637,1.0,9/27,14.37%,PDGFRB;DACH1;ACVRL1;FGF2;RGCC;TNKS;TOM1L1;FGFR4;BMPR2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3827707303959044,1.0073470141532066,0.4658792650918635,0.9409604451721554,1.0,12/39,15.64%,WNT1;KANK1;GCNT2;FBLN1;EFNA5;DMTN;CASK;ADAM15;RHOA;RASA1;ITGB1BP1;ACTN4
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4823346104606864,1.006855694147416,0.4694915254237288,0.9415098432205558,1.0,3/10,14.10%,MLLT3;LMBR1L;SFRP1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.47277986469842626,1.006204773038561,0.47586206896551725,0.942544917527812,1.0,6/11,20.67%,SOAT1;ITM2C;ABCA2;NECAB3;NECAB2;ABCA7
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.37898008251841064,1.005895660749233,0.4639580602883355,0.9426590563150865,1.0,4/39,2.90%,TSPAN5;WNT1;ELF3;EP300
prerank,microtubule polymerization (GO:0046785),0.4073717397954659,1.0056597370748543,0.45850914205344584,0.9425969949946608,1.0,2/28,2.87%,FGF13;NDEL1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32294830137461905,1.0055970863404602,0.46105919003115264,0.9420367902745529,1.0,54/182,22.03%,NOTCH2;ITGB8;PRKAA2;KLF4;LDLR;SMO;ADAM10;OCLN;ZC3H12A;CELF1;WWP2;OLFM1;FLOT2;OVOL2;MOV10;DDRGK1;BMP4;RBMS3;TGFB2;MAP2K2;SMCR8;SNX12;SFMBT2;ZNF148;SH3GL2;MEF2C;TLE5;ATP2B4;SFRP1;FOXP1;HRAS;SETDB1;FLCN;TET1;RIN3;LRP3;POU4F1;HINFP;BMPR1A;PARK7;ROCK2;GPER1;APP;RB1;MAPT;SLC2A10;TERF2;VHL;WDR54;YY1;FBXW7;AP1AR;DLG4;PGR
prerank,regulation of cholesterol storage (GO:0010885),0.44318806833194485,1.0055529947842392,0.4612903225806452,0.9414268953426564,1.0,3/15,3.69%,SREBF2;TTC39B;EHD1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.45380679461976314,1.0052132417927497,0.47266881028938906,0.9415958064032388,1.0,5/14,10.00%,AK1;CMPK1;DCTPP1;AK3;AK5
prerank,regulation of cell development (GO:0060284),0.3851240814889185,1.0045484186740428,0.4434087882822903,0.9426434340697503,1.0,5/36,12.43%,NOTCH2;DOCK7;RHEB;ADGRA2;WNT3
prerank,regulation of translation (GO:0006417),0.32145450707355033,1.004441540302203,0.46977730646871685,0.9421955255907074,1.0,47/173,20.72%,VIM;SAMD4A;YTHDF1;SAMD4B;EPRS1;FOXO3;DAPK3;DAPK1;HSPB1;RPS4X;EIF2B2;EIF4A3;UPF3A;EIF6;EIF4B;SHMT1;LTN1;POLDIP3;EIF4G2;EIF2AK3;CPEB3;SYNCRIP;PLXNB2;FXR1;BTG2;UPF3B;EIF4G1;PYM1;GAPDH;PAIP1;DHX9;EIF5B;EIF3B;EEF2;EIF1;EIF2B4;EIF2AK4;CTIF;EIF4A2;IGF2BP3;YTHDF3;IGF2BP2;APP;ETF1;SOX4;IGF2BP1;ZCCHC4
prerank,regulation of angiogenesis (GO:0045765),0.3234473271394876,1.0043508463331978,0.4708939708939709,0.9417317496262566,1.0,29/192,11.20%,PRKCB;ADAM12;ITGB8;KLF4;ANXA3;COL4A3;EMP2;NIBAN2;GLUL;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;ALOX5;HOXA5;AGGF1;MYDGF;TGFB2;KRIT1;VEGFB;ADAMTS1;PML;EMC10;ADGRA2;SYNJ2BP;TWIST1;AQP1;RAPGEF3
prerank,protein localization to cilium (GO:0061512),-0.3083701646315394,-1.0039545008821738,0.45126353790613716,0.8152612719401439,1.0,13/32,19.18%,IFT122;TTC21B;TULP3;RAB29;TCTN1;ZNF423;INVS;WDR19;BBS1;CSNK1D;TCTN2;NPHP4;BBS4
prerank,multivesicular body organization (GO:0036257),0.398782495372868,1.003764906319135,0.4590395480225989,0.9425957918241452,1.0,13/31,20.11%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;RAB27A;VPS37A;IST1
prerank,DNA metabolic process (GO:0006259),0.31334352137670923,1.0032503423324992,0.48574338085539714,0.9432475218949997,1.0,74/270,22.47%,NT5E;FEN1;RECQL4;DOT1L;SMARCB1;NABP2;ASF1A;NSMCE4A;MRE11;PARP3;DCTPP1;CENPS;INIP;RAD54L;TCF7L2;POLK;RIF1;UBE2B;MUTYH;POLG;DNASE1L2;SRPK2;POLE4;USP3;CSNK1E;HUS1B;TOPBP1;ERCC5;CDK2;MBD4;PWWP3A;BTG2;RPA3;DNASE1L1;REXO4;POLH;ENDOV;POLD2;MCM8;PRIM2;PCNA;FAN1;UBE2N;LIG3;DDB1;MCM6;ATR;RPS27A;UBC;HINFP;NEIL1;NBN;MCM7;INTS3;TRRAP;PARG;RAD50;PARP2;PARK7;RFC1;PNKP;UVRAG;ERCC4;NABP1;ORC2;TERF2;TOP2B;MCM4;PTGES3;LONP1;DDX23;MEN1;SIRT7;IGHMBP2
prerank,lymphocyte chemotaxis (GO:0048247),-0.3136736772864847,-1.0025033161613754,0.432,0.8178061380337457,1.0,15/34,32.56%,CYP7B1;GAS6;SLC12A2;CXCL16;PIK3CD;CCL13;CX3CL1;GPR183;CCL19;ADAM8;HSD3B7;PIK3CG;CCL2;CXCL10;CCL14
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3339385472569651,1.0024872133632627,0.4690366972477064,0.9445510706381532,1.0,17/91,17.90%,RAB17;CDH13;TSC2;STON1;RAB3B;OPHN1;MAP2K2;ATP9A;SNX12;CPLANE2;RAB5C;RAB33B;ABL1;NSF;RAB8B;PACSIN1;STX4
prerank,positive regulation of protein maturation (GO:1903319),-0.4100982520590579,-1.0024433727386899,0.45549738219895286,0.8165837694483488,1.0,4/11,25.77%,CCBE1;NKD2;BAG2;ADAM8
prerank,L-amino acid transport (GO:0015807),0.4021388796163817,1.002413008241764,0.45125348189415043,0.9440696722872524,1.0,8/28,15.34%,SLC36A3;CTNS;SLC36A4;SFXN1;ARL6IP5;SLC1A4;SLC25A12;SLC7A3
prerank,positive regulation of dendrite extension (GO:1903861),-0.36857015303151786,-1.0021293710629395,0.4411764705882353,0.8160174362144458,1.0,10/17,36.54%,SYT1;ITSN2;SMURF1;RIMS1;CPNE9;RNF157;CPNE5;RASAL1;SYT17;SYT4
prerank,positive regulation of nervous system process (GO:0031646),-0.35267073869786186,-1.0020938708551372,0.41839762611275966,0.8147383994736124,1.0,8/18,25.76%,UNC13B;TENM4;TPPP;TNFRSF1B;MYRF;RIMS1;DICER1;NCMAP
prerank,potassium ion transmembrane transport (GO:0071805),0.3259175039932401,1.0018671352528452,0.4702702702702703,0.9448596710224423,1.0,17/135,14.04%,SLC9A2;SLC9A4;HPN;SLC12A8;NALCN;ATP1A2;KCNJ13;ABCC8;KCNA4;SLC9A6;SLC9A7;KCNB1;PKD2L1;SLC12A4;KCNA5;KCNQ5;TMEM175
prerank,regulation of astrocyte differentiation (GO:0048710),0.47142739189597455,1.0017069133502796,0.4735945485519591,0.9445726662976311,1.0,2/12,4.18%,EPHA4;CLCF1
prerank,positive regulation of cell projection organization (GO:0031346),0.33179480869146855,1.0016230507414556,0.4972436604189636,0.9440900941075021,1.0,17/115,7.81%,NTRK3;FBXW8;PLXNB1;PTK7;PLXNA2;MAGI2;EP300;RAP1A;NGF;PTK2B;TIAM2;MAP6;PTPRD;TWF1;AVIL;DVL3;ARSB
prerank,regulation of histone acetylation (GO:0035065),0.3886973556902152,1.0012703227582636,0.4673024523160763,0.9443109227336313,1.0,8/33,14.84%,PPARGC1A;HDAC5;FOXP3;KMT2A;BRD7;RAPGEF3;SET;FLCN
prerank,glutamine family amino acid metabolic process (GO:0009064),0.38673492684061883,1.0011854717089597,0.44026845637583895,0.9438240435667282,1.0,12/33,26.33%,GLUL;DDAH2;GLUD1;PYCR3;PRODH;DGLUCY;KYAT1;ALDH18A1;SIRT4;PYCR2;DDAH1;ALDH5A1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3165693033562304,1.0011195285392949,0.4938650306748466,0.9433065464675058,1.0,39/268,15.08%,SLC9A2;SLC9A4;TRPM3;SLC36A3;ATP6V1B1;ASIC5;SCN3A;HPN;CACNA1A;NALCN;ATP1A2;TRPM8;CACNA2D4;TMEM165;ABCC8;SLC39A3;PKD1;SLC39A6;KCNA4;TRPM6;SLC9A6;SLC9A7;KCNB1;TRPM4;PKD2L1;SLC41A1;ANO6;KCNA5;SLC25A14;TRPM2;SLC39A13;KCNQ5;SLC6A7;TMEM175;ATP2B4;SLC25A27;SLC30A6;HVCN1;SLC9A8
prerank,megakaryocyte differentiation (GO:0030219),-0.41003638047680196,-1.0003097665448621,0.461734693877551,0.8182215391536702,1.0,6/11,40.43%,SH2B3;KIT;TAL1;CDKN2B;IL11;THPO
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.35913566208182485,1.0003000847579748,0.4490566037735849,0.9439649321634117,1.0,19/56,23.41%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.35913566208182485,1.0003000847579748,0.4490566037735849,0.9439649321634117,1.0,19/56,23.41%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10
prerank,neuron migration (GO:0001764),0.36256779631260344,1.0002357998485083,0.46582278481012657,0.9434254059067747,1.0,3/48,0.88%,FGF13;FGFR1;CELSR1
prerank,positive regulation of cellular respiration (GO:1901857),0.48069275181883986,1.0001588624381947,0.4694915254237288,0.9429358025172898,1.0,1/11,2.39%,NUPR1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35544274159643036,-1.0001021581358822,0.4367816091954023,0.8173680183342102,1.0,8/16,21.33%,ARHGAP24;AUTS2;PIK3CB;ALS2;STMN3;RASGRF1;ARF6;GABARAP
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3612004074608574,-0.9999527041719524,0.44984802431610943,0.8163868637582795,1.0,4/16,10.59%,PLCB1;BOC;BTG1;LRRC8A
prerank,nuclear export (GO:0051168),0.34712498870839886,0.9997700070965758,0.4613583138173302,0.9432768036224657,1.0,29/80,23.25%,RANBP3L;SRSF2;EIF4A3;DESI1;PKD1;DDX39B;CHP1;RBM8A;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RITA1;WASHC4;CSE1L;SRSF1;RAE1;SRSF5;XPO4;THOC1;RANBP3;POM121;U2AF1;TPR;SRRM1
prerank,positive regulation of ruffle assembly (GO:1900029),0.4640366693979692,0.9991864721111369,0.45868465430016864,0.9441062266683439,1.0,4/13,14.37%,EPS8L2;NDEL1;PLEKHM1;HRAS
prerank,positive regulation of growth (GO:0045927),-0.255174593827729,-0.9987968460933057,0.5220125786163522,0.8181024966796148,1.0,14/64,13.67%,PLCB1;INSR;LGI1;RFTN1;BCL2;SLC25A33;BRAT1;CXCL16;FXN;EXOSC2;HYAL1;KLHL22;MTPN;MFSD2A
prerank,positive regulation of signal transduction (GO:0009967),0.3149744942463611,0.9986042878970921,0.49896907216494846,0.9449165907897182,1.0,23/238,7.60%,PRKCB;SORBS1;TSPAN5;NTRK3;WNT1;KANK1;SMO;JCAD;ELF3;RSPO3;EMP2;EP300;LIMS2;PTK2B;TRIM44;SMARCB1;PIH1D1;CAV2;DMTN;ZBTB7B;WLS;TGFB2;ILK
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.29283650533937655,-0.9985495036064037,0.4453125,0.8173750185065227,1.0,8/40,10.92%,SLC7A11;SLC13A3;SLC7A5;SLC16A1;SLC7A7;SLC16A7;SLC38A11;SLC38A9
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.32068621365290884,-0.9984742849000676,0.459546925566343,0.8162091392174526,1.0,2/24,1.46%,PID1;DAB2
prerank,regulation of protein metabolic process (GO:0051246),0.36760854883435373,0.9981758305092647,0.46983311938382544,0.9453807395036408,1.0,12/44,21.83%,KLF4;LDLR;LTBP4;MAPK7;MDM2;CENATAC;CHEK2;ROCK2;APP;KLF2;ABCA7;SPOPL
prerank,calcium ion homeostasis (GO:0055074),0.33683724275253696,0.9980528321535311,0.47278911564625853,0.9450093853049847,1.0,11/95,8.10%,ANK2;ATP6V1B1;STIM2;CCL5;CAV1;CSRP3;SELENON;ATP13A3;TMEM165;JPH2;ATP13A4
prerank,regulation of phospholipase C activity (GO:1900274),0.4349252953699209,0.9979369969908894,0.47685185185185186,0.9446089508420705,1.0,2/15,0.84%,FGFR1;NTRK3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.33270879985149315,-0.9972605092060348,0.4754601226993865,0.8182149445472101,1.0,7/21,10.43%,ADCY5;GUCY1B1;ADCY7;GUCY1A1;ADCY1;ADCY4;NPR1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.41593400612694076,-0.9969532465018425,0.45528455284552843,0.8176459115090401,1.0,4/10,20.54%,SMARCD3;DRD2;CX3CL1;CX3CR1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.32872483569543404,0.9963421104494493,0.5053648068669528,0.9480726905146566,1.0,36/149,19.56%,PRKCB;CLU;EDA2R;EDA;CAV1;EP300;TRIM25;MTDH;FLOT2;NFKBIA;DDRGK1;TRIM21;TAB3;RAB7B;TLR6;CARD16;TLR4;MAP3K13;IRAK1;CHUK;DHX9;IKBKG;RNF31;UBE2N;RPS27A;UBC;PRKCZ;PIDD1;TAB2;TRIM37;PRKCQ;PRKD2;NFKB2;APP;FLOT1;ZBTB7A
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4803775720547105,0.9958954701737517,0.4852941176470588,0.9485752747257811,1.0,1/10,0.76%,CHRM1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3469332641816933,0.9957648997094838,0.47841306884480744,0.948187866006721,1.0,28/80,19.81%,RAB9B;SNX8;GCC2;MAGEL2;RAB7B;RAB7A;GGA1;VPS54;SGSM2;VTI1B;RNF126;SNX12;PHETA2;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;WASHC1;VPS50;TBC1D10A;ARFRP1;YKT6;TMEM87B;BET1L;RAB9A;VTI1A;TBC1D17
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3427052274574535,0.9955940072092847,0.46736596736596736,0.9479398974107566,1.0,19/84,14.85%,FGFR1;ANGPT1;ANXA3;ZC3H12A;GFUS;PTK2B;FOXC2;HSPB1;BMP4;EMC10;NRP2;BCAS3;BCAR1;SP1;GATA3;FOXP1;NUS1;AAMP;ITGB1BP1
prerank,protein O-linked mannosylation (GO:0035269),0.4274486714387422,0.9955727355489999,0.4767616191904048,0.9472900365901344,1.0,3/18,4.29%,B4GAT1;TMTC1;LARGE1
prerank,cellular response to hormone stimulus (GO:0032870),0.34326976962620404,0.9954844318973017,0.4602803738317757,0.9468070875656505,1.0,6/69,4.96%,THRB;ADTRP;NCOA3;CAV1;ATP1A2;RAMP1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4269457446422198,0.9949836635885373,0.4838709677419355,0.9473610740249397,1.0,5/18,17.37%,COX19;COX16;COX20;COA8;SMIM20
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.47028156405772337,0.9947821623968442,0.47278911564625853,0.9471755781283504,1.0,3/11,14.17%,TGFB2;TGFBR2;TGFBR3
prerank,ureteric bud development (GO:0001657),0.43846317371965465,0.9945885662334781,0.4884080370942813,0.9469999236301905,1.0,5/17,12.04%,WNT11;BMP4;GPC3;SIX1;NPNT
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3411728633984917,0.994434815386201,0.4723203769140165,0.9467068709196564,1.0,7/72,8.00%,FGFR1;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,long-chain fatty acid transport (GO:0015909),0.3886573919396008,0.9933462095599823,0.454172366621067,0.9489265987442657,1.0,6/30,12.65%,PRKAA2;ABCD1;CPT1B;ACSL3;ACACA;CPT2
prerank,chromatin disassembly (GO:0031498),0.4384464828313852,0.9930779629894226,0.4703125,0.9481980701021517,1.0,6/14,16.27%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,nucleosome disassembly (GO:0006337),0.4384464828313852,0.9930779629894226,0.4703125,0.9481980701021517,1.0,6/14,16.27%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,protein localization to vacuole (GO:0072665),0.457416799664784,0.992858697075137,0.48517940717628705,0.9480831643195582,1.0,9/13,30.47%,CD81;SH3BP4;KPTN;SZT2;GLMP;LAMTOR5;RTN4;ATP13A2;RNF128
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.42079614777162416,0.9925980480151841,0.4786931818181818,0.9480666034365378,1.0,7/22,18.97%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR;HEXIM1;CDK5RAP3
prerank,vesicle organization (GO:0016050),0.36874818910495116,0.9924693571732929,0.474025974025974,0.9476942596241595,1.0,13/46,13.89%,ANXA8;ANXA8L1;CAV1;CAV2;SRGN;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1
prerank,regulation of neuron migration (GO:2001222),0.40384707521695845,0.991843212960652,0.45392022008253097,0.9486458831548495,1.0,2/26,0.86%,PHACTR1;SRGAP2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.39574047752074293,-0.9917321626344876,0.4837837837837838,0.8304469578075264,1.0,2/13,2.50%,PID1;NOS3
prerank,sensory organ development (GO:0007423),0.36640428369899203,0.9917136596550379,0.4610705596107056,0.9482933989700101,1.0,4/51,3.16%,PBX3;PBX1;WNT10A;STRA6
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4627270168993962,0.9913225889601435,0.4937106918238994,0.9485674713111237,1.0,3/12,12.86%,SREBF2;ABCA2;LPCAT3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4393435270801792,0.990982817776746,0.4889589905362776,0.9487586552970636,1.0,9/17,30.00%,MUTYH;ERCC5;MBD4;NEIL1;TERF2;TINF2;TERF1;TERF2IP;TDG
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3582613991950615,-0.9907937030203521,0.44959128065395093,0.8316109798358511,1.0,2/17,9.18%,PLA2G4A;SERAC1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4342637069383533,0.9906477499931859,0.5036818851251841,0.9489575824586176,1.0,8/20,19.73%,NIBAN2;EP300;DDRGK1;TWIST1;GATA3;POU4F1;PARK7;RB1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4186407146010165,0.9905624759374259,0.46799431009957326,0.9484929249586667,1.0,10/20,26.06%,ADAM10;SPPL2B;HM13;SPPL2A;ADAM17;RHBDD1;APH1A;PSEN1;MBTPS2;RELA
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4116291549942538,0.9905188700572907,0.4964336661911555,0.9479051271782144,1.0,5/23,9.19%,MAP3K5;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,negative regulation of gene expression (GO:0010629),0.3109652894707156,0.9903875854271631,0.5030549898167006,0.9475554613474462,1.0,57/302,14.84%,NOTCH2;ITGB8;PRKAA2;KLF4;SMO;ADAM10;OCLN;SAMD4A;ZC3H12A;TWSG1;SAMD4B;CELF1;EPRS1;DAPK3;DAPK1;WWP2;OLFM1;FLOT2;OVOL2;PHF1;MOV10;DDRGK1;EIF4A3;BMP4;RBMS3;TGFB2;SRGN;LGR4;FOXP3;SHMT1;MAP2K2;DNMT3A;SMCR8;PPP1R11;NCOR1;AEBP2;RPS26;SNX12;SFMBT2;EIF2AK3;ZNF148;CPEB3;SH3GL2;SYNCRIP;PPM1D;FXR1;BTG2;MEF2C;TLE5;ATP2B4;SFRP1;FOXP1;HRAS;GAPDH;NCOR2;SETDB1;FLCN
prerank,alpha-amino acid metabolic process (GO:1901605),0.36379393203390875,0.9900390490552303,0.479002624671916,0.9477306859020523,1.0,15/45,24.64%,GLUL;NAALAD2;DDAH2;GLUD1;PYCR3;THAP4;SLC25A12;ASS1;KYAT1;ALDH18A1;PYCR2;GPT2;KMO;DDAH1;KYAT3
prerank,regulation of urine volume (GO:0035809),-0.4130325031808813,-0.9900348914749175,0.47183098591549294,0.8323441114226494,1.0,5/10,27.62%,NPR3;NPR1;ADM;HYAL2;HAS2
prerank,myelin assembly (GO:0032288),0.4893122148237935,0.9895512328753074,0.517799352750809,0.9483315368808571,1.0,3/10,11.07%,GPC1;CD9;ABCA2
prerank,synapse organization (GO:0050808),0.3260346265400879,0.9891473542281514,0.48975188781014023,0.9486773291281179,1.0,12/125,8.49%,CDH1;SDK1;GPC6;UNC13C;GPC4;CACNB3;PTPRD;MYOT;ANK3;PTPRF;FZD5;CDC42
prerank,sensory perception of mechanical stimulus (GO:0050954),0.33789282765702966,0.9887083321750815,0.4867358708189158,0.9490806726611949,1.0,10/85,6.91%,ATP6V1B1;USP53;COL4A3;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1
prerank,regulation of programmed cell death (GO:0043067),0.31951012781966875,0.9883690960351308,0.501577287066246,0.9492535483316961,1.0,22/161,12.21%,CLU;DAXX;ACTN2;NDRG1;PMAIP1;KANK2;DAPK3;DAPK1;PPP1R13B;RARG;IRF3;PERP;SOX9;HAX1;TNFRSF10B;PTPN6;RAF1;TIGAR;USP42;PLSCR3;MARK4;BCAR1
prerank,inflammatory response (GO:0006954),0.3148991407118878,0.9880036302491628,0.5057712486883525,0.9495254481257701,1.0,20/195,11.33%,AGTR1;CD44;CCL5;ELF3;HDAC5;CXCR4;PTGFR;FOS;RELB;HDAC4;CCRL2;NFAM1;ABCF1;TNFRSF1A;TLR6;TAC4;HP;HPR;TLR4;CDO1
prerank,lysosome organization (GO:0007040),-0.3005223964278357,-0.9877941807934751,0.4393305439330544,0.8371736327401478,1.0,11/36,17.79%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;CLN3;TMEM106B;VPS33A;CLVS1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.48927651228056646,0.9876410735459901,0.4983922829581994,0.9497513325768998,1.0,3/10,13.96%,PFKP;HK1;GFPT1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.35604098193330425,-0.987309732221999,0.47151898734177217,0.8371080783351722,1.0,2/17,0.77%,PDGFRB;ITGA1
prerank,triglyceride metabolic process (GO:0006641),0.36138366685113643,0.9872595146042515,0.47881899871630296,0.9499949779417792,1.0,4/48,5.72%,CAV1;DGAT1;MOGAT3;MOGAT1
prerank,positive regulation of innate immune response (GO:0045089),0.3974202664152548,0.9869806586256946,0.49786628733997157,0.9500220733045563,1.0,8/30,15.84%,CCL5;MAVS;POLR3B;LBP;NMI;POLR3C;DHX9;POLR3G
prerank,regulation of cell size (GO:0008361),-0.3308084411107418,-0.9869498190943584,0.4885245901639344,0.8367561190446902,1.0,8/23,18.19%,VAV3;RDX;DEPTOR;PRR16;MTPN;EDN1;AKT1S1;VAV1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2963509310587764,-0.9862686152845759,0.48880597014925375,0.8372099061243545,1.0,6/33,7.53%,PLCB1;RDX;UBE2E2;RGCC;GLI1;EZH2
prerank,negative regulation of protein binding (GO:0032091),0.34498157686950615,0.9862345787509725,0.4843205574912892,0.951299840408589,1.0,14/71,14.85%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;CTSZ;PTPRF;ACTB;CARD16;ADAM15;CSNK1E;TLE5;GSK3B;ITGB1BP1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3839756539649286,0.9858985278169692,0.4585635359116022,0.9514710732241921,1.0,3/29,7.31%,RAET1E;LAMP1;PVR
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.39157616433123904,0.9853473546294691,0.49295774647887325,0.9521911099458512,1.0,11/29,23.03%,FEM1A;FBXO5;ARRDC3;DCUN1D5;FEM1B;DCUN1D1;UBE2N;ABL1;PARK7;FBXW7;TRIB3
prerank,negative regulation of DNA replication (GO:0008156),0.46154353777046014,0.9851518088234646,0.5024311183144247,0.9520319671499208,1.0,6/13,28.68%,S100A11;ATR;WAPL;GTPBP4;TERF1;CDC6
prerank,neurotrophin signaling pathway (GO:0038179),0.41892000320356515,0.985107884672081,0.467438494934877,0.9514465530675581,1.0,10/21,23.96%,MAGI2;RAP1A;NGF;ZFYVE27;BCAR1;RAPGEF1;KIDINS220;CASP3;SOS1;FRS2
prerank,negative regulation of phosphorylation (GO:0042326),0.3383701066386705,0.9848148255983362,0.4852607709750567,0.9515005565151675,1.0,22/85,18.97%,NTRK3;CDKN1A;OCLN;NUPR1;ZC3H12A;HDAC4;FBLN1;BMP4;PIP5KL1;CHP1;FKBP8;TIGAR;NCOR1;IRS2;SH3GL2;DNAJC10;TESK1;PTPN13;GIT1;PARK7;CDKN2D;CDK5RAP3
prerank,positive regulation of cell motility (GO:2000147),0.3146050621498824,0.984788886274684,0.5046923879040668,0.9508825623617031,1.0,17/205,4.38%,SEMA3D;CDH13;NTRK3;LAMC2;TJP1;SMO;MMP9;CCL5;PODXL;PDGFC;ADAM10;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2
prerank,polyamine metabolic process (GO:0006595),0.4520782667539115,0.984783223766433,0.4725274725274725,0.9502072326562995,1.0,1/13,1.39%,SMOX
prerank,protein deubiquitination (GO:0016579),0.3136963452426985,0.9846349134028969,0.5243019648397105,0.9498669163736945,1.0,72/242,24.44%,CFTR;OGT;MINDY2;ZC3H12A;EP300;USP46;USP29;OTUD1;NFKBIA;PSMD11;USP32;USP10;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;USP19;ACTB;USP20;ENY2;USP24;PSMD7;USP42;USP3;RHOA;RNF123;COPS5;ABRAXAS1;TOMM20;FOXK1;MYSM1;PSMB5;GATA3;MYC;TNIP1;MDM2;IKBKG;USP28;RPS27A;UBC;OTUD6B;KEAP1;TRRAP;PSMD1;USP25;STAM;OTULIN;PSMC4;USP16;USP21;TAF9B;PSMD8;INO80D;USP22;INO80C;USP2;YY1;USP11;INO80E;SMURF2;WDR20;MDM4;PSMA7;TADA3;USP13;TFPT;MBD6;BIRC3;CDC25A;STAM2;USP34
prerank,cellular response to virus (GO:0098586),0.38704434686837563,0.9845871828099418,0.49295774647887325,0.9493160461006801,1.0,7/30,15.38%,CCL5;ZC3H12A;IRF3;LGALS8;GSDME;CHUK;HSP90AA1
prerank,calcium ion transport (GO:0006816),0.3274033260133035,0.9844587483747348,0.4922737306843267,0.9489632347373974,1.0,21/113,14.07%,TRPM3;ANK2;STIM2;CCL5;CACNA1A;CAV1;NALCN;TRPM8;CACNB3;RAMP1;CACNA2D4;TMEM165;MICU1;PKD1;TRPM6;MCUR1;TRPM4;ANO6;CACNB2;TRPM2;ATP2B4
prerank,phosphorylation (GO:0016310),0.30764228734485216,0.9843954434358144,0.5341365461847389,0.9484353145288789,1.0,96/384,20.03%,PRKCB;FGFR1;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;GRK5;ADAM10;TSSK6;TSSK4;WNT11;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;AGK;CREB1;RNASEL;STK39;SIK3;CSK;NADK;TGFB2;CDK16;ILK;LATS1;DYRK1B;OXSR1;MAPK9;AURKC;PI4KA;BCR;LMTK2;TXK;HK1;SRPK2;CDKL4;DGKA;GRK2;PDK2;CSNK1E;JAK1;YWHAZ;MARK4;TGFBR2;EIF2AK3;CDK18;SRPK1;MAP3K13;CDK2;GSK3A;IRAK1;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;PLK2;AAK1;PAK6;PRKCZ;ABL1;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PEAK1;RSKR;RARA;STK38L;STK24;ROCK2;TAOK3;PRKD2;APP;PNKP;MAP3K1;CDK11B;PRKAB1;TBCK;CDC42BPG
prerank,sympathetic nervous system development (GO:0048485),0.44345456307521475,0.9843743151884845,0.48154093097913325,0.9478035766664352,1.0,5/15,20.24%,GDNF;NRP2;GATA3;SEMA3A;SOX4
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.29213151505046914,-0.984216170391391,0.49469964664310956,0.8414246798546324,1.0,9/34,9.53%,RUNX1T1;ZFPM2;ENPP1;WNT5A;FOXO1;RORA;TGFB1;BBS12;GATA2
prerank,organelle organization (GO:0006996),0.3071021365740469,0.9840028041496975,0.5306532663316583,0.9480767714411032,1.0,94/388,20.20%,CXADR;SPTSSB;PPARGC1A;FMNL2;FBXW8;ANK1;MICAL2;YTHDF1;GABPB1;CAV1;ABCD1;DIAPH1;TJAP1;ZMYM6;NCKIPSD;TMED1;AGTPBP1;CAPZB;CAV2;DMTN;HCFC1;HAX1;NRF1;SYNE3;MAPK15;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;ARHGAP10;MICAL1;STRIP1;CHMP4A;CHMP4B;CDC42;RAB7A;CENPT;PCLO;MIEF2;TOR1A;AFG1L;BCAS3;NIPSNAP2;ZW10;VPS11;VPS4B;MARK4;AJUBA;EIF2AK3;ZMYM4;OPA1;GOLGB1;CHMP1A;RHOU;MYC;ARFGEF1;NPLOC4;VPS18;VPS4A;DNM1L;ATL2;VPS13D;USP6NL;CHMP2A;PEX6;ATP5F1B;PAK6;MTX1;CAMSAP1;PI4K2A;CFAP61;PACSIN1;CLUH;NUMA1;PDCD6IP;MTFR2;STX4;SEC23IP;PEX3;ODF2;WTIP;PARK7;TMED5;RNF112;PEX2;YTHDF3;SEC31B;RHOT2;MYO18A;SMPD4;STOML2;HSD17B10;MNS1;HILPDA
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.22974148223879454,-0.9837026394785046,0.47572815533980584,0.8414481586964176,1.0,31/113,17.68%,ABCA1;UNC13B;ASAP1;SLF1;ESR1;CUL4B;DAB2IP;PSMC6;GBP5;FNIP1;TFRC;TGFB1;SH3GLB1;TP53;TIRAP;TPPP;BCL2L11;BID;RACK1;RASIP1;BMF;SLF2;FNIP2;CDC42EP2;BAX;TTBK1;ERCC3;GNL3L;SKAP1;GTF2H3;SPIDR
prerank,regulation of axon guidance (GO:1902667),0.485821566714163,0.9836942390083421,0.5068027210884354,0.9481764803532602,1.0,3/10,13.80%,YTHDF1;ZSWIM8;TUBB2B
prerank,homocysteine metabolic process (GO:0050667),-0.4063199774566579,-0.9836910491079414,0.4949238578680203,0.840094803006932,1.0,7/11,43.27%,NOX4;MTHFR;CTH;MMUT;CBS;DPEP1;TST
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3710020718901316,0.9830394757803289,0.476,0.9491930639964845,1.0,4/37,8.80%,OGT;FHIT;DDRGK1;PML
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.2648824619194911,-0.9829067265597711,0.4840764331210191,0.8407658366535767,1.0,15/54,15.44%,DPP10;KCNN2;NOS1AP;KCNIP4;KCNIP3;KCNJ2;BIN1;KCNIP1;KCNJ12;DPP6;KCNJ6;KCNJ10;KCNMB4;KCNMA1;GNB1
prerank,positive regulation of embryonic development (GO:0040019),0.4222362327057799,0.9827433739349521,0.5037481259370314,0.9493146831299385,1.0,3/19,4.23%,WNT1;NIBAN2;RBM19
prerank,regulation of protein neddylation (GO:2000434),-0.41973309259073743,-0.9823302276643442,0.5025252525252525,0.8409822616725254,1.0,5/10,17.57%,HIF1A;EPAS1;RPL11;DCUN1D3;DCUN1D2
prerank,polyol metabolic process (GO:0019751),0.36154381418014525,0.9822079625222383,0.4987012987012987,0.9500135263248051,1.0,11/46,15.86%,NUDT4;PLCB3;PLCD3;IP6K1;INPP4A;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46248350676443856,0.9820841342701195,0.49743589743589745,0.9496444091841103,1.0,7/10,30.77%,SETD7;KMT5A;SMYD2;EHMT1;EEF1AKMT2;METTL18;SETD6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.39669801313408076,0.9816547656985611,0.4845360824742268,0.9500733277915094,1.0,1/25,0.37%,CDH13
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.23240545420212824,-0.9814629897893684,0.5111111111111111,0.8418596305231928,1.0,51/116,33.66%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;ADM;CYSLTR2;MC5R;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;HRH2;FGR;TSHR;FCGR2B;CD247;ADRB1;PLCG2;LHCGR;PLCG1;TREM2;PTH2R;GPR20;CD163;HTR6;GIPR;CRHR1
prerank,membrane depolarization during action potential (GO:0086010),-0.3130184802453397,-0.9813999444327927,0.4927007299270073,0.8406608983095814,1.0,8/26,15.43%,CACNA1C;SLC8A1;SCN7A;KCNJ2;CACNA1G;HCN2;SCN1A;SCN1B
prerank,microtubule bundle formation (GO:0001578),0.37236266654727024,0.9813407241614734,0.47003994673768307,0.950223167478888,1.0,6/42,12.07%,RP1;CFAP206;PSRC1;CHP1;GAS2L1;MARK4
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4267226255343059,0.9812625014306289,0.49453978159126366,0.9497643101571929,1.0,2/16,2.68%,ZC3H12A;ABCD1
prerank,regulation of protein ubiquitination (GO:0031396),0.32703943510497774,0.9812545841929535,0.49286498353457736,0.9491069827020372,1.0,27/108,22.27%,ANGPT1;DAXX;NXN;OGT;CAV1;PRR7;SH3RF2;CENPS;CHP1;HDAC3;HSPBP1;DCUN1D1;GSK3A;PINX1;WASHC1;HSP90AA1;UBE2N;XIAP;STUB1;PARK7;CDK5RAP3;PHF23;SOX4;FBXW7;SPOPL;RCHY1;SIRT7
prerank,macrophage activation (GO:0042116),0.3787401820598603,0.9810647926184797,0.48464619492656874,0.9489388170199181,1.0,10/34,20.35%,CLU;LBP;NMI;TLR4;SBNO2;FOXP1;ITGB2;APP;MAPT;AGER
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.31281364937101375,-0.9810206604796059,0.48,0.8403299039499483,1.0,14/29,32.28%,UTP6;NGDN;UTP20;RRP36;NOP9;RPS21;DHX37;TBL3;KRI1;WDR46;NOL10;ABT1;MRPS11;HELB
prerank,mesonephric tubule development (GO:0072164),0.4483631234725852,0.9808526815445378,0.5087719298245614,0.9488305442090355,1.0,5/15,12.04%,WNT11;BMP4;SIX1;PKD1;NPNT
prerank,B cell activation (GO:0042113),0.34498951698862756,0.980796601201993,0.47946859903381644,0.9483150905809634,1.0,11/68,16.20%,PRKCB;HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;MEF2C;KLF6;TPD52
prerank,inositol phosphate-mediated signaling (GO:0048016),0.431347439512114,0.9807673349877275,0.4853801169590643,0.9477053478588119,1.0,1/19,0.33%,NFATC2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3431791993710753,0.9806267592432943,0.4873035066505441,0.9473912652114806,1.0,23/64,24.83%,MLLT3;GTF2F1;POLR2H;ELOB;POLR2A;SSRP1;ELP4;POLR1E;ELL;TCEA2;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CTR9;CDK9;LEO1;MNAT1;POLR2K
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4196137662678801,0.9805617340401948,0.4903417533432392,0.9468843112522577,1.0,6/18,14.36%,RAP1B;RAP1A;SYN1;RIMS4;VPS18;GSK3B
prerank,positive regulation of immunoglobulin production (GO:0002639),0.39137373709569273,0.9804793413534029,0.4876373626373626,0.9464304430514168,1.0,4/31,9.56%,SASH3;CLCF1;SHLD2;RIF1
prerank,secondary alcohol metabolic process (GO:1902652),0.36297504693343463,0.9799622199001097,0.483160621761658,0.9470760847874041,1.0,9/42,16.04%,SOAT1;STARD3;SULT2B1;IDH3G;FDX1;SOAT2;SQLE;OSBPL5;IDH3A
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4418767025396764,0.9799355621233828,0.5121163166397416,0.9464651497809237,1.0,10/14,29.49%,NABP2;ATRX;PINX1;TNKS2;ATR;TERF2;TINF2;XRCC5;TERT;TERF2IP
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.46287111419740745,0.9795706253973583,0.48896434634974534,0.9466960660995709,1.0,1/11,1.18%,LDLR
prerank,regulation of viral genome replication (GO:0045069),0.35185442456301547,0.9795645072423471,0.4932349323493235,0.9460432255172051,1.0,11/56,16.37%,CCL5;MAVS;SLPI;TARBP2;RNASEL;TMEM39A;SRPK2;SRPK1;TNIP1;OAS2;DDB1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.45000773038296216,0.9792433994915783,0.5007923930269413,0.9462064225992217,1.0,3/13,8.81%,PIGU;DOT1L;IL7R
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.46340885183332003,0.9791540886602783,0.5161812297734628,0.945759192499949,1.0,4/12,19.22%,TLR6;ZNF205;TLR4;RAB27A
prerank,regulation of immunoglobulin production (GO:0002637),0.4070830453421062,0.9787877177404132,0.4885057471264368,0.9460258645065364,1.0,2/23,4.18%,SASH3;CLCF1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4581480427348559,0.9786623284310877,0.4901639344262295,0.945691270288256,1.0,3/12,9.41%,GSN;TRIM26;TRIM11
prerank,cellular response to fatty acid (GO:0071398),-0.3901452454249388,-0.9783279825582964,0.4891304347826087,0.8462242158734755,1.0,1/12,0.08%,PID1
prerank,response to histamine (GO:0034776),-0.41335960437145003,-0.9779027600118521,0.4988399071925754,0.8460623922943251,1.0,6/10,22.04%,GABRB1;GABRG2;DRD2;GABRB2;HRH1;GABRB3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.44890277036415804,0.9778182069233303,0.4869029275808937,0.947211977829079,1.0,3/14,6.72%,ADAMTS7;SOX9;EFEMP1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.439808168003666,0.9774583689854848,0.48757763975155277,0.9474496554796207,1.0,2/16,8.99%,TRIB2;FOXP3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3292353970089405,0.9774128508754865,0.4965437788018433,0.9468949991719753,1.0,34/87,28.58%,COX19;NDUFV1;NDUFB11;COX16;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;COX20;COA8;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;SMIM20;NDUFB5;SDHAF3;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10;UQCRFS1;SURF1;TIMMDC1;NDUFA13;COX14;NDUFAF7;NDUFB3;NDUFS4;LYRM7
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.38619991540365495,0.9774080485749239,0.48153214774281805,0.9462407925469535,1.0,14/30,24.02%,AMN;KIF13A;ANK3;GOLPH3;GCC2;GOLGA7;GGA1;NSF;ARFRP1;RAB10;VAMP2;SEC16A;RAB31;GOLPH3L
prerank,sodium-independent organic anion transport (GO:0043252),0.47580605186884184,0.9773188664234427,0.4914383561643836,0.9458132743695016,1.0,2/10,6.04%,SLCO2A1;SLC16A2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.36615213555085513,0.976954330824744,0.486284289276808,0.9460855991737229,1.0,11/45,14.97%,DDX5;BUD23;POLR2A;BMP4;RBM20;MAP2K2;WDR43;HABP4;HRAS;ZPR1;GRSF1
prerank,regulation of interleukin-1 production (GO:0032652),-0.3541428970939683,-0.976899535419524,0.5042492917847026,0.8474434048040752,1.0,2/15,3.04%,GAS6;TMED10
prerank,eye morphogenesis (GO:0048592),-0.33585780158947454,-0.9768151135524171,0.46254071661237783,0.8462898992351381,1.0,8/19,13.56%,FBN1;MFAP5;COL5A1;IFT122;FBN2;NF1;STAT3;NIPBL
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2586378094426403,-0.9764570192151858,0.5081967213114754,0.8458387624233116,1.0,20/63,20.74%,IGF1;SH3RF1;SP100;WWOX;AR;FAS;THBS1;DEPTOR;TNFSF10;CFLAR;RIPK1;BID;ITGA6;ITGAV;PELI3;ZMYND11;TRADD;SIAH2;TNFSF12;TRAF1
prerank,peroxisomal membrane transport (GO:0015919),0.39039204218520873,0.9764336129248915,0.4837799717912553,0.9467209173858503,1.0,8/27,18.72%,PEX26;ABCD1;SLC25A17;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3092194174193542,-0.9763065659144258,0.4891304347826087,0.8449186103330883,1.0,12/28,20.57%,CLASP2;MAP2;MAP1B;STMN2;PRUNE1;GBA2;STMN3;CAMSAP2;MAP1A;FKBP4;STMN4;MAPRE1
prerank,mitochondrial protein processing (GO:0034982),0.454182863894411,0.9761833985406158,0.49363057324840764,0.9466591841135754,1.0,4/11,19.88%,PMPCA;AFG3L2;SPG7;STOML2
prerank,electron transport chain (GO:0022900),0.4255543655417215,0.9757375202154724,0.48258706467661694,0.9470988379365087,1.0,3/15,9.44%,PPARGC1A;SDHB;CYB561
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4157182168723004,0.975469469011031,0.4808823529411765,0.9471319452716136,1.0,3/20,10.83%,FKBP5;NKTR;PPIC
prerank,protein localization to mitochondrion (GO:0070585),-0.38679687925824935,-0.9751867726117637,0.49066666666666664,0.8465553134045017,1.0,3/11,7.96%,LRRK2;HK2;DNAJA1
prerank,heterocycle biosynthetic process (GO:0018130),0.4445739657959248,0.9749588414793781,0.5040387722132472,0.9476928313852488,1.0,5/14,11.50%,MOCS3;ALOX5;NFS1;PYCR3;NOXRED1
prerank,nuclear pore complex assembly (GO:0051292),0.4752773948481205,0.9748554102836873,0.48217317487266553,0.9473040696706018,1.0,2/10,8.98%,NUP93;NDC1
prerank,RNA destabilization (GO:0050779),0.4189809638772261,0.974478628774949,0.49157733537519144,0.9476032947379732,1.0,7/18,23.14%,YTHDF1;CELF1;MEX3D;YTHDF3;ROCK2;DXO;FTO
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.3159478893093249,-0.9744113801301159,0.5135135135135135,0.8473865490066758,1.0,11/23,19.12%,ENPP1;MOSMO;IFT122;TULP3;MEGF8;RACK1;KCTD21;BTRC;KIF7;ULK3;PTCH2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.305440540216343,0.9743952824119565,0.5737211634904714,0.9471391988308353,1.0,70/532,11.78%,FN1;TNFRSF11B;CD44;CRLF1;MAP3K8;MMP9;CCL5;IL17RE;EDA2R;VIM;EDA;CDKN1A;RORC;IL17RA;RAP1B;IL15;IL16;LAMA5;TNFSF13;PTK2B;FOXO3;TNFRSF8;FOS;CLCF1;TIMP1;EPO;ACKR3;IL3RA;TRIM25;ALOX5;NFKBIA;PSMD11;IRF3;BCL2L1;RNASEL;GPR75;SHC1;CSK;GSTO1;ANXA2;PSMD4;MSN;COMMD7;PSMF1;MTAP;TRIM21;STAT4;TAB3;ILK;RBX1;NDN;CDC42;PML;IL7R;LBP;TNFRSF1A;PYDC1;TRIM26;PTPN6;CCND1;TWIST1;PSMD7;SOD2;SMARCA4;IL1R2;SOCS2;JAK1;FCER1G;IRS2;YWHAZ
prerank,regulation of cell cycle process (GO:0010564),0.328171528670406,0.9743228671420947,0.5028312570781427,0.9466792340474318,1.0,28/104,20.47%,KIF13A;DAPK3;RAB11FIP3;CAV2;BCL2L1;SOX9;KLHL21;PLK3;CDC42;AURKC;FBXO5;USP19;PKMYT1;KLHL13;MARK4;SFRP1;FLCN;PLK2;MAD1L1;CUL9;DYNC1H1;GIT1;NUMA1;ZFYVE26;KIF20B;GPER1;UVRAG;PIK3R4
prerank,glucose import (GO:0046323),-0.38449118641719826,-0.9739756410534086,0.5179063360881543,0.8471395502589535,1.0,2/13,8.80%,SLC2A1;SORT1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4716885751545667,0.9736129249157538,0.5101694915254237,0.9477463636886971,1.0,1/10,0.82%,PRKAA2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4567286908758278,0.9729928877759095,0.4923547400611621,0.9485916059091173,1.0,1/12,0.55%,THRB
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3076877586761271,0.9729151871517053,0.5409504550050556,0.9481322852192485,1.0,45/308,13.18%,ADRA1B;PPARGC1A;NCOA3;SMO;OGT;PDGFC;SCAMP5;NIBAN2;IL15;CAV1;TRPM8;CXCR4;CRB2;GDNF;RBM19;GCNT2;ZBTB16;OLFM1;SHLD2;ESRRB;SOX9;FOXD1;ZBTB7B;BMP4;TGFB2;BAD;ACADL;NFAM1;TGFB1I1;ELOVL6;SIX1;FBXO5;LBP;TXK;RIF1;TWIST1;KDM3A;HDAC3;TRPM4;TGFBR2;PTN;CPT2;PDPN;RREB1;MAP3K13
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4746234352773738,0.9721529626180214,0.5248,0.949386397582351,1.0,1/10,1.24%,NCOA3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3441906356724793,0.9719600014006207,0.503052503052503,0.949211619939084,1.0,6/57,4.46%,CRLF1;CCL5;IL15;PPP2CA;CLCF1;EPO
prerank,mesoderm development (GO:0007498),-0.34530819252097994,-0.9717054326301343,0.5107692307692308,0.8519617166250613,1.0,6/18,13.64%,TBX3;TIE1;BMX;JAK2;TBX1;MEST
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3444787445024664,-0.9709077399114225,0.4574780058651026,0.852742719616568,1.0,9/18,25.90%,MSRA;ASPG;FOLH1;MTHFR;ADI1;ASNS;GOT1;SMS;GOT2
prerank,peptidyl-methionine modification (GO:0018206),0.456681820690925,0.970859360798656,0.5118243243243243,0.9512938192689585,1.0,3/12,13.24%,PDF;NAA15;NAA20
prerank,multivesicular body assembly (GO:0036258),0.3862009080927815,0.970718679059066,0.49222065063649223,0.9509807757299379,1.0,12/30,20.11%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;VPS37A;IST1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3800175676965301,0.9704002580941327,0.4965893587994543,0.9510731912953151,1.0,5/28,7.63%,MAP3K5;BBC3;TMEM117;PPP1R15A;TNFRSF10B
prerank,protein complex oligomerization (GO:0051259),-0.23777540103192038,-0.9703026344096946,0.5080645161290323,0.8531106610729214,1.0,26/85,18.11%,LRRC8C;PKD2;EHD4;IKZF4;OXA1L;EHD3;MAT2A;UPB1;GSDMD;NUDT21;AQP11;JMJD6;TRMT61B;LRRC8A;WDCP;ALS2;CPSF6;G3BP2;CLDN1;GLRA3;KCNC1;MPP2;TIFA;BLM;ATL1;BOK
prerank,nuclear membrane reassembly (GO:0031468),0.35286312302333633,0.9696878330069124,0.48819875776397514,0.9521188687551311,1.0,12/54,15.82%,CC2D1B;PPP2CA;REEP3;NUP93;NSFL1C;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,protein neddylation (GO:0045116),0.44271819712863514,0.9694461052823807,0.4952076677316294,0.9520838410245938,1.0,8/13,29.65%,RBX1;DCUN1D5;DCUN1D1;UBE2F;RNF7;UBE2M;UBA3;NEDD8
prerank,positive regulation of cellular protein localization (GO:1903829),0.3383670989281054,0.969261604428389,0.5070921985815603,0.9518795905451972,1.0,26/69,25.07%,PRKAA2;LIMK2;SESN2;ORMDL3;DDRGK1;SNX33;MARK4;EIF2AK3;GSK3B;CCDC88A;SYT11;TESK1;NUMA1;STX4;PARK7;NECAB2;CDK5RAP3;CROCC;MAPT;ABCA7;TM9SF4;WWTR1;GAS8;FYN;STX3;NUP62
prerank,regulation of signal transduction (GO:0009966),0.3136548822837514,0.9689515706052583,0.5474452554744526,0.951986314551957,1.0,31/190,12.95%,CD55;CLU;IGFBP6;PRAG1;OGT;SREBF2;GRK5;VEPH1;RSPO3;GDNF;PPP2CA;TIMP1;TSC2;FRMPD1;OVOL2;CSK;PXN;ERBB3;ILK;UBTF;FOXP3;ZIC1;LLGL2;USP20;SYNJ2BP;GRK2;SOCS2;PTPN2;CDKN2AIP;RGS6;GATA3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.34763420683883106,-0.9688985293548236,0.4887005649717514,0.8555561833556101,1.0,2/17,6.00%,PLA2G4A;PLAAT3
prerank,Notch signaling pathway (GO:0007219),0.35066579348725085,0.9688612087291654,0.4969400244798042,0.9515568032600333,1.0,5/59,2.90%,NOTCH2;PBX1;ADAM10;NLE1;EP300
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.35994682415120743,0.9680903104990544,0.5025380710659898,0.9528108752122766,1.0,2/41,1.06%,ANK2;ACTN2
prerank,gluconeogenesis (GO:0006094),0.36668553245204377,0.9678629803169614,0.5013192612137203,0.952703145487101,1.0,9/39,18.22%,PPARGC1A;SLC25A1;ENO2;MDH2;ALDOA;GAPDH;SLC25A12;TPI1;PCK2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2532047178440915,-0.9676824067770943,0.5,0.857436858136307,1.0,17/65,14.78%,ERRFI1;HIP1;PTPRJ;TGFA;ITGA1;AFAP1L2;MVB12B;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;CNOT9;BCAR3;EPS15;MVB12A
prerank,mesenchymal cell development (GO:0014031),-0.34755478423404745,-0.9676031556519294,0.49843260188087773,0.856297386108497,1.0,9/18,25.44%,CDH2;NOTCH1;HEYL;PDCD6;SOX11;NOLC1;HEY2;KBTBD8;KLHL12
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.43091479920835724,0.9674863034642179,0.5112179487179487,0.9529639186133787,1.0,4/14,10.00%,AK1;CMPK1;AK3;AK5
prerank,regulation of protein sumoylation (GO:0033233),0.4240702024464948,0.9671990241707848,0.5237388724035609,0.9530041596078184,1.0,5/17,12.89%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,glycoprotein metabolic process (GO:0009100),-0.26595761419354147,-0.9669356502885769,0.5377358490566038,0.8568240463193697,1.0,15/53,18.35%,ST6GALNAC3;MAN1C1;ADAMTS9;HIF1A;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;MAN2B1;B4GALT5;GCNT1;ST8SIA5;B4GALT7;ST8SIA2;PCSK6
prerank,skeletal system development (GO:0001501),0.3144904940098855,0.9667579042248584,0.5329087048832272,0.953458255570887,1.0,16/148,8.25%,TNFRSF11B;KIAA1217;FGFR1;CD44;ITGB8;WNT1;ANKH;AKAP13;WNT11;BMP5;ZBTB16;SOX9;PRELP;DDRGK1;TGFB2;PKD1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21625050247474,-0.9667472428629152,0.5882352941176471,0.8559720161914116,1.0,54/172,21.50%,PLA2G4A;PIK3R1;INPP4B;ETNK1;PIP5K1B;DGKH;GPD1L;INPP5D;DGKB;PIP4K2A;SYNJ2;FGF2;PLD1;ARF3;ABHD3;PTDSS1;MTMR14;MTM1;PLEKHA8;BMX;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6;CDS2;PIK3CD;SLC44A2;PLSCR1;PCYT1A;LPIN2;MTMR7;MTMR2;DGKG;PIK3R3;MFSD2A;SLC44A1;PI4K2B;PIK3C3;CLN3;PIK3R5;RUFY1;AGPAT3;STARD10;PCTP;FIG4;PIK3R2;INPPL1;PNPLA3;AGPAT2;PLA2G4C;PIP4K2B;PIP5K1A;DGKZ;DGKQ
prerank,regulation of JNK cascade (GO:0046328),0.32747918570192586,0.9666591948080385,0.5323660714285714,0.9530453109479168,1.0,7/101,4.38%,WNT16;MAP3K5;EDA2R;CCN2;PTK2B;DUSP10;SH3RF2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3293270134878071,0.9664575898587439,0.5076923076923077,0.952870503582177,1.0,11/95,8.04%,CD109;VEPH1;SMAD6;TRIM33;CAV1;EP300;LTBP4;SPRED3;LATS1;TGFB1I1;PPM1A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.39951090949763507,0.9664460040172576,0.49712643678160917,0.9522410295518285,1.0,8/25,16.09%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3401829676559119,-0.9664095330408206,0.4836795252225519,0.8555164241221405,1.0,11/18,34.73%,AQP4;SPEF2;RFX3;NPHP3;CFAP53;CCDC39;ROPN1L;SPA17;DNAAF2;ODAD4;NEK10
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4310405873332701,0.9663357828209655,0.49447077409162715,0.9518702328487617,1.0,2/15,4.59%,FGFR1;HSPB1
prerank,negative regulation of viral life cycle (GO:1903901),0.4284438174232396,0.9660937115892906,0.5,0.9518226716898734,1.0,3/15,9.41%,GSN;TRIM26;TRIM11
prerank,regulation of focal adhesion assembly (GO:0051893),0.349928089271289,0.9655121941813607,0.5030826140567201,0.9526242263962044,1.0,19/54,18.80%,PHLDB2;S100A10;DAPK3;EFNA5;DMTN;PTPRA;BCAS3;ACTG1;DLC1;EPHA3;RHOA;SFRP1;ITGB1BP1;VCL;ABL1;SLC9A1;DUSP3;PEAK1;ROCK2
prerank,melanosome organization (GO:0032438),0.3908787359398461,0.9651677200329688,0.5028169014084507,0.9528382782994622,1.0,6/26,14.31%,KIF13A;BLOC1S6;AP3B1;BLOC1S2;AP1M1;PMEL
prerank,mRNA destabilization (GO:0061157),0.3704516864671054,0.9650205390272032,0.5033288948069241,0.9525795464257752,1.0,9/38,18.80%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;TUT7;MEX3D;YTHDF3;ROCK2
prerank,digestive tract development (GO:0048565),0.3765459754249429,0.9647793061869951,0.5215633423180593,0.9525466612557022,1.0,6/32,8.25%,COBL;SMO;GLI3;STRA6;TGFB2;PKD1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3437147655313209,-0.9647776377994985,0.5046153846153846,0.8585261040281814,1.0,8/18,19.88%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,glucose homeostasis (GO:0042593),0.3285770295540719,0.9647085557231807,0.5267958950969214,0.9520611003703758,1.0,15/83,12.62%,PRKAA2;PPARGC1A;MCU;ALOX5;HKDC1;HECTD4;KLF7;BAD;TCF7L2;CRY2;HK1;KCNB1;PDK2;PTPN2;FOXK1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.36844724827227177,-0.964634101952839,0.5092838196286472,0.8575724815366744,1.0,5/13,18.90%,GLI2;CAMK4;TOX;CLPTM1;SOD1
prerank,inositol phosphate metabolic process (GO:0043647),0.35653781377741833,0.9644773557248941,0.5131578947368421,0.9519699325008361,1.0,11/46,15.86%,NUDT4;PLCB3;PLCD3;IP6K1;INPP4A;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3387602779015985,-0.9644329538304725,0.4970414201183432,0.8566941460880932,1.0,3/20,8.37%,SP100;SYNE1;TOPORS
prerank,ncRNA transcription (GO:0098781),0.44559645365075207,0.9642917055346049,0.49523809523809526,0.9518004711604622,1.0,5/13,22.28%,ANG;SPIN1;SNAPC3;SIRT7;POLR1G
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2835180644790955,-0.9641797469204952,0.49612403100775193,0.8559805338612468,1.0,13/36,19.66%,HIF1A;WNT5A;GAS6;AXL;PARP14;NLRC5;IRGM;CASP4;RIPK1;EDN1;CD74;CSF1;AGPAT2
prerank,mitotic chromosome condensation (GO:0007076),0.3857621226164106,0.9639687020612778,0.5092198581560283,0.9519058595697278,1.0,10/26,23.02%,TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;RB1;PHF13;NCAPH;SMC4;KMT5A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.348224092628393,0.9635926912048938,0.5144654088050314,0.952233098575493,1.0,5/49,4.46%,CRLF1;CCL5;IL15;CLCF1;EPO
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3169057560601477,-0.9634333132835031,0.5135135135135135,0.8566971908703848,1.0,5/23,7.46%,ERRFI1;CBLB;SH3BP5;ZFYVE28;SOCS5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.37044582492100897,0.9630598540724457,0.50390625,0.9528538656378839,1.0,9/35,14.84%,KANK1;RIPOR2;RASAL3;CCDC125;TGFB2;DLC1;MAPKAP1;SYNGAP1;FLCN
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3739793462001869,0.9627840107829704,0.49389416553595655,0.952829110703028,1.0,5/32,6.60%,PRKAA2;PPARGC1A;NUPR1;BEND3;PFKFB2
prerank,histone H3-K36 demethylation (GO:0070544),0.4702499814821989,0.9625889040725678,0.5132450331125827,0.9526759509226805,1.0,3/10,10.86%,KDM4B;RIOX2;KDM4C
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3351449896886691,-0.9623158408464098,0.5168195718654435,0.8583338651930977,1.0,4/20,6.35%,SLC8A1;ATP1B1;SLC12A2;KCNJ2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3188995122625233,-0.9619016911352906,0.5387323943661971,0.8567845778249338,1.0,4/23,8.56%,ZEB2;DAB2;THBS1;ING2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3188995122625233,-0.9619016911352906,0.5387323943661971,0.8567845778249338,1.0,4/23,8.56%,ZEB2;DAB2;THBS1;ING2
prerank,ear morphogenesis (GO:0042471),0.41008538721683063,0.9617817998990006,0.5233082706766917,0.9540604954204411,1.0,4/20,10.34%,ATP6V1B1;SIX1;ZIC1;TWIST1
prerank,peptidyl-proline modification (GO:0018208),0.39528347473702896,0.9617345599254443,0.5056818181818182,0.9535266646587971,1.0,4/25,10.83%,FKBP5;NTMT1;NKTR;PPIC
prerank,receptor catabolic process (GO:0032801),-0.3144288234943936,-0.961695591785124,0.47368421052631576,0.8560573258673014,1.0,7/24,8.81%,SNX25;ZNRF3;CLTA;MYLIP;TGFB1;AP2B1;SH3GLB1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3874401889949194,-0.9612452208071653,0.5187032418952618,0.8558342814971605,1.0,2/11,8.12%,MOXD1;GCH1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3401527609848412,0.9611549621601284,0.5282112845138055,0.9542502280707296,1.0,18/68,19.86%,LSM10;POLR2H;SNRPB;TAF1C;POLR2A;MAZ;UBTF;WDR33;POLR1C;POLR1E;POLR1F;CSTF1;PABPN1;CLP1;ERCC2;POLR2E;CSTF3;TBP
prerank,response to peptide hormone (GO:0043434),0.3545182397873708,0.9608246620846498,0.5085413929040736,0.9544394418916797,1.0,7/43,7.43%,OGT;CAV1;CREB1;EIF2B2;ZBTB7B;EIF6;STAT4
prerank,tRNA processing (GO:0008033),0.34015654466600576,0.9606252838033059,0.5294117647058824,0.9542457487623821,1.0,23/61,24.34%,FARS2;LCMT2;TRPT1;ELP5;TRIT1;POP1;THG1L;AARS1;ANKRD16;RPP21;SARS1;TRNT1;CTU1;CLP1;TSEN2;TRMT10B;CTU2;TYW5;RPP40;NSUN6;FAM98B;URM1;KARS1
prerank,anterior/posterior pattern specification (GO:0009952),-0.25741804302841553,-0.960562010507915,0.5686274509803921,0.8562922889072255,1.0,20/53,26.31%,PCSK5;HEYL;LRP5;BASP1;HOXA7;DDIT3;TBX1;BHLHE40;BMPR2;HOXB7;HHEX;HOXC4;HOXB6;HOXD3;HEY2;HEY1;BHLHE41;HOXC5;SMAD2;HOXB9
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4080774898659987,0.9603951546459891,0.5074626865671642,0.9541829406074795,1.0,4/20,9.60%,FMNL2;RHOQ;STRIP1;LLGL2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.37679985305119335,0.9602752716492224,0.49132176234979974,0.953832099738987,1.0,8/29,11.92%,ELOVL1;SLC25A1;ELOVL6;ACSL3;ACSF3;ACACA;SCD5;FASN
prerank,cellular sodium ion homeostasis (GO:0006883),-0.3563246661590896,-0.9602138975280484,0.5243553008595988,0.8558463096516602,1.0,3/15,4.92%,SLC8A1;ATP1B1;SLC12A2
prerank,mRNA 3'-end processing (GO:0031124),0.3302485137119799,0.9598695384371726,0.5236447520184544,0.9541650444407607,1.0,29/78,23.50%,SRSF2;AHCYL1;EIF4A3;DDX39B;RBM8A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;RNPS1;CSTF1;SRSF9;UPF3B;GRSF1;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;APP;CSTF3;THOC1;TUT1;U2AF1;PABPC1;SRRM1;LEO1
prerank,negative regulation of leukocyte activation (GO:0002695),0.43249641073914064,0.9597631438173975,0.5331278890600925,0.9537849741650459,1.0,2/15,2.55%,CD200;ZC3H12A
prerank,icosanoid biosynthetic process (GO:0046456),0.45592651515030536,0.9597313374207378,0.5063897763578274,0.9532211568787141,1.0,4/10,13.95%,ALOX5;MGST3;FADS1;LTA4H
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.26119232275545495,-0.9593182116506632,0.5458937198067633,0.8568799248398292,1.0,20/50,20.46%,DCDC2;IFT81;MOSMO;IFT122;RORA;TULP3;GLI1;ARMC9;FGFR2;MEGF8;DLG5;RACK1;KCTD21;BTRC;KIF7;INTU;ULK3;PTCH2;GAS1;FUZ
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3414027901897659,-0.959275630278238,0.5373134328358209,0.8556404286996814,1.0,6/18,16.50%,LYN;SLIT2;IL6R;MTUS1;CAMK1D;EDN3
prerank,regulation of establishment of planar polarity (GO:0090175),0.3264233993731948,0.9590486418560383,0.5128205128205128,0.9541811218954402,1.0,14/88,12.90%,CELSR1;WNT1;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;FZD5;CDC42;PSMD7;AP2A1;RHOA;PSMB5
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.32971526695711373,0.9588149592571253,0.5291375291375291,0.9541199611282991,1.0,10/77,8.69%,CLU;MMP9;QARS1;PIH1D1;BCL2L1;BMP4;LGALS3;MAZ;TCF7L2;NDUFS3
prerank,neural crest cell development (GO:0014032),0.3606273408328266,0.9584120580971734,0.5297157622739018,0.9544212716425328,1.0,4/44,3.81%,SEMA3D;SEMA3B;PEF1;GDNF
prerank,regulation of glucose import (GO:0046324),0.3834351053161627,0.9583890332557483,0.5296495956873315,0.9538322984721197,1.0,4/30,5.15%,SORBS1;OCLN;CREBL2;RHOQ
prerank,pre-miRNA processing (GO:0031054),-0.3568150988159363,-0.9574337111084974,0.5052910052910053,0.8592180636175886,1.0,6/14,21.85%,TUT4;ADAR;DROSHA;AGO1;AGO4;DICER1
prerank,regulation of striated muscle contraction (GO:0006942),0.38702364998524363,0.9570295898478892,0.5421195652173914,0.956589997392588,1.0,2/27,2.78%,ANK2;ATP1A2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.33006603794999795,0.9569048188609033,0.5121107266435986,0.9562537805491957,1.0,7/79,2.47%,WNT1;GPC1;SMAD6;NIBAN2;NBL1;CRIM1;TRIM33
prerank,DNA strand elongation (GO:0022616),0.4151195714184908,0.9568846611505957,0.527190332326284,0.9556587171865003,1.0,7/18,21.61%,MRE11;POLD2;NBN;MCM7;RAD50;GINS3;MCM4
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.44713529451724005,0.9568396361482673,0.5272435897435898,0.9551242040385052,1.0,1/12,0.83%,UNC13C
prerank,negative regulation of cell communication (GO:0010648),-0.32241337052569974,-0.9566513411273989,0.504950495049505,0.8599583931249604,1.0,4/21,12.47%,UBASH3B;GLRA1;SOCS5;KIF26A
prerank,regulation of fat cell differentiation (GO:0045598),0.327680631375908,0.956552228008285,0.5256410256410257,0.9551666786846392,1.0,21/74,19.15%,WNT1;TRIB2;RORC;ZC3H12A;CREBL2;ZBTB16;ALOX5;CREB1;WDFY2;AAMDC;TRIO;TRPM4;GATA3;SFRP1;CCDC85B;LRP3;FRZB;E2F1;CDS1;TAF8;GPER1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.39632125253253075,0.956455807231423,0.5036818851251841,0.9547498686418264,1.0,5/21,11.89%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,telomere maintenance (GO:0000723),0.35359071483619775,0.9561156638318677,0.5193798449612403,0.95493456837433,1.0,25/50,28.18%,RECQL4;MRE11;PARP3;RIF1;HUS1B;NSMCE2;RPA3;POLD2;PCNA;ATR;SMC6;NBN;RAD50;ERCC4;TERF2;PTGES3;TINF2;APEX1;ZBTB48;RPA2;PARP1;POLD1;XRCC5;TERT;TERF1
prerank,endocrine system development (GO:0035270),-0.32141061206334115,-0.9560644722011784,0.5249169435215947,0.860221934609224,1.0,6/21,13.45%,GLI2;WNT4;DKK3;SALL1;NF1;TBX1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3440319723987013,0.9557900065821627,0.5361596009975063,0.9550587641665734,1.0,19/56,21.73%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;RHOA;EFHC2;JTB;RASA1;SEPTIN9;VPS4A;PDCD6IP;ROCK2;IST1;MITD1;RHOC
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.28020377735792346,-0.955719882141266,0.5511811023622047,0.8598148050415242,1.0,18/37,28.73%,IFT81;IFT122;TTC21B;IFT74;WDR19;KIFAP3;IFT43;KIF3B;CLUAP1;DYNC2LI1;DYNLL2;DYNC2I2;IFT27;KIF3C;IFT88;CEP131;IFT140;IFT22
prerank,positive regulation of cell cycle (GO:0045787),0.3363121959128313,0.9556757910055639,0.51145958986731,0.954689032774081,1.0,21/62,21.46%,NUPR1;CDK4;HCFC1;CCND2;TRIM21;TGFB2;PSRC1;PKD1;USP19;EIF4EBP1;CCND1;SRPK2;ANKRD17;MDM2;CDC25B;DUSP3;RARA;APP;ADAM17;USP22;USP2
prerank,regulation of viral transcription (GO:0046782),0.360255129357713,0.9554493234431328,0.538659793814433,0.9545758730785034,1.0,13/39,18.97%,GTF2F1;POLR2H;TARBP2;POLR2A;TRIM21;LARP7;TRIM11;DHX9;HEXIM1;NELFB;POLR2C;POLR2E;NELFA
prerank,negative regulation of myotube differentiation (GO:0010832),0.4463041246979012,0.9547176212682233,0.5191693290734825,0.9557316866375077,1.0,3/12,10.50%,HDAC5;HDAC4;HDAC3
prerank,mismatch repair (GO:0006298),0.3839131945126501,0.954389182452365,0.5245441795231417,0.9559398118063079,1.0,7/27,16.82%,MLH1;MUTYH;MLH3;RPA3;POLD2;PCNA;ABL1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3784694206022942,0.9543683436228295,0.5304709141274239,0.9553442820867935,1.0,8/31,11.76%,ANK1;CRB2;MSN;CDC42;OPHN1;EZR;SYNJ2BP;RHOA
prerank,muscle filament sliding (GO:0030049),0.3656271228467729,0.9542146057302352,0.5211459754433834,0.9544541472565252,1.0,2/38,1.66%,ACTN2;VIM
prerank,actin-myosin filament sliding (GO:0033275),0.3656271228467729,0.9542146057302352,0.5211459754433834,0.9544541472565252,1.0,2/38,1.66%,ACTN2;VIM
prerank,protein transport (GO:0015031),0.29885125474469104,0.9540522186781413,0.5945399393326593,0.9542144099478967,1.0,69/332,18.13%,PRKCB;RAB17;CLU;ATP6V1B1;SCAMP5;AMN;GRTP1;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;RAMP1;SIL1;TMED1;UNC119;ANK3;WLS;GOLPH3;GCC2;RAB3B;STXBP1;RAB7A;ARRDC3;NDC1;LMTK2;GOLGA7;MON1A;ARL6IP5;GGA1;SNX33;TOM1;SGSM2;SCAMP2;AP2A1;ARFIP2;RABL3;TBC1D1;NAPA;VIPAS39;STX11;ARF4;CHMP1A;NAPB;VPS26B;PREB;RAB5C;RAB1B;ATP6V1E1;STX16;ATP6V1D;USP6NL;NECAB3;CHMP2A;ATP6V0D1;TBC1D22A;CANX;LRP2;NSF;TBC1D10A;RAB8B;HDAC6;ARFRP1;COPG1;STX4;SEC23IP;ATP6V1B2
prerank,endosome organization (GO:0007032),0.3607457015979821,0.9534297201620426,0.5231958762886598,0.9550763446456612,1.0,14/41,19.22%,ANXA8;ANXA8L1;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1;PI4K2A;WASHC4;HOOK3;RAB27A
prerank,metal ion export (GO:0070839),-0.2975995587644186,-0.953373652052003,0.512,0.8648597584590475,1.0,4/31,5.94%,KCNT2;KCNK5;ATP1B1;SLC40A1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.355642944912156,0.9529326245114518,0.5153129161118508,0.9556405256402828,1.0,7/41,11.79%,ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;FADS1;SCD5
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3206708946853646,-0.9528684739477125,0.509090909090909,0.864779851523669,1.0,5/22,6.31%,LYN;MFHAS1;DAB2IP;APPL2;NR1H3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3389087098792507,0.9528539209014286,0.531615925058548,0.9551971148004714,1.0,10/65,12.27%,CD109;VEPH1;SMAD6;CAV1;SPRED3;TGFB1I1;PPM1A;LDLRAD4;TGFBR2;DAND5
prerank,insulin secretion (GO:0030073),0.4051983944482986,0.9528278748561404,0.5067873303167421,0.9546194768897142,1.0,7/19,27.60%,GAL;RAB11FIP5;PARK7;ADCYAP1;CYB5R4;PTPRN;PTPRN2
prerank,myeloid leukocyte differentiation (GO:0002573),0.34169348088941043,0.9527098536981052,0.5417661097852029,0.9542689291539679,1.0,17/65,18.82%,MMP9;CDKN1A;IL15;EP300;CDK4;BMP4;CDC42;PML;TGFBR2;SBNO2;CDK2;FOXP1;E2F1;PDE1B;PRTN3;RARA;BATF2
prerank,negative regulation of hemostasis (GO:1900047),0.44496785959049057,0.952560872764191,0.5284810126582279,0.954009714269692,1.0,2/12,6.08%,ADTRP;THBD
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.29914765119837267,0.9523826018148573,0.602020202020202,0.9538091720257087,1.0,60/314,17.61%,FZR1;FBXL7;FBXL20;SPSB4;NFE2L2;WWP2;RNF5;TRIM25;ERLIN2;PSMD11;NSFL1C;PSMD4;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RMND5B;FBXL18;RBX1;FBXO5;FBXO31;ERLIN1;USP19;PML;RNF121;UBE2B;LTN1;PCNP;SIAH3;COP1;PSMD7;AGAP3;FEM1B;RNF126;ZSWIM8;PSMB5;ANAPC4;CDK2;PELI1;GSK3A;NPLOC4;RHBDD2;UBE4A;DNAJC10;NEDD4;MDM2;BFAR;MAEA;FBXL15;DDB1;ARMC8;RPS27A;UBC;UBE2D3;SIAH1;STUB1;UBE2J1;FBXL2;PSMD1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.44897732595232714,0.9523564595069791,0.5160744500846024,0.9532339981352164,1.0,3/11,11.61%,CCL5;ANK3;JAK1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3834304441958628,0.9521407395239119,0.5269121813031161,0.9531328661285268,1.0,8/24,15.66%,ANK3;CHP1;MIEF2;MYO1C;KCNB1;HRAS;ITGB1BP1;ITGB2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.29214154329147846,-0.9520542579220053,0.5448028673835126,0.8655402828108794,1.0,7/29,13.20%,DPP10;KCNN2;KCNIP4;KCNIP3;FGF12;KCNIP1;DPP6
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.28035107436139217,-0.9512973873934756,0.525,0.8662173041149719,1.0,9/36,17.61%,TGFA;SHANK3;HIF1A;EPHB2;JAK2;NLGN3;EDN1;EGF;HDAC2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.37900692584731915,0.9511189781190897,0.5236728837876614,0.9549720015089341,1.0,5/26,8.62%,PRKAA2;ERLIN2;EIF6;ACADL;ERLIN1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.35566916125679787,-0.9508865538985152,0.5369318181818182,0.8658990612773291,1.0,14/16,51.51%,CYRIB;STX7;CEACAM1;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,nuclear transport (GO:0051169),-0.35075452327507045,-0.950864160084569,0.52,0.8646274307875429,1.0,8/16,28.54%,XPO1;NUTF2;NXT1;NUP205;BANF1;RSRC1;NPM1;PSIP1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.32867136847967837,-0.9507078520534143,0.4967741935483871,0.8637243995430297,1.0,3/21,6.26%,EPHA7;AIM2;GRIN2B
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.41231536068931407,0.950613996770234,0.5029498525073747,0.955540147284486,1.0,2/18,1.46%,FGFR1;COL4A3
prerank,modulation by host of viral genome replication (GO:0044827),0.4377039164089189,0.9505871083025659,0.5015479876160991,0.9549666731557577,1.0,5/13,23.50%,ZC3H12A;EIF2AK4;FBXL2;NUCKS1;VAPA
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3897205164845708,0.9505513557371138,0.5214384508990318,0.9544098046060976,1.0,1/25,0.66%,ANK2
prerank,response to hydrogen peroxide (GO:0042542),0.35128808114625404,0.950535665456227,0.5258511979823455,0.9538068343883671,1.0,18/45,27.54%,MAP3K5;NFE2L2;MAPK7;HP;AQP1;TRPM2;APTX;ABL1;HDAC6;PARK7;STK24;SIRPA;RHOB;IL6;FYN;RELA;RPS3;STK25
prerank,regulation of store-operated calcium entry (GO:2001256),0.4634973855009295,0.9502911078749269,0.5296950240770465,0.9537525345479032,1.0,2/10,3.42%,HOMER2;HOMER3
prerank,photoperiodism (GO:0009648),-0.2947224116527263,-0.9502638534694519,0.5255474452554745,0.8635849743507532,1.0,7/28,13.92%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3393876275484831,-0.9501899120122463,0.5459770114942529,0.8624480122717272,1.0,8/17,23.41%,SULF1;ZDHHC17;SLIT2;SFRP4;TMEM204;PCSK6;FSTL3;DOK5
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4353689932135861,0.9497983186375003,0.5235849056603774,0.954289298647906,1.0,2/12,8.75%,STARD3;FDX1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.415176018113677,0.9497435375852038,0.53125,0.9537936114230986,1.0,3/17,10.09%,SCAMP5;UNC13D;KCNB1
prerank,protein sumoylation (GO:0016925),0.3487836694790399,0.9497133216618866,0.5138339920948617,0.9532452837732815,1.0,19/49,25.48%,NUP93;EYA1;NDC1;SUMO2;SUMO3;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,chromatin organization (GO:0006325),0.3090829181153415,0.9490896956769073,0.5586652314316469,0.9541508595810022,1.0,26/132,13.51%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;PHF1;SOX9;HCFC1;KDM5C;ATRX;FOXP3;HDAC3;KDM4C;SMARCA4;DR1;KDM6A;ACTL6B;MPND;MYSM1;BAZ2B;SMARCD2;HMGN1;MYC;PWWP3A
prerank,heart looping (GO:0001947),0.3588943388322117,0.9490475921258268,0.5350993377483444,0.9536253624445485,1.0,3/39,2.24%,TBR1;SMO;MICAL2
prerank,sodium ion transport (GO:0006814),0.32672001277035106,0.9489419405686192,0.548460661345496,0.9532627589715644,1.0,5/85,2.78%,FGF13;ASIC5;SCN3A;NALCN;ATP1A2
prerank,negative regulation of proteolysis (GO:0045861),0.36137413894735243,0.9487718880350673,0.5123859191655802,0.9530397580391834,1.0,5/34,7.38%,EPHA4;TIMP4;TIMP1;TIMP2;TRIM21
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.4023634839193109,0.9482761919155948,0.5390070921985816,0.9536007463152024,1.0,3/23,5.10%,EFNB2;NIBAN2;LMOD3
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4138289606603611,0.9482075608735716,0.5370370370370371,0.9531320493041134,1.0,5/18,24.00%,ADAM10;BACE1;ADAM17;APH1A;PSEN1
prerank,regulation of phosphate metabolic process (GO:0019220),0.4182236422554421,0.9481937391746751,0.544891640866873,0.9525356000671792,1.0,6/16,24.00%,SMG7;TIGAR;IGBP1;MCM7;IKBKB;PSEN1
prerank,negative regulation of dephosphorylation (GO:0035305),0.4111051083163601,0.9479574791878065,0.5234604105571847,0.9524583132229375,1.0,4/18,8.94%,SH3RF2;PPP1R15A;CHP1;YWHAB
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4467412709362926,0.9478821647851257,0.5444444444444444,0.951995217387888,1.0,1/13,0.51%,FGFR1
prerank,receptor clustering (GO:0043113),0.38654732998245694,0.9466552568158293,0.5235457063711911,0.9543042313707361,1.0,8/27,15.67%,MAGI2;ITGB7;SYNJ2BP;MUSK;PTN;ITGB1BP1;ITGB2;FLNA
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.37804816155522136,-0.9465841423461668,0.5103092783505154,0.8705435817382177,1.0,2/12,3.31%,MAP2;STMN2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3922176783034943,0.9464285801827889,0.5221112696148359,0.9542056848033534,1.0,1/22,0.72%,NOTCH2
prerank,cellular response to glucose starvation (GO:0042149),0.36720517071755,0.9464253800676755,0.5452196382428941,0.9535889464408017,1.0,5/41,3.79%,PRKAA2;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,regulation of T cell differentiation (GO:0045580),0.3715577936150817,0.9463606625253607,0.5260347129506008,0.9530937057378601,1.0,1/33,0.33%,NFATC2
prerank,regulation of receptor internalization (GO:0002090),0.3632789700837033,0.9458493308428012,0.5411140583554377,0.9536878566040836,1.0,2/35,2.29%,ANGPT1;MAGI2
prerank,cardiac ventricle development (GO:0003231),-0.3221703941628169,-0.945680368505853,0.5031645569620253,0.8715991407729654,1.0,5/20,9.95%,ENG;NOTCH1;SALL1;HEYL;PDE2A
prerank,mitochondrial translation (GO:0032543),0.32080966529715,0.9455126561184962,0.5751121076233184,0.9538401536947217,1.0,39/104,27.06%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;HARS1;MRPL49;MRPL33;MRPS7;MRPS34;LARS2;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GATB;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44
prerank,regulation of cytokinesis (GO:0032465),0.32818424603064233,0.9455017574472957,0.5531177829099307,0.9532395941908643,1.0,21/78,20.47%,PKP4;KIF13A;RAB11FIP3;BCL2L1;KLHL21;ZFYVE19;PLK3;CDC42;AURKC;RHOA;KLHL13;VPS4A;FLCN;PLK2;CDC25B;GIT1;ZFYVE26;KIF20B;UVRAG;CSPP1;PIK3R4
prerank,protein heterooligomerization (GO:0051291),-0.34337752935156207,-0.9454123338937543,0.5510752688172043,0.8709896374039148,1.0,5/17,11.71%,PKD2;GRIN2B;MAT2A;NUDT21;CPSF6
prerank,bile acid metabolic process (GO:0008206),0.3873732804886098,0.9453896314129263,0.526080476900149,0.952881216128516,1.0,5/27,11.14%,OSBPL9;ACOT8;NPC1;CYP39A1;OSBPL7
prerank,heme biosynthetic process (GO:0006783),0.3896992561998262,0.9450982071126657,0.5240875912408759,0.9529635164938556,1.0,10/22,21.24%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;COX10
prerank,mRNA metabolic process (GO:0016071),0.32677891625895933,0.9450005630701462,0.5507411630558723,0.9525778454766463,1.0,23/90,21.56%,PPARGC1A;LSM10;DDX5;SRSF2;CELF1;SON;SNRPB;USP39;SRRM4;TBRG4;SRSF7;SF3A2;SRSF9;RNASE4;SRSF1;PTBP1;SRSF5;PCBP2;DXO;CSTF3;SF3A3;PRPF8;SFPQ
prerank,positive regulation of DNA binding (GO:0043388),0.3706443170862177,0.944908011664888,0.5124835742444153,0.9521608583417496,1.0,9/31,19.73%,MMP9;NIBAN2;NGF;TWIST1;GATA3;PINX1;POU4F1;PARK7;RB1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3257949726569308,0.9448183200575225,0.5436554132712457,0.9517625865269519,1.0,24/80,24.14%,ANGPT1;CAV1;PEF1;SPSB4;CENPS;RBX1;ARRDC3;DCUN1D5;HDAC3;HSPBP1;DCUN1D1;GSK3A;UBE2N;KDM1A;XIAP;STUB1;CDK5RAP3;PHF23;FBXW7;RCHY1;TRIB3;FBXO4;FANCM;BIRC3
prerank,regulation of receptor binding (GO:1900120),0.4573525634582077,0.9445913339504286,0.5446735395189003,0.9516761331205101,1.0,3/10,10.44%,MMP9;PTPRF;ADAM15
prerank,response to calcium ion (GO:0051592),-0.22334224302535355,-0.9444965843632996,0.6310679611650486,0.8720428597837151,1.0,16/102,7.83%,CPNE8;STIM1;ADGRV1;TRPC3;WNT5A;CAMK2D;RASGRP2;CPNE4;PKD2;SYT9;PRKAA1;THBS1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.38118049462134906,0.9444504578848341,0.5424200278164116,0.95136878473393,1.0,2/25,1.44%,ARAP1;MMP9
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.2695455348103284,-0.944334010987883,0.5950413223140496,0.8711366376288321,1.0,5/38,10.17%,BMP6;SASH1;GBP5;DDX60;PLSCR1
prerank,histone H3 deacetylation (GO:0070932),0.42971527020443273,0.9440800910855902,0.5330330330330331,0.9516369892386043,1.0,7/15,25.10%,HDAC4;HDAC3;SFPQ;SIRT7;PER1;PER2;HDAC8
prerank,embryonic digit morphogenesis (GO:0042733),-0.33081579804602185,-0.9436762527865583,0.5205882352941177,0.8715348440423235,1.0,7/18,17.61%,ECE1;TBX3;SALL1;TBX2;INTU;WDPCP;HDAC2
prerank,establishment of protein localization to membrane (GO:0090150),0.3306328561407294,0.9434284706999575,0.5618374558303887,0.9525682988417005,1.0,8/66,9.73%,NECTIN3;ZDHHC12;VPS37B;FRMPD1;NPC1;SYNE3;GOLGA7;MYO1C
prerank,Notch signaling involved in heart development (GO:0061314),0.4547427222959509,0.9433414733797361,0.5325542570951586,0.9521270716589265,1.0,1/11,0.72%,NOTCH2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3600993382716853,0.9431757927460865,0.5379581151832461,0.9519003868395807,1.0,6/37,11.16%,IL17RA;ZC3H12A;ABCD1;ALOX5;TLR6;TLR4
prerank,regulation of mitochondrial fission (GO:0090140),-0.30714677740636015,-0.9431525384855908,0.5457317073170732,0.8715629042309648,1.0,7/24,14.17%,DCN;KDR;LRRK2;VPS35;FIS1;CYRIB;SPIRE1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.35003360789000854,0.9428299404693518,0.5570719602977667,0.9521113458990188,1.0,11/50,15.64%,NR3C2;EP300;TRIM44;ILK;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4004320803214999,0.9426226738929547,0.5182926829268293,0.9519966529790304,1.0,4/18,15.48%,NUP93;ENY2;POLDIP3;PABPN1
prerank,gonad development (GO:0008406),-0.27664165162653204,-0.9421669999063074,0.5502008032128514,0.8727159196025537,1.0,8/41,10.69%,NR2F2;KITLG;WNT4;AR;WNT5A;SALL1;KIT;BASP1
prerank,synaptic vesicle transport (GO:0048489),0.43651481222243815,0.9416253890418385,0.5363924050632911,0.9537376245637877,1.0,7/11,30.78%,TOR1A;TMEM230;RAB27A;KIF5A;SYNJ1;KIF5C;DNM2
prerank,cellular amino acid catabolic process (GO:0009063),0.32038260176641276,0.941413370967178,0.5768348623853211,0.9536078411603415,1.0,26/87,22.71%,GLUL;CARNMT1;TDO2;PIPOX;GLUD1;ABAT;SHMT1;CARNS1;AMT;SLC25A44;SLC25A21;AUH;OGDH;BCAT2;IVD;DLST;HAAO;PRODH;ECHS1;MCCC2;KYAT1;HSD17B10;GAD1;SARDH;BLMH;GCDH
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2952434407737905,-0.9410497073172109,0.5357142857142857,0.8742638284070801,1.0,7/27,13.92%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,epithelial cell morphogenesis (GO:0003382),0.4076752626292226,0.9410122191380816,0.5287009063444109,0.9539376376061143,1.0,5/17,17.43%,POF1B;GRHL2;DACT2;CNMD;RILPL1
prerank,negative regulation of cellular component organization (GO:0051129),0.32248284119805837,0.9408655351814716,0.5444839857651246,0.95365335226975,1.0,17/74,17.35%,CLU;SCAMP5;EP300;TMEFF2;CRYAB;RUBCN;LGALS3;CDC42;RAF1;SNX33;RAPGEF3;EPHA3;ULK1;GSK3B;SYT11;PRKCZ;HDAC6
prerank,response to glucagon (GO:0033762),-0.3313157311190544,-0.9404187843227355,0.5045871559633027,0.8746168478037847,1.0,11/19,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;CRY1;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4246628933950496,0.9403219420791318,0.5314900153609831,0.9543391924404334,1.0,2/15,4.06%,EDA;WNT6
prerank,protein localization to organelle (GO:0033365),0.3067493266583576,0.9403194798259576,0.5661605206073753,0.9537296137434537,1.0,47/133,25.38%,ANK2;LAMP5;OTOF;CSRP3;EHD1;ARL3;LAMP1;PPP1R15A;DDRGK1;BMP4;GCC2;SIX1;BANP;GET4;TOR1A;RAB35;DCP1A;TOR1AIP1;ATP6V1D;LMNA;MDM2;DHX9;RAB33B;CCDC47;RIPOR1;FAM83H;ARFRP1;WDR35;APP;ZBTB7A;CROCC;ABCA7;TULP1;TULP2;YBX1;VAMP2;SGTA;MTCH2;VAPA;ARL6;ARL1;SIX4;GABARAPL2;TIA1;CYB5A;SNX10;TSPAN17
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3729641742707174,-0.9401372498753523,0.544,0.8739796962945893,1.0,3/13,7.66%,SHANK3;EPHB2;ADCY1
prerank,positive regulation of cell cycle process (GO:0090068),-0.2284856695943895,-0.939851798661388,0.6086956521739131,0.8734158657915377,1.0,12/91,10.25%,IGF1;SVIL;PDGFRB;TGFA;INSR;CDC14A;RGCC;CIT;IGF2;LRP5;PLSCR1;GPSM2
prerank,mitotic cytokinesis (GO:0000281),0.34625685869184786,0.939764616074219,0.5382653061224489,0.9543810991036937,1.0,11/47,12.79%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;EFHC2;JTB;RASA1
prerank,regulation of protein binding (GO:0043393),0.31446850318233155,0.9397035184200759,0.569060773480663,0.9539058699225376,1.0,28/114,19.48%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;HDAC5;PPP2CA;HDAC4;CTSZ;ADD1;BMP4;TRIM21;PKD1;TCF7L2;ACTB;CARD16;CSNK1E;CAPRIN2;TLE5;GSK3B;ITGB1BP1;CRK;KDM1A;SPPL3;PARK7;IDE;APP;FLOT1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3733827091928775,0.9395501399054279,0.5524079320113314,0.9536501218677252,1.0,5/28,7.25%,PRKAA2;CCL5;CTNS;AVIL;EIF6
prerank,protein mannosylation (GO:0035268),0.3919687880099552,0.9390531249104263,0.5397973950795948,0.9542035422207722,1.0,3/22,4.29%,B4GAT1;TMTC1;LARGE1
prerank,regulation of autophagosome maturation (GO:1901096),0.4402089788835532,0.9388140070061795,0.5394126738794436,0.9541274155618548,1.0,5/13,20.16%,TMEM39A;RUBCN;SMCR8;UVRAG;PHF23
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.34578771959141985,0.9384237447024204,0.5645569620253165,0.954442152758962,1.0,5/51,2.47%,WNT1;SMAD6;NBL1;CRIM1;TRIM33
prerank,negative regulation of protein processing (GO:0010955),-0.3823809566291747,-0.9381784298760404,0.55470737913486,0.8763538139313714,1.0,3/12,6.54%,THBS1;SERPINE2;LRRK2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3111391064288028,0.938016797446029,0.5538290788013318,0.9548141014676126,1.0,27/110,18.47%,CLU;GSN;EP300;PIH1D1;CRYAB;HCFC1;MAPK15;LATS1;STXBP1;LGALS3;CDC42;MTLN;RAF1;AJUBA;HRK;NAPA;NAPB;PREB;TRABD2B;ULK1;GSK3B;HSP90AA1;PRKCZ;HDAC6;CDH5;PTPN11;PARK7
prerank,dorsal/ventral pattern formation (GO:0009953),-0.32209042883601713,-0.9380131042583745,0.5491329479768786,0.8754609051385716,1.0,4/20,7.55%,GLI2;ACVRL1;BMPR1B;DSCAML1
prerank,regulation of cellular component biogenesis (GO:0044087),0.36553598772387946,0.9375314951862938,0.5613333333333334,0.9552802581993004,1.0,13/39,18.80%,TJP1;RAP1B;RAP1A;HCFC1;MSN;LATS1;EZR;VPS11;RAPGEF1;HSP90AA1;SPTY2D1;PTPN11;ROCK2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.45838784129201404,0.9374852498662728,0.5517241379310345,0.9547797368001306,1.0,1/11,1.03%,WNT1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4002424249243916,0.9372940794649394,0.5218045112781955,0.9546204205935671,1.0,6/17,17.81%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2524766718086124,-0.9371223972879865,0.6,0.8763676741458305,1.0,13/57,11.50%,DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;SHISA6;DLGAP1;GRIN2B;NLGN1;NEFL;NETO1;CACNG8;SHISA9
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.309572971531854,-0.9370657024103484,0.5448275862068965,0.8752161048814185,1.0,2/24,0.85%,PID1;LEPR
prerank,regulation of DNA binding (GO:0051101),0.3473073709570231,0.9369616202101365,0.5295629820051414,0.9548067604909957,1.0,8/44,10.69%,SMO;MMP9;NGF;DOT1L;NFKBIA;JUN;SUMO3;HABP4
prerank,cognition (GO:0050890),-0.26918951554753073,-0.936941228654429,0.5258620689655172,0.8742398863244338,1.0,12/42,13.67%,SOBP;RP9;TUSC3;SETD5;PTCHD1;GRM5;TTC8;CHD7;NF1;CHMP2B;NIPBL;MFSD2A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4013035856941579,0.9366960015304541,0.5445859872611465,0.9548205653850493,1.0,6/18,18.47%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,gastrulation (GO:0007369),-0.3558539120552654,-0.9366077295057857,0.5457063711911357,0.8737891143656289,1.0,4/15,12.12%,TASOR;LRP5;MEGF8;NPHP3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.280238352975967,-0.9359328554345867,0.5737704918032787,0.8742253433397053,1.0,6/34,7.85%,PTPRB;PTPRJ;UBASH3B;TNS2;PTPN12;PTPRZ1
prerank,leukotriene biosynthetic process (GO:0019370),-0.354047358543804,-0.9355634765490027,0.5342857142857143,0.8738990455930821,1.0,2/14,3.96%,PLA2G4A;GGT5
prerank,striated muscle cell differentiation (GO:0051146),-0.33800550007190916,-0.9355461558165676,0.5482093663911846,0.8726321927982897,1.0,6/16,16.09%,MYEF2;KDM6B;SIK1;SORT1;CBY1;MYOCD
prerank,transcription by RNA polymerase II (GO:0006366),0.290165080094554,0.9352321447025377,0.6561866125760649,0.9575351106118063,1.0,65/305,20.19%,NR3C2;THRB;NOTCH2;PPARGC1A;LSM10;RORC;CCN2;DDX5;MLLT3;GTF2F1;HDAC5;NR6A1;POLR2H;NABP2;ESRRB;SNRPB;TAF1C;RARG;ELOB;NKX2-8;POLR2A;RXRB;ZBTB7B;SSRP1;MAZ;ELP4;NR2C1;WDR33;INTS2;RPRD2;HDAC3;NFE2L3;NFIC;NCOR1;GTF2E1;SP1;TAF5;ELL;RREB1;RPAP1;CSTF1;SRRT;NCOR2;PABPN1;ELP2;TBPL1;CLP1;MED27;ERCC2;NELFB;INTS3;POLR2C;INTS13;RARA;POLR2E;INTS6;NELFA;TAF8;TAF9B;CSTF3;TBP;MED7;TEAD1;MNT;NABP1
prerank,epithelial tube morphogenesis (GO:0060562),-0.28385616773245975,-0.9351206165391936,0.582089552238806,0.8724843590310385,1.0,9/32,14.11%,GLI2;ACVRL1;COL4A1;PKD2;SLIT2;SOX17;MEGF8;RASIP1;RYR2
prerank,base-excision repair (GO:0006284),0.34263023145565086,0.9344633982815774,0.5512010113780025,0.958737014983483,1.0,14/48,20.45%,FEN1;MUTYH;POLG;ERCC5;MBD4;RPA3;POLD2;PCNA;LIG3;NEIL1;PARG;RFC1;PNKP;APEX2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3958241489287191,-0.9340463635438154,0.5441860465116279,0.8739588383159044,1.0,6/10,26.67%,DNAJC19;MTMR2;ABCA3;MFSD2A;MTMR4;PHB2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2906091721775166,0.9337606950292515,0.695,0.9597240158627617,1.0,108/572,16.89%,THRB;PRDM6;TMPRSS6;KLF4;TFAP2C;SREBF2;RORC;FOXP2;GLI3;DDX5;TRIM33;HIVEP1;KLF12;CAV1;FOXP4;ZNF436;EP300;HDAC5;ZMYM5;ZNF692;MXD4;KANK2;FOXO3;FOXC2;ZNF219;GLIS2;CGGBP1;HDAC4;NR6A1;ZBTB16;EPO;WWP2;MTDH;BEND3;RARG;PHF21A;LCOR;FOXM1;SOX9;OTUD7B;HCFC1;ZBTB7B;BMP4;CC2D1A;KLF7;NKAP;PLK3;ZFHX3;LARP7;PPM1A;ATRX;MAZ;JUN;TCF7L2;CRY2;ZFP57;FOXP3;DPF2;BAG3;NR2C1;DNMT3A;RIF1;EZR;APBB1;CCND1;NFIB;SAP130;TWIST1;HDAC3;ZNF205;NFIC;SP2;SMARCA4;NCOR1;DR1;ZNF148;MIER2;MAFK;CPEB3;CHD3;GATA3;RREB1;CBX4;MYC;ZNF177;MEF2C;TLE5;PCGF2;FOXP1;SARS1;IRF2;NCOR2;NEDD4;GATAD2B;FLCN;MDM2;IGBP1;HMBOX1;TCF25;ZGPAT;IRF2BP2;RPS27A;UBC;HEXIM1;E2F1;POU4F1;KDM1A;UBE2D3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3841946211877037,0.9335607162993335,0.5485636114911081,0.9595666017638852,1.0,8/24,18.65%,POLK;RPA3;POLD2;PCNA;LIG3;RPS27A;UBC;RFC1
prerank,sodium ion homeostasis (GO:0055078),-0.31567499736280713,-0.9335284903062062,0.5923566878980892,0.8739259127496386,1.0,3/21,4.92%,SLC8A1;ATP1B1;SLC12A2
prerank,microtubule depolymerization (GO:0007019),-0.3361701257600708,-0.9333334757788162,0.5441176470588235,0.87313296559964,1.0,11/17,34.30%,STMN2;NCKAP5;KIF18A;STMN3;CKAP5;STMN4;KIF18B;KIF14;NCKAP5L;CCSAP;KIF19
prerank,cellular response to ATP (GO:0071318),-0.3546387132863773,-0.9332473640846493,0.541025641025641,0.8720819013485647,1.0,5/14,27.99%,SSH1;P2RY1;P2RY12;CIB2;TAF1
prerank,positive regulation of secretion by cell (GO:1903532),0.32871444847376424,0.9332213655918353,0.5702380952380952,0.9597554227139068,1.0,11/70,10.68%,CFTR;SYTL4;UNC13D;GOLPH3;TGFB2;ANG;EZR;APBB1;KCNB1;IER3IP1;GRK2
prerank,clathrin-dependent endocytosis (GO:0072583),0.37610183089759486,0.932838589480677,0.5403111739745403,0.9600418976196649,1.0,4/26,4.41%,CLTB;FCHSD2;AP2A2;GPR107
prerank,midbody abscission (GO:0061952),0.4145435956498277,0.9325749299551289,0.5382308845577212,0.9600230728281762,1.0,10/17,26.60%,CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;CHMP5;CHMP1B
prerank,cGMP biosynthetic process (GO:0006182),-0.39813878505781414,-0.9324874601186247,0.520618556701031,0.8727963863680841,1.0,3/10,10.43%,GUCY1B1;GUCY1A1;NPR1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.36740414895064466,0.9321374796712693,0.5413223140495868,0.9604023372324754,1.0,3/30,6.65%,OGT;FHIT;DDRGK1
prerank,icosanoid metabolic process (GO:0006690),-0.27687178478115254,-0.9320495950517278,0.5450819672131147,0.8726243831915421,1.0,7/40,6.77%,PLA2G4A;PTGIS;GGT5;CYP1B1;MGLL;PTGS2;PNPLA8
prerank,negative regulation of catalytic activity (GO:0043086),-0.302611452775127,-0.9320439605721437,0.5734767025089605,0.8713623327806922,1.0,7/24,15.15%,NOTCH1;OXA1L;NOSIP;NES;TP53;CAMK2A;CLN3
prerank,amide transport (GO:0042886),-0.299840134075464,-0.9320217950469084,0.5567375886524822,0.8701439100673777,1.0,12/26,32.97%,PLTP;TAP2;PLEKHA8;AQP11;DISP1;SLC5A6;SLC14A1;PLEKHA3;ABCG2;ABCA13;SLC38A5;CPTP
prerank,vasculogenesis (GO:0001570),-0.2894977979160596,-0.9320035928518107,0.5522388059701493,0.8689231247915404,1.0,13/32,17.33%,PDGFRB;ENG;GLMN;KDR;NOTCH1;TGFB1;SOX17;RAMP2;RASIP1;EGFL7;ADM;SOX18;SPRED1
prerank,neurotransmitter uptake (GO:0001504),0.43145084093371466,0.9318395814777017,0.5299837925445705,0.9604645182888946,1.0,2/12,2.78%,GLUL;ATP1A2
prerank,cellular response to glucose stimulus (GO:0071333),-0.2863956814702824,-0.9315648438412737,0.5936395759717314,0.8687370976814289,1.0,8/30,12.35%,UNC13B;ZBTB20;GAS6;PRKAA1;RAB11FIP2;RAB11B;IGF1R;RACK1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3629070684319848,-0.9315126045043103,0.569060773480663,0.8676161777133012,1.0,4/13,10.88%,TBX3;NOTCH1;TGFB1;SRA1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23557597827792023,-0.9314547914674735,0.6242038216560509,0.866480854936909,1.0,29/75,24.27%,PLCB1;PLCE1;RGS5;KCTD8;RGS3;NMT2;MGLL;TULP3;GIT2;ROCK1;RIC8B;CRY1;RGS12;CAMK2A;FNTB;EDN1;MRAP2;RGS16;SAG;RGS4;DGKQ;RPGRIP1L;METAP2;PDE6H;GNG7;RGS20;C3;PDE6A;RNF157
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3587959566122179,-0.9308615118720428,0.5466321243523317,0.8668353033516921,1.0,5/13,17.82%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,positive regulation of proteolysis (GO:0045862),0.3408601531175803,0.930855193624114,0.5685785536159601,0.9620851465603522,1.0,14/55,20.37%,CYFIP2;OGT;ZC3H12A;PERP;BAD;ATP5IF1;SNX33;TNIP1;CTSH;TBC1D10A;STUB1;GPLD1;IST1;RHBDD1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2532529301824389,-0.9307308984603173,0.592964824120603,0.8659420015551264,1.0,11/49,16.64%,AFAP1L2;NOD1;LGALS9;STAT3;TIRAP;RIPK1;DDIT3;IL17D;TLR7;HMGB1;CD74
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3173489901807174,-0.9305941460837991,0.5579937304075235,0.8650117330975297,1.0,2/21,0.77%,PDGFRB;ITGA1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3266288862946485,0.9295120389898465,0.5751789976133651,0.9645052873377576,1.0,19/73,17.76%,WNT1;SMAD6;NBL1;CRIM1;TRIM33;TWSG1;CRB2;FOXD1;BMP4;DAND5;RBPMS2;FBXL15;LRP2;UBE2D3;XIAP;SMAD5;CDH5;NUMA1;BMPR1A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.26170600155402446,-0.929392561208628,0.6142131979695431,0.8668409756020319,1.0,7/46,6.41%,TIMP3;SEMA6A;LYN;WNK2;DAB2IP;EPHB2;RANBP9
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.45473025069610984,0.9292332183254521,0.5631067961165048,0.9645343399859521,1.0,1/10,1.03%,WNT1
prerank,response to steroid hormone (GO:0048545),0.36313670694675415,0.9289769488200489,0.5444887118193891,0.964512727483695,1.0,5/31,11.07%,ADTRP;CAV1;ATP1A2;TGFB2;ABCA2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.36134395698507293,0.928622868197375,0.5475862068965517,0.9647150295926556,1.0,7/32,17.05%,WNT1;OCLN;AVIL;CDC42;RREB1;FSCN1;ARPC2
prerank,protein targeting to peroxisome (GO:0006625),0.3678842449132855,0.9284663267385811,0.5435684647302904,0.9644683208223862,1.0,9/29,18.72%,PEX26;ABCD1;SLC25A17;ZFAND6;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.38186244940418745,-0.9282693580369137,0.5454545454545454,0.8684648786153302,1.0,2/11,1.33%,JAG1;ZFPM2
prerank,mRNA processing (GO:0006397),0.293670322742956,0.9281630381775581,0.6453252032520326,0.9645282737718108,1.0,93/287,25.57%,PPARGC1A;DDX5;GTF2F1;SRSF2;CELF1;RBM19;POLR2H;SNRNP70;SON;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;RPRD2;SF3B3;USP39;MTREX;SRRM4;TBRG4;SRSF7;SF3A2;POLDIP3;ZCCHC8;THOC7;FRG1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;ERCC2;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;THOC1;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;SPEN;RBM15;SRRM1;AURKAIP1;PRKACA;CMTR2;DDX46;CWF19L1;SNRPB2;MNAT1;POLR2K;CPSF7;GEMIN2;RBM15B;LSM5
prerank,lipoprotein biosynthetic process (GO:0042158),-0.3772009640294451,-0.9279072723938528,0.5491606714628298,0.8681197761027718,1.0,3/11,18.16%,UGCG;PIK3C3;ATG10
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3341461673556128,0.9278432655128042,0.5663824604141291,0.9646474876026486,1.0,6/57,10.22%,LPAR1;CHRM1;ADCY9;ADCY6;HTR1B;AKAP5
prerank,protein-containing complex disassembly (GO:0032984),0.33857228074613577,0.9277584197373919,0.5794044665012407,0.9642246549155512,1.0,16/54,19.80%,WNT1;CAV1;RUBCNL;DVL3;FZD5;VTI1B;VIPAS39;MYC;VPS4A;VAMP7;GSK3B;PYM1;MAP1LC3B;TSG101;FZD2;UVRAG
prerank,chromatin remodeling at centromere (GO:0031055),-0.2761070664240012,-0.9275411470898236,0.5604395604395604,0.8677174152634254,1.0,17/31,33.59%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;HELLS;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,negative regulation of cell differentiation (GO:0045596),0.29656334168869875,0.9274607900515763,0.6131386861313869,0.9642959963224413,1.0,21/181,6.81%,WNT1;RANBP3L;TRIB2;ADAMTS7;HPN;SMAD6;COL5A2;CRIM1;CAV1;CDK6;PTK2B;PPP2CA;BMP5;ZBTB16;NFKBIA;ESRRB;OVOL2;SPRED3;SOX9;EFEMP1;BMP4
prerank,mRNA modification (GO:0016556),-0.3129056472011972,-0.9274205256922265,0.5433333333333333,0.8667461890737548,1.0,6/22,16.23%,METTL8;PUS7;METTL16;TRMT61B;DKC1;TRMT6
prerank,toll-like receptor signaling pathway (GO:0002224),0.31681730779536166,0.9272769332782398,0.5742232451093211,0.9641246800902356,1.0,34/84,25.99%,SCARA3;TAB3;LBP;TLR6;NMI;CNPY3;TLR4;S100A1;IRAK1;CHUK;TNIP1;TLR3;IKBKG;ITGB2;RPS27A;UBC;COLEC12;UBE2D3;MAPKAPK2;TAB2;SFTPA1;SFTPA2;IRAK4;MAP3K1;PIK3R4;CTSK;TLR1;EPG5;TLR5;IKBKB;BIRC3;LY96;CASP8;TAB1
prerank,anterograde axonal transport (GO:0008089),0.3485435461498372,0.9271714906527992,0.5558441558441558,0.9637388716643122,1.0,6/37,6.69%,BLOC1S6;AP3B1;HSPB1;KIF1C;KIF1B;AP3S1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.28985133816680775,0.9266340105784345,0.6544715447154471,0.9643993604496647,1.0,76/336,18.47%,NFATC2;WNT1;SUSD6;CDKN1A;ZC3H12A;IKBKE;FEN1;RECQL4;DOT1L;PPP1R15A;NABP2;USP10;IRF3;BCL2L1;PHF1;ASF1A;NSMCE4A;MRE11;MACROD1;MAPK15;PARP3;CENPS;PLK3;INIP;RAD54L;FBXO31;POLK;PML;DCUN1D5;RIF1;UBE2B;APBB1;CCND1;MUTYH;PCLAF;TIGAR;MTREX;USP3;CSNK1E;TOPBP1;CDKN2AIP;MBD4;PAXX;MYC;PWWP3A;BTG2;REXO4;FOXP1;UBR5;POLH;ENDOV;APTX;MCM8;IKBKG;USP28;FAN1;UBA6;DDB1;ATR;E2F1;HINFP;ABL1;SMC6;NBN;MCM7;XIAP;INTS3;MAPKAPK2;TRRAP;CHEK2;PIDD1;RAD50;PARP2;USP16;PARK7;ATF2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4326160685359772,0.9266244590118358,0.5589225589225589,0.9638094903535076,1.0,3/12,12.08%,INSIG1;GPAA1;ANKRD13C
prerank,histone monoubiquitination (GO:0010390),-0.3039708956479599,-0.926567030268167,0.5379537953795379,0.8676058700700595,1.0,8/24,23.36%,CUL4B;WAC;BCOR;DTX3L;KDM2B;PAF1;RYBP;RNF2
prerank,double-strand break repair (GO:0006302),0.3005912057489356,0.9263175956415777,0.6245989304812835,0.9638896670357382,1.0,44/158,22.44%,FEN1;RECQL4;KDM4D;NABP2;KDM4B;RNF138;MRE11;EYA1;PARP3;TENT4A;RIF1;APBB1;RMI1;HUS1B;MDC1;NSMCE2;ABRAXAS1;MMS22L;ERCC5;PAXX;RPA3;APTX;MCM8;FAN1;UBE2N;PRPF19;DCLRE1C;LIG3;SFR1;SMC6;NBN;CHEK2;RAD50;PARP2;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;SWI5;RNF168;NSMCE1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.285425572624378,0.9262679485710942,0.841,0.9634070054177333,1.0,256/1646,14.34%,CDH1;PRKCB;BNC2;NFATC2;ZBTB7C;NR3C2;KLF5;FOXN3;DAXX;TMPRSS6;TBR1;WNT1;KLF4;TFAP2C;PBX3;PPARGC1A;PBX1;KLF3;ZIC4;TFAP2D;DMRT2;MAP3K5;ELF3;OGT;LBH;SREBF2;CDKN1A;RORC;SMAD6;NIBAN2;FOXP2;GLI3;DDX5;MLLT3;HOXA4;TRIM33;HIVEP1;CAND2;WNT11;KLF12;FOXP4;ZNF436;EP300;ZFHX4;TOX4;HDAC5;ZNF692;MXD4;QARS1;RBFOX2;CC2D1B;FOXO3;FOS;DAPK3;PCGF6;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;NOP2;PPP2CA;KLF16;CREBL2;PPP1R13L;HDAC4;NFE2L2;NR6A1;ZBTB16;ZBTB8A;ANXA4;EPO;WWP2;MTDH;CIAO1;TRIM44;SMARCB1;IGSF1;FOXD2;POU2F3;NFE2L1;NACC1;MLF2;CRYAB;ESRRB;RFX7;IRF3;PRRX2;BICRA;SLTM;JUND;OVOL2;NKX2-8;PATZ1;PHF1;POLR2A;LCOR;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;PCGF3;SOX9;FOXD1;HCFC1;ZIC2;NRF1;SHC1;KDM5C;ZBTB7B;KAT6B;EFEMP1;PHF10;BMP4;MEF2D;CC2D1A;KLF7;COMMD7;MED30;STAT4;NKAP;CDK16;ILK;TGFB1I1;DVL3;ZNF471;ZFHX3;DYRK1B;ZNF418;MAGEL2;CIC;PPM1A;L3MBTL3;ATRX;SIX1;PSRC1;MAZ;JUN;POU3F1;TCF7L2;FBXO5;CRY2;ELP4;ZFP57;PML;GRHL2;FOXP3;KMT2A;POU5F2;BRD7;SCML2;DPF2;NR2C1;MYCBP;MAP2K2;ZIC1;YWHAQ;HDGFL3;PHF5A;APBB1;MED29;ILF2;PRDM15;ENY2;NFIB;ZNF467;FADS1;NFYC;TWIST1;KDM3A;HDAC3;ARID4A;ZNF205;NFE2L3;NFIC;SOD2;GON4L;TLE2;BCL7A;SP2;KDM4C;MYT1;SMARCA4;ABCA2;MAMLD1;ARID3B;CREB3L4;CREB3;NCOR1;AEBP2;CALCOCO1;MEF2B;SRCAP;AJUBA;MED8;HOXB5;SFMBT2;NAA15;MAFG;SP1;ZBTB42;ZNF148;ACTL6B;TAF5;CDK18;MAFK;FOXK1;CCNL2;MED12;TFEB;SPIN1;BAZ2B;PIAS1;PIAS3;ZFP30;CHD3;GATA3;SMARCD2;ZSCAN20;TSC22D4;RREB1;SBNO2;GPBP1;NFIA;CHMP1A;BEND5;MED21;TCEA2;CBX4;MYC;POLR3C;ZNF177;PRDM11;MED24;ING4;REXO4;ZFP1;MEF2C;TLE5;PAX3;ZFP92;MYBL1;ATP2B4;SFRP1;SRRT;FOXP1;CHUK;SET;TASP1;ZXDC;PTP4A3;IRF2
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3927678783091929,-0.9256964569160301,0.56,0.8684369953114343,1.0,4/10,21.12%,NIN;BBS4;CCDC68;CEP19
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3182876958938909,0.9253433097765444,0.5852534562211982,0.9650156826578055,1.0,26/88,16.32%,STXBP6;CORO7;BLOC1S6;VPS13A;ARL3;EXOC4;MON2;GOLGA7;MYO5A;STEAP2;EXOC2;AP1S3;SCAMP2;AP2A1;NAPA;SH3GL2;GOLGB1;AP1M1;EXOC8;AP1S2;VAMP7;OSBPL5;CHMP2A;AP4E1;CCDC22;AP1B1
prerank,regulation of glycolytic process (GO:0006110),0.32515818197226426,0.9250564738862972,0.5724725943970768,0.9650548018011076,1.0,12/68,11.27%,PRKAA2;OGT;NUPR1;EP300;HDAC4;NUP93;PFKFB2;EIF6;NDC1;JMJD8;TIGAR;NCOR1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.31489725949038305,-0.9244898541900987,0.564327485380117,0.8702503247597371,1.0,7/20,18.30%,PLA2R1;THBS1;RGCC;ITGA4;SFRP4;PDCD4;CD40
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.3954934196741441,0.9242716953252728,0.5590433482810164,0.9661770972600968,1.0,3/19,5.38%,MCU;RIPOR2;MOSPD2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.35637799295312933,0.9242125260553457,0.55858310626703,0.9657017284859212,1.0,3/33,6.66%,CLU;BCL2L1;MUL1
prerank,cortical cytoskeleton organization (GO:0030865),-0.2634006762767893,-0.923703893505338,0.6079295154185022,0.8709075973576902,1.0,8/41,7.58%,RHOBTB1;RND3;FHOD3;FMNL3;EPB41L3;NLGN1;RHOBTB3;ROCK1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.27772018156009026,-0.9235478131773651,0.5973451327433629,0.8700080426607788,1.0,15/38,19.51%,SP100;NOS3;FAS;THBS1;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4213833925478635,0.9232736263229605,0.552755905511811,0.9672498138099367,1.0,6/14,23.86%,SEC23A;SEC24B;SEC31B;MIA3;SEC31A;SEC24D
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.30963069215966116,0.9232229468138864,0.5706521739130435,0.9667599775579483,1.0,14/118,8.34%,PHLDB2;PDLIM5;FMNL2;EPHA4;DAG1;EMP2;SIPA1L1;CRB2;GDNF;ZMYM6;CAPZB;EFNA5;SRCIN1;STRIP1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.37133671365442483,0.9230265455569487,0.5431266846361186,0.9666040368464631,1.0,4/29,6.02%,KANK1;TJP1;SSH3;TWF1
prerank,development of primary male sexual characteristics (GO:0046546),-0.2860777865162537,-0.9229863077636835,0.562962962962963,0.8701317919270642,1.0,5/34,2.84%,KITLG;WNT4;AR;WNT5A;LHFPL2
prerank,regulation of macroautophagy (GO:0016241),0.3152230344623969,0.9229170267085162,0.5910087719298246,0.9662645725473856,1.0,35/105,23.18%,PRKAA2;ATP6V1B1;NRBP2;SESN2;TSC2;RHEB;EXOC7;EXOC4;CAPNS1;SMCR8;EXOC8;VPS26B;BNIP3L;ULK1;ATP6V1E1;GAPDH;NEDD4;ATP6V1D;IKBKG;RB1CC1;ATP6V0D1;SESN1;PRKAG1;HDAC6;LZTS1;ATP6V1B2;ATP6V0B;PRKAB1;PRKAB2;CDK5R1;GNAI3;VPS26A;UBQLN2;ATP6V0E1;CASP3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3740430728973319,-0.922909851712956,0.5578947368421052,0.8690674458583016,1.0,3/11,7.87%,PARP12;PARP14;PARP8
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.44889459808571724,0.9227893375663573,0.5578583765112263,0.9659442698349111,1.0,3/10,9.43%,PCGF3;ZFP57;DNMT3A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3574362929361331,0.9226298370272619,0.5667574931880109,0.9657148655147244,1.0,15/32,30.07%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;NAF1;CTNNB1;CCT8;CCT6A
prerank,odontogenesis (GO:0042476),0.35273750566807427,0.9225090270390464,0.5673076923076923,0.9653790928132204,1.0,6/35,11.06%,EDA;WNT10A;WNT6;BMP4;TGFB2;AQP1
prerank,negative regulation of transport (GO:0051051),0.3322035136357893,0.9224630759397677,0.5742331288343558,0.9648860387761227,1.0,11/51,12.17%,SCAMP5;WWP2;CRYAB;ERBB3;RUBCN;LGALS3;RAB7A;ARL6IP5;SNX33;EPHA3;SNX12
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3958909502049345,0.9223875636762455,0.555895865237366,0.9644546506190386,1.0,9/19,24.31%,SMAD6;OLFM1;TGFB2;TGFBR2;BMPR1A;SOX4;EFNA1;MDM4;ZFPM1
prerank,amyloid fibril formation (GO:1990000),0.3379714264157888,0.922382012488021,0.563816604708798,0.9638631850967445,1.0,13/51,20.75%,TSPAN5;ADAM10;GSN;GGA1;MDM2;BACE1;RPS27A;UBC;SIAH1;H3-3A;APP;MAPT;APH1A
prerank,ruffle organization (GO:0031529),-0.3368316464396313,-0.9223729481923221,0.5568862275449101,0.8691461720243503,1.0,5/16,22.78%,LIMA1;AIF1L;ARF6;PIP5K1A;CORO1B
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.30994847557880845,0.9223691930853839,0.5816554809843401,0.9632799257433834,1.0,22/93,19.38%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;DMTN;HAX1;LATS1;NLRP2B;RAF1;RAPGEF3;CAPRIN2;ATP2B4;EIF4G1;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,regulation of steroid metabolic process (GO:0019218),0.37694789151005076,0.9223170693842244,0.5588652482269504,0.962797500924987,1.0,4/23,11.07%,RORC;TTC39B;ACADL;ABCA2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.4513572715578956,0.9221794769492235,0.5641025641025641,0.9625232205953098,1.0,3/10,14.56%,ATP1A2;STK39;NEDD4
prerank,positive regulation of chemotaxis (GO:0050921),0.3404171182294601,0.9221299338699555,0.5814863102998696,0.9620251042523904,1.0,3/43,4.59%,CDH13;NTRK3;HSPB1
prerank,ribosomal small subunit assembly (GO:0000028),0.42498072408726817,0.9219607474761478,0.5764525993883792,0.9618267417984953,1.0,8/16,30.82%,MRPS7;RPSA;PWP2;RPS28;RPS27;XRCC5;RPS15;ERAL1
prerank,positive regulation of cell killing (GO:0031343),-0.348957226872355,-0.92193255602017,0.5870786516853933,0.8689820561525672,1.0,1/13,2.77%,WNT5A
prerank,regulation of response to stress (GO:0080134),-0.3753719566580539,-0.921874125503052,0.5473684210526316,0.8679009065110113,1.0,4/10,22.44%,CORO2B;OPRM1;STOX1;ADCY8
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3549448328671471,-0.9218532431367227,0.5470297029702971,0.866719733785463,1.0,3/14,5.34%,IL34;PTK2;THBS1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4038393663254977,0.9216028304644077,0.5572065378900446,0.9620547170803928,1.0,2/19,2.01%,TJP1;OCLN
prerank,protein import into peroxisome membrane (GO:0045046),0.3800304354564711,0.9214778241894448,0.5606508875739645,0.9617319972613768,1.0,7/22,18.72%,PEX26;ABCD1;SLC25A17;PXMP4;RAB8B;PEX3;PEX2
prerank,cellular protein localization (GO:0034613),0.2894118356657805,0.9209492679750599,0.6666666666666666,0.9623295566602339,1.0,56/285,18.08%,RAB17;ANGPT1;ANK2;CELSR1;OCLN;EMP2;PIGU;WNT11;GRTP1;KIF13A;TBC1D16;CSRP3;EHD1;ARL4A;COPA;AP3B1;PTPRU;SNX8;SIL1;TMED1;ARMCX3;CPE;WLS;UNC50;STXBP1;GGA1;TM9SF1;SGSM2;AP2A1;ARFIP2;RABL3;TBC1D1;MESD;NAPA;CPLANE2;VIPAS39;STX11;ARF4;SEPTIN9;NAPB;VPS26B;RAB5C;RAB1B;STX16;USP6NL;FLNA;PRPF19;TBC1D22A;VCL;NSF;TBC1D10A;PACSIN1;HDAC6;ARFRP1;STX4;SEC23IP
prerank,transcription by RNA polymerase III (GO:0006383),0.36941129582493604,0.9209014949136498,0.5589080459770115,0.9618479691463736,1.0,13/27,28.26%,GTF3C3;ELL;POLR3G;GTF3C2;GTF3C5;POLR3H;TBP;SNAPC3;GTF3C4;ICE1;POLR2K;ZC3H8;BRF1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2920208084703565,0.920875250592231,0.6676891615541922,0.9613020201294449,1.0,103/264,28.43%,DDX5;GTF2F1;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;SF3B3;USP39;SRPK2;MTREX;SRSF7;SF3A2;ZCCHC8;FRG1;SRPK1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;SNUPN;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;DDX20;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;SPEN;RBM15;DCPS;SRRM1;CELF4;DDX46;CWF19L1;SNRPB2;CLNS1A;POLR2K;CPSF7;GEMIN8;GEMIN2;RBM15B;LSM5;PPIL3;CDK13;PRPF40A;DDX42;PPIE;GPKOW;RBM6;SNRPD2;SNRPD1;SF1;HNRNPM;HNRNPR;CSTF2;SF3B2;HNRNPH1;HSPA8
prerank,secondary palate development (GO:0062009),-0.3433624737464103,-0.9206219821426704,0.5515463917525774,0.8685982691276897,1.0,4/14,8.72%,LEF1;WNT5A;CHD7;LRRC32
prerank,positive regulation of viral transcription (GO:0050434),0.3740971930220164,0.9203522963593335,0.5679542203147353,0.9618919308856417,1.0,8/25,18.97%,GTF2F1;POLR2H;POLR2A;DHX9;NELFB;POLR2C;POLR2E;NELFA
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3265690965782994,0.9203059849598411,0.5743162901307967,0.9614053342248315,1.0,17/66,14.17%,HPN;NUPR1;CAV1;CDK6;DUSP10;ALOX5;CAV2;SOX9;TGFB2;KRIT1;ATP5IF1;NFIB;CASK;SYNJ2BP;GATA3;SFRP1;TGFBR3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.30710361294788274,0.9202518625327093,0.5968645016797313,0.9609391027390195,1.0,10/102,7.66%,SORBS1;CPEB2;ADCY9;CAV1;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ADCY6
prerank,regulation of chromatin organization (GO:1902275),0.4171076759052889,0.9201308645294982,0.5564142194744977,0.9606234147869686,1.0,2/14,7.03%,MLLT3;SSRP1
prerank,wound healing (GO:0042060),-0.24600996293808602,-0.9199168553780739,0.6440677966101694,0.8691781683483639,1.0,22/62,24.28%,IGF1;WNT5A;PDGFRA;DYSF;FGF2;MYOF;CFLAR;NF1;PPP3CA;MACF1;CLDN1;SMAD3;ANXA6;DCBLD2;PRCP;TSKU;EPB41L4B;JAML;SRF;CORO1B;DSP;PAK1
prerank,sphingolipid biosynthetic process (GO:0030148),0.32259019063650896,0.9198444283500562,0.5769682726204466,0.9607016087972365,1.0,9/71,9.25%,SPTSSB;SGMS2;PPM1L;A4GALT;ELOVL1;LARGE1;AGK;ELOVL6;HACD4
prerank,cellular response to BMP stimulus (GO:0071773),0.32464837823966275,0.9197389300612809,0.5928994082840237,0.9603568735805903,1.0,9/66,7.39%,ADAMTS7;SMAD6;DDX5;HIVEP1;GDF15;BMP5;SOX9;BMP4;TGFB2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.33159954310813305,0.9187389086555622,0.5694618272841051,0.9619609472373386,1.0,10/59,11.52%,OSBPL9;ACOT8;ALOX5;GAMT;CYP39A1;ACSM3;NDUFAB1;ACSF3;OSBPL7;ACACA
prerank,mitotic nuclear membrane organization (GO:0101024),0.33559162678671073,0.9187171967980413,0.5698254364089775,0.9608171589386291,1.0,11/51,15.82%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.33559162678671073,0.9187171967980413,0.5698254364089775,0.9608171589386291,1.0,11/51,15.82%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.39504259403904096,0.9184465395255487,0.5765895953757225,0.960842729193087,1.0,2/19,3.24%,SULT1A1;SULT2B1
prerank,lymphocyte proliferation (GO:0046651),-0.30059130586736205,-0.9181519746026692,0.5844594594594594,0.8721755728443152,1.0,8/22,21.32%,ELF4;BCL2;CTPS1;PPP3CB;HELLS;CD40;HSPD1;FLT3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.32181144373628556,0.9179531636809316,0.5880923450789793,0.9614040846648378,1.0,21/62,24.83%,MLLT3;GTF2F1;POLR2H;ELOB;POLR2A;SSRP1;ELP4;ELL;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CTR9;CDK9;LEO1;MNAT1;POLR2K
prerank,positive regulation of protein kinase activity (GO:0045860),0.2994182201659642,0.9177112348917101,0.6143308746048473,0.9613709223245243,1.0,17/148,9.40%,CLU;DAXX;CCL5;EPHA4;CDKN1A;EMP2;RAP1A;PTK2B;PPP2CA;PIH1D1;UNC119;CAMKK1;ERBB3;TGFB2;SRCIN1;IQGAP1;MAP2K2
prerank,protein modification by small protein removal (GO:0070646),0.29059426701306673,0.9176519538249908,0.679959100204499,0.9609204779676319,1.0,72/252,24.44%,CFTR;OGT;ZC3H12A;EP300;USP46;USP29;OTUD1;NFKBIA;PSMD11;USP32;USP10;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;DESI1;USP19;ACTB;USP20;TOR1A;USP24;PSMD7;USP42;USP3;RHOA;RNF123;COPS5;ABRAXAS1;TOMM20;FOXK1;MYSM1;PSMB5;GATA3;SENP3;MYC;TNIP1;MDM2;IKBKG;USP28;RPS27A;UBC;OTUD6B;KEAP1;TRRAP;PSMD1;USP25;STAM;PSMC4;USP16;USP21;TAF9B;PSMD8;INO80D;USP22;INO80C;USP2;YY1;USP11;INO80E;SMURF2;WDR20;MDM4;PSMA7;TADA3;USP13;TFPT;MBD6;BIRC3;CDC25A;STAM2;USP34
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.37318343039418334,0.9175831934397098,0.5412445730824892,0.9604693627085574,1.0,11/24,21.24%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;SUCLA2;COX10
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3078883345259349,-0.9175535801035095,0.5797101449275363,0.8723986382027794,1.0,8/21,18.73%,ERRFI1;RUNX1;ROCK1;SFRP4;CTSL;SGPP1;ZFP36;MAFF
prerank,regulation of neuron projection arborization (GO:0150011),-0.3523713687115167,-0.917348656249124,0.5630252100840336,0.8716544297093441,1.0,6/15,13.67%,WNT5A;MYO9A;FZD4;NTNG1;MACF1;MFSD2A
prerank,isotype switching (GO:0045190),0.44815492837922344,0.9172702336126536,0.5811688311688312,0.9605955929379766,1.0,5/10,30.45%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,regulation of cellular catabolic process (GO:0031329),0.32591293757438555,0.9170478472750886,0.5819070904645477,0.960502365467709,1.0,17/62,17.52%,NUPR1;ABCD1;EP300;DAPK3;DAPK1;HSPB1;USP10;MAPK15;SMCR8;MTMR3;OSBPL7;WDR91;PIP4K2C;ABL1;KEAP1;HDAC6;FBXL2
prerank,regulation of lipase activity (GO:0060191),-0.35383493720032316,-0.9165403283458912,0.5664893617021277,0.8723687658384477,1.0,1/13,0.56%,PCSK5
prerank,regulation of protein kinase activity (GO:0045859),0.30731567795974496,0.916430175351468,0.5824053452115813,0.961271228481218,1.0,25/106,19.80%,DAXX;TRIB2;CDKN1A;RAP1A;QARS1;PTK2B;HSPB1;TARBP2;TSC2;CAMKK1;IQGAP1;CHP1;PYDC1;SMCR8;GNAQ;JTB;ITGB1BP1;RAP2C;RELN;PRKAG1;TAB2;CAMK2N1;PARK7;RB1;UVRAG
prerank,spermatid development (GO:0007286),-0.27863019830875313,-0.9164168256415824,0.5984848484848485,0.8714636570940505,1.0,7/32,20.00%,ING2;YTHDC2;ZMYND15;BBS4;CIB1;RFX2;NME5
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3343969880218626,0.9163646394526538,0.6010165184243964,0.9608350797167687,1.0,14/52,15.54%,ZBTB17;ADD1;SHC1;MYDGF;FKBP14;SSR1;HYOU1;DNAJB11;GSK3A;PREB;GFPT1;DNAJC3;LMNA;ATP6V0D1
prerank,gene silencing by miRNA (GO:0035195),0.3581223757326631,0.9160726017746078,0.5682119205298013,0.9609442654668078,1.0,4/32,7.25%,CNOT6;TARBP2;MOV10;EIF6
prerank,ephrin receptor signaling pathway (GO:0048013),0.3157150149669233,0.9160419240419532,0.5729047072330654,0.9604257483079118,1.0,22/82,18.80%,MMP9;NGEF;EPHA4;EFNB2;SIPA1L1;AP2A2;EFNA5;CDC42;ACTB;ACTG1;EPHA3;AP2A1;RHOA;RASA1;HRAS;EFNA4;CRK;ARPC2;GIT1;PTPN11;YES1;ROCK2
prerank,maturation of SSU-rRNA (GO:0030490),-0.27920120549355565,-0.9159993740435217,0.6051660516605166,0.8712830264070361,1.0,16/34,32.77%,UTP6;NGDN;NAT10;RRP36;LSM6;DHX37;TSR3;NOB1;WDR3;SNU13;RIOK2;WDR46;NOL10;MRPS11;HELB;NOL11
prerank,regulation of dendrite extension (GO:1903859),0.40046127856302266,0.9159290694439568,0.581570996978852,0.9600739770402523,1.0,1/18,0.95%,OSTN
prerank,hepaticobiliary system development (GO:0061008),0.38613805377173915,0.9158459230319937,0.5555555555555556,0.9596524509084551,1.0,6/20,18.97%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;CDK5RAP3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.30000836290813554,0.915587091372557,0.6169749727965179,0.9596297361620901,1.0,18/136,9.14%,NLRP2;KLF4;CD200;NUPR1;ZC3H12A;GLIS2;HDAC4;ANXA4;WWP2;NFKBIA;COMMD7;TRIM21;NLRP2B;PKD1;TCF7L2;CHP1;FOXP3;PYDC1
prerank,positive regulation of neuron projection development (GO:0010976),0.31218381054850036,0.9154049300622724,0.58675799086758,0.9594442937675074,1.0,11/85,7.81%,NTRK3;COBL;PTK7;MAGI2;EP300;RAP1A;PTK2B;BMP5;TWF1;AVIL;ARSB
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4247785900779447,0.9153422644410141,0.5748031496062992,0.9590062616032163,1.0,5/12,22.39%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,carbohydrate homeostasis (GO:0033500),0.31820753206907265,0.9153147387114531,0.566150178784267,0.9584701363287297,1.0,11/67,12.52%,PRKAA2;MCU;ALOX5;HECTD4;KLF7;BAD;TCF7L2;CRY2;KCNB1;PDK2;PTPN2
prerank,DNA double-strand break processing (GO:0000729),0.39654521750723837,0.91503263688072,0.5688888888888889,0.9584926177547013,1.0,5/18,18.06%,RNF138;MRE11;UBE2N;NBN;RAD50
prerank,RNA stabilization (GO:0043489),-0.273242727772828,-0.9148526947460163,0.6098484848484849,0.8728628597749143,1.0,14/33,29.03%,TENT5A;ZCCHC17;EIF4ENIF1;AXIN2;DKC1;PARN;TENT5D;NOCT;TENT2;PHAX;SLC11A1;DHX36;RBM24;ELAVL1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.33013599467138094,0.9146621549174365,0.5888625592417062,0.9587272915525987,1.0,15/59,16.72%,CDKN1A;CDK4;MOV10;SOX9;MED30;JUN;TCF7L2;CCND1;TWIST1;MED8;MED12;PPM1D;MED24;MED6;MED27
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.35020240435113814,0.9143374669499938,0.5723598435462842,0.9588480370343175,1.0,5/38,6.66%,DAG1;MAGI2;PHLDA3;TSC2;MUL1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.44530128413298276,0.9141789657895114,0.5901360544217688,0.9586090915253023,1.0,2/10,8.89%,NINJ1;LBP
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.42868181755113244,0.9139597955193044,0.5487603305785124,0.9584796916784729,1.0,6/13,25.51%,PPP1R15A;DDRGK1;BFAR;ABCA7;PPP1R15B;NCK1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3627918123513014,0.9139324737795326,0.5686813186813187,0.9579616218015105,1.0,14/30,26.41%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;MNAT1;POLR2K;POLR1B;TTF1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3366297018145678,0.9136965313679608,0.6160493827160494,0.9578933971540692,1.0,7/45,8.46%,REPS2;GAB1;PTK2B;SOX9;SHC1;EFEMP1;IQGAP1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.39184917587889956,0.9136467417828217,0.5841874084919473,0.956839883502038,1.0,5/20,15.85%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,glutathione derivative metabolic process (GO:1901685),0.39184917587889956,0.9136467417828217,0.5841874084919473,0.956839883502038,1.0,5/20,15.85%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,UV-damage excision repair (GO:0070914),-0.3658890501006018,-0.913355321412026,0.5904522613065326,0.8752994094569923,1.0,7/12,38.20%,CUL4B;ACTR5;ERCC1;POLA1;DDB2;POLD3;INO80
prerank,somite development (GO:0061053),0.43173961796122384,0.9132836899195766,0.560200668896321,0.9570556618745064,1.0,1/11,1.40%,SMO
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.30046841727672896,-0.9130447710550446,0.5765765765765766,0.8748012513441139,1.0,4/23,6.77%,PLA2G4A;MBOAT1;PLAAT3;PNPLA8
prerank,protein acetylation (GO:0006473),0.359257813535269,0.9130019673670102,0.5852981969486823,0.9570921714591533,1.0,9/30,21.65%,EP300;NAA40;AANAT;NAA15;ING4;NAA10;MAPT;NAA35;HAT1
prerank,erythrocyte development (GO:0048821),-0.3790136338009196,-0.9129460511103153,0.5647668393782384,0.8738399204589125,1.0,3/10,10.79%,ALAS1;SH2B3;NCKAP1L
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3541241098709859,0.9128423788116737,0.5636856368563685,0.9568639167572555,1.0,9/32,14.85%,PHLDB2;DMTN;CASK;ADAM15;BCAS3;DLC1;MMP12;RASA1;ITGB1BP1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4110477139239118,0.9126819833689457,0.5568,0.9566443956261143,1.0,3/16,7.17%,DDX5;RBFOX2;EGLN2
prerank,nuclear pore organization (GO:0006999),0.41465287435765735,0.9126690951527556,0.5748407643312102,0.9560889083453351,1.0,8/14,28.95%,NUP93;NDC1;TPR;SEH1L;NUP133;TMEM170A;RTN4;NUP35
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.33642408541511737,0.9123105118146431,0.5807259073842302,0.9562875958119618,1.0,9/47,14.07%,ZC3H12A;CAV1;EP300;ERLIN2;ACADL;ERLIN1;ABCA2;PGP;ATP2B4
prerank,embryonic skeletal system development (GO:0048706),0.3506505751354682,0.9118605656511183,0.5811732605729877,0.9566229045192012,1.0,3/35,2.61%,KIAA1217;HOXA4;WNT11
prerank,negative regulation of cellular component movement (GO:0051271),0.41736445687536394,0.9118043089959478,0.5565749235474006,0.9561630408828761,1.0,7/15,16.38%,SPINT2;CD9;FBLN1;CCDC125;GATA3;TGFBR3;CRK
prerank,neuromuscular junction development (GO:0007528),0.3755661727179343,0.9117860998190865,0.5812591508052709,0.9556218369006783,1.0,8/24,17.71%,UNC13C;CACNB3;ANK3;MUSK;CACNB2;NEDD4;F2R;PDZRN3
prerank,potassium ion homeostasis (GO:0055075),0.37677518727470083,0.9117374904339536,0.5656716417910448,0.9551390630778274,1.0,8/23,21.09%,SLC12A8;ATP1A2;SLC12A4;SLC12A6;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,GTP metabolic process (GO:0046039),0.41187050854849927,0.911602693661875,0.5587349397590361,0.9548800144039563,1.0,7/15,22.63%,IMPDH2;RHOQ;AK3;OPA1;GNAI3;RAB23;EFL1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.27539587143055444,-0.9115454188925115,0.5977443609022557,0.8759950807338533,1.0,14/31,34.55%,LYN;GLMN;TNFRSF21;DLG5;CD300A;SOX11;RC3H1;TYROBP;FCGR2B;CD86;LST1;CD80;LILRB1;IL4I1
prerank,regulation of hydrolase activity (GO:0051336),0.32160773550853733,0.9112931048816365,0.6040914560770156,0.955009586122654,1.0,20/71,17.97%,NGEF;PLXNB1;EPHA4;PLXNA2;SIPA1L1;CAV1;ADAP1;EFNA5;ARHGEF5;ATP5IF1;PAFAH1B1;EPHA3;PLXNB2;OCRL;ARHGAP27;ITGB1BP1;PLXNA3;CRK;RAP1GAP;ARHGAP44
prerank,phospholipid biosynthetic process (GO:0008654),0.3546495038892778,0.9108738888800286,0.5847568988173456,0.9553636748273987,1.0,8/36,14.46%,SGMS2;FDPS;AGK;SRD5A3;FADS1;GPAM;DOLK;NUS1
prerank,protein localization to phagophore assembly site (GO:0034497),0.43390660306301787,0.9107264320002205,0.5631399317406144,0.955130175295107,1.0,11/11,56.64%,PACS2;WIPI2;TRAPPC8;WDR45;WIPI1;ATG13;STX17;WDR45B;MFN2;ATG9A;ATG9B
prerank,synaptic vesicle exocytosis (GO:0016079),0.3445818891286043,0.9107263487539312,0.5721583652618135,0.9545537539461056,1.0,5/40,8.86%,UNC13C;OTOF;BLOC1S6;DNAJC5;PCLO
prerank,protein maturation (GO:0051604),0.3101226301404723,0.9105889465612028,0.6251428571428571,0.9542682558548732,1.0,20/95,17.31%,TSPAN5;OGT;ADAM10;NAA40;CIAO1;AANAT;CPE;SRGN;AFG3L2;PITRM1;SDE2;NDUFAB1;ISCA1;NAA15;DNAJB11;NAA10;TASP1;BACE1;LMF2;STUB1
prerank,protein alkylation (GO:0008213),0.3730385588556692,0.9104650595611433,0.5809806835066865,0.9539507406600178,1.0,9/22,27.19%,EEF2KMT;SNRPB;PRMT1;ETF1;PRMT2;FAM98B;FAM98A;CAMKMT;EEF1AKMT2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.34752616353657684,0.9101372026683608,0.5699208443271768,0.9540540512811835,1.0,7/40,10.21%,PGLYRP3;ANG;ROMO1;STAB2;LBP;RNASE3;PPP1R11
prerank,nitric oxide biosynthetic process (GO:0006809),0.4165711310766179,0.9099054928235362,0.5635179153094463,0.9539950273525108,1.0,3/13,7.66%,CYB5R3;DDAH2;CYB5B
prerank,cellular response to nutrient levels (GO:0031669),0.32202477724013523,0.9094095146500065,0.5970695970695971,0.9544840268506017,1.0,17/62,20.87%,PRKAA2;SREBF2;GAS2L1;KCNB1;FADS1;PDK2;TFEB;SFRP1;ULK1;EIF4G1;FLCN;MAP1LC3B;RIPOR1;ZFYVE1;STK24;SREBF1;KLF10
prerank,purine-containing compound biosynthetic process (GO:0072522),0.37172921114001173,0.9093761177504909,0.5665236051502146,0.9539955650860122,1.0,10/25,22.64%,ADK;PAICS;GMPS;SHMT1;GART;AMPD2;DGUOK;PRPS1L1;PRPS1;APRT
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3957673467472508,0.9091043795208784,0.5745682888540031,0.954047814429622,1.0,5/17,8.79%,DOCK5;CCL5;S100A11;DOCK7;ADAMTS1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.438344518342012,0.9090970128037217,0.568695652173913,0.9534939206902802,1.0,3/10,13.02%,CACNB3;NIPSNAP2;CACNB2
prerank,gene expression (GO:0010467),0.2863065115159517,0.9089057669871689,0.694949494949495,0.9533321697631812,1.0,78/348,19.17%,THRB;TSPAN5;CELF2;MRPS16;SRSF2;EEF1A1;MRPL24;MRPL37;CREBL2;POLR2H;HARS1;RPS4X;NKX2-8;MRPS7;POLR2A;RNASEL;NUP93;EIF4A3;GOLPH3;SMG7;ABCF1;DDX39B;RBM8A;XRN2;RPL31;RPSA;NDC1;GSPT2;WDR33;RPL22;AGFG1;MRPS33;PTMA;RPL28;SRSF7;SRBD1;RPS26;POLDIP3;MRPL9;COPS5;THOC7;HNRNPUL1;SYNCRIP;DNAJB11;RNPS1;HARS2;RPL10A;SRSF9;MRPS15;SARS1;TASP1;UPF3B;EIF4G1;TNIP1;PABPN1;MRPS18C;RPL14;DUSP11;RRBP1;MAGOHB;MAGOH;RPS27A;CLP1;E2F1;LMF2;STUB1;AAAS;POLR2C;HBS1L;IGF2BP3;RBMS2;SRSF1;RAE1;POLR2E;SRSF5;EIF4EBP2;RPL6;FARSB
prerank,negative regulation of cell junction assembly (GO:1901889),0.3706677851323108,0.9086571991386034,0.5583090379008746,0.953326871549167,1.0,4/25,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.30452506070538293,-0.9085276870665057,0.5753846153846154,0.8820371473649662,1.0,10/22,27.32%,ESR1;PSMC6;MED4;TP53;PAXIP1;MED16;SRF;SUB1;MED14;DHX36
prerank,regulation of cell growth (GO:0001558),0.2902867456731923,0.9081892544216454,0.6535677352637022,0.9537531195301767,1.0,39/204,16.36%,AGTR1;CDKN1A;ADAM10;HPN;WNT11;FHL1;SGK3;SESN2;PPP2CA;LTBP4;SH3BP4;ROS1;MUL1;OSGIN2;EGLN2;TGFB2;PSRC1;CDC42;NDUFS3;PML;DCUN1D5;APBB1;ADAM15;SMARCA4;SOCS2;EIF4G2;CHPT1;OGFR;BCAR1;CDKN2AIP;CAPRIN2;PRDM11;SFRP1;EIF4G1;FLCN;RAB33B;IP6K2;CCDC85B;FRZB
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.37218088599040033,-0.9076117048778476,0.5813953488372093,0.8818914996782131,1.0,5/11,21.64%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.37218088599040033,-0.9076117048778476,0.5813953488372093,0.8818914996782131,1.0,5/11,21.64%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,regulation of microtubule depolymerization (GO:0031114),0.37110734476063006,0.9074217163645238,0.5927601809954751,0.9549127497361188,1.0,1/25,0.23%,FGF13
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2988919941697984,-0.9069968561643366,0.6101694915254238,0.8821391293171228,1.0,12/24,29.38%,TTLL4;TTLL11;CFAP20;AGBL4;TTLL5;CEP41;VKORC1;GGCX;TTLL7;TTLL8;AGBL5;TTLL6
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.23036258275227273,-0.9068766728861869,0.6470588235294118,0.8811896002504046,1.0,22/73,25.54%,KITLG;TCF12;LMO2;RUNX1;PSMC6;PSMA6;PUS7;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;YTHDF2;PSMA3;SPI1;PSMD10
prerank,positive regulation of organelle organization (GO:0010638),0.3540150151514883,0.9066714387358534,0.5649263721552878,0.955906083181638,1.0,4/32,14.36%,PPARGC1A;ANXA2;SMCR8;GSK3B
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.40295598323148385,0.90661462435831,0.5909797822706065,0.9554512378197286,1.0,3/17,5.38%,MCU;RIPOR2;MOSPD2
prerank,determination of heart left/right asymmetry (GO:0061371),0.33733170599456186,0.9065194749680063,0.5979247730220493,0.955078399957584,1.0,3/42,2.24%,TBR1;SMO;MICAL2
prerank,regulation of nervous system process (GO:0031644),-0.3190330684356387,-0.9063381807976179,0.584958217270195,0.8812911221775138,1.0,3/18,5.51%,SLC8A3;NOS3;DLGAP1
prerank,monosaccharide transmembrane transport (GO:0015749),0.40042693613010094,0.9062316139782243,0.5782208588957055,0.9551237783001645,1.0,3/16,12.59%,SLC2A12;SLC2A8;SLC2A9
prerank,nitric oxide metabolic process (GO:0046209),0.4120427337766255,0.9061670322253046,0.5664,0.9546880327938349,1.0,3/14,7.66%,CYB5R3;DDAH2;CYB5B
prerank,negative regulation of transferase activity (GO:0051348),0.36149518120359125,0.9052414604567354,0.5789473684210527,0.9561450722466894,1.0,11/28,22.09%,FBXO5;IRS2;GSK3A;PINX1;GSK3B;ABL1;EIF4A2;PARK7;ERCC4;MAPT;MEN1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.4280701477479856,0.9050337341190942,0.5751211631663974,0.9559987211067391,1.0,2/11,5.45%,NBL1;DUSP1
prerank,protein localization to synapse (GO:0035418),0.42785286267235995,0.9049566988908824,0.5564387917329093,0.9555899116586225,1.0,6/12,21.86%,ZDHHC12;BSN;PCLO;NLGN2;SHANK1;DLG4
prerank,chemical homeostasis (GO:0048878),-0.23690075005108563,-0.9049261371536776,0.6744186046511628,0.8834181516421621,1.0,11/61,9.65%,ZBTB20;SLC4A10;KLHL3;NR1D2;WNK2;NR1H3;PNPLA8;AQP11;AQP4;PPARG;ACOX1
prerank,positive regulation of sodium ion transport (GO:0010765),0.421268520827451,0.904913309443454,0.5811023622047244,0.955109304790154,1.0,2/12,6.82%,AHCYL1;ANK3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.372025093508152,-0.9046452985964156,0.5652173913043478,0.8828600806253756,1.0,2/10,5.93%,LGALS9;IL18
prerank,positive regulation of axon extension (GO:0045773),0.3755299215958488,0.904531249082542,0.5852187028657617,0.9553552395414928,1.0,6/22,20.66%,ISLR2;ZFYVE27;MAP3K13;SHTN1;MAPT;DBN1
prerank,long-term synaptic potentiation (GO:0060291),-0.3034082770967351,-0.9040556621949659,0.6,0.8830574830425086,1.0,5/21,8.77%,SLC8A3;GRIN2A;GRIN2B;SLC24A2;NFATC4
prerank,genitalia development (GO:0048806),-0.35994876224519495,-0.904013741507848,0.6025974025974026,0.8819606607106513,1.0,4/12,7.99%,WNT5A;TBX3;CHD7;DNAJC19
prerank,regulation of actin filament-based process (GO:0032970),0.32116478524750053,0.903982904738886,0.6078199052132701,0.9559754858553152,1.0,19/70,18.80%,CELSR1;ARHGAP18;CDK10;RHOQ;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;DLC1;EPHA3;RHOA;CCDC88A;TESK1;FSCN1;CRK;ABL1;ARHGAP44;ROCK2
prerank,negative regulation of protein depolymerization (GO:1901880),0.36661429901097875,0.9036512601155693,0.5784883720930233,0.9561076476913988,1.0,1/24,0.23%,FGF13
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.34120010885994156,0.9034972383647245,0.6043256997455471,0.9558518984327197,1.0,13/39,19.89%,RBX1;POLK;ERCC5;RPA3;POLD2;PCNA;FAN1;DDB1;RPS27A;UBC;ERCC2;RFC1;ERCC4
prerank,positive regulation of chemokine production (GO:0032722),-0.255531550691498,-0.9030233188572521,0.6470588235294118,0.8831778871072313,1.0,12/44,17.63%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;MBP;TIRAP;TLR7;HMGB1;CD74;LPL
prerank,axon extension (GO:0048675),0.3695581965393455,0.9027560179246229,0.5699088145896657,0.9569126154018355,1.0,1/23,0.20%,ALCAM
prerank,positive regulation of macroautophagy (GO:0016239),0.3350316458977654,0.9026113101653458,0.5917085427135679,0.9566342571935882,1.0,13/48,16.55%,PRKAA2;SESN2;TSC2;HSPB8;BAG3;SMCR8;VDAC1;PIP4K2C;BNIP3L;VPS13D;IKBKG;SESN1;SLC25A4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38013595246857046,0.9025908076095627,0.5716440422322775,0.9561113644615802,1.0,3/20,10.68%,CCL5;YWHAB;GRK2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3645031846846891,0.9024081887415865,0.5793103448275863,0.9559222645888756,1.0,5/26,10.41%,PPM1B;MUL1;TRIM21;NMI;CARD16
prerank,negative regulation of growth (GO:0045926),0.29771652243486385,0.9024008208913505,0.6312910284463895,0.9553691789804903,1.0,25/121,16.36%,NOTCH2;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;MUL1;OSGIN2;TGFB2;PSRC1;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;CAPRIN2;PRDM11;ING4;SFRP1;FLCN;IP6K2;CCDC85B;FRZB
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.2723468427231893,-0.9020089617296994,0.6389891696750902,0.8843129767237322,1.0,9/33,9.23%,ACVRL1;NOTCH1;FGF2;THBS1;CARD10;RGCC;TGFB1;MECP2;PPARG
prerank,Golgi to endosome transport (GO:0006895),0.40303152489821875,0.9018444973082114,0.5818452380952381,0.9560359524142281,1.0,4/16,11.71%,CORO7;VPS13A;MON2;AP2A1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3219634479400322,-0.9016446478921271,0.6138888888888889,0.88401571804011,1.0,5/18,12.76%,NRXN1;SHANK3;NLGN1;CACNG8;NLGN3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33418183905199583,0.9014426464378071,0.6028460543337646,0.9563269735189865,1.0,3/43,2.24%,TBR1;SMO;MICAL2
prerank,magnesium ion transport (GO:0015693),0.41533423218749765,0.9013116356497707,0.587248322147651,0.95604171403445,1.0,5/12,22.91%,NIPAL3;SLC41A1;NIPA2;CNNM4;MMGT1
prerank,zinc ion transmembrane transport (GO:0071577),-0.29393321544456336,-0.9012752075065131,0.5838509316770186,0.883646177426409,1.0,5/22,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,sphingolipid metabolic process (GO:0006665),0.3020450883618574,0.9009662769057085,0.6433333333333333,0.9562030402069174,1.0,16/108,11.51%,SPTSSB;HEXA;SGMS2;PPM1L;PPP2CA;ELOVL1;ORMDL3;AGK;GLB1;SUMF1;ELOVL6;HACD4;ABCA2;HEXB;SUMF2;CERS2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.4130699733293738,0.9007104065572689,0.567524115755627,0.956187897215625,1.0,3/13,9.25%,ELOVL1;ELOVL6;HACD4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3625364116098768,0.9002774498230336,0.5899182561307902,0.9565368657677303,1.0,5/29,12.24%,CCL5;MOSPD2;LGALS3;CREB3;ANO6
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.29108947048056444,0.9002743131456588,0.6400437636761488,0.9559792469136229,1.0,23/122,16.10%,SORBS1;KLF4;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TGFB2;TLR4;IRS2;POLDIP3;CPEB3;PLXNB2;FXR1;MYC;UPF3B;PYM1;DHX9;HSPH1;PCNA;EEF2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2779016511707282,0.8997829094070425,0.909,0.9564464108931664,1.0,295/1668,16.89%,PRKCB;NFATC2;CDH13;ZBTB7C;NR3C2;KLF5;THRB;PRDM6;TMPRSS6;TBR1;KLF4;TFAP2C;PBX3;PPARGC1A;NCOA3;PBX1;KLF3;GAL;ZIC4;TFAP2D;DMRT2;ELF3;OGT;SREBF2;CDKN1A;RORC;SMAD6;FOXP2;GLI3;DDX5;GTF2F1;HOXA4;TRIM33;HIVEP1;ZC3H12A;GABPB1;GABPB2;KLF12;CAV1;FOXP4;MAVS;ZNF436;EP300;ZFHX4;TOX4;HDAC5;ZMYM5;ZNF692;MXD4;CD81;CC2D1B;KANK2;FOXO3;CSRP3;FOS;GDNF;PCGF6;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;NOP2;KLF16;CGGBP1;PPP1R13L;HDAC4;BMP5;NFE2L2;NR6A1;ZBTB16;ZBTB8A;ANXA4;EPO;WWP2;SSBP3;MTDH;CIAO1;DOT1L;SMARCB1;RHOQ;FOXD2;POU2F3;NFE2L1;NACC1;NFKBIA;BEND3;CDK4;ESRRB;RARG;RFX7;PHF21A;IRF3;PRRX2;SLTM;JUND;OVOL2;NKX2-8;PATZ1;LCOR;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;MOV10;PCGF3;SOX9;OTUD7B;FOXD1;HCFC1;AKNA;ZIC2;HAX1;NRF1;ZBTB7B;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;CC2D1A;KLF7;MED30;STAT4;NKAP;PLK3;DVL3;FIZ1;ZNF471;ZFHX3;ZNF418;LARP7;CIC;PPM1A;ATRX;SIX1;PKD1;MAZ;JUN;FZD5;POU3F1;TCF7L2;CRY2;ELP4;ZFP57;GRHL2;FOXP3;TNFRSF1A;KMT2A;POU5F2;BRD7;TXK;DPF2;NR2C1;DNMT3A;ZIC1;RIF1;EZR;HDGFL3;APBB1;CCND1;MED29;PRDM15;ENY2;NFIB;SAP130;ZNF467;NFYC;TWIST1;BCAS3;KDM3A;HDAC3;ARID4A;ZNF205;NFE2L3;NFIC;SOD2;SP2;KDM4C;MYT1;SMARCA4;ABCA2;MAMLD1;ARID3B;TLR4;CREB3L4;CREB3;NCOR1;AEBP2;DR1;CALCOCO1;MEF2B;SRCAP;MMP12;MED8;HOXB5;MAFG;SP1;ZBTB42;COPS5;ZNF148;ACTL6B;MIER2;DCAF6;MAFK;CPEB3;FOXK1;CCNL2;MPND;MED12;TFEB;MYSM1;BAZ2B;PIAS1;PIAS3;PPM1D;ZFP30;CHD3;GATA3;SMARCD2;ZSCAN20;RREB1;ARF4;SBNO2;NFIA;CAPRIN2;MED21;CBX4;MYC;ZNF177;MED24;ZFP1;MEF2C;TLE5;PAX3;PCGF2;ZFP92;MYBL1;ATP2B4;FOXP1;CHUK;SARS1;ZXDC;IRF2;HRAS;NCOR2;SS18L2;GATAD2B;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;ZFP3;MDM2;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;ELP2;IGBP1;KLF6;HMBOX1;RCOR2;TCF25;CDC5L;ZGPAT;IRF2BP2;CREB3L2;IFRD1;SMARCC1;CRK;RNF10;RPS27A;UBC;HEXIM1;E2F1;POU4F1;HINFP;MED27;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2;UBE2D3
prerank,cellular macromolecule catabolic process (GO:0044265),0.33066836644121206,0.8994726548816349,0.5954198473282443,0.9565267121973532,1.0,9/49,10.46%,RNF5;DENND3;SIDT2;UBE2G2;MANBA;XRN2;RNASE3;DNASE1L2;MTREX
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3322344536123028,-0.8993135413872089,0.5953757225433526,0.8871585321497983,1.0,6/15,25.77%,TNFRSF1B;ADAM9;PACSIN3;SNX9;SH3D19;ADAM8
prerank,ether lipid metabolic process (GO:0046485),0.4027431689907894,0.8991587801753024,0.6024464831804281,0.9566367979074072,1.0,4/14,14.70%,DHRS7B;PAFAH1B1;TMEM86B;PLA2G6
prerank,positive regulation of catalytic activity (GO:0043085),-0.2717879387484981,-0.8986969695787193,0.6679245283018868,0.8874046255856604,1.0,13/37,23.33%,AZIN2;MSH3;IGF2;ABL2;NHEJ1;FGFR4;FXN;B3GAT3;SLC5A3;SOD1;CIB1;MAPK14;NOD2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3312123421929971,0.8984651570880748,0.5965559655596556,0.9575167109058857,1.0,6/48,7.99%,ANK2;DIAPH1;PTK2B;SELENON;GSTO1;JPH2
prerank,positive regulation of histone methylation (GO:0031062),0.36122279402310314,0.8984226833462259,0.5759768451519537,0.9570403251877496,1.0,4/24,9.56%,OGT;PHF1;KMT2A;RIF1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3772204773429257,0.8983005162045336,0.568685376661743,0.9566966714470049,1.0,5/20,11.07%,BMP5;ERLIN2;ACADL;ERLIN1;ABCA2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.42395466092962614,0.8980316793253761,0.5896607431340872,0.9561221466578891,1.0,3/11,11.61%,PTK2B;SHC1;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.42395466092962614,0.8980316793253761,0.5896607431340872,0.9561221466578891,1.0,3/11,11.61%,PTK2B;SHC1;JAK1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2762152408410168,-0.898015883793048,0.6525096525096525,0.8879055151873296,1.0,3/32,2.43%,PDGFRB;ITGA1;PPP1R16B
prerank,protein N-linked glycosylation (GO:0006487),0.31553369115166163,0.8977532434520301,0.600715137067938,0.9561176573699537,1.0,15/66,13.96%,B4GALNT2;ASGR1;MGAT3;TMEM165;MGAT1;FUT8;DDOST;SRD5A3;ALG1;MCFD2;MGAT4C;DPM2;ALG12;ALG5;GFPT1
prerank,regulation of telomere maintenance (GO:0032204),0.36374812933637146,0.8977352109059196,0.5912921348314607,0.9555962305282777,1.0,11/26,25.10%,MRE11;ATRX;PML;MYC;NBN;RAD50;PPP1R10;ERCC4;TERF2;TINF2;HDAC8
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3939512234883169,0.8977228944626507,0.6071964017991005,0.9550690010692112,1.0,7/18,15.38%,CD81;MSN;EZR;ATP5IF1;ABCA2;VPS11;HSP90AA1
prerank,cardiocyte differentiation (GO:0035051),-0.37735776632765816,-0.8972579001658227,0.5942028985507246,0.8884420841410048,1.0,6/10,16.09%,KDM6B;SIK1;EEF1AKMT4-ECE2;GATA6;CBY1;MYOCD
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.34130156674229895,0.8972445281800188,0.6007751937984496,0.9555325208640643,1.0,6/38,8.04%,ZC3H12A;TRIM59;PPM1B;USP10;OTUD7B;PPM1A
prerank,arachidonic acid metabolic process (GO:0019369),-0.2703202098226475,-0.8969807196787651,0.6344086021505376,0.8879115428092578,1.0,7/35,9.27%,PLA2G4A;PTGIS;CYP1B1;MGLL;PTGS2;PNPLA8;PTGES
prerank,chromosome condensation (GO:0030261),0.34131666004965006,0.8963764703650313,0.6002673796791443,0.956827792195657,1.0,12/36,23.02%,ACIN1;TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;GPER1;RB1;PHF13;NCAPH;SMC4;KMT5A
prerank,plasma membrane tubulation (GO:0097320),0.40297869363397004,0.8963600531967031,0.6025236593059937,0.9563071707243209,1.0,4/13,17.29%,CAVIN2;CHMP4A;SNX33;PACSIN1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.33431988750647024,0.8962937721817635,0.5947302383939774,0.955880238506975,1.0,18/48,22.28%,EP300;POLR2H;TAF1C;ASF1A;ACTB;POLR1C;MYO1C;POLR1E;POLR1F;SERTAD1;CDCA4;ZMIZ2;POLR2E;ARID1B;TBP;ELOF1;PHF2;POLR1G
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2674770851170881,-0.8962851881627719,0.6719367588932806,0.8884028845761857,1.0,3/33,3.70%,FBN1;UBASH3B;CAMK4
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.28294827279831214,-0.8962210239929527,0.6509090909090909,0.8873697485201198,1.0,7/27,9.51%,MARK1;IL1RAPL1;MBOAT1;BRSK1;CTNNA2;VPS35;NTNG1
prerank,innate immune response (GO:0045087),0.2865749752909807,0.8957234630563847,0.6974093264248704,0.9564526674788939,1.0,33/217,15.47%,TRIM60;PPP1R14B;SERINC5;MAVS;SLPI;PGLYRP3;PTK2B;RELB;TRIM59;TRIM25;NUB1;CFP;TRIM21;ANG;STYK1;PML;LBP;PYDC1;TRIM26;TRIM11;RNASE3;SRPK2;CR2;ADAM15;TLR4;ANKRD17;FCER1G;SRPK1;IRAK1;CHUK;VNN1;TLR3;IKBKG
prerank,organelle assembly (GO:0070925),0.2798235451998727,0.8953329047618571,0.7537688442211056,0.9566943796390114,1.0,83/384,20.11%,RAB17;PGM5;MAPRE2;CYS1;ABLIM1;PARVA;TMOD3;GSN;YTHDF1;NEK7;TMOD2;EHD1;CNGA2;ARL3;INPP5E;VPS37B;LMOD3;CCDC28B;RAB11FIP3;AVIL;NSFL1C;IFT46;PRRC2C;EXOC7;CFAP54;EXOC4;LSM4;PKD1;CHMP4A;CHMP4B;CC2D2A;IFT80;RAB7A;CENPT;EXOC2;HDAC3;EMC6;NCOR1;VPS4B;CPLANE2;CNGB1;EXOC8;ARF4;CHMP1A;OCRL;MKKS;VPS4A;ULK1;RAB1B;ATP6V1D;SQLE;MAP1LC3B;CHMP2A;RB1CC1;ATP6V0D1;FLNA;TMEM41B;ATXN2L;TMEM138;PTPDC1;ATG16L2;DYNC1H1;RAB8B;HDAC6;RILPL1;CDS1;PDCD6IP;PATL1;ZFYVE1;STAM;TSG101;FHDC1;WDR35;UBAP2L;GALNT11;YTHDF3;TUBGCP5;ABCB6;VPS37A;TXNDC15;CENPF;MAPT;IST1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.33051299768882847,0.8952685303909991,0.592496765847348,0.9562580969590186,1.0,9/46,11.61%,RAP1B;GSTO1;ANXA2;MSN;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,regulation of protein acetylation (GO:1901983),0.40460422889821546,0.8950331166377029,0.5908346972176759,0.9562100251546761,1.0,7/12,30.63%,RAPGEF3;GSK3B;PARK7;KAT5;DDX3X;TERF2IP;TAOK1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35384580050234354,0.8949639424325531,0.5792349726775956,0.9558023766797489,1.0,7/29,16.24%,KANK2;DDRGK1;LATS1;VPS11;GPAM;VPS18;UFM1
prerank,regulation of viral entry into host cell (GO:0046596),0.3527452642284109,0.8947610297675529,0.5903448275862069,0.9556734666149266,1.0,6/30,13.39%,GSN;TRIM25;TRIM21;TRIM26;TRIM11;LGALS1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.40045446360602616,0.8947001403699391,0.5918032786885246,0.9552445896164619,1.0,1/15,1.13%,PPARGC1A
prerank,cellular response to unfolded protein (GO:0034620),0.353017573366645,0.8946999543267741,0.6038291605301914,0.9546894025643566,1.0,4/26,9.28%,DAXX;HSPB8;HSPA14;BAG3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.40679281042472687,0.8945270316728018,0.5881481481481482,0.9545023377996383,1.0,6/13,26.06%,RHOA;IRAK1;ITGB2;NFAT5;IL6;RELA
prerank,extracellular transport (GO:0006858),0.41209922299420987,0.8943410622852728,0.6045380875202593,0.9543559762750802,1.0,4/12,18.00%,WWP2;SPAG17;ADCY10;TSG101
prerank,organelle fission (GO:0048285),0.36726646440908295,0.8943099069171792,0.5949554896142433,0.9538675915308596,1.0,9/24,21.31%,ACOT8;MUL1;PEX11G;MTFR1L;OPA1;DNM1L;MTFR2;TMCC1;MIEF1
prerank,regulation of interleukin-2 production (GO:0032663),-0.25768837971739067,-0.8942959194046503,0.6757990867579908,0.8905562011678255,1.0,8/43,11.72%,PDE4D;CD34;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.3614618599152091,-0.8941194035313859,0.572972972972973,0.8897954265204884,1.0,5/11,23.18%,WNT4;FGFR4;NR1H4;DGKQ;STAR
prerank,histone acetylation (GO:0016573),0.3121206130247146,0.8940082902155693,0.6191616766467066,0.9539239616569956,1.0,19/69,18.96%,CPA4;EP300;NAA40;BEND3;KAT6B;MORF4L2;APBB1;DR1;ACTL6B;TAF5;JADE2;BRD1;ING4;MEAF6;TRRAP;SGF29;TRIM16;ATF2;MRGBP
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3244752112616081,0.8939737607949868,0.6068376068376068,0.9534433233187078,1.0,7/52,11.35%,SORBS1;STAC3;PTPN9;LGALS3;AKAP5;CNPY4;EPHA3
prerank,regulation of glycogen metabolic process (GO:0070873),0.4171447396979151,0.8939669698785585,0.5854838709677419,0.9529049635692313,1.0,5/12,28.48%,RUBCNL;PPP1R3F;PPP1R3C;PPP1R3B;AKT1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.33857784509409267,0.8939433786431346,0.5901426718547341,0.9524081732341282,1.0,6/42,11.16%,GALP;ROMO1;LBP;RNASE3;AQP1;TLR4
prerank,regulation of sodium ion transport (GO:0002028),0.340890190893804,0.8936395194844517,0.5958005249343832,0.9525257758520034,1.0,15/34,24.99%,SLMAP;AHCYL1;ANK3;ATP2B4;WNK1;NEDD4;YWHAH;SCN4B;ATP1A1;WNK4;SNTA1;NKAIN4;NKAIN1;PER1;P2RX4
prerank,metanephros development (GO:0001656),0.36333882102466175,0.89362015774502,0.6049204052098408,0.9520188364829765,1.0,5/26,8.25%,GDNF;FOXD1;BMP4;SIX1;PKD1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.34518416510685834,0.8936030864858124,0.5884718498659517,0.951498667713208,1.0,7/33,16.64%,LSM10;SNRPB;MAZ;WDR33;CSTF1;PABPN1;CLP1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.35137729107561466,-0.8934914376785783,0.5901639344262295,0.890065278603107,1.0,7/13,26.31%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1;SPI1;CHEK1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.37201476075772,-0.893409093318905,0.5798319327731093,0.8890544717180936,1.0,3/10,13.14%,SP100;TP53;RPS6KA6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2917500703293863,0.8931942391831605,0.6684607104413348,0.9518335007041967,1.0,41/148,23.02%,PRKAA2;DAXX;EP300;NOP2;PPP1R13L;PPP1R13B;MRE11;SSRP1;PLK3;PML;BANP;BRD7;RMI1;TOPBP1;TAF5;MAPKAP1;CHD3;CDK2;RPA3;MDM2;PAK1IP1;MEAF6;ATR;HEXIM1;POU4F1;CCNG1;PRKAG1;NBN;CHEK2;RAD50;CDK5RAP3;TAF9B;TBP;PRKAB1;PRKAB2;USP2;CDK5R1;TAF6;PIP4P1;MDM4;KMT5A
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.28261250976882923,0.8929144363952587,0.7064881565396498,0.9518787110314465,1.0,48/248,14.45%,SCEL;IGFBP6;KANK1;PTK7;GLI3;AMER3;MLLT3;WNT11;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PTPRU;AMER2;PSMD11;SOX9;RBMS3;PSMD4;WLS;PSMF1;GPC3;ILK;LATS1;DVL3;LGR4;PPM1A;RBX1;TCF7L2;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;TLE2;CSNK1E;TLE4;GNAQ;TRPM4;PSMB5;CAPRIN2;GSK3A;LMBR1L;TLE5;SFRP1;UBR5;GSK3B;WNK1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2842292355346321,0.8927140848046713,0.6991786447638604,0.9517382448057281,1.0,71/241,23.25%,DDX5;GTF2F1;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;SF3B3;USP39;MTREX;SRSF7;SF3A2;ZCCHC8;FRG1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;SPEN;RBM15;SRRM1
prerank,intracellular cholesterol transport (GO:0032367),0.4059541184941879,0.8925960798537045,0.5964630225080386,0.9514399929209163,1.0,6/15,18.14%,LDLR;NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2781027254587534,0.8924989529771747,0.7685370741482966,0.9510996076187608,1.0,78/476,14.31%,CDH1;NFATC2;WNT1;KLF4;PPARGC1A;MAP3K5;LBH;RORC;NIBAN2;GLI3;MLLT3;CAND2;WNT11;EP300;FOXO3;FOS;FOXC2;GLIS2;CREBL2;HDAC4;ZBTB16;EPO;TRIM44;ESRRB;BICRA;CREB1;FOXM1;RXRB;SOX9;HCFC1;ZIC2;SHC1;KAT6B;BMP4;MED30;ILK;TGFB1I1;DVL3;ZFHX3;DYRK1B;PPM1A;SIX1;PSRC1;MAZ;JUN;POU3F1;PML;FOXP3;KMT2A;BRD7;MAP2K2;ZIC1;PHF5A;APBB1;ILF2;ENY2;NFIB;KDM3A;SMARCA4;CALCOCO1;NAA15;SP1;FOXK1;MED12;TFEB;SPIN1;GATA3;RREB1;MYC;PRDM11;MED24;MEF2C;PAX3;MYBL1;SFRP1;CHUK;TASP1;ZXDC
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2783068748396802,0.8922884497574168,0.7515090543259557,0.9510005663514791,1.0,71/390,15.54%,SORBS1;FGFR1;ANGPT1;CYFIP2;NTRK3;ATP6V1B1;MMP9;NGEF;EPHA4;PDGFC;EFNB2;HPN;FLRT1;GTF2F1;SIPA1L1;GDF15;GAB1;SHB;NGF;RBFOX2;PTK2B;FOXC2;AP2A2;POLR2H;RHOQ;TSC2;CAV2;ROS1;POLR2A;EFNA5;SHC1;AP3S1;PXN;ZFYVE27;ERBB3;FGF22;STYK1;CDC42;VEGFB;LMTK2;ACTB;NRP2;ABI1;MUSK;ACTG1;PDK2;EPHA3;SOCS2;IRS2;MVP;AP2A1;RHOA;BCAR1;EIF2AK3;PTPN2;RASA1;DDR1;DOCK1;GSK3A;FLRT3;SHC2;GSK3B;HRAS;NUS1;ATP6V1E1;EFNA4;AAMP;ATP6V1D;RAPGEF1;HSP90AA1;ATP6V0D1
prerank,protein polyubiquitination (GO:0000209),0.278836520238269,0.8921859086164462,0.7436676798378926,0.9506837615684735,1.0,74/297,23.52%,FZR1;RNF152;FBXL7;FBXW8;FBXL20;LONRF1;WWP2;RNF5;PSMD11;MUL1;PSMD4;PSMF1;TRIM21;MAGEL2;UBE2G2;FBXL18;RBX1;RNF146;FBXO31;UBE2B;PSMD7;FBXW9;UBE2Q1;RNF126;MIB2;PSMB5;ANAPC4;NPEPPS;PELI1;DDA1;UBE4A;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;UBE2N;PRPF19;TNKS2;FBXL15;TPP2;RPS27A;UBC;UBE2D3;SIAH1;STUB1;UBE2J1;PSMD1;PSMC4;RNF41;PSMD8;UBE3C;FBXO9;THOP1;RMND5A;ZFP91;CHFR;FBXW7;TRIM5;UBE2E1;FBXW2;ARIH2;TRAF3IP2;UBE2V1;SMURF2;BLMH;RNF168;RNF213;TRIM3;RNF14;CDC23;PSMA7;FBXO4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3814646003909616,0.8921580551154341,0.593841642228739,0.9501919741764611,1.0,4/18,13.54%,HDAC5;HDAC4;HDAC3;GSK3A
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3693255809356452,0.8921140458779021,0.6075036075036075,0.9497351154764605,1.0,6/25,17.35%,ZYG11B;RNF5;KLHL15;TOR1A;STUB1;HDAC6
prerank,motile cilium assembly (GO:0044458),-0.35751017956880315,-0.8920522345788778,0.6015831134564644,0.8911048812060062,1.0,8/12,46.02%,BBOF1;DNAAF3;CCDC39;RSPH9;CCDC40;E2F4;RSPH6A;DNAAF1
prerank,positive regulation of secretion (GO:0051047),0.4204337988362527,0.892016993242125,0.5756013745704467,0.9493594872937804,1.0,3/11,19.44%,ACSL3;AQP1;GPLD1
prerank,histone modification (GO:0016570),0.3000690725838749,0.8917913800099234,0.6547085201793722,0.9492823257200488,1.0,30/109,21.56%,CPA4;EYA2;EP300;HDAC5;HDAC4;NTMT1;KAT6B;EYA1;MORF4L2;AURKC;UBE2B;ENY2;USP3;MIER2;CDK2;RCOR2;UBE2N;PRMT1;HDAC6;TRRAP;SGF29;PARP2;USP16;USP21;PARK7;MRGBP;PRMT2;RCOR3;USP22;TAF6
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3583782711457718,-0.8916208599322196,0.5896739130434783,0.8909016791083946,1.0,4/11,15.38%,DAB2;RDX;MTMR2;SORL1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3894378728429052,0.8915882302375485,0.5758928571428571,0.9491606591999318,1.0,2/17,2.90%,PBX1;EP300
prerank,regulation of histone deacetylation (GO:0031063),-0.3590389644667851,-0.8914839212872757,0.6311475409836066,0.8900507840509271,1.0,6/13,22.66%,CAMK2D;SAP30BP;ING2;NIPBL;APLNR;PRMT6
prerank,mitochondrial genome maintenance (GO:0000002),-0.36793889047620876,-0.8914045528823367,0.6062176165803109,0.8890332166983546,1.0,3/11,12.36%,AKT3;SLC25A33;TOP3A
prerank,glutathione biosynthetic process (GO:0006750),0.42526313048662784,0.8912441332978823,0.5883306320907618,0.9493173972105334,1.0,1/11,3.31%,HAGH
prerank,intracellular protein transmembrane transport (GO:0065002),0.33978935982656755,0.8909392350967741,0.6096605744125326,0.9493957203303224,1.0,12/42,22.77%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.4274563142527261,0.8907579707552119,0.6006493506493507,0.9492336764589248,1.0,1/11,1.77%,EFNB2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.40359886859837,0.8907170288316218,0.5894039735099338,0.9487615198706668,1.0,1/14,1.38%,ETNK2
prerank,regulation of cardiac conduction (GO:1903779),0.32044662051861567,0.8895134221706065,0.6117216117216118,0.9506973309284756,1.0,4/54,4.79%,ITPR2;ANK2;ATP1A2;AHCYL1
prerank,myeloid cell development (GO:0061515),-0.3168170727092961,-0.8886030578839451,0.6076696165191741,0.8943997816921155,1.0,5/18,11.25%,ALAS1;SH2B3;KIT;NCKAP1L;NRROS
prerank,DNA duplex unwinding (GO:0032508),0.3249534892419822,0.8885892887427971,0.6047678795483061,0.9520964994979133,1.0,14/50,21.61%,RECQL4;MRE11;RBX1;DHX9;DDB1;MCM6;RPS27A;UBC;ERCC2;NBN;MCM7;RAD50;TWNK;MCM4
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.36595744645260614,0.8883557105368405,0.6122733612273361,0.952045456130381,1.0,4/24,7.62%,ANGPT1;NFE2L2;MAPK7;KRIT1
prerank,positive regulation of transferase activity (GO:0051347),0.2901738676552472,0.8879022741525678,0.6626106194690266,0.9524269840990454,1.0,29/142,15.76%,FGFR1;NTRK3;KLF4;EPHA4;SERINC5;CD200;NEK7;LMO4;ROS1;MRE11;MAPK15;ERBB3;MAP3K4;ARRDC3;GRHL2;DCUN1D5;LMTK2;MUSK;EPHA3;DCUN1D1;DDR1;MYC;GSK3A;HSP90AA1;DSTYK;PABPN1;HMBOX1;PCNA;UBE2N
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.3535925407847337,-0.887113605497769,0.5979381443298969,0.8966464921883177,1.0,4/12,21.12%,NIN;BBS4;CCDC68;CEP19
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.40824242322857957,0.8861076823875479,0.616260162601626,0.9556689904088365,1.0,2/13,10.09%,SCAMP5;KCNB1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2895396403546332,-0.8857958952769247,0.6050955414012739,0.8985789796373024,1.0,10/25,22.07%,TMEM50A;LYST;CHMP3;LAPTM4B;SORT1;CHMP2B;MVB12A;CHMP7;UBXN6;CHMP4C
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.36931646128468243,0.8857790375803241,0.6061493411420205,0.9557779988728029,1.0,5/21,9.64%,MMP9;MEF2D;JUN;ADAMTS1;HTR1B
prerank,presynapse assembly (GO:0099054),-0.3279366550296326,-0.8855512466684187,0.6005509641873278,0.8979332690620395,1.0,6/16,16.06%,IL1RAPL1;WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3391597681498711,0.8855324306481704,0.6071428571428571,0.9557244003415674,1.0,4/35,4.92%,CCL5;PIGU;CAV1;DOT1L
prerank,bile acid biosynthetic process (GO:0006699),0.36780173146309586,0.8855002403710677,0.6085626911314985,0.9552467195127571,1.0,4/24,11.14%,OSBPL9;ACOT8;CYP39A1;OSBPL7
prerank,transition metal ion homeostasis (GO:0055076),0.35597838258637426,0.8853677867770525,0.6036161335187761,0.9549727388824577,1.0,4/28,12.85%,TMPRSS6;NEO1;HEPH;CP
prerank,synaptic vesicle membrane organization (GO:0048499),0.388224732024012,0.8853573597098346,0.5982142857142857,0.9544512271281649,1.0,7/17,24.79%,SYP;TOR1A;STX11;STX4;AP3D1;SNAP23;STX3
prerank,metallo-sulfur cluster assembly (GO:0031163),0.36804782636915434,0.8851511714214858,0.5890603085553997,0.9543344560603303,1.0,7/22,20.23%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,regulation of p38MAPK cascade (GO:1900744),0.3456426291434046,0.8851323823854736,0.5909694555112882,0.95382863136091,1.0,8/35,11.96%,ZC3H12A;DUSP10;DUSP1;MAP3K4;RELL1;EZR;EMC10;GADD45B
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4250846129990312,0.8849987992445059,0.5862068965517241,0.953531736696393,1.0,2/10,7.94%,DLGAP4;NPTX2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2759502004095753,0.8849717704982363,0.7847847847847848,0.9530501447814749,1.0,87/497,14.55%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;CDKN1A;NIBAN2;SAMD4A;FOXP2;GLI3;TRIM33;WNT11;SAMD4B;HDAC5;EPRS1;QARS1;RBFOX2;DAPK3;PCGF6;ZNF219;GLIS2;HDAC4;DAPK1;ZBTB16;WWP2;NACC1;CRYAB;S100A11;PATZ1;FOXM1;SOX9;FOXD1;ZIC2;SHC1;KDM5C;KAT6B;EIF4A3;PHF10;BMP4;COMMD7;NKAP;MAGEL2;CIC;L3MBTL3;JUN;TCF7L2;CRY2;PML;FOXP3;BRD7;SCML2;SHMT1;DPF2;YWHAQ;TWIST1;HDAC3;ARID4A;TLE2;BCL7A;SMARCA4;NCOR1;SFMBT2;EIF2AK3;ZNF148;CPEB3;FOXK1;SYNCRIP;GATA3;TSC22D4;FXR1;SBNO2;CHMP1A;BEND5;CBX4;GSK3A;BTG2;PRDM11;ING4;TLE5;SFRP1;FOXP1;SET;GSK3B;GAPDH;NCOR2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.32589794502852765,0.8846256583040484,0.6212121212121212,0.9532217281727525,1.0,2/44,1.06%,ANK2;ACTN2
prerank,lymphocyte migration (GO:0072676),0.35026268264716987,0.8846157565552311,0.614247311827957,0.9527024255547075,1.0,3/32,12.95%,CCL5;MSN;GATA3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.297569594251593,0.8841860262513727,0.6766004415011038,0.9530553419842086,1.0,29/119,19.30%,PITPNM2;TTC7A;PIGU;PITPNM3;MTMR12;PIK3C2B;INPP5E;IP6K1;INPP4A;PI4KA;PIGZ;PGAP2;MTMR3;SOCS2;MBOAT7;PIGA;OCRL;PIP4K2C;EFR3A;DPM2;SOCS6;PIGN;IP6K2;PI4K2A;PTPN13;CDS1;CDIPT;PIGP;PIGQ
prerank,apoptotic DNA fragmentation (GO:0006309),-0.32618267503674364,-0.884040996093549,0.6388888888888888,0.9002254631109106,1.0,9/16,37.02%,CECR2;DNASE2;HMGB1;EXOG;DICER1;FOXL2;KPNB1;ENDOG;DFFB
prerank,lymphocyte differentiation (GO:0030098),0.30989915815042285,0.8836838385760238,0.6111757857974389,0.9534964953401946,1.0,20/68,20.24%,PBX1;HDAC5;RELB;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;GATA3;LMBR1L;GPR89A;GPR89B;KLF6;TPD52;ADAM17;ZBTB7A;IKZF1;DCAF1;SOX4
prerank,cellular response to cytokine stimulus (GO:0071345),0.2784560644697254,0.8835730479802711,0.797583081570997,0.9531940291530319,1.0,80/416,17.14%,FN1;PTPN14;CRLF1;MMP9;CCL5;VIM;ADAMTS7;CDKN1A;RORC;ZC3H12A;IL16;CXCR4;LAMA5;EPRS1;FOXO3;FOS;DAPK3;CLCF1;YBX3;NFE2L2;DAPK1;TIMP1;IL3RA;ALOX5;RIPOR2;DUSP1;USP10;BCL2L1;SOX9;STK39;HAX1;SHC1;CSK;PTPN9;STAT4;UBE2G2;OXSR1;NDN;LBP;TNFRSF1A;SHMT1;PTPN6;CCND1;TWIST1;GSDME;TLR4;IL1R2;SOCS2;JAK1;RHOA;YWHAZ;NPNT;ST3GAL6;PTPN2;SYNCRIP;GATA3;SBNO2;RHOU;MYC;GSK3A;IRAK1;ZFAND6;SFRP1;SOCS6;CHUK;GSK3B;WNK1;GAPDH;RAPGEF1;DHX9;HSP90AA1;ITGB2;FSCN1;CRK;RPS27A;UBC;POU4F1;PDE1B;PRTN3;PTPN13
prerank,dicarboxylic acid metabolic process (GO:0043648),0.32138156345675173,0.883546268816936,0.6316455696202532,0.9527041170274893,1.0,19/52,26.33%,ACOT8;ME3;SHMT1;ALDH1L2;MDH2;ALDH1L1;OGDH;ASS1;DLST;HAAO;SLC19A1;SDHAF3;DGLUCY;ALDH18A1;ACLY;IDH1;GPT2;IDH2;ALDH5A1
prerank,regulation of small molecule metabolic process (GO:0062012),0.35021218209743166,0.8831726897221464,0.616643929058663,0.9529085660374619,1.0,6/28,14.55%,RORC;TTC39B;ACADL;PDK2;FOXK1;NCOR2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2734723988637097,0.8831183869977619,0.887,0.9524796430444836,1.0,202/1082,17.50%,CDH1;NFATC2;CDH13;KLF5;THRB;TMPRSS6;WNT1;KLF4;TFAP2C;PPARGC1A;NCOA3;PBX1;GAL;MAP3K5;ELF3;OGT;LBH;SREBF2;RORC;NIBAN2;GLI3;MLLT3;GTF2F1;HIVEP1;ZC3H12A;CAND2;WNT11;GABPB1;GABPB2;MAVS;EP300;HDAC5;CD81;FOXO3;CSRP3;FOS;GDNF;FOXC2;GLIS2;CREBL2;HDAC4;BMP5;NFE2L2;ZBTB16;EPO;SSBP3;DOT1L;TRIM44;SMARCB1;RHOQ;FOXD2;POU2F3;NFKBIA;ESRRB;RARG;IRF3;BICRA;JUND;NKX2-8;ASF1A;CREB1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;SOX9;HCFC1;AKNA;ZIC2;HAX1;NRF1;SHC1;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;KLF7;MED30;ILK;TGFB1I1;DVL3;FIZ1;ZFHX3;DYRK1B;PPM1A;ATRX;SIX1;PSRC1;PKD1;MAZ;JUN;FZD5;POU3F1;TCF7L2;UBTF;DDX39B;PML;GRHL2;FOXP3;TNFRSF1A;KMT2A;BRD7;TXK;DPF2;MAP2K2;ZIC1;PHF5A;APBB1;ILF2;PRDM15;ENY2;NFIB;TWIST1;BCAS3;KDM3A;HDAC3;WDR43;NFIC;SMARCA4;TLR4;CREB3L4;CREB3;DR1;CALCOCO1;MEF2B;MMP12;NAA15;SP1;EIF2AK3;COPS5;ELL;DCAF6;FOXK1;MPND;MED12;TFEB;MYSM1;SPIN1;GATA3;SMARCD2;RREB1;ARF4;HMGN1;SBNO2;NFIA;CAPRIN2;MED21;MYC;PRDM11;MED24;SERTAD1;MEF2C;PAX3;MYBL1;SFRP1;CHUK;TASP1;ZXDC;IRF2;HRAS;ZPR1;SS18L2;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;CDCA4;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;KLF6;CDC5L;CREB3L2;SMARCC1;SFR1;RNF10;RPS27A;UBC;E2F1;POU4F1;HINFP;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2;RGMB;PRPF6;BCLAF3;F2R;SMAD5;PITHD1;HSF2;CHEK2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3845648269322976,0.8830832122951482,0.6129518072289156,0.952012923634083,1.0,2/17,2.78%,ANK2;ATP1A2
prerank,cellular response to interferon-gamma (GO:0071346),0.3005210510529274,0.8830070915273001,0.6419612314709237,0.9516260667760351,1.0,16/88,15.50%,CD44;CCL5;EPRS1;DAPK3;DAPK1;TRIM25;IRF3;TRIM21;PML;TRIM26;TLR4;JAK1;SYNCRIP;IRF2;GAPDH;OAS2
prerank,chromosome organization (GO:0051276),0.30124497714240867,0.8827452787266329,0.6604651162790698,0.9516012297788183,1.0,26/99,21.28%,HDAC5;DOT1L;PHF1;LATS1;RBX1;TCF7L2;CENPT;HDAC3;SMARCA4;COPS5;ACTL6B;HMGN1;CENPH;MYC;PWWP3A;DDB1;RPS27A;UBC;ABL1;GATAD1;H3-3A;RAE1;ZBTB7A;NUCKS1;SETD7;TOP2B
prerank,"phagocytosis, engulfment (GO:0006911)",0.33306199082279786,0.8826193720585269,0.6151866151866152,0.9513139582621557,1.0,7/36,15.66%,GSN;GULP1;XKR4;CDC42;DOCK1;VAMP7;ITGB2
prerank,organophosphate ester transport (GO:0015748),0.3646123478015646,0.8825875925901554,0.6184971098265896,0.9508394032487242,1.0,3/24,6.33%,LDLR;PITPNC1;PRELID3B
prerank,sulfur amino acid catabolic process (GO:0000098),0.43369849532217275,0.8814901112437449,0.6068376068376068,0.9525356936311332,1.0,3/10,22.37%,ADO;TXN2;BLMH
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3306111094049694,-0.8814895326756168,0.6130790190735694,0.9048325165208351,1.0,6/14,22.20%,IFNGR1;IFNGR2;JAK2;CDC37;HSP90AB1;SOCS3
prerank,hexose biosynthetic process (GO:0019319),0.33126035883959526,0.8814720002905757,0.625974025974026,0.9520391031561904,1.0,10/42,18.35%,PPARGC1A;SLC25A1;ENO2;MDH2;ALDOA;GAPDH;SLC25A12;TPI1;PCK2;CHST15
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.28831816975346247,0.8813757262271468,0.6888185654008439,0.951692793225346,1.0,48/168,24.10%,CNOT6;SAMD4A;DDX5;ZC3H12A;SAMD4B;PPP2CA;RPS4X;EIF4A3;UPF3A;SMG7;RBM8A;XRN2;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;TUT7;RNPS1;RPL10A;DCP1A;UPF3B;EIF4G1;PYM1;RPL14;MAGOHB;MAGOH;RPS27A;CTIF;PATL1;PELO;RPL6;NBDY;DXO;RPS28;SMG9;ETF1;RPL41;TUT1;RPLP2;RPLP1;RPL7;PABPC1;DCPS;RPL21;PAN3;RPL26
prerank,leukotriene metabolic process (GO:0006691),0.3768471737027031,0.8811205161156165,0.6,0.9516668817492016,1.0,5/19,17.34%,ABCC10;ALOX5;MGST3;LTA4H;MAPKAPK2
prerank,neutral amino acid transport (GO:0015804),0.3493669477646974,0.8809670860689885,0.6437956204379562,0.9514651222179327,1.0,6/28,13.72%,SLC36A3;CTNS;SLC36A4;LLGL2;SLC1A4;SLC6A7
prerank,regulation of epithelial cell proliferation (GO:0050678),0.30232735795362975,0.8807702238195287,0.6595744680851063,0.9513122927762789,1.0,12/85,8.72%,ANGPT1;HPN;NUPR1;CDK6;DUSP10;BMP5;SOX9;BMP4;TGFB2;BAD;TCF7L2;LAMC1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3737256303831002,-0.880623608497644,0.6073298429319371,0.905623242143377,1.0,7/10,43.51%,DRD2;FMR1;CALM3;CRHR1;GPR35;DRD3;GNB5
prerank,cellular response to leucine starvation (GO:1990253),0.428126136623155,0.8805992769033236,0.6016260162601627,0.9511031270322777,1.0,4/10,19.73%,SESN2;SESN1;EIF2AK4;GCN1
prerank,cholesterol efflux (GO:0033344),0.37188645316199564,0.8803978915002945,0.613905325443787,0.9509752767353953,1.0,3/20,8.95%,SOAT1;NPC1;SOAT2
prerank,phagosome maturation (GO:0090382),0.34111850749353057,0.8802574838930106,0.6023936170212766,0.9507436223539132,1.0,12/35,27.03%,ATP6V1B1;RAB7A;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6V0E1;RAB31;RAB32;ATP6V0E2;ATP6V0D2
prerank,positive regulation of neutrophil migration (GO:1902624),0.38783678316717907,0.8802451369034511,0.6276923076923077,0.9502390996225438,1.0,3/18,5.38%,MCU;RIPOR2;MOSPD2
prerank,androgen metabolic process (GO:0008209),0.38003481974445785,0.8800683532216544,0.6048632218844985,0.9500845964677653,1.0,3/18,20.02%,SRD5A3;HSD17B11;HSD17B10
prerank,protein heterotetramerization (GO:0051290),-0.3468162475530347,-0.8797529436495479,0.6119791666666666,0.9064881080722953,1.0,5/13,18.47%,PKD2;GRIN2B;NUDT21;CPSF6;CBR4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.30444563780867795,0.8796447623358266,0.6427718040621266,0.9503927810647487,1.0,8/70,12.86%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;CHPT1;TMEM86B;LPCAT3
prerank,cellular lipid catabolic process (GO:0044242),-0.28070958844247923,-0.8796127677193005,0.6412698412698413,0.90563992006067,1.0,7/27,15.80%,CYP1B1;ENPP2;PPARD;ACOX1;LPIN2;ABHD12;SIRT2
prerank,embryonic organ development (GO:0048568),0.31472632584781335,0.8793600000618664,0.6436915887850467,0.9504385453926263,1.0,6/61,3.81%,PBX3;COBL;PBX1;GLI3;STRA6;GDNF
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2758892605568243,-0.8789631430241339,0.6765676567656765,0.9059183099139039,1.0,6/25,10.79%,STAT5B;HIF1A;ACVR1B;ACVR2A;STAT3;NCKAP1L
prerank,protein autoubiquitination (GO:0051865),0.31584815875806704,0.8787767142377542,0.641395908543923,0.9510839056010506,1.0,16/61,19.09%,RNF220;SH3RF2;WWP2;TRIM21;RNF146;UBE2B;KLHL24;RNF141;MDM2;BFAR;RNF10;UBE2D3;STUB1;TRIM37;RNF112;RNF41
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3038545661113382,0.8784853021817662,0.6392857142857142,0.951158194464922,1.0,22/72,19.89%,EP300;POLR2H;POLR2A;RBX1;POLK;COPS5;ERCC5;HMGN1;RPA3;POLD2;ISY1;PCNA;PRPF19;LIG3;DDB1;RPS27A;UBC;ERCC2;POLR2C;RFC1;POLR2E;ERCC4
prerank,regulation of hormone secretion (GO:0046883),-0.3296171177681355,-0.8782495874639955,0.6308139534883721,0.9063158487862788,1.0,12/15,52.55%,EDN1;SOX11;EDN3;NMB;IL11;LIF;VAMP3;SNX6;FGF23;OSM;FFAR2;SCG5
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3372840441347708,0.8782370492046719,0.6039473684210527,0.9511121596658045,1.0,2/34,2.55%,ANK2;ZC3H12A
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3864119729069023,0.8779349187368592,0.6046875,0.9511707715694552,1.0,3/16,12.52%,CAV1;PPP2CA;PTPN2
prerank,negative regulation of telomere maintenance (GO:0032205),0.39330461173034736,0.8769794997989976,0.6211656441717791,0.9526211015085626,1.0,9/15,29.49%,PINX1;TNKS2;NBN;RAD50;ERCC4;TERF2;PARP1;TERF1;TERF2IP
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2727435513399077,0.8767421950166121,0.858,0.9525565426507129,1.0,149/807,16.89%,THRB;PRDM6;FOXN3;DAXX;TMPRSS6;TBR1;KLF4;TFAP2C;ELF3;LBH;SREBF2;RORC;NIBAN2;FOXP2;GLI3;DDX5;TRIM33;HIVEP1;WNT11;KLF12;CAV1;FOXP4;ZNF436;EP300;HDAC5;ZMYM5;ZNF692;MXD4;QARS1;RBFOX2;KANK2;FOXO3;PCGF6;FOXC2;ZNF219;GLIS2;CGGBP1;HDAC4;NR6A1;ZBTB16;EPO;WWP2;MTDH;NACC1;CRYAB;BEND3;RARG;PHF21A;PATZ1;LCOR;CREB1;FOXM1;SOX9;OTUD7B;FOXD1;HCFC1;ZIC2;SHC1;KDM5C;ZBTB7B;KAT6B;PHF10;BMP4;KLF7;COMMD7;NKAP;PLK3;ZFHX3;MAGEL2;LARP7;CIC;PPM1A;L3MBTL3;MAZ;JUN;TCF7L2;CRY2;ZFP57;PML;FOXP3;BRD7;SCML2;DPF2;NR2C1;DNMT3A;YWHAQ;RIF1;EZR;APBB1;CCND1;SAP130;TWIST1;HDAC3;ARID4A;ZNF205;NFIC;TLE2;BCL7A;SP2;SMARCA4;NCOR1;DR1;SFMBT2;ZNF148;MIER2;MAFK;CPEB3;FOXK1;CHD3;GATA3;TSC22D4;RREB1;SBNO2;CHMP1A;BEND5;CBX4;MYC;ZNF177;PRDM11;ING4;MEF2C;TLE5;PCGF2;SFRP1;FOXP1;SET;SARS1;IRF2;NCOR2;GATAD2B;FLCN;MDM2;IGBP1;HMBOX1;FLNA;RCOR2;TCF25;ZGPAT;IRF2BP2;NAB2;CCDC85B;RPS27A;UBC;HEXIM1;E2F1;POU4F1;HINFP;KDM1A;UBE2D3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.27338748345688185,0.8766111684677712,0.7832661290322581,0.9522809944626485,1.0,59/341,18.10%,FZR1;FBXL7;RNF43;SPSB4;ATE1;NFE2L2;WWP2;RNF5;TRIM25;VPS37B;PSMD11;NUB1;OTUD7B;NSFL1C;PSMD4;PSMF1;FEM1C;FEM1A;TGFB1I1;KLHL15;UBE2G2;RMND5B;RBX1;RNF146;PML;UBE2B;PCNP;PPP1R11;SIAH3;COP1;PSMD7;AGAP3;FEM1B;VPS4B;RNF126;ZSWIM8;WDR91;PSMB5;ANAPC4;PELI1;GSK3A;NPLOC4;VPS4A;UBE4A;NEDD4;UBE2H;MDM2;BFAR;MAEA;UBA6;DDB1;ARMC8;UBE2D3;SIAH1;KEAP1;STUB1;PSMD1;TSG101;PSMC4
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3829856261405033,0.8764659937604491,0.6269956458635704,0.9520296239134087,1.0,4/19,10.41%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,cardiac myofibril assembly (GO:0055003),0.39568211850368384,0.8764216482145514,0.6021505376344086,0.9515821329385377,1.0,2/15,3.66%,NEBL;CSRP3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3348083400896505,-0.8758220546180019,0.627906976744186,0.9104250760004308,1.0,4/14,16.46%,SRSF4;SAP18;SRSF10;SRSF12
prerank,endoderm development (GO:0007492),0.39854941512389513,0.8756671586820416,0.5996810207336523,0.9526250707417474,1.0,2/13,8.72%,DUSP1;LAMC1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.1948090002850461,-0.8755658955188526,0.9032258064516129,0.9098060078558379,1.0,42/203,16.68%,PLCB1;CDK14;CLASP2;CEP250;EPS8;USP37;CUL4B;BRSK1;CCP110;ACVR1B;CCDC57;CCNH;CEP78;ALMS1;GSPT1;TPD52L1;CCNY;TAF2;NES;RPS6KB1;NDE1;PRKAR2B;UBE2S;RCC1;CTDP1;ANAPC7;NASP;SPDYA;NEDD1;PPME1;CAMK2A;BTRC;CSNK1D;CUL5;CCNJ;CRLF3;SDCCAG8;BORA;DBF4;CUL1;MASTL;CHMP7
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.281539864040667,-0.8754286358300435,0.6813559322033899,0.9089298374232144,1.0,8/26,17.91%,LYN;AIM2;GRIN2B;STAT3;MBP;PSME1;TTBK1;APH1B
prerank,ATP transport (GO:0015867),-0.36365250669414106,-0.8750973729675185,0.6440677966101694,0.9085210440621365,1.0,1/10,1.03%,CD47
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4076671286722443,0.8749531932691705,0.6136363636363636,0.9535465873796545,1.0,2/10,12.29%,NFE2L2;EIF2AK3
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4021957810368666,0.8749457174011628,0.6332288401253918,0.9530286567202891,1.0,2/13,7.09%,GLUL;GLUD1
prerank,negative regulation of RNA splicing (GO:0033119),-0.3031248650638888,-0.8746428007978605,0.6385542168674698,0.9083078437425177,1.0,6/19,19.70%,SRSF4;SAP18;SRSF10;TMBIM6;SRSF12;PTBP2
prerank,DNA replication (GO:0006260),0.29208907653772254,0.8741176823699903,0.6577777777777778,0.9541177611122954,1.0,25/105,19.56%,FEN1;GRWD1;RECQL4;MRE11;PTMS;REV1;PCLAF;POLG;RMI1;TOPBP1;CDK2;ING4;RPA3;SET;DONSON;POLD2;MCM8;MCM6;ATR;NBN;MCM7;RAD50;NT5M;RFC1;PNKP
prerank,response to amino acid (GO:0043200),-0.26691208380721954,-0.8738464491829326,0.6439393939393939,0.9088590779154088,1.0,11/31,18.93%,GLRA1;IPO5;CPEB1;SLC38A9;TMBIM6;LAMTOR1;GLRA3;RRAGD;GLRA2;RRAGA;GLRB
prerank,mitochondrion distribution (GO:0048311),-0.3575163751165108,-0.8731058076682302,0.6385224274406333,0.9094273566555726,1.0,5/12,16.83%,LRRK2;MTM1;TRAK2;ATCAY;MSTO1
prerank,inorganic anion transmembrane transport (GO:0098661),0.31311253396103284,0.8730525349452989,0.6678876678876678,0.9557522755433092,1.0,10/63,14.52%,CFTR;SLC12A8;SLC25A3;SLC20A1;ANO7;SLC12A4;ANO6;SLC25A14;ANO3;SLC37A1
prerank,detection of mechanical stimulus (GO:0050982),-0.3063955095819234,-0.8726175922258456,0.6517571884984026,0.9093443075747675,1.0,3/19,4.78%,CDH2;PTK2;PKD2
prerank,positive regulation of macrophage migration (GO:1905523),-0.30836316879862435,-0.8722474102480382,0.592391304347826,0.9089494757310477,1.0,7/19,20.44%,IL34;PTK2;THBS1;CSF1;RARRES2;P2RY12;CX3CL1
prerank,visual system development (GO:0150063),0.33790179053520886,0.8714159820645988,0.6228868660598179,0.9584842435871206,1.0,2/37,1.28%,PBX3;PBX1
prerank,protein secretion (GO:0009306),-0.2424263466662141,-0.8713168638775964,0.7049180327868853,0.9098046724625902,1.0,10/56,11.91%,ABCA1;PCSK5;STEAP3;MTTP;RCN3;SEL1L;TVP23B;PPY;TMEM167A;TANGO2
prerank,positive regulation of phosphorylation (GO:0042327),0.2735982327334685,0.8712872328558273,0.746177370030581,0.9582106474317336,1.0,32/240,10.50%,FGFR1;ANGPT1;PRKAA2;NTRK3;LIMK2;DAXX;ADTRP;MMP9;CCL5;EPHA4;MAVS;LMO4;ROS1;EFNA5;KRAS;MRE11;SOX9;WDFY2;PFKFB2;MYDGF;BMP4;CCND2;ERBB3;ILK;ANG;DVL3;FGF22;VEGFB;LMTK2;CCND1;MUSK;HDAC3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4205606665066038,0.8710316543137917,0.606312292358804,0.9581803845239346,1.0,3/10,19.44%,PMAIP1;IRS2;GPLD1
prerank,response to ketone (GO:1901654),-0.2885171342633119,-0.8710206680222,0.6666666666666666,0.90930259717549,1.0,10/24,22.96%,THBS1;NR1H3;SLIT2;TGFB1;UBE3A;SLIT3;CATSPER3;ABHD2;YAP1;CCL19
prerank,eye development (GO:0001654),0.320643425584912,0.8705580910434336,0.6506765067650676,0.9586342877464987,1.0,6/54,7.39%,PBX3;PBX1;COL5A2;STRA6;EFEMP1;TGFB2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.35584763943453823,-0.8703935187120975,0.6120218579234973,0.9095322387221294,1.0,2/10,5.46%,CAMK2D;HECW1
prerank,protein-DNA complex assembly (GO:0065004),0.2853981345312536,0.8697833837954461,0.6790799561883899,0.9595991373604684,1.0,25/116,18.29%,DAXX;GRWD1;PSMD11;ASF1A;SOX9;KAT6B;PSMD4;PSMF1;ATRX;RBX1;PSMD7;ERCC5;PSMB5;RPA3;MCM8;DDB1;MCM6;RPS27A;UBC;ERCC2;SPTY2D1;MCM7;PSMD1;PSMC4;H3-3A
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.4034032991274469,0.8696542527821773,0.6147672552166934,0.9593145014265635,1.0,3/12,10.56%,EPHA4;NFIB;PAFAH1B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.33178824608689456,-0.8694924939242088,0.6404199475065617,0.9091591879459837,1.0,6/14,35.87%,SLCO2B1;ABCG2;SLCO1B1;ABCC1;HMOX1;BLVRB
prerank,heme catabolic process (GO:0042167),-0.33178824608689456,-0.8694924939242088,0.6404199475065617,0.9091591879459837,1.0,6/14,35.87%,SLCO2B1;ABCG2;SLCO1B1;ABCC1;HMOX1;BLVRB
prerank,regulation of heart contraction (GO:0008016),0.29431297268587,0.8694586676409762,0.6700564971751413,0.9591828397727927,1.0,5/90,4.79%,ITPR2;ANK2;CELF2;ATP1A2;AHCYL1
prerank,heart trabecula morphogenesis (GO:0061384),-0.3028040472365949,-0.8693949665053549,0.6337209302325582,0.9081811224223427,1.0,3/18,4.22%,ENG;TEK;NOTCH1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.36220539000847346,0.8686704222061697,0.6334310850439883,0.9601810336393842,1.0,3/22,4.75%,AHNAK;CACNB3;STAC3
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3133462803740871,-0.868008579224296,0.6497005988023952,0.9099922041362035,1.0,6/17,22.02%,NUDT21;CPEB1;HSF1;CPSF6;NELFE;NCBP1
prerank,regulation of endothelial cell migration (GO:0010594),0.2980601199837182,0.8679518147337718,0.6647531572904707,0.9610586626761422,1.0,20/85,14.85%,ANGPT1;ANXA3;EMP2;GLUL;ZC3H12A;GFUS;PTK2B;FOXC2;BMP4;KRIT1;EMC10;NRP2;SYNJ2BP;BCAS3;BCAR1;PTN;GATA3;FOXP1;AAMP;ITGB1BP1
prerank,thyroid hormone generation (GO:0006590),-0.3669146870026798,-0.8679197589095132,0.6520618556701031,0.9090247008528018,1.0,5/10,33.11%,CPQ;SLC5A5;FOXE1;DIO2;TG
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3180053601681774,0.8678628225621468,0.666256157635468,0.9607122267610149,1.0,9/55,10.84%,NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;PML;BCAP31;GSDME
prerank,negative chemotaxis (GO:0050919),0.33575867473795895,0.8672031736714495,0.6306666666666667,0.9615083064641107,1.0,2/33,2.81%,SEMA3D;SEMA3B
prerank,positive regulation of protein phosphorylation (GO:0001934),0.27039654419744796,0.8670603851714593,0.7907444668008048,0.9612719232539039,1.0,39/348,8.79%,ANGPT1;CD44;NTRK3;LIMK2;DAXX;ADTRP;MMP9;PDGFC;CDKN1A;IL15;GDF15;CAV1;TWSG1;MAVS;RAP1A;CD81;NGF;PTK2B;CREBL2;BMP5;DOCK7;EFNA5;CAMKK1;KRAS;MRE11;SOX9;HAX1;WDFY2;MYDGF;DDRGK1;BMP4;CCND2;TGFB2;ILK;LATS1;DVL3;FGF22;IQGAP1;VEGFB
prerank,C21-steroid hormone metabolic process (GO:0008207),0.36453125498258226,0.8669722832439288,0.6070381231671554,0.9609155072538195,1.0,4/20,20.44%,STARD3;FDX1;HSD17B10;TSPO
prerank,negative regulation of inflammatory response (GO:0050728),-0.18929837463479338,-0.8667054151532373,0.8688524590163934,0.9104396797681608,1.0,54/182,25.69%,IGF1;TEK;ADCY5;CALCRL;LYN;PTGIS;MFHAS1;GGT5;ADCY7;NR1H3;RORA;VPS35;PPARD;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;PPARG;RAMP2;PRKAR2B;GPR45;CYSLTR1;TNFRSF1B;CCN3;PTHLH;MVK;GNB1;ADM;CYSLTR2;MC5R;PPARA;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;TNFAIP3;NR1H4;LRFN5;MAPK14;VIPR2;ADCY3;ADCY8;GPS2;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;SMPDL3B
prerank,negative regulation of MAPK cascade (GO:0043409),0.3001413502121481,0.8666681385418444,0.6697038724373576,0.9609975743412456,1.0,25/87,20.67%,DAG1;CAV1;QARS1;DUSP10;DUSP1;FBLN1;FOXM1;SPRED3;BMP4;EZR;PRDM15;SYNJ2BP;TLR4;PTPN2;MYC;FLCN;ITGB1BP1;TNIP1;IGBP1;DUSP3;CAMK2N1;CDK5RAP3;GPER1;RGS2;ABCA7
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3711550574227012,0.866439575340717,0.605301914580265,0.9609226279855969,1.0,3/20,4.24%,EP300;SESN2;NFE2L2
prerank,ion homeostasis (GO:0050801),-0.2661703168306312,-0.8663206255512687,0.6654411764705882,0.9101238772093303,1.0,5/30,7.70%,SLC4A10;CAMK2D;KLHL3;WNK2;UNC80
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.2029147345805599,-0.8660440994613336,0.8723404255319149,0.9095389128338455,1.0,50/117,33.66%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;ADM;CYSLTR2;MC5R;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;HRH2;FGR;TSHR;CD247;ADRB1;PLCG2;LHCGR;PLCG1;TREM2;PTH2R;GPR20;CD163;HTR6;GIPR;CRHR1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.3528329270113554,-0.8659671414280729,0.6242937853107344,0.9085471167415394,1.0,3/11,13.14%,SP100;TP53;RPS6KA6
prerank,regulation of membrane depolarization (GO:0003254),0.37071588174337666,0.8657372758698092,0.6253731343283582,0.9617811048471062,1.0,2/18,3.11%,ABCD1;FHL1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2888251207533275,0.8655922671595516,0.7052980132450332,0.9615408381931625,1.0,22/113,14.37%,CDH13;NOTCH2;HPN;BMP5;NRAS;SOX9;AGGF1;MYDGF;BMP4;BAD;ANG;TCF7L2;LAMC1;VEGFB;EMC10;NRP2;MMP12;PTN;RREB1;MYC;SFRP1;HRAS
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.34958951871025357,-0.8655239737659688,0.6435643564356436,0.9082996675554114,1.0,5/11,16.45%,WNT5A;LRP5;FGFR2;TBX1;CTNNBIP1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3751753353498475,0.8655232959415592,0.6359447004608295,0.9611507461042553,1.0,4/17,11.27%,PRKAA2;CAV1;EIF6;NCOR1
prerank,negative regulation of mRNA processing (GO:0050686),-0.32617074358751996,-0.8649145105149885,0.6608187134502924,0.9084213452702983,1.0,4/15,16.46%,SRSF4;SAP18;SRSF10;SRSF12
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.33659684687299646,-0.8644803669359151,0.6407506702412868,0.9081940556158397,1.0,6/14,24.80%,AUTS2;WDR5;PAXIP1;PRDM9;SMAD4;BRCA1
prerank,chloride transmembrane transport (GO:1902476),0.31695505855358647,0.8643598820344269,0.6489226869455006,0.9629044395816465,1.0,2/48,2.32%,CFTR;SLC12A8
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30204433545489123,-0.863384840442138,0.6811145510835913,0.9093692303033147,1.0,4/20,10.79%,SHANK3;NLGN1;LRP8;DLG5
prerank,regulation of superoxide anion generation (GO:0032928),-0.3355764099230807,-0.8625764896476562,0.6538461538461539,0.909981121629386,1.0,5/14,26.34%,AATF;TGFB1;SOD1;TYROBP;ITGAM
prerank,microvillus assembly (GO:0030033),0.3954657563337661,0.8622231507108988,0.6280587275693311,0.9664295855021762,1.0,4/14,9.59%,RAP1B;RAP1A;ESPN;EZR
prerank,neuron maturation (GO:0042551),-0.29909242452075047,-0.8620896089203337,0.6337209302325582,0.9098067487231409,1.0,7/18,23.46%,ADGRB3;ANKS1A;B4GALT5;C1QA;EPHA8;CX3CL1;C3
prerank,microtubule anchoring (GO:0034453),0.41611490270726925,0.8620162287384521,0.6161137440758294,0.9662753367187842,1.0,2/12,7.67%,DAG1;GCC2
prerank,protein localization to centrosome (GO:0071539),-0.312573187774916,-0.8619215546900152,0.6894586894586895,0.9090418153987359,1.0,8/17,27.82%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,response to tumor necrosis factor (GO:0034612),0.29439997461026185,0.8617927369584312,0.6833890746934225,0.966178100798201,1.0,16/91,15.59%,CCL5;ADAMTS7;ADAM10;ZC3H12A;AFF3;YBX3;NFE2L2;NUB1;GSDME;NPNT;GATA3;ZFAND6;SFRP1;CHUK;DHX9;IGBP1
prerank,positive regulation of signaling (GO:0023056),-0.2530582239241291,-0.8617730544859459,0.7288135593220338,0.9082082422333746,1.0,12/37,22.99%,GRIK2;ECE1;LGI1;SYT1;CLSTN2;RAB29;EDN1;SOX11;EDN3;KCTD13;RIMS1;RIMS3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.22219997554665605,-0.8616562398552898,0.7902097902097902,0.9073216677335746,1.0,19/70,22.81%,TCF12;LMO2;RUNX1;N4BP2L2;PSMC6;PSMA6;PUS7;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;YTHDF2
prerank,T cell migration (GO:0072678),-0.3361779651834859,-0.8613441585590081,0.656084656084656,0.9068251468710794,1.0,7/13,31.42%,SLC12A2;CXCL16;PIK3CD;GPR183;S1PR1;PIK3CG;CXCL10
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3769237743946013,0.8612598054427971,0.6180451127819548,0.9666507308679421,1.0,2/17,6.81%,NOTCH2;BMP4
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.30038184582050814,-0.8612287052962224,0.6545454545454545,0.9059348776049602,1.0,3/18,8.78%,ADAMTS9;BPGM;SAMHD1
prerank,protein import into peroxisome matrix (GO:0016558),0.4019980622640014,0.8611157439556376,0.640194489465154,0.9664136273857387,1.0,3/12,18.72%,PEX26;PEX6;PEX2
prerank,lysosome localization (GO:0032418),0.3288544845852119,0.8610988953945256,0.6245110821382008,0.9659175909636141,1.0,13/37,25.00%,SYTL4;NDEL1;MAP6;PLEKHM1;BLOC1S2;TFEB;FLCN;HDAC6;BORCS6;PIP4P1;ARL8B;KLC2;FAM98A
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.33239942230762026,0.8610882757788649,0.6671140939597315,0.9654084644748134,1.0,9/33,19.24%,CD81;UBASH3A;LGALS3;EZR;PTPN2;IKBKG;SH2D1A;DUSP3;PRKD2
prerank,neuron development (GO:0048666),0.2818193111275201,0.8609871369806713,0.7144408251900108,0.9650863107217025,1.0,28/141,14.56%,RP1;PBX3;PBX1;EHD1;GDNF;BLOC1S6;ARL3;UNK;DOCK7;MAP4;ZFYVE27;TGFB2;CDK16;OPHN1;HDGFL3;TOR1A;RAB35;SRRM4;ACTL6B;BLOC1S2;SH3GL2;BTG2;FLRT3;MEF2C;ULK1;GSK3B;WNK1;NEDD4
prerank,regulation of dephosphorylation (GO:0035303),0.3866327701694493,0.8607683623111556,0.6230031948881789,0.9649769714519145,1.0,5/15,18.97%,SMG7;PPP1R16A;MTMR3;IGBP1;CDK5RAP3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3590222936078843,0.860763018981223,0.6328233657858137,0.9644583070592049,1.0,5/24,6.72%,MBOAT2;ADAMTS7;ZBTB16;SOX9;EFEMP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.35069117087232093,0.8607471148229735,0.6428571428571429,0.963960344976342,1.0,7/26,19.22%,ABCD1;ALOX5;TLR6;TLR4;COA8;PARK7;RAB27A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37404093888767753,0.8603291006125028,0.6129518072289156,0.96424665716256,1.0,7/18,24.21%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2;CDC25A
prerank,negative regulation of immune response (GO:0050777),-0.19589743253160266,-0.8602731024115838,0.8714285714285714,0.9068495572370122,1.0,69/154,34.40%,ADCY5;CALCRL;LYN;GGT5;ADCY7;IRAK3;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;MAPKBP1;PTHLH;CD300A;GNB1;SIRT2;ADM;CYSLTR2;MC5R;RC3H1;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;TNFAIP3;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;LYAR;ADCYAP1R1;GPR27;SPI1;HCK;NPSR1;CALCA;GNG2;HRH2;FER;FGR;TSHR;FCGR2B;CD247;ADRB1;TRIM27;PLCG2;CCR2;LHCGR;DHX58;PLCG1;TREM2;PTH2R;SAMSN1;TYRO3;GPR20;RNF26;CD163;HTR6;GIPR;CRHR1;LILRB1;GLP1R
prerank,regulation of organelle assembly (GO:1902115),0.30444777358874925,0.8599164182849193,0.6767554479418886,0.964520153893548,1.0,20/72,18.00%,GSN;RABEP2;TBC1D16;MAPK15;MSN;CEP76;EZR;MTMR3;VPS11;TBC1D1;ODAD3;RAB1B;USP6NL;PLK2;ATXN2L;TBC1D22A;TBC1D10A;PDCD6IP;STAM;TSG101
prerank,negative regulation of histone acetylation (GO:0035067),-0.3556500375218127,-0.8598331668710444,0.6417910447761194,0.9066653506587785,1.0,5/11,25.12%,THAP7;NOC2L;SIN3A;BRCA1;SPI1
prerank,substantia nigra development (GO:0021762),0.3254570131325187,0.8596110683102173,0.6350461133069829,0.9646162409845523,1.0,11/37,12.55%,GLUD1;SYNGR3;CDC42;NDUFS3;ACTB;YWHAQ;S100A1;RHOA;ZNF148;ATP5PF;MAPKAP1
prerank,regulation of ERAD pathway (GO:1904292),0.41644495980430896,0.8593040513356757,0.6373056994818653,0.9646861597075503,1.0,4/11,23.80%,TMEM259;USP19;USP25;USP13
prerank,acylglycerol biosynthetic process (GO:0046463),0.3502341407446519,0.858854528788344,0.6280400572246065,0.9650479700529988,1.0,5/23,11.60%,DGAT1;MOGAT3;MOGAT1;ANG;GPAM
prerank,response to light stimulus (GO:0009416),0.3100074957522392,0.8586380177602816,0.6773794808405439,0.9649640790872552,1.0,12/55,19.95%,OPN1SW;AANAT;REV1;CPT1B;CRY2;UBE2B;PCLAF;ERCC5;ERCC2;CDKN2D;ERCC4;USF1
prerank,ncRNA processing (GO:0034470),0.2748315878155907,0.8580328794787423,0.738045738045738,0.9656348821800897,1.0,57/200,22.56%,DGCR8;PES1;UTP11;FARS2;PIH1D1;TARBP2;TRPT1;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;POP1;RPL22;INTS2;THG1L;AARS1;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;RPP21;ZCCHC8;TUT7;NOC4L;SENP3;RPL10A;NOL6;RRP9;SRRT;SARS1;RPF1;UTP14A;UTP4;IMP4;RPL14;INTS3;PDCD11;IMP3;INTS6;RPL6;RPS28;RPL41;TUT1;RPLP2;DDX52;BYSL;RPLP1;RPL7;INTS1;WDR74
prerank,protein insertion into membrane (GO:0051205),-0.2643895638275809,-0.8576508625737553,0.6602316602316602,0.9103543273467366,1.0,6/32,8.65%,ALDH3A2;OXA1L;TRAM1;STX5;REEP1;SERP1
prerank,MAPK cascade (GO:0000165),0.2708126436818136,0.8569669101132372,0.8004052684903749,0.9671528776134836,1.0,46/295,14.37%,FGF13;FGFR1;ANGPT1;MAP3K8;ACTN2;CCL5;MAP3K5;MRAS;GDNF;IL3RA;SPTBN2;PSMD11;GFRA3;RASAL3;BCL2L1;NRAS;KRAS;SOX9;SHC1;PSMD4;PTPRA;PSMF1;ERBB3;FGF22;RBX1;RALGDS;YWHAB;RASA2;GOLGA7;MAP2K2;RAF1;PSMD7;SPTAN1;JAK1;IRS2;PPP1CB;RASA1;SYNGAP1;PSMB5;RASA3;MYC;MEF2C;SHC2;BRAP;CHUK;HRAS
prerank,membrane fusion (GO:0061025),0.3335558670259873,0.8569177522370797,0.6361221779548473,0.9667241190277562,1.0,13/33,24.73%,OTOF;NSFL1C;CHP1;VTI1B;NAPA;OPA1;STX11;DNM1L;NSF;VAMP2;SNAP23;VAPA;UBXN2A
prerank,protein phosphorylation (GO:0006468),0.2661172378919272,0.8567510457914028,0.838,0.9665188075157345,1.0,112/478,20.29%,PRKCB;FGFR1;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;EPHA4;GRK5;ADAM10;TSSK6;TSSK4;WNT11;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;CREB1;RNASEL;STK39;SIK3;CSK;MAPK15;EFEMP1;BMP4;TGFB2;CDK16;ILK;LATS1;DYRK1B;STK16;PKD1;OXSR1;MAPK9;AURKC;BCR;LMTK2;TXK;PTPN6;ABI1;MUSK;SRPK2;CDKL4;GRK2;TLR4;PDK2;CSNK1E;EPHA3;JAK1;YWHAZ;MARK4;TGFBR2;EIF2AK3;CDK18;SRPK1;DDR1;MAP3K13;CDK2;GSK3A;IRAK1;TGFBR3;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;TLR3;PLK2;AAK1;PAK6;TTK;ATR;PRKCZ;RELN;ABL1;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PEAK1;PRKCQ;MAP3K3;RSKR;RARA;STK38L;STK24;ROCK2;CAB39;TAOK3;PRKD2;APP;MAP3K1;CDK11B;PRKAB1;TBCK;CDC42BPG;PRKX;CAMK2B
prerank,negative regulation of kinase activity (GO:0033673),0.3065519884738347,0.8566664151912238,0.692588092345079,0.966166048308301,1.0,10/62,11.69%,TRIB2;QARS1;HSPB1;TARBP2;TSC2;CHP1;PYDC1;SMCR8;GNAQ;IRS2
prerank,regulation of mitochondrial translation (GO:0070129),-0.29323433162156654,-0.8566501467503501,0.6591639871382636,0.9113579669844843,1.0,10/21,32.50%,RPUSD4;FASTKD2;TSFM;TRMT10C;FASTKD3;ALKBH1;RMND1;SHMT2;MPV17L2;COA3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3523923379930262,-0.8566258562551263,0.6476683937823834,0.9102579938180921,1.0,5/11,20.23%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1
prerank,regulation of stem cell differentiation (GO:2000736),-0.21410740927440158,-0.8563797438744141,0.8392857142857143,0.9096517678706852,1.0,24/89,22.81%,JAG1;TCF12;PDGFRA;LMO2;NOTCH1;RUNX1;PSMC6;PSMA6;PUS7;NUDT21;OCIAD1;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;SP7;YTHDF2
prerank,response to unfolded protein (GO:0006986),0.31197172909095733,0.8560589722635553,0.6878306878306878,0.9668154520782221,1.0,10/48,15.88%,DAXX;HSPB1;HSPB2;HSPB8;HSPA4;HSPA14;BAG3;HSP90AA1;HSPH1;DNAJC4
prerank,protein glycosylation (GO:0006486),0.2834412905952759,0.8559511430909749,0.7118093174431203,0.9664996576495963,1.0,13/125,6.59%,B3GALT1;ST3GAL4;OGT;B4GAT1;GALNT1;MGAT3;GCNT2;LARGE1;TMEM165;MGAT1;FUT8;NPC1;DDOST
prerank,signal peptide processing (GO:0006465),-0.34486252394492684,-0.8559300741591037,0.634020618556701,0.9094588770414004,1.0,2/11,9.97%,PCSK5;SPCS2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37804094976161223,0.8559065797607643,0.6188271604938271,0.9660540570504608,1.0,6/15,22.77%,TCF7L2;BAG3;RAPGEF3;GSK3B;XPO4;TPR
prerank,negative regulation of defense response (GO:0031348),0.2983290513689889,0.8558908810106692,0.6781065088757396,0.9655571247390139,1.0,19/77,19.73%,KLF4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;PTPN2;LPCAT3;GATA3;CDH5;FNDC4;OTULIN;ILRUN;GPER1;PCBP2;RB1
prerank,regulation of intracellular signal transduction (GO:1902531),0.266384041143029,0.8558074949849863,0.8311557788944723,0.9651955947653696,1.0,109/420,21.87%,PRKAA2;NTRK3;SRGAP3;SRGAP2;MOB3B;DAXX;ARAP1;NGEF;LBH;ARHGEF17;ARHGAP18;AKAP13;EP300;ARHGEF12;ARAP2;TIAM2;NOP2;PPP1R13L;HSPB1;PPP1R13B;RHOQ;NFKBIA;ROS1;ARHGEF18;MRE11;GRM2;ARHGAP29;SSRP1;ARHGAP21;ARHGAP10;PLK3;CDC42;PML;BCR;ARHGEF5;BANP;BRD7;OPHN1;TRIO;EZR;AKAP5;DLC1;RMI1;GNA13;RHOA;TOPBP1;TAF5;MAPKAP1;SOS2;CHD3;INPP5B;CDK2;OCRL;ARHGAP31;RHOU;PIP4K2C;PRDM11;RPA3;ZFAND6;PRKAR2A;FLCN;MDM2;ARHGDIB;PAK1IP1;IKBKG;MEAF6;ARHGEF1;CRK;PAK6;TAGAP;ATR;POU4F1;ARHGAP33;CCNG1;PRKAG1;NBN;PTPN13;XIAP;PLEKHG2;CHEK2;FBXL2;PIDD1;ARHGAP44;RAD50;TMEM127;ARHGEF6;TAOK3;RNF41;TAF9B;PRKD2;RHOT2;FBXO9;TBP;PRKAB1;TBCK;MAPT;ATP6AP2;AGER;PRKAB2;TRAF4;CASTOR2;CMKLR1;USP2;WDR54;CDK5R1;TAF6;ARHGEF11;RHOC;TPTE
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.29165325881344384,0.8557493564906988,0.6993243243243243,0.9647837758903283,1.0,19/88,21.72%,FBXL7;FBXL20;PSMD11;PSMD4;PSMF1;FBXL18;RBX1;FBXO31;PSMD7;PSMB5;FBXL15;FBXL2;PSMD1;PSMC4;PSMD8;FBXO9;DMAC2;FBXW7;CUL2
prerank,negative regulation of insulin secretion (GO:0046676),0.37592997398758543,0.8556358841795425,0.641860465116279,0.9644855656107695,1.0,10/17,32.97%,KLF7;KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PRKN;PSMD9;REST;MIDN
prerank,positive regulation of neurogenesis (GO:0050769),0.2980533791071862,0.855020972863363,0.6971098265895954,0.9651161827706595,1.0,7/68,4.84%,FBXW8;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;PTPRD
prerank,regulation of cilium assembly (GO:1902017),0.3032419525081069,0.8548719772828053,0.6491442542787286,0.9648767883906353,1.0,21/62,24.33%,LIMK2;RABEP2;CDK10;TBC1D16;MAPK15;TBC1D1;MARK4;ODAD3;CCDC88A;USP6NL;TESK1;TBC1D22A;TBC1D10A;TBC1D17;CROCC;CEP97;RABGAP1;TAPT1;CEP120;ODF2L;ATG3
prerank,negative regulation of peptidase activity (GO:0010466),0.3196024654269207,0.8548039046969085,0.6364812419146184,0.9644778692529001,1.0,6/47,8.78%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,regulation of neutrophil migration (GO:1902622),-0.34742541113793907,-0.8544554711719133,0.6534653465346535,0.9113154136203998,1.0,8/10,44.46%,NCKAP1L;RHOH;JAM3;BST1;RAC2;RHOG;OLFM4;RAC1
prerank,axonogenesis (GO:0007409),0.271417915542415,0.854395466901983,0.7618069815195072,0.9647622628623415,1.0,38/237,11.69%,SEMA3D;NOTCH2;GPC1;EPHA4;EFNB2;DAG1;NIBAN2;S100A6;GAB1;SEMA3B;CXCR4;LAMA5;DOK6;GDNF;SPTBN2;ENAH;GFRA3;DOCK7;EFNA5;SHC1;ANK3;MAPK7;KLF7;PTPRA;UNC5B;AFG3L2;PARD6B;LMTK2;OPHN1;ACTB;EZR;APBB1;SLC9A6;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3257795975991843,0.8542340553428934,0.6416558861578266,0.9645616041871441,1.0,8/40,10.23%,ABCD1;PMAIP1;BCL2L1;BAD;PIP5KL1;MTLN;ATP5IF1;ARL6IP5
prerank,visual perception (GO:0007601),0.29250070659828237,0.8540673456147359,0.7,0.9643455858202407,1.0,9/84,6.72%,ABLIM1;GUCY2F;CRYBB3;CACNA2D4;CRYBG3;UNC119;EML2;ZIC2;EFEMP1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2678504660401808,0.8534678149638943,0.8113017154389506,0.9649908772807143,1.0,67/327,18.47%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;MLF2;ESRRB;PRRX2;PATZ1;PHF1;POLR2A;HCFC1;KAT6B;EFEMP1;RALY;ZFHX3;ATRX;SIX1;PML;FOXP3;MYCBP;APBB1;FADS1;NFYC;ZNF205;GON4L;MYT1;AJUBA;SP1;TAF5;TFEB;SPIN1;CHD3;RREB1;SBNO2;GPBP1;NFIA;REXO4;MEF2C;MYBL1;SRRT;PTP4A3;IRF2;UTP4;ACTN4;NAB2;PAK6;E2F1;HINFP;SPTY2D1;ABL1;MLLT6;LIN54;TRRAP;CHEK2;PRKCQ;BRDT;APBB3;SUFU;WTIP;ATF2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.2847418204080207,0.8529267918073231,0.7117516629711752,0.9655120678154712,1.0,19/108,14.16%,KANK1;NXN;RSPO3;PTK7;AMER3;RNF43;PPP2CA;AMER2;TSC2;WLS;GPC3;CXXC4;FOXP3;SMARCA4;HMGXB4;GNAQ;SPIN1;SFRP1;TRABD2B
prerank,small GTPase mediated signal transduction (GO:0007264),0.28570192176338466,0.8526845823146977,0.6931567328918322,0.96545837058985,1.0,26/103,15.53%,CDKN1A;MRAS;ARHGAP18;TIAM2;ARL3;ARHGEF18;NRAS;KRAS;RHEB;SHC1;KRIT1;JUN;CHP1;BCR;RALGDS;ARFIP2;RREB1;CDK2;ARHGAP31;SHC2;BRAP;HRAS;CCDC88A;SETDB1;PLK2;USP28
prerank,regulation of cellular senescence (GO:2000772),-0.2715318990367915,-0.8526491192116094,0.7298387096774194,0.9139813337529041,1.0,8/28,12.55%,SLC30A10;AKT3;RBL1;B2M;ING2;RSL1D1;HMGA2;NEK6
prerank,cellular response to purine-containing compound (GO:0071415),-0.3614065730438544,-0.8526072723792905,0.6330749354005168,0.9129404845712628,1.0,4/10,22.16%,SLC8A1;RYR2;P2RY1;CASQ2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3529140838687748,0.8525045105702581,0.6419019316493314,0.9652937870058794,1.0,8/22,18.47%,INSIG1;DMTN;CHP1;SIAH3;ITGB1BP1;UFM1;SUFU;PARK7
prerank,neuron projection morphogenesis (GO:0048812),0.281255873839476,0.8523745048641472,0.7150715071507151,0.9650254600573965,1.0,20/137,10.07%,ALCAM;SRGAP2;PLXNB1;FLRT1;NBL1;S100A6;NGF;MAP6;DOCK7;ANK3;KLF7;AFG3L2;PARD6B;IQGAP1;CDC42;LMTK2;ACTB;TRIO;APBB1;SLC9A6
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2804828036440458,0.8521112177827533,0.7259825327510917,0.9650090532082775,1.0,20/124,14.10%,PLCB3;CELSR1;WNT1;WNT11;AP2A2;PSMD11;MOV10;PSMD4;PSMF1;DVL3;FZD5;TCF7L2;CDC42;PSMD7;GNAO1;AP2A1;RHOA;PSMB5;PDE6B;SFRP1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3566780859134567,0.8515889902882099,0.6431654676258993,0.9655475598041492,1.0,4/21,12.06%,COX19;COX16;COX20;COA8
prerank,regulation of cellular response to stress (GO:0080135),0.28015881093094014,0.8515160861108406,0.7110862262038073,0.9651768459688966,1.0,38/115,25.78%,NUPR1;ABCD1;EP300;BAG1;ALOX5;CRYAB;HSPB8;NUP93;CHORDC1;USP19;NDC1;BAG3;AJUBA;RPA3;GSK3B;EIF4G1;HSP90AA1;HSPH1;ATR;ABL1;MAPKAPK2;AAAS;RAE1;ROCK2;MAPT;CAMK2B;HIKESHI;PTGES3;POM121;TPR;RANBP2;ARMT1;NUP42;AIFM2;NUP62;SLC38A2;SEH1L;MBTPS2
prerank,prostanoid metabolic process (GO:0006692),-0.32742735536241974,-0.8514581054343258,0.6712328767123288,0.9141805710597976,1.0,5/13,25.58%,PTGES;ACOX1;HPGD;CYP2S1;PTGR1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3877554205909548,0.8511615031114576,0.6466049382716049,0.9653127229094206,1.0,1/13,0.66%,ANK2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3727918256102216,0.8511339550113844,0.6463414634146342,0.9648479741427605,1.0,4/15,12.15%,EIF4A3;SIX1;TWIST1;TGFBR2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3110501166684225,-0.8508980049321595,0.6715116279069767,0.9141431868032619,1.0,1/16,0.12%,SOX5
prerank,negative regulation of protein polymerization (GO:0032272),0.34554258166242446,0.8508207903557483,0.6495726495726496,0.9649443696307262,1.0,8/27,17.48%,KANK1;SSH3;TWF1;EML2;ARFGEF1;KANK4;PFN2;CDH5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36180903674316234,-0.8507109857808031,0.6503856041131105,0.9133889937867067,1.0,4/10,23.46%,APPL2;NCKAP1L;CD300A;C3
prerank,regulation of actin nucleation (GO:0051125),0.39455218396086333,0.8504816882412068,0.6370716510903427,0.9650593397720343,1.0,2/12,11.73%,GSN;ARFIP2
prerank,C4-dicarboxylate transport (GO:0015740),-0.3306395204789252,-0.8504410489700712,0.6805555555555556,0.9127949443979259,1.0,2/14,5.61%,SLC1A2;SLC1A1
prerank,regulation of phosphatase activity (GO:0010921),0.35128872235167213,0.8503105268472871,0.641726618705036,0.9648626956877283,1.0,3/24,8.66%,PPP6R3;SH3RF2;CHP1
prerank,positive regulation of protein secretion (GO:0050714),0.29692091574169716,0.8502445311892889,0.6831566548881036,0.964463688745175,1.0,22/69,20.54%,SYTL4;MCU;GLUD1;WLS;GOLPH3;TGFB2;BAD;ANG;TCF7L2;EZR;APBB1;IER3IP1;TLR4;IRS2;AACS;DNM1L;NLGN2;APBB3;GPER1;MYO18A;SOX4;FRMD4A
prerank,regulation of mononuclear cell migration (GO:0071675),0.3537585484722019,0.8499990442474028,0.662704309063893,0.9644433996604438,1.0,4/23,8.28%,CCL5;BMP5;MSN;LGALS3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3217695658502335,-0.8499463395456596,0.6559139784946236,0.912710481652027,1.0,8/14,37.35%,IL18;SOCS5;CCL19;CD86;MALT1;CD80;NFKBID;NLRP3
prerank,regulation of protein localization to cell surface (GO:2000008),0.3318793920002347,0.8496116331742909,0.6653491436100132,0.9646467897508608,1.0,5/33,11.07%,ACTN2;TOR1A;SNX33;RAB11FIP5;ABCA2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.29590809162723253,-0.8492140620229862,0.6613924050632911,0.9130698119503751,1.0,7/20,18.11%,DCC;FAS;BCL2;CASP9;ITGAV;BAX;BOK
prerank,lipid homeostasis (GO:0055088),0.3036945251817689,0.8490424469067985,0.676214196762142,0.9651948488310697,1.0,8/57,11.69%,PRKAA2;ABCD1;ABHD5;ORMDL3;THADA;TLCD2;ABCA2;IRS2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2839328761598839,-0.8489003061631469,0.6818181818181818,0.912643554033889,1.0,6/21,20.54%,SMARCD3;NES;DRD2;TOX;CX3CL1;CX3CR1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.23528279104964983,-0.8487082700112946,0.7709251101321586,0.9119358511711381,1.0,5/46,5.36%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.34685494400939343,0.8485559928362236,0.6775956284153005,0.9656082705740612,1.0,4/27,10.61%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2872322471329749,0.8478619069322192,0.7057471264367816,0.966394477868239,1.0,18/88,19.01%,SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;EIF4A3;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH;HDAC6;CAMK2N1;IGF2BP3;CDK5RAP3;IGF2BP2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.347530716196079,0.8477248380101762,0.6392757660167131,0.9661489690044149,1.0,3/26,6.64%,ST3GAL4;B4GAT1;PRELP
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3240433204712966,0.8472592196321252,0.6623376623376623,0.9665075778982838,1.0,12/37,19.89%,RBX1;POLK;ERCC5;RPA3;POLD2;PCNA;DDB1;RPS27A;UBC;ERCC2;RFC1;ERCC4
prerank,cellular response to gamma radiation (GO:0071480),0.36937481527454546,0.8472396835132049,0.6462035541195477,0.9660202206068768,1.0,5/17,16.83%,CRYAB;HRAS;MDM2;ATR;KDM1A
prerank,negative regulation of signaling (GO:0023057),-0.27485292878773,-0.846852478765798,0.7255639097744361,0.9144708387162762,1.0,6/25,21.40%,UBASH3B;GLRA1;SOCS5;KIF26A;OPRM1;OPTN
prerank,negative regulation of cell cycle (GO:0045786),0.2954793481830438,0.8465736469659699,0.687715269804822,0.966784900382104,1.0,13/73,13.57%,NUPR1;CDK6;PPP1R13B;IPO7;DUSP1;ZBTB17;BMP4;LATS1;NLRP2B;CDK5RAP1;GATA3;CHMP1A;BTG2
prerank,response to prostaglandin E (GO:0034695),0.4154843467043317,0.8465021903890604,0.6565143824027073,0.9663976012135489,1.0,3/10,14.17%,ADCY6;SFRP1;TGFBR3
prerank,negative regulation of protein phosphorylation (GO:0001933),0.276574932346999,0.8464727458449729,0.7574468085106383,0.9659492392366491,1.0,30/150,14.87%,NTRK3;TRIB2;OCLN;SMAD6;ZC3H12A;CAV1;QARS1;HSPB1;TARBP2;TSC2;FBLN1;SPRED3;DMTN;NLRP2B;PIP5KL1;CHP1;PYDC1;FKBP8;PTPN6;SMCR8;TWIST1;GNAQ;LDLRAD4;MVP;SH3GL2;SFRP1;EIF4G1;DNAJC10;ITGB1BP1;DNAJC3
prerank,centromere complex assembly (GO:0034508),-0.24194370891319728,-0.8463681171721805,0.7131474103585658,0.9143349597057762,1.0,18/36,33.59%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;HELLS;MIS18BP1;KNL1;CENPE;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,response to muramyl dipeptide (GO:0032495),0.401013321868636,0.8458789146022707,0.6494522691705791,0.9665570085338594,1.0,2/12,7.27%,VIM;TRIM41
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3553470078117326,0.8457977371576815,0.6369327073552425,0.9661884489547242,1.0,9/17,26.16%,ATP5PF;ATP5F1B;STOML2;VPS9D1;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4001239171418194,0.8455267547004184,0.6464968152866242,0.9662134154942539,1.0,4/12,19.38%,CCL5;RHOA;JAM2;APP
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.33616814792492544,0.8451677230694099,0.6609442060085837,0.966374266174687,1.0,7/26,14.39%,LSM10;CDK10;CCND2;ADAMTS1;CCND1;ANKRD17;EIF4G1
prerank,rRNA processing (GO:0006364),0.27358242092371876,0.8449081178761859,0.751863684771033,0.9663911790677859,1.0,33/172,15.89%,NSA2;NOP2;PES1;UTP11;PIH1D1;EIF6;KRR1;MAK16;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;UTP4;IMP4;RPL14
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.28181483120820966,-0.8449068366071218,0.7033333333333334,0.9160624966916042,1.0,13/21,36.09%,PAG1;SOX11;TNFAIP3;JAK3;FCGR2B;PIBF1;BANK1;LST1;FOXJ1;SAMSN1;LAX1;IL4I1;PTPN22
prerank,regulation of mitotic cell cycle (GO:0007346),0.27425786891793186,0.8448442525513744,0.759958071278826,0.9660108123759853,1.0,32/171,19.78%,FZR1;NEK7;CDK10;DAPK3;PSMD11;CAV2;PSMD4;PSMF1;IQGAP1;FBXO5;EIF4EBP1;PSMD7;PKMYT1;PSMB5;ANAPC4;BTG2;MDM2;MAEA;DDB1;ERCC2;CUL9;CDC25B;PSMD1;DUSP3;INTS13;PSMC4;KIF20B;CDK5RAP3;APP;PSMD8;RB1;CDK11B
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3549074187207963,0.8445051478470209,0.6671490593342981,0.9661609545272424,1.0,8/22,19.26%,VPS37B;VPS4B;RNF126;VPS4A;NEDD4;STAM;TSG101;VPS37A
prerank,negative regulation of cyclase activity (GO:0031280),0.37642348288324456,0.844182448054146,0.6523031203566122,0.9662829685230752,1.0,4/14,11.57%,PALM;GRM2;AKAP5;GABBR2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.30370905971126544,-0.8437647865699104,0.6994047619047619,0.9172845280324008,1.0,1/17,0.03%,PRKG1
prerank,protein ubiquitination (GO:0016567),0.2611850907110334,0.843322588223304,0.8575727181544633,0.9673874601182214,1.0,124/471,23.52%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;FBXL20;RNF220;SPSB4;NFE2L2;LONRF1;SH3RF2;WWP2;TRIM25;TRIM44;PSMD11;NUB1;ELOB;RNF138;KLHL21;MUL1;PSMD4;CBLL1;PSMF1;TRIM41;TRIM21;UBE2G2;FBXL18;RBX1;RNF146;FBXO31;SDE2;TRIM47;TRIM26;TRIM11;UBE2B;RNF182;PCNP;KLHL24;PSMD7;FBXW9;UBE2Q1;VPS11;KLHL13;RNF126;MIB2;ZSWIM8;RNF141;PSMB5;DTX3;NPEPPS;PELI1;DDA1;VPS18;UBE4A;BRAP;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;PCNA;UBE2N;CCDC22;MSL2;PRPF19;TNKS2;FBXL15;UBA6;DDB1;TPP2;RNF10;CAND1;RPS27A;UBC;CUL9;DTX2;UBE2D3;SIAH1;KEAP1;STUB1;UBE2J1;FBXL2;PSMD1;PDZRN3;TRIM37;OTULIN;PSMC4;RNF112;PEX2;RNF41;PSMD8;UBE2Z;ASB5;UBE3C;FBXO9;THOP1;RMND5A;CHFR;USP22;VHL;FBXW7;CUL2;TRIM5;UBE2E1;FBXW2;RCHY1;ARIH2;UBE2V1;SMURF2;BLMH;RNF168;DET1;RNF213;TRIM3;CTR9;RNF14;RNF7;CDC23;PSMA7;LEO1;FBXO4
prerank,mesenchymal cell differentiation (GO:0048762),0.3110398863159141,0.8432863546404146,0.6979293544457978,0.9669441135306743,1.0,6/51,7.39%,FGFR1;RANBP3L;DDX5;SOX9;AKNA;TGFB2
prerank,regulation of postsynapse organization (GO:0099175),0.3418530177328169,0.8431989219251126,0.6731571627260083,0.9666023965794425,1.0,3/28,2.48%,PDLIM5;EPHA4;SIPA1L1
prerank,relaxation of cardiac muscle (GO:0055119),0.39678705756393784,0.8430249334719222,0.6284403669724771,0.9664011157760193,1.0,2/13,2.78%,GSN;ATP1A2
prerank,sphingolipid catabolic process (GO:0030149),-0.32201378646295087,-0.8429514095216373,0.6766467065868264,0.9178438920253341,1.0,2/15,4.73%,ACER2;ENPP2
prerank,receptor internalization (GO:0031623),0.30956763198662185,0.8425389881310765,0.6828025477707006,0.966815311269423,1.0,9/44,15.66%,CAV1;CD81;ACKR3;RAMP1;CD9;GRK2;FCER1G;NEDD4;ITGB2
prerank,response to UV-B (GO:0010224),0.3941896463154291,0.8421510089632532,0.6540284360189573,0.9670060286278416,1.0,1/12,1.93%,CDKN1A
prerank,mRNA export from nucleus (GO:0006406),0.2830938139254704,0.8420834601856788,0.7160356347438753,0.9666140031239159,1.0,33/102,25.55%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;ENY2;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.2553012558246867,-0.841887719305844,0.7489878542510121,0.9188312081705943,1.0,2/33,2.85%,PRKG1;IGFBP5
prerank,cellular response to ionizing radiation (GO:0071479),0.30806163251358115,0.8415921921737759,0.6653796653796654,0.9670347860772737,1.0,13/47,24.28%,CDKN1A;KDM4D;CRYAB;EEF1D;HRAS;MDM2;ATR;KDM1A;NUCKS1;SWI5;RHOB;RPL26;RAD9A
prerank,"transcription, DNA-templated (GO:0006351)",0.26716750941001516,0.8415693516180662,0.7792887029288703,0.9665649042171756,1.0,55/207,24.93%,THRB;DDX5;MLLT3;GTF2F1;FOXO3;CREBL2;POLR2H;TAF1C;ELOB;NKX2-8;POLR2A;ZBTB7B;SSRP1;UBTF;POLR1C;NFE2L3;NFIC;PTMA;GTF3C3;GTF2E1;TAF5;ELL;RREB1;RPAP1;TCEA2;RNPS1;POLR3G;GTF3C2;TBPL1;E2F1;ERCC2;NELFB;POLR2C;GTF3C5;POLR3H;POLR2E;NELFA;TAF9B;TBP;MNT;SNAPC3;TWNK;GTF2E2;TAF6;GTF3C4;AFF4;TFAM;CTR9;CDK9;LEO1;GMEB2;MBD1;MNAT1;POLR2K;BAZ2A
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3325823002184944,-0.8415322731980949,0.6713483146067416,0.9184504117247286,1.0,3/12,10.54%,ALDH6A1;CTPS1;DPYSL5
prerank,protein dephosphorylation (GO:0006470),0.2760848750054629,0.8413066024324554,0.7341907824222936,0.9665632279467025,1.0,33/135,18.01%,PTPN14;EYA2;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;PPP1R15A;DUSP12;DUSP1;UBLCP1;PTPRF;EYA1;PTPN9;PTPRA;PP2D1;PPP2R2D;PPM1A;PTPN6;MTMR3;PTPRE;PPP1CB;PTPN2;PPM1D;PGP;PPP2CB;DUSP11;PTPN13;PPP2R2C;PDP1;DUSP3;PTPN11
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.37446174569742463,0.8408966585579453,0.6682027649769585,0.9668186316417589,1.0,5/16,21.61%,RECQL4;MCM6;MCM7;TWNK;MCM4
prerank,cardiolipin metabolic process (GO:0032048),-0.333052186290914,-0.8402548732954925,0.6648936170212766,0.9199470219877364,1.0,2/13,6.77%,PLA2G4A;PNPLA8
prerank,regulation of ion transmembrane transport (GO:0034765),0.3278806299214654,0.840251604543369,0.6689008042895442,0.9674764841315499,1.0,6/33,14.56%,WWP2;KCNJ13;AHCYL1;ANO6;WNK1;NEDD4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3214576622252948,-0.8401306559987256,0.6827195467422096,0.9190613940429074,1.0,3/13,2.88%,WNT5A;GAS6;AXL
prerank,cellular defense response (GO:0006968),-0.24418953010285818,-0.8400292539134859,0.7454545454545455,0.9181396430206115,1.0,7/40,15.78%,DCDC2;LSP1;CCR9;VEZF1;ADORA2A;NCF2;IL1RL2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3758971619571766,0.8398739025864526,0.6548956661316212,0.9676651010073523,1.0,4/15,14.70%,ORMDL3;TNFRSF1A;SMPD2;PLA2G6
prerank,positive regulation of transport (GO:0051050),0.2862155312417363,0.8397665852404185,0.715922107674685,0.967349080360374,1.0,22/85,20.93%,CHRM1;IL15;ANXA2;CBLL1;GPC3;SYNGR3;ACSL3;CHP1;KMT2A;ACTB;ZNF205;FCER1G;GSK3A;GSK3B;DYNC1H1;CDH3;NUMA1;RAB27A;GPLD1;FLOT1;ABCA7;TULP1
prerank,regulation of dendrite development (GO:0050773),0.3263183399270366,0.8396090871139429,0.6770428015564203,0.9671244892455081,1.0,3/37,4.13%,RAB17;COBL;BMP5
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3395145317646625,0.8393410876810561,0.6713681241184767,0.9671403148867043,1.0,8/26,23.77%,NINJ1;CAV1;LBP;TLR3;FLOT1;TLR1;WDFY1;TLR5
prerank,positive regulation of rRNA processing (GO:2000234),0.4059302960268804,0.8388023724446823,0.6486042692939245,0.9676022373032116,1.0,4/10,22.27%,BUD23;WDR43;TRMT112;SIRT7
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3211592008657558,0.8384861129260089,0.6901041666666666,0.9676841803701624,1.0,14/38,23.00%,EPHA4;CAV1;UNC119;SHC1;ERBB3;SRCIN1;MVP;RAP2C;RELN;SH3BP5L;APP;DLG4;EFNA1;FCGR1A
prerank,negative regulation of lyase activity (GO:0051350),0.3698969411589422,0.8383793426151604,0.6782477341389728,0.9673883104405651,1.0,4/16,11.57%,PALM;GRM2;AKAP5;GABBR2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30833723902568183,0.8383099677849497,0.6996245306633292,0.9669982386336787,1.0,8/53,11.14%,NUPR1;DDRGK1;PSMF1;DESI1;PKD1;USP19;OPHN1;OSBPL7
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.30806359199395095,0.838287291830015,0.6811224489795918,0.9665329015302693,1.0,8/48,10.45%,OGT;EP300;NUP93;RUBCNL;EIF6;NDC1;JMJD8;TIGAR
prerank,cellular calcium ion homeostasis (GO:0006874),0.2752606948673959,0.8382726340746464,0.7462526766595289,0.9660497959609913,1.0,15/133,8.84%,ANK2;STIM2;CCL5;CAV1;MCU;CSRP3;ATP13A3;MCUB;TMEM165;CAV2;MICU1;AFG3L2;ATP13A4;PML;HCRTR1
prerank,cellular protein catabolic process (GO:0044257),0.30094356652828474,0.8382684636977901,0.7122302158273381,0.9655510352702078,1.0,17/59,19.32%,ADAMTS7;AP2A2;RNF5;DENND3;CTSZ;CAPN2;UBE2G2;RAB7A;AFG1L;AP2A1;RNF123;BNIP3L;MDM2;CTSH;CHEK2;PISD;IDE
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.370952135985048,0.8379438614233693,0.6285289747399703,0.9656442172025396,1.0,5/15,16.00%,HPN;TMC2;PDZD7;MKKS;TMEM120A
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.28743996675341493,-0.8379152908673352,0.713855421686747,0.9212023618262454,1.0,4/21,11.84%,CYP26B1;PPARD;ACOX1;LPIN2
prerank,relaxation of muscle (GO:0090075),0.39823630364627816,0.8377952020492623,0.6724409448818898,0.965414404414675,1.0,2/13,2.78%,GSN;ATP1A2
prerank,cyclooxygenase pathway (GO:0019371),0.4071938408478791,0.837671472010828,0.6523235800344234,0.9651442309988857,1.0,3/10,11.23%,PTGDS;HPGDS;PTGES2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3184430133194015,0.8374946812953747,0.6697736351531292,0.9649581016697183,1.0,1/35,0.40%,CLU
prerank,oxoacid metabolic process (GO:0043436),0.3323820127151957,0.8374189041436733,0.65,0.9645782127766847,1.0,2/27,3.24%,SULT1A1;SULT2B1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3223166021370155,0.8373715104138444,0.6954248366013072,0.964156624312897,1.0,6/39,10.56%,DYNC1I1;MYO1H;NDEL1;MYO5A;MYO1C;PAFAH1B1
prerank,B cell proliferation (GO:0042100),-0.2936307830239694,-0.83714295606163,0.6655518394648829,0.9216327372459681,1.0,4/17,19.44%,BCL2;CTPS1;CD40;HSPD1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.27011830206076287,0.8369993403898952,0.7727748691099476,0.9643359504794862,1.0,27/163,18.10%,PRKCB;NFATC2;ZC3H12A;FYB2;PSMD11;EIF2B2;CSK;PSMD4;PSMF1;NFAM1;TXK;PSMD7;BCAR1;PSMB5;GATA3;MEF2C;CHUK;WNK1;IKBKG;RNF31;UBE2N;EIF2B4;PSMD1;TAB2;SPPL3;PRKCQ;PSMC4
prerank,positive regulation of protein modification process (GO:0031401),0.2650627791944682,0.8368987857136412,0.765495867768595,0.964003706896996,1.0,45/203,19.54%,ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;MAVS;RAMP1;EFNA5;KRAS;SOX9;WDFY2;MYDGF;BMP4;CCND2;ILK;DVL3;NNMT;FGF22;CHP1;VEGFB;CCND1;MUSK;HDAC3;DLC1;RAPGEF3;FXR1;TRABD2B;HRAS;FLCN;HSP90AA1;RB1CC1;TESK1;UBE2N;ABL1;CDH5;SPPL3;TMEM119;GPNMB;ROCK2;PTBP1;GPER1;APP;FLOT1;ADAM17
prerank,transcription by RNA polymerase I (GO:0006360),0.32481253698598245,0.8368937528131322,0.6487935656836461,0.963509394722096,1.0,15/34,26.41%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;TCOF1;MNAT1;POLR2K;POLR1B;TTF1
prerank,negative regulation of GTPase activity (GO:0034260),0.35032205278935163,0.8361734120765585,0.6685472496473907,0.9643023152351908,1.0,7/22,17.04%,CPEB2;SH3BP4;BCAS3;ARFGEF1;HRAS;WNK1;FICD
prerank,response to estradiol (GO:0032355),0.33146148514110985,0.8361593779129286,0.6708333333333333,0.9638285787789911,1.0,7/31,19.15%,NCOA3;FAM210B;LCOR;SOCS2;SFRP1;POU4F1;GPER1
prerank,positive regulation of heart contraction (GO:0045823),0.36364474690146315,0.8360806815917151,0.6661631419939577,0.9634589536245479,1.0,4/19,13.54%,ATP1A2;TGFB2;TRPM4;GSK3A
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.30709921798234696,0.8358600666018011,0.6852085967130215,0.9633398195942795,1.0,5/46,8.42%,CDH13;CCL5;BMP4;ANG;TCF7L2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.33584132160357777,0.8357002209408835,0.6707988980716253,0.9631198876492696,1.0,14/27,25.99%,TAB3;TLR6;TLR4;IRAK1;TNIP1;RPS27A;UBC;TAB2;IRAK4;MAP3K1;TLR1;TLR5;LY96;TAB1
prerank,T cell homeostasis (GO:0043029),0.4037643607605886,0.8355331409360801,0.6181229773462783,0.9629296694746602,1.0,2/10,8.99%,PMAIP1;FOXP3
prerank,positive regulation of transporter activity (GO:0032411),0.3860371892801818,0.8353187058262105,0.6640127388535032,0.9628466702420883,1.0,3/13,9.04%,STK39;SYNGR3;KMT2A
prerank,cAMP biosynthetic process (GO:0006171),-0.34915577648221957,-0.8350278909096419,0.7067307692307693,0.9246112106715276,1.0,4/10,7.75%,ADCY5;ADCY7;ADCY1;ADCY4
prerank,positive regulation of T cell differentiation (GO:0045582),-0.24781188576338614,-0.8348673895830877,0.7574468085106383,0.923814998705323,1.0,6/36,11.72%,LEF1;GLI2;ZMIZ1;CD46;NCKAP1L;PNP
prerank,cellular response to hexose stimulus (GO:0071331),-0.2707861271880976,-0.834781630551071,0.7109144542772862,0.9228734356478768,1.0,6/23,12.35%,UNC13B;ZBTB20;GAS6;PRKAA1;IGF1R;RACK1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2853923888235471,-0.834690301552594,0.7088607594936709,0.9219427276585515,1.0,5/19,18.90%,MAOB;ACOX1;GPX1;PRDX4;SOD1
prerank,regulation of microtubule-based movement (GO:0060632),-0.3391441492925793,-0.8345458697513065,0.6738544474393531,0.9211403725128685,1.0,2/11,5.62%,MAP2;TTC21B
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.28267377863822424,0.834517933503041,0.7413600891861761,0.9638452971704283,1.0,34/110,24.10%,PPP2CA;RPS4X;EIF4A3;UPF3A;SMG7;RBM8A;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;RNPS1;RPL10A;DCP1A;UPF3B;EIF4G1;PYM1;RPL14;MAGOHB;MAGOH;RPS27A;CTIF;RPL6;RPS28;SMG9;ETF1;RPL41;RPLP2;RPLP1;RPL7;PABPC1;RPL21;RPL26
prerank,regulation of macrophage chemotaxis (GO:0010758),0.34881575086075395,0.8344561654975473,0.659606656580938,0.9634628706377976,1.0,2/21,3.61%,CCL5;PTK2B
prerank,negative regulation of hydrolase activity (GO:0051346),0.30923983440973146,0.8343722667316597,0.6993788819875777,0.963114394541559,1.0,12/49,17.04%,CPEB2;SH3RF2;SH3BP4;MAPK7;CHP1;ATP5IF1;BCAS3;ARFGEF1;HRAS;WNK1;NEIL1;FICD
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.27938253171109967,0.8342586116468442,0.7090301003344481,0.9623133302635614,1.0,19/104,18.10%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,cellular response to lectin (GO:1990858),0.27938253171109967,0.8342586116468442,0.7090301003344481,0.9623133302635614,1.0,19/104,18.10%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,sphingosine biosynthetic process (GO:0046512),-0.34120135067328927,-0.8340130300054852,0.6666666666666666,0.9199970367331162,1.0,6/11,33.29%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,sphingoid biosynthetic process (GO:0046520),-0.34120135067328927,-0.8340130300054852,0.6666666666666666,0.9199970367331162,1.0,6/11,33.29%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2948512838382131,0.8333045886777517,0.7182254196642686,0.9635225062707705,1.0,14/70,15.26%,DAXX;NGF;BCL2L1;ERBB3;TGFB2;BAD;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2;GSK3A;GSK3B;TLR3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3340561846007851,0.8328741308444496,0.6882022471910112,0.9638037013568078,1.0,8/27,18.39%,DDX5;BMP4;MAP2K2;AJUBA;FXR1;EIF4G1;DHX9;WTIP
prerank,positive regulation of metabolic process (GO:0009893),0.28052483441604426,0.8326199523462313,0.7419712070874862,0.9637808329369473,1.0,16/103,12.65%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;BEND3;ZBTB7B;ACADL;ELOVL6;KDM3A;HDAC3;ACACA;FASN;PIGA;CPT2
prerank,regulation of myelination (GO:0031641),-0.2688420158903212,-0.8325746712113394,0.6989966555183946,0.9216836900358715,1.0,7/25,15.80%,TNFRSF21;PTPRZ1;TENM4;TPPP;TNFRSF1B;MYRF;SIRT2
prerank,nucleotide metabolic process (GO:0009117),0.3400458723857162,0.8323201987388021,0.6571834992887624,0.9638176819930866,1.0,5/23,14.47%,FHIT;AK1;CMPK1;AK5;CTPS2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.34692763230243956,-0.8319662682957584,0.6649350649350649,0.9206575624461248,1.0,3/10,7.51%,CLTA;MYLIP;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.34692763230243956,-0.8319662682957584,0.6649350649350649,0.9206575624461248,1.0,3/10,7.51%,CLTA;MYLIP;AP2B1
prerank,regulation of mitotic spindle organization (GO:0060236),0.32403069238103877,0.8319164189910995,0.7031662269129287,0.9640314243446008,1.0,15/35,26.60%,PARP3;PSRC1;CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;RAE1;CEP97;TPR;CHMP5;NUP62;CHMP1B
prerank,regulation of cell projection organization (GO:0031344),-0.328545831544352,-0.8318703869345524,0.6991643454038997,0.9197312328062337,1.0,4/13,13.67%,MYO9A;NTNG1;MACF1;MFSD2A
prerank,neuronal action potential (GO:0019228),0.3485666827887576,0.8317865732155282,0.663235294117647,0.9637622343200186,1.0,6/22,21.43%,SCN3A;ANK3;SCN9A;GPER1;KCNMB2;KCNMB3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.35217737266239013,0.83174384996332,0.66,0.9633412365691393,1.0,5/21,12.70%,PMAIP1;BCL2L1;CREB3;EIF2AK3;OPA1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.28880268450252516,0.8315008261437117,0.7248858447488584,0.9632883673140078,1.0,13/78,14.07%,SORBS1;STAC3;RHOQ;BCL2L1;PTPN9;LGALS3;ACTB;AKAP5;CNPY4;EPHA3;VTI1B;VPS4A;ATP2B4
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3405939738242409,0.8314049212897814,0.6710334788937409,0.962979942494481,1.0,5/20,15.38%,DAXX;DCUN1D5;DCUN1D1;WASHC1;HSP90AA1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2782960153871013,0.8312469256958464,0.7160356347438753,0.9627677685662404,1.0,19/105,18.10%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,regulation of interleukin-10 production (GO:0032653),-0.2348276558268184,-0.8310520509979713,0.7892156862745098,0.9202907405054702,1.0,17/44,29.88%,CD47;CD34;LGALS9;TNFRSF21;CD46;STAT3;HMGB1;HSPD1;TYROBP;NOD2;JAK3;PYCARD;FCGR2B;PIBF1;ISG15;PLCG2;VSIR
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3417279593037645,-0.8308301020043265,0.6972010178117048,0.9195998898661087,1.0,7/11,29.32%,PLEKHA7;KIT;CCN3;KIFC3;DSP;JUP;CAMSAP3
prerank,protein targeting to membrane (GO:0006612),0.2820623380051734,0.830662819710531,0.7268518518518519,0.9633259549436693,1.0,24/83,24.33%,PEX26;ABCD1;ZDHHC12;VPS37B;SIL1;CHMP4A;CHMP4B;SSR1;GOLGA7;MYO1C;SLC25A17;PXMP4;RAB8B;PEX3;PEX2;VPS37A;PARD3;ARL6IP1;ZDHHC3;SGTA;SRP14;ARL6;RAB3IP;ATG3
prerank,muscle tissue morphogenesis (GO:0060415),-0.3017421168168174,-0.8305910839365293,0.7408450704225352,0.9189106880349556,1.0,2/16,4.22%,MYLK;NOTCH1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3528186654591521,-0.8302836679751201,0.6873385012919897,0.9183852358112286,1.0,6/10,30.63%,MTHFD2L;DHFR;MTHFR;TYMS;SHMT2;MTHFS
prerank,monocyte differentiation (GO:0030224),-0.3466838377351961,-0.830203758373728,0.6926952141057935,0.9174514171424392,1.0,3/10,15.42%,IL31RA;PPARG;PIR
prerank,negative regulation of nuclear division (GO:0051784),0.395436653546893,0.8301928039560622,0.6724960254372019,0.9637180349351525,1.0,4/11,23.65%,BMP4;FBXO5;TOM1L2;AURKAIP1
prerank,glycosphingolipid metabolic process (GO:0006687),0.31561716356754743,0.8300076672185588,0.687741935483871,0.9635483225767904,1.0,10/42,14.45%,HEXA;A4GALT;LARGE1;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ESYT2;SMPD2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.368158109217209,0.8297627327928141,0.6671802773497689,0.9635026773574902,1.0,5/15,18.47%,MRE11;HUS1B;MDC1;CHEK2;ATF2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.380508942513485,0.8297276023693897,0.6864535768645358,0.9630681959327538,1.0,4/13,11.57%,PALM;GRM2;AKAP5;GABBR2
prerank,acetyl-CoA metabolic process (GO:0006084),0.37474164180817304,0.8295037412748002,0.6701807228915663,0.9629640307550518,1.0,6/15,22.89%,TDO2;PMVK;ACACA;HMGCS1;ACLY;MLYCD
prerank,regulation of epithelial cell migration (GO:0010632),0.30509830754258044,0.8293083143092801,0.7039312039312039,0.9628206131948405,1.0,10/51,13.12%,DOCK5;EMP2;GLUL;DUSP10;SOX9;TGFB2;ARSB;PTN;DOCK1;RREB1
prerank,ceramide biosynthetic process (GO:0046513),0.31450886878373163,0.8292033288631219,0.6798975672215108,0.9624975063810023,1.0,3/40,5.86%,SPTSSB;SGMS2;AGK
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3973082555596663,0.82900560467932,0.6605960264900662,0.9623314970814912,1.0,3/10,17.41%,INSIG1;UBE2G2;UBE2J1
prerank,cellular metal ion homeostasis (GO:0006875),0.27548465670860545,0.8288726469427518,0.7301762114537445,0.9621003302177596,1.0,8/102,5.63%,ANK2;STIM2;CCL5;CAV1;ATP1A2;CSRP3;ATP13A3;TMEM165
prerank,cell cycle G1/S phase transition (GO:0044843),0.29376826891873054,0.8283727042500466,0.7003699136868065,0.9625055116976596,1.0,13/61,16.71%,CDKN1A;CDK6;USP29;CDK4;PLK3;LATS1;EIF4EBP1;CCND1;CDK2;MYC;PLK2;E2F1;HINFP
prerank,regulation of biomineral tissue development (GO:0070167),0.3412730458427776,0.8283632877046044,0.6856368563685636,0.9620328230422288,1.0,5/26,10.34%,ANKH;SGMS2;SOX9;FBXO5;TWIST1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.28127782117022126,0.8280712902381426,0.727683615819209,0.9620217981225239,1.0,31/96,25.55%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,synaptic vesicle recycling (GO:0036465),-0.25164903119742954,-0.8279716952443409,0.75,0.9206787087978471,1.0,8/31,14.77%,SYNJ2;SYT1;NLGN1;TBC1D24;STON2;NLGN3;AMPH;FCHO2
prerank,axonal transport (GO:0098930),0.31612114062925045,0.8277656468786699,0.686429512516469,0.962073941318207,1.0,14/36,24.48%,BLOC1S6;AP3B1;KIF1B;AP3S1;PAFAH1B1;BLOC1S2;OPA1;DYNC1H1;AP3S2;AP3M1;MAPT;AP3D1;BLOC1S5;RAB21
prerank,cellular response to mechanical stimulus (GO:0071260),0.31027466862687353,0.8277210862118077,0.7104930467762326,0.9616597244658533,1.0,8/46,11.16%,TNFRSF8;SOX9;BAD;TNFRSF10B;TNFRSF1A;HABP4;AQP1;TLR4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.26582253852392207,0.8276986637909308,0.8066528066528067,0.9612052269521086,1.0,24/190,10.34%,PRKAA2;PIK3IP1;MMP9;DAG1;UACA;MAGI2;ZC3H12A;CAV1;PHLDA3;TRIM59;PPM1B;DUSP1;SH3BP4;USP10;TSC2;BCL2L1;OTUD7B;MUL1;PPM1A;NDUFS3;UBE2B;NMI;PRDM15;TWIST1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3671926646559958,0.827423629478091,0.6707503828483921,0.961193122269765,1.0,11/16,32.25%,PIH1D1;SIK3;FLCN;PIP4P1;SEH1L;GPR137;LARS1;LAMTOR5;RRAGB;TELO2;CLEC16A
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.29417277265071146,-0.8267749819837145,0.7237569060773481,0.9218442629140166,1.0,3/19,5.34%,IL34;PTK2;THBS1
prerank,ERBB signaling pathway (GO:0038127),0.28919672381550615,0.8265986767436586,0.7216374269005847,0.9622352184788092,1.0,17/64,20.17%,REPS2;GAB1;PTK2B;SOX9;SHC1;EFEMP1;ERBB3;IQGAP1;MVP;BCAR1;AAMP;HSP90AA1;STUB1;PTPN11;PTPN18;ADAM17;HBEGF
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.3548542784774664,-0.8265080004717396,0.6813725490196079,0.9212335432301734,1.0,6/10,25.64%,NOTCH1;LRP6;SOX11;BMP7;LIN7C;DLL4
prerank,retinoic acid metabolic process (GO:0042573),-0.322833380370231,-0.8260627387952487,0.6666666666666666,0.9210018823388889,1.0,2/14,5.05%,ALDH1A2;CYP26B1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.32508043781358553,0.8257271336022795,0.6722689075630253,0.9633041912280937,1.0,1/32,0.23%,FGF13
prerank,DNA repair (GO:0006281),0.2585901901400545,0.8255232189172698,0.835881753312946,0.963172215286831,1.0,66/284,20.45%,FEN1;MLH1;RECQL4;DOT1L;NABP2;KDM4B;ASF1A;NSMCE4A;MRE11;EYA1;PARP3;TEX264;CENPS;INIP;RAD54L;TENT4A;POLK;WDR33;UBE2B;APBB1;MUTYH;USP3;CSNK1E;HUS1B;MDC1;TOPBP1;ABRAXAS1;ERCC5;MBD4;MLH3;PWWP3A;BTG2;RPA3;REXO4;POLH;ENDOV;APTX;POLD2;PCNA;FAN1;UBE2N;DCLRE1C;LIG3;DDB1;ATR;RPS27A;UBC;HINFP;ERCC2;ABL1;NEIL1;NBN;INTS3;TRRAP;CHEK2;RAD50;PARP2;PARK7;CDKN2D;PNKP;NUCKS1;UVRAG;ERCC4;NABP1;POLN;APEX2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.23922473893404642,-0.8251299414107772,0.8059071729957806,0.9216536234620031,1.0,12/42,17.61%,SMARCA2;MBD2;ARID1A;CHD8;ACTR6;SMARCC2;SMARCE1;NASP;ACTR5;CECR2;MBD3;HDAC2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3455644614156349,0.8250399233850948,0.6835820895522388,0.9635453457645545,1.0,8/22,20.35%,ZC3H12A;MAP3K4;RELL1;EMC10;GADD45B;PRMT1;RELL2;AGER
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.38235147351515597,0.8250241717733852,0.6671875,0.963080625261877,1.0,2/14,9.56%,SHLD2;RIF1
prerank,regulation of biosynthetic process (GO:0009889),0.3847716534010254,0.8241199617659742,0.6710743801652893,0.9641951506409016,1.0,1/11,5.07%,ALOX5
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3825708505544758,0.8240771547611709,0.6780185758513931,0.9637751651875608,1.0,1/12,2.39%,NUPR1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2814820604925712,0.8235956301149401,0.732183908045977,0.9641507735064556,1.0,8/86,6.47%,ANGPT1;CD44;IL15;CD81;PTK2B;EFNA5;DMTN;HAX1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2578996775495758,0.8235435202531344,0.8767535070140281,0.9637449061964892,1.0,69/417,14.24%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;NIBAN2;FOXP2;GLI3;TRIM33;WNT11;HDAC5;QARS1;RBFOX2;PCGF6;ZNF219;GLIS2;HDAC4;ZBTB16;WWP2;NACC1;CRYAB;PATZ1;FOXM1;SOX9;FOXD1;ZIC2;SHC1;KDM5C;KAT6B;PHF10;BMP4;COMMD7;NKAP;MAGEL2;CIC;L3MBTL3;JUN;TCF7L2;CRY2;PML;FOXP3;BRD7;SCML2;DPF2;YWHAQ;TWIST1;HDAC3;ARID4A;TLE2;BCL7A;SMARCA4;NCOR1;SFMBT2;ZNF148;FOXK1;GATA3;TSC22D4;SBNO2;CHMP1A;BEND5;CBX4;PRDM11;ING4;TLE5;SFRP1;FOXP1;SET
prerank,neuron fate commitment (GO:0048663),-0.31217075117015225,-0.8233845608321826,0.7232876712328767,0.9238250962891369,1.0,8/14,43.71%,ID2;MYT1L;DLL4;SHH;POU3F2;PAX6;ASCL1;ISL1
prerank,histone H3 acetylation (GO:0043966),-0.24095866250407078,-0.8232694176262543,0.7510729613733905,0.9229405056356961,1.0,9/40,15.40%,LEF1;MBIP;KAT7;JADE1;TAF12;BRCA2;TAF5L;KAT6A;WDR5
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.28008827092334254,0.823175510636639,0.7595505617977528,0.9638944896428906,1.0,11/90,10.50%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;ZBTB7B;ACADL;ELOVL6;KDM3A;HDAC3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3855302865094017,0.822989885824337,0.6742671009771987,0.9637490965213475,1.0,2/12,8.16%,SERINC5;PHGDH
prerank,chromatin assembly or disassembly (GO:0006333),-0.3391596945755443,-0.8228923214109201,0.703125,0.9225583105432569,1.0,4/11,24.44%,TP53;NOC2L;SUV39H2;MTA2
prerank,inorganic ion transmembrane transport (GO:0098660),0.3834655485674464,0.822866207942346,0.6790322580645162,0.9634714246074232,1.0,3/12,11.40%,ABCC8;TRPM4;PKD2L1
prerank,glucose metabolic process (GO:0006006),0.2928786351211198,0.8227972785023885,0.707673568818514,0.9631015854213738,1.0,11/58,16.09%,PPARGC1A;HECTD4;SLC25A1;ENO2;MDH2;IRS2;ALDOA;GAPDH;SLC25A12;DCXR;TPI1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.292347775709275,0.8227672290048156,0.7297297297297297,0.9626639561137605,1.0,8/68,10.00%,SULT1A1;ACOT8;SULT2B1;RHOQ;NT5C2;BAD;ACSM3;AK3
prerank,regulation of chemotaxis (GO:0050920),0.322709572446205,0.8226933382844946,0.7034965034965035,0.9623115565702831,1.0,6/30,12.52%,EFNB2;YTHDF1;CXCR4;ADGRA2;ZSWIM8;PTPN2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.24769069402176555,-0.8226812452060405,0.7841726618705036,0.9218888997334282,1.0,11/32,24.07%,CDK14;CDK17;BRD4;ID2;DHFR;NPAT;ORC1;TYMS;BACH1;CDC45;TFDP2
prerank,cilium organization (GO:0044782),0.26131958356751717,0.8226188832319188,0.8260869565217391,0.9619605234500622,1.0,40/209,18.73%,RAB17;CYS1;ABLIM1;PARVA;GSN;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;IFT46;EXOC7;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;EXOC2;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;ATP6V1D;ATP6V0D1;FLNA;TMEM138;PTPDC1;CFAP61;RAB8B;HDAC6;RILPL1;FHDC1;ODF2;WDR35;GALNT11
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.38927686151871765,0.8225742947759583,0.6661341853035144,0.9615528758628922,1.0,1/12,3.31%,HAGH
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.313935293128194,-0.8224020036684012,0.7282913165266106,0.9213082330046857,1.0,3/14,5.34%,SULF1;FGF2;THBS1
prerank,glucose transmembrane transport (GO:1904659),-0.29625877319412947,-0.8221765528605898,0.7121212121212122,0.9206561766916812,1.0,3/18,8.80%,SLC2A1;PPARD;SORT1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.30112769669111206,0.822043656838372,0.7267080745341615,0.9619982539165798,1.0,7/51,11.16%,NLRP2;IL16;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2728670545267716,-0.8220170873460704,0.7462235649546828,0.9198829478683774,1.0,6/23,15.80%,TGM2;LRRK2;PDE4B;RYR2;GNB1;SIRT2
prerank,regulation of plasminogen activation (GO:0010755),0.38425751611262005,0.8214258356143057,0.6644628099173554,0.9625690939195278,1.0,2/12,6.15%,HPN;CTSZ
prerank,negative regulation of cation channel activity (GO:2001258),0.33671985976493546,0.8213409506213456,0.6776034236804565,0.9622347500821207,1.0,3/26,6.87%,MMP9;EPO;GSTO1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2554271368241673,-0.8212461360140035,0.7865168539325843,0.9202074264207296,1.0,8/29,15.09%,TUT4;ADAR;HNRNPA2B1;ZC3H7B;DROSHA;SMAD3;SNIP1;AGO1
prerank,peroxisome organization (GO:0007031),0.3344647118221634,0.8208103729554285,0.6934097421203438,0.9626871571645694,1.0,7/25,18.72%,ACOT8;ABCD1;PEX11G;DNM1L;PEX6;PEX3;PEX2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.38002757781697744,0.8197405989314727,0.6666666666666666,0.9640593925421787,1.0,6/13,22.63%,RHOQ;AK3;OPA1;GNAI3;RAB23;EFL1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.35602725361956655,0.8191750363901447,0.6941529235382309,0.9645330382592511,1.0,4/17,9.75%,CCND2;PSRC1;PKD1;CCND1
prerank,establishment of mitotic spindle localization (GO:0040001),0.3313844714763333,0.8190881876135196,0.7005571030640668,0.9641948611509897,1.0,7/28,18.68%,NDEL1;NSFL1C;PAFAH1B1;ZW10;INSC;NUMA1;MISP
prerank,organelle disassembly (GO:1903008),0.31128684615070096,0.8190810803039509,0.704,0.9637179365804669,1.0,8/33,18.05%,DDRGK1;TEX264;PLK3;KLC1;ULK1;RB1CC1;UFM1;PELO
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3981480690769393,0.8190700085493587,0.6760330578512397,0.9632485197319036,1.0,4/10,23.97%,ATP1A2;VDAC1;SESTD1;CBARP
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.35711161878990283,0.8186526188749452,0.6845329249617151,0.9634908735342831,1.0,6/16,23.23%,CWC15;SRSF1;WBP4;SFSWAP;DDX23;DCPS
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.25621979843704257,0.8184032472155356,0.8829465186680121,0.9634487078691496,1.0,77/366,19.78%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;FOXO3;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;MLF2;ESRRB;PRRX2;PATZ1;PHF1;POLR2A;HCFC1;KAT6B;EFEMP1;ZFHX3;ATRX;SIX1;FBXO5;PML;FOXP3;MYCBP;APBB1;FADS1;NFYC;ZNF205;GON4L;MYT1;ANKRD17;RABL3;AJUBA;SP1;TAF5;TFEB;SPIN1;CHD3;RREB1;SBNO2;GPBP1;NFIA;REXO4;MEF2C;MYBL1;SRRT;PTP4A3;IRF2;CCDC88A;UTP4;NAB2;PAK6;E2F1;HINFP;SPTY2D1;ABL1;EIF2B4;MLLT6;LIN54;TRRAP;CHEK2;PRKCQ;BRDT;APBB3;SUFU;WTIP;ATF2;RPL6;NFKB2;APP;NUCKS1;RB1;CDK11B
prerank,regulation of cellular component size (GO:0032535),0.31966911127772835,0.8183809754042456,0.6979310344827586,0.9630046911201181,1.0,6/30,9.59%,PPP1R15A;RARG;MSN;PEX11G;RAB3B;EZR
prerank,aromatic amino acid family metabolic process (GO:0009072),0.39220866692722256,0.8183487272905999,0.6868852459016394,0.9625666312223872,1.0,2/10,19.46%,THAP4;KYAT1
prerank,Golgi to lysosome transport (GO:0090160),-0.33032495857362143,-0.8180555117771403,0.7158176943699732,0.9249511873261179,1.0,6/11,24.34%,EHD3;SORT1;CLN3;RBSN;CCDC91;GAK
prerank,phagosome-lysosome fusion (GO:0090385),0.3986782539817607,0.8178459421741973,0.6661290322580645,0.9629349938557834,1.0,2/10,8.70%,RAB7B;RAB7A
prerank,peptidyl-amino acid modification (GO:0018193),0.3967836148955972,0.8178299077311558,0.6654676258992805,0.9624823992322276,1.0,1/10,2.90%,PDF
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.36786408073966353,0.8178170660707634,0.6918238993710691,0.9620237585582504,1.0,5/15,14.10%,RSPO3;GPC3;WNT5B;CSNK1E;SFRP1
prerank,actin filament network formation (GO:0051639),0.3968423332362088,0.8173926932427811,0.6650641025641025,0.9622778717062186,1.0,1/11,1.26%,COBL
prerank,negative regulation of protein kinase activity (GO:0006469),0.28276215721973263,0.8168341767471434,0.75,0.962750555711423,1.0,23/88,19.73%,TRIB2;CDKN1A;CAV1;QARS1;DUSP10;HSPB1;TARBP2;TSC2;SRCIN1;CHP1;PYDC1;SMCR8;GNAQ;MVP;ITGB1BP1;TESK1;ABL1;DUSP3;CAMK2N1;PARK7;CDK5RAP3;SH3BP5L;RB1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.30757138762018693,0.8167361909152413,0.6980392156862745,0.9624447738978971,1.0,16/41,25.48%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;AAAS;RAE1;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L
prerank,BMP signaling pathway (GO:0030509),0.2903616474007267,0.8161384897324634,0.7266099635479951,0.9630097324497356,1.0,7/62,7.39%,SMAD6;DDX5;HIVEP1;GDF15;BMP5;BMP4;TGFB2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3216192312635193,0.8158654664551006,0.6815114709851552,0.9630253876646584,1.0,7/29,13.48%,EP300;PYGO2;TCF7L2;TLE2;SMARCA4;TLE4;MYC
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.28234190548494215,0.8158381626940673,0.7520564042303173,0.9625892945886602,1.0,11/69,15.50%,CLU;MAVS;TNFRSF8;HSPB1;FZD5;LBP;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,T cell receptor signaling pathway (GO:0050852),-0.1883373597936433,-0.8152827723418987,0.9594594594594594,0.9290641788173495,1.0,30/138,20.31%,PTPRJ;PIK3R1;PDE4D;PAK3;PAG1;INPP5D;EIF2B3;PSMC6;RFTN1;PSMA6;PIK3CB;FYB1;TNFRSF21;PDE4B;THEMIS;PIK3CD;TRAF6;RBCK1;BTRC;PSME1;PSMB10;CUL1;PSMD5;SKAP1;RC3H1;PIK3R2;ICOSLG;PSMD3;PSMA4;PSMB9
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.25032138319768726,-0.8151445216021326,0.7706766917293233,0.9271293164975568,1.0,14/29,31.03%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.25032138319768726,-0.8151445216021326,0.7706766917293233,0.9271293164975568,1.0,14/29,31.03%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA
prerank,positive regulation of immune system process (GO:0002684),0.3607477722429008,0.8149903265272432,0.6940298507462687,0.9635709494142662,1.0,2/16,7.39%,IL15;TGFB2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.29523259816310576,-0.8143364092877183,0.735202492211838,0.9275629376688717,1.0,5/18,16.87%,DAB2IP;NF1;TP53;CD300A;B4GALT7
prerank,monocyte chemotaxis (GO:0002548),-0.25175293580777,-0.8139930424031984,0.782258064516129,0.9271093605342776,1.0,1/32,0.06%,FLT1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.37076899169207067,0.8139392312408622,0.6948640483383686,0.9648798695002906,1.0,3/16,6.87%,ANK2;ATP1A2;GSTO1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.29472218697946917,-0.8138022563067563,0.7002801120448179,0.9263901105416248,1.0,9/15,35.11%,DAB2;PIK3CB;NEU3;HIP1R;TNK2;WASL;BMP2K;SCYL2;DGKD
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3783320633148973,0.8137935173187204,0.6953846153846154,0.9646391587746569,1.0,6/14,21.50%,PPP2CA;DUSP1;PPP2R2D;PPP2CB;PPP2R2C;PPP1R15B
prerank,epithelium development (GO:0060429),0.2697578441539712,0.8132114779603791,0.77665544332211,0.9651271796328115,1.0,11/107,8.90%,UPK1B;SMO;DAG1;KANK2;ANXA4;PIH1D1;SOX9;SIX1;PKD1;LGALS3;GRHL2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3905487455772169,0.8117841874753868,0.684640522875817,0.9671629751186398,1.0,4/10,23.62%,RIF1;DCLRE1C;TERF2;APEX1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.33440339896787946,0.8117750111715886,0.6785714285714286,0.9666992778425962,1.0,2/24,2.09%,CDKN1A;NIBAN2
prerank,stress-activated MAPK cascade (GO:0051403),0.2885902204518853,0.8116628197906357,0.7197062423500612,0.9664029879368765,1.0,13/61,18.38%,MAP3K8;MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;CHUK;IKBKG;UBE2N;RPS27A;UBC;TAB2;ARHGEF6
prerank,ERBB2 signaling pathway (GO:0038128),-0.24183096850054672,-0.8114774868769028,0.8007518796992481,0.929526160113575,1.0,9/31,17.58%,PIK3R1;ERBIN;PTPN12;ERBB4;MYOC;GRB2;CUL5;CDC37;EGF
prerank,regulation of protein kinase B signaling (GO:0051896),0.2592621977813798,0.8110398948761718,0.8114583333333333,0.9669869846046393,1.0,19/193,8.42%,FGFR1;ANGPT1;NTRK3;DAG1;MAGI2;GDF15;GAB1;PHLDA3;GCNT2;MTDH;TSC2;HAX1;GRM2;MYDGF;MUL1;ERBB3;FGF22;MAZ;TCF7L2
prerank,homeostasis of number of cells (GO:0048872),0.3775668234797347,0.8109674756898292,0.6798107255520505,0.9666327726997592,1.0,1/12,0.90%,NAPEPLD
prerank,intermediate filament organization (GO:0045109),0.35102166665121287,0.8107242972544237,0.6993865030674846,0.9665602104057989,1.0,2/17,10.10%,VIM;KLHL24
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.32509144933833123,0.81058022220797,0.7059659090909091,0.966336481477909,1.0,9/26,18.83%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B;SLC9A1;SPPL3;PTBP1
prerank,cellular response to peptide (GO:1901653),0.2917071956916362,0.8100152441627871,0.732685297691373,0.9667929640992916,1.0,7/56,11.16%,VIM;EPHA4;CACNA1A;CAV1;TRIM41;TLR6;TLR4
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2246558470637941,-0.8096595034194568,0.8511627906976744,0.9317989108134036,1.0,5/48,5.36%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3781108528730565,0.8095169027870729,0.7085346215780999,0.9671727046210659,1.0,6/12,30.41%,FEN1;WAPL;RB1;HDAC8;CTNNB1;DDX11
prerank,response to progesterone (GO:0032570),-0.2893187628851376,-0.8094033280521611,0.737012987012987,0.9311825768485501,1.0,7/18,20.30%,THBS1;NR1H3;TGFB1;UBE3A;CATSPER3;ABHD2;YAP1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.289872076730519,-0.8091004208874414,0.7195121951219512,0.9306428533952752,1.0,4/18,12.76%,NRXN1;SHANK3;NLGN1;NLGN3
prerank,protein catabolic process (GO:0030163),0.2862978743375929,0.8089774171267827,0.7503030303030302,0.9675936573974826,1.0,14/59,19.32%,PMAIP1;ATE1;RNF5;DENND3;UBE2G2;MANBA;SOCS6;HSP90AA1;PRPF19;DDB1;SIAH1;CHEK2;RNF41;IDE
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.36499475464259523,0.8080418562991465,0.6766561514195584,0.9686946488180804,1.0,3/15,6.49%,HOMER2;HOMER3;GRM2
prerank,heterochromatin assembly (GO:0031507),-0.27313841545653283,-0.8079953477794696,0.7074829931972789,0.9316121827000833,1.0,5/20,15.80%,MBD2;SMCHD1;HMGA2;HELLS;SIRT2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.29061722754308283,0.8079686609981755,0.7389749702026222,0.9683358745815399,1.0,13/60,16.72%,CDKN1A;CDK4;MOV10;SOX9;MED30;TCF7L2;CCND1;MED8;MED12;PPM1D;MED24;MED6;MED27
prerank,positive regulation of histone modification (GO:0031058),0.31485723786375125,0.8078617905161793,0.72,0.9680446936750744,1.0,7/33,16.83%,PPARGC1A;ZBTB7B;FOXP3;BRD7;TET1;UBE2N;KDM1A
prerank,intracellular protein transport (GO:0006886),0.2524472623662474,0.8078507237572409,0.8593117408906883,0.9675813471974668,1.0,79/304,22.77%,RAB17;RANBP3L;GRTP1;HOMER3;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;SIL1;TMED1;IPO7;TSC2;NUP93;WLS;DESI1;STXBP1;PKD1;TNPO2;CHP1;RAB7A;BAG3;MYO1C;GGA1;SGSM2;AP1S3;TECPR2;AP2A1;ARFIP2;RABL3;TBC1D1;MMP12;NAPA;VIPAS39;STX11;ARF4;NAPB;VPS26B;PREB;RAB5C;TNPO1;NXT2;RAB1B;STX16;RANBP6;HEATR3;USP6NL;IPO4;AP4E1;TBC1D22A;NSF;TBC1D10A;HDAC6;ARFRP1;STAM;CSE1L;STX4;SEC23IP;PPP1R10;TMED5;SEC31B;YWHAH;XPO4;TBC1D17;TBCK;HIKESHI;ARFIP1;SEC16A;RANBP3;POM121;VPS26A;RAB3GAP2;SEC31A;RABGAP1;RAB23;AP3D1;TPR
prerank,ncRNA metabolic process (GO:0034660),0.31151975684373623,0.8076951941634526,0.7156462585034014,0.9673802254084455,1.0,7/37,15.77%,DGCR8;TARBP2;MOV10L1;ZCCHC8;TUT7;DTD1;MEPCE
prerank,cellular response to zinc ion (GO:0071294),-0.3030730868690914,-0.807452325302955,0.7376623376623377,0.9315056901976768,1.0,10/15,36.66%,GLRA1;GLRA2;MT1H;MT1M;MT1X;MT1A;MT1F;MT1E;MT1G;MT1B
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3140672034537567,0.8072098881744503,0.7129120879120879,0.9677198498081374,1.0,10/31,24.41%,SCAMP5;STXBP1;KCNB1;SYT6;SYT11;SYT12;SYT3;SYT2;CBARP;SYT13
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.26802579692724915,-0.8071369444344527,0.7272727272727273,0.9310330198232091,1.0,4/22,7.31%,SLC7A5;RFTN1;IL18;TGFB1
prerank,regulation of mRNA processing (GO:0050684),0.31644358005311324,0.8070145022427574,0.7021857923497268,0.9675830015257266,1.0,8/32,15.48%,AHCYL1;SON;SLTM;LARP7;SRPK2;SRPK1;DHX9;PABPN1
prerank,cellular response to interleukin-12 (GO:0071349),0.29712772662885834,0.8069073260218363,0.7271540469973891,0.9672855188429471,1.0,9/48,11.61%,RAP1B;GSTO1;ANXA2;MSN;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,regulation of trophoblast cell migration (GO:1901163),0.3676524023274353,0.8061368547689269,0.6965408805031447,0.9681200651375504,1.0,5/14,24.23%,TIMP1;ARHGDIB;YTHDF3;SMURF2;C1QBP
prerank,negative regulation of protein modification process (GO:0031400),0.278863595390352,0.8060717736489438,0.7479579929988331,0.9677442764191928,1.0,14/79,14.41%,PRKAA2;NTRK3;OCLN;ZC3H12A;PPP1R15A;FBLN1;PIP5KL1;CHP1;YWHAB;FKBP8;SH3GL2;ATP2B4;GSK3B;DNAJC10
prerank,positive regulation of tissue remodeling (GO:0034105),0.39348228875544267,0.8057023863674304,0.6921797004991681,0.9678977267973363,1.0,1/10,2.47%,IL15
prerank,negative regulation of chemotaxis (GO:0050922),0.31321667710826245,0.8047395249477169,0.7321428571428571,0.9690536029389101,1.0,2/31,2.81%,SEMA3D;SEMA3B
prerank,quinone biosynthetic process (GO:1901663),0.3702928944009063,0.8046194546861523,0.6902086677367576,0.968762523793729,1.0,2/14,8.23%,UBIAD1;PDSS2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3378344153895055,0.8045491772403849,0.7004279600570613,0.9683965029770316,1.0,2/22,6.81%,CDKN1A;BMP4
prerank,regulation of transport (GO:0051049),-0.23376150331503048,-0.8043079745186915,0.7983539094650206,0.9349136978032994,1.0,6/36,11.88%,LEPR;EPB41;LRRK2;DNAJA1;ICA1;MYO6
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.359689276354539,0.8039943663925496,0.6979332273449921,0.9688771270704406,1.0,1/15,1.18%,LDLR
prerank,negative regulation of histone methylation (GO:0031061),-0.33717923064197297,-0.8039474597720484,0.7067307692307693,0.934434689556258,1.0,6/10,26.80%,JARID2;BCOR;MTF2;WDR5;BRCA1;AASS
prerank,mitotic metaphase plate congression (GO:0007080),0.2937406888637304,0.8038421044416095,0.7347715736040609,0.9686445294278518,1.0,21/51,26.60%,PSRC1;CHMP4A;CHMP4B;ZW10;VPS4B;CHMP1A;PINX1;VPS4A;MAD1L1;CHMP2A;PDCD6IP;RMDN1;NUDC;CDC23;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,telomere capping (GO:0016233),0.36116788673105427,0.8038397282884183,0.7081413210445469,0.9681710961322125,1.0,8/16,29.49%,MRE11;DCLRE1C;NBN;RAD50;TERF2;TINF2;TERF1;TERF2IP
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.25001164850346114,0.8036753988467988,0.965,0.9679861862692384,1.0,147/834,16.87%,CDH13;KLF5;THRB;TMPRSS6;KLF4;TFAP2C;PPARGC1A;NCOA3;PBX1;GAL;ELF3;OGT;SREBF2;MICAL2;GLI3;GTF2F1;HIVEP1;ZC3H12A;GABPB1;GABPB2;MAVS;EP300;HDAC5;CD81;FOXO3;CSRP3;FOS;GDNF;FOXC2;GLIS2;HDAC4;BMP5;NFE2L2;SSBP3;DOT1L;SMARCB1;RHOQ;FOXD2;POU2F3;NFKBIA;ESRRB;RARG;IRF3;JUND;NKX2-8;CREB1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;SOX9;HCFC1;AKNA;HAX1;NRF1;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;KLF7;TGFB2;MED30;DVL3;FIZ1;ZFHX3;LARP7;ATRX;SIX1;PKD1;JUN;FZD5;TCF7L2;GRHL2;FOXP3;TNFRSF1A;KMT2A;TXK;DPF2;APBB1;PRDM15;NFIB;TWIST1;BCAS3;HDAC3;NFIC;SMARCA4;TLR4;CREB3L4;CREB3;DR1;CALCOCO1;MEF2B;MMP12;SP1;COPS5;ELL;DCAF6;MPND;MED12;TFEB;MYSM1;GATA3;SMARCD2;RREB1;ARF4;SBNO2;NFIA;CAPRIN2;MED21;MYC;MED24;MEF2C;PAX3;MYBL1;CHUK;IRF2;HRAS;SS18L2;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;KLF6;MEPCE;CDC5L;RNF10;RPS27A;UBC;E2F1;POU4F1;HINFP;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2
prerank,cellular protein-containing complex assembly (GO:0034622),0.2598918511319424,0.8036720551271989,0.7922350472193075,0.9675159973064204,1.0,17/159,9.90%,CLU;ANGPT1;STXBP6;CLTB;PSMD11;NUP93;POMP;PXN;PSMD4;STXBP1;HSPA4;CHMP4A;CHMP4B;CENPT;EIF4B;NDC1;COX7A2L
prerank,sister chromatid segregation (GO:0000819),-0.239930223515316,-0.8035375505804813,0.7881944444444444,0.9340419475894436,1.0,17/31,32.09%,KIF18A;NCAPG2;RAN;KLHL22;WRAP73;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;KIFC1;NSL1;NDC80;TUBG2;CDCA8;SGO1
prerank,axonal fasciculation (GO:0007413),-0.3111150459203444,-0.8029683766268783,0.7386934673366834,0.933919293112277,1.0,6/12,17.76%,SEMA5A;NRCAM;EPHB2;MEGF8;EPHB3;ARHGAP35
prerank,tyrosine metabolic process (GO:0006570),-0.3269664051069635,-0.8028423577133854,0.7493333333333333,0.9330973742377914,1.0,1/11,3.53%,GSTZ1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.38933636669839494,0.8027120868144623,0.6988352745424293,0.9687086823280359,1.0,4/10,18.35%,RARG;RXRB;ACTN4;RARA
prerank,vesicle transport along actin filament (GO:0030050),-0.28309161909738007,-0.8026544454918443,0.735632183908046,0.9323540723332521,1.0,5/19,11.88%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO6
prerank,regulation of cellular response to heat (GO:1900034),0.27688037187878434,0.8025927632932237,0.7339782345828295,0.9684493008711107,1.0,28/77,26.81%,EP300;BAG1;CRYAB;HSPB8;NUP93;CHORDC1;NDC1;BAG3;RPA3;GSK3B;HSP90AA1;HSPH1;ATR;MAPKAPK2;AAAS;RAE1;MAPT;CAMK2B;HIKESHI;PTGES3;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;RPA2;NUP133
prerank,acute-phase response (GO:0006953),-0.3089784025276201,-0.802250273090311,0.7005494505494505,0.9319922184200972,1.0,4/12,22.44%,IL6R;PLSCR1;IL22;SIGIRR
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3329146539786805,0.8021189279172187,0.7097701149425287,0.9687832729955629,1.0,4/22,10.51%,TIMP4;TIMP1;TIMP2;SNX33
prerank,transferrin transport (GO:0033572),0.30859897740079867,0.8020321904295639,0.7068493150684931,0.9684634100324083,1.0,13/33,27.03%,ATP6V1B1;LMTK2;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6AP1;REP15;ATP6V0E1;HFE;ATP6V0E2;ATP6V0D2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.33226758334370243,0.8019895494623311,0.7062841530054644,0.9680582384448263,1.0,4/24,10.37%,NUPR1;FOXO3;TGFB2;SRPK2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.314194035225274,-0.8019749466446422,0.7024128686327078,0.9314096356464546,1.0,3/12,11.00%,BDP1;TAF1B;TAF12
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.3209783427021227,-0.8019256265281728,0.7573333333333333,0.9304228538443627,1.0,3/12,7.58%,TMED10;RANBP9;ROCK1
prerank,mRNA methylation (GO:0080009),-0.3013071288632331,-0.8018035389785673,0.718475073313783,0.9296142370901964,1.0,5/15,21.98%,METTL8;METTL16;TRMT61B;TRMT6;TRMT10C
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.38945959865240415,0.8017181091580066,0.6980830670926518,0.967580982787109,1.0,3/10,20.93%,CACNA2D4;CNGB1;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.38945959865240415,0.8017181091580066,0.6980830670926518,0.967580982787109,1.0,3/10,20.93%,CACNA2D4;CNGB1;TULP1
prerank,acute inflammatory response (GO:0002526),0.3358575984573254,0.8016988231545251,0.7012622720897616,0.9671294522394069,1.0,5/23,14.98%,LBP;HP;HPR;ANO6;VNN1
prerank,primary alcohol metabolic process (GO:0034308),0.3249287967824451,0.8016541181450355,0.6988636363636364,0.9667320799551788,1.0,2/25,2.95%,NAPEPLD;ADH7
prerank,epithelial cell differentiation (GO:0030855),0.26840479086192737,0.8015583704363882,0.775,0.9664170945738967,1.0,14/88,15.69%,UPK1B;ANXA4;PIH1D1;OVOL2;BMP4;LATS1;SIX1;LGALS3;GRHL2;PTER;GATA3;VDAC1;GSTK1;PCNA
prerank,regulation of secretion by cell (GO:1903530),-0.21827280494679874,-0.8007605576433791,0.8306878306878307,0.9303807991675299,1.0,15/54,21.19%,SNCAIP;RIC1;MCTP2;SYT1;STXBP5L;CAMK2A;MCTP1;KCNMB4;RAB3D;CPLX2;DISP1;FMR1;RAB3C;DNAJC1;RIMS1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.27380832621799656,-0.800705407630723,0.7824675324675324,0.9294135667863642,1.0,2/22,5.29%,PDE3B;PRKAA1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.2408810847040474,-0.8006641256367117,0.7991967871485943,0.9284300784520665,1.0,2/32,2.45%,CEMIP;TRPC3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.29737671216556066,0.8006389648240672,0.7381864623243933,0.9675181195271125,1.0,9/45,15.50%,CD44;TRIM25;IRF3;TRIM21;PML;TRIM26;JAK1;IRF2;OAS2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.31987358312540237,0.800479482144934,0.7107776261937244,0.9673249568898904,1.0,1/27,0.58%,CD44
prerank,DNA conformation change (GO:0071103),-0.28809490464259635,-0.8000117742185379,0.7430340557275542,0.9284591959359075,1.0,6/17,22.79%,TOP3A;KAT6A;ERCC3;HMGB1;HHEX;TOP2A
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3300597461858021,0.7997606250794649,0.7227138643067846,0.9680501663360329,1.0,5/23,10.63%,DGAT1;ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,B cell differentiation (GO:0030183),0.29689023393292074,0.799548513560371,0.7168597168597168,0.9679368198736736,1.0,13/46,20.22%,HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;KLF6;IRF2BP2;TPD52;ADAM17;ZBTB7A;DCAF1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3702076264921277,0.7994525157375283,0.7268518518518519,0.9676288321099474,1.0,4/14,14.46%,GAB1;VEGFB;MYO1C;NUS1
prerank,DNA geometric change (GO:0032392),0.3280372210831406,0.7985316312110363,0.7140804597701149,0.968701263909838,1.0,5/24,18.06%,RECQL4;MRE11;DHX9;NBN;RAD50
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.19958949451445793,-0.7984869833925453,0.9181818181818182,0.9300429412325395,1.0,36/82,36.71%,CEP250;CCP110;CEP78;ALMS1;NDE1;PRKAR2B;TP53;NEDD1;CSNK1D;SDCCAG8;KCNH5;CKAP5;CEP41;MAPRE1;HAUS4;HAUS7;CEP72;YWHAE;SSNA1;HAUS6;TPX2;TUBB4B;NPM1;CEP131;CEP135;HMMR;KIF14;PCNT;TUBA4A;ATAD5;HAUS3;NEK10;CETN2;PLK1;AURKA;CDK1
prerank,cellular response to interleukin-7 (GO:0098761),0.3500189155506273,0.7979099593670815,0.7175226586102719,0.9688404610291889,1.0,5/17,11.69%,IL7R;SMARCA4;SOCS2;JAK1;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3500189155506273,0.7979099593670815,0.7175226586102719,0.9688404610291889,1.0,5/17,11.69%,IL7R;SMARCA4;SOCS2;JAK1;IRS2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3148387120323408,-0.7976446030548795,0.7403598971722365,0.930475928887536,1.0,4/12,17.61%,AR;TGFB1;EDN1;HDAC2
prerank,RNA biosynthetic process (GO:0032774),0.31822958703289467,0.7975523643390856,0.7034013605442176,0.9689612230395325,1.0,11/31,28.26%,POLR2A;TAF5;TCEA2;PRIM2;TBPL1;TBP;TAF6;TTF1;TAF4;TERT;BRF1
prerank,ceramide catabolic process (GO:0046514),0.3625463360300085,0.7975323618219557,0.7136222910216719,0.9685267216340725,1.0,3/14,14.66%,HEXA;HEXB;NAGA
prerank,rRNA modification (GO:0000154),-0.27041331865103235,-0.7968859422385257,0.7703488372093024,0.9306874884684004,1.0,10/21,27.09%,NAT10;NSUN4;DKC1;THUMPD1;TFB1M;NOP10;TSR3;DIMT1;MRM2;MTERF4
prerank,central nervous system development (GO:0007417),0.25248778305756087,0.7968368509352941,0.86414708886619,0.9692422005246493,1.0,28/250,10.15%,CELSR1;TBR1;PBX3;PBX1;SMO;ZIC4;PDGFC;GSN;CXCR4;QARS1;ADGRL2;GLIS2;ZBTB16;CTNS;EIF2B2;SOX9;ZIC2;LSR;ZFHX3;CIC;PHGDH;PKD1;GRHL2;CDK5RAP1;ZIC1;ADGRA2;NFIB;IER3IP1
prerank,response to peptide (GO:1901652),0.3153292436272906,0.7966339813542201,0.7379679144385026,0.9691088209260786,1.0,4/33,7.43%,MMP9;CACNA1A;EIF2B2;STAT4
prerank,glial cell differentiation (GO:0010001),0.3240333236418348,0.7964790678436303,0.7276536312849162,0.9688994294732632,1.0,5/28,10.48%,GPC1;SOX9;ERBB3;NFIB;ADGRG6
prerank,RNA export from nucleus (GO:0006405),0.26872174674011323,0.796112476591212,0.7675977653631285,0.969045075038675,1.0,31/100,25.55%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,regulation of hippo signaling (GO:0035330),0.3510788627479127,0.7959804694571854,0.7110091743119266,0.9687811693235441,1.0,1/17,0.88%,MOB3B
prerank,regulation of monocyte differentiation (GO:0045655),0.3627109776584552,0.7959100126379643,0.7131537242472267,0.9684351944479386,1.0,4/14,14.18%,CDK6;ACIN1;MYC;FOXP1
prerank,DNA packaging (GO:0006323),-0.29085515069587886,-0.7956737206309535,0.7394957983193278,0.9317426675325333,1.0,5/16,24.15%,TP53;KAT6A;NOC2L;AIFM1;BANF1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2966440248821728,0.7956491596450709,0.7334167709637046,0.9683848185991021,1.0,9/48,17.50%,IKBKE;EP300;PHLDA3;BCL2L1;PML;USP28;E2F1;ABL1;CHEK2
prerank,regulation of protein polymerization (GO:0032271),0.310696642815952,0.7954285968492895,0.7423230974632844,0.9683020771264796,1.0,13/35,20.66%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1;RASA1;HSP90AA1;CAMSAP1;PFN2;ABL1;PLEKHG2;MAPT;DBN1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3835437620856114,0.7954073451002494,0.6929133858267716,0.9678625448357694,1.0,3/11,10.78%,ZC3H12A;BCL2L1;DLC1
prerank,histone mRNA metabolic process (GO:0008334),0.3192187754836873,0.7953504466798108,0.7116991643454039,0.9674838561943325,1.0,2/27,5.43%,LSM10;SNRPB
prerank,receptor metabolic process (GO:0043112),0.29084018200508027,0.7952635355651515,0.7732342007434945,0.9671794491833033,1.0,13/53,15.66%,CAV1;CD81;ACKR3;RAMP1;CD9;LMTK2;GRK2;FCER1G;PHETA2;PLEKHJ1;PHETA1;NEDD4;ITGB2
prerank,negative regulation of blood coagulation (GO:0030195),0.3023355229486416,0.7950965912075179,0.7150395778364116,0.9670013645493034,1.0,3/38,6.28%,ADTRP;THBD;KLKB1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3011209705557478,0.7949492737164219,0.739240506329114,0.9667795338021342,1.0,7/42,12.80%,WNT1;EMP2;GCNT2;DMTN;RHOA;NPNT;PDPN
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2688883216282999,-0.7949016361061658,0.7654320987654321,0.9319958517613094,1.0,9/22,26.97%,CDK12;KAT7;BRD4;SUPT4H1;ALYREF;EAPP;THOC5;ERCC6;TCERG1
prerank,glycogen catabolic process (GO:0005980),0.3559573268409632,0.7948108604684052,0.7302839116719243,0.9665540591815481,1.0,4/15,15.51%,PHKA2;PGM2;PHKB;RB1CC1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2947491302788002,0.7946238634981455,0.7402269861286255,0.9663823228360124,1.0,12/48,16.86%,ADCY9;GUCY2F;IMPDH2;NUDT2;DCAKD;GMPS;ADCY6;AK5;ADCY10;AMPD2;PPCDC;ADSS2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.35343614075451785,0.7945667924353241,0.706060606060606,0.9660170192685783,1.0,3/16,9.56%,SHLD2;KLHL15;RIF1
prerank,regulation of exit from mitosis (GO:0007096),-0.22642246851389522,-0.7945082105387665,0.8502202643171806,0.9315927893714652,1.0,10/38,22.93%,ANAPC11;CDC14A;RGCC;UBE2S;ANAPC15;ANAPC7;SIRT2;ANLN;BUB3;MAD2L1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.31246958527048024,0.794238167265651,0.7300275482093664,0.966101969230661,1.0,2/30,2.09%,CDKN1A;NIBAN2
prerank,positive regulation of protein binding (GO:0032092),0.28846848616113013,0.7941299965835822,0.7641154328732748,0.9658060037131436,1.0,16/56,19.48%,MMP9;CAV1;PPP2CA;ADD1;BMP4;TRIM21;PKD1;TCF7L2;CAPRIN2;GSK3B;PPP2CB;ABL1;SPPL3;IDE;APP;FLOT1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.32103530973966043,-0.7939315491557168,0.7272727272727273,0.9315483928879966,1.0,6/12,23.03%,LRRK2;CLN3;VPS33A;CLN6;CCDC115;TMEM9
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.37329629871262227,0.7939074830406244,0.7024922118380063,0.9656912652563873,1.0,3/11,17.90%,MAVS;ITGB2;STX4
prerank,outflow tract septum morphogenesis (GO:0003148),0.3275715960466343,0.7930425076345351,0.7230538922155688,0.9666732997022512,1.0,6/24,12.15%,PARVA;SMAD6;BMP4;TGFB2;NRP2;TGFBR2
prerank,peptide biosynthetic process (GO:0043043),0.2594421096309229,0.7925475867814628,0.8317358892438764,0.9670269933017426,1.0,60/153,28.74%,MRPS16;EEF1A1;MRPL24;MRPL37;HARS1;RPS4X;MRPS7;ABCF1;RPL31;RPSA;GSPT2;RPL22;MRPS33;CARNS1;RPL28;SRBD1;RPS26;MRPL9;COPS5;HARS2;RPL10A;MRPS15;SARS1;EIF4G1;TNIP1;MRPS18C;RPL14;RRBP1;RPS27A;HBS1L;IGF2BP3;EIF4EBP2;RPL6;FARSB;RPS28;RHD;RPL41;RPLP2;YARS2;RPLP1;RPL7;IGHMBP2;MRPL32;RPL21;RPL26;MRPS21;RPS27;MRPS12;RPS12;RPL18;MRPL35;RPS17;RPS3;MRPL18;MRPS6;RSL24D1;RPL24;EEF1A2;GGTA1;RPS6
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3120090411425409,0.7924269625838954,0.7302904564315352,0.9667681534740923,1.0,13/32,26.26%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;MNAT1;POLR2K;POLR1B
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3255279417265544,0.7919238527451505,0.7308228730822873,0.96713778954634,1.0,5/28,7.60%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.35564991694179326,0.7915488951918362,0.7352941176470589,0.9672948807867947,1.0,6/15,23.96%,NGF;ZFYVE27;BCAR1;CASP3;SOS1;FRS2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.318139744847134,0.7915476352202934,0.7415730337078652,0.9668299589535496,1.0,6/26,21.93%,OCLN;PSRC1;NUMA1;MAPT;CDK5R1;TRPV4
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3589105113048924,0.791415218049963,0.7114197530864198,0.96658370362086,1.0,3/15,11.16%,IL17RA;TLR6;TLR4
prerank,phospholipid transport (GO:0015914),0.28820562167438346,0.7913847501682566,0.7406931964056482,0.9661646336752507,1.0,5/52,6.78%,LDLR;ATP10A;PITPNC1;PRELID3B;ATP8B2
prerank,protein export from nucleus (GO:0006611),0.31386590919547075,0.7911495974805781,0.7347826086956522,0.9660789683031673,1.0,4/27,8.66%,RANBP3L;DESI1;PKD1;CHP1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.27367742021882,0.7910706365953433,0.7868080094228505,0.9657443539095678,1.0,11/73,15.50%,CLU;MAVS;TNFRSF8;HSPB1;FZD5;LBP;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3603372176229841,0.7909980549937156,0.6989966555183946,0.9654071896677897,1.0,3/13,11.11%,HEXA;ARSB;HEXB
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3070332222508998,0.7908227488669823,0.7450462351387054,0.9652215388381544,1.0,2/33,1.44%,ARAP1;MMP9
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.330676387263042,0.7904388021274233,0.7267605633802817,0.9653808601714842,1.0,4/22,9.21%,CDKN1A;IPO7;LATS1;CDK5RAP1
prerank,import into nucleus (GO:0051170),0.27576212589919963,0.7904004902630829,0.7733175914994097,0.9649793509047809,1.0,28/73,27.62%,IPO7;SNRPB;TSC2;NUP93;TNPO2;MMP12;TNPO1;NXT2;GEMIN6;RANBP6;HEATR3;IPO4;CSE1L;PPP1R10;SNUPN;DDX20;HIKESHI;POM121;GEMIN5;TPR;IPO9;NUP62;GEMIN8;GEMIN2;NUP133;SNRPD2;SNRPD1;IPO8
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.27074357877630373,-0.7903002777512932,0.7572815533980582,0.9366189635340746,1.0,10/18,34.81%,CORO2B;DKC1;CCT7;CCT2;CCT4;WRAP53;CEP135;TREM2;CCT3;CEP295
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.37354856054032215,0.7902907443698068,0.7288401253918495,0.9646885891928787,1.0,6/12,19.56%,SMARCA4;NCOR1;SFRP1;FOXP1;NCOR2;ZBTB7A
prerank,histone H2B ubiquitination (GO:0033523),-0.3282461800900368,-0.7899381127424617,0.7451923076923077,0.9362143461311254,1.0,3/10,18.20%,WAC;DTX3L;PAF1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3057592755824124,0.7897702123221737,0.7421555252387448,0.9650838351227915,1.0,1/35,0.37%,CDH13
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.1954666151492844,-0.7895548448398527,0.8943089430894309,0.9357195050662379,1.0,14/91,13.00%,BMP6;SLC30A10;SCARA5;SLC39A12;FBXL5;SLC40A1;SLC39A8;TFRC;ATOX1;SLC39A10;CYB561A3;GLRX3;SLC30A1;FXN
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2604114924234425,-0.7894090687043833,0.7560975609756098,0.9348957907455833,1.0,3/24,6.45%,CDH2;BOC;CTNNA2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3579278556892737,0.789235269656984,0.6945736434108527,0.9655006572383148,1.0,5/14,27.20%,CD81;IKBKG;PRKD2;RELA;RPS3
prerank,regulation of defense response to virus (GO:0050688),0.361272899120609,0.7889210925275348,0.7123493975903614,0.9655392411483406,1.0,5/14,24.23%,PPM1B;DHX9;ILRUN;PCBP2;C1QBP
prerank,covalent chromatin modification (GO:0016569),-0.30121446008079195,-0.7886833632763366,0.7462235649546828,0.935010477499786,1.0,2/14,4.18%,MBD2;SETD5
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3714537566547898,0.7886110561299905,0.7185430463576159,0.9655849406414917,1.0,2/11,14.01%,EP300;PGP
prerank,regulation of histone modification (GO:0031056),0.35890882232572957,0.7885254608370055,0.7020602218700476,0.9652550268399597,1.0,7/13,23.27%,NNMT;FLCN;UBE2N;PARG;PARK7;AKAP8;CDK9
prerank,tRNA modification (GO:0006400),0.28252901458230983,0.7876692847348207,0.7796817625458996,0.9661902251162076,1.0,17/62,20.36%,MOCS3;LCMT2;THADA;ELP5;TRIT1;METTL6;THG1L;AARS1;ANKRD16;TYW1;THUMPD3;WDR6;DUS2;CTU1;TRMT112;CTU2;TYW5
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33446078585526173,0.7872424871422568,0.7214611872146118,0.9664283897438166,1.0,6/18,24.83%,UBTF;WDR43;EIF2AK3;FLNA;SIRT7;POLR2K
prerank,calcium ion import (GO:0070509),0.32134139348021157,0.7871843338336162,0.7441540577716643,0.966061423700729,1.0,7/28,13.02%,CACNA1A;MCU;MCUB;MICU1;AFG3L2;MCUR1;CACNB2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.24531075177673492,-0.7869134353197614,0.8231046931407943,0.9368381146618041,1.0,14/28,27.23%,NOTCH3;TSPAN15;ARRB1;GATA2;BEND6;EGFL7;LFNG;EGF;TCIM;HEY1;YTHDF2;DLL4;EGFR;HIF1AN
prerank,mesenchyme development (GO:0060485),0.3497482335089801,0.7868664710502297,0.7209302325581395,0.9660996285342367,1.0,2/15,6.81%,WNT11;BMP4
prerank,regulation of T cell proliferation (GO:0042129),0.2726846708763608,0.786722434445977,0.7704326923076923,0.9658567932625509,1.0,5/61,8.99%,CCL5;IL15;SDC4;LGALS3;FOXP3
prerank,nucleus organization (GO:0006997),0.28990671314307326,0.7866555420874741,0.7605985037406484,0.9655015573044796,1.0,14/47,17.82%,REEP3;NUP93;CHMP4A;CHMP4B;NDC1;TOR1A;VPS4B;CHMP1A;VPS4A;CHMP2A;REEP4;NUMA1;PDCD6IP;SUN2
prerank,response to amyloid-beta (GO:1904645),0.2955995195868036,0.7863945411133655,0.765685019206146,0.965449721642285,1.0,7/44,14.36%,MMP9;EPHA4;CACNA1A;TLR6;TLR4;MMP12;GSK3B
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3432745808917323,0.7863171839989591,0.728110599078341,0.9651121118180556,1.0,6/17,17.30%,NUPR1;HDAC4;TIGAR;NCOR1;FLCN;GIT1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2949168293728474,0.7860583314230063,0.7453333333333333,0.965050071136359,1.0,10/39,22.25%,MCU;GLUD1;BAD;TCF7L2;IRS2;AACS;NLGN2;GPER1;SOX4;ADCYAP1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3248815139949484,0.7859600482623882,0.7301587301587301,0.9647499724261879,1.0,5/23,15.85%,ALOX5;ELOVL6;FADS1;LTA4H;GSTM2
prerank,regulation of integrin activation (GO:0033623),0.3512692776955462,0.7857984890269217,0.7239747634069401,0.9645492491131363,1.0,1/15,2.26%,RAP1B
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22471427079798978,-0.7857560696338152,0.8645418326693227,0.9377090594114769,1.0,6/41,9.11%,JAG1;ENG;NOTCH1;TGFB1;HEYL;FGFR2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3453182006163725,0.7852738454089259,0.7176820208023774,0.9648889459635872,1.0,10/17,29.93%,FCHSD2;ARFIP2;WASF1;ARFIP1;BRK1;NCKAP1;WASF3;WASF2;ARF1;CYFIP1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.34678292574681097,0.7849908355561102,0.6948356807511737,0.964876864042748,1.0,4/14,12.52%,NLRP2B;PYDC1;CARD16;PTPN2
prerank,superoxide anion generation (GO:0042554),-0.3031346248333405,-0.7840537762907086,0.75,0.9394321851196467,1.0,3/13,21.29%,NOX4;NCF2;CYBB
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.37677445982606095,0.7837852578288707,0.6991304347826087,0.9663423799175679,1.0,3/10,16.83%,ATRX;RIF1;KDM1A
prerank,smoothened signaling pathway (GO:0007224),0.30646174741177973,0.7836193371001191,0.7558620689655172,0.9661592627385673,1.0,4/32,11.40%,SMO;GLI3;CC2D2A;PKD2L1
prerank,protein insertion into ER membrane (GO:0045048),0.2984818629304508,0.7834448015332893,0.7456953642384105,0.9659876713864827,1.0,13/37,24.97%,OTOF;EMC9;EMC10;GET4;EMC6;EMC2;CCDC47;APP;VAMP2;SGTA;MMGT1;VAPA;CYB5A
prerank,inositol phosphate biosynthetic process (GO:0032958),0.37239046705989043,0.7833766040909527,0.7116968698517299,0.9656384861238922,1.0,3/11,15.86%,IP6K1;PPIP5K2;IP6K2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.1789627129980656,-0.7833478694259467,0.9594594594594594,0.9395322509227344,1.0,34/128,23.68%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CCNH;CEP78;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;PPME1;BTRC;CSNK1D;SDCCAG8;BORA;CUL1;MASTL;CKAP5;CEP41;BRSK2;MAPRE1;OPTN;HAUS4;HAUS7;CEP72;YWHAE;SSNA1;BACH1
prerank,liver development (GO:0001889),0.30648037331178046,0.7829353577813806,0.7435897435897436,0.9658713215786611,1.0,7/32,18.97%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;PCK2;CDK5RAP3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2935058780247798,0.7828813736398469,0.7551020408163265,0.9655078817756829,1.0,18/40,26.26%,NSMCE4A;FBXO5;FEM1B;FXR1;MYC;POLH;UBE2N;ABL1;PARG;MAPT;UBE2V1;SIRT7;NSMCE1;KMT5A;CDK9;ARMT1;SMYD2;RPA2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3638126980043498,0.7825390129511869,0.7133550488599348,0.9655880747411156,1.0,3/13,10.02%,SOX9;BMP4;NFIB
prerank,negative regulation of JUN kinase activity (GO:0043508),0.38173050799311803,0.7823639480165304,0.7455429497568882,0.9654063088762236,1.0,1/10,4.06%,DUSP10
prerank,phagolysosome assembly (GO:0001845),0.36991707065806245,0.7819085773398314,0.7311320754716981,0.9656713556047865,1.0,2/12,8.70%,RAB7B;RAB7A
prerank,regulation of autophagosome assembly (GO:2000785),0.3052778914285125,0.7818288546444557,0.7510259917920656,0.9653572554957356,1.0,12/33,22.66%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8;MTMR3;PIP4K2C;RAB1B;FEZ1;PHF23;RAB3GAP2;UBQLN2
prerank,regulation of multicellular organismal development (GO:2000026),-0.25380783522705597,-0.7809835838621648,0.8020477815699659,0.9423616932494615,1.0,4/25,13.56%,INSR;SOX17;TRIP12;NIPBL
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2542473714802398,-0.7808078081657709,0.7841726618705036,0.9416092610490914,1.0,6/24,14.75%,JARID2;SUZ12;EZH2;TASOR;CREBZF;MTF2
prerank,mRNA transport (GO:0051028),0.2632573722991424,0.7805134243305184,0.7932960893854749,0.9669776874311576,1.0,31/101,25.55%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,RNA transport (GO:0050658),0.2733668545753885,0.7804979399344024,0.7827102803738317,0.9665379889588813,1.0,24/71,23.25%,SRSF2;EIF4A3;SIDT2;DDX39B;RBM8A;SRSF7;POLDIP3;TGFBR2;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;SRSF1;RAE1;SRSF5;FLOT1;THOC1;YBX1;POM121;U2AF1;TPR;SRRM1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.25831218022974556,-0.7800246547562766,0.8309352517985612,0.9418001781729168,1.0,10/24,33.80%,NOX4;MSRA;MTR;MTHFR;ADI1;CTH;SMS;AHCY;MMUT;GCLC
prerank,spliceosomal snRNP assembly (GO:0000387),0.2959483077456405,0.7799531547085974,0.7696404793608522,0.9669488698885094,1.0,14/38,27.57%,SNRPB;LSM4;GEMIN6;PRPF19;PRPF6;SNUPN;DDX20;PRPF8;GEMIN5;CLNS1A;GEMIN8;GEMIN2;SNRPD2;SNRPD1
prerank,cellular response to superoxide (GO:0071451),-0.32707100225364405,-0.7797657522100826,0.743142144638404,0.9411559309199926,1.0,3/10,18.90%,NOS3;SOD3;SOD1
prerank,extracellular matrix assembly (GO:0085029),0.3242637780858398,0.7796522204100841,0.7383040935672515,0.9669660064720799,1.0,3/23,9.95%,TNXB;PXDN;LAMB2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.24136877396362527,-0.7795718531706697,0.8418803418803419,0.9403972107215085,1.0,10/33,17.72%,UBR1;GLRA1;IPO5;CPEB1;SLC38A9;LAMTOR1;KLHL22;RRAGD;GLRA2;RRAGA
prerank,amide biosynthetic process (GO:0043604),0.29072750328273667,0.779465906310949,0.7849056603773585,0.966789363949504,1.0,4/47,6.98%,SPTSSB;SGMS2;AGK;AANAT
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.31983614530493554,0.7793948001197103,0.7517433751743375,0.9664464815882595,1.0,4/28,9.56%,KDM4D;SHLD2;PARP3;RIF1
prerank,long-term memory (GO:0007616),0.3337734125664054,0.778914468238756,0.7540983606557377,0.9667786333251046,1.0,1/19,1.18%,LDLR
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.28198624320320564,0.778850444650982,0.774074074074074,0.9664299747512296,1.0,4/51,3.27%,SRGAP2;PLXNB1;NBL1;NGF
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.34653249778246353,0.7788431833959059,0.7124600638977636,0.9659854163421849,1.0,2/15,5.11%,MAGI2;IGSF1
prerank,adipose tissue development (GO:0060612),0.3721273528997998,0.7782519616539374,0.7278688524590164,0.966477308719134,1.0,2/11,7.91%,RORC;DYRK1B
prerank,necroptotic process (GO:0070266),-0.2862118020990603,-0.7781496421950445,0.790273556231003,0.9416240494762794,1.0,6/16,22.22%,ITPK1;PGAM5;RIPK1;IPMK;MLKL;CYLD
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.35404489574470577,0.7779891182473504,0.7205651491365777,0.966449590297897,1.0,5/14,17.04%,DDRGK1;TMEM33;COPS5;BFAR;FICD
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2555436241346537,0.7779531183804759,0.8353067814854682,0.9660483073353764,1.0,27/128,17.76%,SMAD6;DDX5;HIVEP1;GDF15;TWSG1;FOS;BMP5;GCNT2;ARHGEF18;PXN;BMP4;TGFB2;TGFB1I1;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;RGMB;SMAD5;STUB1;CDH5;BMPR1A
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2989837271409609,0.7779061813229853,0.7610738255033557,0.9656544304636013,1.0,15/35,30.07%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;NAF1;CTNNB1;CCT8;CCT6A
prerank,positive regulation of protein deacetylation (GO:0090312),-0.30071903634997726,-0.7778470359870512,0.7596685082872928,0.9410607287425469,1.0,6/14,21.92%,SAP30BP;ING2;NIPBL;DYRK1A;APLNR;BRMS1
prerank,iron-sulfur cluster assembly (GO:0016226),0.3209475248017803,0.7778396500755845,0.7405857740585774,0.9653021354497693,1.0,7/24,20.23%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.35562712298870464,0.7768667659927605,0.7156398104265402,0.9662893607030578,1.0,2/13,6.25%,ZC3H12A;MOV10
prerank,glycine metabolic process (GO:0006544),0.3641598885112546,0.776516445594978,0.7207488299531981,0.9663806333530555,1.0,2/12,12.05%,SHMT1;AMT
prerank,cilium assembly (GO:0060271),0.24561568058500793,0.7762122032444567,0.9155645981688708,0.9663768884620436,1.0,50/296,18.73%,RAB17;RP1;CYS1;ABLIM1;PARVA;GSN;DYNLRB1;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;IFT46;EXOC7;CFAP54;EXOC4;CFAP206;PKD1;CC2D2A;CEP76;IFT80;EXOC2;PAFAH1B1;CSNK1E;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;TNPO1;ATP6V1D;HSP90AA1;ATP6V0D1;FLNA;KIF17;TMEM138;PTPDC1;DYNC1H1;RAB8B;HDAC6;RILPL1;FHDC1;ODF2;WDR35;SFI1;GALNT11
prerank,regulation of endopeptidase activity (GO:0052548),0.2781547986399666,0.775862454483607,0.7800480769230769,0.9664521417266928,1.0,6/59,8.78%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,cellular response to type I interferon (GO:0071357),-0.22276462026439334,-0.7750702577214935,0.8595744680851064,0.9432639547238312,1.0,16/41,29.10%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1;TYK2;IFI35;GBP2;BST2;IFIT3;IRF8;RSAD2;IFITM1;ISG15;IRF7
prerank,type I interferon signaling pathway (GO:0060337),-0.22276462026439334,-0.7750702577214935,0.8595744680851064,0.9432639547238312,1.0,16/41,29.10%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1;TYK2;IFI35;GBP2;BST2;IFIT3;IRF8;RSAD2;IFITM1;ISG15;IRF7
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.33620282074353625,0.7749743083188965,0.7324364723467862,0.9673510053008294,1.0,2/18,3.88%,JCAD;FOXC2
prerank,presynaptic endocytosis (GO:0140238),-0.25317222803361705,-0.7749379209552771,0.8280701754385965,0.9424377116213274,1.0,7/24,14.77%,SYNJ2;SYT1;NLGN1;STON2;NLGN3;AMPH;FCHO2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.33677924820338595,0.7748740132050077,0.7226277372262774,0.9670498075852627,1.0,3/18,7.44%,TSSK4;CD200;LPAR5
prerank,cell differentiation in hindbrain (GO:0021533),0.35902309443930297,0.7746391944452011,0.7346278317152104,0.9669505353927818,1.0,3/11,13.81%,AGTPBP1;OPHN1;CEND1
prerank,histone H4 deacetylation (GO:0070933),0.3857112197084551,0.7745660747393884,0.7227722772277227,0.9666073525542409,1.0,2/10,10.50%,HDAC4;HDAC3
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.2691518941180413,-0.77441473243739,0.7943037974683544,0.9422325612727174,1.0,7/20,20.62%,SULF1;FGF2;THBS1;SPRY4;SPRY1;FGFBP3;SMOC2
prerank,ubiquinone metabolic process (GO:0006743),0.34784460965659597,0.7726891865716872,0.7414330218068536,0.9691767079012018,1.0,2/15,8.23%,UBIAD1;PDSS2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2826796866316073,0.7725297984085325,0.7701863354037267,0.968956788169238,1.0,14/50,24.78%,CDKN1A;CCND2;ACTB;CCND1;PKMYT1;SERTAD1;CCNG1;CAMK2N1;CDKN2D;CDK5RAP3;CDK5R1;GTPBP4;CDC25A;MNAT1
prerank,endothelial tube morphogenesis (GO:0061154),0.36770154790348997,0.7720524410796912,0.7108843537414966,0.9692462929915401,1.0,4/10,23.75%,BMP4;RHOA;PRKD2;RHOB
prerank,negative regulation of T cell proliferation (GO:0042130),-0.2390612374968058,-0.7713870434708674,0.8299319727891157,0.9458510708291363,1.0,4/28,10.79%,GLMN;LGALS9;TNFRSF21;DLG5
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.32670045314427837,0.7713323073398458,0.7384843982169391,0.9698987510875995,1.0,6/21,20.76%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.1770726229531583,-0.7707962577727525,0.9571428571428572,0.9457173498211565,1.0,23/129,16.47%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CCNH;CEP78;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;PPME1;BTRC;CSNK1D;SDCCAG8;BORA;CUL1;MASTL
prerank,Golgi organization (GO:0007030),0.25282454235581064,0.7707862672350143,0.8296213808463252,0.970307631076564,1.0,26/112,19.44%,FBXW8;TJAP1;TMED1;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;PLK3;GCC2;CDC42;BCAS3;ZW10;YWHAZ;VTI1B;GOLGB1;ARFGEF1;NPLOC4;STX16;ATL2;USP6NL;PI4K2A;SEC23IP;FHDC1;TMED5;VTI1A;MYO18A
prerank,receptor recycling (GO:0001881),0.3793268920528115,0.7706033164896822,0.7564935064935064,0.9701257431756566,1.0,4/10,13.89%,LMTK2;PHETA2;PLEKHJ1;PHETA1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.27686490486708176,0.7704786050809784,0.8024242424242424,0.9698640421581758,1.0,9/66,11.16%,NLRP2;ZC3H12A;HSPB1;NLRP2B;FZD5;PYDC1;TLR6;CARD16;TLR4
prerank,negative regulation of ATPase activity (GO:0032780),-0.2821885496801221,-0.7704738381793292,0.7963525835866262,0.9451716906113643,1.0,3/16,10.36%,TSC1;OXA1L;TP53
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3013603981258642,-0.7703158023668049,0.7862796833773087,0.9443679180637766,1.0,5/13,24.79%,PTGIS;PTGS2;NAXE;NAXD;NAMPT
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3047095335905897,0.7702293585758119,0.7407932011331445,0.9698122113472009,1.0,6/28,21.49%,OCLN;PSRC1;GIT1;NUMA1;MAPT;CDK5R1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.37076696433845713,0.7700084079875611,0.7534246575342466,0.9697232622257396,1.0,1/10,2.68%,ABCD1
prerank,inorganic anion transport (GO:0015698),-0.2157252510481557,-0.7700028830206119,0.8915094339622641,0.9437971397011138,1.0,13/53,19.17%,SLC26A7;ENPP1;SLC4A10;ANO4;GLRA1;ENPP3;XPR1;TTYH1;CLIC5;SLC5A5;SLC26A6;CLCN1;FXYD1
prerank,ovarian follicle development (GO:0001541),0.35698317501338905,0.7695389099792022,0.729607250755287,0.9700165705550574,1.0,3/13,16.85%,EIF2B2;ANG;EIF2B4
prerank,lysine catabolic process (GO:0006554),0.3507903246473018,0.7690167642159755,0.7335526315789473,0.9699189912136396,1.0,5/12,22.71%,PIPOX;SLC25A21;OGDH;DLST;GCDH
prerank,lysine metabolic process (GO:0006553),0.3507903246473018,0.7690167642159755,0.7335526315789473,0.9699189912136396,1.0,5/12,22.71%,PIPOX;SLC25A21;OGDH;DLST;GCDH
prerank,regulation of innate immune response (GO:0045088),0.274121798228743,0.7689871239589513,0.7941888619854721,0.9695037010339985,1.0,12/57,18.01%,CCL5;RNASEL;MUL1;TRIM21;POLR3B;PTPN6;NMI;POLR3C;DHX9;POLR3G;XIAP;PTPN11
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.28379799901781305,0.7688586370699876,0.7793548387096774,0.969260293601864,1.0,9/44,18.80%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;BTG2;MEX3D;YTHDF3;ROCK2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.3182776112901198,-0.7687207153771697,0.7453271028037384,0.944717878504037,1.0,4/11,17.84%,LRRK2;CHMP3;USP7;MAP2K1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.30813953671515854,0.7684990962246424,0.7436974789915967,0.9693617973921214,1.0,4/29,6.54%,NOTCH2;NGF;EPO;SHC1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2895148376703087,0.7684520919686769,0.7723684210526316,0.9689894863586179,1.0,16/41,25.48%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;AAAS;RAE1;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.32790889780512855,0.7683701377451408,0.7330097087378641,0.9686679730787588,1.0,8/16,26.16%,ATP5PF;ATP5F1B;STOML2;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2627246831438286,0.7683689982273568,0.8171557562076749,0.9682199960151833,1.0,20/87,17.76%,SMAD6;GDF15;TWSG1;FOS;GCNT2;ARHGEF18;PXN;TGFB2;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;SMAD5;CDH5;BMPR1A
prerank,cellular iron ion homeostasis (GO:0006879),-0.2042583144066723,-0.7680879691377375,0.9202127659574468,0.9445883452122372,1.0,15/55,22.76%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1;SMAD4;CCDC115;ATP6V1G1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3652550348533444,0.7680850198532015,0.7251184834123223,0.9681742817164863,1.0,1/11,2.67%,TWSG1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.32393510018400623,-0.7679331444452921,0.7493734335839599,0.9437754227279144,1.0,5/10,20.17%,GALNT13;GALNT16;GALNT2;POGLUT3;MGAT5B
prerank,skeletal system morphogenesis (GO:0048705),0.28631462323014173,0.7676562062296417,0.7730220492866408,0.9683694205738025,1.0,2/42,2.42%,FGFR1;HOXA4
prerank,regulation of aerobic respiration (GO:1903715),0.347657443218776,0.767188523954384,0.7667731629392971,0.9686124254265499,1.0,2/15,9.90%,ABCD1;COX7A2L
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.30149747551695666,0.7671437904875806,0.7349228611500701,0.9682308790911064,1.0,4/30,9.25%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,B cell activation involved in immune response (GO:0002312),0.36061496288695594,0.7670877117448287,0.749211356466877,0.9678612261433442,1.0,5/13,30.45%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,mitochondrial fission (GO:0000266),0.33989155563122553,0.7669683358298897,0.7507692307692307,0.967598488253078,1.0,6/16,21.31%,MUL1;MTFR1L;OPA1;DNM1L;MTFR2;MIEF1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3305923048933495,0.7669603530735353,0.7376093294460642,0.9671593787604242,1.0,9/19,26.60%,CHMP4B;VPS4B;CHMP1A;CHMP2A;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,regulation of fibrinolysis (GO:0051917),0.35496147762344554,0.7668431681131689,0.7573770491803279,0.9668806166431924,1.0,2/13,6.28%,THBD;KLKB1
prerank,tRNA 5'-leader removal (GO:0001682),0.34830511298781996,0.7666567881632504,0.7515625,0.9667136045183493,1.0,3/13,12.36%,POP4;POP1;RPP21
prerank,regulation of smooth muscle contraction (GO:0006940),0.33302861409090645,0.7663913370172301,0.7418879056047197,0.9666623315684826,1.0,2/20,3.76%,CAV1;DAPK3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2760158041325306,0.7658865319412669,0.7930174563591023,0.9670308838922363,1.0,20/51,30.07%,NEK7;MAPK15;MAP3K4;PINX1;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;TERF2;TINF2;FBXO4;CCT5;EXOSC10;XRCC5;TERF1;NAF1;CTNNB1;CCT8;CCT6A
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.24247868841584205,-0.7658621837016643,0.8033898305084746,0.9457845271032436,1.0,17/30,33.84%,DNAJB4;DNAJC18;DNAJB12;SELENOF;ST13;DNAJB5;CCT2;ENTPD5;HSPA9;DNAJB1;GAK;HSPA1B;UGGT1;HSPA2;SDF2L1;HSPA5;CHCHD4
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3571912905351407,0.7656313064539081,0.7523219814241486,0.9669712303205099,1.0,3/13,17.90%,LAMP1;ITGB2;STX4
prerank,regulation of interleukin-6 production (GO:0032675),0.2581848077964789,0.7654544699636812,0.8115124153498872,0.9667998867104978,1.0,18/96,18.01%,CD200;IL17RA;ZC3H12A;MAVS;IL16;RAB7B;LBP;TLR6;PTPN6;TWIST1;TLR4;CD200R1;TLR3;SYT11;DHX9;F2R;MAPKAPK2;PTPN11
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2882474885369398,-0.7652383085818709,0.7636887608069164,0.945667522927909,1.0,5/15,26.19%,NEK6;ANAPC7;HECW2;CENPE;RIOK2
prerank,copper ion transport (GO:0006825),-0.3120634816570159,-0.7652365394365994,0.7960687960687961,0.9446418182722853,1.0,2/11,6.66%,STEAP3;ATOX1
prerank,myeloid dendritic cell activation (GO:0001773),-0.30102270194429237,-0.764261543553422,0.7541899441340782,0.9450238720970718,1.0,4/12,25.34%,CAMK4;HMGB1;DOCK2;PYCARD
prerank,RNA metabolic process (GO:0016070),0.2545266298856042,0.7642321880797971,0.8440567066521265,0.9681878149267926,1.0,30/127,20.33%,CELF2;GTF2F1;ZC3H12A;RBFOX2;POLR2H;POLR2A;RNASEL;SIDT2;DDX39B;XRN2;HNRNPH2;RNASE3;MTREX;TBRG4;HNRNPUL1;SYNCRIP;DHX9;PABPN1;DUSP11;CLP1;RNASE4;WTAP;POLR2C;HNRNPA3;RBMS2;POLR2E;PTBP1;PCBP2;DDX20;THOC1
prerank,negative regulation of signal transduction (GO:0009968),0.24389667673172755,0.7638798465675829,0.9040816326530612,0.9683013746763829,1.0,24/249,8.94%,PRKCB;KANK1;NXN;GPC1;CCL5;NIBAN2;GLI3;GDF15;TMEM25;RNF43;QARS1;KANK2;PALM;GLIS2;BMP5;WWP2;TSC2;GPC3;ERBB3;LGR4;NLRP2B;MAZ;CXXC4;YWHAB
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2897307184382906,0.7636475241817018,0.7906976744186046,0.9682031292551009,1.0,10/39,16.78%,TTC7A;PIK3C2B;IP6K1;PI4KA;SOCS2;PIP4K2C;EFR3A;SOCS6;IP6K2;PI4K2A
prerank,proteasomal protein catabolic process (GO:0010498),0.2432708138578337,0.7628777944547441,0.8917793964620188,0.9689518436690803,1.0,43/201,19.58%,PMAIP1;SPSB4;ATE1;NFE2L2;WWP2;RNF5;PSMD11;NSFL1C;PSMD4;PSMF1;FEM1C;RMND5B;RBX1;PML;UBE2B;PCNP;SIAH3;COP1;PSMD7;AGAP3;FEM1B;RNF126;ZSWIM8;PSMB5;PELI1;GSK3A;SOCS6;NEDD4;MDM2;BFAR;CCDC47;PRPF19;MAEA;DDB1;ARMC8;UBE2D3;SIAH1;STUB1;PSMD1;PSMC4;RNF41;PSMD8;PCBP2
prerank,iron ion homeostasis (GO:0055072),-0.20363213776022887,-0.7628032538305735,0.9166666666666666,0.9460420770423349,1.0,16/58,22.76%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;B2M;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1;SMAD4;CCDC115;ATP6V1G1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.23010541243711308,-0.7626992992655894,0.8587786259541985,0.9451481027466159,1.0,8/32,20.66%,TMED10;TSC1;GRM5;ROCK1;MTPN;ATXN2;NOLC1;NR1H4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2448708212465009,0.7625433749108723,0.8725182863113897,0.9690098381315982,1.0,31/186,14.36%,IGFBP6;NXN;GLI3;MLLT3;WNT11;CAV1;RNF43;PTPRU;AMER2;PSMD11;TSC2;SOX9;RBMS3;PSMD4;PSMF1;LATS1;DVL3;RBX1;TCF7L2;CXXC4;PSMD7;TLE2;HMGXB4;TLE4;PSMB5;GSK3A;LMBR1L;TLE5;SFRP1;TRABD2B;GSK3B
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.2442599078134368,-0.7625121647804645,0.8211678832116789,0.9443759279404002,1.0,5/26,10.32%,PDE8A;STAT5B;DAB2IP;PTPN12;GAREM1
prerank,JNK cascade (GO:0007254),0.2868153790756963,0.761537534274018,0.7953367875647669,0.9700812502064649,1.0,11/40,18.38%,MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;IKBKG;UBE2N;RPS27A;UBC;TAB2;ARHGEF6
prerank,cellular response to misfolded protein (GO:0071218),0.32557168752425003,0.7614894292794234,0.7393939393939394,0.9697220096257113,1.0,5/20,17.31%,RNF5;KLHL15;TOR1A;RNF126;STUB1
prerank,protein methylation (GO:0006479),0.2846333303326147,0.7607332080134677,0.7894039735099337,0.9704150390740713,1.0,15/40,27.19%,EEF2KMT;NTMT1;SNRPB;EEF1AKMT3;PRMT1;TRMT112;ETF1;PRMT2;ATPSCKMT;FAM98B;N6AMT1;FAM98A;CAMKMT;EHMT1;EEF1AKMT2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.37227872537008133,0.7600766299308972,0.7342657342657343,0.9709988958069274,1.0,2/10,11.16%,FOXP3;TLR4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.30219874522096807,0.7598066314105214,0.7634854771784232,0.9709683860132636,1.0,8/29,20.56%,MAVS;RNASEL;MUL1;PTPN6;PTPN2;PTPN11;YTHDF3;ZBP1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2816109618553065,0.7597287042394718,0.7795969773299748,0.970636850200602,1.0,6/45,11.16%,NLRP2;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3024953075469323,0.759329745345158,0.7932011331444759,0.970787175845131,1.0,5/27,11.89%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3261689055823924,0.7591193713226558,0.7633928571428571,0.9706562416480967,1.0,5/21,13.65%,MED30;JUN;TWIST1;MED12;MED24
prerank,tRNA wobble uridine modification (GO:0002098),0.34430090938589253,0.7587207224793492,0.7464566929133858,0.9708077909088899,1.0,5/14,23.36%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,negative regulation of DNA binding (GO:0043392),0.3045206438578726,0.758555016760949,0.7613793103448275,0.9706011572620389,1.0,8/28,19.06%,SMO;NFKBIA;JUN;SUMO3;HABP4;E2F1;KDM1A;ILRUN
prerank,t-circle formation (GO:0090656),-0.3153603649009402,-0.757824984334656,0.7876543209876543,0.947922542989353,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3153603649009402,-0.757824984334656,0.7876543209876543,0.947922542989353,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3153603649009402,-0.757824984334656,0.7876543209876543,0.947922542989353,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.31163092810254783,-0.7574048625610488,0.7789473684210526,0.9474977936253636,1.0,3/11,12.22%,FOXO1;NOTCH1;GLRX3
prerank,mRNA catabolic process (GO:0006402),-0.21484379982837104,-0.7573618545932311,0.9140271493212669,0.946556625364241,1.0,19/44,29.97%,TUT4;METTL16;RNH1;AGO1;LSM6;RC3H1;ZFP36;UPF1;LSM2;CNOT10;AGO4;YTHDF2;NUDT16;MRTO4;DCP2;ERN1;EXOSC9;HSPA1B;PNPT1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3166799959372025,0.7573271059199221,0.7666174298375185,0.9719800638342028,1.0,6/22,18.69%,PDGFC;MRE11;RAP2C;NBN;RAD50;GPNMB
prerank,negative regulation of bone mineralization (GO:0030502),0.3489903835630175,0.7569779578466309,0.7488,0.9720591626450796,1.0,3/13,11.35%,PTK2B;SRGN;TRPM4
prerank,protein localization to nucleus (GO:0034504),0.2516027666932454,0.7565131496166685,0.83675799086758,0.9722832159355344,1.0,32/102,24.25%,IPO7;TSC2;NUP93;BMP4;SIX1;TNPO2;PML;BANP;TOR1A;MMP12;PINX1;TOR1AIP1;TNPO1;NXT2;RANBP6;HEATR3;LMNA;MDM2;IPO4;CSE1L;INTS13;PPP1R10;ARL2BP;TAF8;ZBTB7A;HIKESHI;ABCA7;POM121;TPR;TOR1AIP2;IPO9;SIX4
prerank,positive regulation of double-strand break repair (GO:2000781),0.2917773138174025,0.7559710508285803,0.7772020725388601,0.9726328785851533,1.0,5/39,9.56%,KDM4D;SHLD2;FOXM1;PARP3;RIF1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.31803983754828125,0.7559574039444795,0.7492625368731564,0.972211274681364,1.0,4/21,14.10%,SMO;PDCL;EVC;SFRP1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.327599160665201,0.755653219461481,0.7631975867269984,0.9722309163319369,1.0,7/18,21.70%,CHRM1;GRK2;GNAQ;GNA11;GNA15;CDK5R1;CHRM5
prerank,placenta development (GO:0001890),-0.30050005617548525,-0.7556440505287736,0.7642276422764228,0.9479544535516231,1.0,2/12,9.23%,PTK2;PPARG
prerank,cellular potassium ion homeostasis (GO:0030007),-0.2992104093833051,-0.755443848673757,0.8054054054054054,0.9471981697674262,1.0,3/13,6.35%,ATP1B1;SLC12A2;KCNJ2
prerank,glycogen metabolic process (GO:0005977),-0.24246641169999794,-0.7553248134158149,0.8689655172413793,0.9463235880303594,1.0,3/27,7.79%,PRKAG2;PHKA1;GAA
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2828324705109952,-0.7552643106735529,0.7748538011695907,0.9453909861029807,1.0,6/15,26.37%,SRPRB;SPCS2;RYR2;SRPRA;RAB3GAP1;EDEM1
prerank,cellular response to inorganic substance (GO:0071241),-0.2524680106888087,-0.7552200893549081,0.8096590909090909,0.9444353623428544,1.0,6/21,19.48%,GUCY1B1;FOXO1;MTR;BLM;SPIDR;FMR1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2782033945707456,0.7546724028635997,0.7957658779576587,0.9732411087744602,1.0,16/49,24.31%,EP300;MOV10;EIF6;RAB7B;KMT2A;MEF2C;MTURN;PRMT1;PITHD1;PRKCQ;H3-3A;KMT2B;RBM15;KMT2C;KMT2E;ZFPM1
prerank,zinc ion transport (GO:0006829),0.31522738469958694,0.7544122066839046,0.7593423019431988,0.9731751730817529,1.0,5/21,14.89%,SLC39A3;SLC39A6;TRPM2;SLC39A13;SLC30A6
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.34414304089738096,0.7542473687080823,0.7650695517774343,0.9729810418213479,1.0,5/13,22.39%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,negative regulation of lipid storage (GO:0010888),0.3167073645797116,0.7539353947199156,0.780380673499268,0.9730130243783589,1.0,3/19,5.36%,TTC39B;ABHD5;NFKBIA
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.24893145147624365,0.7535737341417338,0.8821052631578947,0.9730967784346963,1.0,36/145,24.61%,FBXL7;FHL1;CDK4;PSMD11;AVEN;PSMD4;PSMF1;RBX1;CEP76;FBXO5;CCND1;PSMD7;PAFAH1B1;CSNK1E;VPS4B;PSMB5;CDK2;PINX1;HSP90AA1;CDC25B;DYNC1H1;PSMD1;PSMC4;ODF2;SFI1;PSMD8;CENPF;RCC2;HAUS1;CEP192;PSMA7;PLK4;CDC25A;PRKACA;TUBG1;PCM1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2663064990775412,0.7535083850370405,0.7980295566502463,0.9727408050604818,1.0,14/60,19.56%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PCNA;TNKS2;ATR;PRKCQ;PRKD2;PNKP
prerank,renal absorption (GO:0070293),0.3698344112473779,0.7534107557488631,0.7589134125636672,0.9724468977068408,1.0,1/10,2.11%,GSN
prerank,endodermal cell fate commitment (GO:0001711),-0.3177892075348999,-0.7525985732646775,0.8057553956834532,0.947073341372423,1.0,2/10,18.20%,SOX17;PAF1
prerank,positive regulation of protein transport (GO:0051222),0.26152460345280387,0.7523712927607382,0.8186157517899761,0.9734932421309346,1.0,12/67,10.46%,SYTL4;GOLPH3;TGFB2;PLK3;ANG;ACSL3;CHP1;ARHGEF5;EZR;APBB1;IER3IP1;BCAS3
prerank,nucleotide-excision repair (GO:0006289),0.25244884876691637,0.7522796002424395,0.8568232662192393,0.9731747672620309,1.0,25/101,19.89%,EP300;POLR2H;POLR2A;RBX1;POLK;HUS1B;COPS5;ERCC5;HMGN1;RPA3;POLD2;ISY1;PCNA;FAN1;PRPF19;LIG3;DDB1;RPS27A;UBC;ERCC2;POLR2C;RFC1;POLR2E;PNKP;ERCC4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.317775376730227,0.7518905083430582,0.7747875354107648,0.9733171929379246,1.0,4/23,10.41%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,neural crest cell differentiation (GO:0014033),-0.268995793171449,-0.7514729657067296,0.8037383177570093,0.9476149243922516,1.0,8/18,25.44%,CDH2;LRP6;PDCD6;SOX11;NOLC1;KBTBD8;HTR2B;KLHL12
prerank,establishment of protein localization to organelle (GO:0072594),0.25909418371250853,0.7514182799913962,0.8144690781796966,0.973534258492421,1.0,15/72,18.16%,LAMP5;LAMP1;IPO7;TSC2;NUP93;TNPO2;HK1;MMP12;TNPO1;NXT2;RANBP6;HEATR3;IPO4;CSE1L;PPP1R10
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3387285218394421,0.7512633592797588,0.7551342812006319,0.9733090535899328,1.0,1/16,1.13%,PPARGC1A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.24485493778681802,0.7511467141052321,0.8768736616702355,0.9730392328235112,1.0,21/151,12.86%,SPTSSB;ST3GAL4;SGMS2;PPM1L;ELOVL1;LARGE1;MOCS3;LCMT2;MGST3;GSTO1;GOLPH3;ELOVL6;HPGDS;HACD4;NFS1;TYW1;CDO1;CERS2;LPCAT2;CHPT1;LPCAT3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.338154046877446,0.7508677700748104,0.75625,0.9730185497258275,1.0,3/15,10.00%,AK1;CMPK1;AK5
prerank,histone H2A ubiquitination (GO:0033522),-0.27401821806039317,-0.750689521999134,0.7940298507462686,0.9476803909058189,1.0,8/17,30.25%,CUL4B;BCOR;DTX3L;KDM2B;RYBP;RNF2;DDB2;SKP1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.3599242072821116,0.7506647085957945,0.7440381558028617,0.9728766623205386,1.0,3/11,14.47%,NT5C3A;SLC19A2;CTPS2
prerank,positive regulation of viral life cycle (GO:1903902),0.3154464670026897,0.7505587927064243,0.7824207492795389,0.9725784706476676,1.0,7/22,18.00%,VPS37B;TRIM11;LGALS1;VPS4A;CHMP2A;DDB1;TSG101
prerank,ribosome biogenesis (GO:0042254),0.24116095666147777,0.7505142518697235,0.8886576482830385,0.9721924268480088,1.0,35/187,15.89%,GLUL;PES1;UTP11;PIH1D1;EIF6;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;SDAD1;RRP12;MPHOSPH6;BMS1;NIP7;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;HEATR3;UTP4;PAK1IP1;IMP4;RPL14
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2637086690871361,-0.750502082558833,0.7982456140350878,0.946921383746356,1.0,3/18,7.77%,WNT5A;THBS1;IL33
prerank,positive regulation of cell aging (GO:0090343),0.3556411492802905,0.7504853324287806,0.7614678899082569,0.9718008616263207,1.0,3/11,14.97%,YPEL3;EEF1E1;LMNA
prerank,ncRNA catabolic process (GO:0034661),-0.23771062651267238,-0.7503050681338762,0.84,0.9461661590786404,1.0,5/28,13.21%,TUT4;DIS3L;EXOSC7;PARN;EXOSC2
prerank,tRNA methylation (GO:0030488),-0.2361124579041477,-0.7497914138088304,0.8604651162790697,0.945814644268371,1.0,15/34,25.50%,TARBP1;METTL1;TRMT61B;TRMT10A;THUMPD2;TRMT5;TRMO;TRMT1L;GTPBP3;TRMT44;TRMT10C;ALKBH8;TYW3;BCDIN3D;PRORP
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.330648488464116,0.7492911407564585,0.7668711656441718,0.9731678064466727,1.0,5/17,14.46%,SRD5A3;ALG1;ALG12;DOLK;NUS1
prerank,miRNA metabolic process (GO:0010586),0.3174985154834874,0.7490398197671331,0.7756315007429421,0.9730830369319217,1.0,3/20,12.99%,DGCR8;TARBP2;TUT7
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.31427006741507724,0.7487497746687396,0.7705882352941177,0.9730303719951701,1.0,4/20,14.01%,EP300;NCOR1;GSK3A;PGP
prerank,positive regulation of cell development (GO:0010720),0.2894369978240841,0.7486975803196712,0.7874015748031497,0.972667543091856,1.0,4/31,7.49%,NIBAN2;LMOD3;BMP4;BAD
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.33781272534108947,0.7481242660306828,0.7732919254658385,0.97306805243089,1.0,5/14,18.32%,NFKBIA;PKD1;CCDC22;KEAP1;SUFU
prerank,regulation of osteoblast proliferation (GO:0033688),0.32407398316510894,0.7474531063410114,0.7522935779816514,0.9736236146154021,1.0,4/17,18.50%,PLXNB1;RHOA;SFRP1;TMEM119
prerank,rRNA catabolic process (GO:0016075),-0.27889756584338704,-0.7473385371458998,0.8369905956112853,0.9480466812726196,1.0,3/16,13.21%,DIS3L;EXOSC7;EXOSC2
prerank,peptidyl-serine modification (GO:0018209),0.24140074409503295,0.7472462787543733,0.8891213389121339,0.973484347165748,1.0,35/166,19.24%,PRKCB;IKBKE;MKNK2;GALNT1;SGK3;NTMT1;STK39;LATS1;DYRK1B;PKD1;MAPK9;LMTK2;SRPK2;GRK2;CSNK1E;TGFBR2;EIF2AK3;MAP3K13;CDK2;NAA10;CHUK;ULK1;GSK3B;WNK1;PLK2;TTK;ATR;PRKCZ;MAPKAPK2;PRKCQ;PARP2;STK38L;ROCK2;CAB39;PRKD2
prerank,peptidyl-lysine modification (GO:0018205),0.25136144294688123,0.7470899328761273,0.847651775486827,0.9732794951940635,1.0,31/99,25.48%,EP300;HDAC4;NUP93;EYA1;NDC1;SUMO2;SUMO3;NDUFAB1;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;VIPAS39;EEF1AKMT3;SENP3;P3H3;HDAC6;AAAS;PARK7;RAE1;SIRT4;ATPSCKMT;POM121;SIRT7;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,negative regulation of cell division (GO:0051782),0.35243367588336016,0.7464371941971378,0.7632,0.9738045161897433,1.0,3/11,13.87%,ZFYVE19;MYC;VPS4A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24215556997134705,0.7460993444181933,0.8690601900739177,0.9738497187703241,1.0,32/153,19.24%,PRKCB;IKBKE;MKNK2;SGK3;STK39;LATS1;DYRK1B;PKD1;MAPK9;LMTK2;MAP2K2;SRPK2;GRK2;CSNK1E;TGFBR2;EIF2AK3;MAP3K13;CDK2;CHUK;ULK1;GSK3B;WNK1;PLK2;TTK;ATR;PRKCZ;MAPKAPK2;PRKCQ;STK38L;ROCK2;CAB39;PRKD2
prerank,cellular response to pH (GO:0071467),0.32546759278885873,0.7457263558363166,0.7688821752265861,0.9739564568137088,1.0,6/17,19.44%,CHP1;RAB11FIP5;PKD2L1;HVCN1;SLC9A1;GPLD1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2921833404754313,0.7455769358173583,0.7892561983471075,0.9733070065480146,1.0,3/31,6.01%,GTF2F1;POLR2H;POLR2A
prerank,7-methylguanosine RNA capping (GO:0009452),0.2921833404754313,0.7455769358173583,0.7892561983471075,0.9733070065480146,1.0,3/31,6.01%,GTF2F1;POLR2H;POLR2A
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.21816545358935352,-0.7446560088618028,0.8693877551020408,0.9505166638206743,1.0,14/36,27.47%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;RNF2;RAD51;TFDP2;BRCA1;CHEK1;PHC1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.30672360424806955,0.7444948544668339,0.7624633431085044,0.9744260097591194,1.0,6/22,17.81%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3210740265733288,0.7439376060806312,0.7801857585139319,0.9747795017664471,1.0,4/18,10.63%,ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,positive regulation of cellular component movement (GO:0051272),-0.24183660487999886,-0.7435950082888715,0.8233082706766918,0.9509395870793692,1.0,3/24,9.37%,LYN;SPOCK2;CFAP20
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3299636025717768,0.7435713562309766,0.7707692307692308,0.9748622603677236,1.0,3/16,12.62%,RORC;PDK2;FOXK1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.29664527693989706,0.7434593092056618,0.7971428571428572,0.9745818647383447,1.0,3/25,7.61%,CCL5;ILK;ANG
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.33338645825384794,0.7427093213937342,0.7740303541315345,0.9752502318760717,1.0,2/13,10.40%,CD81;BCAP31
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2552465987363615,-0.7423784804463177,0.8411764705882353,0.9505226202256918,1.0,6/20,17.93%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2552465987363615,-0.7423784804463177,0.8411764705882353,0.9505226202256918,1.0,6/20,17.93%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,membrane lipid catabolic process (GO:0046466),-0.3151899152554146,-0.7419425170969273,0.7727272727272727,0.9500924693766403,1.0,2/10,4.73%,CYP1B1;ENPP2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.26913256434330635,0.7415575208141515,0.8121890547263682,0.9763824096592126,1.0,2/54,0.54%,FGFR1;ANGPT1
prerank,cellular response to interferon-beta (GO:0035458),-0.27140800221461114,-0.7415125394069666,0.813953488372093,0.9496621550183164,1.0,5/14,29.97%,AIM2;IRGM;HTRA2;TRIM6;PNPT1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2942100400543436,-0.7414725189653417,0.8190954773869347,0.948710789607057,1.0,5/13,20.65%,SRSF10;CD2BP2;SRSF12;USP4;LSM2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.28444337672450454,0.7413484032106443,0.8190224570673712,0.9762409246676852,1.0,7/37,10.71%,MMP9;CDKN1A;MEF2D;JUN;ADAMTS1;HTR1B;SOD2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2592483956341888,0.7412037845724245,0.845873786407767,0.9760024726532218,1.0,16/71,18.34%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3475305241187827,0.7409980703924923,0.7507936507936508,0.9758371350012788,1.0,3/12,14.55%,ZC3H12A;NCOR1;NCOR2
prerank,chloride transport (GO:0006821),0.25950092943977504,0.7406323367524488,0.8388625592417062,0.975932568680716,1.0,8/74,12.24%,CFTR;SLC12A8;ANO8;ANO7;CLIC1;CLCN4;SLC12A4;ANO6
prerank,monoacylglycerol metabolic process (GO:0046462),0.3396713607021963,0.7403927269777895,0.7845659163987139,0.9758384580224031,1.0,2/13,4.20%,DGAT1;MOGAT3
prerank,cellular amide metabolic process (GO:0043603),0.24787835008634082,0.7401168056277788,0.8577878103837472,0.9757949017290412,1.0,25/102,22.89%,NAPEPLD;ACOT8;PPP2CA;ORMDL3;CPE;NNMT;ACSM3;SHMT1;NIT1;ABCA2;ALDH1L2;PCCA;SMPD2;ALDH1L1;VNN1;ABCB9;GNE;SLC19A1;MCCC2;THOP1;ABHD4;AASDHPPT;SGPL1;ST6GAL1;MLYCD
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.24678864945250953,0.7396093250531726,0.8814655172413793,0.9760603175196639,1.0,26/112,17.76%,WNT10A;SMAD6;GDF15;TWSG1;FOS;GCNT2;OVOL2;ARHGEF18;SOX9;PXN;MAPK7;TGFB2;JUN;RHOA;TGFBR2;MEF2C;SFRP1;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;SMAD5;CDH5;BMPR1A
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.30053433470004876,0.7395169832625704,0.820476858345021,0.9757690405725883,1.0,6/26,17.29%,ITPR2;ITPR3;LETM1;TRPM2;SLC8B1;F2R
prerank,positive regulation of cell growth (GO:0030307),0.24835007779301194,0.7386698882330462,0.8539325842696629,0.976592218794745,1.0,22/96,21.89%,ISLR2;ADAM10;HPN;NGF;ZFYVE27;TGFB2;CDC42;EIF4G2;CDKN2AIP;MAP3K13;SFRP1;EIF4G1;SHTN1;H3-3A;TAF9B;ADAM17;MAPT;DBN1;MMP14;SYT3;UNC13A;SYT2
prerank,pyroptosis (GO:0070269),-0.26876245388166076,-0.737806094135993,0.7897727272727273,0.9524519732997019,1.0,3/15,11.65%,AIM2;GSDMD;CASP4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3475058031758652,0.7374982654722627,0.7651888341543513,0.9778016429466516,1.0,2/12,8.49%,CHMP4A;CHMP4B
prerank,histone lysine methylation (GO:0034968),0.2872700970332768,0.7374629120319198,0.7937584803256446,0.9774070355927658,1.0,13/33,25.45%,DOT1L;SMYD3;KMT2A;KDM6A;SETDB1;TRMT112;DYDC2;SMYD1;MEN1;KMT2B;CXXC1;N6AMT1;SMYD2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.29028235240221806,0.7372365571122185,0.819971870604782,0.9772951875219261,1.0,5/31,12.15%,HOXA4;EIF4A3;SIX1;TWIST1;TGFBR2
prerank,ubiquinone biosynthetic process (GO:0006744),0.33523277883374913,0.7372240505868606,0.7878787878787878,0.9768748915187617,1.0,2/15,8.23%,UBIAD1;PDSS2
prerank,peptidyl-arginine modification (GO:0018195),-0.26984575323495624,-0.7371223302930501,0.8095238095238095,0.9523798941500627,1.0,3/15,20.05%,ART3;PADI2;KRTCAP2
prerank,histone methylation (GO:0016571),0.3046327619966011,0.7369941795095383,0.8070422535211268,0.9767736176124069,1.0,10/26,26.59%,NTMT1;SMYD3;PRMT1;TRMT112;PRMT2;SMYD1;SIRT7;N6AMT1;SMYD2;EHMT1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.26053129876379194,0.7367576711950686,0.8530465949820788,0.9766599788969649,1.0,14/68,20.35%,IL17RA;MAVS;IL16;RAB7B;LBP;TLR6;TWIST1;TLR4;TLR3;DHX9;F2R;PTPN11;APP;AGER
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.24745195762674793,-0.7359830750108017,0.8484848484848485,0.9528453727242808,1.0,6/22,20.64%,MAN1C1;SEL1L;SYVN1;UGGT2;EDEM2;TRIM13
prerank,negative regulation of RNA metabolic process (GO:0051253),0.31871359135841815,0.7358971575773356,0.7648854961832061,0.9774463891452221,1.0,7/18,23.23%,ZC3H12A;NCOR1;RPS26;NCOR2;PTBP1;NRDE2;SHQ1
prerank,negative regulation of cellular senescence (GO:2000773),0.34622569146250726,0.735508444190629,0.7738998482549317,0.9775521042654254,1.0,7/13,21.57%,CDK6;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,gas transport (GO:0015669),-0.30904466772140915,-0.735409124983423,0.7901234567901234,0.9525264902511141,1.0,3/10,15.21%,IPCEF1;CYGB;CA2
prerank,synaptic vesicle cycle (GO:0099504),-0.22829772994555864,-0.734811422705159,0.8872727272727273,0.9522423947233084,1.0,9/30,21.19%,BRSK1;NLGN1;SNAPIN;SLC17A6;SNAP25;SYNDIG1;CPLX2;SYT10;RIMS1
prerank,positive regulation of cell communication (GO:0010647),-0.2280285073712677,-0.7346616627197469,0.8659420289855072,0.9514231811595011,1.0,10/28,22.99%,GRIK2;LGI1;SYT1;CLSTN2;EDN1;SOX11;EDN3;KCTD13;RIMS1;RIMS3
prerank,endochondral bone morphogenesis (GO:0060350),-0.29915484470191217,-0.7338174454729914,0.8044554455445545,0.9514866123380561,1.0,5/11,23.58%,COL13A1;BMPR1B;BMPR2;INPPL1;FGFR3
prerank,integrated stress response signaling (GO:0140467),0.32704048257225754,0.7334224167895078,0.773015873015873,0.9800348566335356,1.0,3/14,17.04%,NFE2L2;EIF2AK3;EIF2AK4
prerank,fatty acid metabolic process (GO:0006631),0.24355993642486262,0.7318428401430965,0.8902305159165752,0.9818102521909748,1.0,16/115,13.29%,PPARGC1A;ACOT8;ALOX5;SLC27A3;CPT1B;ACSL3;MSMO1;ACSM3;NDUFAB1;ACSF3;PON3;ACACA;GPAM;FASN;CPT2;ACADM
prerank,iron ion transport (GO:0006826),0.2693869156026496,0.7314760394059155,0.8200514138817481,0.9818748193026623,1.0,13/47,21.12%,ATP6V1B1;LMTK2;HEPH;CP;ATP6V1E1;ATP6V1D;ATP6V0D1;SLC11A2;ATP6V1B2;ATP6V0B;ATP6AP1;REP15;MELTF
prerank,regulation of ion transport (GO:0043269),0.25120376883703416,0.7314118605393496,0.8694638694638694,0.9815240761808989,1.0,12/76,15.28%,CHRM1;GDNF;WWP2;KCNJ13;ANK3;TOR1A;KCNA5;SYT6;WNK1;NEDD4;SYT11;SYT12
prerank,negative regulation of transposition (GO:0010529),0.3266485653319104,0.7313453882263428,0.7847533632286996,0.9811825149047015,1.0,5/16,24.45%,MOV10;TUT7;MYBL1;SIRT7;TEX15
prerank,positive regulation of TOR signaling (GO:0032008),0.2803826386691213,0.7312932912968347,0.8271767810026385,0.9808190956676316,1.0,6/40,10.50%,PIH1D1;RHEB;SIK3;GOLPH3;SMCR8;HDAC3
prerank,regulation of macrophage activation (GO:0043030),0.28927930023301535,0.7307972797814977,0.8076398362892224,0.9810208927062335,1.0,5/30,11.16%,CD200;ZC3H12A;LBP;TLR6;TLR4
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22298074696707815,-0.7306874325796707,0.8788927335640139,0.9544216174112093,1.0,12/31,23.80%,USP8;STAMBPL1;OTUD7A;BABAM2;BRCC3;USP7;TNFAIP3;BABAM1;OTUD5;ATXN3;CYLD;YOD1
prerank,regulation of TOR signaling (GO:0032006),0.25996519375851485,0.7301441030868911,0.841596130592503,0.9814935375302725,1.0,9/67,10.50%,PRKAA2;PIH1D1;SH3BP4;TSC2;ROS1;RHEB;GOLPH3;SMCR8;HDAC3
prerank,ceramide transport (GO:0035627),-0.2915976752491549,-0.7292967407573665,0.8090452261306532,0.955074205871774,1.0,3/12,13.62%,PLTP;PLEKHA8;SGPP1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.24934705656592085,0.7289926577621944,0.8736842105263158,0.9826638336403195,1.0,13/80,14.35%,KIF2A;ERGIC1;COPA;KIF1C;GOLPH3;ERGIC2;ZW10;ATP9A;KLC1;ERGIC3;NAPA;ARF4;RAB1B
prerank,microvillus organization (GO:0032528),0.33830092670681655,0.7287064692008351,0.7983739837398374,0.9826180893260935,1.0,3/13,9.59%,RAP1B;RAP1A;EZR
prerank,autophagy of nucleus (GO:0044804),0.32938808088569066,0.7282249552798946,0.7745098039215687,0.9828426093136632,1.0,9/16,31.51%,ULK1;RB1CC1;ATG3;WIPI2;ATG2B;ATG12;WDR45;WIPI1;ATG13
prerank,autophagy of peroxisome (GO:0030242),0.34287279434130347,0.7281756901915133,0.7633587786259542,0.982483400088241,1.0,4/12,27.42%,MAP1LC3B;RB1CC1;PIK3R4;TRAPPC8
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3167919306815308,0.7280778246845844,0.8,0.9821815115662533,1.0,4/20,15.15%,CHRM1;GRK2;GNAQ;GNA11
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.29254485218543097,-0.7279305551613249,0.8089005235602095,0.9557137640574275,1.0,2/12,6.48%,HPRT1;PRPSAP2
prerank,neuromuscular process (GO:0050905),0.32948308682080585,0.7274897650842473,0.7897897897897898,0.9825640459491719,1.0,3/16,10.56%,STRA6;AGTPBP1;PAFAH1B1
prerank,natural killer cell activation (GO:0030101),0.3008548850411829,0.7267410301029366,0.7935578330893118,0.9831603578900355,1.0,1/23,1.28%,PBX1
prerank,superoxide metabolic process (GO:0006801),-0.2263498423378663,-0.7266743674261178,0.8819188191881919,0.9562206115764419,1.0,8/29,21.29%,SH3PXD2B;NOS3;NOX4;NRROS;NCF2;SOD3;SOD1;CYBB
prerank,muscle cell migration (GO:0014812),0.35008362663220427,0.7266124200756637,0.7893890675241158,0.9828815175960574,1.0,4/10,14.85%,SIX1;DDR1;AAMP;ITGB1BP1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.27002225697081234,-0.7265385881784011,0.8582887700534759,0.9553917913909771,1.0,5/15,17.82%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,programmed necrotic cell death (GO:0097300),-0.2570570846525466,-0.7263536777102212,0.879154078549849,0.9546281342561016,1.0,6/18,22.22%,ITPK1;PGAM5;RIPK1;IPMK;MLKL;CYLD
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.24136759680311481,0.7260659856332307,0.8780760626398211,0.9832067731134568,1.0,9/107,8.72%,ANK2;STIM2;CCL5;CAV1;CSRP3;ATP13A3;TMEM165;ATP13A4;SLC39A6
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.25292942646252636,0.7259496792825891,0.8633615477629988,0.9829277186530879,1.0,16/73,18.34%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,regulation of interleukin-8 production (GO:0032677),0.2546321152194052,0.7257120191505678,0.8633686690223793,0.9828062401166896,1.0,7/69,11.16%,KLF4;MAVS;ANXA4;OTUD7B;LBP;TLR6;TLR4
prerank,neuron projection fasciculation (GO:0106030),0.3532083749733495,0.7255527842800255,0.805,0.9825725414917873,1.0,1/10,1.67%,EPHA4
prerank,T-helper cell differentiation (GO:0042093),0.3257321747134925,0.7255366556317671,0.8103727714748784,0.9821598453880996,1.0,1/14,1.95%,RORC
prerank,rRNA metabolic process (GO:0016072),0.2364122281990447,0.7251119606532951,0.9042553191489362,0.982283569768485,1.0,61/160,29.39%,PES1;UTP11;PIH1D1;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;UTP4;IMP4;RPL14;PDCD11;IMP3;RPL6;RPS28;MAPT;RPL41;RPLP2;DDX52;BYSL;RPLP1;RPL7;WDR74;RPL21;RPL26;WDR18;RPS27;RPL18;NOP53;MDN1;RPS17;EXOSC4;EXOSC10;ESF1;NOP58;TEX10;RPL24;DDX10;RPS6;POP5;LAS1L;DDX49;RPL37A
prerank,diacylglycerol metabolic process (GO:0046339),0.29574732418422944,0.7240034390988539,0.8025568181818182,0.9833398069683017,1.0,5/23,11.60%,DGAT1;MOGAT1;ANG;DGKA;GPAM
prerank,negative regulation of bone remodeling (GO:0046851),-0.2905765913108716,-0.7230961534705378,0.8190709046454768,0.957413748787927,1.0,4/11,25.42%,UBASH3B;TNFAIP3;GREM1;CALCA
prerank,sulfur compound catabolic process (GO:0044273),0.2757775495369392,0.7229624679061881,0.8305304010349288,0.984367847118097,1.0,7/38,13.97%,HEXA;PRELP;GLB1;ARSB;HEXB;ADO;TXN2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.28666725490327294,0.7228101753663406,0.8060941828254847,0.9841533139005587,1.0,5/27,14.47%,AK1;CMPK1;AK5;AK6;CTPS2
prerank,negative regulation of translational initiation (GO:0045947),0.32750023494275704,0.7222496183123274,0.7993579454253612,0.984459140554064,1.0,4/13,22.77%,EIF4EBP1;EIF2AK4;EIF4EBP2;TPR
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2454689137819956,0.7218346564444486,0.8773690078037905,0.9845846500744504,1.0,12/101,13.83%,CCL5;VIM;ZC3H12A;MTDH;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,early endosome to Golgi transport (GO:0034498),-0.2930397835777839,-0.7212591774044836,0.8233830845771144,0.9585719228329371,1.0,4/11,18.70%,EHD3;STX5;SURF4;RBSN
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.30290906828511494,0.7210944654615947,0.7979351032448377,0.9851077329999695,1.0,9/22,23.94%,PPP1R15A;LGALS3;CRY2;PPP1R11;GSK3B;PPP1R1B;ROCK2;TIPRL;IKBKB
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.29375167540368613,0.7204113002695874,0.8178082191780822,0.9855974478941402,1.0,3/26,8.29%,ATP1A2;GSTO1;THADA
prerank,protein K48-linked deubiquitination (GO:0071108),0.29724752419416955,0.7200294434014832,0.8035190615835777,0.9856959757336935,1.0,3/23,9.94%,MINDY2;OTUD7B;USP20
prerank,regulation of adaptive immune response (GO:0002819),0.30689596442938655,0.7194649043568431,0.8165413533834587,0.9860192976515982,1.0,1/18,2.07%,SASH3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.29979435200339183,0.7193582587813259,0.8181818181818182,0.9857315238504692,1.0,2/21,5.36%,CAV1;NFKBIA
prerank,DNA-dependent DNA replication (GO:0006261),0.23742047295216834,0.7193414151987815,0.9052863436123348,0.9853187418215544,1.0,30/128,22.27%,RECQL4;PSMD11;PSMD4;PSMF1;POLG;SRPK2;PSMD7;POLE4;TOPBP1;PSMB5;CDK2;RPA3;POLD2;MCM8;PRIM2;MCM6;RPS27A;UBC;MCM7;PSMD1;PSMC4;RFC1;PSMD8;PNKP;GINS3;ORC2;TWNK;MCM4;DDX23;SIRT7
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.29621929294814386,0.7193133560737371,0.8429172510518934,0.9849295259417258,1.0,1/24,0.49%,ITPR2
prerank,lipid transport (GO:0006869),0.24388385438259919,0.7190613773433527,0.8755656108597285,0.9848399660766859,1.0,7/97,6.48%,SLCO2A1;LDLR;SLC10A5;ABCD1;PITPNC1;PRELID3B;SLC27A3
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2719910084420889,-0.7186189058969958,0.8223495702005731,0.960760590639549,1.0,7/14,32.50%,RPUSD4;FASTKD2;TRMT10C;FASTKD3;RMND1;MPV17L2;COA3
prerank,histone H2A acetylation (GO:0043968),0.3242234061667923,0.7185902058199297,0.7899686520376176,0.9850229853178705,1.0,4/16,17.42%,NAA40;MORF4L2;MEAF6;TRRAP
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3527874229045322,0.7181981913773398,0.7933450087565674,0.9851035369630929,1.0,3/10,13.48%,SOX9;TGFBR2;MYC
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.25501079406917676,0.7181744820006183,0.8510131108462455,0.9846958713263602,1.0,20/56,25.99%,TAB3;LBP;TLR6;CNPY3;TLR4;S100A1;IRAK1;TLR3;RPS27A;UBC;MAPKAPK2;TAB2;SFTPA1;SFTPA2;IRAK4;CTSK;TLR1;TLR5;LY96;TAB1
prerank,response to interleukin-1 (GO:0070555),0.25147162819747687,0.7180936331235993,0.8594470046082949,0.9843654448779456,1.0,6/73,6.28%,CCL5;ADAMTS7;ZC3H12A;HDAC4;USP10;SOX9
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3134655615444526,0.7180644371566886,0.799396681749623,0.9839685039959786,1.0,5/17,18.35%,FCER1G;GATA3;PRKCZ;PRKCQ;RARA
prerank,positive regulation of endocytosis (GO:0045807),0.2655444893929628,0.7180515225176339,0.850383631713555,0.9835548904490897,1.0,6/45,12.24%,CLU;CBLL1;GPC3;CDC42;TOR1A;ANO6
prerank,spindle assembly (GO:0051225),0.2538652232322386,0.71773309393009,0.855072463768116,0.9835578210515638,1.0,13/67,18.92%,MAPRE2;NEK7;KIF2A;HDAC3;NCOR1;RHOA;ABRAXAS1;FLNA;CHEK2;NUMA1;AAAS;MISP;TUBGCP5
prerank,positive regulation of macrophage activation (GO:0043032),-0.2593781639846992,-0.7171568544576807,0.8680351906158358,0.9614043463858988,1.0,5/17,19.44%,WNT5A;THBS1;IL33;TTBK1;HSPD1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.309037186265956,0.7168081351467547,0.7964071856287425,0.9843774843502004,1.0,4/18,13.16%,LBP;NMI;FCER1G;SBNO2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.274934968383883,0.7160450000931082,0.8493333333333334,0.9849780600446861,1.0,6/39,12.95%,ANGPT1;NFE2L2;MAPK7;KRIT1;ANO6;GATA3
prerank,tRNA 5'-end processing (GO:0099116),0.32053463495021123,0.7157165864718111,0.8166409861325116,0.9849834128700469,1.0,5/15,21.58%,POP4;POP1;RPP21;HSD17B10;RPP40
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.27916648221465357,0.715344465947234,0.8223140495867769,0.9850484223503496,1.0,10/29,24.32%,COPA;VTI1B;NAPA;COG8;RAB33B;NSF;COPG1;VTI1A;GOSR1;GABARAPL2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3108865650010954,0.7152643704311976,0.792341678939617,0.9847272694840296,1.0,8/17,25.35%,ADD1;TNFRSF1A;VCL;CDH5;ROCK2;IKBKB;PPP1R12A;F11R
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23748615714392546,0.7152419794470379,0.8972677595628415,0.9843224228166612,1.0,20/109,19.71%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;JUN;MAPK9;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;TAB2;PRKCQ;PSMC4;PSMD8;MAP3K1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2579821983155144,0.7148912815974896,0.8614823815309842,0.9843724141829919,1.0,15/58,19.89%,MRE11;RIF1;MDC1;NSMCE2;ABRAXAS1;PAXX;UBE2N;PRPF19;DCLRE1C;LIG3;NBN;RAD50;ZBTB7A;UVRAG;ERCC4
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.27310460618751703,0.714481393017683,0.83994708994709,0.9844601826972723,1.0,9/38,18.29%,ASF1A;CENPS;ATRX;CENPT;UBN1;CENPH;IPO4;CENPO;H3-3A
prerank,regulation of B cell differentiation (GO:0045577),-0.2549605867625322,-0.7142535710765708,0.8284023668639053,0.9636202521503768,1.0,8/17,37.90%,ID2;NCKAP1L;CD27;BTK;XBP1;IL4I1;PPP2R3C;IKZF3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2771063314602994,0.714195133087798,0.8335664335664336,0.9844014370065397,1.0,4/31,9.28%,DAXX;HSPB8;HSPA14;BAG3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24089869965593655,0.713997300968326,0.8930957683741648,0.9842215610146868,1.0,21/104,19.80%,TRIB2;CDKN1A;PPP2CA;PIH1D1;CCND2;ACTB;MAP2K2;CCND1;PKMYT1;RHOA;SERTAD1;TESK1;CCNG1;ABL1;MTCP1;TSG101;CDKN2D;CAB39;CDK5RAP3;RB1;UVRAG
prerank,regulation of cellular amine metabolic process (GO:0033238),0.25914568324116505,0.7137394047782659,0.8571428571428571,0.9841169506043167,1.0,9/50,19.46%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,lipid translocation (GO:0034204),0.29843794377455635,0.7136984324210617,0.8,0.9837399023847908,1.0,3/21,10.94%,ATP10A;ATP8B2;ATP9A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2614441244245096,0.7136582378700368,0.8496894409937888,0.9833683884686458,1.0,5/52,8.91%,CNOT6;SAMD4A;SAMD4B;LSM4;EXOSC3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2436843297356121,0.7133882791166538,0.8735362997658079,0.9833059111673262,1.0,17/83,16.71%,CDKN1A;CDK6;USP29;CDK4;CDK16;PLK3;LATS1;FBXO5;EIF4EBP1;CCND1;CDK18;CDK2;MYC;PLK2;PCNA;E2F1;HINFP
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.30461823263902865,0.7132350597939277,0.8118361153262519,0.9830939666933629,1.0,4/18,14.36%,MUL1;ZNF205;GSK3A;GSK3B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.33392916521683647,0.7132046625547015,0.7716535433070866,0.9827024259231009,1.0,3/12,14.55%,ZC3H12A;NCOR1;NCOR2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.2754501452716548,-0.7123612015592435,0.8575342465753425,0.9648470591065367,1.0,6/12,29.42%,STX2;SNAP25;STX1B;SNAP29;STX19;STX1A
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3223996043821445,0.7118451476319634,0.8018575851393189,0.9840458985013398,1.0,5/14,20.84%,TNFRSF10B;TLR6;IRAK1;TLR3;ZFP91
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.33079892993504667,0.7115744813074344,0.808,0.9839659218426587,1.0,4/11,18.39%,AJUBA;FXR1;DHX9;WTIP
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.30308436901586855,-0.7115184484821605,0.823960880195599,0.9647582554807209,1.0,4/10,22.03%,DKC1;RPUSD4;NOP10;TSR3
prerank,defense response to symbiont (GO:0140546),0.24599989632569025,0.7114119549069993,0.882943143812709,0.9837666056863276,1.0,8/92,6.44%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;RNASEL;MOV10;NT5C3A
prerank,rRNA methylation (GO:0031167),0.2946681206643488,0.7113510766974976,0.8190743338008415,0.9834126445740063,1.0,2/22,4.73%,NOP2;BUD23
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3056814988690428,0.7108186134802725,0.799079754601227,0.9836684855634634,1.0,9/18,32.97%,KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PRKN;PSMD9;REST;MIDN
prerank,amino sugar metabolic process (GO:0006040),0.34519700245883167,0.7108178842295505,0.7980295566502463,0.9832418536362961,1.0,1/10,1.52%,B4GALNT2
prerank,response to growth factor (GO:0070848),0.2644938791357866,0.7106150998217245,0.8558441558441559,0.9830764538775179,1.0,9/41,17.76%,KLF4;SHC1;MAPK7;TGFBR2;MYC;SFRP1;LRP2;HDAC6;BMPR1A
prerank,positive regulation of T cell activation (GO:0050870),0.2516342708454841,0.7105055154529476,0.8696711327649208,0.9827903210915129,1.0,4/62,4.97%,CCL5;IL15;CD81;FLOT2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2968314134462437,0.7103079250591415,0.8330975954738331,0.9826321651266908,1.0,8/25,19.73%,NIBAN2;DOT1L;TWIST1;GATA3;POU4F1;PARK7;ZBTB7A;RB1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2088455314476897,-0.7100920413804064,0.9307359307359307,0.9653249694436921,1.0,14/38,27.47%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;RNF2;RAD51;TFDP2;BRCA1;CHEK1;PHC1
prerank,protein lipidation (GO:0006497),0.25818075581576155,0.7099257588551957,0.8415841584158416,0.9826846343561924,1.0,13/59,21.37%,GLUL;PIGU;ZDHHC12;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ;GPLD1;ZDHHC3;ZDHHC13
prerank,protein import into nucleus (GO:0006606),0.24691318992007333,0.7092022211339105,0.8652482269503546,0.9831880313063434,1.0,15/66,18.16%,KPNA7;IPO7;TSC2;NUP93;TNPO2;KPNA4;MMP12;TNPO1;NXT2;RANBP6;HEATR3;IPO4;KPNA1;CSE1L;PPP1R10
prerank,striated muscle contraction (GO:0006941),0.25842705755644163,0.7091145903261741,0.8462484624846248,0.9828751961741918,1.0,9/53,15.16%,ATP1A2;CSRP3;STAC3;LMOD3;GRK2;MYL4;ALDOA;CCDC78;TNNI3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3225468669551354,0.7085779356379415,0.81421647819063,0.983138998572661,1.0,3/13,15.92%,NIBAN2;NEDD4;CNMD
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.30744627863355656,0.7084111103696065,0.8160237388724035,0.9829125717636608,1.0,5/18,12.17%,MSN;MAP2K2;EZR;VPS11;SNX12
prerank,protein processing (GO:0016485),0.23841405517703174,0.708374067529871,0.9018058690744921,0.9825369942117248,1.0,24/102,21.14%,OGT;ADAM10;PRSS12;KLKB1;CPE;SRGN;AFG3L2;PITRM1;SDE2;KLK1;HP;HPR;SPCS3;CTSH;HM13;BACE1;SEC11A;PIDD1;SPPL3;SPG7;ADAM17;STOML2;APH1A;MMP14
prerank,positive regulation of RNA splicing (GO:0033120),0.28507864276719286,0.7081328445367332,0.8256756756756757,0.9824082508506292,1.0,5/29,14.63%,POLR2A;RBM20;HABP4;DAZAP1;ZPR1
prerank,positive regulation of vacuole organization (GO:0044090),-0.29687608511073815,-0.7081301526270785,0.854320987654321,0.9664142399670651,1.0,5/10,22.21%,PIP4K2A;SH3GLB1;PIP4K2B;RALB;RAB3GAP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.31341381122157363,0.7065988129226569,0.8202080237741456,0.9839309028605361,1.0,4/17,19.70%,SPRED3;DMTN;EIF4G1;PARD3
prerank,Fc receptor signaling pathway (GO:0038093),0.23455094181319136,0.7062509492375361,0.9103825136612022,0.9839736025640274,1.0,20/110,19.71%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;JUN;MAPK9;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;TAB2;PRKCQ;PSMC4;PSMD8;MAP3K1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.24449754409991364,0.7052555918295144,0.8736842105263158,0.9848205705468934,1.0,16/72,20.84%,RELB;PSMD11;PSMD4;PSMF1;TNFRSF10B;TLR6;PSMD7;PSMB5;IRAK1;CHUK;TLR3;PSMD1;PSMC4;NFKB2;PSMD8;ZFP91
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.27197376060373163,0.7043419748538128,0.8317631224764468,0.9855620174427363,1.0,8/33,17.42%,FAM210B;FOXO3;HOXA5;RAB7B;BRD1;MTURN;PRMT1;PITHD1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2628712160107803,-0.7043308736593914,0.8658892128279884,0.9695218101578101,1.0,14/16,51.45%,TNFRSF1B;SOX11;AHR;TNFSF8;IL27;LST1;PTPN22;IKZF3;IL12A;CD22;TNFSF9;FGF10;IL12B;TNFSF18
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2835732469862645,0.7042477492307888,0.8271428571428572,0.9852493729539582,1.0,6/26,18.35%,CDK6;TLR4;PTPN2;MYC;TLR3;RARA
prerank,cardiac muscle contraction (GO:0060048),0.27742670435103606,0.7040106489191053,0.8613728129205922,0.9851253705591594,1.0,5/34,11.42%,GSN;ATP1A2;CSRP3;GRK2;MYL4
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.24141614963456576,-0.7036400059564257,0.8651315789473685,0.9692623560785814,1.0,11/20,30.57%,NR2F2;APC;IPO5;MYOCD;HHEX;INCA1;CDKN1B;PTEN;CEBPA;HEXIM2;CDKN1C
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.28009480022457584,0.7035915705576317,0.8434547908232118,0.9852150717327528,1.0,4/30,7.60%,TRIM33;TWSG1;LTBP4;LATS1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.30187349918502016,0.7035526260247003,0.8162962962962963,0.9848395301822929,1.0,5/18,15.12%,MCU;MUL1;MIEF2;DNM1L;DDHD1
prerank,regulation of intracellular transport (GO:0032386),0.26862404917753047,0.7035336946789356,0.8580814717477004,0.9844356002587822,1.0,7/38,17.63%,NDEL1;LAMP1;CRYAB;ATP9A;DYNC1H1;NUMA1;AAAS
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.24657418729956457,0.7030710658744442,0.8830694275274056,0.9846227191262509,1.0,15/70,18.34%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,negative regulation of receptor internalization (GO:0002091),0.3329504261875966,0.7030384619949274,0.8140293637846656,0.9842389263075592,1.0,7/12,28.31%,RIN3;NECAB2;WDR54;DLG4;UBQLN2;ANKRD13D;ANKRD13B
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.24690014689302764,-0.7030115807049162,0.8715596330275229,0.9689658439491898,1.0,12/19,50.29%,CHRNB1;SLC5A7;CHRNA4;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;APOE
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.29747294789790296,0.7025714763757449,0.8196022727272727,0.984387022047098,1.0,4/20,9.75%,CCND2;PSRC1;PKD1;CCND1
prerank,kinetochore organization (GO:0051383),0.3217213858380756,0.7024386033213025,0.8006482982171799,0.9841315735678547,1.0,4/13,25.01%,CENPT;CENPH;CENPF;MIS12
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2644832020218656,-0.7022713617747207,0.8575342465753425,0.9687356595246936,1.0,9/15,35.13%,RPL11;DTX3L;BAG5;BAG2;MAD2L1;LIMK1;SMAD7;RPS7;MAD2L2
prerank,response to ionizing radiation (GO:0010212),0.24501568536534676,0.7007206701259863,0.8742368742368742,0.9858493717525496,1.0,10/70,13.48%,CDKN1A;KDM4D;NABP2;EYA1;INIP;COP1;TOPBP1;ABRAXAS1;EEF1D;MYC
prerank,response to hydroxyurea (GO:0072710),-0.2874061890099304,-0.7004246976339117,0.8337595907928389,0.9696449362043673,1.0,4/11,19.48%,KAT7;BLM;SPIDR;FMR1
prerank,T cell differentiation (GO:0030217),0.2642090560422911,0.7001700830296214,0.8686605981794538,0.9861269513669605,1.0,9/40,15.37%,GLI3;FCER1G;RABL3;PTPN2;GATA3;LMBR1L;GPR89A;GPR89B;MR1
prerank,macrophage activation involved in immune response (GO:0002281),0.31832688348832555,0.7000293551925284,0.8117088607594937,0.9858685210023124,1.0,3/13,13.16%,LBP;NMI;SBNO2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.34388804271499096,0.6995315764467452,0.8186528497409327,0.9856473022180825,1.0,3/10,14.70%,TNFRSF1A;SMPD2;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.34388804271499096,0.6995315764467452,0.8186528497409327,0.9856473022180825,1.0,3/10,14.70%,TNFRSF1A;SMPD2;PLA2G6
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.25208785055185273,0.6994240542108948,0.875609756097561,0.9853505807709649,1.0,11/56,14.39%,LSM10;CDK4;CCND2;FBXO5;ADAMTS1;CCND1;ANKRD17;VPS4B;NSMCE2;ANAPC4;EIF4G1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.27676445420136403,0.6991351434566453,0.8577235772357723,0.9852993610501337,1.0,2/34,4.18%,SASH3;CLCF1
prerank,regulation of gene silencing by RNA (GO:0060966),0.25235880577465336,0.6989213586666263,0.86489898989899,0.9847120933543246,1.0,22/50,28.99%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;AAAS;POLR2C;H3-3A;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.25235880577465336,0.6989213586666263,0.86489898989899,0.9847120933543246,1.0,22/50,28.99%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;AAAS;POLR2C;H3-3A;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,regulation of cellular localization (GO:0060341),0.26150698482311435,0.6980611525607552,0.8683544303797468,0.9853167786132369,1.0,12/46,17.60%,GSN;UNC13D;EFNA5;CDK16;DVL3;PARD6B;CSNK1E;HSP90AA1;MAD1L1;KDM1A;DYNC1H1;NUMA1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3166596811841268,0.6980322721652589,0.8015267175572519,0.984931844798025,1.0,4/15,16.82%,PTK2B;TXK;DDR1;ABL1
prerank,response to interferon-gamma (GO:0034341),0.24596726010826175,0.6968545683983368,0.8907766990291263,0.9859951448211995,1.0,6/67,7.38%,CCL5;EPRS1;DAPK3;DAPK1;NUB1;TRIM21
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3304350625809728,0.6966390053732819,0.8405797101449275,0.9858497625916071,1.0,6/12,28.68%,HUS1B;TOPBP1;CHEK2;STK33;SETMAR;CDC6
prerank,purine-containing compound salvage (GO:0043101),-0.27923641085311757,-0.6963894374074611,0.8508997429305912,0.9728477673330602,1.0,4/12,12.80%,HPRT1;AMPD3;PNP;DCK
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3384588805326917,0.6959971702092778,0.8054607508532423,0.9862254234414856,1.0,1/11,2.65%,CAV1
prerank,lipid catabolic process (GO:0016042),0.300173844578215,0.6957066892363638,0.8410104011887073,0.9861459510558804,1.0,2/18,7.50%,HSD17B14;ACADL
prerank,retinal metabolic process (GO:0042574),0.31823298701720626,0.6954137062591389,0.8102310231023102,0.9860601734506749,1.0,2/12,9.57%,DHRS13;ALDH8A1
prerank,cellular response to interleukin-1 (GO:0071347),0.22818856583241165,0.6952477439951673,0.9319148936170213,0.9858504582406334,1.0,27/143,18.10%,MAP3K8;CCL5;ADAMTS7;ZC3H12A;NFKBIA;PSMD11;USP10;SOX9;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;SFRP1;CHUK;IKBKG;UBE2N;RPS27A;UBC;PSMD1;TAB2;MAP3K3;PSMC4
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2800473294194721,0.6951695401354377,0.84593837535014,0.9855254544540785,1.0,6/29,18.23%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,peptidyl-lysine dimethylation (GO:0018027),0.2947957112688696,0.6950882387396703,0.8379204892966361,0.9851918171145918,1.0,7/18,28.65%,KMT2A;SETD7;KMT2B;SMYD2;EHMT1;EEF1AKMT2;SETMAR
prerank,organophosphate biosynthetic process (GO:0090407),0.2658124228406056,0.6948837374330751,0.8624833110814419,0.9850086139980185,1.0,8/37,16.09%,MOCS3;IP6K1;PPIP5K2;NFS1;FADS1;GPAM;IP6K2;TPI1
prerank,fibrinolysis (GO:0042730),-0.2642812303829253,-0.6948626213660773,0.8392370572207084,0.973450424846779,1.0,13/13,73.60%,PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;FGG;SERPINF2;PLAUR;SERPINE1;PLAT
prerank,fluid transport (GO:0042044),-0.2728417489695898,-0.6936073064509434,0.8652291105121294,0.9737588857488884,1.0,3/12,17.69%,AQP11;AQP4;SLC26A6
prerank,hexose metabolic process (GO:0019318),0.26468573880266805,0.6936014700530972,0.8565789473684211,0.9860877269967381,1.0,8/39,15.07%,SLC35A2;HECTD4;HK1;IRS2;FUOM;ALDOA;DCXR;GALK2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3063974719751724,0.6924755396752436,0.8279569892473119,0.9870298835500928,1.0,2/16,6.81%,VIM;BMP4
prerank,synaptonemal complex organization (GO:0070193),0.31137805368591853,0.6923655918486281,0.820919175911252,0.9863195586311164,1.0,1/15,6.13%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.31137805368591853,0.6923655918486281,0.820919175911252,0.9863195586311164,1.0,1/15,6.13%,SYCP2
prerank,response to metal ion (GO:0010038),0.2420563450954281,0.6923524603377508,0.8985507246376812,0.985912790205922,1.0,13/67,17.53%,NDRG1;CAV1;PEF1;PPP2CA;AHCYL1;ITPR3;NEDD4;SLC25A12;HVCN1;SNCB;PPP2CB;HAAO;SLC11A2
prerank,negative regulation of receptor binding (GO:1900121),0.3368884953873166,0.6916187513223646,0.8169491525423729,0.9863503892852181,1.0,2/10,10.44%,PTPRF;ADAM15
prerank,ether lipid biosynthetic process (GO:0008611),0.3320120826332501,0.6912248880287067,0.8295081967213115,0.9864429620704146,1.0,3/10,12.14%,DHRS7B;LPCAT2;CHPT1
prerank,glycerophospholipid metabolic process (GO:0006650),0.24197658813155407,0.6911303759815964,0.9094117647058824,0.9861423371595841,1.0,18/75,19.58%,PLCB3;SERINC5;AGK;PIGZ;PAFAH1B1;PIGA;PIGX;DPM2;PGP;PLA2G6;PLCD1;PIGN;ABHD6;SERINC1;PIGP;PIGQ;GPLD1;SMPD4
prerank,tRNA wobble base modification (GO:0002097),0.31720501706285187,0.6909162004219792,0.8253205128205128,0.9859822473787938,1.0,5/14,23.36%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,anterior/posterior axis specification (GO:0009948),0.30600789035604065,0.6907598627852081,0.809748427672956,0.9857374013761797,1.0,2/15,8.36%,WLS;FZD5
prerank,regulation of centrosome cycle (GO:0046605),0.2879106474561645,0.690756385060654,0.8335724533715926,0.9853247396125641,1.0,6/21,17.64%,CHMP4B;VPS4B;MARK4;CHMP1A;CHMP2A;PDCD6IP
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3011725014852371,0.6905550035263199,0.8278443113772455,0.9851478990818933,1.0,2/18,4.98%,PMAIP1;TMEM259
prerank,positive regulation of cytokinesis (GO:0032467),0.2694276293269882,0.6903561670611853,0.8601108033240997,0.984959397874489,1.0,7/32,20.17%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,regulation of DNA repair (GO:0006282),0.25469410261539155,0.6903233335989922,0.877892030848329,0.9845800568077047,1.0,15/44,23.27%,EYA2;EYA1;PML;TIGAR;ABRAXAS1;UBR5;POLH;DHX9;PCNA;UBE2N;PARG;UBE2V1;SIRT7;RNF168;CDK9
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.23492719264692238,0.6900561371493593,0.9085714285714286,0.9844931051479388,1.0,19/88,18.47%,CLU;PIH1D1;SDC4;LGALS3;RAB7A;MTLN;VPS4B;AJUBA;HRK;VPS4A;TRABD2B;GSK3B;CHMP2A;PFN2;CDH5;PDCD6IP;STAM;TSG101;PARK7
prerank,protein O-linked glycosylation (GO:0006493),0.2334999099699695,0.6895863033784685,0.9238521836506159,0.9846387713445948,1.0,6/96,4.29%,ST3GAL4;OGT;B4GAT1;TMTC1;GALNT1;LARGE1
prerank,macroautophagy (GO:0016236),0.23056209660064841,0.6894006184186393,0.9303370786516854,0.9844402777052431,1.0,31/118,20.47%,PRKAA2;VPS37B;RUBCNL;TOMM5;CHMP4A;CHMP4B;MTMR3;PLEKHM1;VPS4B;VTI1B;TOMM20;VIPAS39;VDAC1;VPS4A;VAMP7;ULK1;MAP1LC3B;CHMP2A;RB1CC1;ATG4B;PRKAG1;ZFYVE1;STAM;TSG101;ILRUN;VPS37A;UVRAG;PRKAB1;TOMM40;PRKAB2;PIK3R4
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2246420802159102,0.6893920803686299,0.946058091286307,0.9840302299031717,1.0,26/184,18.57%,FZR1;PSMD11;PSMD4;PSMF1;PKD1;CEP76;FBXO5;PTPN6;PSMD7;PAFAH1B1;ZW10;CSNK1E;PSMB5;ANAPC4;CDK2;HSP90AA1;DDB1;RPS27A;UBC;E2F1;ERCC2;DYNC1H1;PSMD1;PSMC4;ODF2;SFI1
prerank,ncRNA export from nucleus (GO:0097064),-0.2077966128644303,-0.68852999231531,0.9536679536679536,0.9777115163856831,1.0,12/36,23.28%,TSC1;NUP85;NUP54;RAN;NUP210;NUP214;XPOT;NUP88;NUP188;NUP37;PHAX;NUP205
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2865047443596819,0.6884140709938251,0.844213649851632,0.984783456805751,1.0,3/24,6.86%,SESN2;NFE2L2;MAPK7
prerank,regulation of Golgi organization (GO:1903358),0.3011027250674483,0.6883347785530021,0.8282208588957055,0.9844568821891746,1.0,5/17,15.46%,MAP2K2;MYO5A;ARMH3;USP6NL;RAB33B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.327963408405792,0.6879471524804348,0.7918781725888325,0.9844933760191693,1.0,1/10,2.27%,SYP
prerank,urogenital system development (GO:0001655),-0.2833180586212961,-0.6869427569231322,0.8560606060606061,0.9782036837374153,1.0,4/11,23.87%,EPHB2;EPHB3;PAX8;PAX2
prerank,protein modification process (GO:0036211),-0.1721747227692902,-0.6867849036059686,0.9848484848484849,0.9773608710198124,1.0,11/76,12.29%,PLOD2;ST3GAL1;ST8SIA4;MSRA;SERP1;CHRM3;UBE2S;ABL2;ARAF;MAN2B1;LOX
prerank,female gamete generation (GO:0007292),0.27244922713709047,0.6866605510434843,0.8561643835616438,0.985621957887549,1.0,4/29,15.44%,DIAPH2;TOB2;PTN;MCM8
prerank,regulation of stem cell proliferation (GO:0072091),-0.24592466831880183,-0.68596588364671,0.8681948424068768,0.9771860844918709,1.0,4/17,20.30%,ACE;HMGA2;SOX11;YAP1
prerank,protein deneddylation (GO:0000338),0.3286165705072495,0.6857678083437172,0.8165784832451499,0.9862602514227933,1.0,2/10,12.30%,TOR1A;COPS5
prerank,phospholipid translocation (GO:0045332),0.27097857413694176,0.6857392826740457,0.8647540983606558,0.9858798636939482,1.0,5/28,12.24%,ATP10A;ATP8B2;ATP9A;PLSCR3;ANO6
prerank,neuron projection organization (GO:0106027),-0.2537297484533433,-0.6857114689847605,0.884514435695538,0.9764121740540591,1.0,4/15,15.91%,INSR;PLS1;ABCD2;MAP1A
prerank,cellular senescence (GO:0090398),0.2753595541551514,0.68507809188053,0.8434065934065934,0.9862426222270735,1.0,6/27,16.92%,CDKN1A;PML;NSMCE2;OPA1;HRAS;SMC6
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.23706763716295218,0.6841166145345094,0.9061032863849765,0.9869637455387785,1.0,22/78,24.78%,CDKN1A;IPO7;CCND2;LATS1;PSRC1;PKD1;CDK5RAP1;ACTB;CCND1;PKMYT1;SERTAD1;HEXIM1;CCNG1;CDKN2D;CDK5RAP3;ADAM17;CDK5R1;MEN1;LATS2;GTPBP4;CDC25A;MNAT1
prerank,potassium ion import across plasma membrane (GO:1990573),0.25619182217589986,0.6838751173687927,0.8707124010554089,0.9868552625430348,1.0,3/41,4.49%,SLC12A8;ATP1A2;KCNJ13
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.19533833717106502,-0.683843841996924,0.9619047619047619,0.9771070698111801,1.0,14/45,22.93%,BRINP3;RGCC;TGFB1;BTG1;PTPN3;PRCC;TOM1L1;SMAD3;BRINP2;ZWILCH;GAS1;BMP7;CDKN1B;MAD2L1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.23844006444286986,0.6835442602436117,0.9,0.986827765890933,1.0,13/69,17.41%,RNF5;TRIM25;ERLIN2;UBE2G2;ERLIN1;USP19;RNF121;NPLOC4;RHBDD2;UBE4A;DNAJC10;STUB1;UBE2J1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2813336869393378,0.6825315002417985,0.8651026392961877,0.9876068054173823,1.0,3/23,13.96%,GUCY2F;CNGB1;PDE6B
prerank,ganglion development (GO:0061548),0.324563306303713,0.6824871284142656,0.8324958123953099,0.9872464950556142,1.0,2/11,17.95%,NRP2;SEMA3A
prerank,determination of left/right symmetry (GO:0007368),-0.19939866222056132,-0.6823451264857505,0.9254901960784314,0.9775406188996713,1.0,10/36,18.26%,NOTCH1;PKD2;MEGF8;RFX3;NPHP3;ZIC3;TBX1;BBS7;DNAH11;KIF3B
prerank,negative regulation of synaptic transmission (GO:0050805),0.28211068701052355,0.6820964704062603,0.8362068965517241,0.987275800043829,1.0,5/23,15.37%,TMEM25;STXBP1;SYT11;PLK2;PNKD
prerank,ERAD pathway (GO:0036503),0.23221360634413937,0.6813041535915342,0.9140534262485482,0.9877963275093169,1.0,16/83,17.41%,RNF5;TRIM25;ERLIN2;UBE2G2;ERLIN1;USP19;RNF121;GET4;TOR1A;NPLOC4;RHBDD2;UBE4A;DNAJC10;CCDC47;STUB1;UBE2J1
prerank,histone H2A monoubiquitination (GO:0035518),0.3016251278465029,0.6812934964433239,0.8489984591679507,0.9873954024115648,1.0,8/17,26.51%,PCGF6;PCGF3;PCGF2;DDB1;TRIM37;RNF168;RING1;BMI1
prerank,positive regulation of ATPase activity (GO:0032781),-0.1950387464064766,-0.6811589856338147,0.9521739130434783,0.9776136648093037,1.0,11/41,24.17%,ATP1B1;MSH3;VMP1;PLSCR1;RYR2;DNAJB2;TNNT3;DYNLL2;DNAL4;DNAJB1;AHSA1
prerank,polyol biosynthetic process (GO:0046173),0.29874773857806003,0.6811248644642977,0.8369230769230769,0.9871699929073586,1.0,3/16,15.86%,IP6K1;PPIP5K2;IP6K2
prerank,peptidyl-threonine modification (GO:0018210),0.2399987964476333,0.6808685574163711,0.9099756690997567,0.9870521760626674,1.0,23/66,25.20%,CDK10;GALNT1;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;ULK1;GSK3B;WNK1;CDC42BPA;GALNT11;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;GALNT3;PDPK1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2733372272791072,0.6797788873913542,0.8673469387755102,0.9879019337252117,1.0,6/26,18.47%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,male gonad development (GO:0008584),0.26200891004740734,0.6795636182849153,0.8846675712347354,0.9877162637010134,1.0,5/34,12.95%,TFAP2C;SOX9;TGFB2;MAMLD1;GATA3
prerank,C-terminal protein amino acid modification (GO:0018410),0.32711085335255474,0.6794664513998091,0.8118811881188119,0.987415968753098,1.0,2/11,7.95%,AGTPBP1;AGBL1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.27694245552352204,0.6793761209876058,0.8473177441540578,0.9871163430458337,1.0,10/25,28.31%,UNC119;ABCA2;RIN3;APP;WDR54;DLG4;UBQLN2;PSEN1;ANKRD13D;ANKRD13B
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.2811514307399783,0.6793654249909071,0.8717201166180758,0.9867172974240564,1.0,11/24,25.82%,BCAP31;FCER1G;SEC23A;ABCB9;CANX;SEC24B;IDE;SEC31A;SEC24D;TAPBP;HFE
prerank,response to hexose (GO:0009746),0.2786356175554883,0.6793288278796217,0.8587731811697575,0.9863540195130486,1.0,6/25,21.69%,EIF2B2;TCF7L2;IRS2;EIF2B4;GPLD1;VAMP2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.24044683273982975,0.6791547022513617,0.9044025157232705,0.9861323023484848,1.0,16/61,19.24%,EYA2;MRE11;EYA1;PARP3;ATRX;PML;TIGAR;ABRAXAS1;MYC;DHX9;PCNA;UBE2N;NBN;RAD50;PPP1R10;PRKD2
prerank,pre-replicative complex assembly (GO:0036388),0.23668640200918833,0.6774316505668997,0.9046483909415971,0.9876721938807569,1.0,15/64,21.61%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;MCM8;MCM6;RPS27A;UBC;MCM7;PSMD1;PSMC4;PSMD8;ORC2;MCM4
prerank,regulation of receptor recycling (GO:0001919),0.30224347205662583,0.6771467320022551,0.8257575757575758,0.9875658518418343,1.0,2/16,6.90%,TBC1D16;ANXA2
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.1955362200935011,-0.6768534188121971,0.9484126984126984,0.9805698922659956,1.0,10/37,24.80%,AATF;MTMR2;ITGAV;EDNRB;EDN1;SIRT2;ATXN2;OPTN;PAX2;BRCA1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2968921277679581,0.6752338575118699,0.8614916286149162,0.9892848845494563,1.0,2/17,6.81%,VIM;BMP4
prerank,stem cell development (GO:0048864),-0.24810062314367262,-0.6748104289012166,0.876750700280112,0.9813719062013531,1.0,10/16,36.44%,CDH2;PDCD6;SOX11;NOLC1;KBTBD8;KLHL12;SNAI2;NRG1;SHH;WNT7A
prerank,stem cell differentiation (GO:0048863),0.2548105401308797,0.6745914167994689,0.8809523809523809,0.9895789688655426,1.0,7/39,16.97%,MLLT3;PSMD11;TGFB2;LMBR1L;MEF2C;SFRP1;NELFB
prerank,response to lipid (GO:0033993),0.22513993424828277,0.6745909060252968,0.9488574537540805,0.9891655080716113,1.0,23/105,19.54%,SMAD6;SLPI;FOXO3;RARG;RXRB;SOX9;LBP;ABCA2;TLR4;SOCS2;VPS4B;PELI1;IRAK1;FOXP1;CTSH;F2R;MAPKAPK2;TAB2;TRIM16;PCK2;RARA;CDKN2D;ADAM17
prerank,regulation of cellular metabolic process (GO:0031323),0.2488790840878349,0.6745320590187566,0.8936170212765957,0.9888139076818626,1.0,13/45,19.48%,TBC1D16;FOXM1;EIF6;ABCA2;PDK2;ACACA;MBOAT7;FASN;ARF4;NCOR2;STUB1;RNF41;FLOT1
prerank,serine family amino acid catabolic process (GO:0009071),0.3270258296223074,0.6737834726360881,0.8481421647819063,0.9892133485421069,1.0,2/10,12.05%,SHMT1;AMT
prerank,cellular response to leucine (GO:0071233),-0.2786113464201562,-0.6734397194349685,0.8605263157894737,0.9805819108712959,1.0,3/10,15.29%,UBR1;KLHL22;RRAGD
prerank,response to leucine (GO:0043201),-0.2786113464201562,-0.6734397194349685,0.8605263157894737,0.9805819108712959,1.0,3/10,15.29%,UBR1;KLHL22;RRAGD
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2566361093136791,0.6723596045210944,0.8841961852861036,0.9903861458856332,1.0,4/35,6.12%,CDK6;FAM210B;FOXO3;HOXA5
prerank,regulation of lipid catabolic process (GO:0050994),0.29115243006123837,0.6715082115494377,0.8669724770642202,0.9909141139190393,1.0,1/19,2.68%,ABCD1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2822051012729857,0.6714466247245292,0.8548387096774194,0.9901599039160878,1.0,6/21,19.89%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2822051012729857,0.6714466247245292,0.8548387096774194,0.9901599039160878,1.0,6/21,19.89%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3049124933669142,0.6712931980425175,0.8666666666666667,0.989914491559417,1.0,4/15,24.55%,TDO2;HAAO;KYAT1;KMO
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22763651119619227,0.6699771188544109,0.9437570303712036,0.9909382595311262,1.0,23/94,19.49%,MAP3K8;NFKBIA;PSMD11;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;CHUK;IKBKG;UBE2N;RPS27A;UBC;PSMD1;TAB2;MAP3K3;PSMC4;PSMD8;IRAK4
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2246803965012191,0.6698158625106347,0.9323144104803494,0.990689827589067,1.0,17/117,11.92%,ADH7;HAGH;ME3;GAMT;LDHB;NPC1;ABAT;CPT1B;ACSL3;MSMO1;LDHAL6B;ALDH8A1;CKMT1A;ACSF3;GPAM;PCCA;FASN
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.26803484210307,0.6696817316317811,0.8679504814305364,0.9904171717569255,1.0,7/29,16.77%,RBX1;ERCC5;RPA3;DDB1;RPS27A;UBC;ERCC2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3209044506104071,0.6692197922379594,0.8365695792880259,0.9905073276550324,1.0,2/10,9.28%,JUN;BAG3
prerank,tRNA transport (GO:0051031),0.25923418848382845,0.668941736108985,0.8748317631224765,0.9904050207027277,1.0,14/35,26.81%,NUP93;NDC1;TOMM20;NOL6;AAAS;RAE1;YBX1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2413133087183839,0.6688525173956924,0.9006211180124224,0.9900840229098705,1.0,1/53,0.76%,CHRM1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.1910774259332908,-0.6688117888379359,0.9537037037037037,0.9835508770590975,1.0,19/42,32.78%,SMCHD1;UBQLN4;PPP4C;SPIDR;MRNIP;FANCB;WDR48;CGAS;RMI2;ERCC6;RAD51;WRAP53;PARPBP;CHEK1;SIRT6;SHLD3;RTEL1;HELB;RAD51AP1
prerank,regulation of spindle organization (GO:0090224),0.28810186859386516,0.6687716532533591,0.8437956204379562,0.9897612250931909,1.0,5/18,18.54%,PARP3;PSRC1;DYNC1H1;NUMA1;RAE1
prerank,axonemal dynein complex assembly (GO:0070286),0.2681802074380677,0.6685294645404081,0.8565340909090909,0.9896126617935688,1.0,8/27,26.71%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DRC1;SPAG1;DNAAF4
prerank,skeletal muscle contraction (GO:0003009),0.28781969123623047,0.6682387867533209,0.8638426626323752,0.989517918394841,1.0,3/19,15.16%,STAC3;CCDC78;TNNI3
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.30091325439215344,0.6681792390491526,0.8614173228346457,0.9891734624082577,1.0,3/13,13.54%,CPE;TGFBR2;GSK3A
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.308199049483544,0.6679463653277314,0.8503184713375797,0.9890220264510922,1.0,5/12,26.29%,UPP2;UMPS;UPP1;UCK2;UCKL1
prerank,regulation of oxidoreductase activity (GO:0051341),0.31076616479870456,0.6674989235407959,0.848780487804878,0.989081934347337,1.0,5/13,21.96%,HP;ABL1;HDAC6;SIRT4;SZT2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3196477688163096,0.66732651847767,0.834920634920635,0.9888543745591695,1.0,2/11,8.91%,LARP7;EXOSC3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.27194807845459895,0.6665841013221419,0.8828451882845189,0.9892436448460263,1.0,4/26,11.07%,CYB5R3;DDAH2;CYB5B;ABCA2
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.21145522080879042,-0.6661159373371166,0.931740614334471,0.9847798820350584,1.0,8/26,20.81%,CCDC57;HSF1;RPS6KB1;MEIS2;TAL1;ASNS;SMOC2;SPHK1
prerank,positive regulation of binding (GO:0051099),0.22759854198442717,0.6656690844388408,0.9352601156069364,0.989779272540429,1.0,9/84,8.42%,MMP9;CAV1;NGF;KDM4D;ADD1;BMP4;TRIM21;PKD1;TCF7L2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.287422486143808,0.6653701261260236,0.8490284005979073,0.9896925600422745,1.0,6/18,21.61%,POLD2;PCNA;LIG3;MCM7;GINS3;MCM4
prerank,mRNA stabilization (GO:0048255),0.24988568133641154,0.6647353925878043,0.8977719528178244,0.9899332060669979,1.0,11/40,22.90%,GDNF;YBX3;SYNCRIP;BOLL;PAIP1;DHX9;E2F1;MAPKAPK2;IGF2BP1;YBX1;PABPC1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23984385723935836,0.6645935831430109,0.9175126903553299,0.9896609101755437,1.0,9/53,19.46%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,glycerol metabolic process (GO:0006071),0.3240766986795654,0.6638284578970887,0.8341463414634146,0.990040814678964,1.0,6/10,30.22%,PGP;TPI1;COQ3;ANGPTL3;GK;COQ2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3015119415272526,0.6628230049347944,0.8429003021148036,0.9906761530819437,1.0,2/13,11.15%,CIAO1;ISCA1
prerank,vasodilation (GO:0042311),-0.2618598078606872,-0.662523978082302,0.9121813031161473,0.9866796529356656,1.0,3/13,18.90%,NOS3;KCNMA1;SOD1
prerank,defense response to virus (GO:0051607),0.22817648085924552,0.6624896621193427,0.9482948294829483,0.9905974690639319,1.0,8/100,6.44%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;RNASEL;MOV10;NT5C3A
prerank,protein acylation (GO:0043543),0.2526633415818019,0.6614971110651525,0.8899082568807339,0.991215208307904,1.0,3/38,4.61%,GLUL;EP300;ZDHHC12
prerank,folic acid metabolic process (GO:0046655),0.2881974432612574,0.6614379227726527,0.8764880952380952,0.9908698475650356,1.0,4/18,18.65%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2611848794328235,0.6609891529737069,0.8900949796472184,0.990938137016761,1.0,6/31,18.23%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,regulation of collagen biosynthetic process (GO:0032965),0.28478415919572075,0.6608085537806214,0.8639760837070254,0.9907175033053583,1.0,2/19,6.81%,VIM;BMP4
prerank,cellular response to estrogen stimulus (GO:0071391),0.2920327293994682,0.6602870447280457,0.866877971473851,0.9908354277591578,1.0,5/14,23.31%,BCAS3;SFRP1;SFR1;RARA;NCOA4
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.28339662232511226,0.6597842632039436,0.874251497005988,0.990937675573457,1.0,6/21,15.10%,PPP1R15A;CRY2;YWHAB;PPP1R11;GSK3B;PPP1R1B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.27241159115533475,0.6586936265888076,0.8707782672540382,0.9916287428856058,1.0,8/23,23.95%,MTMR12;MTMR3;INPP5B;OCRL;TPTE;PIP4P1;MTMR10;MTMR9
prerank,RNA polyadenylation (GO:0043631),0.2670882458292844,0.6563048795756989,0.898876404494382,0.9932781962679021,1.0,9/26,23.50%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.2670882458292844,0.6563048795756989,0.898876404494382,0.9932781962679021,1.0,9/26,23.50%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,lipid droplet formation (GO:0140042),0.3115413955181803,0.6560335316046068,0.8655172413793103,0.9931214056208947,1.0,3/10,17.75%,SQLE;CDS1;ZFYVE1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.2334932385473086,0.6557260146422964,0.9367396593673966,0.9930162956791727,1.0,12/61,19.46%,CAV1;PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PDK2;PSMB5;NCOR2;PSMD1;PSMC4;PSMD8
prerank,positive regulation of organelle assembly (GO:1902117),0.24567725383356437,0.6554996610323548,0.9121887287024901,0.9928323406443845,1.0,16/44,25.08%,CNOT6;SDC4;MARK4;PIP4K2C;CCDC88A;FSCN1;DYNC1H1;NUMA1;PDCD6IP;CROCC;RAB3GAP2;TAPT1;PLK4;CEP120;NUP62;LRSAM1
prerank,negative regulation of T cell activation (GO:0050868),0.2509023886913042,0.6554986443737462,0.9089709762532981,0.9924249212695931,1.0,4/35,8.99%,RIPOR2;SDC4;LGALS3;FOXP3
prerank,regulation of interleukin-17 production (GO:0032660),0.26187279004612674,0.6547773726277629,0.9005449591280654,0.9927578759973524,1.0,4/31,11.16%,IL15;ZBTB7B;FOXP3;TLR4
prerank,primary miRNA processing (GO:0031053),0.31444505996388017,0.6545132556645993,0.8316993464052288,0.9926236784664496,1.0,2/10,14.14%,DGCR8;SRRT
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.30667838312829543,0.6544568687553306,0.8592233009708737,0.9922780917432684,1.0,11/11,69.35%,PRKCQ;NLRP10;CLEC6A;IL12B;NFKBIZ;IL23R;IL23A;CARD9;IL12RB1;NFKBID;MALT1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.318139912112465,0.654189986859149,0.8415492957746479,0.9921193052690949,1.0,4/10,22.88%,NAGK;GNE;GNPDA2;ST6GAL1
prerank,synaptic vesicle localization (GO:0097479),-0.2497505281718366,-0.6535860510198955,0.8977900552486188,0.9928041758999376,1.0,3/13,13.07%,NLGN1;SNAPIN;SYNDIG1
prerank,NAD biosynthetic process (GO:0009435),-0.23419710631526047,-0.6532807148138496,0.9042904290429042,0.9920238960796771,1.0,6/20,24.79%,PTGIS;PTGS2;NAXE;QPRT;NAXD;NAMPT
prerank,protein deacetylation (GO:0006476),0.24728346358937758,0.6532409108182281,0.911651728553137,0.9926464381838634,1.0,11/41,22.27%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;FLNA;RCOR2;HDAC6;RCOR3;SIRT4;SIRT7
prerank,response to gamma radiation (GO:0010332),0.266093052873572,0.652884748467974,0.8772727272727273,0.9925928426674676,1.0,6/24,16.83%,CRYAB;MYC;HRAS;MDM2;ATR;KDM1A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.24375396623175194,0.6520309086575917,0.916243654822335,0.9930264094426265,1.0,9/47,15.59%,QARS1;FOXM1;TGFB2;MAP2K2;ARL6IP5;COPS5;MYC;TGFBR3;IGBP1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.30276605125283595,0.6520148195904276,0.8762057877813505,0.9926377672567528,1.0,2/13,15.37%,PVR;MR1
prerank,I-kappaB phosphorylation (GO:0007252),0.3129989624398125,0.6512355411736985,0.8739635157545605,0.9929740238413433,1.0,3/10,15.26%,TLR4;CHUK;TLR3
prerank,negative regulation of secretion (GO:0051048),-0.27015453221579744,-0.6511307343789647,0.8935643564356436,0.9926773796196124,1.0,3/10,17.58%,NR1H3;CD74;EGF
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.27751221490470757,0.6508220487778139,0.8822652757078987,0.9929741230802349,1.0,5/19,15.66%,LBP;NMI;TLR4;IRAK1;ITGB2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2328840856869413,0.6507724510957534,0.9310344827586207,0.9926108042910222,1.0,20/59,25.20%,CDK10;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;ULK1;GSK3B;WNK1;CDC42BPA;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;PDPK1
prerank,regulation of protein localization to centrosome (GO:1904779),0.3098139452806908,0.6503260592988891,0.8403361344537815,0.9926566132703235,1.0,3/10,14.36%,NSFL1C;MARK4;GSK3B
prerank,serine family amino acid metabolic process (GO:0009069),0.2865006234771937,0.6490556854533158,0.8746031746031746,0.993492467047499,1.0,3/16,14.26%,SHMT1;CDO1;SARS1
prerank,erythrocyte differentiation (GO:0030218),0.2418020788934011,0.6486844778258992,0.9085133418043202,0.9934557724221296,1.0,14/44,24.96%,ACIN1;EPO;DMTN;ATP5IF1;SLC25A38;PTPN2;TGFBR3;CDK5RAP3;IKZF1;FLVCR1;CASP3;KMT2E;ZFPM1;ABCB10
prerank,response to alcohol (GO:0097305),0.2639184048579316,0.6485042887371623,0.8826739427012278,0.9932248974673864,1.0,5/27,14.17%,ADH7;PMVK;ABCA2;TGFBR2;TGFBR3
prerank,phasic smooth muscle contraction (GO:0014821),0.31531435432202404,0.6485000298992111,0.8838709677419355,0.9928240419238579,1.0,1/10,3.81%,GDNF
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.24781095372180728,-0.6483259047235358,0.907608695652174,0.9937483836585976,1.0,7/14,29.97%,SLC25A33;MTERF2;TFB1M;MRPL12;EARS2;FASTKD5;PNPT1
prerank,regulation of B cell apoptotic process (GO:0002902),0.30198789397692655,0.6475100372018839,0.8576051779935275,0.9933864649417267,1.0,3/12,14.18%,ORMDL3;IRS2;FOXP1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2547087993948724,-0.6474437529853226,0.9212598425196851,0.9934439092512563,1.0,3/12,17.32%,TASOR;APOBEC1;SETDB2
prerank,pancreas development (GO:0031016),-0.2640566823992111,-0.6473935073883534,0.8886010362694301,0.992474916875471,1.0,5/12,29.27%,NPHP3;ZIC3;NKX6-1;CCDC39;FOXF1
prerank,regulation of regulated secretory pathway (GO:1903305),0.25184342292939077,0.6470333347164092,0.9118046132971506,0.9934310335391184,1.0,11/34,21.89%,UNC13D;SYN1;RIMS4;VPS18;SYT6;GSK3B;SYT11;SYT12;RAB27A;SYT3;SYT2
prerank,regulation of spindle assembly (GO:0090169),0.26579523230682417,0.646930881036849,0.8795013850415513,0.9931182016246922,1.0,11/25,26.60%,CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.24180833865051157,-0.6466319515831374,0.9090909090909091,0.9919884312264319,1.0,8/15,35.51%,GLI1;EZH2;PAF1;PHB2;NPM1;PLCG2;ATAD5;FAM83D
prerank,regulation of protein dephosphorylation (GO:0035304),0.2488724833726845,0.6465245563578184,0.9109947643979057,0.9931218908819403,1.0,8/37,18.83%,PPP6R3;PPP1R15A;YWHAB;PPP1R16A;DLC1;CDH5;SPPL3;PTBP1
prerank,negative regulation of neurogenesis (GO:0050768),0.2511784136352431,0.6461798071661067,0.9112582781456954,0.9930262776648373,1.0,1/34,0.73%,RTN4R
prerank,protein palmitoylation (GO:0018345),0.2540051290596541,0.6460041084127421,0.8857901726427623,0.9927954260182803,1.0,3/30,9.26%,GLUL;ZDHHC12;GOLGA7
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.26639921059717875,0.645335626317982,0.8870967741935484,0.9929984893330126,1.0,5/23,16.57%,RBX1;COPS5;DDB1;RPS27A;UBC
prerank,nuclear body organization (GO:0030575),0.30828563009489207,0.6451590062645283,0.8699186991869918,0.9927682417997296,1.0,4/12,14.63%,PML;SRPK2;HABP4;ZPR1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22555132134277067,0.6447276284044215,0.9356014580801945,0.9927825867299567,1.0,26/62,28.99%,POLR2H;POLR2A;NUP93;NDC1;AJUBA;FXR1;EIF4G1;DHX9;AAAS;POLR2C;H3-3A;WTIP;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.29578731218733656,0.6441339113111976,0.8651162790697674,0.9929336340543075,1.0,4/14,18.47%,BCL2L1;CREB3;OPA1;PARK7
prerank,regulation of cytokine production (GO:0001817),0.21092149194637638,0.6440869524910029,0.9698275862068966,0.9925791647806973,1.0,24/126,20.56%,SCAMP5;IL15;TWSG1;ALOX5;IRF3;TRIM21;NFAM1;SRGN;LGR4;FOXP3;TXK;PPP1R11;GATA3;FOXP1;GAPDH;SYT11;MAPKAPK2;IGF2BP3;GPNMB;IGF2BP2;FLOT1;HILPDA;IGF2BP1;ZBP1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.2535596088194664,-0.6438877445009766,0.9168900804289544,0.9929472371803738,1.0,4/13,26.34%,TGFB1;SOD1;TYROBP;ITGAM
prerank,negative regulation of cell cycle process (GO:0010948),0.23271446322750325,0.6438455364322826,0.9448441247002398,0.9923914937574011,1.0,14/61,20.98%,PCGF6;MGA;BMP4;ZFYVE19;FBXO5;VPS4A;PCGF2;CHMP2A;E2F1;PPP1R10;WAPL;GPER1;TOM1L2;TERF2
prerank,regulation of histone methylation (GO:0031060),0.2948367339561021,0.6436721289363386,0.8687196110210696,0.9921474171515922,1.0,3/13,15.42%,PIH1D1;NNMT;TET1
prerank,membrane repolarization (GO:0086009),0.2900036748795114,0.6435037105473687,0.8773584905660378,0.9919140382014217,1.0,1/15,2.78%,ATP1A2
prerank,regulation of centrosome duplication (GO:0010824),0.25565295961360257,0.6426332249751565,0.9186206896551724,0.9923295277665561,1.0,8/29,17.64%,CHMP4B;CEP76;VPS4B;CHMP1A;PLK2;CHMP2A;CENATAC;PDCD6IP
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2130881962658495,0.6422275877256206,0.9712070874861573,0.9922871172618541,1.0,20/112,19.38%,CLU;ZC3H12A;MAVS;TNFRSF8;HSPB1;FZD5;LBP;PTPN6;TWIST1;TLR4;FOXP1;TLR3;SYT11;DHX9;OAS2;MAPKAPK2;PTPN11;RARA;ILRUN;APP
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.29111318566320094,0.6418721464705297,0.8762057877813505,0.9922173146686556,1.0,5/14,27.64%,PES1;DDX18;RPL7;ZNHIT6;URB1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2568065911835884,0.641360204282706,0.8995633187772926,0.9922814202329382,1.0,3/25,8.71%,BAG1;SDF2;HSPA14
prerank,regulation of peptidase activity (GO:0052547),0.27564873121374783,0.641140561903244,0.8870728083209509,0.992074655218356,1.0,1/19,2.65%,CAV1
prerank,mitochondrial transcription (GO:0006390),0.30844635456487196,0.6401703913322603,0.8764415156507414,0.9925726259521881,1.0,1/10,3.62%,FOXO3
prerank,actin filament-based transport (GO:0099515),0.27513313662900407,0.6401609101063653,0.9085457271364318,0.9921782627990848,1.0,7/21,17.82%,MYO1H;MYO5A;MYO1C;MYO15A;ACTN4;MYO1E;SUN2
prerank,protein prenylation (GO:0018342),-0.2719776409503376,-0.6383331004185732,0.910941475826972,0.9958266098226701,1.0,5/10,33.85%,FNTB;CHM;PTAR1;RCE1;FNTA
prerank,histone deacetylation (GO:0016575),0.24071760370304987,0.6379829363572899,0.9258793969849246,0.9937505018277802,1.0,14/43,25.10%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;RCOR2;HDAC6;RCOR3;SFPQ;SIRT7;PER1;BAZ2A;PER2;HDAC8
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2659598461902519,0.6374888847107344,0.8712121212121212,0.9938162713129348,1.0,4/19,17.17%,PIPOX;SLC25A21;OGDH;DLST
prerank,regulation of DNA replication (GO:0006275),-0.17392601507931277,-0.6372807405986455,0.9952830188679245,0.9955661507152777,1.0,11/49,19.92%,GLI2;ACVRL1;USP37;KAT7;GLI1;ORC5;BCAR3;BLM;EGF;CTC1;STN1
prerank,protein targeting (GO:0006605),0.2099395128481233,0.6370919920513497,0.9615384615384616,0.9937709834931181,1.0,30/118,24.33%,TIMM10;HOMER3;TIMM44;ZDHHC12;VPS37B;TOMM5;PITRM1;GOLGA7;MYO1C;BCAP31;SPCS3;AP1S3;TOMM20;ZFAND6;TIMM17B;AP4E1;PEX6;VPS37A;PARD3;TIMM9;TOMM40;TSPO;ZDHHC3;SRP14;TIMM23;AP4M1;AIP;ARL6;RAB3IP;ATG3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.22033820194795367,-0.6366560193681506,0.9382352941176471,0.9950107228431798,1.0,7/19,21.68%,HPRT1;AMPD3;PNP;DCK;TYMS;GMPR2;CDA
prerank,histone deubiquitination (GO:0016578),0.27415551576412595,0.6365525675857138,0.8893939393939394,0.9938214145138505,1.0,6/18,21.28%,ENY2;USP3;TRRAP;USP16;USP21;USP22
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.22442112249014098,-0.6359608309706372,0.9173789173789174,0.9944766201554871,1.0,1/18,1.34%,FBN1
prerank,negative regulation of viral transcription (GO:0032897),0.2897456372000592,0.6355666393754181,0.8820826952526799,0.9943162659205098,1.0,3/13,9.41%,TRIM21;LARP7;TRIM11
prerank,negative regulation of JNK cascade (GO:0046329),0.24810584332999938,0.6355251441839774,0.9113756613756614,0.9939458546716173,1.0,10/31,25.58%,DUSP10;SH3RF2;HDAC3;NCOR1;DUSP3;TAOK3;MEN1;SIRPA;PER1;MAPK8IP1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.303743498040525,0.6354709718365488,0.858843537414966,0.9935918041842472,1.0,2/10,12.52%,PPP2CA;PTPN2
prerank,regulation of DNA recombination (GO:0000018),0.25029194949567096,0.6339786797452456,0.9027962716378163,0.994520840132566,1.0,7/32,20.33%,SHLD2;MRE11;IL7R;KDM1A;KPNA1;RAD50;THOC1
prerank,regulation of microtubule polymerization (GO:0031113),0.23997855214899172,0.6337805546720975,0.9235836627140975,0.9943016515777947,1.0,10/40,22.92%,OCLN;EML2;PSRC1;CAMSAP1;ABL1;CDH5;NUMA1;MAPT;CDK5R1;TBCD
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.30458958174438294,0.6337763207230448,0.8700657894736842,0.9939033691342499,1.0,2/10,13.96%,CNGB1;PDE6B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.2943237349711273,0.6335740317486596,0.8763066202090593,0.9936809983024324,1.0,3/11,16.45%,STAT4;JAK1;CANX
prerank,positive regulation of type 2 immune response (GO:0002830),0.2882881228046247,0.6330849351739893,0.8940397350993378,0.99370044678495,1.0,5/14,26.43%,CD81;PRKCZ;RARA;IL6;DENND1B
prerank,protein localization to Golgi apparatus (GO:0034067),0.2583442184949277,0.6316124287155299,0.9018492176386913,0.9945782975103984,1.0,7/27,17.51%,VPS13A;GOLPH3;GCC2;VPS13D;RAB33B;RIPOR1;ARFRP1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.24790507483522348,0.6303891857420352,0.9392712550607287,0.9952284103792522,1.0,11/33,25.28%,CDKN1A;DDRGK1;PKD1;PTPN6;ATP2B4;E2F1;FBXW7;PLK5;SUSD2;CRNN;TRIM39
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.26378305440486327,0.6302841531571592,0.9068047337278107,0.9949246143039552,1.0,4/21,12.80%,RASAL3;TGFB2;MAPKAP1;SYNGAP1
prerank,cilium movement (GO:0003341),0.23190225295328804,0.6297787930857691,0.940337224383917,0.9949783384042442,1.0,8/47,17.12%,CFAP91;CFAP54;CFAP206;ODAD3;SPAG17;ADCY10;DNAAF5;CFAP61
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24765821052057854,0.6293347582345712,0.9329829172141918,0.994962832465188,1.0,7/35,15.10%,MAGI2;PPP6R3;PPP1R15A;CRY2;PPP1R11;GSK3B;PPP1R1B
prerank,thymus development (GO:0048538),-0.243319181764866,-0.6292914943466865,0.9279778393351801,0.9977308246494266,1.0,7/13,39.27%,TBX1;EPHB3;SOD1;FOXE1;FADD;SHH;HES1
prerank,histone mRNA catabolic process (GO:0071044),-0.23263442007938923,-0.6290183644606583,0.9532163742690059,0.9969034997537467,1.0,4/15,25.39%,TUT4;TENT2;UPF1;DCP2
prerank,regulation of sequestering of triglyceride (GO:0010889),0.27784470489022356,0.6288678358085197,0.8869969040247678,0.9949653283306307,1.0,1/15,3.17%,ABHD5
prerank,atrioventricular valve development (GO:0003171),-0.24326488240726485,-0.6279585967792428,0.9376623376623376,0.9965968998896411,1.0,4/14,14.37%,NOTCH1;HEYL;SLIT3;BMPR2
prerank,regulation of leukocyte activation (GO:0002694),0.2833121984051481,0.6279289464244937,0.8832807570977917,0.9953394523487078,1.0,1/14,2.15%,CD200
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.25361241691537595,0.6274948434516111,0.8911845730027548,0.9953174289466784,1.0,3/29,8.80%,CAV1;PMAIP1;PML
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.20867624663861953,0.6268959093626042,0.9856353591160221,0.9954124126713605,1.0,26/125,21.29%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;AURKC;CENPT;PAFAH1B1;ZW10;EFHC2;CENPH;PLK2;MAD1L1;DYNC1LI2;CENPO;TTK;DYNC1H1;ZWINT;SUN2;INTS13;TBCE;CENPF;RCC2;WDR62;RMDN1;NUDC
prerank,cellular response to acid chemical (GO:0071229),0.2557288720078622,0.6268713362883007,0.9050279329608939,0.9950287739762018,1.0,4/27,12.58%,SESN2;SH3BP4;CAPN2;CPEB3
prerank,response to glucose (GO:0009749),0.2306053804338299,0.6254993312613285,0.9230769230769231,0.9958020308414798,1.0,11/46,21.69%,PRKAA2;EIF2B2;TCF7L2;KCNB1;IRS2;EIF2B4;PCK2;GPER1;GPLD1;SOX4;VAMP2
prerank,protein auto-ADP-ribosylation (GO:0070213),0.29564738648597205,0.6253808637481677,0.8840125391849529,0.9954927205965087,1.0,7/12,28.75%,PARP3;PARP6;TNKS2;PARP2;PARP11;PARP1;TIPARP
prerank,neurotransmitter secretion (GO:0007269),0.23175472780076317,0.6245849249719481,0.9319371727748691,0.9957098644736442,1.0,5/44,8.86%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,protein localization to kinetochore (GO:0034501),0.2843105293851861,0.6238387337647502,0.8946515397082658,0.9959264358063586,1.0,5/14,25.01%,CENPT;ZW10;TTK;RCC2;MIS12
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.30623932684914534,0.6235719115173435,0.8715447154471545,0.995754868419728,1.0,4/10,21.19%,TUT7;RPS27A;UBC;CHFR
prerank,cytoplasmic translational initiation (GO:0002183),0.2729809963753371,0.6235497067520374,0.9080996884735203,0.995370819930695,1.0,5/17,17.44%,EIF4B;EIF3M;EIF4G1;EIF4A1;EIF4A2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2801189540778769,0.6235249026309462,0.8911353032659409,0.994992650963295,1.0,3/14,17.34%,YBX3;BOLL;MAPKAPK2
prerank,membrane lipid metabolic process (GO:0006643),0.26247812669903514,0.6234294571222768,0.9025110782865583,0.9946863964583107,1.0,5/22,18.79%,AGK;ST3GAL6;ST6GALNAC4;SERINC1;TEX2
prerank,positive regulation of cellular senescence (GO:2000774),0.3040820223321278,0.6229986776517782,0.8869701726844584,0.9946309280220297,1.0,2/10,13.52%,YPEL3;EEF1E1
prerank,signal release from synapse (GO:0099643),0.23255723838251624,0.6228527005384024,0.9351851851851852,0.9943485170420046,1.0,5/43,8.86%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,alcohol catabolic process (GO:0046164),0.30039929622141665,0.6226874061640194,0.8752052545155994,0.9940897764240625,1.0,1/10,8.39%,SRD5A3
prerank,protein localization to chromatin (GO:0071168),-0.22228772814518377,-0.6218918392741514,0.9430379746835443,0.9993620328459282,1.0,5/18,18.84%,ESR1;TASOR;NIPBL;CHMP7;MRNIP
prerank,amyloid-beta metabolic process (GO:0050435),0.2785179500136281,0.6214778769911152,0.8846761453396524,0.9946884165107915,1.0,6/16,24.00%,MGAT3;BACE1;IDE;ABCA7;APH1A;PSEN1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2076117443324347,-0.620958830123229,0.954983922829582,0.9988765607597528,1.0,7/22,24.74%,PSMA6;PSMB10;PSMA4;PSMB9;PSMA8;PSMB7;PSMA3
prerank,positive regulation of cholesterol transport (GO:0032376),0.24571258045869754,0.6208018231381266,0.9166666666666666,0.9948514127991022,1.0,2/27,5.36%,CAV1;NFKBIA
prerank,negative regulation of biosynthetic process (GO:0009890),0.27386372168996925,0.6206265724186055,0.8841463414634146,0.9946050848973064,1.0,4/16,19.15%,ABCD1;COA8;PARK7;GPER1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2807897898807889,0.6204462705666166,0.8987138263665595,0.9943716490123615,1.0,1/13,5.45%,DUSP1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2172828286865296,-0.6198165411800763,0.9495548961424333,0.9985839920447909,1.0,12/18,51.85%,NCKAP1L;PRDM1;CCR2;PRKDC;IL4I1;IKZF3;CRTAM;ZFP36L2;TBX21;SLAMF8;PRELID1;CD2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.2961764780771581,0.6197893850434107,0.8862928348909658,0.9945191102253541,1.0,3/11,18.47%,ABCD1;COA8;PARK7
prerank,DNA replication initiation (GO:0006270),0.23743278163676929,0.6184318524370432,0.9302013422818792,0.9952032007035757,1.0,13/37,26.94%,POLE4;TOPBP1;CDK2;RPA3;MCM8;PRIM2;MCM6;MCM7;ORC2;MCM4;ORC3;RPA2;MCM2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2892103091746284,0.618375336513271,0.8956661316211878,0.9948525132687762,1.0,3/11,20.21%,LPCAT3;ATL2;ARL6IP1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.28941660081049253,0.6158932620396882,0.9030694668820679,0.9963732808678032,1.0,8/13,26.56%,CHP1;UFM1;SUFU;PARK7;RAB23;TPR;RANGAP1;APOD
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2541303975773773,0.615737621249637,0.922514619883041,0.9961055546100732,1.0,11/25,27.91%,LARP7;WDR43;ELL;HEXIM1;NELFB;NELFA;RNF168;LEO1;LDB1;CDK13;RNF8
prerank,intracellular sterol transport (GO:0032366),0.28645785225320497,0.6153498025934553,0.9090909090909091,0.9960141655970653,1.0,5/13,18.14%,NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,regulation of secretion (GO:0051046),0.2796558591579207,0.6153008860186676,0.8981191222570533,0.9956526360964973,1.0,4/13,19.44%,ERBB3;ACSL3;OAS2;GPLD1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2129073106597635,-0.6143549555426254,0.963076923076923,1.0,1.0,5/19,25.39%,NAT10;GNL3L;CTC1;STN1;DCP2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.23554122130679814,-0.6142779178000985,0.9551451187335093,0.999798871598898,1.0,5/13,23.34%,GPD1L;MAP1A;HSP90AB1;TYROBP;TMEM35A
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.22174817522185444,-0.613726083194755,0.9361111111111111,0.99911850186365,1.0,3/15,21.15%,BCL2L11;ZFP36;NR3C1
prerank,action potential (GO:0001508),0.2266469556703049,0.6124507434049844,0.9459459459459459,0.997446308062311,1.0,11/44,21.43%,SCN3A;ANK3;KCNB1;GNAQ;GNA11;SCN9A;GPER1;YWHAH;GNA15;KCNMB2;KCNMB3
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2887014277753272,0.6123771865041205,0.9016129032258065,0.9971121684849406,1.0,1/11,6.77%,PXDN
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2734341920169468,0.6117767384537522,0.9187898089171974,0.9972082234169556,1.0,2/15,8.99%,TGFB2;FOXP3
prerank,negative regulation of interferon-gamma production (GO:0032689),0.25427613961275786,0.6108422242653977,0.9201101928374655,0.9975467309447877,1.0,3/23,11.16%,ZC3H12A;FOXP3;TLR4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2874153793981074,0.610839352839968,0.8969230769230769,0.9971545130634586,1.0,2/12,9.55%,PCGF3;LRIF1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2674422172930042,0.6108061055615642,0.9058823529411765,0.9967839195596028,1.0,8/16,29.00%,PINX1;TNKS2;ERCC4;TERF2;TINF2;PARP1;TERF1;NAF1
prerank,activation of adenylate cyclase activity (GO:0007190),0.23575785449868822,0.6100886321910474,0.9375830013280213,0.9969272956417338,1.0,4/35,9.99%,ADCY9;ADCY6;LGR4;RAF1
prerank,regulation of rRNA processing (GO:2000232),0.2685023249994976,0.609776267661866,0.9209726443768997,0.9967751737177438,1.0,5/16,23.23%,BUD23;WDR43;TRMT112;SIRT7;SHQ1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.2573767763881045,0.6096226513915338,0.9121338912133892,0.9965021483826039,1.0,3/23,7.60%,TRIM33;LTBP4;LATS1
prerank,mitotic spindle organization (GO:0007052),0.19826004674198028,0.6091676206893214,0.9850905218317358,0.9964649866919322,1.0,43/153,25.80%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;AURKC;CENPT;PAFAH1B1;ZW10;RHOA;EFHC2;ABRAXAS1;CENPH;PLK2;MAD1L1;FLNA;DYNC1LI2;CENPO;TTK;DYNC1H1;CHEK2;AAAS;ZWINT;SUN2;INTS13;TBCE;MISP;CENPF;RCC2;WDR62;RMDN1;NUDC;CEP192;RANBP2;SMC3;TUBG1;CEP126;RANGAP1;MIS12;KIFC2;SEH1L;RPS27;DCTN2
prerank,innate immune response in mucosa (GO:0002227),0.2915439284877766,0.6088539788126799,0.8850393700787401,0.9963085019104985,1.0,1/10,9.98%,RNASE3
prerank,cellular response to heat (GO:0034605),0.2332799224090967,0.6086629379798275,0.9434724091520862,0.9960576418543611,1.0,9/35,24.31%,DAXX;BAG3;HSP90AA1;STUB1;MAPT;HIKESHI;TRPV4;TPR;PRKACA
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.21732726914042494,0.6085026594942755,0.9567307692307693,0.9957888752398809,1.0,13/59,18.80%,RELB;NFKBIA;TAB3;TNFRSF1A;TLR4;CHUK;TLR3;IKBKG;RNF31;RPS27A;UBC;TAB2;ROCK2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.19220052819481082,-0.6084142538580393,0.9787985865724381,1.0,1.0,7/27,28.33%,PPP1R16B;TGFB1;CNEP1R1;PPP1R7;CDCA2;CALM3;NSMF
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.25561468981469615,0.6082755415169463,0.9249291784702549,0.9955687138624608,1.0,5/22,16.77%,RBX1;DDB1;RPS27A;UBC;ERCC2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.2898927569540435,0.6068121538906853,0.8796147672552167,0.9962528762336552,1.0,3/11,16.09%,FBXO5;DONSON;LIG3
prerank,interstrand cross-link repair (GO:0036297),-0.16826682428071135,-0.6066522949048233,0.9946808510638298,1.0,1.0,16/53,26.17%,ERCC6L2;FANCL;FANCI;FANCC;USP1;FAAP100;FANCB;WDR48;FANCD2;DCLRE1A;NEIL3;EXO5;RAD51;ERCC1;RAD51AP2;CENPX
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.1824000717349376,-0.6060723793112013,0.9958677685950413,1.0,1.0,2/32,4.78%,CEMIP;PKD2
prerank,positive regulation of peptidase activity (GO:0010952),-0.2064625184733906,-0.605852291182353,0.9302325581395349,0.9995431726067824,1.0,4/20,17.91%,RCN3;MAPK12;PSME1;APH1B
prerank,methylguanosine-cap decapping (GO:0110156),-0.24823895720401218,-0.6043783012787755,0.9241706161137441,0.9994057915973595,1.0,2/10,12.41%,DCP1B;EDC4
prerank,regulation of DNA metabolic process (GO:0051052),0.2245467808644408,0.6043121516414206,0.9445145018915511,0.9976350788849752,1.0,16/44,25.10%,IL7R;GRHL2;MYC;POLH;UBE2N;NBN;KPNA1;PARG;NUCKS1;THOC1;TERF2;UBE2V1;SIRT7;CDK9;WDR18;HDAC8
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2697987536329861,0.6040405283571065,0.9090909090909091,0.9974352761798888,1.0,6/14,31.84%,ANKRD17;TLR3;TLR5;PUM2;PUM1;USP15
prerank,mesenchymal to epithelial transition (GO:0060231),0.2923325690403996,0.6030688649892512,0.8986486486486487,0.997743931827423,1.0,2/10,12.95%,BMP4;GATA3
prerank,regulation of viral life cycle (GO:1903900),0.24919790251930762,0.6025743851888725,0.9194729136163983,0.9976989512863688,1.0,5/21,21.77%,TRIM25;TRIM21;VPS4A;TSG101;TRIM5
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.2588749996592824,0.601987977506933,0.9354354354354354,0.9977328994017756,1.0,8/18,31.84%,ANKRD17;NPLOC4;BIRC3;C1QBP;NOP53;PUM2;PUM1;USP15
prerank,actin nucleation (GO:0045010),0.2535406166009199,0.6019159124458094,0.9147398843930635,0.9973885969681323,1.0,4/21,17.05%,LMOD3;MAGEL2;WASHC1;ARPC2
prerank,cellular response to amyloid-beta (GO:1904646),0.23307329527662582,0.6018570139835765,0.9408602150537635,0.9970402520447585,1.0,11/35,24.64%,EPHA4;CACNA1A;TLR6;TLR4;GSK3B;APP;AGER;ATP1A3;PSEN1;FYN;CACNA2D1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.24521762909113837,0.6017735139113963,0.9235048678720446,0.9966992385410266,1.0,4/26,12.96%,DUSP1;FBXO5;NSMCE2;ANAPC4
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.20443953843444684,0.601750479304898,0.9745011086474501,0.99632557558465,1.0,11/95,13.83%,VIM;ZC3H12A;TRIM41;FZD5;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.22480101506443562,-0.6001049342655995,0.9342857142857143,1.0,1.0,8/15,39.39%,SEL1L;SYVN1;FAF2;OS9;DERL1;UFD1;HERPUD1;VCP
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2451083074907009,0.6000226292557691,0.9369627507163324,0.9971411074365624,1.0,3/26,8.12%,FLOT2;LGR4;NLRP2B
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.2365768542104439,-0.5986398569650523,0.9342857142857143,0.9993243120741385,1.0,4/11,19.63%,DKC1;CCT7;CCT2;CCT4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.2365768542104439,-0.5986398569650523,0.9342857142857143,0.9993243120741385,1.0,4/11,19.63%,DKC1;CCT7;CCT2;CCT4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.24926290391323416,-0.5981480924202163,0.921760391198044,0.9985699544602987,1.0,5/10,27.75%,APC;SIRT2;ECT2;KNSTRN;SPAG5
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2763117303182652,0.5980397877690914,0.9046822742474916,0.998140429015727,1.0,4/12,26.94%,MCM6;MCM7;MCM4;MCM2
prerank,regulation of catabolic process (GO:0009894),-0.2152476848780469,-0.5959215724084944,0.963963963963964,0.9986227069821336,1.0,10/18,39.09%,FAP;HPGD;RARRES2;TMEM9;FAF1;ZDHHC2;FAM83D;ZDHHC7;SNF8;HGS
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2479415450848217,-0.5958087831205919,0.9262899262899262,0.9977039874868239,1.0,2/10,17.23%,LGALS9;RC3H1
prerank,positive regulation of phospholipid transport (GO:2001140),0.2888930257947968,0.5955324093010507,0.8938848920863309,0.9994900688009254,1.0,3/10,23.47%,TRIAP1;ABCA7;ABCB4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.27426663250253236,0.5948534350469571,0.9004739336492891,0.9995509851368922,1.0,3/13,13.67%,SRD5A3;ALG1;ALG12
prerank,response to molecule of bacterial origin (GO:0002237),0.20785018910109387,0.5947658072546732,0.9837587006960556,0.9992219133624205,1.0,11/69,17.63%,SMAD6;SLPI;FZD5;LBP;TLR4;PELI1;IRAK1;FOXP1;F2R;MAPKAPK2;TAB2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.2863479800615759,0.5930681301722145,0.9250425894378195,0.9999510374045584,1.0,2/10,12.17%,WWP2;SNX12
prerank,cell junction maintenance (GO:0034331),0.2696805156444144,0.5929309094299328,0.9183359013867488,0.999656458012929,1.0,3/14,17.29%,NLGN2;PRTN3;F2R
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.23671633072313186,0.5927863922306705,0.9427792915531336,0.998973102177994,1.0,2/29,9.11%,ACOT8;ACSM3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.23671633072313186,0.5927863922306705,0.9427792915531336,0.998973102177994,1.0,2/29,9.11%,ACOT8;ACSM3
prerank,negative regulation of histone modification (GO:0031057),0.26647581199166104,0.591697099672811,0.9366883116883117,0.9993162979465889,1.0,3/14,14.24%,FOXP3;TWIST1;SET
prerank,positive regulation of DNA repair (GO:0045739),0.22085507635006743,0.5909732545292803,0.9528795811518325,0.9993755543587722,1.0,8/46,15.76%,EYA2;FOXM1;EYA1;TIGAR;ABRAXAS1;DHX9;PCNA;UBE2N
prerank,autophagosome assembly (GO:0000045),0.2187371172256951,0.5904550074992609,0.9613466334164589,0.999310731729792,1.0,23/52,29.51%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;GABARAPL2;ATG3;UBXN2A;PACS2;WIPI2;ATG2B;STX12;ATG12;TRAPPC8;WDR45;RAB19;WIPI1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.21993350563325606,-0.5896912660898241,0.9512893982808023,0.9996151455691291,1.0,6/16,24.80%,AUTS2;BCOR;WDR5;PAXIP1;SMAD4;BRCA1
prerank,fatty acid transport (GO:0015908),0.2565692081703793,0.5893978782259783,0.9204892966360856,0.9996093341603784,1.0,4/17,18.33%,SLC27A3;CPT1B;SLC25A17;SLC27A4
prerank,lipoprotein catabolic process (GO:0042159),0.27987742378233094,0.5889903937859725,0.9110032362459547,0.9994926361330746,1.0,3/11,19.43%,ABHD10;LYPLAL1;ABHD17C
prerank,positive regulation of hormone secretion (GO:0046887),-0.2169365273132006,-0.58856733245325,0.973293768545994,0.9992057296566047,1.0,12/17,50.57%,EDN1;SOX11;EDN3;GRP;RASL10B;VAMP8;NMB;C1QTNF3;PLA2G3;TFR2;CYP19A1;HCAR2
prerank,DNA recombination (GO:0006310),0.22181948652643996,0.585504017930537,0.9521857923497268,1.0,1.0,3/37,8.09%,RECQL4;MRE11;RAD54L
prerank,cranial nerve development (GO:0021545),-0.23948988823046508,-0.5850039361761414,0.9340659340659341,0.9998140691134698,1.0,2/11,7.59%,SALL1;CHD7
prerank,alpha-amino acid catabolic process (GO:1901606),0.23625776230923398,0.5849824990823644,0.9337931034482758,1.0,1.0,8/29,24.55%,TDO2;HAAO;PRODH;KYAT1;HSD17B10;SARDH;BLMH;KMO
prerank,RNA methylation (GO:0001510),0.2117091445004017,0.5840233793065043,0.9660606060606061,1.0,1.0,8/60,12.33%,NOP2;BUD23;LCMT2;CBLL1;THADA;METTL6;THUMPD3;WDR6
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.24987922377470312,0.5830690839194005,0.927007299270073,1.0,1.0,7/21,22.77%,FBXO5;ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.22451013640871492,0.582792474154646,0.9536423841059603,1.0,1.0,6/37,13.74%,SIDT2;XRN2;RNASE3;DNASE1L2;MTREX;DNASE1L1
prerank,vacuolar acidification (GO:0007035),-0.19994188018741846,-0.5825722044917879,0.9801324503311258,0.999864367492569,1.0,9/21,30.41%,ATP6V1H;CLN3;CLN6;CCDC115;TMEM9;ATP6V0A4;DMXL1;SLC11A1;PPT1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.19014735802958,-0.5816425785966574,0.9617834394904459,0.9993128784145217,1.0,5/22,22.25%,DTX1;B2M;NEPRO;BMP7;HEY1
prerank,cellular response to increased oxygen levels (GO:0036295),0.2732416705205034,0.5810372868695568,0.9114331723027376,1.0,1.0,1/11,2.65%,CAV1
prerank,glial cell development (GO:0021782),0.23999065988920265,0.5805008038974183,0.9326647564469914,1.0,1.0,2/25,6.19%,CDK6;EIF2B2
prerank,telomere maintenance via recombination (GO:0000722),0.2723046153274407,0.5791216180627101,0.9285714285714286,1.0,1.0,4/11,19.89%,NSMCE2;SMC6;RAD50;ERCC4
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.21650096702891536,-0.5785475793721326,0.9558823529411765,0.9995705036893703,1.0,10/14,49.68%,TRAF6;CSF1;TYROBP;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,Golgi inheritance (GO:0048313),0.2702648724004856,0.5780738559178908,0.918825561312608,1.0,1.0,2/11,11.78%,PLK3;YWHAZ
prerank,lipoxygenase pathway (GO:0019372),0.2592525517490871,0.5779089364201542,0.9356357927786499,1.0,1.0,2/14,11.30%,ALOX5;PON3
prerank,RNA modification (GO:0009451),0.20777724022053298,0.5774959692949505,0.9713574097135741,1.0,1.0,7/54,10.27%,NOP2;LCMT2;ELP5;TRIT1;THG1L;AARS1;ANKRD16
prerank,regulation of myotube differentiation (GO:0010830),0.2428678126937545,0.5774815533595274,0.9399141630901288,1.0,1.0,3/24,10.50%,HDAC5;HDAC4;HDAC3
prerank,carbohydrate transport (GO:0008643),-0.23482340276111502,-0.5769638715440346,0.946236559139785,0.9992960191249354,1.0,8/11,46.00%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;SLC50A1;SLC2A5;AQP9
prerank,negative regulation of double-strand break repair (GO:2000780),0.22894127824629662,0.5767922477350006,0.9594594594594594,1.0,1.0,5/30,14.23%,SHLD2;KLHL15;RIF1;TWIST1;UBR5
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.2438424627008286,-0.5767897800103333,0.9536585365853658,0.9983886865978129,1.0,5/10,37.07%,THAP7;NOC2L;BRCA1;KLF15;TAF7
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23197504776636832,0.5758382415388548,0.9534883720930233,1.0,1.0,13/28,26.06%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2;OTULIN;UBE2V1;CASP8;TAB1;RELA
prerank,ribosomal subunit export from nucleus (GO:0000054),0.2622203451189787,0.5746389494781283,0.9308176100628931,1.0,1.0,2/13,9.70%,EIF6;SDAD1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2546185085998121,0.5744022147032208,0.9316109422492401,1.0,1.0,7/16,32.20%,DAZAP1;CELF4;RBM3;RBMXL1;TRA2B;NCL;NUP98
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.23745540779995583,0.5743460273658361,0.9392655367231638,1.0,1.0,8/24,17.63%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2474673956459948,0.5724673172687935,0.946824224519941,1.0,1.0,4/19,18.65%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,autophagosome organization (GO:1905037),0.2138677973372502,0.5723888504831586,0.9699248120300752,1.0,1.0,23/50,30.19%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;GABARAPL2;ATG3;UBXN2A;PACS2;WIPI2;ATG2B;STX12;ATG12;WDR45;RAB19;WIPI1;ATP13A2
prerank,cytoplasmic translation (GO:0002181),0.2002995138718485,0.57222101789297,0.9851258581235698,1.0,1.0,29/91,27.55%,TMA7;RPS4X;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;RPL10A;EIF3M;EIF4A1;RPL14;RPS27A;EIF4A2;RPL6;RPS28;ETF1;RPL41;RPLP1;RPL7;RPL21;RPL26;RPS27;RPS12;FTSJ1;RPL18;RPS17;RPS3;RPL22L1
prerank,regulation of cholesterol transport (GO:0032374),0.24537551754749756,0.5722193315638986,0.9341142020497804,1.0,1.0,3/20,14.46%,TTC39B;ABCA2;NUS1
prerank,cilium-dependent cell motility (GO:0060285),-0.19163811571255873,-0.5718887818265832,0.971875,0.9994383993661177,1.0,10/22,35.74%,CFAP44;RFX3;DNAH3;DNAH2;CCDC39;RSPH9;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,establishment of spindle localization (GO:0051293),0.257393618413696,0.5715822511671823,0.9285714285714286,1.0,1.0,5/14,21.85%,MAP4;LLGL2;DYNC1H1;TLE6;LLGL1
prerank,TOR signaling (GO:0031929),0.22805793620491444,0.5710557137491471,0.953257790368272,1.0,1.0,11/26,28.74%,EIF4EBP1;MAPKAP1;GATA3;CCDC88A;FLCN;EIF4EBP2;TIPRL;SYAP1;AKT1;LARP1;RPS6
prerank,rRNA 3'-end processing (GO:0031125),0.27780716223302937,0.5707568287182638,0.9228187919463087,1.0,1.0,2/10,9.41%,EXOSC3;ERI3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.26821919527964355,0.5698117501206307,0.939935064935065,1.0,1.0,12/12,73.20%,PRKCQ;NLRP10;IL1B;CLEC6A;IL12B;IL23R;ZBTB1;IL23A;CARD9;IL12RB1;CCR2;SLC11A1
prerank,nucleoside salvage (GO:0043174),-0.24006193139998874,-0.5693056229731163,0.9336870026525199,0.9995025116911082,1.0,4/10,22.88%,HPRT1;DCK;CDA;UCK1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.21882559373121213,0.5690642318419159,0.972936400541272,1.0,1.0,6/34,15.26%,LGR4;NLRP2B;RAB7B;TLR6;TLR4;TLR3
prerank,regulation of transposition (GO:0010528),0.26145637162586316,0.568469414552835,0.9341500765696784,1.0,1.0,13/13,73.88%,MYBL1;SIRT7;TEX15;SMYD5;AICDA;UBR2;PIWIL1;BTBD18;SPOCD1;PIWIL4;DDX4;TDRD9;PIWIL2
prerank,response to lipopolysaccharide (GO:0032496),0.18775759277408963,0.5671104274286028,0.9935622317596566,1.0,1.0,19/138,17.63%,VIM;SMAD6;ZC3H12A;SLPI;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;PELI1;IRAK1;MEF2C;FOXP1;PABPN1;F2R;GIT1;MAPKAPK2;TAB2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.24506933852483614,0.5667993327766241,0.9196969696969697,1.0,1.0,3/17,21.69%,ANK3;KCNRG;VAMP2
prerank,replication fork processing (GO:0031297),0.21935610222521104,0.5663575360006061,0.9659239842726082,1.0,1.0,11/38,25.26%,MRE11;CENPS;ATRX;MMS22L;PCNA;ATR;NUCKS1;THOC1;CDK9;FANCM;FBH1
prerank,RNA catabolic process (GO:0006401),0.21049222669418105,0.5655031612278433,0.9834183673469388,1.0,1.0,5/46,10.46%,FEN1;SIDT2;XRN2;RNASE3;MTREX
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.18398827431207398,-0.5650310049133342,0.9832775919732442,1.0,1.0,4/25,14.39%,SRSF4;SRSF10;TXNL4A;WDR83
prerank,inner dynein arm assembly (GO:0036159),0.2713864306784662,0.5613147479542272,0.9275123558484349,1.0,1.0,10/10,72.88%,DNAAF5;DNAAF4;CFAP73;ZMYND10;DNAI3;DNAAF1;DNAH1;CCDC40;CFAP100;CCDC39
prerank,tRNA export from nucleus (GO:0006409),0.22140709887862622,0.5613046598486016,0.9749303621169917,1.0,1.0,12/32,26.81%,NUP93;NDC1;NOL6;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.22140709887862622,0.5613046598486016,0.9749303621169917,1.0,1.0,12/32,26.81%,NUP93;NDC1;NOL6;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,myeloid cell differentiation (GO:0030099),0.20933114570963968,0.5612439074797788,0.9774718397997497,1.0,1.0,6/47,12.52%,ACIN1;ZBTB16;EPO;ATP5IF1;SLC25A38;PTPN2
prerank,ncRNA 3'-end processing (GO:0043628),0.24859666907757913,0.560379519498632,0.940625,1.0,1.0,3/14,18.77%,INTS2;TRNT1;INTS6
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.22847734389511004,-0.560096965048352,0.9430051813471503,0.9999857793605186,1.0,5/11,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.22847734389511004,-0.560096965048352,0.9430051813471503,0.9999857793605186,1.0,5/11,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2636836419703896,0.5583737079179234,0.9475308641975309,1.0,1.0,4/12,23.18%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.2636836419703896,0.5583737079179234,0.9475308641975309,1.0,1.0,4/12,23.18%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2636836419703896,0.5583737079179234,0.9475308641975309,1.0,1.0,4/12,23.18%,NSMCE2;ANAPC4;RB1;CDC23
prerank,sulfate transport (GO:0008272),0.253999114978875,0.5578955686686714,0.9308755760368663,1.0,1.0,3/14,13.62%,SLC13A4;SLC25A14;SLC26A4
prerank,acyl-CoA metabolic process (GO:0006637),0.2168473795330976,0.5574957489847536,0.9774834437086093,1.0,1.0,8/35,22.89%,ACOT8;ACSM3;ACACA;OGDH;DLST;HMGCS1;SUCLA2;MLYCD
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2265381758450037,0.5571570144817334,0.9552447552447553,1.0,1.0,8/26,17.63%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.24381876430411806,0.5564173845485263,0.9403453689167975,1.0,1.0,2/20,7.98%,TARBP2;TSNAX
prerank,apoptotic nuclear changes (GO:0030262),-0.1865866725044002,-0.5558082273630889,0.996742671009772,1.0,1.0,9/24,25.45%,CECR2;DNASE2;HMGB1;EXOG;ACVR1C;DICER1;TOP2A;FOXL2;BLCAP
prerank,V(D)J recombination (GO:0033151),-0.2283555292752641,-0.5552886227067424,0.9634464751958225,0.9996531982606469,1.0,2/11,16.46%,LIG1;HMGB1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.22931429700124467,0.5550602409425935,0.9504950495049505,1.0,1.0,3/22,9.41%,PES1;EXOSC3;ERI3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2672391822574336,0.5544611182984358,0.9257425742574258,1.0,1.0,3/10,26.02%,ATRX;STOML2;WIZ
prerank,glycogen biosynthetic process (GO:0005978),-0.21473905124121262,-0.5515392972094982,0.9727047146401985,0.9989552927531989,1.0,6/12,29.96%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),-0.21473905124121262,-0.5515392972094982,0.9727047146401985,0.9989552927531989,1.0,6/12,29.96%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2661004882439965,0.5514555495193679,0.9459901800327333,1.0,1.0,1/10,5.27%,PIH1D1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.2296057769537647,0.5511918225268211,0.962589928057554,1.0,1.0,5/25,13.41%,DDX39B;WDR43;ELL;HMGN1;TCEA2
prerank,regulation of cilium movement (GO:0003352),0.26700955595311454,0.5508143281938876,0.947098976109215,1.0,1.0,3/10,24.02%,CFAP206;ODAD2;DRC1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.26657877166820937,0.5497977656232909,0.9224283305227656,1.0,1.0,2/10,11.00%,DDX39B;FEM1B
prerank,regulation of T cell activation (GO:0050863),0.20272362491651008,0.5489309734424845,0.986198243412798,1.0,1.0,6/42,18.69%,CCL5;LGALS3;ABL1;DUSP3;PRKCQ;GPNMB
prerank,snRNA processing (GO:0016180),0.23741017123990538,0.5485107519547588,0.941717791411043,1.0,1.0,5/16,22.46%,INTS2;INTS3;INTS6;TUT1;INTS1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.1936314835127822,0.5471448855688216,0.9904306220095693,1.0,1.0,14/57,24.10%,GLUL;PES1;SDAD1;NIP7;HEATR3;PAK1IP1;RPL14;METTL17;RPS28;BYSL;RPL7;WDR74;SHQ1;RPL26
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.25620294165318097,0.5471320566030411,0.931095406360424,1.0,1.0,5/10,26.16%,VPS9D1;ATP5PD;ATP5F1D;ATP5F1C;ATP5MC3
prerank,pseudouridine synthesis (GO:0001522),-0.20999920263693908,-0.54633785261283,0.9817708333333334,0.999577518888431,1.0,3/13,19.85%,PUS7;DKC1;NOP10
prerank,DNA dealkylation (GO:0035510),0.2644197577355174,0.5449479679193645,0.9433333333333334,1.0,1.0,10/10,73.57%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.2644197577355174,0.5449479679193645,0.9433333333333334,1.0,1.0,10/10,73.57%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.22215423588709132,0.5449038566858891,0.9696969696969697,1.0,1.0,7/23,25.26%,DNASE1L2;DNASE1L1;REXO4;KPNA1;CASP3;DFFA;FBH1
prerank,organonitrogen compound catabolic process (GO:1901565),0.194044838959701,0.5432531859588711,0.9925925925925926,1.0,1.0,14/57,22.81%,NAGK;GGACT;NPEPPS;ADO;LTA4H;TXN2;SMPD2;PLA2G6;SIAH1;IDE;PDXDC1;LVRN;GNPDA2;SGPL1
prerank,sensory perception of taste (GO:0050909),0.2585828155400741,0.5429437282446736,0.9420289855072463,1.0,1.0,10/10,74.16%,PKD2L1;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3
prerank,P-body assembly (GO:0033962),-0.21421797790326144,-0.5388911967902108,0.9700272479564033,1.0,1.0,5/12,24.76%,EIF4ENIF1;ATXN2;RC3H1;LIMD1;LSM3
prerank,positive regulation of cell division (GO:0051781),0.20476471623596224,0.5388186378306317,0.9757738896366084,1.0,1.0,7/38,20.17%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,hexose transmembrane transport (GO:0008645),0.22230864685322282,0.5383919397071709,0.9685714285714285,1.0,1.0,3/21,12.59%,SLC2A12;SLC2A8;SLC2A9
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.24888631220000157,0.5377454128643043,0.9464285714285714,1.0,1.0,3/13,17.41%,UBE2G2;BCAP31;UBE2J1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.20930065987163715,0.5372120881078332,0.9814077025232404,1.0,1.0,17/40,30.87%,CENPS;ATRX;MMS22L;DONSON;PCNA;ATR;NUCKS1;THOC1;CDK9;FANCM;FBH1;POLD1;SETMAR;PRIMPOL;ZRANB3;DDX11;RFWD3
prerank,glutathione metabolic process (GO:0006749),0.20751573697645675,0.5364369950640584,0.9750982961992136,1.0,1.0,6/38,18.47%,HAGH;CTNS;HPGDS;GSTK1;GSTM2;PARK7
prerank,positive regulation of bone resorption (GO:0045780),0.2593639281753022,0.5349938495314727,0.9474548440065681,1.0,1.0,3/11,24.30%,PLEKHM1;ATP6AP1;PRKCA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.24072242733380877,0.534947459411762,0.9569377990430622,1.0,1.0,6/14,28.72%,TRPT1;CLP1;TSEN2;FAM98B;CSTF2;RTCB
prerank,protein monoubiquitination (GO:0006513),0.20193522568326536,0.5315806864262554,0.9847328244274809,1.0,1.0,5/36,12.16%,TRIM25;TRIM21;RBX1;UBE2B;RNF126
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.25128553069138676,0.5307532619710508,0.9547657512116317,1.0,1.0,1/11,4.79%,AHCYL1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.18559529550809498,-0.5306112831904035,0.9801699716713881,1.0,1.0,3/18,17.40%,LYN;SPG21;SH2B2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22597548022685093,0.5304509443919099,0.9653543307086614,1.0,1.0,7/19,26.17%,ELL;POLR3C;POLR3G;NAB2;POLR3F;ICE1;ZC3H8
prerank,mitotic sister chromatid segregation (GO:0000070),0.1785423168202965,0.5303202042753281,0.9954699886749717,1.0,1.0,30/98,26.60%,PSRC1;CHMP4A;CHMP4B;TENT4A;NCAPD3;ZW10;VPS4B;CHMP1A;PINX1;VPS4A;SET;CHMP2A;NCAPH2;PDCD6IP;ZWINT;RB1;PHF13;NUDC;NCAPH;SMC4;KMT5A;CDC23;TUBG1;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,snRNA 3'-end processing (GO:0034472),-0.18469260913395105,-0.529792425420886,0.9848942598187311,1.0,1.0,9/19,32.84%,EXOSC7;EXOSC2;INTS14;TOE1;USB1;INTS5;EXOSC9;EXOSC5;EXOSC8
prerank,cellular modified amino acid catabolic process (GO:0042219),0.24083376164563297,0.5297788524076856,0.9649923896499238,1.0,1.0,1/15,3.38%,GGACT
prerank,regulation of protein localization (GO:0032880),0.1911882682829802,0.5291270757060229,0.9951980792316927,1.0,1.0,15/58,22.77%,TRIM25;TRIM21;DVL3;CSNK1E;SLC26A4;VPS4A;HSP90AA1;TESK1;AAK1;KDM1A;RAB9A;FBXW7;TRIM5;ADCYAP1;TPR
prerank,global genome nucleotide-excision repair (GO:0070911),0.21657023739619496,0.5278828426026426,0.9734265734265735,1.0,1.0,6/26,19.89%,RBX1;DDB1;RPS27A;UBC;ERCC2;ERCC4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.17271550149884693,-0.527315879203034,0.9930313588850174,1.0,1.0,5/24,19.92%,TNKS;NAT10;GNL3L;CTC1;STN1
prerank,pinocytosis (GO:0006907),0.26017293930488594,0.5264846476159214,0.9515050167224081,1.0,1.0,2/10,17.34%,SNX33;MAPKAPK2
prerank,regulation of double-strand break repair (GO:2000779),0.19874475584957726,0.5220199790430115,0.9885786802030457,1.0,1.0,6/39,16.83%,SHLD2;FOXM1;PML;TWIST1;UBR5;KDM1A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.18672689431929732,0.5209294541543623,0.9938042131350682,1.0,1.0,12/54,19.54%,NLRP2B;TNFRSF1A;PYDC1;CARD16;PTPN2;CHUK;IKBKG;RNF31;SPPL2B;OTULIN;SPPL2A;ADAM17
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.23433718407911888,0.5207964793380904,0.9602446483180428,1.0,1.0,3/15,17.05%,MAGEL2;WASHC1;ARPC2
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.16134980368509375,-0.5205880110360044,0.9963503649635036,1.0,1.0,6/29,19.57%,TENT5A;EIF4ENIF1;AXIN2;TENT5D;FMR1;NOCT
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2328185048721817,0.5184167028261871,0.968503937007874,1.0,1.0,2/15,11.69%,PMAIP1;IRS2
prerank,modulation by symbiont of host process (GO:0044003),-0.21542595318695845,-0.517541361212617,0.9796437659033079,1.0,1.0,6/10,39.09%,B2M;MRC1;UBB;UBA52;TLR2;HGS
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.243306714497115,0.5173645998760078,0.9621087314662273,1.0,1.0,1/11,8.99%,FOXP3
prerank,lipid droplet organization (GO:0034389),-0.17347708398086908,-0.5147685078325216,1.0,1.0,1.0,5/22,22.42%,CDS2;PNPLA3;PLA2G4C;RAB3GAP1;FITM2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.16098918299029508,-0.514752167430546,0.9964912280701754,1.0,1.0,7/27,25.77%,IL6R;NCKAP1L;ICAM1;EDN3;CSF1;JAM3;ADAM8
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.23955126125900378,0.5139143174890122,0.9585406301824212,1.0,1.0,3/13,17.57%,KPNA7;KPNA4;KPNA1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.17677277837709557,0.5126646393078986,0.997737556561086,1.0,1.0,29/91,28.78%,SIL1;RPS4X;SSR1;RPL31;RPSA;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;ARL6IP1;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17;RPS3;RPL24;RPS6;SSR2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2543685146107304,0.5118340064426399,0.9519725557461407,1.0,1.0,2/10,17.35%,HP;HDAC6
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.20570183529083264,-0.5114072539065192,0.9770408163265306,0.9999865914298814,1.0,1/11,6.60%,UBQLN1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.18660796088382137,-0.5056186669922644,0.9852941176470589,1.0,1.0,8/16,37.55%,HUS1;TIPIN;ORC1;CDC45;DNA2;NAE1;RAD9B;TICRR
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.21022379401141156,0.5054871768176241,0.9816124469589816,1.0,1.0,2/22,9.26%,ZDHHC12;GOLGA7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.21022379401141156,0.5054871768176241,0.9816124469589816,1.0,1.0,2/22,9.26%,ZDHHC12;GOLGA7
prerank,protein localization to chromosome (GO:0034502),0.19458378127293297,0.5044141581747514,0.9920739762219286,1.0,1.0,9/34,20.98%,PARP3;ATRX;PINX1;MCM8;TNKS2;ATR;WAPL;RB1;TERF2
prerank,regulation of microtubule nucleation (GO:0010968),0.24088020135104982,0.5040058140381637,0.9728813559322034,1.0,1.0,2/10,17.30%,EML2;GIT1
prerank,protein localization to condensed chromosome (GO:1903083),-0.20149003219750344,-0.503877852922105,0.9822335025380711,0.9996487916182912,1.0,4/12,22.54%,IK;ZWILCH;BUB3;KNL1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.22559698750384347,0.5029112408954834,0.9722650231124808,1.0,1.0,3/15,18.75%,MUL1;PTPN2;YTHDF3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.2208676306729821,0.5026766682416065,0.9654654654654654,1.0,1.0,6/18,21.14%,ACTB;ABCA2;VTI1B;VPS4A;MISP;MMP14
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.1880453764802037,0.5014935712537764,0.9909443725743855,1.0,1.0,17/45,29.93%,FOXO3;GCNT2;MEX3D;EIF2B4;APP;GEMIN5;ZC3H7A;EIF2A;PER1;TCOF1;ZC3H10;RBM3;LARP1;TRIM71;PUM2;METTL18;CYFIP1
prerank,inositol phosphate catabolic process (GO:0071545),-0.1985424868660722,-0.5005591177387095,0.9738903394255874,0.9992925912505274,1.0,5/12,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,female gonad development (GO:0008585),0.21474070623425545,0.4977871607408618,0.9723435225618632,1.0,1.0,2/19,7.61%,EIF2B2;ANG
prerank,mitotic nuclear division (GO:0140014),0.17318651539722962,0.49746387917089896,0.9953488372093023,1.0,1.0,21/71,25.13%,NDEL1;KIF2A;PPP2R2D;CHMP4B;ZW10;RHOA;ABRAXAS1;CHMP2A;FLNA;CHEK2;AAAS;ZWINT;MISP;SMC4;CEP192;SMC3;KLHDC8B;TUBG1;MIS12;NUP62;KIFC2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.18102047290698722,-0.4965461942895905,1.0,0.999055400476635,1.0,7/17,31.03%,IK;BOD1;ZWILCH;BUB3;KNL1;SPDL1;CENPA
prerank,male meiosis I (GO:0007141),0.21465597290370722,0.4964023737457827,0.9737654320987654,1.0,1.0,4/16,23.43%,MOV10L1;MYBL1;BRDT;FOXJ2
prerank,mitotic spindle assembly (GO:0090307),0.1870643317846432,0.49549259595020967,0.9894179894179894,1.0,1.0,12/42,25.13%,KIF2A;AURKC;RHOA;ABRAXAS1;FLNA;CHEK2;AAAS;MISP;CEP192;SMC3;RACGAP1;KIFC2
prerank,body fluid secretion (GO:0007589),0.2218343859630144,0.49294483847529,0.9778129952456418,1.0,1.0,1/15,6.57%,ZBTB7B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.17253157859067128,0.4921234012358601,0.9988249118683902,1.0,1.0,16/70,24.75%,PSMD11;PSMD4;PSMF1;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;SNAP23;FCGR1A;PSMA7;IKBKB;TAPBP
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2077427192360406,0.4911560661046417,0.9823269513991163,1.0,1.0,4/21,18.47%,ABCD1;COA8;HDAC6;PARK7
prerank,positive regulation of cilium assembly (GO:0045724),0.21513155071129328,0.4908316836751934,0.9847560975609756,1.0,1.0,6/18,23.98%,MARK4;SEPTIN9;CCDC88A;CROCC;TAPT1;CEP120
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.20483699899546187,-0.4901331457369375,0.9847328244274809,0.997299878727372,1.0,1/11,2.87%,PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),-0.20483699899546187,-0.4901331457369375,0.9847328244274809,0.997299878727372,1.0,1/11,2.87%,PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.20483699899546187,-0.4901331457369375,0.9847328244274809,0.997299878727372,1.0,1/11,2.87%,PANK2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2357371493127472,0.489868526664679,0.9785123966942149,1.0,1.0,10/10,76.44%,NPLOC4;C1QBP;SEC14L1;RNF125;GPATCH3;TSPAN6;RIOK3;UFD1;DHX58;TKFC
prerank,histone ubiquitination (GO:0016574),0.20656625403261747,0.489868461805067,0.9820627802690582,1.0,1.0,6/21,23.50%,UBE2B;UBE2N;USP22;UBE2E1;CTR9;LEO1
prerank,maintenance of protein localization in organelle (GO:0072595),0.21172842813551407,0.489605710002925,0.9817351598173516,1.0,1.0,5/19,23.63%,PML;HK1;ARL2BP;TAF8;TAPT1
prerank,histone exchange (GO:0043486),0.18728195702119763,0.4867988135256138,0.9894875164257556,1.0,1.0,7/37,17.92%,CENPS;CENPT;SRCAP;CENPH;CENPO;SPTY2D1;ZNHIT1
prerank,autophagy of mitochondrion (GO:0000422),-0.1434768940584722,-0.48503178145265036,1.0,0.9971277637525002,1.0,38/38,85.69%,ATG5;FIS1;FUNDC2;MAP1LC3A;GABARAP;PHB2;AMBRA1;ATG14;ATG7;ULK2;USP30;BECN1;MARK2;GABARAPL1;FUNDC1;ATG9B;ATG9A;SQSTM1;SPATA18;PINK1;ATG2A;WDR45B;BNIP3;ATG13;PRKN;WIPI1;WDR45;ATG12;FBXO7;CISD2;ATG2B;WIPI2;ATG3;GABARAPL2;CTSK;RB1CC1;MAP1LC3B;ULK1
prerank,negative regulation of innate immune response (GO:0045824),0.18687195306612503,0.4843373866574812,0.9906417112299465,1.0,1.0,4/34,12.52%,MUL1;TRIM21;NMI;PTPN2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2132325608203075,0.48151420726411853,0.985207100591716,1.0,1.0,3/18,16.57%,RNF5;RPS27A;UBC
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.21093960403120882,0.47801663200655586,0.984399375975039,1.0,1.0,2/16,8.49%,CHMP4A;CHMP4B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.16657296391830104,0.47348161877094447,1.0,1.0,1.0,15/67,24.75%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;SNAP23;FCGR1A;PSMA7;IKBKB;TAPBP
prerank,regulation of chromosome organization (GO:0033044),0.19260326018556953,0.4731426456112761,0.9869186046511628,1.0,1.0,9/22,29.49%,MYC;WAPL;RB1;MAPT;TERF2;HDAC8;XRCC5;SETMAR;TERF2IP
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.21141802933007825,0.47284609244451725,0.9824561403508771,1.0,1.0,6/15,28.72%,TRPT1;CLP1;TSEN2;FAM98B;CSTF2;RTCB
prerank,protein targeting to ER (GO:0045047),0.16038828624590137,0.4728393529799509,1.0,1.0,1.0,26/99,26.54%,RPS4X;CHMP4A;CHMP4B;RPL31;RPSA;RPL22;SPCS3;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SGTA;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17
prerank,regulation of centriole replication (GO:0046599),0.2049574120664745,0.47263945157131587,0.983358547655068,1.0,1.0,5/17,25.07%,CEP76;PLK2;TRIM37;PLK4;NUP62
prerank,osteoclast differentiation (GO:0030316),0.19585806846509646,0.46559404772234936,0.9900142653352354,1.0,1.0,3/22,14.18%,ANXA2;SBNO2;FOXP1
prerank,piRNA metabolic process (GO:0034587),0.20086330064970714,0.4628395503578442,0.9912663755458515,1.0,1.0,2/19,14.06%,MOV10L1;MYBL1
prerank,DNA biosynthetic process (GO:0071897),-0.16713912153917523,-0.46277262218394327,0.9972067039106145,0.9990548786002644,1.0,7/16,35.01%,WRNIP1;TYMS;RFC3;POLA1;POLD4;POLL;POLD3
prerank,ribosomal small subunit biogenesis (GO:0042274),0.18012310986138783,0.46198842706872256,0.9947575360419397,1.0,1.0,7/39,21.35%,MRPS7;RPSA;PWP2;UTP4;METTL17;RPS28;DDX52
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.20128960185481434,0.45863374078024,0.991044776119403,1.0,1.0,2/17,10.23%,TGFB2;ARL6IP5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.21511119737301873,0.45247526214383205,0.992,1.0,1.0,1/11,11.40%,PKD2L1
prerank,oogenesis (GO:0048477),-0.1681457096274909,-0.4521802232519662,0.9972677595628415,0.9992066872162,1.0,5/15,32.77%,MARF1;PIWIL2;NANOS3;TRIP13;MEI4
prerank,calcium-ion regulated exocytosis (GO:0017156),0.17907304655256967,0.45193259898305,0.991701244813278,1.0,1.0,9/27,24.41%,SYT6;VAMP7;SYT11;SYT12;SYT3;VAMP2;SYT2;ARL8B;SYT13
prerank,positive regulation of lipid transport (GO:0032370),-0.17996359299479,-0.44793048554091386,0.9922077922077922,0.9986653082775996,1.0,12/12,82.02%,ABCA3;LRP1;ABCA12;CYP19A1;APOE;PRELID1;PRAP1;ADIPOQ;DBI;SPP1;ABCB4;TRIAP1
prerank,cellular response to hydroxyurea (GO:0072711),0.2130212205628383,0.4475813931367587,0.9899497487437185,1.0,1.0,3/10,23.81%,ATRX;DDI2;RTF2
prerank,defense response to fungus (GO:0050832),0.18906191133994746,0.44616509968175,0.9894736842105263,1.0,1.0,17/17,81.11%,GAPDH;RNASE7;FAM3A;BCL10;DEFB119;NLRP10;CLEC4E;LTF;CLEC6A;S100A8;CLEC4D;CARD9;S100A9;HRG;PLCG2;CX3CR1;RARRES2
prerank,nucleocytoplasmic transport (GO:0006913),0.1713531772047321,0.44565732822516513,0.9961439588688946,1.0,1.0,13/40,27.57%,SNRPB;NXT2;GEMIN6;RITA1;AAAS;SNUPN;DDX20;GEMIN5;GEMIN8;GEMIN2;RBM15B;SNRPD2;SNRPD1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.20277801697112885,0.44514704657285586,0.9834983498349835,1.0,1.0,5/13,26.19%,OGDH;DLST;IDH1;GPT2;IDH2
prerank,mitotic DNA replication (GO:1902969),0.21661818460116405,0.4410227262356534,0.9911816578483245,1.0,1.0,4/10,26.94%,MCM6;GINS3;MCM4;MCM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.21023500830364245,0.4386665541045665,0.9838969404186796,1.0,1.0,2/11,15.85%,GSTO1;GSTM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.21023500830364245,0.4386665541045665,0.9838969404186796,1.0,1.0,2/11,15.85%,GSTO1;GSTM2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2015321406646207,0.43680502762834345,0.9850498338870431,1.0,1.0,4/12,25.48%,MAD1L1;RMDN1;MIS12;SEH1L
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.17970271934612872,0.43411283366113135,0.9928774928774928,1.0,1.0,8/23,28.46%,TECPR2;NPLOC4;PREB;SEC16A;TMEM129;HSP90B1;LMAN1;DERL2
prerank,coenzyme A metabolic process (GO:0015936),0.20078427052021353,0.4338477009455962,0.9889064976228209,1.0,1.0,4/14,25.08%,DCAKD;PPCDC;ACLY;PANK1
prerank,regulation of dopamine secretion (GO:0014059),0.1743986342769189,0.4311892772310817,1.0,1.0,1.0,8/25,26.12%,GDNF;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA
prerank,positive regulation of mRNA processing (GO:0050685),0.18213792237156157,0.43072440613953505,0.9926362297496318,1.0,1.0,21/21,81.81%,DAZAP1;LEO1;CELF4;RBM3;RBMXL1;TRA2B;NCL;CDC73;NUP98;RBMX;PRDX6;SNW1;TRA2A;CIRBP;THRAP3;CELF3;NCBP2;DHX36;SF3B4;NCBP1;PAF1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.18469552350036636,0.4274695910209893,0.9911111111111112,1.0,1.0,6/20,22.77%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.18469552350036636,0.4274695910209893,0.9911111111111112,1.0,1.0,6/20,22.77%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.18469552350036636,0.4274695910209893,0.9911111111111112,1.0,1.0,6/20,22.77%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,regulation of catecholamine secretion (GO:0050433),0.16758535453541268,0.4246110516418077,0.9971711456859972,1.0,1.0,10/29,26.68%,KCNB1;GRK2;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA;CHGA
prerank,establishment of skin barrier (GO:0061436),0.19252889810785068,0.42420291991345477,0.9888178913738019,1.0,1.0,1/15,7.34%,LSR
prerank,regulation of water loss via skin (GO:0033561),0.19252889810785068,0.42420291991345477,0.9888178913738019,1.0,1.0,1/15,7.34%,LSR
prerank,T cell activation involved in immune response (GO:0002286),0.19767975661562548,0.42342595248951925,0.9906687402799378,1.0,1.0,2/12,17.04%,FCER1G;EIF2AK4
prerank,regulation of chromosome segregation (GO:0051983),0.18622464996546717,0.41923366725947453,0.9889064976228209,1.0,1.0,16/16,81.40%,SMC6;NUMA1;IHO1;CDC6;PUM2;PUM1;MKI67;HORMAD1;AURKB;KIF2C;BUB1;CSNK2A2;CSNK2A1;RMI2;RAD18;SMC5
prerank,positive regulation of DNA recombination (GO:0045911),0.1695349883138762,0.41732705278753235,0.9986522911051213,1.0,1.0,2/27,9.56%,SHLD2;RIF1
prerank,mitochondrion disassembly (GO:0061726),0.16289183408923255,0.41597712450051993,0.9986320109439124,1.0,1.0,14/34,30.20%,ULK1;MAP1LC3B;RB1CC1;CTSK;GABARAPL2;ATG3;WIPI2;ATG2B;CISD2;FBXO7;ATG12;WDR45;WIPI1;PRKN
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.16979649823936555,-0.4153789952204903,1.0,0.999685135810976,1.0,2/11,17.32%,TASOR;SETDB2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.17725752735985023,0.41295225291164833,0.9909638554216867,1.0,1.0,8/18,33.22%,AQP1;PCK2;ZFP36L1;UBE2L3;FAM107A;REST;HNRNPU;ANXA1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.18110274830251968,0.41179590835075663,0.99185667752443,0.9997206985912573,1.0,5/16,26.68%,GSK3A;NECAB2;GPER1;PRKCA;CHGA
prerank,meiosis I (GO:0007127),-0.13260465788288017,-0.4101756494045249,0.9968051118210862,0.9989583084914074,1.0,11/23,40.38%,ING2;BCL2L11;ZSCAN21;HSF2BP;SYCP3;SGO1;TDRD9;DDX4;MEIOB;ZCWPW1;SLC25A31
prerank,regulation of T cell mediated immunity (GO:0002709),0.19873230868214048,0.41003491532131076,0.9900497512437811,0.9994895013125248,1.0,2/10,20.35%,TRPM4;AGER
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.14167828939714308,0.40783552108484844,1.0,0.9992758403740447,1.0,23/87,27.20%,RPS4X;RPL31;RPSA;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17;RPS3
prerank,cellular response to oxygen levels (GO:0071453),0.19667105805142704,0.40513234325149183,1.0,0.9991062873034681,1.0,6/10,33.24%,ATP6V0D1;ATP6AP1;TMEM199;ATP6V0A2;CPEB4;NDUFS2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.17258915118031137,0.38793478906386825,0.995334370139969,0.9993591399119124,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.17258915118031137,0.38793478906386825,0.995334370139969,0.9993591399119124,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.16916993132348823,0.3823041254539762,1.0,0.9992421297954862,1.0,6/17,28.46%,NPLOC4;HM13;RHBDD1;TMEM129;HSP90B1;DERL2
prerank,B cell mediated immunity (GO:0019724),0.17931159168034683,0.3666550379376331,0.9983766233766234,0.9994526764340808,1.0,1/10,11.65%,FCER1G
prerank,regulation of RNA export from nucleus (GO:0046831),0.16392910629151866,0.350621601760995,1.0,0.9994824354288432,1.0,3/11,23.08%,DHX9;TPR;NRDE2
